data_2l38_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l38 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 159.0 12.26 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.935 0.894 . . . . 0.0 110.429 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.2 -9.13 56.07 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.261 0.934 . . . . 0.0 112.881 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -163.34 143.3 8.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.068 2.147 . . . . 0.0 110.375 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -143.75 160.78 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 125.377 1.471 . . . . 0.0 109.679 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.02 -173.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 127.603 2.361 . . . . 0.0 112.008 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.28 -19.82 9.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -17.03 48.6 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.384 1.469 . . . . 0.0 112.435 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.69 67.87 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.617 1.167 . . . . 0.0 112.765 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -106.19 -2.8 22.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.261 1.824 . . . . 0.0 114.15 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.6 tp -67.11 138.65 57.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.954 1.302 . . . . 0.0 109.204 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.6 141.28 20.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.97 0.508 . . . . 0.0 110.984 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.59 -33.68 70.25 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.67 -47.45 76.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.143 1.377 . . . . 0.0 113.978 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.32 -54.28 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.653 1.181 . . . . 0.0 108.729 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.1 -33.77 27.63 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.04 1.736 . . . . 0.0 113.094 -175.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.44 -59.35 5.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.493 1.917 . . . . 0.0 110.88 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -35.76 81.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.921 1.689 . . . . 0.0 111.992 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.36 -45.8 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.129 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.42 -32.3 73.87 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 -19.78 60.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.581 1.152 . . . . 0.0 113.823 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -58.61 -32.51 69.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.859 -1.151 . . . . 0.0 111.645 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.301 1.441 . . . . 0.0 113.037 175.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.453 HD13 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.0 149.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.483 1.113 . . . . 0.0 111.468 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' H ' ' HG2' ' A' ' 168' ' ' LYS . . . -125.79 110.12 13.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.144 1.378 . . . . 0.0 111.924 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.83 118.55 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.001 1.32 . . . . 0.0 109.78 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 168.98 40.82 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.222 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.31 130.72 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.0 109.576 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.4 105.02 8.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.283 1.033 . . . . 0.0 111.761 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -73.22 85.56 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.671 2.388 . . . . 0.0 111.955 175.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -137.53 46.08 2.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.823 -1.173 . . . . 0.0 111.38 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -2.45 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 175.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.71 24.28 62.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.365 0.983 . . . . 0.0 114.8 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.75 114.64 1.06 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.582 1.563 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -53.42 127.59 25.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.945 1.298 . . . . 0.0 111.289 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 37' ' ' ASN . 53.7 m0 -91.38 157.37 17.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -137.9 109.56 7.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.951 1.701 . . . . 0.0 111.094 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 143.22 50.88 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.314 -0.866 . . . . 0.0 110.234 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -47.35 3.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.343 1.457 . . . . 0.0 113.066 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -156.63 171.49 20.25 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.633 1.573 . . . . 0.0 111.199 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.59 121.82 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 111.869 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -100.9 129.25 46.73 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 110.017 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -153.36 160.43 42.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.911 1.285 . . . . 0.0 112.018 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -116.43 -8.1 11.62 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.497 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 p -53.62 157.77 2.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.582 1.953 . . . . 0.0 112.79 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -35.16 -66.44 0.35 Allowed Glycine 0 N--CA 1.469 0.893 0 C-N-CA 127.96 2.695 . . . . 0.0 115.945 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -165.44 178.46 6.78 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.778 1.631 . . . . 0.0 111.492 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.9 171.39 8.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 111.648 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -154.67 -28.21 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.832 -1.168 . . . . 0.0 113.294 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.9 158.24 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.261 1.824 . . . . 0.0 110.832 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 tt -73.24 132.82 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.462 1.105 . . . . 0.0 111.654 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.01 122.26 82.95 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.377 1.071 . . . . 0.0 110.19 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.77 114.87 2.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.359 3.373 . . . . 0.0 112.689 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.17 -55.16 17.71 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.58 153.64 30.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.456 1.102 . . . . 0.0 110.68 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.38 121.22 16.32 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.694 0.798 . . . . 0.0 111.592 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.94 162.06 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.716 2.277 . . . . 0.0 112.05 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -62.1 156.88 20.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.449 0.7 . . . . 0.0 112.172 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.2 p 41.78 49.44 3.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.37 1.868 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -141.24 -171.42 3.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.997 1.719 . . . . 0.0 111.361 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.14 -177.02 5.69 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.832 -1.167 . . . . 0.0 110.298 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.09 142.52 16.09 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.133 -0.979 . . . . 0.0 112.214 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.53 170.44 8.02 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.889 0.875 . . . . 0.0 110.735 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -152.15 165.71 33.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.473 1.509 . . . . 0.0 107.882 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.1 m -145.07 169.14 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.677 1.191 . . . . 0.0 109.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -157.54 7.19 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.314 0.483 . . . . 0.0 112.072 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 125.59 1.556 . . . . 0.0 110.627 175.025 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 t -147.58 121.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.48 -1.387 . . . . 0.0 113.485 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HB1' ' CE2' ' A' ' 102' ' ' PHE . . . -148.08 164.72 32.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.46 1.104 . . . . 0.0 111.212 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.18 110.2 4.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.647 1.179 . . . . 0.0 108.369 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.05 152.92 48.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.255 1.022 . . . . 0.0 112.069 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.78 148.96 39.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.435 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -122.83 124.24 42.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.961 1.304 . . . . 0.0 110.105 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.56 109.26 2.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 110.178 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.11 153.21 38.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.013 1.325 . . . . 0.0 111.17 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -63.87 -22.03 66.73 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.21 1.8 20.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.299 1.04 . . . . 0.0 113.781 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.76 19.52 70.45 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.663 1.125 . . . . 0.0 113.864 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -102.59 171.21 7.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 109.221 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.1 m -133.55 103.51 5.95 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.539 -1.351 . . . . 0.0 112.109 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 tp -69.75 126.65 30.36 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.297 -0.877 . . . . 0.0 110.345 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.23 107.47 3.06 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.18 165.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 117.632 0.716 . . . . 0.0 110.333 175.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -151.41 140.75 21.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.232 177.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.453 ' CE1' HD13 ' A' ' 31' ' ' ILE . 27.6 p90 -153.34 160.04 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.662 0.744 . . . . 0.0 110.313 175.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -162.14 167.43 24.2 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.732 1.613 . . . . 0.0 109.19 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.42 106.64 57.08 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 123.011 2.474 . . . . 0.0 113.234 179.77 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 111.38 0.141 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -73.1 148.5 43.91 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.43 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.9 p-90 -148.04 169.43 19.96 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.519 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.9 t70 179.62 163.57 0.99 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 128.048 2.539 . . . . 0.0 110.379 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.6 p -165.6 136.65 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.079 2.152 . . . . 0.0 109.252 174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -152.42 156.6 39.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.87 1.268 . . . . 0.0 110.483 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.79 106.16 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.658 1.583 . . . . 0.0 107.767 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -74.69 98.74 3.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.273 1.029 . . . . 0.0 109.338 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.4 t -59.07 137.49 57.93 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.738 -1.226 . . . . 0.0 110.828 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.2 -117.42 5.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.496 1.522 . . . . 0.0 110.124 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 128.16 12.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.503 1.121 . . . . 0.0 111.253 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.37 114.72 10.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.068 1.347 . . . . 0.0 111.221 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.05 164.71 23.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 110.283 174.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.95 109.0 15.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.903 -0.498 . . . . 0.0 109.822 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.38 -173.28 4.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.202 1.401 . . . . 0.0 110.019 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.63 -43.29 56.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.002 0.921 . . . . 0.0 111.202 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -33.32 38.93 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.556 1.074 . . . . 0.0 114.329 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.1 ttt -70.51 -60.15 2.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.829 0.815 . . . . 0.0 110.452 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -56.94 -31.18 64.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.16 0.984 . . . . 0.0 113.632 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.33 -39.15 93.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 110.148 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -26.58 67.48 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.547 -1.346 . . . . 0.0 111.872 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mt -78.39 -43.41 27.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.236 1.414 . . . . 0.0 112.028 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.08 -28.32 16.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.62 -40.42 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.802 1.641 . . . . 0.0 111.707 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.63 -58.25 8.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.749 1.642 . . . . 0.0 111.572 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -178.75 88.29 0.22 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 127.225 2.21 . . . . 0.0 111.637 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.73 141.02 40.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.303 2.002 . . . . 0.0 111.234 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -112.83 173.75 6.23 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.37 1.468 . . . . 0.0 111.575 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.98 134.08 46.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.52 1.528 . . . . 0.0 110.718 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.22 106.85 0.7 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.436 1.017 . . . . 0.0 112.362 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -121.5 71.97 0.99 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.133 1.373 . . . . 0.0 111.117 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 59.61 101.09 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.692 2.797 . . . . 0.0 115.868 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.2 161.88 9.65 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.454 1.026 . . . . 0.0 114.593 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.5 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 m95 -78.55 150.65 32.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.725 1.21 . . . . 0.0 110.629 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -152.04 133.13 14.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.862 1.665 . . . . 0.0 110.718 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.8 146.13 49.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.31 1.444 . . . . 0.0 112.387 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -150.46 157.55 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.88 0.848 . . . . 0.0 112.123 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -80.53 92.98 5.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.486 1.514 . . . . 0.0 108.088 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 tp -52.51 -39.83 61.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.23 30.26 2.75 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.28 -22.61 1.97 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.448 1.624 . . . . 0.0 115.175 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.74 -21.56 1.82 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.265 1.412 . . . . 0.0 114.035 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 pp -124.1 173.52 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.731 1.612 . . . . 0.0 112.538 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -116.3 158.66 23.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.02 1.328 . . . . 0.0 111.336 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.31 155.03 47.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.584 0.354 . . . . 0.0 110.926 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.44 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.5 tppt? -126.16 127.47 45.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.545 1.938 . . . . 0.0 109.727 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.72 137.63 14.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 126.105 1.812 . . . . 0.0 112.812 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.5 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -117.13 146.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.496 1.118 . . . . 0.0 111.063 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.25 145.78 51.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.959 0.904 . . . . 0.0 109.352 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.0 p -144.03 126.62 15.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.171 1.388 . . . . 0.0 110.949 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m -89.07 178.52 6.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.002 2.121 . . . . 0.0 112.059 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.39 -178.7 0.18 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.95 2.5 . . . . 0.0 112.534 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 161.87 51.43 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.259 -0.901 . . . . 0.0 111.72 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 55.64 29.49 13.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.519 1.127 . . . . 0.0 112.792 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -126.53 144.56 50.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.115 1.766 . . . . 0.0 112.819 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.459 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 24.6 tptp -162.64 149.46 13.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.54 137.78 37.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.2 2.2 . . . . 0.0 112.682 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -135.6 157.33 47.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.876 1.67 . . . . 0.0 110.59 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.3 mm -129.32 124.52 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.36 1.064 . . . . 0.0 110.769 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 131.99 54.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.425 1.49 . . . . 0.0 111.65 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.423 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 11.3 pt -118.23 134.26 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.813 1.645 . . . . 0.0 110.455 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.6 p -163.47 177.17 9.08 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.515 1.526 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.782 1.233 . . . . 0.0 111.919 -176.21 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.83 173.25 4.55 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.522 0.677 . . . . 0.0 110.388 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.63 -36.32 3.83 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.1 p -137.02 161.13 36.9 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.624 -1.515 . . . . 0.0 111.48 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.1 mm -137.8 163.41 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.904 1.281 . . . . 0.0 110.416 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 pt -67.62 -170.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.893 2.077 . . . . 0.0 110.458 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.43 -28.15 4.9 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 119.722 -1.861 . . . . 0.0 115.932 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.2 69.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.465 1.031 . . . . 0.0 113.803 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.19 -42.06 39.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.524 1.13 . . . . 0.0 111.29 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -8.3 59.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.227 1.411 . . . . 0.0 114.106 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.83 143.79 50.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 0.0 110.305 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.25 150.74 31.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.527 1.131 . . . . 0.0 109.906 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -55.19 -26.68 40.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -62.05 -58.16 8.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.617 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.18 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.077 0.551 . . . . 0.0 109.73 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -23.66 66.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.407 1.083 . . . . 0.0 113.456 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.24 -51.51 13.14 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.363 -1.461 . . . . 0.0 110.374 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -40.52 96.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 112.908 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.164 0.986 . . . . 0.0 112.857 -174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.9 -31.86 57.02 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 110.891 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.43 -37.26 74.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.933 0.893 . . . . 0.0 111.921 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -19.89 47.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.028 1.331 . . . . 0.0 114.517 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 127.206 2.202 . . . . 0.0 113.336 175.062 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.947 0.404 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.19 142.02 43.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 125.196 1.398 . . . . 0.0 111.946 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.32 18.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.965 1.706 . . . . 0.0 109.684 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.75 128.76 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.873 1.269 . . . . 0.0 109.088 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.12 -179.53 40.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.523 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 3.4 mp -130.41 146.02 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.795 0.838 . . . . 0.0 111.543 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -96.7 109.41 22.06 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.296 -0.877 . . . . 0.0 111.63 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 91.61 6.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.078 0.951 . . . . 0.0 111.244 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.1 56.74 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.25 1.42 . . . . 0.0 109.697 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t -119.77 -45.63 2.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.194 1.397 . . . . 0.0 113.346 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 13.91 2.18 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.657 1.122 . . . . 0.0 115.878 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.33 146.57 17.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.093 1.33 . . . . 0.0 112.552 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 m -73.92 145.03 45.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.718 1.607 . . . . 0.0 110.589 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -112.52 166.49 11.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.666 -0.647 . . . . 0.0 112.573 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.9 m -143.62 109.43 5.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.19 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.24 151.31 46.44 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.818 -1.176 . . . . 0.0 111.232 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.429 ' H ' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -106.91 -55.1 2.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.7 1.6 . . . . 0.0 111.6 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -160.9 -172.95 3.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.904 1.682 . . . . 0.0 110.829 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.02 137.76 29.5 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.103 1.361 . . . . 0.0 111.325 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.01 127.74 52.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.515 1.526 . . . . 0.0 110.151 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.35 162.79 30.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 112.584 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -124.0 -43.98 2.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.673 1.589 . . . . 0.0 112.27 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.8 p -129.61 113.28 14.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.891 1.276 . . . . 0.0 112.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 114.9 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.332 1.444 . . . . 0.0 111.485 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.09 178.72 3.65 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.875 0.845 . . . . 0.0 112.001 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.02 162.78 1.75 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.576 1.95 . . . . 0.0 112.294 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.38 -32.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.104 -0.998 . . . . 0.0 112.22 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.08 169.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.986 2.114 . . . . 0.0 111.905 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -70.27 127.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.872 1.269 . . . . 0.0 112.801 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.74 129.78 60.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.62 146.53 79.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.501 2.8 . . . . 0.0 111.244 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.89 -53.08 3.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 112.417 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -122.08 143.94 49.22 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 110.44 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.9 t -136.27 130.14 18.11 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.644 1.177 . . . . 0.0 110.563 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.02 163.15 25.85 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.88 3.054 . . . . 0.0 112.562 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -70.07 14.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -140.24 15.68 2.42 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.09 1.756 . . . . 0.0 114.268 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.88 155.1 47.37 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.524 1.13 . . . . 0.0 112.522 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.23 -177.01 3.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.609 1.195 . . . . 0.0 112.159 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.77 154.22 34.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 175.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.7 mt -138.11 167.22 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.283 1.433 . . . . 0.0 109.495 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -141.71 165.83 26.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.532 1.533 . . . . 0.0 109.966 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -145.99 169.1 19.32 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.35 1.06 . . . . 0.0 110.887 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.32 177.44 27.51 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.472 1.034 . . . . 0.0 111.109 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.574 1.15 . . . . 0.0 112.904 -176.62 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.06 113.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.773 2.029 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.31 176.6 10.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 111.542 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.48 118.66 5.13 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -126.04 160.71 29.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.053 0.941 . . . . 0.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.87 169.32 9.97 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.582 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.51 121.32 14.44 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.559 1.144 . . . . 0.0 110.943 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.17 111.08 2.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.224 1.01 . . . . 0.0 109.223 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -72.2 153.87 41.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 111.034 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -58.01 -28.37 64.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -80.67 3.75 21.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.789 1.236 . . . . 0.0 114.306 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.28 -0.92 87.47 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.344 1.45 . . . . 0.0 114.516 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -78.58 178.65 7.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.61 1.564 . . . . 0.0 110.878 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 m -140.57 110.76 6.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.832 -1.168 . . . . 0.0 112.651 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -75.63 122.59 24.18 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.09 4.35 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 118.856 0.753 . . . . 0.0 112.471 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.41 160.99 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.294 1.047 . . . . 0.0 112.071 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.35 167.11 23.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.427 -0.796 . . . . 0.0 112.638 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -169.48 158.6 8.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.026 1.331 . . . . 0.0 112.098 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 132.51 3.73 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.126 1.77 . . . . 0.0 108.381 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.93 138.15 26.31 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 119.096 0.862 . . . . 0.0 109.087 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.543 0.958 0 C-N-CA 122.765 2.31 . . . . 0.0 111.741 174.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 120.91 0.386 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -82.52 150.12 27.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.49 1.116 . . . . 0.0 112.161 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -161.44 149.01 14.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.799 1.64 . . . . 0.0 108.715 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -167.97 117.5 0.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.132 0.973 . . . . 0.0 110.871 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.12 135.2 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 123.007 0.523 . . . . 0.0 110.706 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -148.73 142.8 25.93 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.067 175.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.3 115.82 30.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -86.04 109.66 18.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.0 t -66.82 93.35 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.527 -1.358 . . . . 0.0 111.52 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.05 148.22 6.39 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 128.048 2.737 . . . . 0.0 111.796 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -48.13 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.68 2.392 . . . . 0.0 114.305 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -111.92 103.06 11.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.187 1.395 . . . . 0.0 112.978 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 162.49 14.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.419 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.08 114.44 18.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.39 -174.15 4.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.475 1.11 . . . . 0.0 111.676 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -51.12 -49.01 61.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.031 -1.043 . . . . 0.0 111.781 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -36.18 45.06 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.197 0.904 . . . . 0.0 113.673 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.4 ttt -67.49 -62.43 1.42 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.792 0.837 . . . . 0.0 110.045 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -55.03 -34.13 63.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -64.32 -39.27 93.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.464 1.506 . . . . 0.0 110.623 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -25.14 68.16 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.873 -1.142 . . . . 0.0 111.772 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mt -84.43 -44.15 13.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.661 1.184 . . . . 0.0 112.551 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.97 -29.1 25.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.905 1.282 . . . . 0.0 114.359 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.99 -34.04 3.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.479 1.512 . . . . 0.0 113.714 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.31 61.22 3.13 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.504 2.002 . . . . 0.0 114.516 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.86 67.25 1.13 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 127.401 2.281 . . . . 0.0 110.817 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.82 149.01 92.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.236 2.624 . . . . 0.0 112.268 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -114.9 178.68 4.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.412 1.085 . . . . 0.0 111.843 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -128.08 135.61 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.002 1.321 . . . . 0.0 111.768 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.06 97.42 2.0 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.437 1.018 . . . . 0.0 113.055 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -65.48 -79.97 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.226 1.01 . . . . 0.0 111.665 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.7 p30 177.75 -16.82 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.913 2.085 . . . . 0.0 115.606 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.23 163.12 20.97 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 119.939 1.245 . . . . 0.0 113.452 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.435 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 79.9 m95 -72.34 147.5 46.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.27 0.628 . . . . 0.0 110.682 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -151.75 123.31 7.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.283 1.433 . . . . 0.0 111.626 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.36 143.7 41.74 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.469 1.508 . . . . 0.0 113.599 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.71 149.76 26.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.353 1.461 . . . . 0.0 112.655 174.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.7 97.88 9.39 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.483 1.513 . . . . 0.0 108.379 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -52.96 -52.46 58.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.924 1.689 . . . . 0.0 111.425 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.04 57.14 0.01 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.392 0.996 . . . . 0.0 115.499 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.22 -27.07 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 131.69 -9.78 5.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.903 1.239 . . . . 0.0 114.671 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.01 170.08 13.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.811 1.305 . . . . 0.0 112.547 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 ttp-105 -133.58 130.24 38.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.452 1.901 . . . . 0.0 110.265 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.59 139.82 46.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.663 0.385 . . . . 0.0 110.852 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.4 128.3 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.578 1.551 . . . . 0.0 109.128 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.7 153.88 16.76 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 123.83 0.729 . . . . 0.0 112.824 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.435 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -137.15 141.14 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.548 1.939 . . . . 0.0 108.199 175.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 115.4 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.045 1.738 . . . . 0.0 107.754 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 p -109.0 170.44 8.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.7 p -70.76 167.71 18.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.428 1.091 . . . . 0.0 112.335 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.81 147.62 27.69 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.213 -0.93 . . . . 0.0 112.876 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.01 80.98 0.44 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.967 1.27 . . . . 0.0 113.698 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 50.22 39.02 18.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.848 1.659 . . . . 0.0 113.707 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -138.35 170.05 16.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.247 1.419 . . . . 0.0 111.436 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.444 ' CG ' ' H ' ' A' ' 169' ' ' MET . 5.2 tptt -156.01 -172.45 4.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.67 0.748 . . . . 0.0 111.609 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.444 ' H ' ' CG ' ' A' ' 168' ' ' LYS . 1.0 OUTLIER -118.25 157.43 27.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.187 2.195 . . . . 0.0 109.846 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -164.41 150.35 10.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.01 1.324 . . . . 0.0 110.034 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 24.8 mm -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.59 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -126.99 136.76 52.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.228 1.377 . . . . 0.0 112.375 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.0 pt -96.52 133.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -142.33 164.59 29.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.638 0.775 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.353 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.07 -179.67 1.29 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.89 0.876 . . . . 0.0 110.641 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.8 -38.65 3.07 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.572 -1.33 . . . . 0.0 111.702 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.7 p -137.06 160.01 40.22 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.674 -1.486 . . . . 0.0 111.793 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.9 mm -136.44 163.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.164 1.385 . . . . 0.0 110.082 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -70.65 -169.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.979 2.112 . . . . 0.0 110.423 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.63 -23.26 4.09 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.94 73.81 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.836 0.732 . . . . 0.0 113.784 -174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.06 40.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.695 1.198 . . . . 0.0 111.547 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -6.24 57.57 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.196 1.398 . . . . 0.0 113.714 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.94 142.75 45.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.104 1.761 . . . . 0.0 111.02 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -146.13 145.79 30.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.639 1.176 . . . . 0.0 109.713 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -55.74 -29.47 59.59 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -60.01 -55.71 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.682 1.193 . . . . 0.0 112.269 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.76 -44.35 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 122.006 -0.433 . . . . 0.0 109.845 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -32.08 69.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.229 1.012 . . . . 0.0 113.207 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.81 -55.16 14.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.159 0.983 . . . . 0.0 110.373 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -35.02 74.6 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.718 -0.614 . . . . 0.0 112.034 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -45.26 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.115 0.871 . . . . 0.0 112.645 -176.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -24.9 53.63 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.611 0.641 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.41 -26.76 62.89 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.96 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -48.54 -25.27 1.63 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 120.925 1.693 . . . . 0.0 114.483 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.417 ' HB2' HH22 ' A' ' 74' ' ' ARG . 48.0 mt . . . . . 0 CA--C 1.551 1.013 0 C-N-CA 126.674 1.989 . . . . 0.0 115.799 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.469 ' CD1' ' HE2' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -136.89 123.27 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.266 1.427 . . . . 0.0 112.019 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.81 91.09 3.51 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.211 2.204 . . . . 0.0 110.943 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.72 126.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.579 -1.326 . . . . 0.0 110.675 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.69 167.2 37.72 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-O 121.776 0.654 . . . . 0.0 114.701 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -144.29 121.68 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -76.95 105.11 7.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.037 -1.039 . . . . 0.0 111.324 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.53 93.07 4.74 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.161 -0.962 . . . . 0.0 112.013 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -142.92 39.29 1.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.323 1.058 . . . . 0.0 111.82 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.74 -0.26 54.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.047 1.739 . . . . 0.0 114.815 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.6 14.24 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.268 0.937 . . . . 0.0 114.578 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.02 135.84 7.77 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.673 1.606 . . . . 0.0 112.463 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -67.18 134.07 51.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.48 1.112 . . . . 0.0 109.262 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -95.34 163.86 13.07 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -146.27 113.93 6.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.447 1.499 . . . . 0.0 111.035 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.36 135.77 42.48 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 -50.32 3.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.379 1.071 . . . . 0.0 111.83 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -156.35 171.93 19.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.207 1.003 . . . . 0.0 111.964 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.58 132.49 31.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.984 1.714 . . . . 0.0 111.469 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -116.62 122.64 45.19 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.553 1.541 . . . . 0.0 110.183 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 152.55 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.809 2.444 . . . . 0.0 110.44 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.91 -53.25 2.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.164 0.986 . . . . 0.0 110.25 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.488 ' HB3' ' H ' ' A' ' 85' ' ' VAL . 2.3 t -71.21 127.0 31.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.406 1.882 . . . . 0.0 109.581 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.31 -133.26 8.51 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.175 0.893 . . . . 0.0 112.736 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.06 -156.47 0.61 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.14 1.776 . . . . 0.0 109.585 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.88 166.83 1.34 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.373 3.069 . . . . 0.0 111.928 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.63 -29.42 0.11 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.17 173.01 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.244 2.218 . . . . 0.0 112.049 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.97 128.2 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.603 1.161 . . . . 0.0 111.677 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 tp -85.09 132.29 46.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.33 122.3 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.901 3.067 . . . . 0.0 110.8 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.86 -59.39 3.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.798 0.839 . . . . 0.0 112.555 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -125.52 145.5 50.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.52 1.528 . . . . 0.0 110.169 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.47 131.36 16.17 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.577 1.151 . . . . 0.0 108.936 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.42 163.97 24.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.782 2.988 . . . . 0.0 112.531 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.28 18.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -141.98 17.06 2.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.597 1.559 . . . . 0.0 114.173 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.438 1.472 . . . . 0.0 112.679 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.58 -176.6 5.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 122.425 1.107 . . . . 0.0 112.521 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.21 152.68 31.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.049 0.939 . . . . 0.0 111.592 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 mt -134.66 162.42 32.37 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.884 1.274 . . . . 0.0 111.111 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.28 163.91 31.49 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.066 1.346 . . . . 0.0 109.632 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 m -144.92 165.28 28.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.279 1.431 . . . . 0.0 110.164 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.68 162.88 33.79 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.41 1.481 . . . . 0.0 109.553 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.417 HH22 ' HB2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 125.984 1.714 . . . . 0.0 111.031 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.395 0.617 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' H ' ' HB3' ' A' ' 52' ' ' SER . 3.6 t -127.45 110.24 22.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 109.757 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.99 176.9 8.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 109.972 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.02 137.59 15.13 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.943 1.697 . . . . 0.0 106.498 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -143.12 162.03 36.63 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.268 0.627 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.71 136.79 52.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.755 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.68 121.86 45.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 110.939 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -70.27 123.47 21.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.912 1.285 . . . . 0.0 110.211 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptm -97.1 155.09 16.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.552 0.615 . . . . 0.0 111.394 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.4 m -56.14 -22.47 28.69 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -2.03 20.87 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.767 1.227 . . . . 0.0 113.384 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.14 84.46 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.655 1.597 . . . . 0.0 114.638 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -100.45 171.38 7.78 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.443 1.097 . . . . 0.0 110.46 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.1 m -135.03 99.89 4.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.744 1.218 . . . . 0.0 111.621 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.59 113.75 7.16 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.414 -0.804 . . . . 0.0 111.42 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.6 107.84 3.54 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.264 1.411 . . . . 0.0 109.717 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -84.2 146.11 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 117.493 0.646 . . . . 0.0 111.045 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -125.23 142.47 51.48 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.925 1.29 . . . . 0.0 110.568 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -151.27 158.92 44.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.107 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -158.06 175.24 14.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.47 100.05 50.92 Favored Pre-proline 0 N--CA 1.467 0.392 0 C-N-CA 126.51 1.924 . . . . 0.0 111.792 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.542 0.897 0 C-N-CA 122.699 2.266 . . . . 0.0 110.063 174.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -77.4 139.0 39.61 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.086 0.954 . . . . 0.0 112.98 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -161.83 149.27 14.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.489 1.916 . . . . 0.0 108.844 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -179.87 158.59 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.333 2.253 . . . . 0.0 111.263 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.67 147.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 127.766 2.427 . . . . 0.0 109.055 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -141.67 141.2 33.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.776 0.83 . . . . 0.0 109.635 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.6 mt -103.27 113.31 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.872 0.869 . . . . 0.0 108.693 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -82.42 111.0 18.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 t -65.42 87.51 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.015 -1.053 . . . . 0.0 111.476 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.93 164.58 11.92 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.938 2.685 . . . . 0.0 112.211 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -60.5 123.6 17.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.798 1.239 . . . . 0.0 111.778 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -133.6 104.28 6.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.589 1.555 . . . . 0.0 112.138 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.96 153.64 33.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.763 0.825 . . . . 0.0 110.634 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 117.58 21.33 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.721 0.408 . . . . 0.0 111.132 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.63 -176.8 6.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.082 1.753 . . . . 0.0 112.108 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.3 -47.23 25.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.33 1.452 . . . . 0.0 112.119 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.71 -46.99 80.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.102 0.858 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.4 ttp -60.22 -53.26 59.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.404 0.682 . . . . 0.0 110.684 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -53.35 -38.03 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.378 0.99 . . . . 0.0 113.078 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -43.54 95.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.699 1.2 . . . . 0.0 110.734 175.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.59 -20.63 65.4 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.357 -1.464 . . . . 0.0 113.939 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.52 -11.0 35.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.18 -35.09 3.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.011 1.324 . . . . 0.0 112.248 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -114.5 -25.55 8.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.186 1.395 . . . . 0.0 112.918 -175.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.5 -34.68 90.55 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.737 1.161 . . . . 0.0 113.752 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.09 83.44 5.6 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 126.018 1.727 . . . . 0.0 110.28 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.5 120.23 7.33 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.548 1.499 . . . . 0.0 112.325 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.76 165.02 22.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.811 1.244 . . . . 0.0 113.892 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -134.22 139.06 45.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.437 1.895 . . . . 0.0 111.531 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -127.02 110.43 1.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.907 1.241 . . . . 0.0 112.168 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -124.03 70.14 1.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.459 1.904 . . . . 0.0 113.364 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 50.76 60.3 3.97 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.05 2.14 . . . . 0.0 114.023 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -175.83 139.78 4.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.614 0.626 . . . . 0.0 113.92 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -63.43 135.46 56.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.031 1.332 . . . . 0.0 111.69 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -150.09 130.69 13.98 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.634 1.173 . . . . 0.0 111.672 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.66 158.5 25.39 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.118 1.767 . . . . 0.0 111.566 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 161.57 39.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.0 1.32 . . . . 0.0 110.677 175.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.17 93.92 4.01 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.902 0.881 . . . . 0.0 108.799 174.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 tp -47.43 -32.36 4.99 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.98 1.312 . . . . 0.0 113.984 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.54 32.26 2.36 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 117.396 1.718 . . . . 0.0 117.396 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.06 -28.69 1.16 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 148.77 -24.29 1.32 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.749 1.166 . . . . 0.0 114.504 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.46 175.5 5.43 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.634 1.973 . . . . 0.0 111.626 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -126.89 165.31 19.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.009 . . . . 0.0 112.222 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.94 156.91 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.428 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.86 129.22 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.713 1.605 . . . . 0.0 108.584 -177.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.11 144.56 18.48 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.407 0.527 . . . . 0.0 113.27 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.2 147.71 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.273 1.429 . . . . 0.0 109.762 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.46 117.38 11.08 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.6 1.16 . . . . 0.0 109.3 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.9 p -122.18 147.75 45.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.641 1.176 . . . . 0.0 110.055 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -131.49 -178.31 4.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.586 1.954 . . . . 0.0 110.649 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 73.69 95.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.379 2.271 . . . . 0.0 113.302 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.42 -106.51 3.06 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.87 1.7 . . . . 0.0 114.355 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -115.78 17.72 15.99 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.631 2.373 . . . . 0.0 113.569 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.06 163.08 25.53 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.601 2.361 . . . . 0.0 115.021 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.469 ' HE2' ' CD1' ' A' ' 31' ' ' ILE . 8.1 tptp -163.11 155.28 18.18 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.873 1.269 . . . . 0.0 114.34 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 136.39 33.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.118 2.567 . . . . 0.0 112.512 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -141.08 154.51 45.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.026 1.73 . . . . 0.0 110.221 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.01 120.55 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.529 1.132 . . . . 0.0 111.045 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -98.84 114.04 26.44 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.316 1.046 . . . . 0.0 109.482 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.12 134.18 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.801 0.44 . . . . 0.0 109.828 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 92.8 p -156.37 167.35 30.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.408 1.483 . . . . 0.0 112.458 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.92 6.55 36.41 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.123 1.769 . . . . 0.0 113.128 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.99 -16.21 39.35 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.178 1.37 . . . . 0.0 115.502 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 p -146.04 162.97 36.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.158 1.479 . . . . 0.0 110.28 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' H ' ' A' ' 7' ' ' ILE . 26.5 mm -134.73 173.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 109.38 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.433 ' H ' ' CG2' ' A' ' 6' ' ' ILE . 5.6 pt -85.4 -171.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 129.036 2.934 . . . . 0.0 110.461 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.96 -15.19 61.92 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.3 65.71 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 124.583 1.087 . . . . 0.0 113.62 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.18 81.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.144 1.378 . . . . 0.0 112.956 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -1.17 53.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 113.822 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.27 140.82 58.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.042 1.337 . . . . 0.0 110.491 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.84 145.75 26.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.116 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.61 -38.17 69.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.753 0.821 . . . . 0.0 113.134 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -56.62 -50.06 73.13 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.098 0.863 . . . . 0.0 112.783 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.81 -48.41 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.903 0.881 . . . . 0.0 110.587 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -56.24 -37.62 69.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 112.081 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -57.57 -55.82 29.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.447 1.899 . . . . 0.0 111.566 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -22.87 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.77 -52.3 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.514 1.506 . . . . 0.0 110.886 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.72 -32.06 72.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.611 0.364 . . . . 0.0 111.721 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -85.68 -28.28 24.79 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -52.9 -21.18 3.99 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.761 2.024 . . . . 0.0 112.815 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.9 tp . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.453 1.901 . . . . 0.0 111.802 174.913 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.195 0.521 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.88 148.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.609 1.164 . . . . 0.0 110.73 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.04 100.04 4.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.925 1.69 . . . . 0.0 111.035 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 p -113.94 144.88 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.117 1.367 . . . . 0.0 107.396 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.36 167.27 36.5 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 118.418 0.554 . . . . 0.0 114.425 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.21 145.84 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.703 1.201 . . . . 0.0 110.872 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -107.68 104.25 13.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 111.472 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -89.12 116.95 27.76 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.377 1.471 . . . . 0.0 112.187 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -150.03 14.9 0.82 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.885 0.85 . . . . 0.0 112.182 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -78.55 -45.88 20.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.608 1.563 . . . . 0.0 114.356 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.63 16.82 1.43 Allowed Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.39 133.96 6.74 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.491 1.646 . . . . 0.0 113.006 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.7 m -69.93 122.11 18.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.236 1.414 . . . . 0.0 110.906 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -91.03 161.8 14.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.827 -0.546 . . . . 0.0 111.805 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 m -136.66 109.82 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.059 1.743 . . . . 0.0 111.088 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.9 114.14 4.9 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.914 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.95 -61.4 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.868 1.267 . . . . 0.0 111.385 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -159.9 169.88 22.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.985 1.314 . . . . 0.0 111.966 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.72 135.44 40.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.869 2.068 . . . . 0.0 111.047 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -120.71 130.61 54.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.453 1.501 . . . . 0.0 109.8 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.47 140.42 52.16 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.784 2.034 . . . . 0.0 109.838 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -0.91 14.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.198 1.399 . . . . 0.0 113.842 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -80.23 -155.23 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.068 1.347 . . . . 0.0 109.781 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.78 -76.07 0.25 Allowed Glycine 0 N--CA 1.471 0.986 0 O-C-N 120.579 -1.326 . . . . 0.0 114.267 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -162.38 -178.14 6.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.349 1.46 . . . . 0.0 111.307 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 160.37 20.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.315 1.446 . . . . 0.0 113.69 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -141.81 -29.03 0.62 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.65 159.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.081 1.353 . . . . 0.0 111.787 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.9 tp -79.44 133.88 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.191 0.996 . . . . 0.0 109.583 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.0 tp -84.33 124.4 73.87 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.572 1.149 . . . . 0.0 109.642 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.74 120.09 7.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.706 3.604 . . . . 0.0 112.52 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.3 -55.19 23.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.41 150.62 36.11 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.728 1.211 . . . . 0.0 109.62 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.0 135.1 18.34 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.66 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -67.26 -164.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.702 2.935 . . . . 0.0 112.364 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -114.3 25.63 10.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.649 1.58 . . . . 0.0 113.712 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -149.44 8.36 0.7 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.279 1.431 . . . . 0.0 114.434 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -144.84 113.53 6.74 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.781 1.628 . . . . 0.0 114.459 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.01 174.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.748 1.219 . . . . 0.0 112.675 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.12 154.05 38.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.613 -0.679 . . . . 0.0 112.05 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.82 175.96 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.496 0.718 . . . . 0.0 112.42 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -147.64 161.51 41.0 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.526 1.53 . . . . 0.0 110.525 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.0 p -152.95 165.34 35.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.849 1.26 . . . . 0.0 112.451 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.38 172.75 24.14 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.027 0.822 . . . . 0.0 114.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -148.21 116.95 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.392 1.077 . . . . 0.0 111.705 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.24 173.01 14.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.374 1.47 . . . . 0.0 111.288 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.61 127.82 9.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.417 1.087 . . . . 0.0 109.476 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.92 173.85 11.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.474 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.18 149.71 48.71 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -128.69 117.2 20.77 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.361 1.864 . . . . 0.0 111.78 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -69.06 104.91 2.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.916 1.686 . . . . 0.0 109.816 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.8 mtp -66.5 148.75 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.216 1.007 . . . . 0.0 110.569 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -24.63 63.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.272 1.029 . . . . 0.0 113.501 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t -69.58 -13.7 62.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.342 1.857 . . . . 0.0 114.494 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.34 12.34 48.82 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.677 1.132 . . . . 0.0 114.967 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -103.17 175.43 5.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.373 2.269 . . . . 0.0 110.088 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.1 m -138.25 110.29 7.28 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.033 -1.042 . . . . 0.0 112.715 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.4 tp -74.67 113.45 11.95 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.551 1.14 . . . . 0.0 112.936 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.0 102.68 2.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.36 1.933 . . . . 0.0 110.401 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.4 160.27 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.535 1.134 . . . . 0.0 110.591 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.436 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -142.08 153.31 44.07 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.387 0.675 . . . . 0.0 111.556 174.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -161.23 156.11 23.7 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.783 1.233 . . . . 0.0 110.834 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 t -168.63 138.44 2.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.788 1.235 . . . . 0.0 109.221 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.42 95.71 7.48 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.537 0.65 0 C-N-CA 123.035 2.49 . . . . 0.0 111.628 178.326 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 p30 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.447 ' CZ2' ' CE2' ' A' ' 135' ' ' TYR . 15.0 p-90 -114.09 157.98 21.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.7 0.8 . . . . 0.0 112.548 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -158.02 174.14 15.69 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.605 1.962 . . . . 0.0 110.12 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 154.96 133.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 129.221 3.009 . . . . 0.0 112.347 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.04 140.95 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.261 1.024 . . . . 0.0 109.015 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -133.35 149.32 51.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.801 1.24 . . . . 0.0 109.177 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.92 98.46 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.103 0.961 . . . . 0.0 109.024 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.19 99.94 0.2 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.402 1.081 . . . . 0.0 109.46 174.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.9 t -68.22 84.97 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.423 1.089 . . . . 0.0 110.86 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.98 -114.9 0.69 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.797 2.142 . . . . 0.0 110.302 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -150.35 123.34 8.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.965 1.306 . . . . 0.0 111.404 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.69 105.96 4.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.565 1.546 . . . . 0.0 112.48 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 167.22 3.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.416 1.086 . . . . 0.0 111.461 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.54 112.33 17.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.08 -0.388 . . . . 0.0 111.21 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.28 -179.44 6.94 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -51.85 -42.04 62.29 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.001 -1.062 . . . . 0.0 112.018 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.71 97.06 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.389 0.995 . . . . 0.0 113.798 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -65.01 -45.72 84.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.798 1.299 . . . . 0.0 111.297 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -57.54 -39.92 77.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.693 0.797 . . . . 0.0 110.99 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -67.09 -40.47 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.474 1.11 . . . . 0.0 112.221 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.67 -29.77 70.96 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.443 -1.411 . . . . 0.0 112.883 174.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -76.38 -55.6 5.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.211 1.405 . . . . 0.0 111.615 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.447 ' CE2' ' CZ2' ' A' ' 114' ' ' TRP . 10.8 m-85 -76.5 -26.91 55.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -126.85 -33.85 2.44 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.213 1.005 . . . . 0.0 113.444 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.38 -49.41 45.16 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.839 1.209 . . . . 0.0 112.527 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -166.58 73.63 1.14 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 126.133 1.773 . . . . 0.0 111.565 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 133.01 23.92 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.34 2.026 . . . . 0.0 112.127 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -112.15 -175.17 2.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.552 2.341 . . . . 0.0 111.832 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -134.34 139.56 45.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.146 2.179 . . . . 0.0 110.636 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.36 91.13 0.14 Allowed Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.771 0.714 . . . . 0.0 113.823 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.63 -47.31 19.61 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.81 -1.406 . . . . 0.0 113.438 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 p30 179.37 88.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.974 2.51 . . . . 0.0 112.062 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.19 148.23 6.63 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.48 -0.762 . . . . 0.0 114.255 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -77.54 145.19 37.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.712 1.205 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -153.2 141.37 20.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.271 1.429 . . . . 0.0 111.641 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -118.03 147.2 43.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.851 1.66 . . . . 0.0 111.207 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -149.82 166.45 29.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.309 1.044 . . . . 0.0 112.069 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -79.92 108.31 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.74 -32.76 74.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.61 14.16 4.9 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.52 -26.06 3.07 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.141 1.471 . . . . 0.0 114.704 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.2 10.78 1.27 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.423 -1.21 . . . . 0.0 115.469 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.75 165.5 26.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.534 1.667 . . . . 0.0 112.369 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.01 141.33 52.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.597 1.159 . . . . 0.0 108.947 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.0 157.68 37.24 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.601 0.76 . . . . 0.0 109.386 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.9 129.25 56.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.1 159.03 19.7 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 123.34 0.495 . . . . 0.0 112.467 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.39 156.05 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.842 1.657 . . . . 0.0 110.432 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -153.73 114.21 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.8 p -102.03 150.97 22.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.818 0.847 . . . . 0.0 110.425 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.31 156.14 45.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.029 1.731 . . . . 0.0 110.431 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.17 128.5 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.995 2.518 . . . . 0.0 112.908 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.86 -179.0 51.73 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 122.229 0.905 . . . . 0.0 114.244 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.32 80.83 1.36 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.414 1.885 . . . . 0.0 112.48 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.55 164.0 34.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.739 1.216 . . . . 0.0 112.802 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -153.54 -178.91 7.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.746 1.619 . . . . 0.0 113.636 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.0 ptm -102.11 166.62 10.51 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.896 2.079 . . . . 0.0 113.653 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -154.8 153.76 31.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.888 1.275 . . . . 0.0 109.955 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.8 mm -135.47 117.63 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.892 1.277 . . . . 0.0 110.114 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -112.89 111.94 23.05 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.867 -1.146 . . . . 0.0 111.503 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 10.0 pt -95.51 131.73 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 109.086 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.5 t -150.71 158.76 44.53 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.633 -0.667 . . . . 0.0 111.227 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.127 1.371 . . . . 0.0 112.185 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.56 -41.39 1.45 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.55 -25.56 8.97 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 125.423 1.487 . . . . 0.0 116.213 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 p -138.34 158.18 44.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.694 1.747 . . . . 0.0 111.447 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mm -136.2 165.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.774 -1.204 . . . . 0.0 110.382 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -170.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.881 1.273 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.4 -43.75 5.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 -29.56 6.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.18 1.371 . . . . 0.0 112.897 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.13 73.64 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.296 1.048 . . . . 0.0 111.491 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.4 m -86.53 -8.53 57.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.823 2.049 . . . . 0.0 114.345 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.63 131.36 45.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.47 1.108 . . . . 0.0 109.21 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.612 1.165 . . . . 0.0 109.163 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -54.61 -29.58 52.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.928 0.785 . . . . 0.0 112.988 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -58.28 -56.74 18.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 112.434 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.46 -44.62 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.893 0.877 . . . . 0.0 109.841 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -25.48 67.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.591 1.156 . . . . 0.0 113.472 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -74.72 -53.1 9.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.102 -1.624 . . . . 0.0 110.373 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -39.85 83.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 112.934 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.65 -33.36 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.339 0.972 . . . . 0.0 113.082 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.8 -36.59 42.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.498 0.719 . . . . 0.0 110.522 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.84 -44.14 97.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.814 0.846 . . . . 0.0 111.664 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -20.53 57.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 CA--C 1.542 0.665 0 C-N-CA 126.327 1.851 . . . . 0.0 112.731 174.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.0 148.72 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.519 1.128 . . . . 0.0 111.426 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 97.74 3.34 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.58 1.952 . . . . 0.0 111.19 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.41 129.77 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.942 -1.099 . . . . 0.0 110.248 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.95 171.49 42.37 Favored Glycine 0 C--O 1.235 0.205 0 O-C-N 121.57 -0.706 . . . . 0.0 114.273 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.61 122.85 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 0.0 109.99 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.97 102.66 2.05 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.387 -1.445 . . . . 0.0 111.747 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -76.75 92.0 3.53 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.4 -0.813 . . . . 0.0 112.225 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -143.54 48.78 1.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.057 0.943 . . . . 0.0 111.586 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -109.8 -8.43 14.91 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.31 57.07 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.561 1.077 . . . . 0.0 115.558 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.44 134.68 6.98 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.129 1.347 . . . . 0.0 113.059 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.2 m -61.87 141.2 58.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.999 1.32 . . . . 0.0 110.816 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -104.68 163.49 12.45 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.472 -0.768 . . . . 0.0 111.343 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -143.41 102.0 3.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.022 1.329 . . . . 0.0 111.02 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.98 163.36 22.39 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.292 -0.88 . . . . 0.0 111.131 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.23 -60.65 1.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.126 1.371 . . . . 0.0 111.062 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -153.01 -173.84 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 111.096 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 147.96 35.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.44 1.496 . . . . 0.0 110.895 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -132.13 134.59 45.61 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.135 1.374 . . . . 0.0 110.568 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.48 157.9 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.204 2.202 . . . . 0.0 111.223 -174.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -127.13 -37.14 2.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.092 1.357 . . . . 0.0 112.924 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.3 t -133.46 92.97 3.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.25 121.19 2.1 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.344 0.973 . . . . 0.0 114.726 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.427 HG21 ' H ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -69.25 -179.04 1.46 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.11 1.764 . . . . 0.0 112.759 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.427 ' H ' HG21 ' A' ' 54' ' ' THR . 16.2 p -88.16 158.56 18.5 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.779 1.232 . . . . 0.0 111.673 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -155.49 -22.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.163 1.385 . . . . 0.0 112.608 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 m -128.13 161.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.712 2.005 . . . . 0.0 110.353 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 tt -91.92 135.26 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.302 1.441 . . . . 0.0 110.975 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.99 125.85 86.33 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 0.0 109.123 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.02 148.47 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.197 2.598 . . . . 0.0 111.043 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.48 -56.14 3.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.749 0.82 . . . . 0.0 112.309 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -119.2 134.97 54.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.094 1.358 . . . . 0.0 110.334 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.5 t -133.4 132.77 22.15 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.526 1.13 . . . . 0.0 111.484 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.56 164.28 35.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.807 3.005 . . . . 0.0 112.557 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 22.03 0.2 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.0 1.72 . . . . 0.0 115.381 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 p -146.7 23.53 1.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.528 1.531 . . . . 0.0 113.379 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -148.06 130.55 15.8 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.878 1.217 . . . . 0.0 112.607 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.04 179.17 5.79 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.365 1.079 . . . . 0.0 111.443 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 142.97 21.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.812 1.245 . . . . 0.0 109.588 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.8 mt -122.39 -178.05 3.79 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.584 1.154 . . . . 0.0 110.555 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -155.5 164.76 38.26 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.689 -1.257 . . . . 0.0 110.326 174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -142.65 174.54 10.55 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.093 0.957 . . . . 0.0 111.943 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.06 -171.55 12.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.385 1.469 . . . . 0.0 112.61 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 125.658 1.583 . . . . 0.0 114.484 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.33 114.52 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.031 2.533 . . . . 0.0 110.742 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.05 177.13 10.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.275 1.43 . . . . 0.0 111.887 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.54 127.84 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.394 1.477 . . . . 0.0 109.059 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -132.36 159.9 37.87 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.805 0.842 . . . . 0.0 112.066 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.33 144.35 50.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.114 0.565 . . . . 0.0 111.29 -177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.61 121.9 41.29 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.485 1.514 . . . . 0.0 110.2 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.65 111.59 4.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.912 1.285 . . . . 0.0 110.354 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.7 mtp -72.32 142.68 48.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.745 1.218 . . . . 0.0 110.4 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.3 t -53.86 -33.7 57.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.433 1.093 . . . . 0.0 113.89 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -10.51 30.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.52 26.4 9.29 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.506 1.05 . . . . 0.0 114.291 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -117.73 177.53 4.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.383 1.873 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.5 m -140.21 106.19 5.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.9 1.28 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.0 tp -74.95 118.83 18.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.182 0.993 . . . . 0.0 110.314 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.81 107.51 3.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.88 1.229 . . . . 0.0 113.521 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.67 158.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 112.533 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.43 168.86 18.81 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.241 1.016 . . . . 0.0 112.136 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 31' ' ' ILE . 47.0 p90 -171.68 150.31 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.633 1.573 . . . . 0.0 110.375 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.8 m -162.01 130.63 4.26 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.494 1.518 . . . . 0.0 107.355 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.1 t -107.04 128.45 26.05 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.438 -0.791 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 122.493 2.129 . . . . 0.0 111.258 -179.32 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 p30 . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 121.435 0.636 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -121.69 144.92 48.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.922 1.289 . . . . 0.0 112.267 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -155.51 160.24 40.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.535 1.134 . . . . 0.0 110.474 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 173.7 132.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.167 2.987 . . . . 0.0 111.008 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.17 140.92 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.72 1.608 . . . . 0.0 109.794 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -135.61 158.57 44.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.304 1.441 . . . . 0.0 110.805 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.22 99.4 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.769 1.628 . . . . 0.0 108.088 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -65.32 103.77 0.85 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.144 -0.972 . . . . 0.0 109.67 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.1 t -68.79 83.43 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.634 -1.291 . . . . 0.0 111.347 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.76 -111.64 0.49 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 127.117 2.294 . . . . 0.0 111.502 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -146.26 135.84 23.12 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.89 1.676 . . . . 0.0 111.852 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -158.31 113.84 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.695 1.598 . . . . 0.0 112.15 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 165.63 24.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.165 0.586 . . . . 0.0 111.236 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.67 113.04 16.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.647 0.779 . . . . 0.0 110.37 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -158.88 -174.74 4.91 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.698 1.599 . . . . 0.0 112.839 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -50.61 -40.95 54.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.256 -0.902 . . . . 0.0 112.865 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.91 -39.91 56.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.246 0.93 . . . . 0.0 113.269 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.3 ttt -67.41 -57.79 5.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.41 1.084 . . . . 0.0 111.507 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -53.47 -34.91 59.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.38 0.991 . . . . 0.0 112.691 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -66.64 -46.81 74.57 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.206 1.002 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -25.75 66.9 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.502 -1.374 . . . . 0.0 113.122 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.35 -45.07 57.26 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.727 2.011 . . . . 0.0 113.11 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.69 -31.76 14.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -116.31 -20.95 9.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.897 1.279 . . . . 0.0 113.163 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.68 -63.85 2.25 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.568 1.556 . . . . 0.0 114.166 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -122.52 64.45 21.58 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.898 1.279 . . . . 0.0 112.161 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -60.65 122.66 11.6 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.999 2.466 . . . . 0.0 112.851 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.37 -171.9 2.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.405 1.482 . . . . 0.0 111.351 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -139.26 135.58 34.03 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.735 -1.228 . . . . 0.0 112.997 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.73 8.16 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.265 1.412 . . . . 0.0 110.697 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -130.65 56.71 1.76 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.043 1.337 . . . . 0.0 110.825 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.5 p30 40.41 65.06 0.82 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.506 2.322 . . . . 0.0 115.432 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.28 154.02 21.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.819 1.199 . . . . 0.0 113.158 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.441 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 42.6 m95 -70.01 142.33 52.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.17 . . . . 0.0 110.951 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -145.4 131.67 19.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.799 1.239 . . . . 0.0 111.929 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -107.24 141.88 37.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 112.147 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -148.37 157.74 43.67 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 123.336 1.541 . . . . 0.0 112.248 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.11 88.28 7.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.828 2.851 . . . . 0.0 106.436 175.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.1 tp -54.54 -27.84 41.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.594 1.557 . . . . 0.0 114.26 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.76 36.62 2.75 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -133.12 -20.32 2.17 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.1 2.96 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.579 1.085 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.47 176.68 8.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.378 1.871 . . . . 0.0 111.665 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -116.24 163.4 16.05 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.664 1.186 . . . . 0.0 111.127 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.174 0.988 . . . . 0.0 112.274 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -116.16 124.6 50.72 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 126.726 2.011 . . . . 0.0 108.144 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.21 149.26 18.58 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 119.095 0.861 . . . . 0.0 112.98 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.441 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -134.67 151.5 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.738 1.615 . . . . 0.0 108.919 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.9 tpp -156.45 109.01 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.722 1.609 . . . . 0.0 108.462 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.7 p -132.72 156.0 47.82 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.96 2.104 . . . . 0.0 110.037 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.9 p -158.21 -176.48 5.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.859 1.663 . . . . 0.0 110.882 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.82 34.98 14.03 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.855 1.662 . . . . 0.0 115.45 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 148.46 88.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.466 1.031 . . . . 0.0 113.274 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 44.8 55.64 5.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.17 2.588 . . . . 0.0 112.166 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.26 163.69 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.051 1.74 . . . . 0.0 113.804 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.453 ' HG3' ' H ' ' A' ' 169' ' ' MET . 1.8 tptp -159.09 -168.34 2.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.453 ' H ' ' HG3' ' A' ' 168' ' ' LYS . 19.7 ptm -121.31 149.5 42.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.058 1.743 . . . . 0.0 111.06 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -167.51 152.37 6.99 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.391 1.476 . . . . 0.0 109.177 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.75 122.0 64.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 123.579 0.752 . . . . 0.0 109.243 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 114.11 25.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 108.365 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.4 pt -99.66 134.83 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.086 0.554 . . . . 0.0 110.531 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p -155.88 165.06 37.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.711 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.961 1.304 . . . . 0.0 112.474 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.351 0.119 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.22 169.22 2.21 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.805 0.812 . . . . 0.0 110.592 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.66 -40.01 2.57 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.7 p -131.51 155.79 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.678 1.591 . . . . 0.0 111.61 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mm -140.31 160.59 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.268 1.427 . . . . 0.0 110.283 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -66.73 -171.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.082 2.553 . . . . 0.0 111.67 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.34 -28.29 58.53 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.26 61.56 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.212 1.386 . . . . 0.0 112.929 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.72 -43.03 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.705 1.202 . . . . 0.0 111.799 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.3 p -85.48 -13.09 50.2 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.7 138.61 34.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.862 2.065 . . . . 0.0 110.021 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m -145.7 149.51 34.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.9 0.88 . . . . 0.0 109.618 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -52.7 -26.49 14.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.29 -51.31 64.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.168 0.987 . . . . 0.0 112.11 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.23 -39.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.35 -0.844 . . . . 0.0 110.776 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -23.98 67.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.314 1.046 . . . . 0.0 112.338 176.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.16 -54.22 13.83 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.352 -1.467 . . . . 0.0 109.021 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -44.75 78.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.373 1.069 . . . . 0.0 112.62 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.04 -35.91 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.331 0.969 . . . . 0.0 113.414 -175.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD13 ' HZ3' ' A' ' 30' ' ' LYS . 35.2 mt -84.93 -32.3 23.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 111.801 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.23 -23.01 66.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.269 0.627 . . . . 0.0 111.584 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -48.15 -25.91 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.36 1.864 . . . . 0.0 113.657 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 125.576 1.55 . . . . 0.0 112.317 174.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HZ2' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.367 0.127 . . . . 0.0 111.286 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.433 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -131.25 133.55 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.891 0.877 . . . . 0.0 111.635 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.6 102.62 9.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.107 2.163 . . . . 0.0 113.843 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.02 121.33 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.571 -1.331 . . . . 0.0 109.96 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.83 33.81 Favored Glycine 0 N--CA 1.461 0.363 0 O-C-N 121.053 -1.029 . . . . 0.0 112.956 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.42 134.45 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.335 1.064 . . . . 0.0 113.817 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 2.6 m-20 -76.41 106.76 8.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.69 1.596 . . . . 0.0 113.148 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -84.06 104.27 13.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.683 1.23 . . . . 0.0 112.977 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -145.49 23.8 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.078 -1.014 . . . . 0.0 113.021 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.51 -9.52 54.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.496 1.519 . . . . 0.0 114.66 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.95 49.48 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.493 1.044 . . . . 0.0 115.148 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.62 110.66 0.91 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.833 1.682 . . . . 0.0 110.166 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -59.58 147.2 38.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.801 1.3 . . . . 0.0 110.906 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -117.3 161.41 19.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.53 0.732 . . . . 0.0 111.506 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -133.01 113.63 13.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.331 2.253 . . . . 0.0 111.996 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 115.64 15.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.599 1.159 . . . . 0.0 110.831 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -54.85 8.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.521 1.528 . . . . 0.0 110.259 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.74 -174.03 3.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.72 1.608 . . . . 0.0 111.825 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 144.67 28.22 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.53 1.532 . . . . 0.0 111.622 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.62 119.94 37.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.54 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.32 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 109.562 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -5.12 43.64 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.162 1.385 . . . . 0.0 113.833 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 p -73.56 -137.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.017 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.85 -84.55 0.91 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.446 1.022 . . . . 0.0 112.663 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -146.17 176.03 10.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.517 1.127 . . . . 0.0 112.193 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -77.74 158.36 29.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.38 1.472 . . . . 0.0 113.051 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -135.22 -34.14 0.87 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.688 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.0 176.84 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.855 2.062 . . . . 0.0 110.129 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -100.93 131.8 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.442 1.497 . . . . 0.0 110.987 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.26 131.61 52.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.63 177.68 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.165 3.243 . . . . 0.0 112.411 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -117.81 -36.68 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.839 1.256 . . . . 0.0 112.279 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.13 157.92 33.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.952 1.301 . . . . 0.0 111.72 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.99 97.44 7.92 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 124.747 1.219 . . . . 0.0 108.681 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.99 174.61 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.795 1.663 . . . . 0.0 110.54 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -63.2 165.49 7.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.45 0.7 . . . . 0.0 109.887 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 t 46.08 30.81 1.01 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.162 1.385 . . . . 0.0 113.14 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -145.26 158.68 43.77 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.916 1.686 . . . . 0.0 112.138 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -140.34 -173.84 3.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.707 1.242 . . . . 0.0 110.105 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.91 153.88 28.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.926 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.2 mt -139.26 155.16 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.796 1.238 . . . . 0.0 108.578 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.07 160.26 33.35 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.119 1.368 . . . . 0.0 108.747 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 m -151.26 170.1 20.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.439 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.82 -171.2 21.35 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 124.613 1.165 . . . . 0.0 109.789 -177.078 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -151.88 121.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 127.357 2.263 . . . . 0.0 111.329 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.1 176.02 12.28 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.797 1.639 . . . . 0.0 110.389 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.46 116.97 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.541 1.136 . . . . 0.0 108.441 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -127.22 170.08 12.81 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.264 1.026 . . . . 0.0 112.651 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.91 157.72 45.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.97 112.38 14.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.136 1.774 . . . . 0.0 112.147 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.3 104.09 1.41 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.297 1.839 . . . . 0.0 111.032 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.43 140.37 58.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.492 1.117 . . . . 0.0 110.111 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -57.62 -20.72 34.96 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -74.39 -10.02 59.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.258 1.423 . . . . 0.0 113.905 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.76 11.77 45.91 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.058 1.313 . . . . 0.0 114.837 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.12 174.56 6.26 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.261 1.824 . . . . 0.0 109.7 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m -143.64 109.52 5.25 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.951 -1.093 . . . . 0.0 112.588 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.56 121.5 21.66 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.068 -1.02 . . . . 0.0 111.627 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 110.7 3.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.868 1.223 . . . . 0.0 113.367 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.58 150.13 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.193 0.997 . . . . 0.0 112.21 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -135.65 152.16 50.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.115 1.366 . . . . 0.0 110.774 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CE2' HD13 ' A' ' 31' ' ' ILE . 23.7 p90 -164.69 158.45 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.374 1.07 . . . . 0.0 110.474 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 m -163.17 154.39 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.87 2.068 . . . . 0.0 108.181 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.66 100.1 37.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 C-N-CA 122.767 2.311 . . . . 0.0 111.828 179.149 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.664 0.745 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -92.18 140.44 29.62 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.301 1.44 . . . . 0.0 112.622 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -163.1 138.32 6.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -161.24 152.12 18.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.766 -0.584 . . . . 0.0 112.441 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.96 143.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 127.161 2.185 . . . . 0.0 110.119 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 150.13 45.18 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.178 1.791 . . . . 0.0 109.872 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.84 103.55 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.232 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -66.45 101.36 0.75 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.851 -1.156 . . . . 0.0 109.093 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 t -67.49 82.22 0.16 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.847 -1.158 . . . . 0.0 111.525 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.47 -107.25 0.32 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.088 2.28 . . . . 0.0 111.423 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -153.19 144.64 23.27 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.849 1.26 . . . . 0.0 111.903 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -165.34 116.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.966 1.706 . . . . 0.0 111.788 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.71 164.92 20.56 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.538 0.735 . . . . 0.0 111.732 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.41 118.73 22.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.329 -0.232 . . . . 0.0 110.58 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.63 -179.09 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.139 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -48.84 42.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.943 1.297 . . . . 0.0 112.715 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.0 -33.52 60.71 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.001 0.81 . . . . 0.0 113.515 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.6 ttp -67.44 -56.42 9.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.412 1.106 . . . . 0.0 111.455 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -49.47 -39.81 34.97 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.296 0.953 . . . . 0.0 111.997 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -66.07 -43.14 88.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.079 0.952 . . . . 0.0 112.202 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -17.91 64.92 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.022 -1.673 . . . . 0.0 113.918 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.5 mt -96.23 -24.84 16.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.376 1.47 . . . . 0.0 113.39 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.81 -32.99 11.07 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.945 -1.097 . . . . 0.0 112.928 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -118.13 -33.67 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 112.759 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.19 -21.23 71.83 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.408 1.004 . . . . 0.0 114.517 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -154.11 87.0 3.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.462 2.305 . . . . 0.0 108.374 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.36 108.9 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.086 1.857 . . . . 0.0 110.953 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -139.88 158.95 43.25 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -147.42 167.67 23.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.963 1.705 . . . . 0.0 112.637 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.36 111.31 0.48 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.129 0.871 . . . . 0.0 112.93 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.03 70.39 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.986 0.914 . . . . 0.0 111.434 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.0 92.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.952 2.501 . . . . 0.0 114.993 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.09 130.17 1.09 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.581 1.086 . . . . 0.0 112.362 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.434 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 5.7 m95 -58.81 123.96 18.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.641 1.177 . . . . 0.0 111.164 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -131.75 118.24 19.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.422 1.489 . . . . 0.0 111.553 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.37 142.85 46.31 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.347 1.059 . . . . 0.0 112.615 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.23 156.82 41.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.688 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -74.62 104.36 5.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.73 -22.68 58.23 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.18 35.68 2.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.753 1.644 . . . . 0.0 116.523 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -135.42 -24.54 1.38 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.57 -18.03 1.13 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.204 1.383 . . . . 0.0 114.391 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp -131.04 163.44 27.6 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.129 1.372 . . . . 0.0 112.523 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -102.3 136.72 41.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.289 1.436 . . . . 0.0 112.211 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -115.07 135.72 53.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.149 0.58 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.427 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.8 tptm -103.87 119.69 39.45 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.884 2.074 . . . . 0.0 110.468 176.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.18 146.87 18.62 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.354 1.454 . . . . 0.0 112.773 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.434 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 4.1 tp -124.15 157.05 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.096 1.759 . . . . 0.0 110.226 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.0 tpt -152.34 90.87 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.463 1.505 . . . . 0.0 109.086 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.7 p -82.45 152.24 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 111.471 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.1 t -127.94 163.47 24.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.204 1.002 . . . . 0.0 112.049 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 65.05 144.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.575 2.75 . . . . 0.0 113.133 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 38.8 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.479 1.527 0 C-N-CA 126.877 2.18 . . . . 0.0 113.34 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.539 ' HG2' ' HZ2' ' A' ' 30' ' ' LYS . 2.1 tm-20 -75.59 64.11 1.63 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.376 1.87 . . . . 0.0 109.599 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.5 111.7 23.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.202 1.801 . . . . 0.0 111.768 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.1 161.69 36.41 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 140.33 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 127.739 2.416 . . . . 0.0 110.295 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.6 157.12 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.708 1.603 . . . . 0.0 109.018 173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.6 mp -128.31 134.54 64.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 124.464 1.106 . . . . 0.0 109.697 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 109.11 13.26 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.318 2.247 . . . . 0.0 110.737 175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.7 pt -91.54 124.47 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.134 1.374 . . . . 0.0 110.183 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.4 p -155.69 170.52 21.85 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.315 1.446 . . . . 0.0 112.735 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.38 169.72 10.18 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 110.654 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.87 -27.64 19.66 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 113.231 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -146.6 160.54 42.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.99 1.716 . . . . 0.0 111.641 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -139.83 166.81 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.571 1.549 . . . . 0.0 110.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 pt -73.91 -170.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.917 2.487 . . . . 0.0 110.308 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.05 19.8 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 -10.48 73.91 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.75 1.167 . . . . 0.0 114.36 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.7 -45.69 35.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.56 1.144 . . . . 0.0 111.497 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -81.62 -7.31 59.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.947 1.299 . . . . 0.0 113.869 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.5 tp -59.81 144.19 49.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.822 1.249 . . . . 0.0 110.396 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.3 146.43 29.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.247 1.019 . . . . 0.0 110.082 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -55.79 -29.06 59.08 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -60.85 -57.32 13.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.44 -43.68 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.766 -0.584 . . . . 0.0 110.073 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -30.86 68.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 112.766 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -69.55 -47.27 64.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.986 1.715 . . . . 0.0 111.824 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -35.65 77.81 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.857 -1.152 . . . . 0.0 112.131 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -39.14 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.052 -1.03 . . . . 0.0 113.642 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -31.58 61.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.233 0.469 . . . . 0.0 111.79 175.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -70.22 -33.41 71.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.319 1.448 . . . . 0.0 112.27 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -46.63 -29.44 1.85 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.457 2.303 . . . . 0.0 114.208 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 125.365 1.466 . . . . 0.0 110.94 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.4 141.67 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.729 1.612 . . . . 0.0 112.028 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 104.94 11.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.854 1.662 . . . . 0.0 110.338 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG12 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.12 142.87 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 124.257 1.023 . . . . 0.0 113.52 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.11 173.48 34.59 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.535 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mt -139.71 150.02 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.422 1.489 . . . . 0.0 110.613 -174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.39 118.09 31.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 110.617 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.73 103.69 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 0.0 111.922 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.58 7.97 2.82 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.823 1.249 . . . . 0.0 112.988 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 t -66.19 -16.26 63.84 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.62 16.73 28.21 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.595 1.093 . . . . 0.0 115.361 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.43 136.92 8.38 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.262 1.411 . . . . 0.0 112.886 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -67.36 141.63 57.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.437 1.495 . . . . 0.0 111.749 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.511 ' CH2' ' HB3' ' A' ' 37' ' ' ASN . 40.3 m0 -108.01 165.82 11.18 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.647 1.179 . . . . 0.0 112.179 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -146.55 98.8 3.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 111.997 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.29 139.77 58.8 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.019 -1.05 . . . . 0.0 110.428 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.4 -61.37 1.57 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.872 0.869 . . . . 0.0 110.187 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.63 -164.12 0.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.913 2.885 . . . . 0.0 108.892 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.85 134.77 20.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.206 1.803 . . . . 0.0 111.329 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -103.98 112.48 25.48 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.601 1.56 . . . . 0.0 109.376 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 130.81 55.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.543 1.537 . . . . 0.0 109.839 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -31.02 7.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.746 1.618 . . . . 0.0 113.258 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -141.8 91.85 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.241 1.016 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.17 125.94 3.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.8 1.667 . . . . 0.0 111.946 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -74.7 175.49 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.897 0.856 . . . . 0.0 111.775 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p -62.55 171.02 2.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.683 1.993 . . . . 0.0 113.122 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.34 -50.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.035 1.334 . . . . 0.0 109.785 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.9 164.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.476 1.51 . . . . 0.0 111.761 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 tp -71.88 134.25 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 110.452 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -91.79 114.2 61.21 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.696 1.198 . . . . 0.0 109.724 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.31 120.53 7.68 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.308 3.339 . . . . 0.0 111.422 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.51 -67.58 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.499 0.72 . . . . 0.0 112.402 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -97.33 132.61 42.89 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.547 0.739 . . . . 0.0 109.561 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.67 128.04 22.98 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.816 0.847 . . . . 0.0 111.099 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.77 149.64 38.13 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.028 3.152 . . . . 0.0 112.805 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.89 17.96 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -141.0 8.62 2.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.412 1.885 . . . . 0.0 113.946 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -145.59 134.44 22.43 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 119.885 1.22 . . . . 0.0 113.038 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.23 -176.36 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 110.992 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.02 157.22 41.39 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.409 -0.807 . . . . 0.0 112.187 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 170.78 14.29 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 123.608 0.763 . . . . 0.0 111.65 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.48 157.76 43.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.231 1.813 . . . . 0.0 109.885 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.7 m -145.39 160.52 41.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.154 1.782 . . . . 0.0 108.799 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.81 -179.57 16.88 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.615 1.102 . . . . 0.0 111.984 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -130.86 108.0 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.878 2.071 . . . . 0.0 108.891 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.89 178.62 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 111.128 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.76 120.7 5.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -125.97 161.56 27.23 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.312 1.045 . . . . 0.0 113.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.52 148.82 52.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.01 102.37 8.13 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.286 2.234 . . . . 0.0 112.094 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -69.06 117.88 11.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.471 1.508 . . . . 0.0 110.374 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.9 mtp -82.42 153.1 25.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 111.516 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 m -58.74 -16.59 17.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -73.87 -17.88 60.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 113.565 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.27 33.82 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.248 1.88 . . . . 0.0 114.937 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -78.78 168.21 20.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.734 1.267 . . . . 0.0 111.573 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.8 m -136.43 106.51 6.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.318 1.047 . . . . 0.0 112.332 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.47 111.48 4.72 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.674 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.405 ' CA ' ' HE3' ' A' ' 130' ' ' MET . . . -94.6 105.77 3.33 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 0.0 113.486 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.31 149.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 122.099 -0.648 . . . . 0.0 110.882 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 145.43 48.4 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.209 -0.932 . . . . 0.0 109.793 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.485 ' CG ' HG12 ' A' ' 33' ' ' VAL . 40.8 p90 -167.71 135.16 2.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 123.308 1.528 . . . . 0.0 114.234 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 m -150.51 130.62 13.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.768 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.21 90.9 42.85 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 CA--C 1.541 0.855 0 C-N-CA 122.569 2.179 . . . . 0.0 112.818 -178.383 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.401 0.619 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -85.84 159.85 19.6 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.324 0.65 . . . . 0.0 110.249 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -161.45 171.03 18.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.951 1.3 . . . . 0.0 109.399 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 148.26 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.558 3.143 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.61 160.88 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.684 0.793 . . . . 0.0 109.847 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.25 158.07 26.66 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.56 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.479 ' HB ' ' CE2' ' A' ' 153' ' ' TYR . 34.1 mt -105.53 117.3 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -66.78 87.85 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.873 1.669 . . . . 0.0 110.189 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.5 t -73.02 81.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.0 110.949 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.62 -82.13 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.717 1.151 . . . . 0.0 112.938 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 177.8 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.38 2.672 . . . . 0.0 111.116 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -155.39 159.21 39.71 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.937 2.095 . . . . 0.0 109.338 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.16 173.86 10.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.123 2.169 . . . . 0.0 111.173 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.64 109.7 5.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.721 0.408 . . . . 0.0 111.863 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -163.68 -169.81 2.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 111.099 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.7 -48.88 69.11 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.442 -0.786 . . . . 0.0 110.707 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.54 50.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.422 1.01 . . . . 0.0 113.659 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.405 ' HE3' ' CA ' ' A' ' 99' ' ' GLY . 3.8 ttt -66.34 -63.63 1.03 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.739 0.815 . . . . 0.0 110.595 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.88 -34.1 62.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.999 0.92 . . . . 0.0 112.776 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.63 -40.09 95.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.681 1.592 . . . . 0.0 111.019 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -21.89 65.76 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.261 -1.525 . . . . 0.0 113.26 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.4 mt -82.15 -41.11 20.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.492 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 -34.69 14.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -113.11 -36.56 5.03 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.481 1.512 . . . . 0.0 112.128 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.81 -69.58 1.02 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.747 1.642 . . . . 0.0 112.487 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -171.13 75.57 0.54 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 125.437 1.495 . . . . 0.0 112.933 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.73 161.32 32.78 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.751 2.3 . . . . 0.0 113.86 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -126.53 177.19 6.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.125 2.17 . . . . 0.0 112.224 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -108.24 124.0 49.63 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.055 2.142 . . . . 0.0 111.584 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.64 101.96 2.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.493 1.52 . . . . 0.0 112.928 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -136.86 23.96 3.08 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 71.2 99.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.81 2.444 . . . . 0.0 113.386 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.96 139.41 2.66 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.691 1.615 . . . . 0.0 111.987 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -69.83 154.91 41.33 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 122.216 -0.579 . . . . 0.0 111.354 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -142.08 124.47 15.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.305 1.442 . . . . 0.0 111.694 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -121.79 138.64 54.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.231 2.212 . . . . 0.0 111.34 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 159.44 38.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.92 1.288 . . . . 0.0 111.694 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -81.63 86.6 6.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.091 1.356 . . . . 0.0 110.083 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 153' ' ' TYR . 7.3 tt -58.42 -52.51 65.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.456 1.502 . . . . 0.0 112.949 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.58 42.37 0.02 OUTLIER Glycine 0 CA--C 1.542 1.761 0 N-CA-C 118.584 2.194 . . . . 0.0 118.584 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.479 ' CE2' ' HB ' ' A' ' 119' ' ' ILE . 0.5 OUTLIER -150.05 5.01 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.642 1.721 . . . . 0.0 115.61 -176.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.87 -57.21 0.44 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.448 1.499 . . . . 0.0 112.496 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.84 176.24 7.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.824 0.85 . . . . 0.0 111.652 174.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.24 123.94 31.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.648 1.579 . . . . 0.0 109.999 175.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.2 156.02 19.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.58 130.96 39.12 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.762 1.225 . . . . 0.0 109.977 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -124.41 152.66 17.46 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 124.269 0.938 . . . . 0.0 113.588 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 141.24 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.278 1.431 . . . . 0.0 110.396 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.31 99.13 5.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.931 1.242 . . . . 0.0 110.931 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.59 53.86 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 0.0 111.89 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.5 m -123.06 129.02 50.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.674 1.989 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.64 68.15 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.842 2.857 . . . . 0.0 109.151 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.2 -90.46 0.02 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.38 1.943 . . . . 0.0 114.536 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -75.81 11.22 1.45 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.57 2.348 . . . . 0.0 114.802 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.37 170.28 16.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.69 1.596 . . . . 0.0 113.032 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 -167.99 1.89 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.1 ptm -114.05 164.12 14.25 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.858 2.063 . . . . 0.0 110.99 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -150.64 146.03 26.24 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.165 1.386 . . . . 0.0 110.009 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.0 mm -121.03 128.69 76.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.311 1.045 . . . . 0.0 108.726 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -115.58 114.55 25.09 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.504 1.522 . . . . 0.0 108.965 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 13.3 pt -111.07 134.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.59 1.156 . . . . 0.0 110.709 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.5 p -162.72 158.97 23.69 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.8 1.24 . . . . 0.0 110.79 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.248 1.419 . . . . 0.0 112.212 -175.043 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.75 166.85 5.05 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.024 0.916 . . . . 0.0 110.403 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.64 -42.17 1.99 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.93 1.729 . . . . 0.0 110.89 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.3 p -139.1 159.98 40.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.429 1.491 . . . . 0.0 111.932 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mm -142.11 162.9 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 111.402 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.5 pt -69.1 -169.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.072 2.149 . . . . 0.0 111.073 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.08 -25.84 23.87 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.28 -21.59 34.05 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.411 1.005 . . . . 0.0 113.355 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -44.1 70.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.444 1.122 . . . . 0.0 111.845 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.64 -11.67 59.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.018 1.327 . . . . 0.0 113.365 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -66.15 159.12 26.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.59 146.84 27.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.685 0.794 . . . . 0.0 109.916 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -55.52 -33.93 64.21 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.96 -47.77 79.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.456 1.103 . . . . 0.0 113.049 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.1 -45.94 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 110.439 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -41.3 66.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 111.426 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.67 -53.3 40.47 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.619 1.968 . . . . 0.0 112.317 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -27.12 41.84 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -35.82 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.181 1.355 . . . . 0.0 111.742 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.27 -23.91 37.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.208 1.003 . . . . 0.0 112.463 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.9 -33.77 22.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.645 1.578 . . . . 0.0 114.235 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -19.89 16.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 112.935 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 127.457 2.303 . . . . 0.0 111.038 174.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -145.41 148.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.683 1.193 . . . . 0.0 113.005 176.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.467 ' H ' ' HG2' ' A' ' 168' ' ' LYS . . . -121.77 105.63 10.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.591 2.356 . . . . 0.0 112.603 174.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -115.7 144.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 108.75 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.61 170.54 22.56 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 118.195 0.452 . . . . 0.0 112.8 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.02 124.88 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.888 0.875 . . . . 0.0 111.528 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -71.2 109.34 5.18 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.348 -0.845 . . . . 0.0 111.902 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.87 102.68 14.55 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.656 1.217 . . . . 0.0 111.271 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.14 44.41 1.55 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.07 -1.019 . . . . 0.0 110.94 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -2.32 9.05 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.41 75.81 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.946 -1.096 . . . . 0.0 115.266 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.37 107.85 1.71 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.758 1.647 . . . . 0.0 111.509 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.2 m -67.74 116.75 8.79 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.638 1.219 . . . . 0.0 110.632 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -85.78 161.25 19.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.588 0.355 . . . . 0.0 111.916 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -138.01 104.12 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.448 1.899 . . . . 0.0 111.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.93 141.27 58.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.884 -1.135 . . . . 0.0 110.528 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.42 -47.45 3.78 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.195 1.398 . . . . 0.0 111.774 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -155.63 171.35 20.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.027 0.931 . . . . 0.0 112.13 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.13 135.33 30.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 0.0 111.604 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -115.16 129.01 56.55 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.333 1.453 . . . . 0.0 109.088 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -147.22 161.15 41.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.869 1.267 . . . . 0.0 112.452 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -120.94 -31.84 4.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.738 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.462 ' CB ' ' H ' ' A' ' 85' ' ' VAL . 83.2 p -60.19 130.97 49.3 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.712 1.205 . . . . 0.0 112.344 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 37.13 -100.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.285 1.898 . . . . 0.0 113.904 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -165.04 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.478 1.911 . . . . 0.0 108.244 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 p -137.31 164.9 27.45 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.411 2.284 . . . . 0.0 112.119 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -154.67 -38.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.523 1.529 . . . . 0.0 111.358 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -102.31 165.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.682 1.593 . . . . 0.0 112.24 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.5 tt -80.24 136.62 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.641 1.176 . . . . 0.0 110.957 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.22 107.08 36.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.907 0.883 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.14 113.96 3.03 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 124.322 3.348 . . . . 0.0 110.386 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.49 -46.61 87.66 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.641 -0.662 . . . . 0.0 112.024 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.78 145.31 29.93 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.954 0.797 . . . . 0.0 110.854 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.11 94.19 16.26 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 124.723 1.209 . . . . 0.0 108.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.15 173.94 13.65 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.268 1.978 . . . . 0.0 112.125 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.72 166.82 3.06 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.343 0.657 . . . . 0.0 112.103 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.26 8.5 t 43.07 38.19 1.41 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.076 1.75 . . . . 0.0 113.396 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -148.74 151.41 34.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.039 1.736 . . . . 0.0 111.592 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.12 -175.62 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.32 . . . . 0.0 109.373 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.75 145.16 19.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.964 1.305 . . . . 0.0 109.368 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.08 39.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.25 1.02 . . . . 0.0 110.082 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -139.45 169.2 18.19 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 109.793 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -154.49 -177.8 6.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.339 1.055 . . . . 0.0 110.722 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.11 -167.03 12.79 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.354 1.93 . . . . 0.0 110.903 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.462 ' H ' ' CB ' ' A' ' 52' ' ' SER . 47.1 t -152.36 114.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.357 2.263 . . . . 0.0 112.719 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . . . -143.98 167.0 23.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.488 1.515 . . . . 0.0 110.448 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 122.95 10.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.255 1.422 . . . . 0.0 107.45 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -139.23 164.01 30.95 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 112.315 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.11 151.73 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -131.83 112.16 12.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.958 1.703 . . . . 0.0 110.937 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -65.91 105.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.252 1.421 . . . . 0.0 110.655 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -73.47 153.46 40.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.203 1.001 . . . . 0.0 110.998 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.5 p -59.63 -20.56 56.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -76.27 -4.45 42.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 114.058 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.1 6.3 71.84 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.293 1.425 . . . . 0.0 114.851 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.59 177.28 5.86 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.235 1.414 . . . . 0.0 111.293 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.9 m -133.48 112.0 11.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.323 1.049 . . . . 0.0 113.12 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 tp -73.45 122.84 22.78 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.66 108.57 3.14 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.0 154.76 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.337 0.589 . . . . 0.0 110.828 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.38 148.22 44.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.532 1.133 . . . . 0.0 108.924 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' A' ' 31' ' ' ILE . 21.3 p90 -162.17 147.05 12.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.234 1.016 . . . . 0.0 110.488 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.2 m -151.55 165.4 34.36 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.94 1.296 . . . . 0.0 108.379 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.51 96.68 23.39 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.54 0.818 0 C-N-CA 122.976 2.451 . . . . 0.0 114.718 -175.018 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 121.86 0.838 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -84.16 144.41 29.01 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.259 1.024 . . . . 0.0 112.547 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -153.45 150.93 29.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.472 0.653 . . . . 0.0 111.831 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.61 151.21 4.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.046 1.338 . . . . 0.0 111.079 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.0 135.55 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.261 1.824 . . . . 0.0 108.748 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -146.43 155.01 42.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.102 1.361 . . . . 0.0 109.872 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.16 107.16 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.396 1.478 . . . . 0.0 107.863 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.66 104.83 4.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.277 1.031 . . . . 0.0 109.22 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t -65.6 97.02 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.799 -1.188 . . . . 0.0 110.097 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.8 19.26 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 127.194 2.33 . . . . 0.0 110.317 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -126.93 129.85 48.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.107 1.763 . . . . 0.0 111.018 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.75 121.68 5.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.841 1.657 . . . . 0.0 111.563 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.59 175.36 5.66 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.483 1.113 . . . . 0.0 110.85 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.59 115.06 22.42 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.71 -0.619 . . . . 0.0 111.905 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -151.27 -174.53 4.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.441 1.096 . . . . 0.0 111.682 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.56 -51.7 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.512 1.125 . . . . 0.0 110.668 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.06 46.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.202 0.906 . . . . 0.0 113.83 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.7 ttt -66.04 -65.2 0.71 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.629 0.714 . . . . 0.0 110.185 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -54.14 -31.78 53.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.47 1.108 . . . . 0.0 112.683 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.47 -47.88 82.05 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.802 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -23.69 67.44 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.464 -1.397 . . . . 0.0 113.806 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.09 -18.17 53.81 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.431 1.492 . . . . 0.0 114.44 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.76 -31.33 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.905 1.282 . . . . 0.0 114.433 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.52 -5.74 13.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.0 2.12 . . . . 0.0 112.268 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.03 -88.68 0.46 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.244 1.878 . . . . 0.0 110.744 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -160.98 73.08 2.7 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.695 1.598 . . . . 0.0 111.692 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.26 177.63 8.37 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.731 2.287 . . . . 0.0 114.914 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -127.03 -178.24 4.34 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.231 2.212 . . . . 0.0 113.056 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 144.65 48.85 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.378 -1.451 . . . . 0.0 111.848 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.97 116.5 0.76 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.587 1.089 . . . . 0.0 111.952 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -115.46 68.78 0.72 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.348 1.459 . . . . 0.0 112.83 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 64.55 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.281 2.633 . . . . 0.0 113.758 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.78 142.11 3.48 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.982 1.277 . . . . 0.0 112.5 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -67.82 147.9 51.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.481 0.713 . . . . 0.0 111.951 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -148.41 122.82 9.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.706 1.602 . . . . 0.0 110.926 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.12 141.58 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.987 0.915 . . . . 0.0 111.633 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -146.01 148.85 33.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.352 0.596 . . . . 0.0 110.452 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.53 92.72 8.6 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.92 -32.16 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.99 21.97 5.46 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -128.44 20.43 6.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.875 1.338 . . . . 0.0 114.445 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.85 12.11 83.11 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.348 -0.845 . . . . 0.0 113.827 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.87 166.97 23.2 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.41 1.884 . . . . 0.0 111.633 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 169.74 13.2 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.26 1.424 . . . . 0.0 109.824 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.81 167.52 23.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.897 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 137.02 54.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.295 1.438 . . . . 0.0 108.253 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.06 141.36 15.83 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.536 0.589 . . . . 0.0 112.632 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.22 101.97 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.516 1.526 . . . . 0.0 111.089 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.5 tpt -96.63 105.08 17.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.982 1.264 . . . . 0.0 110.998 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.8 p -114.7 145.36 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.08 0.952 . . . . 0.0 111.449 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -137.86 139.56 39.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.865 1.666 . . . . 0.0 111.968 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.6 -179.29 0.11 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 130.344 3.458 . . . . 0.0 108.744 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.09 -12.86 45.92 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 115.077 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.21 11.28 0.91 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.76 1.624 . . . . 0.0 114.769 -175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.96 169.11 12.76 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.546 -1.346 . . . . 0.0 113.745 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 19.6 tptt -167.14 151.36 6.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 113.091 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.6 ptm -81.19 165.76 21.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -154.37 161.0 41.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.332 1.453 . . . . 0.0 110.782 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 mm -123.14 135.35 63.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -118.12 126.99 53.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.411 1.084 . . . . 0.0 108.289 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 14.5 pt -110.82 117.0 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -156.05 145.02 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.372 0.669 . . . . 0.0 112.322 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.509 1.924 . . . . 0.0 112.003 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.81 5.26 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 121.451 0.643 . . . . 0.0 110.188 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.43 -27.64 19.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.8 1.191 . . . . 0.0 113.039 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 p -145.79 155.27 42.82 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.109 1.364 . . . . 0.0 111.532 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -135.15 162.25 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.1 1.36 . . . . 0.0 110.435 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -72.51 -165.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 127.837 2.455 . . . . 0.0 111.231 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.05 -24.78 26.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.39 -19.62 34.89 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.53 1.062 . . . . 0.0 114.185 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.38 75.19 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.296 1.048 . . . . 0.0 111.81 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -85.67 -7.85 58.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.733 1.613 . . . . 0.0 114.15 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.92 149.94 46.09 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.204 1.002 . . . . 0.0 111.582 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -145.06 145.62 31.52 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.396 1.078 . . . . 0.0 110.528 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -51.77 -37.94 53.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.452 1.101 . . . . 0.0 113.359 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -56.26 -48.51 76.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.416 1.007 . . . . 0.0 112.651 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -52.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.658 1.583 . . . . 0.0 109.238 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.42 -41.39 65.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.537 1.535 . . . . 0.0 111.848 -175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.42 -51.95 67.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.414 1.486 . . . . 0.0 111.216 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -38.32 89.35 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.337 -0.852 . . . . 0.0 112.086 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.89 -51.09 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 110.959 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.11 -33.98 76.63 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.52 -23.04 63.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.1 1.36 . . . . 0.0 113.404 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.47 -23.34 49.29 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.648 -1.282 . . . . 0.0 113.471 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 127.162 2.185 . . . . 0.0 112.629 177.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.67 142.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.9 111.17 17.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.582 1.953 . . . . 0.0 110.722 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -127.36 127.12 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.434 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.37 30.56 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.468 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 69' ' ' LEU . 2.6 mp -136.85 142.49 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.874 1.27 . . . . 0.0 110.6 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.16 111.7 22.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.052 1.741 . . . . 0.0 111.546 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.88 89.65 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.132 1.773 . . . . 0.0 111.741 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -132.1 7.66 4.32 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.914 0.886 . . . . 0.0 112.684 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t -81.29 -6.98 59.47 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.55 20.02 36.06 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.594 1.092 . . . . 0.0 115.527 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.74 121.56 2.81 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.499 1.523 . . . . 0.0 111.667 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -57.43 144.13 37.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.594 1.558 . . . . 0.0 111.446 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -107.66 168.06 9.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.246 0.618 . . . . 0.0 112.547 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.8 m -153.74 105.16 2.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.895 2.078 . . . . 0.0 109.787 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.0 139.4 56.33 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.651 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.01 -54.56 2.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.38 1.072 . . . . 0.0 112.349 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -153.53 171.15 19.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.17 0.988 . . . . 0.0 111.187 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 136.23 43.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.153 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -119.16 136.54 54.13 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.883 1.273 . . . . 0.0 110.286 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.96 145.26 12.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.643 1.577 . . . . 0.0 112.068 -176.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -115.61 -11.02 11.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.582 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -151.47 137.75 18.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.031 1.732 . . . . 0.0 112.128 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 39.1 3.17 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.017 0.818 . . . . 0.0 114.6 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 m -30.19 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.04 2.936 . . . . 0.0 113.158 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -71.94 162.81 28.91 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.282 -0.886 . . . . 0.0 112.732 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -132.61 5.88 4.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.159 0.983 . . . . 0.0 113.581 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.33 163.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.051 1.74 . . . . 0.0 112.523 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.81 123.44 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.867 1.267 . . . . 0.0 112.856 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.7 130.37 61.55 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -70.21 142.58 46.3 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.844 2.362 . . . . 0.0 109.696 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 62' ' ' PHE . 2.0 pm0 -85.2 -77.86 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.904 0.882 . . . . 0.0 110.59 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.4 ' H ' ' HG2' ' A' ' 61' ' ' GLU . 3.6 m-85 -100.86 149.25 24.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.632 1.173 . . . . 0.0 110.506 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.0 133.34 14.14 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.131 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.11 -151.69 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.257 3.972 . . . . 0.0 113.796 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -119.63 15.76 12.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.076 1.751 . . . . 0.0 113.678 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -141.61 18.24 2.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.882 1.673 . . . . 0.0 113.775 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -136.77 -173.3 3.4 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.974 1.309 . . . . 0.0 113.238 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.87 -178.49 6.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.492 1.517 . . . . 0.0 110.339 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -146.22 160.93 41.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.525 -0.734 . . . . 0.0 111.32 178.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mt -141.39 157.3 45.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.481 1.112 . . . . 0.0 109.562 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.67 159.04 43.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.191 1.796 . . . . 0.0 108.593 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 m -150.05 140.07 22.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 110.516 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.96 165.07 13.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.028 1.299 . . . . 0.0 114.272 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 113.773 -175.554 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' H ' ' CG2' ' A' ' 104' ' ' VAL . . . . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.6 t -150.35 111.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.988 1.315 . . . . 0.0 113.131 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -140.57 164.61 29.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.228 1.014 . . . . 0.0 112.016 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 124.31 10.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.439 1.096 . . . . 0.0 108.972 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -132.95 160.6 36.6 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.183 0.993 . . . . 0.0 113.186 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.51 149.0 44.5 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -127.58 114.41 17.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.827 2.051 . . . . 0.0 110.58 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -71.22 116.71 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 111.05 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.98 23.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.016 2.126 . . . . 0.0 111.491 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -19.7 30.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.74 1.65 22.36 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.97 39.64 11.43 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 125.403 1.478 . . . . 0.0 112.09 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.547 HD21 HG22 ' A' ' 119' ' ' ILE . 9.4 p-10 -137.59 170.59 15.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.008 2.523 . . . . 0.0 113.16 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.9 m -131.7 110.22 10.74 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.28 117.35 14.93 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.382 1.073 . . . . 0.0 110.384 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.43 117.16 5.78 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.08 0.847 . . . . 0.0 112.711 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.95 164.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.727 0.811 . . . . 0.0 110.832 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.05 161.37 38.97 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.243 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 14.9 p90 -166.59 160.44 15.15 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.718 1.207 . . . . 0.0 111.565 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 119.85 0.94 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.968 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.413 ' CG2' ' H ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -81.35 146.03 56.91 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 N--CA 1.455 -0.779 0 C-N-CA 121.878 1.719 . . . . 0.0 109.712 175.245 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -72.81 143.25 47.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.626 0.77 . . . . 0.0 112.033 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -152.99 151.66 30.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.29 0.636 . . . . 0.0 109.914 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -167.52 138.04 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.37 1.468 . . . . 0.0 109.305 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.56 134.21 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.783 1.233 . . . . 0.0 109.187 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -152.41 155.49 37.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.41 1.084 . . . . 0.0 109.497 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.547 HG22 HD21 ' A' ' 96' ' ' ASN . 67.9 mt -109.37 101.72 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.03 99.25 0.63 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.134 -0.979 . . . . 0.0 109.39 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -66.1 87.15 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.231 1.015 . . . . 0.0 110.634 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.33 -134.33 3.32 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.512 2.482 . . . . 0.0 110.321 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -149.99 109.9 4.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.717 1.607 . . . . 0.0 111.33 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -144.53 120.7 10.82 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.223 1.809 . . . . 0.0 112.139 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 174.5 5.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.692 1.197 . . . . 0.0 110.771 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.61 114.47 20.32 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.566 . . . . 0.0 110.043 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.97 -165.85 1.59 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.847 1.659 . . . . 0.0 110.471 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.37 -50.4 30.76 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.971 1.308 . . . . 0.0 110.996 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.52 -27.77 54.79 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.427 1.013 . . . . 0.0 114.609 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.8 ttt -75.59 -61.3 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.041 0.921 . . . . 0.0 110.179 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -53.96 -32.24 53.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.903 1.281 . . . . 0.0 112.665 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.39 -42.97 99.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 107.478 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -30.37 70.2 Favored 'General case' 0 CA--C 1.559 1.315 0 O-C-N 120.769 -1.207 . . . . 0.0 108.034 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.2 mt -75.76 -37.52 59.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.672 1.589 . . . . 0.0 113.879 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -27.93 14.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.421 1.488 . . . . 0.0 114.766 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.4 -40.23 2.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.383 1.473 . . . . 0.0 112.225 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.6 -70.68 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.149 1.833 . . . . 0.0 112.401 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.46 73.38 4.33 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 142.48 63.34 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.997 1.798 . . . . 0.0 112.996 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -122.97 -178.92 4.09 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.898 2.079 . . . . 0.0 109.275 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.73 143.43 50.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.381 1.472 . . . . 0.0 112.472 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.23 101.53 2.8 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.368 1.461 . . . . 0.0 113.446 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.57 19.96 4.26 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 54.92 80.22 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.148 2.179 . . . . 0.0 113.234 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.34 165.84 23.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.029 1.299 . . . . 0.0 113.327 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.447 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 9.2 m95 -68.86 130.1 41.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.066 1.346 . . . . 0.0 111.586 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -139.48 118.8 12.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.63 1.172 . . . . 0.0 113.654 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.88 145.21 30.15 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.274 1.43 . . . . 0.0 109.541 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -143.84 156.39 44.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.9 1.28 . . . . 0.0 109.675 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.31 100.2 13.04 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.94 -31.94 63.38 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.69 30.7 6.7 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 119.302 2.481 . . . . 0.0 119.302 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -131.67 -21.86 2.45 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.96 -15.67 1.74 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 118.666 0.666 . . . . 0.0 114.632 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.26 171.57 13.16 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 126.169 1.788 . . . . 0.0 110.029 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.18 164.44 19.48 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.322 1.049 . . . . 0.0 110.637 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.96 164.15 31.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.464 1.126 . . . . 0.0 112.757 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -128.57 125.39 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.227 1.811 . . . . 0.0 108.473 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.96 153.27 17.69 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.533 1.54 . . . . 0.0 112.863 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.447 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -129.48 149.73 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.728 1.611 . . . . 0.0 109.687 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 6.6 tpt -150.2 119.06 6.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.247 1.819 . . . . 0.0 109.387 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.9 122.46 32.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.313 1.845 . . . . 0.0 111.472 -175.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.9 p -87.85 73.61 9.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.885 1.674 . . . . 0.0 112.397 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.45 17.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.227 1.011 . . . . 0.0 113.021 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.87 -7.41 88.0 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.89 1.233 . . . . 0.0 114.459 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -125.53 7.92 7.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.136 2.175 . . . . 0.0 113.721 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -128.59 174.31 9.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.18 1.392 . . . . 0.0 112.575 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.42 -178.55 6.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.965 1.706 . . . . 0.0 112.906 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.85 151.81 24.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.479 1.911 . . . . 0.0 109.983 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -162.26 148.1 13.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.269 1.428 . . . . 0.0 108.82 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.18 136.24 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.688 0.795 . . . . 0.0 108.94 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -121.46 124.58 44.81 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.296 1.039 . . . . 0.0 108.71 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 5.3 pt -94.99 145.53 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.778 0.831 . . . . 0.0 109.51 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.5 t -159.0 170.01 23.03 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.788 -0.57 . . . . 0.0 112.171 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.972 1.709 . . . . 0.0 112.682 177.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 111.239 0.089 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.15 -174.31 0.48 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.578 0.751 . . . . 0.0 110.469 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.36 -31.76 7.12 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.402 -1.436 . . . . 0.0 111.538 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 p -146.39 155.96 42.97 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.543 1.537 . . . . 0.0 110.902 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.7 mm -136.56 166.91 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 126.334 1.854 . . . . 0.0 109.815 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -165.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.731 1.613 . . . . 0.0 111.339 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.12 -32.84 23.99 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.96 -14.65 37.45 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.995 1.283 . . . . 0.0 113.8 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.31 63.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.49 1.145 . . . . 0.0 111.291 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -85.71 -9.89 56.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.627 1.571 . . . . 0.0 114.258 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.49 143.2 54.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.454 1.101 . . . . 0.0 110.119 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.2 143.12 24.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.641 0.776 . . . . 0.0 109.959 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.06 -32.6 68.17 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -54.78 -51.06 66.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.452 1.101 . . . . 0.0 113.02 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.03 -52.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.18 -39.96 64.02 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.89 1.276 . . . . 0.0 112.432 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -52.22 -63.99 0.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.334 2.254 . . . . 0.0 110.237 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -66.51 -23.01 66.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -46.1 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.702 1.137 . . . . 0.0 111.91 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -26.38 61.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.205 1.002 . . . . 0.0 111.412 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.46 -43.35 49.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.489 1.916 . . . . 0.0 113.861 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -23.57 2.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.977 1.711 . . . . 0.0 114.841 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 127.607 2.363 . . . . 0.0 114.826 175.009 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.03 145.28 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 127.504 2.321 . . . . 0.0 112.335 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 168' ' ' LYS . . . -138.46 129.08 26.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 127.195 2.198 . . . . 0.0 111.819 175.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.43 144.98 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 120.26 1.391 . . . . 0.0 112.033 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.42 174.62 46.41 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.382 0.513 . . . . 0.0 114.382 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.75 114.73 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.247 1.819 . . . . 0.0 108.61 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.51 106.0 1.32 Allowed 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.403 -1.436 . . . . 0.0 110.966 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.411 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . 9.5 t-20 -82.03 92.95 6.88 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 123.519 1.628 . . . . 0.0 112.143 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.81 43.74 1.59 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.391 1.076 . . . . 0.0 110.525 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -2.22 16.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.295 1.838 . . . . 0.0 114.433 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.88 17.06 73.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.569 1.081 . . . . 0.0 115.046 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.19 129.35 5.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.949 1.737 . . . . 0.0 111.422 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -79.18 118.79 21.46 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 117.93 0.865 . . . . 0.0 109.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 37' ' ' ASN . 5.9 m0 -88.03 161.66 17.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 m -137.86 107.74 6.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.33 1.852 . . . . 0.0 110.618 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.57 156.01 31.24 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.069 -1.02 . . . . 0.0 111.461 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -57.98 1.2 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.098 1.359 . . . . 0.0 112.438 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -147.69 167.99 23.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.285 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.25 137.63 40.97 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.357 1.463 . . . . 0.0 110.705 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.71 134.08 50.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.246 1.419 . . . . 0.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 155.47 45.12 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.059 2.144 . . . . 0.0 110.419 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -119.95 -44.23 2.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.277 1.431 . . . . 0.0 111.624 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -121.46 97.36 5.47 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.022 1.329 . . . . 0.0 111.479 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.63 109.34 2.78 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.92 1.247 . . . . 0.0 112.662 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -64.68 179.66 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.575 1.15 . . . . 0.0 113.231 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -65.6 152.89 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.598 1.559 . . . . 0.0 113.141 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -147.25 -21.66 0.39 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.49 164.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.294 2.238 . . . . 0.0 111.954 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 tt -73.59 130.66 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.925 0.89 . . . . 0.0 109.95 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 tp -78.91 128.42 76.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.59 126.82 15.36 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.782 2.988 . . . . 0.0 111.067 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.55 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.296 -0.878 . . . . 0.0 112.531 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -109.72 143.83 38.96 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.449 1.1 . . . . 0.0 110.389 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.75 86.99 53.69 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.384 1.074 . . . . 0.0 109.192 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.98 136.93 16.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.061 2.507 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -46.94 146.73 1.56 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.786 1.235 . . . . 0.0 112.705 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.327 1.4 p 74.47 32.55 0.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.125 2.17 . . . . 0.0 111.996 -175.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -150.4 146.98 27.02 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.013 2.125 . . . . 0.0 110.799 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.65 -177.91 3.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.314 1.046 . . . . 0.0 109.588 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.75 142.8 19.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.529 0.732 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.32 -179.85 3.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.558 0.743 . . . . 0.0 110.433 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -159.01 159.33 34.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.905 1.682 . . . . 0.0 109.318 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -138.19 164.01 30.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.069 1.348 . . . . 0.0 110.89 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.94 -179.9 16.46 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.74 1.162 . . . . 0.0 113.398 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.6 t -140.86 123.99 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 127.982 2.513 . . . . 0.0 111.248 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -153.01 177.01 11.25 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.219 1.009 . . . . 0.0 111.875 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.7 125.71 11.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.345 1.458 . . . . 0.0 107.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -136.69 162.65 32.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.046 0.939 . . . . 0.0 110.52 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.11 150.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.454 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.88 123.49 40.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.534 1.534 . . . . 0.0 110.758 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.41 109.0 2.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.189 1.796 . . . . 0.0 110.881 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.0 mtp -71.63 155.36 40.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.67 0.788 . . . . 0.0 111.68 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -58.17 -30.46 66.43 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 113.164 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 1.26 11.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.909 1.684 . . . . 0.0 114.687 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.65 9.29 85.82 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.756 -1.215 . . . . 0.0 114.341 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -89.05 178.87 6.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.079 1.752 . . . . 0.0 109.819 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -142.58 110.25 5.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.398 -1.439 . . . . 0.0 111.488 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.3 tp -77.09 121.02 22.98 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.67 107.64 3.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.483 1.516 . . . . 0.0 112.857 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -80.06 168.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 122.273 1.035 . . . . 0.0 111.377 174.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.446 ' SD ' ' CZ3' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -146.46 157.54 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.606 1.962 . . . . 0.0 109.511 174.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -165.08 134.07 3.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.031 1.332 . . . . 0.0 108.374 175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.4 m -147.05 130.61 16.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.116 0.567 . . . . 0.0 110.165 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.3 132.54 42.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.902 -0.571 . . . . 0.0 111.203 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.542 0.881 0 C-N-CA 122.773 2.315 . . . . 0.0 113.038 177.047 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.421 0.629 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CZ3' ' SD ' ' A' ' 101' ' ' MET . 40.8 p-90 -84.38 152.93 23.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.635 0.774 . . . . 0.0 110.358 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -158.97 128.48 5.58 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 109.452 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.412 ' HB3' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -177.82 126.73 0.13 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.766 1.227 . . . . 0.0 111.12 -176.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.5 m -118.01 166.74 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.314 1.046 . . . . 0.0 111.927 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.91 158.17 43.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.107 0.963 . . . . 0.0 111.39 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.27 106.7 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.01 1.724 . . . . 0.0 107.195 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.39 99.13 2.87 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.055 -1.028 . . . . 0.0 108.954 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.4 t -65.63 88.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.822 -1.174 . . . . 0.0 110.911 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.47 -141.39 8.85 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.691 2.091 . . . . 0.0 110.633 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -128.81 124.02 34.32 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.956 1.702 . . . . 0.0 111.284 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -149.25 120.03 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.471 1.508 . . . . 0.0 111.383 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.61 170.6 10.43 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.322 0.649 . . . . 0.0 110.633 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.28 115.71 18.19 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.71 -178.4 7.26 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.909 1.284 . . . . 0.0 113.629 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -51.79 -41.04 61.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.349 1.46 . . . . 0.0 113.778 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.93 88.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.091 0.853 . . . . 0.0 112.75 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.7 ttm -64.68 -50.97 64.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.797 0.799 . . . . 0.0 110.437 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -61.11 -34.1 74.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.691 0.797 . . . . 0.0 112.769 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.74 -35.14 79.59 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.784 -1.198 . . . . 0.0 111.532 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -12.71 55.85 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.785 -1.197 . . . . 0.0 113.566 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 mt -91.69 -54.1 4.02 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.336 1.855 . . . . 0.0 109.318 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -75.37 -43.32 50.97 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.84 -35.4 7.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.818 1.247 . . . . 0.0 112.999 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -48.79 -69.33 1.01 Allowed Glycine 0 N--CA 1.47 0.911 0 C-N-CA 125.234 1.397 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -164.47 84.27 1.2 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.994 0.917 . . . . 0.0 111.591 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.78 143.92 38.17 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.914 1.743 . . . . 0.0 113.158 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 116' ' ' ASP . 2.3 m-85 -114.92 -168.57 1.4 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.397 1.479 . . . . 0.0 112.003 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.79 127.82 48.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.72 2.008 . . . . 0.0 111.787 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.85 96.02 0.64 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 125.04 1.305 . . . . 0.0 114.48 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.91 79.65 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.254 1.421 . . . . 0.0 111.748 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.7 p30 35.28 67.27 0.27 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.835 2.454 . . . . 0.0 115.363 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 135.6 3.48 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.374 0.987 . . . . 0.0 113.231 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -64.88 144.89 56.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.333 1.053 . . . . 0.0 111.646 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -145.36 135.67 24.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.556 1.142 . . . . 0.0 112.121 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -119.39 144.82 46.7 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 110.399 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -151.77 163.66 38.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.623 1.169 . . . . 0.0 110.894 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.32 91.78 7.38 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.35 -34.51 47.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.873 1.269 . . . . 0.0 113.871 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 115.58 39.05 0.94 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 118.037 1.975 . . . . 0.0 118.037 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -137.02 -32.78 0.78 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.87 -23.57 1.15 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.149 1.357 . . . . 0.0 114.006 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 173.09 6.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.478 1.911 . . . . 0.0 111.242 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -127.15 160.02 32.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.841 1.256 . . . . 0.0 110.509 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.34 39.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.366 0.603 . . . . 0.0 111.9 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.87 132.01 56.77 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.257 1.423 . . . . 0.0 107.293 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.75 153.79 16.67 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.106 0.86 . . . . 0.0 112.648 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 151.83 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.657 1.183 . . . . 0.0 111.766 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 21.1 tpp -147.43 91.88 2.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.656 1.583 . . . . 0.0 109.124 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.1 p -76.5 150.12 36.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 109.852 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 m -44.37 -69.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.312 1.845 . . . . 0.0 115.711 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -176.03 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.933 1.693 . . . . 0.0 112.398 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -47.15 89.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.212 0 C-N-CA 128.102 2.763 . . . . 0.0 115.432 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 45.5 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.078 2.151 . . . . 0.0 112.339 -175.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -143.43 159.42 42.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 113.426 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 2.2 mmtm -148.03 173.2 13.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.555 1.542 . . . . 0.0 113.922 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.3 ptm -99.49 154.56 18.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.994 1.717 . . . . 0.0 112.15 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -160.73 157.15 26.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.64 120.83 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.037 1.335 . . . . 0.0 109.573 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.43 101.64 12.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.407 1.083 . . . . 0.0 110.682 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 24.8 pt -91.66 133.33 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.134 0.574 . . . . 0.0 110.338 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.1 t -150.61 157.55 43.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.649 1.179 . . . . 0.0 111.386 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.608 1.163 . . . . 0.0 112.268 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.576 0.227 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 170.35 179.23 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.659 3.584 . . . . 0.0 107.759 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.76 -34.6 1.63 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.863 -1.148 . . . . 0.0 113.691 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -135.04 146.43 48.97 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.891 1.346 . . . . 0.0 111.675 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.0 mm -136.05 177.83 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.278 1.831 . . . . 0.0 109.443 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.32 165.52 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.868 2.067 . . . . 0.0 110.755 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -28.95 65.14 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.186 -1.571 . . . . 0.0 115.068 -175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.87 -7.26 3.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.389 1.471 . . . . 0.0 114.108 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 -35.56 63.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.115 1.366 . . . . 0.0 113.848 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -120.73 -2.18 9.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.301 1.441 . . . . 0.0 113.971 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 tp -86.68 133.56 33.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.931 0.892 . . . . 0.0 112.012 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.7 m -144.75 -94.54 0.1 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.213 1.005 . . . . 0.0 110.16 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -158.68 -38.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.679 1.992 . . . . 0.0 110.804 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -52.81 -56.1 18.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.53 -47.16 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -43.3 68.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.533 1.133 . . . . 0.0 113.314 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.37 -62.08 1.84 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.361 2.264 . . . . 0.0 110.392 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -67.07 -30.46 70.52 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 117.803 -1.094 . . . . 0.0 113.658 176.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -52.26 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.212 1.369 . . . . 0.0 109.453 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -33.55 76.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.64 0.376 . . . . 0.0 111.685 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.47 -33.21 58.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 114.763 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -21.59 11.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.596 1.158 . . . . 0.0 113.829 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.727 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 24' ' ' LEU . 35.8 mmtt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.37 152.36 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.438 1.895 . . . . 0.0 111.061 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.95 114.72 20.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.131 1.773 . . . . 0.0 108.592 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.75 133.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.449 1.5 . . . . 0.0 110.201 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.67 177.77 38.18 Favored Glycine 0 N--CA 1.454 -0.143 0 O-C-N 121.492 -0.755 . . . . 0.0 112.392 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.475 ' H ' HD13 ' A' ' 69' ' ' LEU . 1.1 mp -138.95 146.9 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.247 1.019 . . . . 0.0 110.471 -174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 106.83 19.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.293 1.837 . . . . 0.0 111.474 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.99 98.54 8.65 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.286 1.035 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -138.1 13.07 2.86 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -9.0 59.86 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.06 31.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 130.33 4.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.282 1.42 . . . . 0.0 112.217 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.1 m -62.25 141.51 58.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.94 1.696 . . . . 0.0 111.347 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -104.65 170.09 8.08 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.8 m -152.04 107.26 3.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.81 2.044 . . . . 0.0 110.555 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.18 152.33 45.64 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.855 -1.153 . . . . 0.0 109.807 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.11 -43.4 2.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.93 0.892 . . . . 0.0 112.357 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.76 -175.47 1.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.826 2.051 . . . . 0.0 110.578 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.45 139.03 18.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.421 . . . . 0.0 110.678 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.88 112.98 24.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.573 1.549 . . . . 0.0 109.174 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.73 150.52 35.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.189 2.195 . . . . 0.0 109.418 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.29 -43.58 2.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 111.089 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -137.32 111.91 8.73 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.029 1.332 . . . . 0.0 111.941 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.39 88.87 1.72 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 124.658 1.123 . . . . 0.0 111.99 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.6 m -81.16 99.17 8.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.229 1.012 . . . . 0.0 110.976 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 t -63.37 166.5 6.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -128.92 -4.01 5.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.848 1.659 . . . . 0.0 113.648 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.8 160.0 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.026 0.931 . . . . 0.0 112.564 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.35 126.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 112.793 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tt -86.33 119.72 71.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.866 1.266 . . . . 0.0 109.36 175.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 127.42 17.13 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 124.111 3.207 . . . . 0.0 111.438 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -79.44 -68.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.341 -0.849 . . . . 0.0 111.078 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.14 143.17 31.56 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.785 -0.572 . . . . 0.0 110.434 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.92 134.08 25.54 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 109.03 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.03 152.3 45.8 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.392 2.728 . . . . 0.0 111.858 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -65.38 17.04 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.856 2.462 . . . . 0.0 116.339 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -149.18 34.41 0.73 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 128.732 2.813 . . . . 0.0 111.162 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -153.46 163.86 39.21 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.414 -1.429 . . . . 0.0 112.201 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.05 175.02 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 111.401 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -144.68 159.74 42.33 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.338 0.655 . . . . 0.0 111.789 175.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.7 mt -139.21 158.81 43.52 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.784 1.234 . . . . 0.0 109.179 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 163.17 32.48 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.933 2.493 . . . . 0.0 108.019 175.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -151.04 178.26 9.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.214 1.806 . . . . 0.0 108.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.46 -177.51 31.62 Favored Glycine 0 N--CA 1.471 0.985 0 O-C-N 121.083 -1.011 . . . . 0.0 113.612 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.138 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -143.75 115.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.368 2.667 . . . . 0.0 111.784 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.33 178.98 9.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.916 1.686 . . . . 0.0 110.614 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.28 115.37 3.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.835 1.254 . . . . 0.0 108.24 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -122.68 170.94 9.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.549 1.139 . . . . 0.0 113.031 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.44 154.13 51.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -128.11 121.56 29.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.771 2.029 . . . . 0.0 112.376 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -74.03 104.75 4.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.445 1.898 . . . . 0.0 111.945 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 mtp -69.66 151.98 45.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.539 1.536 . . . . 0.0 113.02 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -30.65 65.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.483 1.513 . . . . 0.0 113.624 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -66.07 -13.73 60.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.588 1.155 . . . . 0.0 113.454 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.25 28.58 11.44 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.991 1.281 . . . . 0.0 114.175 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.37 168.75 10.34 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.757 1.623 . . . . 0.0 110.526 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.6 m -131.34 102.53 6.0 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.588 -1.32 . . . . 0.0 112.926 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 tp -73.66 124.56 26.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.818 -1.176 . . . . 0.0 112.188 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.07 102.46 2.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.729 1.157 . . . . 0.0 112.226 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.33 171.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.161 0.984 . . . . 0.0 111.955 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 2.3 ttp -144.67 144.78 31.41 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -161.06 142.27 11.68 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -158.15 154.45 27.45 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.074 1.349 . . . . 0.0 110.166 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.3 t -111.35 101.07 49.69 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.455 -0.744 0 C-N-CA 122.89 2.393 . . . . 0.0 111.046 178.338 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -86.49 158.28 19.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.904 0.882 . . . . 0.0 111.908 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.481 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.5 p-90 -160.97 162.13 31.8 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.874 1.27 . . . . 0.0 110.63 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 170.74 139.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.087 2.555 . . . . 0.0 110.511 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.87 122.09 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.663 1.585 . . . . 0.0 108.663 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -127.72 162.37 26.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.491 2.316 . . . . 0.0 109.886 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.6 mt -108.38 121.25 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.895 1.678 . . . . 0.0 108.489 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -84.11 101.99 12.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 t -52.92 139.61 26.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.16 -0.962 . . . . 0.0 111.025 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.04 -118.56 4.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.788 1.185 . . . . 0.0 110.336 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -136.07 137.35 41.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.233 1.813 . . . . 0.0 111.259 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -159.52 117.67 2.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.882 1.273 . . . . 0.0 112.734 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 174.49 4.7 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.919 0.888 . . . . 0.0 111.25 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.54 121.79 31.3 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.799 -0.563 . . . . 0.0 110.004 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.71 177.07 10.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.95 0.9 . . . . 0.0 111.156 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -52.06 -45.35 64.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.002 0.921 . . . . 0.0 112.075 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.93 -50.06 63.37 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.725 0.679 . . . . 0.0 112.685 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.74 -55.97 28.27 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.461 0.63 . . . . 0.0 110.303 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -44.68 36.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 112.608 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.409 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 1.4 tt0 -69.36 -33.52 73.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.747 1.619 . . . . 0.0 108.944 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.58 -14.9 2.35 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.113 1.365 . . . . 0.0 113.456 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.1 mp -90.49 -21.73 21.7 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.232 1.413 . . . . 0.0 113.785 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -97.5 -42.57 7.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.446 2.298 . . . . 0.0 113.151 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.409 ' CE1' ' HG2' ' A' ' 132' ' ' GLU . 2.2 p90 -115.09 -26.87 7.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.4 -32.12 81.87 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.349 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 176.35 71.16 0.08 OUTLIER Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 130.117 3.367 . . . . 0.0 111.714 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.47 142.32 48.9 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.644 2.229 . . . . 0.0 113.266 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -129.45 177.79 6.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.247 1.819 . . . . 0.0 112.848 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -115.97 125.85 53.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.921 2.088 . . . . 0.0 111.059 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.5 109.89 1.32 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.401 1.477 . . . . 0.0 109.545 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -160.05 89.17 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.436 1.494 . . . . 0.0 110.24 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.81 101.34 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.385 2.674 . . . . 0.0 115.147 174.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.13 134.54 3.33 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.102 1.334 . . . . 0.0 111.686 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -64.43 145.43 56.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.713 0.805 . . . . 0.0 112.176 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.19 130.47 19.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 112.743 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 156.92 47.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.055 2.142 . . . . 0.0 111.216 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.6 19.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.021 1.728 . . . . 0.0 111.585 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -64.55 102.22 0.53 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.349 1.46 . . . . 0.0 109.387 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.94 -39.44 78.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.62 11.43 5.5 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -132.92 -34.11 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.131 1.466 . . . . 0.0 114.456 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 138.65 35.33 0.16 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.893 1.235 . . . . 0.0 113.98 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.82 163.46 37.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 110.591 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -136.25 103.82 5.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.333 1.853 . . . . 0.0 112.55 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.09 159.97 20.07 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.159 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.68 139.1 54.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.767 174.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.18 136.23 11.84 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.403 1.478 . . . . 0.0 113.292 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -116.12 138.9 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.166 1.386 . . . . 0.0 111.145 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.1 tpt -121.87 130.98 53.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.427 1.012 . . . . 0.0 109.317 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 47.2 p -137.24 144.12 42.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.444 1.098 . . . . 0.0 110.28 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.3 t -148.33 -174.05 4.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.247 1.419 . . . . 0.0 111.56 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.09 42.26 5.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.789 2.035 . . . . 0.0 113.966 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.83 73.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.906 1.241 . . . . 0.0 112.637 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 35.92 67.07 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.98 2.512 . . . . 0.0 113.866 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -139.12 172.81 12.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.777 0.831 . . . . 0.0 112.822 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.32 171.49 20.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 112.541 -175.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 142.16 28.01 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.218 1.007 . . . . 0.0 112.048 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -133.13 155.8 48.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.625 1.57 . . . . 0.0 109.827 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.91 125.41 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.847 1.259 . . . . 0.0 110.181 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -108.06 115.99 31.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.913 1.285 . . . . 0.0 110.113 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.42 129.76 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 0.0 110.157 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.5 m -171.65 172.09 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.025 1.33 . . . . 0.0 111.566 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.487 1.115 . . . . 0.0 113.008 178.072 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.42 -59.87 2.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.35 -36.84 0.16 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 126.786 2.136 . . . . 0.0 117.517 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.2 p -138.16 151.75 48.04 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 110.918 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.71 162.42 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.457 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 pt -70.36 -169.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.554 1.942 . . . . 0.0 110.409 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.33 -22.08 17.72 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.79 11.43 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.623 1.106 . . . . 0.0 113.714 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.86 83.82 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.284 1.042 . . . . 0.0 111.856 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -80.74 -9.61 59.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.859 1.264 . . . . 0.0 113.698 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.4 159.23 21.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.748 1.219 . . . . 0.0 112.636 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.51 145.88 27.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.867 0.867 . . . . 0.0 109.846 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -56.32 -30.89 63.15 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -58.3 -52.96 63.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.061 0.944 . . . . 0.0 112.371 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.91 -46.56 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -40.65 60.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.425 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.07 -58.04 9.26 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.382 1.473 . . . . 0.0 112.116 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -23.78 61.51 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -44.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.087 1.312 . . . . 0.0 111.227 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -28.96 61.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.142 0.977 . . . . 0.0 112.189 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.14 -39.25 34.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.142 1.377 . . . . 0.0 112.185 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -48.32 -24.82 1.32 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.716 2.406 . . . . 0.0 113.263 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 6.5 tt . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 126.287 1.835 . . . . 0.0 111.689 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.62 139.13 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.004 0.921 . . . . 0.0 112.917 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.01 101.67 6.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.481 1.512 . . . . 0.0 113.462 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -107.81 118.24 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 120.259 -1.526 . . . . 0.0 109.695 174.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.86 155.56 23.82 Favored Glycine 0 N--CA 1.46 0.293 0 O-C-N 121.924 -0.485 . . . . 0.0 113.006 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.81 99.46 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.532 0.733 . . . . 0.0 111.637 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.36 102.99 0.26 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.878 1.271 . . . . 0.0 111.655 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -90.72 106.18 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.735 0.778 . . . . 0.0 112.877 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.266 31.3 tt0 -150.7 19.54 0.81 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.02 0.914 . . . . 0.0 111.278 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -5.1 20.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.258 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.76 17.44 51.9 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.525 1.536 . . . . 0.0 114.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.55 115.26 0.85 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.815 1.674 . . . . 0.0 111.377 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.7 m -55.52 148.53 15.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.066 1.347 . . . . 0.0 111.466 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -119.72 172.51 7.64 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.572 -0.705 . . . . 0.0 112.63 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -136.15 113.22 10.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.063 2.145 . . . . 0.0 111.458 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 105.65 3.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.839 0.856 . . . . 0.0 110.648 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -56.83 9.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.056 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.421 ' ND2' HH11 ' A' ' 125' ' ' ARG . 42.8 t30 -167.48 172.4 9.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.792 1.637 . . . . 0.0 111.549 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.65 135.41 34.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.78 2.032 . . . . 0.0 111.412 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -119.13 129.02 54.81 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.715 1.606 . . . . 0.0 110.107 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.72 126.28 21.93 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.36 2.264 . . . . 0.0 110.041 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.45 -16.92 19.95 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.202 1.401 . . . . 0.0 110.888 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -76.37 102.56 5.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.36 1.064 . . . . 0.0 110.151 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.94 -118.83 11.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.423 1.487 . . . . 0.0 113.654 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -136.72 -172.71 3.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.937 1.695 . . . . 0.0 111.148 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.96 167.17 20.13 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.574 1.949 . . . . 0.0 112.36 174.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -144.96 -45.55 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.87 0.868 . . . . 0.0 110.834 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.86 156.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.553 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.31 142.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.926 1.29 . . . . 0.0 111.134 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.68 128.96 41.98 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.412 1.085 . . . . 0.0 110.0 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.58 116.52 3.83 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 124.636 3.557 . . . . 0.0 112.033 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.45 -33.82 63.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -124.08 150.91 44.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.103 0.961 . . . . 0.0 112.188 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.8 t -138.64 96.12 9.69 Favored Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 124.876 1.27 . . . . 0.0 108.239 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 171.75 14.56 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.238 1.959 . . . . 0.0 111.421 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -64.82 174.98 1.63 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.665 -0.647 . . . . 0.0 110.615 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 14.6 t 49.15 24.66 0.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.56 1.544 . . . . 0.0 113.783 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -151.77 130.12 12.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.709 2.004 . . . . 0.0 110.826 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.29 -173.67 2.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.652 1.215 . . . . 0.0 109.643 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.33 162.46 40.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.606 1.162 . . . . 0.0 109.835 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.78 166.35 21.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.566 1.174 . . . . 0.0 108.162 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.85 161.13 43.15 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.134 1.373 . . . . 0.0 107.95 175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 49.5 m -155.42 146.03 22.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.12 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.84 -161.57 36.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.782 0.706 . . . . 0.0 111.774 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.193 1.397 . . . . 0.0 111.025 178.045 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -147.63 135.17 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.732 2.013 . . . . 0.0 113.367 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -155.51 170.77 21.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.32 1.448 . . . . 0.0 110.803 174.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.06 114.98 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.226 1.41 . . . . 0.0 109.431 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -126.91 167.11 16.29 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.447 1.099 . . . . 0.0 112.24 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.54 154.15 44.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.12 0.568 . . . . 0.0 111.267 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.57 109.88 9.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.969 1.308 . . . . 0.0 113.337 -175.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -71.1 96.34 1.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.705 1.602 . . . . 0.0 111.03 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 151.7 45.09 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.836 -1.165 . . . . 0.0 111.339 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -16.36 15.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -70.34 1.33 5.06 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.657 1.983 . . . . 0.0 113.658 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.92 19.03 71.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.026 1.298 . . . . 0.0 114.013 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -121.3 175.81 5.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.035 1.734 . . . . 0.0 110.382 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -137.32 102.26 4.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.249 1.02 . . . . 0.0 112.956 -177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 tp -69.12 115.8 8.83 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.441 -0.787 . . . . 0.0 110.339 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.99 111.9 3.96 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.7 151.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.415 1.086 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -138.63 148.75 44.46 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.38 1.072 . . . . 0.0 110.002 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.7 p90 -157.21 159.57 37.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -164.46 150.57 10.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.1 t -108.73 98.59 29.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.537 0.666 0 C-N-CA 121.588 1.526 . . . . 0.0 110.794 175.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 121.572 0.701 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -84.45 135.73 34.14 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.361 1.064 . . . . 0.0 113.128 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -151.4 125.56 9.3 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.128 0.971 . . . . 0.0 109.733 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.02 150.23 11.25 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.967 -1.083 . . . . 0.0 111.999 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.9 143.34 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.049 1.74 . . . . 0.0 110.138 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -135.47 126.48 27.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.42 1.488 . . . . 0.0 109.144 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.8 mt -93.27 100.04 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.237 1.015 . . . . 0.0 109.316 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -68.41 100.98 1.15 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.845 -1.159 . . . . 0.0 109.406 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 80.64 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.723 1.209 . . . . 0.0 111.132 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.35 -106.75 0.29 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.317 2.389 . . . . 0.0 111.22 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -156.56 150.3 24.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.369 1.868 . . . . 0.0 111.553 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -164.96 106.82 0.82 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.236 1.415 . . . . 0.0 113.877 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.421 HH11 ' ND2' ' A' ' 47' ' ' ASN . 0.2 OUTLIER -59.43 153.4 19.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.368 1.067 . . . . 0.0 111.182 174.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.96 10.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.741 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.39 -175.76 5.21 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.633 1.173 . . . . 0.0 111.471 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.0 -46.07 68.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.408 -1.432 . . . . 0.0 111.909 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.2 -31.59 62.38 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.555 1.074 . . . . 0.0 113.767 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.6 tpt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -48.11 -39.46 20.5 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.432 1.093 . . . . 0.0 112.453 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.36 -42.17 96.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.203 1.001 . . . . 0.0 111.598 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.84 68.51 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.288 -1.508 . . . . 0.0 113.462 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.3 mt -90.24 -7.85 52.48 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.06 -27.31 3.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.45 1.5 . . . . 0.0 114.116 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.49 -37.11 3.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.729 1.212 . . . . 0.0 111.706 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.27 -67.53 1.33 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.229 1.871 . . . . 0.0 113.168 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.53 67.88 0.29 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.822 1.649 . . . . 0.0 113.429 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.66 173.02 15.21 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.938 1.759 . . . . 0.0 115.207 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.92 173.18 10.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.163 1.785 . . . . 0.0 112.972 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -115.8 137.61 51.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.724 2.01 . . . . 0.0 112.042 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -138.1 116.65 1.34 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.722 1.153 . . . . 0.0 111.541 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -126.25 69.95 1.23 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.74 94.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.13 2.572 . . . . 0.0 113.898 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.01 139.74 2.75 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.753 1.644 . . . . 0.0 111.49 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -70.25 127.44 32.78 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -129.53 146.29 51.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.589 1.156 . . . . 0.0 111.634 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -142.33 137.77 30.78 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.452 1.501 . . . . 0.0 110.362 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 158.33 43.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.713 1.205 . . . . 0.0 110.892 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 94.08 1.02 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.714 1.206 . . . . 0.0 109.553 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tp -51.53 -36.33 44.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.329 1.451 . . . . 0.0 113.752 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 120.38 33.97 0.98 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.11 -32.28 0.79 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.07 -28.3 0.9 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.987 1.28 . . . . 0.0 114.344 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 175.14 5.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.824 2.05 . . . . 0.0 112.541 175.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -118.19 145.38 45.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.222 1.009 . . . . 0.0 112.164 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.88 147.7 45.66 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 130.89 53.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.426 1.89 . . . . 0.0 107.851 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -123.11 155.16 17.26 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 122.149 0.861 . . . . 0.0 112.951 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.1 131.02 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.067 1.747 . . . . 0.0 108.505 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.1 tpp -126.42 103.31 7.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.403 0.547 . . . . 0.0 109.529 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 68.9 p -98.73 141.32 31.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.142 1.377 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 89.58 1.2 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.47 -0.769 . . . . 0.0 111.812 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.18 30.23 0.17 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.701 1.2 . . . . 0.0 114.083 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.85 134.12 1.76 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.888 1.232 . . . . 0.0 112.419 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 43.45 59.82 2.86 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.439 1.496 . . . . 0.0 112.576 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -137.56 163.43 31.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.925 1.29 . . . . 0.0 112.024 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -163.26 144.85 9.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.5 ptm -77.61 160.49 28.5 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.157 1.783 . . . . 0.0 113.927 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -154.21 160.93 42.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.173 1.789 . . . . 0.0 109.477 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.7 mm -131.84 113.99 23.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 C-N-CA 125.126 1.37 . . . . 0.0 109.692 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -110.63 139.82 45.54 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.72 0.808 . . . . 0.0 110.891 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 10.2 pt -120.95 132.68 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.715 0.806 . . . . 0.0 109.731 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.2 p -148.05 161.47 41.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.329 . . . . 0.0 112.846 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 117.748 -1.12 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.7 -49.33 4.25 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.555 1.07 . . . . 0.0 113.266 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.56 -33.15 1.42 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.53 1.538 . . . . 0.0 116.694 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.1 p -138.61 146.57 41.91 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.445 2.122 . . . . 0.0 111.972 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.41 161.44 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.781 -1.2 . . . . 0.0 108.817 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 pt -75.05 177.55 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.487 1.915 . . . . 0.0 111.858 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.45 16.34 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.02 -18.18 40.18 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.148 1.356 . . . . 0.0 112.674 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.59 70.04 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.642 1.577 . . . . 0.0 113.632 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -112.32 -2.59 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.892 1.677 . . . . 0.0 113.311 174.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.76 148.84 32.83 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.338 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.91 146.83 27.29 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 0.0 110.047 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.39 -34.66 66.92 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.006 0.821 . . . . 0.0 112.763 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -59.43 -56.26 24.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.671 1.189 . . . . 0.0 113.018 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.25 -45.87 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.303 0.641 . . . . 0.0 111.026 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -55.22 -38.7 68.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.183 0.993 . . . . 0.0 111.95 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -52.25 -57.65 9.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.258 1.823 . . . . 0.0 111.705 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.05 60.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 176.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.82 -49.17 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.762 1.164 . . . . 0.0 110.838 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -21.76 65.93 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -24.84 22.84 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -20.03 62.56 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.282 1.033 . . . . 0.0 113.595 -175.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 124.843 1.257 . . . . 0.0 114.031 175.03 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.95 0.405 . . . . 0.0 111.673 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.406 HD13 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -127.22 143.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.163 1.385 . . . . 0.0 111.491 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.98 100.22 6.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.592 1.957 . . . . 0.0 111.778 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.34 127.09 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.538 1.135 . . . . 0.0 109.918 174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.19 157.7 26.8 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.964 -0.636 . . . . 0.0 114.278 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.66 121.97 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.185 0.994 . . . . 0.0 110.229 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -74.1 105.12 5.17 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.363 -0.835 . . . . 0.0 110.689 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.62 91.95 4.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.223 1.809 . . . . 0.0 113.447 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.33 21.27 2.4 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.996 0.903 . . . . 0.0 112.392 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -7.07 54.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.698 1.599 . . . . 0.0 114.924 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.86 18.44 65.46 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.046 -1.034 . . . . 0.0 114.66 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.6 127.77 5.14 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.214 1.864 . . . . 0.0 110.736 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.3 m -69.4 131.01 44.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.73 0.765 . . . . 0.0 110.527 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.9 m0 -96.75 162.47 13.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.136 0.493 . . . . 0.0 111.954 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -138.83 107.46 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 127.1 2.16 . . . . 0.0 109.617 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 150.64 47.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.259 -0.9 . . . . 0.0 110.711 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -54.67 1.99 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.559 1.144 . . . . 0.0 111.993 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -156.92 172.22 19.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.974 0.91 . . . . 0.0 111.667 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.34 140.08 35.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.958 1.303 . . . . 0.0 111.841 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -118.65 127.44 53.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 109.659 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.4 119.56 39.82 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.217 1.807 . . . . 0.0 107.627 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -11.78 49.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.235 0.541 . . . . 0.0 111.295 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.01 114.25 7.43 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 108.961 -175.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.71 -165.88 53.87 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.228 0.918 . . . . 0.0 113.679 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 t -119.41 -170.75 1.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.665 1.586 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 163.06 22.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.709 1.604 . . . . 0.0 111.695 174.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -141.31 -44.46 0.37 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.093 0.957 . . . . 0.0 111.824 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.68 164.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.726 2.01 . . . . 0.0 111.421 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 tt -77.51 134.76 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.37 1.068 . . . . 0.0 112.032 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.83 128.98 52.2 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.148 0.979 . . . . 0.0 110.285 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.89 115.35 3.21 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 124.562 3.508 . . . . 0.0 112.14 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -62.65 -48.0 81.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -115.4 153.5 30.94 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.189 0.995 . . . . 0.0 111.577 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.75 88.87 13.59 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.434 1.094 . . . . 0.0 108.754 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.81 143.36 29.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.023 2.482 . . . . 0.0 111.336 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -48.88 153.98 0.78 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.526 1.13 . . . . 0.0 112.697 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 p 63.9 46.86 3.71 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.638 1.575 . . . . 0.0 110.047 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' A' ' 68' ' ' ALA . 17.4 ttmt -155.52 172.01 18.97 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.503 1.521 . . . . 0.0 111.09 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' H ' ' HG2' ' A' ' 67' ' ' LYS . . . -142.23 -176.67 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 108.77 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.5 144.98 9.38 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.34 -0.85 . . . . 0.0 110.619 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -117.36 170.15 8.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.893 1.33 . . . . 0.0 108.496 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.31 160.31 43.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.162 1.385 . . . . 0.0 107.708 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -147.38 148.12 31.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.832 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.8 -170.91 37.17 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.752 0.691 . . . . 0.0 112.165 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 125.853 1.661 . . . . 0.0 111.673 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -150.07 118.75 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.808 1.243 . . . . 0.0 112.946 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.42 160.0 43.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.529 1.532 . . . . 0.0 110.127 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.57 22.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -143.28 168.78 18.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 111.406 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.99 150.32 44.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.736 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -130.93 115.3 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.64 1.576 . . . . 0.0 110.373 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -73.7 104.08 4.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.382 1.473 . . . . 0.0 111.291 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -71.71 158.27 36.43 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.135 -0.978 . . . . 0.0 112.63 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -58.5 -24.97 61.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.831 1.252 . . . . 0.0 113.732 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 t -73.72 -3.24 27.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.998 1.319 . . . . 0.0 113.948 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.48 17.67 72.96 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.416 1.008 . . . . 0.0 114.265 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -102.83 163.18 12.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.594 1.558 . . . . 0.0 110.683 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -127.58 102.74 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.55 0.74 . . . . 0.0 112.982 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.72 116.45 12.11 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.418 -0.801 . . . . 0.0 110.855 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.09 104.16 3.1 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.306 1.431 . . . . 0.0 111.024 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.78 160.59 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 156.51 45.52 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.036 1.334 . . . . 0.0 110.261 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.406 ' CE1' HD13 ' A' ' 31' ' ' ILE . 10.7 p90 -166.96 155.25 9.83 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.501 1.521 . . . . 0.0 110.893 175.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.92 124.17 1.81 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.369 1.468 . . . . 0.0 110.38 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.1 t -81.73 131.99 56.0 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 122.501 2.134 . . . . 0.0 111.922 175.33 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.753 0.787 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -97.8 159.38 14.97 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -161.98 153.26 18.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.993 1.317 . . . . 0.0 109.494 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -174.47 104.18 0.1 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.122 1.369 . . . . 0.0 111.311 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.08 132.06 45.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.736 1.214 . . . . 0.0 108.507 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -140.48 160.98 38.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.118 1.367 . . . . 0.0 110.021 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 93.3 mt -118.65 112.5 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.498 1.519 . . . . 0.0 109.171 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.41 100.69 6.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -56.12 121.89 10.45 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.95 -1.094 . . . . 0.0 108.977 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.67 -140.46 15.41 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -128.41 132.09 48.48 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.391 1.476 . . . . 0.0 112.613 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -160.01 124.04 3.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.519 1.527 . . . . 0.0 112.238 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -179.28 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 111.459 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.83 109.19 19.57 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.842 -0.536 . . . . 0.0 111.154 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.89 -172.22 4.06 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 111.473 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.84 -47.51 31.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.893 0.877 . . . . 0.0 111.496 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.18 -47.44 55.3 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.402 1.001 . . . . 0.0 114.088 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.1 ttp -65.75 -52.23 52.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 111.276 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -56.31 -37.33 69.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.77 0.795 . . . . 0.0 112.767 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.42 -47.41 79.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.876 2.07 . . . . 0.0 110.049 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -26.98 69.08 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.696 1.135 . . . . 0.0 113.677 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mp -70.4 -49.19 51.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.955 1.302 . . . . 0.0 112.909 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.27 -29.54 13.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.24 -26.59 8.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.981 1.312 . . . . 0.0 112.156 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -63.83 4.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.449 1.5 . . . . 0.0 111.278 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -174.3 80.29 0.35 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.877 2.071 . . . . 0.0 111.331 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.22 154.2 66.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.134 1.89 . . . . 0.0 111.511 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -120.41 -164.58 1.11 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.576 1.95 . . . . 0.0 111.041 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.75 131.37 46.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.805 2.442 . . . . 0.0 111.509 -175.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -142.34 115.38 0.95 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.863 1.697 . . . . 0.0 111.054 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.78 -55.02 2.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 84.99 0.14 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 120.323 1.419 . . . . 0.0 111.398 174.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.26 163.86 24.01 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 122.0 0.778 . . . . 0.0 114.687 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.442 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 59.5 m95 -82.1 145.44 30.16 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.002 1.721 . . . . 0.0 111.983 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -161.12 123.42 3.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.217 1.407 . . . . 0.0 112.154 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.6 154.95 18.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.837 1.655 . . . . 0.0 111.651 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 145.81 24.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.794 1.237 . . . . 0.0 110.052 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -72.82 93.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -51.96 -36.88 50.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.085 1.354 . . . . 0.0 113.841 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.15 40.22 2.14 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.97 -32.48 0.96 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.73 -34.36 0.68 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.739 1.161 . . . . 0.0 113.548 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.31 172.63 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.168 1.787 . . . . 0.0 111.998 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -127.04 165.17 19.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.607 1.163 . . . . 0.0 110.603 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.48 163.6 39.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 146' ' ' TRP . 6.3 tptt -119.99 127.29 52.48 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.504 1.522 . . . . 0.0 108.153 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.36 146.76 17.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.815 0.721 . . . . 0.0 111.879 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.442 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -124.95 131.15 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 125.085 1.354 . . . . 0.0 109.313 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 125.89 36.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.07 0.85 . . . . 0.0 108.755 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 19.8 p -126.1 137.5 53.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.05 1.74 . . . . 0.0 111.783 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.6 p -129.93 128.93 43.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.111 2.164 . . . . 0.0 110.765 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.56 -54.4 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.412 1.885 . . . . 0.0 111.365 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.13 -49.08 0.2 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.735 1.16 . . . . 0.0 113.715 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.74 28.53 8.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.915 1.686 . . . . 0.0 112.778 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.55 159.67 23.14 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.276 1.43 . . . . 0.0 113.78 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.7 OUTLIER -150.92 168.91 23.07 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.46 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 7.1 ttp -102.78 138.07 40.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.729 1.612 . . . . 0.0 111.262 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -137.3 150.83 48.05 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.57 1.148 . . . . 0.0 109.689 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.1 mm -126.23 124.35 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.106 0.962 . . . . 0.0 109.286 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -112.96 106.96 15.34 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.029 -1.045 . . . . 0.0 110.439 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 17.3 pt -92.9 125.91 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.783 0.833 . . . . 0.0 109.933 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.2 p -155.59 149.36 25.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.219 1.808 . . . . 0.0 112.952 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.01 128.67 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.717 1.607 . . . . 0.0 111.918 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.67 -15.05 9.79 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.42 1.962 . . . . 0.0 113.597 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p -167.37 162.79 14.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.149 2.58 . . . . 0.0 109.213 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.0 mt -140.24 172.56 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.557 1.143 . . . . 0.0 109.021 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -162.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 125.77 1.628 . . . . 0.0 110.317 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.7 60.2 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.4 -25.63 12.09 Favored Glycine 0 N--CA 1.488 2.13 0 O-C-N 123.951 0.782 . . . . 0.0 112.698 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.02 63.36 Favored 'General case' 0 CA--C 1.59 2.519 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -96.24 -3.76 43.57 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.571 1.548 . . . . 0.0 114.267 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.16 139.41 58.13 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.303 -0.873 . . . . 0.0 108.926 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.51 141.03 20.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.244 0.618 . . . . 0.0 110.403 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -55.75 -32.28 63.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -57.45 -49.06 77.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.746 1.218 . . . . 0.0 111.8 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -69.88 -50.42 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.476 1.11 . . . . 0.0 109.375 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -32.7 62.29 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.26 -61.28 2.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.201 1.8 . . . . 0.0 109.976 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -40.4 86.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.429 1.492 . . . . 0.0 112.677 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.16 -50.62 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.289 1.436 . . . . 0.0 111.613 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -35.24 65.76 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.1 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.36 -30.93 69.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.429 1.491 . . . . 0.0 113.267 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -55.78 -28.79 57.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.543 1.137 . . . . 0.0 113.633 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 123.907 0.883 . . . . 0.0 111.991 177.272 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 pttm . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 151.19 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.057 . . . . 0.0 110.852 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.15 101.99 4.14 Favored 'General case' 0 CA--C 1.573 1.837 0 C-N-CA 126.295 1.838 . . . . 0.0 111.317 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.78 132.92 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.306 1.442 . . . . 0.0 110.087 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.3 165.32 38.36 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -140.45 119.79 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.979 1.311 . . . . 0.0 112.378 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.75 115.91 7.84 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 121.381 -0.825 . . . . 0.0 111.08 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.05 85.32 4.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.482 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.96 13.67 5.76 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -76.27 -13.26 60.16 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 14.59 43.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.627 1.108 . . . . 0.0 115.437 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.33 126.09 3.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.387 1.47 . . . . 0.0 112.813 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.5 m -64.32 140.92 58.92 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.066 1.346 . . . . 0.0 111.253 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -106.57 171.95 7.08 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -150.55 110.82 4.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.134 1.773 . . . . 0.0 111.871 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.01 58.06 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 120.979 -1.076 . . . . 0.0 110.222 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.59 -46.26 4.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.397 0.679 . . . . 0.0 112.186 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.93 173.7 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.356 1.063 . . . . 0.0 111.244 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.03 128.77 23.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.105 0.962 . . . . 0.0 112.949 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.82 117.14 33.32 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.842 1.657 . . . . 0.0 110.32 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -116.92 129.95 56.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.076 1.75 . . . . 0.0 109.343 175.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.56 4.65 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -152.96 92.51 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.794 1.238 . . . . 0.0 110.215 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.07 19.33 0.28 Allowed Glycine 0 N--CA 1.475 1.28 0 N-CA-C 117.474 1.75 . . . . 0.0 117.474 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -40.04 113.77 0.38 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.143 2.177 . . . . 0.0 113.188 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 t -66.21 -179.67 0.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.783 1.633 . . . . 0.0 115.312 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.12 -9.71 3.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.077 1.751 . . . . 0.0 114.033 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -87.69 166.45 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.326 1.05 . . . . 0.0 112.581 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 tt -68.93 130.13 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.469 1.108 . . . . 0.0 112.63 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 tp -84.41 117.47 68.81 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.495 0.718 . . . . 0.0 109.769 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.03 119.96 6.9 Favored 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 122.758 2.305 . . . . 0.0 109.741 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.39 -64.25 1.2 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.935 0.894 . . . . 0.0 112.515 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -96.75 151.53 19.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.669 0.788 . . . . 0.0 109.963 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 132.93 9.63 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.007 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -71.55 -150.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 125.102 3.868 . . . . 0.0 112.914 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.96 15.13 9.25 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.939 1.696 . . . . 0.0 114.287 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -142.06 30.44 1.61 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.306 1.442 . . . . 0.0 112.752 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -146.1 -175.96 4.96 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.678 1.191 . . . . 0.0 113.077 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.26 173.78 11.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.112 1.365 . . . . 0.0 107.472 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.61 148.97 29.28 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.855 -1.153 . . . . 0.0 111.287 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.24 162.13 26.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.861 0.864 . . . . 0.0 111.266 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.38 163.52 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.272 1.429 . . . . 0.0 110.001 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.1 m -135.77 -166.53 1.87 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.4 1.48 . . . . 0.0 110.383 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.4 178.29 33.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.367 -0.833 . . . . 0.0 113.461 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 124.227 1.011 . . . . 0.0 112.481 -175.901 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.48 113.94 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.898 1.279 . . . . 0.0 113.216 -175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.51 170.97 20.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 111.094 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.52 124.12 7.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.661 1.584 . . . . 0.0 108.757 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -128.49 163.8 24.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.661 1.184 . . . . 0.0 112.055 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.97 142.88 49.86 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -122.42 113.97 20.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.982 2.113 . . . . 0.0 111.151 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.42 108.32 2.33 Favored 'General case' 0 N--CA 1.382 -3.828 0 C-N-CA 124.836 1.255 . . . . 0.0 112.625 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.1 mtp -73.08 155.09 40.09 Favored 'General case' 0 CA--C 1.627 3.906 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -58.95 -23.62 61.75 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.61 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -67.98 -9.19 43.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.895 2.078 . . . . 0.0 114.178 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 8.06 68.71 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.71 1.148 . . . . 0.0 114.794 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.5 175.41 5.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.028 1.731 . . . . 0.0 110.412 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.84 104.06 6.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.963 -1.086 . . . . 0.0 112.314 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 tp -69.39 119.07 13.09 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 120.994 -1.066 . . . . 0.0 110.79 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 104.55 3.18 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.621 1.105 . . . . 0.0 111.065 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.15 162.46 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.211 0.529 . . . . 0.0 111.322 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.79 149.78 30.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.013 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.85 154.24 32.4 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.097 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -160.15 157.36 28.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.668 1.587 . . . . 0.0 107.377 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 95.33 47.84 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 121.327 -0.858 . . . . 0.0 109.211 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 C-N-CA 121.9 1.733 . . . . 0.0 111.802 -178.146 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 123.346 1.546 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -91.91 158.06 16.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.436 1.495 . . . . 0.0 112.377 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -165.1 126.79 2.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 110.064 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.98 91.07 1.02 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.33 150.8 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.538 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -142.97 135.07 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.241 1.416 . . . . 0.0 108.733 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.12 103.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.268 1.027 . . . . 0.0 109.651 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -69.91 96.73 1.04 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.7 t -63.63 99.68 0.24 Allowed 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.79 -124.02 3.16 Favored Glycine 0 CA--C 1.578 3.986 0 N-CA-C 104.518 -3.433 . . . . 0.0 104.518 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -141.85 116.54 9.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.854 0.827 . . . . 0.0 111.969 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -134.73 111.88 10.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.51 1.124 . . . . 0.0 112.996 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 167.3 5.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.608 1.163 . . . . 0.0 110.781 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.17 119.54 31.36 Favored 'General case' 1 N--CA 1.336 -6.145 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . 0.259 2.0 t70 -165.59 -177.04 4.19 Favored 'General case' 0 N--CA 1.522 3.153 0 O-C-N 127.602 3.064 . . . . 0.0 104.185 -163.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.46 -47.95 48.0 Favored 'General case' 1 CA--C 1.632 4.111 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.116 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.26 -31.46 34.56 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 121.849 2.113 . . . . 0.0 113.383 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.8 ttt -72.75 -58.56 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.386 0.674 . . . . 0.0 110.498 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -57.5 -31.18 65.76 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.82 -44.38 96.29 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.31 1.444 . . . . 0.0 109.704 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.47 -2.41 4.62 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.05 0.94 . . . . 0.0 113.471 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.7 mt -102.05 -45.87 5.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.662 1.585 . . . . 0.0 111.989 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -93.57 -23.4 18.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -121.25 -1.65 9.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.621 1.569 . . . . 0.0 111.974 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -121.98 72.91 0.37 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.591 2.043 . . . . 0.0 113.185 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.3 m120 73.58 68.66 0.27 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 127.005 2.122 . . . . 0.0 112.503 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.25 114.78 3.17 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.369 2.713 . . . . 0.0 111.749 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -124.78 162.59 23.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.42 1.888 . . . . 0.0 111.598 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.9 mtm105 -145.57 165.51 28.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.298 1.439 . . . . 0.0 112.008 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -134.32 -57.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.3 t0 48.81 69.36 0.58 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.643 1.977 . . . . 0.0 113.907 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.59 100.79 0.02 OUTLIER 'General case' 0 C--O 1.25 1.111 0 C-N-CA 129.213 3.005 . . . . 0.0 114.58 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.98 104.09 0.19 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -53.77 101.92 0.05 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 112.506 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -119.21 131.08 55.78 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.891 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.82 133.89 55.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.747 2.019 . . . . 0.0 109.846 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -140.4 157.51 45.42 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.262 0.553 . . . . 0.0 110.76 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -76.78 98.35 4.78 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.1 tp -57.66 -23.77 53.08 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.01 24.7 5.65 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-O 117.851 -1.527 . . . . 0.0 116.726 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -130.24 -27.56 2.21 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.813 1.807 . . . . 0.0 115.636 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.03 -33.01 1.05 Allowed Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.534 1.064 . . . . 0.0 113.83 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 172.7 6.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.741 1.616 . . . . 0.0 111.885 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.14 158.89 32.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 0.0 110.887 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 165.02 28.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.591 0.71 . . . . 0.0 111.144 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -128.14 136.79 51.63 Favored 'General case' 0 N--CA 1.396 -3.137 0 C-N-CA 124.826 1.25 . . . . 0.0 112.049 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.18 160.29 22.93 Favored Glycine 1 CA--C 1.618 6.518 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.44 156.94 41.0 Favored 'Isoleucine or valine' 1 CA--C 1.629 4.016 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.81 87.04 1.4 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.0 p -73.81 165.11 25.7 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.238 1.015 . . . . 0.0 110.704 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -128.46 -163.08 1.24 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.737 1.215 . . . . 0.0 112.042 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.62 7.07 4.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.534 2.333 . . . . 0.0 115.116 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.82 169.66 19.44 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.516 1.055 . . . . 0.0 110.732 -175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 65.6 -51.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.755 2.022 . . . . 0.0 114.568 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.98 163.44 7.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.568 2.347 . . . . 0.0 112.694 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -154.07 165.12 37.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 123.155 1.455 . . . . 0.0 114.524 -174.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.513 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 24.8 ptm -93.12 164.94 13.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.172 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -153.27 156.15 37.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.03 138.75 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.887 1.675 . . . . 0.0 109.145 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.44 117.74 23.54 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.103 1.361 . . . . 0.0 109.704 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.79 126.14 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.552 0.741 . . . . 0.0 110.17 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.7 t -152.53 158.84 43.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.577 0 C-N-CA 126.122 1.769 . . . . 0.0 111.134 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.63 165.81 11.79 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 110.597 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.71 -25.4 27.64 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.195 1.379 . . . . 0.0 112.573 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -149.19 151.63 34.65 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.522 1.661 . . . . 0.0 111.535 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 mm -144.12 158.9 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.743 1.217 . . . . 0.0 111.312 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.67 -173.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 127.502 2.321 . . . . 0.0 111.984 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.73 -22.34 3.45 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.0 -25.32 14.42 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.648 1.118 . . . . 0.0 114.144 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -36.87 75.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.158 0.979 . . . . 0.0 111.969 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -7.12 58.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.942 1.297 . . . . 0.0 113.619 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tt -64.67 156.4 30.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.382 1.473 . . . . 0.0 112.651 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -148.55 143.38 26.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.041 0.936 . . . . 0.0 110.116 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -56.25 -32.86 64.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.653 0.781 . . . . 0.0 113.104 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -55.52 -57.28 12.55 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.081 1.352 . . . . 0.0 112.342 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.19 -51.42 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.706 0.803 . . . . 0.0 109.892 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.44 -37.1 62.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.172 1.389 . . . . 0.0 113.615 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.26 -49.08 65.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.27 1.428 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -36.52 83.55 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.339 -0.851 . . . . 0.0 111.301 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.57 -53.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.802 1.241 . . . . 0.0 111.345 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -63.85 -34.93 79.04 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.98 -25.39 58.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -54.95 -26.81 38.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.342 1.428 . . . . 0.0 112.893 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 128.312 2.645 . . . . 0.0 114.606 -178.121 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 tptt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.19 146.02 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.969 1.708 . . . . 0.0 115.007 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.51 110.47 7.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.725 2.81 . . . . 0.0 109.404 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -116.12 125.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.31 157.71 30.31 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.178 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.48 ' H ' HD22 ' A' ' 69' ' ' LEU . 1.5 mp -139.19 117.58 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 0.0 111.572 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.89 102.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.421 -1.424 . . . . 0.0 111.746 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 87.16 3.38 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.88 1.272 . . . . 0.0 111.82 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -143.15 45.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.684 1.194 . . . . 0.0 111.295 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.47 1.3 29.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.014 1.325 . . . . 0.0 114.465 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.27 17.29 69.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.383 0.992 . . . . 0.0 115.139 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.16 131.76 4.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.945 1.736 . . . . 0.0 111.742 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -59.08 142.51 51.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.033 1.333 . . . . 0.0 111.194 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -104.68 167.16 9.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 111.505 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -152.58 102.49 2.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.269 2.227 . . . . 0.0 109.407 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 166.43 14.31 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.344 -0.848 . . . . 0.0 111.617 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -67.8 0.77 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.668 1.587 . . . . 0.0 110.432 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -156.66 -176.17 5.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.985 1.714 . . . . 0.0 110.995 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.85 37.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.97 1.708 . . . . 0.0 110.844 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -127.94 130.06 47.82 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.574 1.549 . . . . 0.0 109.684 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.16 137.44 34.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 128.485 2.714 . . . . 0.0 109.121 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -14.84 15.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.32 1.448 . . . . 0.0 112.324 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.81 99.08 3.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.642 1.977 . . . . 0.0 109.056 176.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.22 102.08 0.94 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 124.401 1.001 . . . . 0.0 112.807 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -65.94 -103.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.411 1.884 . . . . 0.0 110.914 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.6 p -150.51 172.67 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 111.916 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -148.75 -4.02 0.44 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.633 2.373 . . . . 0.0 113.125 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.81 166.86 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 127.416 2.287 . . . . 0.0 112.128 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.21 128.65 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.11 1.764 . . . . 0.0 112.576 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 tp -81.59 123.66 80.58 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 108.511 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -65.54 124.55 12.99 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.884 3.056 . . . . 0.0 110.827 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.07 -76.75 0.26 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.233 -0.917 . . . . 0.0 112.188 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.54 125.57 40.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.87 0.868 . . . . 0.0 110.28 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 121.98 26.46 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.228 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.94 179.21 6.51 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.179 3.252 . . . . 0.0 112.323 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -66.8 169.18 8.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.301 1.44 . . . . 0.0 112.64 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p 43.39 43.49 4.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.413 2.285 . . . . 0.0 115.016 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -144.49 177.58 8.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.608 1.963 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.08 -174.44 4.1 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.492 1.517 . . . . 0.0 108.324 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -156.27 154.17 30.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -129.35 163.72 25.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.771 0.829 . . . . 0.0 110.467 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.26 161.35 42.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.392 1.477 . . . . 0.0 109.502 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.6 m -147.02 178.49 8.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.296 1.438 . . . . 0.0 110.801 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.17 167.25 30.67 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.468 0.556 . . . . 0.0 113.471 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 125.216 1.407 . . . . 0.0 112.971 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 CA-C-O 120.257 0.075 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.11 126.43 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.375 1.87 . . . . 0.0 111.986 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.8 167.39 25.74 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.338 1.455 . . . . 0.0 110.87 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 118.38 7.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.0 109.288 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -123.5 162.93 21.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.434 1.094 . . . . 0.0 112.55 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.23 145.76 50.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.972 0.909 . . . . 0.0 111.986 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.73 113.49 16.07 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.669 1.987 . . . . 0.0 110.89 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.96 122.11 16.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.847 1.259 . . . . 0.0 110.591 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.3 ttt -92.8 149.03 21.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.831 1.252 . . . . 0.0 111.017 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -22.71 16.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 t -72.01 -11.48 60.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.843 1.257 . . . . 0.0 113.789 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.49 4.87 60.59 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.672 1.606 . . . . 0.0 114.72 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -95.05 173.18 7.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.211 1.404 . . . . 0.0 110.769 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.8 m -137.16 104.37 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.961 1.304 . . . . 0.0 111.947 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.12 125.13 25.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.941 0.896 . . . . 0.0 110.346 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.67 104.84 2.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.19 1.376 . . . . 0.0 112.389 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.86 169.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.857 0.837 . . . . 0.0 112.175 175.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -149.0 147.48 28.61 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.189 1.396 . . . . 0.0 111.682 177.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -157.76 146.31 19.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.497 0.719 . . . . 0.0 112.088 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -153.31 122.04 6.4 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.482 0.713 . . . . 0.0 112.169 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.59 137.05 38.96 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 CA--C 1.538 0.678 0 C-N-CA 122.395 2.063 . . . . 0.0 112.741 176.232 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.199 0.524 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -81.38 162.14 23.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.041 0.937 . . . . 0.0 112.229 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.49 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 4.8 p-90 -159.91 169.4 23.59 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.129 1.372 . . . . 0.0 110.928 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 t70 164.26 138.6 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 128.713 2.805 . . . . 0.0 112.265 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.42 128.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.344 1.858 . . . . 0.0 108.959 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -129.03 158.21 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.324 1.85 . . . . 0.0 110.234 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.2 mt -112.76 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.719 1.608 . . . . 0.0 108.383 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -70.49 102.78 2.29 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.724 -1.235 . . . . 0.0 110.136 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.2 t -67.01 90.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.79 -134.71 4.97 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.853 2.644 . . . . 0.0 109.629 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.26 124.7 26.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.042 1.337 . . . . 0.0 111.899 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -143.61 117.14 9.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.234 1.814 . . . . 0.0 110.868 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.24 165.94 18.97 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.142 0.428 . . . . 0.0 110.985 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.47 112.58 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.438 -0.789 . . . . 0.0 110.601 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -155.97 -172.84 4.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.365 1.466 . . . . 0.0 112.797 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -42.65 84.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.018 0.927 . . . . 0.0 110.868 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.7 -41.08 56.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.469 1.509 . . . . 0.0 112.887 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -64.83 0.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.501 1.12 . . . . 0.0 109.94 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -53.37 -34.35 57.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.201 1.001 . . . . 0.0 113.431 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -41.07 95.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.824 1.25 . . . . 0.0 111.388 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -21.71 66.69 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.484 -1.385 . . . . 0.0 112.386 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mt -85.3 -48.78 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.53 -33.25 31.89 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -114.66 -37.38 4.27 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.894 1.278 . . . . 0.0 112.708 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.64 -68.71 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.039 1.304 . . . . 0.0 112.479 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.77 79.0 1.8 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.99 153.38 72.56 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.06 175.91 8.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.136 2.174 . . . . 0.0 112.448 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -127.1 141.63 51.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.186 1.794 . . . . 0.0 110.826 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -141.46 108.56 0.55 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.561 1.076 . . . . 0.0 111.029 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -123.16 64.88 0.99 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.559 1.143 . . . . 0.0 112.264 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.04 95.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.619 2.368 . . . . 0.0 114.754 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.46 154.28 6.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.378 1.942 . . . . 0.0 112.405 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 63.1 m95 -77.18 144.74 38.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.274 1.03 . . . . 0.0 111.891 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -149.66 127.18 11.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.183 1.393 . . . . 0.0 112.364 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -120.67 152.46 38.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.234 1.814 . . . . 0.0 112.37 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -145.67 161.46 39.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.629 1.572 . . . . 0.0 110.636 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -75.04 98.76 3.71 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -57.84 7.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.935 1.294 . . . . 0.0 111.492 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.17 14.38 0.47 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -129.22 -16.58 3.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.56 -4.09 5.1 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.98 171.48 14.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.893 1.677 . . . . 0.0 110.801 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.71 161.19 31.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.019 . . . . 0.0 111.948 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.62 149.16 40.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.358 0.663 . . . . 0.0 111.815 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.8 OUTLIER -119.25 134.54 55.15 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.79 1.636 . . . . 0.0 108.988 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.27 136.44 12.62 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.097 1.332 . . . . 0.0 113.068 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -109.3 132.39 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.187 1.795 . . . . 0.0 108.691 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.88 105.97 11.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.746 0.818 . . . . 0.0 109.817 175.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 p -123.6 145.91 48.55 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.927 1.291 . . . . 0.0 110.562 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.7 p -140.46 -112.46 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.527 1.131 . . . . 0.0 110.504 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 52.38 13.48 0.3 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 120.833 1.651 . . . . 0.0 115.33 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 146.45 5.84 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.547 2.022 . . . . 0.0 110.779 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.23 38.4 29.21 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -144.83 170.87 15.29 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.562 1.545 . . . . 0.0 111.803 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -165.76 146.0 6.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.089 0.956 . . . . 0.0 112.99 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.62 144.87 45.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.506 1.922 . . . . 0.0 113.752 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -145.07 153.28 41.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.594 1.958 . . . . 0.0 109.83 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 mp -124.5 122.61 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.409 1.084 . . . . 0.0 109.963 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -100.1 132.14 45.64 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.985 0.914 . . . . 0.0 109.378 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 6.1 pt -116.85 133.07 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.724 0.81 . . . . 0.0 110.123 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.8 p -154.22 170.42 21.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.857 1.263 . . . . 0.0 112.798 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.736 -0.173 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.65 145.76 51.21 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 109.892 175.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.52 -38.86 1.82 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 127.111 2.291 . . . . 0.0 111.435 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -143.51 159.09 43.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.948 1.299 . . . . 0.0 112.374 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -139.19 169.83 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.42 1.888 . . . . 0.0 110.235 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.98 -166.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 127.854 2.462 . . . . 0.0 111.128 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.04 -16.58 13.29 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.64 -21.85 40.87 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.907 1.242 . . . . 0.0 114.068 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.12 86.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.567 1.183 . . . . 0.0 111.581 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -85.61 -15.69 41.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.906 1.283 . . . . 0.0 113.717 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 tt -61.14 150.06 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.205 1.002 . . . . 0.0 110.99 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -149.54 144.41 26.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.915 0.886 . . . . 0.0 109.132 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -50.91 -38.65 51.34 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 112.117 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -50.82 -53.32 33.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.408 1.083 . . . . 0.0 113.705 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.67 -47.42 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.97 -0.456 . . . . 0.0 110.171 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -35.74 65.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.327 1.451 . . . . 0.0 112.283 -176.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -64.13 -51.09 65.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.829 2.452 . . . . 0.0 110.67 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -35.22 79.6 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.674 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.67 -50.79 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.613 1.165 . . . . 0.0 111.702 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.15 -31.96 73.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 112.809 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.18 -9.11 59.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.075 -1.016 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -25.2 55.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.465 -1.397 . . . . 0.0 112.408 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 126.826 2.05 . . . . 0.0 113.757 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' H ' ' NH1' ' A' ' 74' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.975 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -154.8 132.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.857 0.753 . . . . 0.0 112.416 174.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.74 115.7 22.5 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.603 1.961 . . . . 0.0 109.524 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 157.98 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.94 177.0 28.72 Favored Glycine 0 N--CA 1.451 -0.336 0 O-C-N 121.525 -0.734 . . . . 0.0 111.453 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -136.89 132.77 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.878 0.846 . . . . 0.0 111.631 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.42 104.92 16.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.374 1.47 . . . . 0.0 111.491 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -82.27 96.43 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.033 0.933 . . . . 0.0 112.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.06 13.44 5.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.813 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -3.34 54.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.609 1.564 . . . . 0.0 115.114 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 26.02 60.41 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.165 -0.96 . . . . 0.0 114.766 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.94 125.13 2.51 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.801 1.667 . . . . 0.0 111.44 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.0 m -64.23 141.42 58.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.028 0.931 . . . . 0.0 111.128 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -110.19 169.83 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.09 0.956 . . . . 0.0 111.708 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -144.14 101.2 3.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.074 1.35 . . . . 0.0 112.315 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 154.11 42.52 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.558 -1.339 . . . . 0.0 110.421 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.63 -54.28 2.57 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.237 1.415 . . . . 0.0 112.193 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -162.49 -171.93 2.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.106 1.762 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.7 145.37 30.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.658 1.583 . . . . 0.0 110.716 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -123.33 126.02 46.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.669 1.587 . . . . 0.0 110.119 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 137.04 46.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.827 2.451 . . . . 0.0 109.622 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -110.31 -43.3 3.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.191 1.796 . . . . 0.0 111.605 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -100.21 156.74 17.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 109.148 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.42 -171.39 19.93 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -145.19 166.15 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.97 1.308 . . . . 0.0 110.259 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 p -67.76 152.25 45.9 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -163.81 -30.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.958 1.703 . . . . 0.0 113.53 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.97 157.11 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.059 1.744 . . . . 0.0 111.49 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 tt -85.89 138.11 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.25 1.02 . . . . 0.0 112.11 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.88 131.76 42.23 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.222 1.409 . . . . 0.0 109.627 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.07 118.82 5.92 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.745 2.963 . . . . 0.0 110.926 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.11 -53.82 52.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.385 0.674 . . . . 0.0 112.475 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -119.94 136.62 54.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.208 1.003 . . . . 0.0 110.587 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.47 122.01 37.51 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.013 0.925 . . . . 0.0 110.609 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.64 171.0 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.684 2.923 . . . . 0.0 113.0 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -66.02 154.13 40.33 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.266 1.426 . . . . 0.0 112.742 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.7 t 36.87 56.03 1.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.099 2.16 . . . . 0.0 113.303 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -144.18 -178.49 5.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.95 1.3 . . . . 0.0 111.735 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.72 -178.79 6.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.069 0.937 . . . . 0.0 111.35 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.36 150.03 30.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 110.961 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.69 151.02 47.16 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.308 1.443 . . . . 0.0 108.486 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -127.98 159.84 33.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.573 1.549 . . . . 0.0 109.553 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.9 m -135.8 170.17 16.41 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.56 1.544 . . . . 0.0 109.931 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.434 ' H ' HD22 ' A' ' 24' ' ' LEU . . . 138.93 89.38 0.19 Allowed Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.527 1.06 . . . . 0.0 111.362 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.488 ' NH1' ' H ' ' A' ' 30' ' ' LYS . 52.2 ttt180 . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 124.926 1.29 . . . . 0.0 113.632 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.341 0.591 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -155.76 111.47 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.775 2.03 . . . . 0.0 107.858 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -156.43 167.51 30.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.483 1.135 . . . . 0.0 110.383 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.97 128.31 9.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.338 1.055 . . . . 0.0 108.824 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -127.2 165.02 20.4 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.028 0.931 . . . . 0.0 111.931 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.1 150.27 51.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.557 0.743 . . . . 0.0 112.481 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -125.57 114.8 19.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.971 1.308 . . . . 0.0 110.466 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -71.36 100.0 2.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.689 1.596 . . . . 0.0 110.539 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.0 mtp -64.86 146.64 54.62 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.951 -1.093 . . . . 0.0 112.028 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -57.51 -26.09 60.8 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -71.67 -4.72 28.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.702 1.201 . . . . 0.0 113.58 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.16 27.13 16.71 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.894 1.235 . . . . 0.0 114.457 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -117.57 166.46 12.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.623 1.569 . . . . 0.0 110.746 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 45.0 m -130.43 104.16 7.09 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.08 0.952 . . . . 0.0 112.44 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -77.27 113.35 14.94 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.957 0.903 . . . . 0.0 110.033 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.87 111.4 4.21 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.749 1.642 . . . . 0.0 112.075 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.65 154.66 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 110.857 175.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.1 ttp -134.83 148.82 50.25 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.861 1.265 . . . . 0.0 110.035 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 12.4 p90 -153.97 142.46 20.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.367 0.667 . . . . 0.0 109.299 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 m -150.93 165.83 32.47 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.005 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 74' ' ' ARG . 95.2 t -119.78 142.2 32.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.314 1.046 . . . . 0.0 109.964 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD3' HD22 ' A' ' 113' ' ' ASN . 80.2 Cg_endo . . . . . 0 CA--C 1.546 1.114 0 C-N-CA 123.641 2.894 . . . . 0.0 112.706 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.485 HD22 ' HD3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -93.22 137.34 32.64 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.987 1.715 . . . . 0.0 111.829 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -164.32 134.79 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.371 1.868 . . . . 0.0 108.394 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -156.16 151.74 27.03 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.333 1.053 . . . . 0.0 110.44 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.88 132.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.437 1.095 . . . . 0.0 110.33 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HE2' ' CE1' ' A' ' 120' ' ' TYR . 18.5 ttpt -144.76 158.61 43.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.872 0.869 . . . . 0.0 111.709 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.83 112.07 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.428 1.091 . . . . 0.0 110.47 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.464 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 27.0 m-85 -81.3 101.14 9.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -62.84 93.02 0.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.225 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.75 -138.78 8.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.401 2.429 . . . . 0.0 110.544 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -117.08 127.06 53.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.59 1.956 . . . . 0.0 111.778 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -148.73 108.05 3.94 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.2 168.81 18.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.13 0.972 . . . . 0.0 111.435 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.93 118.25 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.888 0.875 . . . . 0.0 111.37 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -161.88 -174.53 4.21 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.769 1.228 . . . . 0.0 112.114 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -48.73 -48.61 40.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.978 1.311 . . . . 0.0 111.556 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.51 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.31 0.957 . . . . 0.0 113.426 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.4 ttp -68.76 -49.31 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.238 1.019 . . . . 0.0 112.467 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.87 -39.27 68.49 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.488 0.585 . . . . 0.0 112.198 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -45.53 79.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.265 1.426 . . . . 0.0 111.199 175.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -21.94 66.69 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.336 -1.478 . . . . 0.0 113.716 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.91 -41.72 14.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.776 1.631 . . . . 0.0 112.824 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -88.95 -28.22 20.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -122.61 -32.07 3.63 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 112.313 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.85 -39.12 94.91 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.118 0.866 . . . . 0.0 113.431 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.53 75.38 9.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.15 120.72 8.0 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.415 2.077 . . . . 0.0 113.284 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.47 173.4 7.69 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.704 2.002 . . . . 0.0 112.369 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -139.83 140.02 36.47 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.565 1.946 . . . . 0.0 112.224 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -136.88 109.78 0.74 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.286 0.946 . . . . 0.0 114.188 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -87.28 -68.25 0.76 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.622 1.569 . . . . 0.0 112.44 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -173.12 114.97 0.26 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 0.0 112.089 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.37 160.17 8.67 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.704 1.145 . . . . 0.0 114.079 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.406 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 92.1 m95 -78.04 147.03 34.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.124 1.37 . . . . 0.0 112.5 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -150.61 127.6 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.664 1.585 . . . . 0.0 112.452 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.6 152.59 24.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.36 1.464 . . . . 0.0 112.37 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -158.65 169.91 23.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.868 1.267 . . . . 0.0 112.627 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -85.44 99.79 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.77 1.628 . . . . 0.0 107.807 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tp -60.88 -36.16 78.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.19 24.51 2.21 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -135.92 -29.12 1.04 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 119.157 1.479 . . . . 0.0 114.727 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 133.19 23.0 0.77 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.052 1.31 . . . . 0.0 114.66 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.2 162.63 37.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.224 1.512 . . . . 0.0 112.048 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 136.77 50.79 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.481 1.513 . . . . 0.0 108.875 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.45 168.48 14.16 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.006 0.922 . . . . 0.0 110.841 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 128.24 50.62 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.82 152.74 18.0 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.441 1.02 . . . . 0.0 112.02 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.406 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -133.65 145.96 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.236 178.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.9 tpt -154.88 100.85 2.24 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.337 1.055 . . . . 0.0 110.182 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -90.54 149.46 22.16 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 109.542 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -59.67 164.33 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.358 1.463 . . . . 0.0 112.867 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.68 129.85 40.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.756 0.823 . . . . 0.0 112.391 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.77 79.22 0.05 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.001 0.81 . . . . 0.0 112.091 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 67.97 -50.7 0.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.651 2.38 . . . . 0.0 115.322 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.52 169.86 7.01 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.475 1.91 . . . . 0.0 113.492 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -152.88 -177.56 6.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.987 1.715 . . . . 0.0 112.315 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 138.3 40.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.996 2.118 . . . . 0.0 112.288 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -146.42 156.29 43.19 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.345 1.458 . . . . 0.0 110.764 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.4 mm -131.9 125.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 110.283 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 112.76 19.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.311 1.044 . . . . 0.0 112.379 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.2 pt -97.63 132.11 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.721 1.608 . . . . 0.0 110.517 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 t -154.16 158.69 40.76 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.445 -0.784 . . . . 0.0 111.491 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.998 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.21 29.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.0 1.72 . . . . 0.0 114.387 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.4 -5.6 10.22 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.021 1.772 . . . . 0.0 115.392 -175.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -167.49 162.18 14.29 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.304 2.642 . . . . 0.0 109.36 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -142.4 167.39 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.774 1.23 . . . . 0.0 109.901 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.03 -164.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 127.958 2.503 . . . . 0.0 110.045 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.04 -14.82 39.63 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -26.4 24.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.874 1.702 . . . . 0.0 113.571 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.53 81.34 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 118.373 1.086 . . . . 0.0 112.166 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -12.71 49.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.042 1.337 . . . . 0.0 113.842 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.36 129.73 41.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.857 1.263 . . . . 0.0 109.371 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -142.24 144.06 33.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.701 0.8 . . . . 0.0 109.319 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -54.96 -29.79 57.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.592 0.633 . . . . 0.0 112.381 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -58.63 -55.99 27.9 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 112.119 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -62.4 -47.04 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.9 63.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.005 1.322 . . . . 0.0 113.323 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -52.91 14.83 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 119.938 -1.726 . . . . 0.0 110.754 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -64.32 -38.93 92.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.117 1.767 . . . . 0.0 112.231 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.8 -34.45 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.429 1.092 . . . . 0.0 112.155 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.2 -40.55 37.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.258 1.423 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -72.45 -17.11 61.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -30.97 70.57 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.645 -1.284 . . . . 0.0 112.554 175.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 112.262 177.574 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.597 0.237 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.18 130.98 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.646 1.178 . . . . 0.0 110.367 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.73 95.29 4.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.749 2.02 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -101.73 113.41 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.626 -1.296 . . . . 0.0 109.178 174.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.6 160.02 28.56 Favored Glycine 0 C--O 1.235 0.171 0 C-N-CA 120.857 -0.687 . . . . 0.0 114.745 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -135.61 130.97 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.193 1.397 . . . . 0.0 110.129 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 4.2 m-20 -86.7 104.4 16.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.344 1.058 . . . . 0.0 111.943 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -81.12 100.39 9.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.829 1.195 . . . . 0.0 112.102 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.64 21.49 2.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.197 0.999 . . . . 0.0 112.845 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -6.38 58.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.482 1.513 . . . . 0.0 114.621 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.53 22.82 55.51 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.384 0.992 . . . . 0.0 114.97 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.15 126.87 3.65 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.444 1.497 . . . . 0.0 112.275 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -58.6 143.95 44.56 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.464 1.106 . . . . 0.0 110.565 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -108.05 164.77 12.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.69 0.796 . . . . 0.0 111.858 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.1 m -149.9 104.15 3.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.141 1.776 . . . . 0.0 110.307 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.36 144.62 55.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.733 -1.229 . . . . 0.0 111.211 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -47.8 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.743 1.617 . . . . 0.0 113.149 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -157.73 171.33 20.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.497 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.64 128.67 25.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.894 1.277 . . . . 0.0 110.859 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -120.31 141.64 49.84 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.286 1.434 . . . . 0.0 110.373 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -154.22 155.73 35.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.527 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -120.15 -13.11 8.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.035 1.734 . . . . 0.0 111.093 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.4 m -143.04 131.23 21.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.649 1.98 . . . . 0.0 110.219 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 107.29 0.98 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -73.79 176.23 6.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.125 2.17 . . . . 0.0 111.378 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -69.13 163.14 25.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.452 1.12 . . . . 0.0 113.155 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.0 -29.74 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.986 1.314 . . . . 0.0 112.937 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.66 164.05 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.411 1.884 . . . . 0.0 110.233 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 tp -64.26 134.54 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.062 0.945 . . . . 0.0 110.786 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.29 109.56 34.37 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 108.295 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -61.46 123.47 12.82 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.032 3.154 . . . . 0.0 111.154 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.2 -59.56 2.51 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.346 -0.846 . . . . 0.0 112.483 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -105.22 144.73 31.6 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 110.697 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.44 124.46 17.11 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.595 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.17 170.48 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.072 2.514 . . . . 0.0 112.493 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -62.66 148.73 45.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.012 0.925 . . . . 0.0 111.133 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 p 53.9 42.86 31.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.808 1.643 . . . . 0.0 114.832 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -145.2 127.9 16.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.807 1.643 . . . . 0.0 112.723 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -84.64 176.1 8.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.978 0.911 . . . . 0.0 111.819 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 150.51 30.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.342 -0.849 . . . . 0.0 112.003 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 169.18 11.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.177 1.391 . . . . 0.0 112.128 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -145.7 160.65 41.41 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.87 164.65 33.04 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.725 1.61 . . . . 0.0 111.262 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.59 173.45 39.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.645 0.64 . . . . 0.0 113.703 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 . . . . . 0 N--CA 1.477 0.91 0 C-N-CA 126.442 1.897 . . . . 0.0 109.802 178.799 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.57 ' H ' ' CG2' ' A' ' 104' ' ' VAL . . . . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.778 0.323 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.08 112.87 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.505 1.922 . . . . 0.0 111.088 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.57 163.99 27.64 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.526 1.131 . . . . 0.0 111.18 175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.2 112.81 4.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.766 1.226 . . . . 0.0 108.635 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -122.64 165.17 16.92 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.969 1.308 . . . . 0.0 110.747 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.03 153.61 47.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.267 0.556 . . . . 0.0 111.511 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -127.96 112.9 15.18 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.967 1.307 . . . . 0.0 109.93 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.64 107.03 2.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.187 1.395 . . . . 0.0 110.329 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.15 144.92 50.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.212 1.405 . . . . 0.0 110.845 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.6 t -55.42 -27.33 47.21 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.175 0.99 . . . . 0.0 113.369 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -9.3 40.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.312 1.445 . . . . 0.0 114.837 174.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.12 55.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.872 1.225 . . . . 0.0 115.094 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.05 172.82 6.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.508 1.523 . . . . 0.0 110.445 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -136.33 108.36 7.18 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.312 1.045 . . . . 0.0 111.141 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 tp -73.75 125.87 29.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.013 -1.055 . . . . 0.0 109.091 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.88 99.12 1.93 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.9 162.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.786 0.803 . . . . 0.0 111.227 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -148.1 158.29 43.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.502 0.721 . . . . 0.0 111.322 174.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.435 ' CD2' ' HB ' ' A' ' 33' ' ' VAL . 45.8 p90 -160.3 162.72 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.928 1.291 . . . . 0.0 109.325 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.22 168.76 24.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.809 1.244 . . . . 0.0 109.108 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.57 ' CG2' ' H ' ' A' ' 84' ' ' ALA . 12.3 m -136.11 97.38 12.21 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 109.723 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 CA--C 1.541 0.836 0 C-N-CA 122.303 2.002 . . . . 0.0 110.865 175.022 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 122.017 0.913 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -86.23 157.55 19.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.679 1.191 . . . . 0.0 112.617 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.412 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 6.0 p-90 -160.94 148.32 15.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.762 0.825 . . . . 0.0 111.505 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -172.1 107.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.317 1.847 . . . . 0.0 111.699 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.6 t -116.36 137.24 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.683 0.793 . . . . 0.0 109.063 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -145.96 143.64 29.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.875 1.67 . . . . 0.0 110.484 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.409 ' H ' ' CD1' ' A' ' 151' ' ' LEU . 3.6 mp -81.88 153.42 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -122.62 96.34 4.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.247 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t -70.71 90.51 0.78 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.54 -1.35 . . . . 0.0 111.599 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.85 -112.57 0.52 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.31 1.909 . . . . 0.0 110.831 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -159.21 117.78 2.89 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.706 1.602 . . . . 0.0 110.513 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -140.04 108.6 5.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.241 1.416 . . . . 0.0 111.404 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.01 171.35 6.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.638 0.775 . . . . 0.0 111.153 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.77 113.67 22.12 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.728 -0.608 . . . . 0.0 110.651 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.09 -175.22 4.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.083 1.353 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.06 -45.04 21.38 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.827 1.251 . . . . 0.0 112.236 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.06 46.88 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.576 1.084 . . . . 0.0 114.397 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 ttp -70.02 -60.61 2.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.781 1.291 . . . . 0.0 109.63 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -53.54 -33.39 54.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.845 0.858 . . . . 0.0 113.241 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.22 -38.59 91.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.568 1.147 . . . . 0.0 110.837 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -23.61 66.78 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.329 -1.482 . . . . 0.0 112.458 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mt -84.01 -47.28 11.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.518 1.527 . . . . 0.0 111.345 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.18 -26.44 26.78 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -122.46 -38.88 2.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.681 1.192 . . . . 0.0 112.219 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.52 -55.95 24.48 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.737 1.161 . . . . 0.0 112.761 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -160.97 70.44 2.67 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.04 115.19 3.15 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.848 2.365 . . . . 0.0 112.99 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.21 -178.33 3.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.536 1.135 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.57 144.33 49.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.077 2.551 . . . . 0.0 111.022 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.45 108.29 0.63 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.853 1.216 . . . . 0.0 111.865 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -120.15 64.9 0.82 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.725 1.61 . . . . 0.0 114.094 -174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.94 96.03 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.923 2.089 . . . . 0.0 114.314 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.99 135.26 2.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.343 1.449 . . . . 0.0 112.017 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -66.41 144.63 56.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 111.371 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -143.6 131.2 21.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.363 1.065 . . . . 0.0 111.805 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -133.81 143.74 48.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.645 1.578 . . . . 0.0 112.346 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 161.98 40.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.462 1.505 . . . . 0.0 112.224 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -97.67 96.62 8.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.396 1.079 . . . . 0.0 108.886 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.409 ' CD1' ' H ' ' A' ' 119' ' ' ILE . 0.1 OUTLIER -53.54 -51.07 64.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.523 1.529 . . . . 0.0 112.014 -174.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.94 51.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.791 1.076 . . . . 0.0 115.791 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -135.44 -31.29 0.97 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -29.75 2.31 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.21 1.386 . . . . 0.0 113.321 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.61 172.14 6.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.904 1.682 . . . . 0.0 112.766 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -134.53 151.83 51.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.912 1.685 . . . . 0.0 109.782 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.54 152.99 51.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 133.71 49.1 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.504 1.521 . . . . 0.0 109.918 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.07 136.41 11.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.477 1.037 . . . . 0.0 112.591 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tp -108.24 149.81 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.091 1.757 . . . . 0.0 109.641 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.88 93.58 2.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.68 1.192 . . . . 0.0 110.707 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.9 p -91.88 161.62 14.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.247 1.019 . . . . 0.0 111.183 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.14 -26.52 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.734 1.214 . . . . 0.0 112.398 175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.33 114.86 9.83 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 110.911 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.03 -95.11 0.64 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.083 1.325 . . . . 0.0 113.078 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.01 64.15 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.45 1.5 . . . . 0.0 111.265 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.27 91.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.864 1.666 . . . . 0.0 113.977 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.462 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -156.66 168.84 26.19 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -174.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.462 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 17.8 ptm -135.31 160.47 38.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.227 2.611 . . . . 0.0 112.567 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -153.64 162.51 41.18 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.192 1.797 . . . . 0.0 109.558 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.1 mm -136.48 108.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -95.87 116.18 28.53 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 112.024 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.2 pt -103.67 132.19 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 0.0 111.101 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.7 p -155.48 170.96 20.73 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.284 -0.885 . . . . 0.0 112.643 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.65 171.54 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.85 -19.44 44.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.393 0.997 . . . . 0.0 113.659 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.8 p -163.38 156.99 19.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.784 2.834 . . . . 0.0 109.05 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -141.84 173.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.957 1.703 . . . . 0.0 109.065 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -167.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.558 1.543 . . . . 0.0 110.033 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.34 -40.2 11.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.72 -32.64 5.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.594 1.569 . . . . 0.0 113.083 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.588 1.194 . . . . 0.0 111.588 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.0 m -83.82 -6.54 59.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.607 1.963 . . . . 0.0 113.902 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 tt -66.27 138.09 57.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.578 1.151 . . . . 0.0 109.792 176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -141.79 142.17 33.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.863 0.865 . . . . 0.0 109.922 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -55.93 -32.45 63.82 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -56.62 -49.78 73.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.442 1.019 . . . . 0.0 112.771 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.11 -49.53 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.014 -0.429 . . . . 0.0 109.861 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -36.56 52.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.271 1.428 . . . . 0.0 112.222 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.92 -65.79 0.54 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.196 1.798 . . . . 0.0 111.211 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -65.05 -24.45 67.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 177.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.41 -46.6 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.707 1.203 . . . . 0.0 112.285 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -26.93 55.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.247 0.619 . . . . 0.0 112.063 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.21 -38.36 51.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.173 1.389 . . . . 0.0 113.714 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.45 -27.06 45.73 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.198 0.908 . . . . 0.0 113.039 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 126.853 2.061 . . . . 0.0 113.7 175.058 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.87 147.39 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.351 1.061 . . . . 0.0 112.11 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 110.96 11.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.27 1.828 . . . . 0.0 111.287 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.45 HG12 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -130.32 157.46 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 C-N-CA 125.189 1.396 . . . . 0.0 112.601 175.005 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 156.54 177.32 29.59 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -133.78 147.97 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.747 0.819 . . . . 0.0 110.46 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.79 102.07 13.79 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.926 -1.109 . . . . 0.0 112.049 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -82.16 98.61 8.79 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 113.124 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -133.91 10.61 3.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 113.44 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -5.36 35.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.22 42.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.855 1.217 . . . . 0.0 114.826 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.98 127.04 3.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.358 1.456 . . . . 0.0 112.328 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.7 m -57.8 142.03 46.99 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.361 1.065 . . . . 0.0 110.968 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.67 165.27 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.118 0.967 . . . . 0.0 111.938 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -142.01 99.85 3.61 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.118 1.767 . . . . 0.0 112.008 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.02 145.06 54.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.714 -1.241 . . . . 0.0 108.95 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -48.99 4.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.476 1.111 . . . . 0.0 111.733 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -176.6 176.03 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.818 2.047 . . . . 0.0 110.272 -174.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.65 40.61 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.089 1.755 . . . . 0.0 111.006 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -125.58 137.24 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.931 1.292 . . . . 0.0 110.364 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.57 42.22 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.151 1.78 . . . . 0.0 109.201 -175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 -23.13 3.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.87 68.11 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.073 1.416 . . . . 0.0 109.584 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.45 179.31 32.27 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.923 1.725 . . . . 0.0 110.969 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -141.98 162.31 35.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.311 1.444 . . . . 0.0 110.141 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 p -65.25 160.01 22.51 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.304 -0.873 . . . . 0.0 112.278 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.78 -19.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 161.8 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.462 1.905 . . . . 0.0 110.814 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.17 135.96 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.65 0.78 . . . . 0.0 110.038 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.8 tp -91.95 113.96 60.57 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.217 1.007 . . . . 0.0 108.393 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -66.45 125.48 13.98 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.624 2.883 . . . . 0.0 110.337 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -57.37 9.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.899 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.53 130.34 54.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.003 0.82 . . . . 0.0 111.164 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.81 121.76 49.82 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.367 1.067 . . . . 0.0 109.627 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.03 148.28 86.05 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.456 2.104 . . . . 0.0 111.285 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.5 155.4 5.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 175.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 t 40.6 55.32 2.94 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.597 1.559 . . . . 0.0 113.096 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -159.89 136.28 8.93 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.007 1.723 . . . . 0.0 111.895 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.35 177.49 5.82 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.43 1.092 . . . . 0.0 111.787 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.87 149.61 30.71 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.682 0.793 . . . . 0.0 111.912 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 171.31 7.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.731 1.212 . . . . 0.0 110.653 175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.2 158.16 37.13 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.638 1.975 . . . . 0.0 108.611 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -150.14 175.47 11.72 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.022 0.929 . . . . 0.0 111.118 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.02 172.73 29.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.886 0.755 . . . . 0.0 114.158 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 126.159 1.784 . . . . 0.0 113.378 -174.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.24 108.36 2.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 126.045 1.738 . . . . 0.0 110.837 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.83 179.83 7.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.122 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.18 138.47 17.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.206 1.003 . . . . 0.0 108.594 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.66 168.92 20.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.307 0.643 . . . . 0.0 111.359 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.49 30.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.785 0.803 . . . . 0.0 113.073 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -135.45 113.85 11.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.395 1.478 . . . . 0.0 110.099 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.1 115.02 7.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.923 1.289 . . . . 0.0 109.995 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.3 ttp -82.3 153.32 25.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.391 0.676 . . . . 0.0 112.029 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -59.15 -24.05 62.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.96 -7.73 43.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.547 1.539 . . . . 0.0 114.205 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.15 -1.45 73.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.407 1.479 . . . . 0.0 114.764 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.05 175.34 6.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.046 1.339 . . . . 0.0 111.184 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.7 m -136.7 115.24 11.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.266 1.427 . . . . 0.0 110.983 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 tp -81.49 126.15 31.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.03 117.35 5.28 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.412 1.006 . . . . 0.0 112.221 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -90.39 146.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.903 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -129.43 135.54 48.8 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.373 1.469 . . . . 0.0 109.879 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CG ' HG12 ' A' ' 33' ' ' VAL . 53.0 p90 -153.19 145.42 23.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.048 0.928 . . . . 0.0 113.013 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -151.04 149.72 29.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.277 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.76 95.26 49.12 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 CA--C 1.541 0.862 0 C-N-CA 122.491 2.127 . . . . 0.0 110.609 176.262 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 121.136 0.493 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.436 ' CZ3' ' HB2' ' A' ' 139' ' ' PRO . 50.9 m95 -97.22 147.04 24.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.335 1.054 . . . . 0.0 112.813 176.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -154.92 151.81 28.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.407 174.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -175.6 119.0 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.4 1.88 . . . . 0.0 110.186 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.88 137.7 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.056 1.743 . . . . 0.0 109.516 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -134.03 159.54 40.46 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 110.365 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.99 104.74 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.785 1.634 . . . . 0.0 108.548 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -76.33 106.52 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.321 1.448 . . . . 0.0 109.61 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -70.38 85.25 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.481 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.55 -122.47 1.35 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.508 2.004 . . . . 0.0 110.563 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -146.64 144.65 29.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.578 1.151 . . . . 0.0 111.101 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -150.49 122.95 8.46 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.139 1.376 . . . . 0.0 110.789 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.69 152.66 45.23 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.038 1.335 . . . . 0.0 109.873 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.444 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -80.81 115.26 20.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.483 -0.761 . . . . 0.0 109.289 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.9 p30 -156.79 -177.77 6.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.618 1.167 . . . . 0.0 113.012 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -53.75 -38.42 64.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.382 1.073 . . . . 0.0 112.73 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.93 -42.5 94.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.414 1.007 . . . . 0.0 112.378 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 ptm -60.72 -50.94 71.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.188 0.994 . . . . 0.0 110.383 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -57.9 -36.54 72.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.658 0.783 . . . . 0.0 112.226 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.65 -46.6 78.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 0.0 110.912 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -20.72 66.22 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.321 -1.487 . . . . 0.0 113.48 174.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.35 -17.17 37.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.867 2.467 . . . . 0.0 115.131 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.23 -23.44 4.89 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -123.83 -25.74 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.829 1.252 . . . . 0.0 111.968 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.28 -68.19 1.74 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.775 1.655 . . . . 0.0 113.579 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -141.62 55.02 4.58 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 98.1 Cg_endo -64.33 141.06 73.33 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 123.905 3.07 . . . . 0.0 113.966 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -124.07 174.73 7.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.643 1.977 . . . . 0.0 113.102 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -129.23 141.95 50.99 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.623 -1.298 . . . . 0.0 110.546 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.61 120.02 1.07 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -134.06 83.97 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.49 0.716 . . . . 0.0 111.705 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 m120 56.75 93.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.976 2.51 . . . . 0.0 114.478 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 148.56 140.6 3.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.918 1.723 . . . . 0.0 111.928 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -67.06 141.58 57.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.009 0.923 . . . . 0.0 111.849 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -144.3 140.96 29.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.907 1.283 . . . . 0.0 111.915 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -132.24 151.83 51.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 127.537 2.335 . . . . 0.0 110.506 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -150.86 157.56 43.06 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 110.638 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.63 88.33 3.92 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tp -50.01 -39.42 41.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.966 1.707 . . . . 0.0 114.314 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.38 1.61 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 117.767 1.867 . . . . 0.0 117.767 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -132.52 -32.93 1.28 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.09 -37.54 0.7 Allowed Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.665 1.126 . . . . 0.0 113.239 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.31 172.2 7.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.283 1.833 . . . . 0.0 111.112 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -133.13 156.32 47.66 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.544 1.538 . . . . 0.0 109.681 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.99 30.29 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.253 0.621 . . . . 0.0 110.902 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 134.7 53.17 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.726 1.21 . . . . 0.0 108.296 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.4 148.42 18.92 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.217 0.913 . . . . 0.0 112.421 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -121.65 113.86 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.734 1.214 . . . . 0.0 111.168 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.52 125.9 45.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.829 0.74 . . . . 0.0 109.385 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.3 p -123.63 159.87 28.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.205 1.802 . . . . 0.0 110.365 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.5 t -147.23 -73.63 0.21 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.11 -0.994 . . . . 0.0 112.376 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.33 106.79 0.48 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.79 1.236 . . . . 0.0 112.469 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.31 97.89 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 60.29 79.36 0.24 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.392 1.877 . . . . 0.0 113.274 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.03 86.14 0.24 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.134 1.373 . . . . 0.0 113.853 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 -170.62 3.06 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.1 ptm -155.4 169.48 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.04 1.336 . . . . 0.0 111.477 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -148.33 157.24 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.994 1.317 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 37.2 mm -123.7 123.01 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.833 1.253 . . . . 0.0 108.62 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -118.43 122.52 42.96 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.49 0.716 . . . . 0.0 110.289 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.2 pt -105.72 132.89 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.449 1.099 . . . . 0.0 108.829 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.7 p -150.93 163.71 38.06 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.316 0.647 . . . . 0.0 110.645 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.229 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.46 169.81 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.337 1.065 . . . . 0.0 110.982 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.6 -30.48 9.59 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.643 1.592 . . . . 0.0 111.567 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.5 p -144.87 146.08 31.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.656 1.728 . . . . 0.0 111.966 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -139.71 156.39 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.6 1.16 . . . . 0.0 110.839 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.21 163.32 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.431 1.493 . . . . 0.0 111.984 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.48 -29.43 58.74 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.48 -15.47 3.89 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.267 1.889 . . . . 0.0 112.327 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.99 -28.85 69.32 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.414 1.485 . . . . 0.0 114.115 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -119.88 3.25 11.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.898 1.679 . . . . 0.0 113.848 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -78.36 133.02 37.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.439 1.096 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.48 147.88 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.637 1.175 . . . . 0.0 109.196 175.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.16 -32.91 56.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.217 0.917 . . . . 0.0 113.202 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -60.99 -48.4 82.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.89 1.276 . . . . 0.0 113.509 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.07 -45.2 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 121.559 -0.713 . . . . 0.0 110.602 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.24 -37.59 62.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.956 1.303 . . . . 0.0 112.125 -176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -52.03 -67.2 0.27 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.436 2.295 . . . . 0.0 110.871 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -38.16 79.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.834 0.854 . . . . 0.0 112.056 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.2 -48.64 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.235 1.379 . . . . 0.0 111.435 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.18 -27.27 59.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.322 1.049 . . . . 0.0 113.44 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.37 -35.14 54.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 116.986 -1.483 . . . . 0.0 112.41 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -45.3 -27.77 0.71 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.71 2.804 . . . . 0.0 114.52 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 CA--C 1.55 0.967 0 C-N-CA 123.963 0.905 . . . . 0.0 111.41 175.044 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.12 137.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.541 1.136 . . . . 0.0 112.194 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.27 116.49 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.549 2.339 . . . . 0.0 110.564 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.19 127.95 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 120.819 -1.176 . . . . 0.0 110.739 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.21 170.88 43.24 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 121.969 -0.457 . . . . 0.0 113.699 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.34 126.57 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.509 1.523 . . . . 0.0 110.108 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -77.53 108.0 10.38 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.523 -1.36 . . . . 0.0 112.125 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.89 93.73 9.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.211 1.404 . . . . 0.0 113.258 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.19 18.5 2.6 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 120.799 -1.188 . . . . 0.0 112.644 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 -7.8 59.5 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.5 7.61 71.95 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.657 1.123 . . . . 0.0 115.44 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.58 100.01 0.38 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.778 1.656 . . . . 0.0 111.891 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -52.18 124.44 13.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.784 2.033 . . . . 0.0 113.108 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.8 168.03 12.03 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.521 -0.737 . . . . 0.0 112.783 175.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -140.37 111.83 7.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.179 2.192 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.21 162.51 19.76 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.068 -1.02 . . . . 0.0 111.975 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.41 -64.56 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.628 1.171 . . . . 0.0 112.587 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -145.87 167.41 23.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.858 0.863 . . . . 0.0 111.533 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.3 134.46 31.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.816 1.247 . . . . 0.0 111.622 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -117.19 118.0 31.13 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.038 1.735 . . . . 0.0 109.749 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 118.86 25.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.372 2.269 . . . . 0.0 109.265 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.28 -30.54 11.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.206 1.403 . . . . 0.0 112.452 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -120.41 107.37 12.83 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.448 1.499 . . . . 0.0 108.447 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.99 123.09 3.35 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.524 1.059 . . . . 0.0 113.666 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -95.91 100.96 12.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.426 1.49 . . . . 0.0 109.515 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -67.68 168.99 10.22 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -138.92 0.32 1.96 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.936 1.695 . . . . 0.0 113.071 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.09 156.12 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.747 -1.221 . . . . 0.0 111.876 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.41 128.11 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.863 1.265 . . . . 0.0 112.537 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 tp -80.79 130.1 65.36 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 108.968 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 123.35 11.31 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.79 2.993 . . . . 0.0 111.184 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.65 -53.39 9.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.73 0.812 . . . . 0.0 112.96 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -114.58 157.35 23.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.165 0.986 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.71 87.98 11.04 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 124.024 0.93 . . . . 0.0 108.843 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.65 159.21 54.59 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.849 1.699 . . . . 0.0 111.183 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -58.47 158.49 7.46 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.718 -0.613 . . . . 0.0 111.035 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 6.9 p 58.17 42.47 22.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.223 1.409 . . . . 0.0 112.157 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -155.65 163.9 39.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.475 1.91 . . . . 0.0 111.762 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.06 -174.73 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.789 0.804 . . . . 0.0 109.422 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.52 154.52 28.75 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.542 -0.724 . . . . 0.0 111.425 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.15 164.42 28.07 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.901 0.881 . . . . 0.0 111.348 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.71 163.55 30.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.797 1.239 . . . . 0.0 109.698 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -131.01 172.36 12.17 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.3 1.84 . . . . 0.0 109.245 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.65 117.02 0.83 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-O 118.706 -1.052 . . . . 0.0 111.568 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 125.253 1.421 . . . . 0.0 111.135 -177.404 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -155.37 119.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.609 1.963 . . . . 0.0 109.034 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -150.12 171.65 16.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.205 1.402 . . . . 0.0 109.119 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 127.67 6.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -131.1 165.09 24.03 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.007 0.923 . . . . 0.0 111.309 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.61 148.66 48.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -123.36 120.09 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.216 1.406 . . . . 0.0 110.528 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -71.73 102.35 2.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 0.0 110.23 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.4 mtp -66.11 152.35 44.91 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 0.0 111.893 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -56.57 -30.65 63.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.489 1.116 . . . . 0.0 113.423 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.4 p -65.27 -11.9 46.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.966 2.106 . . . . 0.0 115.157 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 18.8 41.89 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.519 1.057 . . . . 0.0 114.579 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -111.68 167.6 10.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.762 1.625 . . . . 0.0 110.804 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.1 m -128.94 101.06 5.9 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.233 -0.917 . . . . 0.0 112.767 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.64 116.34 11.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.749 0.82 . . . . 0.0 110.97 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.34 105.11 3.22 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.208 0.909 . . . . 0.0 111.876 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.04 156.32 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 0.0 110.152 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -136.57 162.85 31.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.759 1.224 . . . . 0.0 109.046 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -162.97 155.55 18.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.112 0.565 . . . . 0.0 111.022 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 t -153.53 164.01 38.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 110.645 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 m -105.02 146.64 33.06 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.493 1.117 . . . . 0.0 112.367 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 CA--C 1.541 0.841 0 C-N-CA 124.033 3.155 . . . . 0.0 112.055 176.341 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.343 0.592 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -84.38 142.54 30.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.331 1.452 . . . . 0.0 113.146 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.01 146.2 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -163.17 152.88 15.4 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.106 0.962 . . . . 0.0 112.957 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.9 140.84 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.031 0.932 . . . . 0.0 109.258 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -145.32 133.97 22.16 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.164 1.386 . . . . 0.0 109.387 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.3 mt -95.61 110.17 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 124.869 1.267 . . . . 0.0 108.496 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -76.21 96.26 3.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.3 p -55.69 119.42 5.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.82 -111.61 3.04 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 143.0 27.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.549 1.14 . . . . 0.0 112.281 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -158.87 117.53 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.657 1.583 . . . . 0.0 111.902 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 166.74 22.46 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.745 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 115.52 20.04 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.198 0.599 . . . . 0.0 110.535 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.21 -173.14 4.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.789 1.236 . . . . 0.0 111.872 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -50.73 -49.43 57.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.136 0.974 . . . . 0.0 111.732 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.73 -36.87 50.31 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.597 1.094 . . . . 0.0 113.683 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.72 -63.25 1.11 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.106 0.962 . . . . 0.0 110.425 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -51.61 -34.14 36.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.271 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -64.73 -47.86 76.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.645 1.178 . . . . 0.0 110.627 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.08 -25.25 66.93 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.11 -1.619 . . . . 0.0 113.401 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -83.48 -12.2 56.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.857 1.663 . . . . 0.0 114.941 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -124.16 -32.6 3.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.93 1.292 . . . . 0.0 114.094 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -114.87 -23.75 8.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.883 1.673 . . . . 0.0 112.778 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.93 -85.87 0.03 OUTLIER Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.251 1.881 . . . . 0.0 112.21 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -164.07 63.35 1.13 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.643 1.577 . . . . 0.0 112.15 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.15 178.32 7.45 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.896 2.398 . . . . 0.0 115.706 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.57 -171.07 2.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.539 1.936 . . . . 0.0 113.819 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -139.2 146.58 40.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.535 1.934 . . . . 0.0 111.365 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.65 -57.74 0.46 Allowed Glycine 0 N--CA 1.479 1.554 0 C-N-CA 124.503 1.049 . . . . 0.0 115.664 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.1 t0 52.86 68.62 0.8 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.826 1.651 . . . . 0.0 114.431 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.312 0.1 OUTLIER 40.95 69.05 0.37 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.122 2.169 . . . . 0.0 114.441 176.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 119.75 0.8 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.213 1.863 . . . . 0.0 111.496 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -57.78 132.89 54.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.159 0.983 . . . . 0.0 112.028 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -147.9 125.06 11.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.293 1.037 . . . . 0.0 112.364 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.01 137.47 49.99 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.895 1.678 . . . . 0.0 109.859 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 151.77 40.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.111 0.965 . . . . 0.0 110.877 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -74.53 93.94 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tp -48.62 -30.46 5.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.58 31.59 2.12 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.81 -27.36 1.15 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.45 -15.35 0.96 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.594 1.092 . . . . 0.0 114.675 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.49 171.64 13.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.647 1.579 . . . . 0.0 111.208 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.44 157.11 24.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.515 1.126 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -134.94 164.65 27.13 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.637 0.775 . . . . 0.0 109.447 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -133.2 122.8 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.924 1.69 . . . . 0.0 108.757 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.43 143.76 17.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.564 0.602 . . . . 0.0 113.19 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.11 143.84 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.514 1.526 . . . . 0.0 110.222 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 9.6 tpt -132.44 124.9 29.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.122 1.369 . . . . 0.0 109.458 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.9 p -128.96 135.53 49.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.933 0.893 . . . . 0.0 110.82 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -97.43 178.31 5.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.666 1.986 . . . . 0.0 112.135 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.05 -171.04 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.045 2.138 . . . . 0.0 112.132 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.66 174.67 45.25 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 47.43 21.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.472 1.909 . . . . 0.0 116.137 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.24 150.27 45.5 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.503 1.921 . . . . 0.0 113.079 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -164.63 154.41 13.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.053 1.341 . . . . 0.0 113.654 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.55 138.7 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.333 2.253 . . . . 0.0 112.448 174.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -143.11 161.45 38.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.22 1.808 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 mm -126.44 117.11 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.436 1.095 . . . . 0.0 109.96 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -96.24 117.16 30.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.534 1.134 . . . . 0.0 108.181 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 4.3 pt -109.88 130.9 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.31 142.93 2.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.736 0.814 . . . . 0.0 112.342 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.49 1.516 . . . . 0.0 113.435 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 142.95 33.56 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.343 0.592 . . . . 0.0 110.875 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.63 -21.81 13.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.249 1.88 . . . . 0.0 112.242 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -150.67 155.64 39.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.699 1.999 . . . . 0.0 112.005 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -140.82 167.91 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.93 1.692 . . . . 0.0 111.17 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -169.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.301 1.841 . . . . 0.0 111.04 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.72 -41.98 5.14 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.01 -32.55 5.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.161 1.362 . . . . 0.0 112.84 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 118.437 1.119 . . . . 0.0 111.608 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -85.39 -5.33 59.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.107 1.763 . . . . 0.0 113.778 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 HE22 ' A' ' 170' ' ' GLN . 5.0 tt -65.46 137.33 57.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.089 0.956 . . . . 0.0 109.914 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.55 146.01 35.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.322 1.049 . . . . 0.0 109.799 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -54.87 -32.8 61.18 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.888 0.767 . . . . 0.0 112.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -56.6 -56.45 21.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.452 1.101 . . . . 0.0 112.702 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.56 -49.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -19.17 26.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.237 1.415 . . . . 0.0 113.523 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -82.59 -47.92 11.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.973 2.109 . . . . 0.0 111.514 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -33.25 73.14 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.546 -1.346 . . . . 0.0 110.84 174.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -45.69 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.493 1.517 . . . . 0.0 112.821 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -33.53 68.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.819 0.448 . . . . 0.0 111.259 175.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.85 -23.04 58.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.77 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -47.38 -25.22 0.96 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.813 2.045 . . . . 0.0 113.19 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 126.164 1.786 . . . . 0.0 112.33 175.012 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.41 139.55 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 112.313 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.83 98.93 6.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.365 2.266 . . . . 0.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.33 159.3 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.796 -1.19 . . . . 0.0 110.881 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.3 -176.34 43.35 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-O 121.36 0.422 . . . . 0.0 112.079 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.39 144.7 29.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.022 0.929 . . . . 0.0 110.703 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.17 106.05 16.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.508 1.523 . . . . 0.0 112.006 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 p-10 -93.45 107.66 19.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.676 1.59 . . . . 0.0 111.963 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -136.84 10.27 3.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.302 1.441 . . . . 0.0 112.206 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -8.66 55.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.656 1.582 . . . . 0.0 115.13 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.05 28.38 41.63 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.611 1.101 . . . . 0.0 114.419 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.12 128.15 3.47 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.005 1.764 . . . . 0.0 111.206 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 m -58.22 147.6 29.89 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.315 1.446 . . . . 0.0 111.35 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 37' ' ' ASN . 45.9 m0 -110.72 173.48 6.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.875 -1.141 . . . . 0.0 112.966 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -153.63 98.78 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.573 1.549 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.67 137.34 45.96 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.005 -1.684 . . . . 0.0 110.603 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 -64.35 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.409 0.684 . . . . 0.0 111.224 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -154.26 -171.82 4.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.494 1.918 . . . . 0.0 110.885 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.23 134.77 29.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.033 1.333 . . . . 0.0 111.886 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -110.3 131.0 55.44 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.832 1.253 . . . . 0.0 109.915 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -153.0 162.29 41.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.069 1.348 . . . . 0.0 111.377 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -124.58 -56.67 1.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.143 1.377 . . . . 0.0 109.885 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.6 m -91.83 113.3 25.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.111 0.965 . . . . 0.0 110.559 177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.09 115.78 3.71 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -76.17 -179.76 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.911 1.284 . . . . 0.0 112.238 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.4 p -79.6 163.36 24.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 112.184 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -35.65 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.981 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 160.25 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.59 1.956 . . . . 0.0 109.709 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 tt -80.32 133.89 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.85 0.86 . . . . 0.0 110.743 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.7 tp -80.88 128.33 71.83 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.05 163.77 27.45 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.347 2.031 . . . . 0.0 111.132 175.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -112.6 -66.05 1.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.514 1.126 . . . . 0.0 110.356 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.6 126.74 44.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.975 0.91 . . . . 0.0 109.819 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.32 129.91 24.45 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.593 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.26 -172.51 0.44 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.044 3.829 . . . . 0.0 113.204 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -82.06 153.01 26.35 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 119.685 -1.884 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.9 p 49.83 42.15 23.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.618 1.567 . . . . 0.0 114.736 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -156.0 122.6 5.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.067 1.747 . . . . 0.0 113.875 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -177.86 6.82 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.497 1.519 . . . . 0.0 114.125 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.27 152.37 41.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.244 1.418 . . . . 0.0 110.633 174.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 164.18 19.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -136.53 166.78 22.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.089 1.755 . . . . 0.0 110.539 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.6 p -138.71 168.5 19.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.297 1.439 . . . . 0.0 111.098 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 165.97 36.63 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.337 0.97 . . . . 0.0 111.569 174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.981 1.313 . . . . 0.0 112.082 175.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.819 0 CA-C-O 121.193 0.52 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.6 105.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.77 2.428 . . . . 0.0 110.59 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 102' ' ' PHE . . . -135.06 156.21 49.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.287 1.041 . . . . 0.0 110.897 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.29 111.65 5.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.517 1.127 . . . . 0.0 109.091 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -125.73 154.17 42.87 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.518 1.127 . . . . 0.0 112.074 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.88 140.6 50.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.274 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.66 110.36 19.05 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.712 1.205 . . . . 0.0 110.022 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.72 96.0 0.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.253 1.421 . . . . 0.0 110.41 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.4 ttt -62.95 146.91 51.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.038 1.735 . . . . 0.0 111.522 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 t -53.27 -23.65 9.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.648 1.179 . . . . 0.0 114.118 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 m -67.42 0.5 2.91 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.87 54.41 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.388 0.994 . . . . 0.0 112.125 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -124.15 166.52 15.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.486 1.914 . . . . 0.0 109.649 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.5 m -137.83 101.05 4.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.159 -0.963 . . . . 0.0 111.697 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -69.77 112.72 6.42 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.345 -0.847 . . . . 0.0 110.794 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.5 102.97 2.99 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.705 1.145 . . . . 0.0 112.782 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.62 151.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.67 0.788 . . . . 0.0 111.699 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 6.3 ttp -134.54 150.65 50.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.385 1.474 . . . . 0.0 111.642 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CE2' ' HB1' ' A' ' 86' ' ' ALA . 4.6 p90 -162.34 151.37 15.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.341 1.057 . . . . 0.0 110.78 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -158.35 126.86 5.42 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 110.447 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.12 128.4 60.17 Favored Pre-proline 0 N--CA 1.48 1.049 0 O-C-N 121.209 -0.932 . . . . 0.0 111.2 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 C--N 1.355 0.875 0 C-N-CA 123.802 3.002 . . . . 0.0 112.529 176.28 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -97.67 131.16 44.48 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.078 0.951 . . . . 0.0 112.447 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.6 129.19 15.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.159 0.981 . . . . 0.0 109.941 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.73 107.76 1.52 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 m -115.83 161.5 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.368 0.667 . . . . 0.0 109.337 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -154.65 154.48 33.03 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.06 0.544 . . . . 0.0 111.367 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.439 ' H ' ' CD2' ' A' ' 151' ' ' LEU . 5.3 mp -107.66 110.19 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.991 0.916 . . . . 0.0 109.869 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.64 92.74 1.98 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.829 1.652 . . . . 0.0 109.919 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -68.78 81.08 0.29 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.567 -1.333 . . . . 0.0 111.497 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.13 -99.12 0.13 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.453 1.978 . . . . 0.0 112.354 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -165.33 104.19 0.74 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.911 1.684 . . . . 0.0 110.832 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -149.86 103.44 3.22 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 172.26 1.75 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.16 1.384 . . . . 0.0 112.386 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.39 119.96 19.3 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.62 -0.675 . . . . 0.0 112.184 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.62 -173.29 3.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.579 1.551 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -51.06 -52.98 38.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.427 1.091 . . . . 0.0 112.183 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.03 -31.05 64.48 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.769 0.7 . . . . 0.0 113.175 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.7 ttt -65.81 -64.45 0.86 Allowed 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -53.65 -33.67 56.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.026 0.93 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.48 -49.14 78.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.039 0.936 . . . . 0.0 109.195 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.54 -3.79 19.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.8 mt -102.78 -22.23 13.94 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.91 -25.24 9.52 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.959 -1.088 . . . . 0.0 113.671 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.56 0.85 8.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.408 1.483 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.99 71.63 0.3 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.401 1.953 . . . . 0.0 114.535 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.27 2.2 m120 85.49 57.49 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 130.203 3.401 . . . . 0.0 112.376 -175.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.91 125.0 14.47 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.763 2.976 . . . . 0.0 112.886 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.58 173.75 6.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.24 1.416 . . . . 0.0 112.82 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.06 142.84 51.43 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.119 1.767 . . . . 0.0 110.212 -174.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.09 118.07 1.66 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 121.658 0.588 . . . . 0.0 112.569 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -97.67 26.17 5.26 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.459 2.303 . . . . 0.0 114.528 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 77.12 94.86 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.235 2.614 . . . . 0.0 111.919 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 138.74 2.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.112 1.339 . . . . 0.0 112.862 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.456 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 22.4 m95 -64.59 130.81 45.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.487 1.515 . . . . 0.0 112.037 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -145.25 119.27 9.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.416 1.486 . . . . 0.0 112.114 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.91 143.02 27.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.546 1.138 . . . . 0.0 111.788 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.32 155.93 29.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.108 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 96.91 2.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.892 0.877 . . . . 0.0 108.923 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 2.7 tp -49.82 -49.97 46.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.458 1.103 . . . . 0.0 112.048 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.6 80.12 1.25 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.883 1.706 . . . . 0.0 114.733 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -168.92 -36.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.819 2.047 . . . . 0.0 111.688 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.07 -80.51 0.06 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.372 1.463 . . . . 0.0 113.058 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.07 -179.2 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.786 1.235 . . . . 0.0 112.837 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -117.29 145.35 44.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 0.0 112.169 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.34 172.32 13.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.069 0.938 . . . . 0.0 112.211 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -133.18 139.13 46.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.499 1.12 . . . . 0.0 110.263 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -122.55 164.46 15.56 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.233 1.397 . . . . 0.0 113.516 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.456 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 5.2 tp -139.23 95.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.18 99.04 10.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.861 -1.775 . . . . 0.0 112.351 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.71 132.68 56.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.436 1.094 . . . . 0.0 112.725 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 69.4 p -152.86 91.82 1.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.395 1.478 . . . . 0.0 112.711 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.9 52.5 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.511 -1.368 . . . . 0.0 111.57 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.8 125.94 1.44 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.252 17.5 pt-20 46.02 36.74 3.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.595 1.558 . . . . 0.0 114.195 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.21 162.46 18.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.085 2.154 . . . . 0.0 112.507 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.97 -172.68 4.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.541 1.536 . . . . 0.0 112.991 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -119.24 153.54 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.798 2.039 . . . . 0.0 111.883 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.461 HE22 HD13 ' A' ' 12' ' ' LEU . 31.4 tt0 -136.72 154.72 50.51 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.785 1.634 . . . . 0.0 110.468 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.68 120.19 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 109.731 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -112.08 111.06 21.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.581 1.552 . . . . 0.0 109.707 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 pt -97.23 144.3 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.882 1.273 . . . . 0.0 111.761 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.7 p -158.07 151.73 23.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.34 1.056 . . . . 0.0 112.535 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.679 1.591 . . . . 0.0 112.325 -176.138 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.21 -34.45 76.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.529 1.059 . . . . 0.0 112.75 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 159.0 12.26 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.935 0.894 . . . . 0.0 110.429 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.2 -9.13 56.07 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.261 0.934 . . . . 0.0 112.881 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -163.34 143.3 8.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.068 2.147 . . . . 0.0 110.375 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -143.75 160.78 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 125.377 1.471 . . . . 0.0 109.679 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.02 -173.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 127.603 2.361 . . . . 0.0 112.008 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.28 -19.82 9.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -17.03 48.6 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.384 1.469 . . . . 0.0 112.435 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.69 67.87 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.617 1.167 . . . . 0.0 112.765 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -106.19 -2.8 22.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.261 1.824 . . . . 0.0 114.15 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.6 tp -67.11 138.65 57.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.954 1.302 . . . . 0.0 109.204 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.6 141.28 20.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.97 0.508 . . . . 0.0 110.984 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.59 -33.68 70.25 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.67 -47.45 76.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.143 1.377 . . . . 0.0 113.978 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.32 -54.28 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.653 1.181 . . . . 0.0 108.729 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.1 -33.77 27.63 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.04 1.736 . . . . 0.0 113.094 -175.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.44 -59.35 5.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.493 1.917 . . . . 0.0 110.88 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -35.76 81.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.921 1.689 . . . . 0.0 111.992 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.36 -45.8 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.129 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.42 -32.3 73.87 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 -19.78 60.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.581 1.152 . . . . 0.0 113.823 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -58.61 -32.51 69.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.859 -1.151 . . . . 0.0 111.645 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.44 -44.15 89.05 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.301 1.441 . . . . 0.0 113.037 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.67 150.45 10.01 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.414 1.007 . . . . 0.0 112.042 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -81.16 87.24 6.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.094 0.958 . . . . 0.0 111.07 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.54 158.26 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.932 1.693 . . . . 0.0 111.806 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.43 22.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.013 1.725 . . . . 0.0 114.249 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -141.7 120.26 12.48 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.524 1.529 . . . . 0.0 113.213 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -137.42 106.36 5.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.369 1.467 . . . . 0.0 109.703 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.453 HD13 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.0 149.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.483 1.113 . . . . 0.0 111.468 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' H ' ' HG2' ' A' ' 168' ' ' LYS . . . -125.79 110.12 13.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.144 1.378 . . . . 0.0 111.924 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.83 118.55 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.001 1.32 . . . . 0.0 109.78 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 168.98 40.82 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.222 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.31 130.72 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.0 109.576 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.4 105.02 8.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.283 1.033 . . . . 0.0 111.761 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -73.22 85.56 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.671 2.388 . . . . 0.0 111.955 175.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -137.53 46.08 2.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.823 -1.173 . . . . 0.0 111.38 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -2.45 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 175.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.71 24.28 62.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.365 0.983 . . . . 0.0 114.8 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.75 114.64 1.06 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.582 1.563 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -53.42 127.59 25.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.945 1.298 . . . . 0.0 111.289 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 37' ' ' ASN . 53.7 m0 -91.38 157.37 17.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -137.9 109.56 7.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.951 1.701 . . . . 0.0 111.094 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 143.22 50.88 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.314 -0.866 . . . . 0.0 110.234 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -47.35 3.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.343 1.457 . . . . 0.0 113.066 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -156.63 171.49 20.25 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.633 1.573 . . . . 0.0 111.199 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.59 121.82 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 111.869 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -100.9 129.25 46.73 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 110.017 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -153.36 160.43 42.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.911 1.285 . . . . 0.0 112.018 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -116.43 -8.1 11.62 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.497 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 p -53.62 157.77 2.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.582 1.953 . . . . 0.0 112.79 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -35.16 -66.44 0.35 Allowed Glycine 0 N--CA 1.469 0.893 0 C-N-CA 127.96 2.695 . . . . 0.0 115.945 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -165.44 178.46 6.78 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.778 1.631 . . . . 0.0 111.492 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.9 171.39 8.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 111.648 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -154.67 -28.21 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.832 -1.168 . . . . 0.0 113.294 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.9 158.24 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.261 1.824 . . . . 0.0 110.832 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 tt -73.24 132.82 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.462 1.105 . . . . 0.0 111.654 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.01 122.26 82.95 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.377 1.071 . . . . 0.0 110.19 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.77 114.87 2.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.359 3.373 . . . . 0.0 112.689 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.17 -55.16 17.71 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.58 153.64 30.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.456 1.102 . . . . 0.0 110.68 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.38 121.22 16.32 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.694 0.798 . . . . 0.0 111.592 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.94 162.06 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.716 2.277 . . . . 0.0 112.05 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -62.1 156.88 20.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.449 0.7 . . . . 0.0 112.172 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.2 p 41.78 49.44 3.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.37 1.868 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -141.24 -171.42 3.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.997 1.719 . . . . 0.0 111.361 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.14 -177.02 5.69 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.832 -1.167 . . . . 0.0 110.298 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.09 142.52 16.09 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.133 -0.979 . . . . 0.0 112.214 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.53 170.44 8.02 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.889 0.875 . . . . 0.0 110.735 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -152.15 165.71 33.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.473 1.509 . . . . 0.0 107.882 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.1 m -145.07 169.14 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.677 1.191 . . . . 0.0 109.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -157.54 7.19 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.314 0.483 . . . . 0.0 112.072 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -144.05 160.92 40.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.59 1.556 . . . . 0.0 110.627 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -112.53 -49.89 2.93 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.031 -1.043 . . . . 0.0 110.688 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 50.23 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.018 2.127 . . . . 0.0 113.832 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t -139.22 13.16 2.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.091 1.756 . . . . 0.0 113.108 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.71 -112.08 0.14 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.504 1.526 . . . . 0.0 112.669 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.12 -24.57 10.99 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 CA-C-N 120.057 1.928 . . . . 0.0 112.509 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -150.71 176.99 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 127.475 2.31 . . . . 0.0 109.78 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 -35.58 22.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.91 1.684 . . . . 0.0 112.873 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -142.86 138.51 30.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.48 1.912 . . . . 0.0 112.825 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 128.28 -142.37 13.46 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 127.913 2.673 . . . . 0.0 111.579 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 177.16 145.22 0.1 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.025 2.53 . . . . 0.0 112.395 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 t -147.58 121.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.48 -1.387 . . . . 0.0 113.485 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HB1' ' CE2' ' A' ' 102' ' ' PHE . . . -148.08 164.72 32.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.46 1.104 . . . . 0.0 111.212 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.18 110.2 4.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.647 1.179 . . . . 0.0 108.369 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.05 152.92 48.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.255 1.022 . . . . 0.0 112.069 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.78 148.96 39.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.435 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -122.83 124.24 42.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.961 1.304 . . . . 0.0 110.105 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.56 109.26 2.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 110.178 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.11 153.21 38.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.013 1.325 . . . . 0.0 111.17 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -63.87 -22.03 66.73 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.21 1.8 20.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.299 1.04 . . . . 0.0 113.781 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.76 19.52 70.45 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.663 1.125 . . . . 0.0 113.864 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -102.59 171.21 7.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 109.221 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.1 m -133.55 103.51 5.95 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.539 -1.351 . . . . 0.0 112.109 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 tp -69.75 126.65 30.36 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.297 -0.877 . . . . 0.0 110.345 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.23 107.47 3.06 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.18 165.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 117.632 0.716 . . . . 0.0 110.333 175.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -151.41 140.75 21.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.232 177.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' CE1' HD13 ' A' ' 31' ' ' ILE . 27.6 p90 -153.34 160.04 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.662 0.744 . . . . 0.0 110.313 175.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -162.14 167.43 24.2 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.732 1.613 . . . . 0.0 109.19 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.42 106.64 57.08 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.25 -9.91 25.0 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.011 2.474 . . . . 0.0 113.234 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.66 12.5 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.575 2.75 . . . . 0.0 116.143 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -137.71 4.45 2.58 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.224 2.21 . . . . 0.0 114.183 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -130.67 61.25 1.62 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.016 1.727 . . . . 0.0 111.679 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -56.91 -19.21 16.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.243 1.017 . . . . 0.0 113.542 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -35.12 60.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.033 1.733 . . . . 0.0 112.842 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -136.57 175.27 9.76 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.309 1.444 . . . . 0.0 111.847 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.2 t -81.96 -173.95 4.78 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.91 0.862 . . . . 0.0 110.969 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.44 114.22 21.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.37 1.468 . . . . 0.0 111.38 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -73.1 148.5 43.91 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.43 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.9 p-90 -148.04 169.43 19.96 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.519 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.9 t70 179.62 163.57 0.99 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 128.048 2.539 . . . . 0.0 110.379 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.6 p -165.6 136.65 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.079 2.152 . . . . 0.0 109.252 174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -152.42 156.6 39.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.87 1.268 . . . . 0.0 110.483 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.79 106.16 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.658 1.583 . . . . 0.0 107.767 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -74.69 98.74 3.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.273 1.029 . . . . 0.0 109.338 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.4 t -59.07 137.49 57.93 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.738 -1.226 . . . . 0.0 110.828 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.2 -117.42 5.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.496 1.522 . . . . 0.0 110.124 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 128.16 12.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.503 1.121 . . . . 0.0 111.253 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.37 114.72 10.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.068 1.347 . . . . 0.0 111.221 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.05 164.71 23.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 110.283 174.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.95 109.0 15.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.903 -0.498 . . . . 0.0 109.822 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.38 -173.28 4.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.202 1.401 . . . . 0.0 110.019 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.63 -43.29 56.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.002 0.921 . . . . 0.0 111.202 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -33.32 38.93 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.556 1.074 . . . . 0.0 114.329 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.1 ttt -70.51 -60.15 2.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.829 0.815 . . . . 0.0 110.452 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -56.94 -31.18 64.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.16 0.984 . . . . 0.0 113.632 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.33 -39.15 93.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 110.148 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -26.58 67.48 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.547 -1.346 . . . . 0.0 111.872 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mt -78.39 -43.41 27.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.236 1.414 . . . . 0.0 112.028 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.08 -28.32 16.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.62 -40.42 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.802 1.641 . . . . 0.0 111.707 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.63 -58.25 8.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.749 1.642 . . . . 0.0 111.572 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -178.75 88.29 0.22 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 127.225 2.21 . . . . 0.0 111.637 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.73 141.02 40.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.303 2.002 . . . . 0.0 111.234 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -112.83 173.75 6.23 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.37 1.468 . . . . 0.0 111.575 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.98 134.08 46.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.52 1.528 . . . . 0.0 110.718 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.22 106.85 0.7 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.436 1.017 . . . . 0.0 112.362 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -121.5 71.97 0.99 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.133 1.373 . . . . 0.0 111.117 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 59.61 101.09 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.692 2.797 . . . . 0.0 115.868 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.2 161.88 9.65 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.454 1.026 . . . . 0.0 114.593 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.5 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 m95 -78.55 150.65 32.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.725 1.21 . . . . 0.0 110.629 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -152.04 133.13 14.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.862 1.665 . . . . 0.0 110.718 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.8 146.13 49.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.31 1.444 . . . . 0.0 112.387 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -150.46 157.55 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.88 0.848 . . . . 0.0 112.123 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -80.53 92.98 5.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.486 1.514 . . . . 0.0 108.088 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 tp -52.51 -39.83 61.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.23 30.26 2.75 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.28 -22.61 1.97 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.448 1.624 . . . . 0.0 115.175 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.74 -21.56 1.82 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.265 1.412 . . . . 0.0 114.035 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 pp -124.1 173.52 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.731 1.612 . . . . 0.0 112.538 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -116.3 158.66 23.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.02 1.328 . . . . 0.0 111.336 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.31 155.03 47.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.584 0.354 . . . . 0.0 110.926 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.44 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.5 tppt? -126.16 127.47 45.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.545 1.938 . . . . 0.0 109.727 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.72 137.63 14.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 126.105 1.812 . . . . 0.0 112.812 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.5 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -117.13 146.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.496 1.118 . . . . 0.0 111.063 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.25 145.78 51.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.959 0.904 . . . . 0.0 109.352 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.0 p -144.03 126.62 15.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.171 1.388 . . . . 0.0 110.949 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m -89.07 178.52 6.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.002 2.121 . . . . 0.0 112.059 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.39 -178.7 0.18 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.95 2.5 . . . . 0.0 112.534 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 161.87 51.43 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.259 -0.901 . . . . 0.0 111.72 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 55.64 29.49 13.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.519 1.127 . . . . 0.0 112.792 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -126.53 144.56 50.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.115 1.766 . . . . 0.0 112.819 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.459 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 24.6 tptp -162.64 149.46 13.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.54 137.78 37.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.2 2.2 . . . . 0.0 112.682 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -135.6 157.33 47.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.876 1.67 . . . . 0.0 110.59 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.3 mm -129.32 124.52 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.36 1.064 . . . . 0.0 110.769 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 131.99 54.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.425 1.49 . . . . 0.0 111.65 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.423 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 11.3 pt -118.23 134.26 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.813 1.645 . . . . 0.0 110.455 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.6 p -163.47 177.17 9.08 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.515 1.526 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.782 1.233 . . . . 0.0 111.919 -176.21 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.734 0.302 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.83 -45.71 49.61 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.902 -1.124 . . . . 0.0 111.825 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.83 173.25 4.55 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.522 0.677 . . . . 0.0 110.388 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.63 -36.32 3.83 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.1 p -137.02 161.13 36.9 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.624 -1.515 . . . . 0.0 111.48 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.1 mm -137.8 163.41 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.904 1.281 . . . . 0.0 110.416 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 pt -67.62 -170.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.893 2.077 . . . . 0.0 110.458 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.43 -28.15 4.9 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 119.722 -1.861 . . . . 0.0 115.932 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.2 69.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.465 1.031 . . . . 0.0 113.803 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.19 -42.06 39.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.524 1.13 . . . . 0.0 111.29 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -8.3 59.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.227 1.411 . . . . 0.0 114.106 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.83 143.79 50.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 0.0 110.305 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.25 150.74 31.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.527 1.131 . . . . 0.0 109.906 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -55.19 -26.68 40.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -62.05 -58.16 8.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.617 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.18 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.077 0.551 . . . . 0.0 109.73 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -23.66 66.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.407 1.083 . . . . 0.0 113.456 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.24 -51.51 13.14 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.363 -1.461 . . . . 0.0 110.374 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -40.52 96.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 112.908 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.164 0.986 . . . . 0.0 112.857 -174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.9 -31.86 57.02 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 110.891 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.43 -37.26 74.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.933 0.893 . . . . 0.0 111.921 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -19.89 47.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.028 1.331 . . . . 0.0 114.517 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.6 -34.67 72.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.206 2.202 . . . . 0.0 113.336 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.76 -153.84 7.57 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.951 2.215 . . . . 0.0 112.789 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -132.1 14.19 4.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.53 1.932 . . . . 0.0 113.186 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.76 129.95 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.615 1.966 . . . . 0.0 111.713 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -65.22 -4.42 5.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.98 1.312 . . . . 0.0 114.391 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -115.28 121.48 43.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.302 2.241 . . . . 0.0 108.119 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 -175.09 4.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.811 1.245 . . . . 0.0 111.497 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.19 142.02 43.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 125.196 1.398 . . . . 0.0 111.946 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.94 115.32 18.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.965 1.706 . . . . 0.0 109.684 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.75 128.76 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.873 1.269 . . . . 0.0 109.088 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.12 -179.53 40.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.523 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 3.4 mp -130.41 146.02 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.795 0.838 . . . . 0.0 111.543 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -96.7 109.41 22.06 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.296 -0.877 . . . . 0.0 111.63 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 91.61 6.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.078 0.951 . . . . 0.0 111.244 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.1 56.74 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.25 1.42 . . . . 0.0 109.697 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t -119.77 -45.63 2.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.194 1.397 . . . . 0.0 113.346 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 13.91 2.18 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.657 1.122 . . . . 0.0 115.878 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.33 146.57 17.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.093 1.33 . . . . 0.0 112.552 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 m -73.92 145.03 45.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.718 1.607 . . . . 0.0 110.589 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -112.52 166.49 11.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.666 -0.647 . . . . 0.0 112.573 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.9 m -143.62 109.43 5.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.19 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.24 151.31 46.44 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.818 -1.176 . . . . 0.0 111.232 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.429 ' H ' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -106.91 -55.1 2.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.7 1.6 . . . . 0.0 111.6 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -160.9 -172.95 3.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.904 1.682 . . . . 0.0 110.829 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.02 137.76 29.5 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.103 1.361 . . . . 0.0 111.325 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.01 127.74 52.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.515 1.526 . . . . 0.0 110.151 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.35 162.79 30.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 112.584 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -124.0 -43.98 2.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.673 1.589 . . . . 0.0 112.27 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.8 p -129.61 113.28 14.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.891 1.276 . . . . 0.0 112.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 114.9 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.332 1.444 . . . . 0.0 111.485 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.09 178.72 3.65 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.875 0.845 . . . . 0.0 112.001 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.02 162.78 1.75 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.576 1.95 . . . . 0.0 112.294 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.38 -32.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.104 -0.998 . . . . 0.0 112.22 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.08 169.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.986 2.114 . . . . 0.0 111.905 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -70.27 127.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.872 1.269 . . . . 0.0 112.801 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.74 129.78 60.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.62 146.53 79.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.501 2.8 . . . . 0.0 111.244 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.89 -53.08 3.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 112.417 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -122.08 143.94 49.22 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 110.44 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.9 t -136.27 130.14 18.11 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.644 1.177 . . . . 0.0 110.563 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.02 163.15 25.85 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.88 3.054 . . . . 0.0 112.562 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -70.07 14.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -140.24 15.68 2.42 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.09 1.756 . . . . 0.0 114.268 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.88 155.1 47.37 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.524 1.13 . . . . 0.0 112.522 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.23 -177.01 3.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.609 1.195 . . . . 0.0 112.159 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.77 154.22 34.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 175.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.7 mt -138.11 167.22 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.283 1.433 . . . . 0.0 109.495 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -141.71 165.83 26.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.532 1.533 . . . . 0.0 109.966 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -145.99 169.1 19.32 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.35 1.06 . . . . 0.0 110.887 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.32 177.44 27.51 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.472 1.034 . . . . 0.0 111.109 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.38 176.79 8.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.574 1.15 . . . . 0.0 112.904 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -92.52 90.41 7.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.064 1.346 . . . . 0.0 110.873 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.17 -17.13 61.4 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -155.09 18.61 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.879 2.071 . . . . 0.0 112.79 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.68 39.31 93.7 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 120.33 -1.481 . . . . 0.0 113.85 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.73 -32.02 7.92 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 124.154 3.236 . . . . 0.0 115.931 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.63 160.3 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.669 1.987 . . . . 0.0 108.929 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.56 74.81 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.252 -0.905 . . . . 0.0 112.479 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.0 t -167.54 172.99 8.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.448 1.499 . . . . 0.0 111.845 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.05 -123.29 26.64 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.18 0.895 . . . . 0.0 111.968 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.12 179.13 7.11 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.311 1.844 . . . . 0.0 111.691 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.06 113.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.773 2.029 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.31 176.6 10.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 111.542 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.48 118.66 5.13 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -126.04 160.71 29.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.053 0.941 . . . . 0.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.87 169.32 9.97 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.582 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.51 121.32 14.44 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.559 1.144 . . . . 0.0 110.943 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.17 111.08 2.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.224 1.01 . . . . 0.0 109.223 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -72.2 153.87 41.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 111.034 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -58.01 -28.37 64.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -80.67 3.75 21.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.789 1.236 . . . . 0.0 114.306 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.28 -0.92 87.47 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.344 1.45 . . . . 0.0 114.516 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -78.58 178.65 7.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.61 1.564 . . . . 0.0 110.878 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 m -140.57 110.76 6.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.832 -1.168 . . . . 0.0 112.651 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -75.63 122.59 24.18 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.09 4.35 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 118.856 0.753 . . . . 0.0 112.471 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.41 160.99 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.294 1.047 . . . . 0.0 112.071 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.35 167.11 23.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.427 -0.796 . . . . 0.0 112.638 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -169.48 158.6 8.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.026 1.331 . . . . 0.0 112.098 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 132.51 3.73 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.126 1.77 . . . . 0.0 108.381 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.93 138.15 26.31 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 119.096 0.862 . . . . 0.0 109.087 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 178.34 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.765 2.31 . . . . 0.0 111.741 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.04 171.15 14.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.906 1.282 . . . . 0.0 111.122 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.25 102.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.93 1.292 . . . . 0.0 111.661 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -152.43 162.78 40.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.281 1.032 . . . . 0.0 112.875 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.67 -51.56 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.404 1.482 . . . . 0.0 111.694 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -80.4 131.45 35.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.637 1.175 . . . . 0.0 111.631 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -95.56 114.51 26.27 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.153 1.381 . . . . 0.0 110.51 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.5 p -149.05 143.02 25.8 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.522 1.129 . . . . 0.0 110.787 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.16 114.62 7.16 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.437 1.095 . . . . 0.0 110.845 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -82.52 150.12 27.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.49 1.116 . . . . 0.0 112.161 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -161.44 149.01 14.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.799 1.64 . . . . 0.0 108.715 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -167.97 117.5 0.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.132 0.973 . . . . 0.0 110.871 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.12 135.2 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 123.007 0.523 . . . . 0.0 110.706 -175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -148.73 142.8 25.93 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.067 175.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.3 115.82 30.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -86.04 109.66 18.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.0 t -66.82 93.35 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.527 -1.358 . . . . 0.0 111.52 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.05 148.22 6.39 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 128.048 2.737 . . . . 0.0 111.796 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -48.13 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.68 2.392 . . . . 0.0 114.305 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -111.92 103.06 11.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.187 1.395 . . . . 0.0 112.978 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 162.49 14.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.419 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.08 114.44 18.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.39 -174.15 4.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.475 1.11 . . . . 0.0 111.676 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -51.12 -49.01 61.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.031 -1.043 . . . . 0.0 111.781 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -36.18 45.06 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.197 0.904 . . . . 0.0 113.673 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.4 ttt -67.49 -62.43 1.42 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.792 0.837 . . . . 0.0 110.045 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -55.03 -34.13 63.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -64.32 -39.27 93.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.464 1.506 . . . . 0.0 110.623 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -25.14 68.16 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.873 -1.142 . . . . 0.0 111.772 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mt -84.43 -44.15 13.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.661 1.184 . . . . 0.0 112.551 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.97 -29.1 25.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.905 1.282 . . . . 0.0 114.359 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.99 -34.04 3.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.479 1.512 . . . . 0.0 113.714 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.31 61.22 3.13 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.504 2.002 . . . . 0.0 114.516 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.86 67.25 1.13 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 127.401 2.281 . . . . 0.0 110.817 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.82 149.01 92.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.236 2.624 . . . . 0.0 112.268 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -114.9 178.68 4.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.412 1.085 . . . . 0.0 111.843 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -128.08 135.61 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.002 1.321 . . . . 0.0 111.768 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.06 97.42 2.0 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.437 1.018 . . . . 0.0 113.055 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -65.48 -79.97 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.226 1.01 . . . . 0.0 111.665 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.7 p30 177.75 -16.82 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.913 2.085 . . . . 0.0 115.606 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.23 163.12 20.97 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 119.939 1.245 . . . . 0.0 113.452 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.435 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 79.9 m95 -72.34 147.5 46.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.27 0.628 . . . . 0.0 110.682 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -151.75 123.31 7.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.283 1.433 . . . . 0.0 111.626 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.36 143.7 41.74 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.469 1.508 . . . . 0.0 113.599 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.71 149.76 26.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.353 1.461 . . . . 0.0 112.655 174.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.7 97.88 9.39 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.483 1.513 . . . . 0.0 108.379 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -52.96 -52.46 58.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.924 1.689 . . . . 0.0 111.425 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.04 57.14 0.01 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.392 0.996 . . . . 0.0 115.499 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.22 -27.07 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 131.69 -9.78 5.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.903 1.239 . . . . 0.0 114.671 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.01 170.08 13.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.811 1.305 . . . . 0.0 112.547 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 ttp-105 -133.58 130.24 38.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.452 1.901 . . . . 0.0 110.265 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.59 139.82 46.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.663 0.385 . . . . 0.0 110.852 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.4 128.3 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.578 1.551 . . . . 0.0 109.128 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.7 153.88 16.76 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 123.83 0.729 . . . . 0.0 112.824 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.435 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -137.15 141.14 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.548 1.939 . . . . 0.0 108.199 175.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 115.4 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.045 1.738 . . . . 0.0 107.754 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 p -109.0 170.44 8.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.7 p -70.76 167.71 18.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.428 1.091 . . . . 0.0 112.335 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.81 147.62 27.69 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.213 -0.93 . . . . 0.0 112.876 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.01 80.98 0.44 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.967 1.27 . . . . 0.0 113.698 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 50.22 39.02 18.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.848 1.659 . . . . 0.0 113.707 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -138.35 170.05 16.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.247 1.419 . . . . 0.0 111.436 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.444 ' CG ' ' H ' ' A' ' 169' ' ' MET . 5.2 tptt -156.01 -172.45 4.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.67 0.748 . . . . 0.0 111.609 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.444 ' H ' ' CG ' ' A' ' 168' ' ' LYS . 1.0 OUTLIER -118.25 157.43 27.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.187 2.195 . . . . 0.0 109.846 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -164.41 150.35 10.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.01 1.324 . . . . 0.0 110.034 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 24.8 mm -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.59 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -126.99 136.76 52.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.228 1.377 . . . . 0.0 112.375 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.0 pt -96.52 133.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -142.33 164.59 29.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.638 0.775 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.353 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.308 0.099 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.09 -30.96 7.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.039 1.336 . . . . 0.0 112.718 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.07 -179.67 1.29 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.89 0.876 . . . . 0.0 110.641 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.8 -38.65 3.07 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.572 -1.33 . . . . 0.0 111.702 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.7 p -137.06 160.01 40.22 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.674 -1.486 . . . . 0.0 111.793 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.9 mm -136.44 163.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.164 1.385 . . . . 0.0 110.082 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -70.65 -169.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.979 2.112 . . . . 0.0 110.423 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.63 -23.26 4.09 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.94 73.81 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.836 0.732 . . . . 0.0 113.784 -174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.06 40.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.695 1.198 . . . . 0.0 111.547 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -6.24 57.57 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.196 1.398 . . . . 0.0 113.714 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.94 142.75 45.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.104 1.761 . . . . 0.0 111.02 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -146.13 145.79 30.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.639 1.176 . . . . 0.0 109.713 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -55.74 -29.47 59.59 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -60.01 -55.71 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.682 1.193 . . . . 0.0 112.269 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.76 -44.35 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 122.006 -0.433 . . . . 0.0 109.845 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -32.08 69.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.229 1.012 . . . . 0.0 113.207 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.81 -55.16 14.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.159 0.983 . . . . 0.0 110.373 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -35.02 74.6 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.718 -0.614 . . . . 0.0 112.034 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -45.26 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.115 0.871 . . . . 0.0 112.645 -176.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -24.9 53.63 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.611 0.641 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.41 -26.76 62.89 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.96 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -48.54 -25.27 1.63 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 120.925 1.693 . . . . 0.0 114.483 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.417 ' HB2' HH22 ' A' ' 74' ' ' ARG . 48.0 mt -79.22 -9.32 59.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.674 1.989 . . . . 0.0 115.799 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.74 -154.17 8.5 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.297 1.904 . . . . 0.0 112.81 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -141.56 7.76 1.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.23 131.8 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.537 1.535 . . . . 0.0 113.883 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -66.56 1.69 1.62 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.94 103.37 7.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.416 1.886 . . . . 0.0 110.205 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -143.11 -173.99 4.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.279 1.832 . . . . 0.0 111.889 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.469 ' CD1' ' HE2' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -136.89 123.27 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.266 1.427 . . . . 0.0 112.019 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.81 91.09 3.51 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.211 2.204 . . . . 0.0 110.943 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.72 126.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.579 -1.326 . . . . 0.0 110.675 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.69 167.2 37.72 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-O 121.776 0.654 . . . . 0.0 114.701 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -144.29 121.68 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -76.95 105.11 7.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.037 -1.039 . . . . 0.0 111.324 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.53 93.07 4.74 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.161 -0.962 . . . . 0.0 112.013 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -142.92 39.29 1.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.323 1.058 . . . . 0.0 111.82 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.74 -0.26 54.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.047 1.739 . . . . 0.0 114.815 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.6 14.24 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.268 0.937 . . . . 0.0 114.578 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.02 135.84 7.77 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.673 1.606 . . . . 0.0 112.463 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -67.18 134.07 51.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.48 1.112 . . . . 0.0 109.262 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -95.34 163.86 13.07 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -146.27 113.93 6.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.447 1.499 . . . . 0.0 111.035 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.36 135.77 42.48 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 -50.32 3.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.379 1.071 . . . . 0.0 111.83 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -156.35 171.93 19.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.207 1.003 . . . . 0.0 111.964 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.58 132.49 31.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.984 1.714 . . . . 0.0 111.469 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -116.62 122.64 45.19 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.553 1.541 . . . . 0.0 110.183 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 152.55 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.809 2.444 . . . . 0.0 110.44 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.91 -53.25 2.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.164 0.986 . . . . 0.0 110.25 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.488 ' HB3' ' H ' ' A' ' 85' ' ' VAL . 2.3 t -71.21 127.0 31.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.406 1.882 . . . . 0.0 109.581 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.31 -133.26 8.51 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.175 0.893 . . . . 0.0 112.736 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.06 -156.47 0.61 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.14 1.776 . . . . 0.0 109.585 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.88 166.83 1.34 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.373 3.069 . . . . 0.0 111.928 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.63 -29.42 0.11 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.17 173.01 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.244 2.218 . . . . 0.0 112.049 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.97 128.2 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.603 1.161 . . . . 0.0 111.677 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 tp -85.09 132.29 46.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.33 122.3 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.901 3.067 . . . . 0.0 110.8 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.86 -59.39 3.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.798 0.839 . . . . 0.0 112.555 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -125.52 145.5 50.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.52 1.528 . . . . 0.0 110.169 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.6 t -138.47 131.36 16.17 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.577 1.151 . . . . 0.0 108.936 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.42 163.97 24.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.782 2.988 . . . . 0.0 112.531 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.28 18.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -141.98 17.06 2.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.597 1.559 . . . . 0.0 114.173 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.438 1.472 . . . . 0.0 112.679 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.58 -176.6 5.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 122.425 1.107 . . . . 0.0 112.521 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.21 152.68 31.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.049 0.939 . . . . 0.0 111.592 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.6 mt -134.66 162.42 32.37 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.884 1.274 . . . . 0.0 111.111 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.28 163.91 31.49 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.066 1.346 . . . . 0.0 109.632 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 m -144.92 165.28 28.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.279 1.431 . . . . 0.0 110.164 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.68 162.88 33.79 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.41 1.481 . . . . 0.0 109.553 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.417 HH22 ' HB2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -167.5 -160.7 0.37 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.984 1.714 . . . . 0.0 111.031 176.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -48.43 83.05 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 130.277 3.431 . . . . 0.0 113.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.63 -16.18 7.79 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -120.08 5.84 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.088 2.155 . . . . 0.0 111.006 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.7 26.82 Favored Glycine 0 CA--C 1.545 1.955 0 CA-C-O 117.401 -1.777 . . . . 0.0 115.966 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.76 -39.91 10.77 Favored 'Trans proline' 0 C--N 1.357 0.991 0 CA-C-N 121.838 2.819 . . . . 0.0 115.024 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.288 4.1 p 51.48 4.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 129.492 3.117 . . . . 0.0 116.986 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 1.22 2.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.979 2.112 . . . . 0.0 113.859 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -132.75 128.5 37.0 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.515 1.126 . . . . 0.0 110.932 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.39 -74.48 0.56 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.547 1.07 . . . . 0.0 111.552 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -177.76 113.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.429 1.891 . . . . 0.0 110.397 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' H ' ' HB3' ' A' ' 52' ' ' SER . 3.6 t -127.45 110.24 22.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 109.757 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.99 176.9 8.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 109.972 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.02 137.59 15.13 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.943 1.697 . . . . 0.0 106.498 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -143.12 162.03 36.63 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.268 0.627 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.71 136.79 52.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.755 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.68 121.86 45.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 110.939 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -70.27 123.47 21.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.912 1.285 . . . . 0.0 110.211 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptm -97.1 155.09 16.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.552 0.615 . . . . 0.0 111.394 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.4 m -56.14 -22.47 28.69 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -2.03 20.87 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.767 1.227 . . . . 0.0 113.384 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.14 84.46 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.655 1.597 . . . . 0.0 114.638 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -100.45 171.38 7.78 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.443 1.097 . . . . 0.0 110.46 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.1 m -135.03 99.89 4.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.744 1.218 . . . . 0.0 111.621 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.59 113.75 7.16 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.414 -0.804 . . . . 0.0 111.42 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.6 107.84 3.54 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.264 1.411 . . . . 0.0 109.717 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -84.2 146.11 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 117.493 0.646 . . . . 0.0 111.045 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -125.23 142.47 51.48 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.925 1.29 . . . . 0.0 110.568 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -151.27 158.92 44.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.107 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -158.06 175.24 14.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.47 100.05 50.92 Favored Pre-proline 0 N--CA 1.467 0.392 0 C-N-CA 126.51 1.924 . . . . 0.0 111.792 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.92 77.33 2.74 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.699 2.266 . . . . 0.0 110.063 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.91 -44.09 77.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.778 1.231 . . . . 0.0 111.838 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.47 105.95 0.29 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.975 1.31 . . . . 0.0 112.089 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -69.64 11.61 0.25 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.533 1.933 . . . . 0.0 114.671 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.9 -16.25 39.86 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.764 2.026 . . . . 0.0 114.428 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 19.8 t90 58.64 30.04 19.35 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.061 1.744 . . . . 0.0 114.345 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.46 172.87 12.66 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.839 -1.163 . . . . 0.0 113.707 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -50.81 111.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.165 2.186 . . . . 0.0 112.624 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.02 140.42 39.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -77.4 139.0 39.61 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.086 0.954 . . . . 0.0 112.98 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -161.83 149.27 14.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.489 1.916 . . . . 0.0 108.844 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -179.87 158.59 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.333 2.253 . . . . 0.0 111.263 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.67 147.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 127.766 2.427 . . . . 0.0 109.055 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -141.67 141.2 33.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.776 0.83 . . . . 0.0 109.635 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.6 mt -103.27 113.31 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.872 0.869 . . . . 0.0 108.693 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -82.42 111.0 18.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 t -65.42 87.51 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.015 -1.053 . . . . 0.0 111.476 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.93 164.58 11.92 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.938 2.685 . . . . 0.0 112.211 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -60.5 123.6 17.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.798 1.239 . . . . 0.0 111.778 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -133.6 104.28 6.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.589 1.555 . . . . 0.0 112.138 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.96 153.64 33.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.763 0.825 . . . . 0.0 110.634 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 117.58 21.33 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.721 0.408 . . . . 0.0 111.132 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.63 -176.8 6.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.082 1.753 . . . . 0.0 112.108 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.3 -47.23 25.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.33 1.452 . . . . 0.0 112.119 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.71 -46.99 80.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.102 0.858 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.4 ttp -60.22 -53.26 59.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.404 0.682 . . . . 0.0 110.684 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -53.35 -38.03 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.378 0.99 . . . . 0.0 113.078 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -43.54 95.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.699 1.2 . . . . 0.0 110.734 175.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.59 -20.63 65.4 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.357 -1.464 . . . . 0.0 113.939 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.52 -11.0 35.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.18 -35.09 3.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.011 1.324 . . . . 0.0 112.248 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -114.5 -25.55 8.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.186 1.395 . . . . 0.0 112.918 -175.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.5 -34.68 90.55 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.737 1.161 . . . . 0.0 113.752 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.09 83.44 5.6 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 126.018 1.727 . . . . 0.0 110.28 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.5 120.23 7.33 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.548 1.499 . . . . 0.0 112.325 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.76 165.02 22.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.811 1.244 . . . . 0.0 113.892 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -134.22 139.06 45.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.437 1.895 . . . . 0.0 111.531 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -127.02 110.43 1.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.907 1.241 . . . . 0.0 112.168 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -124.03 70.14 1.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.459 1.904 . . . . 0.0 113.364 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 50.76 60.3 3.97 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.05 2.14 . . . . 0.0 114.023 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -175.83 139.78 4.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.614 0.626 . . . . 0.0 113.92 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -63.43 135.46 56.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.031 1.332 . . . . 0.0 111.69 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -150.09 130.69 13.98 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.634 1.173 . . . . 0.0 111.672 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.66 158.5 25.39 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.118 1.767 . . . . 0.0 111.566 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 161.57 39.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.0 1.32 . . . . 0.0 110.677 175.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.17 93.92 4.01 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.902 0.881 . . . . 0.0 108.799 174.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 tp -47.43 -32.36 4.99 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.98 1.312 . . . . 0.0 113.984 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.54 32.26 2.36 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 117.396 1.718 . . . . 0.0 117.396 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.06 -28.69 1.16 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 148.77 -24.29 1.32 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.749 1.166 . . . . 0.0 114.504 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.46 175.5 5.43 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.634 1.973 . . . . 0.0 111.626 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -126.89 165.31 19.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.009 . . . . 0.0 112.222 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.94 156.91 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.428 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.86 129.22 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.713 1.605 . . . . 0.0 108.584 -177.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.11 144.56 18.48 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.407 0.527 . . . . 0.0 113.27 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.2 147.71 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.273 1.429 . . . . 0.0 109.762 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.46 117.38 11.08 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.6 1.16 . . . . 0.0 109.3 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.9 p -122.18 147.75 45.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.641 1.176 . . . . 0.0 110.055 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -131.49 -178.31 4.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.586 1.954 . . . . 0.0 110.649 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 73.69 95.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.379 2.271 . . . . 0.0 113.302 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.42 -106.51 3.06 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.87 1.7 . . . . 0.0 114.355 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -115.78 17.72 15.99 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.631 2.373 . . . . 0.0 113.569 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.06 163.08 25.53 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.601 2.361 . . . . 0.0 115.021 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.469 ' HE2' ' CD1' ' A' ' 31' ' ' ILE . 8.1 tptp -163.11 155.28 18.18 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.873 1.269 . . . . 0.0 114.34 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 136.39 33.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.118 2.567 . . . . 0.0 112.512 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -141.08 154.51 45.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.026 1.73 . . . . 0.0 110.221 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.01 120.55 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.529 1.132 . . . . 0.0 111.045 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -98.84 114.04 26.44 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.316 1.046 . . . . 0.0 109.482 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.12 134.18 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.801 0.44 . . . . 0.0 109.828 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 92.8 p -156.37 167.35 30.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.408 1.483 . . . . 0.0 112.458 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 111.181 0.067 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mp -106.96 -83.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.203 1.401 . . . . 0.0 109.385 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.92 6.55 36.41 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.123 1.769 . . . . 0.0 113.128 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.99 -16.21 39.35 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.178 1.37 . . . . 0.0 115.502 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 p -146.04 162.97 36.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.158 1.479 . . . . 0.0 110.28 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' H ' ' A' ' 7' ' ' ILE . 26.5 mm -134.73 173.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 109.38 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.433 ' H ' ' CG2' ' A' ' 6' ' ' ILE . 5.6 pt -85.4 -171.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 129.036 2.934 . . . . 0.0 110.461 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.96 -15.19 61.92 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.3 65.71 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 124.583 1.087 . . . . 0.0 113.62 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.18 81.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.144 1.378 . . . . 0.0 112.956 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -1.17 53.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 113.822 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.27 140.82 58.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.042 1.337 . . . . 0.0 110.491 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.84 145.75 26.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.116 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.61 -38.17 69.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.753 0.821 . . . . 0.0 113.134 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -56.62 -50.06 73.13 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.098 0.863 . . . . 0.0 112.783 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.81 -48.41 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.903 0.881 . . . . 0.0 110.587 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -56.24 -37.62 69.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 112.081 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -57.57 -55.82 29.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.447 1.899 . . . . 0.0 111.566 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -22.87 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.77 -52.3 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.514 1.506 . . . . 0.0 110.886 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.72 -32.06 72.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.611 0.364 . . . . 0.0 111.721 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -85.68 -28.28 24.79 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -52.9 -21.18 3.99 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.761 2.024 . . . . 0.0 112.815 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.9 tp -48.41 -43.03 33.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.453 1.901 . . . . 0.0 111.802 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.08 142.44 6.88 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.76 1.171 . . . . 0.0 112.469 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -75.86 85.52 2.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.574 1.15 . . . . 0.0 111.898 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.18 173.91 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.154 2.182 . . . . 0.0 111.482 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.7 m -63.09 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.666 1.986 . . . . 0.0 112.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 56.98 -179.74 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.845 2.458 . . . . 0.0 112.921 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -177.68 5.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.791 1.636 . . . . 0.0 110.808 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.88 148.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.609 1.164 . . . . 0.0 110.73 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.04 100.04 4.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.925 1.69 . . . . 0.0 111.035 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 p -113.94 144.88 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.117 1.367 . . . . 0.0 107.396 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.36 167.27 36.5 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 118.418 0.554 . . . . 0.0 114.425 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.21 145.84 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.703 1.201 . . . . 0.0 110.872 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -107.68 104.25 13.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 111.472 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -89.12 116.95 27.76 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.377 1.471 . . . . 0.0 112.187 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -150.03 14.9 0.82 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.885 0.85 . . . . 0.0 112.182 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -78.55 -45.88 20.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.608 1.563 . . . . 0.0 114.356 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.63 16.82 1.43 Allowed Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.39 133.96 6.74 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.491 1.646 . . . . 0.0 113.006 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.7 m -69.93 122.11 18.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.236 1.414 . . . . 0.0 110.906 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -91.03 161.8 14.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.827 -0.546 . . . . 0.0 111.805 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 m -136.66 109.82 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.059 1.743 . . . . 0.0 111.088 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.9 114.14 4.9 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.914 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.95 -61.4 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.868 1.267 . . . . 0.0 111.385 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -159.9 169.88 22.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.985 1.314 . . . . 0.0 111.966 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.72 135.44 40.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.869 2.068 . . . . 0.0 111.047 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -120.71 130.61 54.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.453 1.501 . . . . 0.0 109.8 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.47 140.42 52.16 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.784 2.034 . . . . 0.0 109.838 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -0.91 14.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.198 1.399 . . . . 0.0 113.842 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -80.23 -155.23 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.068 1.347 . . . . 0.0 109.781 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.78 -76.07 0.25 Allowed Glycine 0 N--CA 1.471 0.986 0 O-C-N 120.579 -1.326 . . . . 0.0 114.267 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -162.38 -178.14 6.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.349 1.46 . . . . 0.0 111.307 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 160.37 20.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.315 1.446 . . . . 0.0 113.69 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -141.81 -29.03 0.62 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.65 159.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.081 1.353 . . . . 0.0 111.787 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.9 tp -79.44 133.88 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.191 0.996 . . . . 0.0 109.583 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.0 tp -84.33 124.4 73.87 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.572 1.149 . . . . 0.0 109.642 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.74 120.09 7.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.706 3.604 . . . . 0.0 112.52 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.3 -55.19 23.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.41 150.62 36.11 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.728 1.211 . . . . 0.0 109.62 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.0 135.1 18.34 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.66 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -67.26 -164.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.702 2.935 . . . . 0.0 112.364 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -114.3 25.63 10.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.649 1.58 . . . . 0.0 113.712 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -149.44 8.36 0.7 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.279 1.431 . . . . 0.0 114.434 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -144.84 113.53 6.74 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.781 1.628 . . . . 0.0 114.459 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.01 174.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.748 1.219 . . . . 0.0 112.675 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.12 154.05 38.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.613 -0.679 . . . . 0.0 112.05 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.82 175.96 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.496 0.718 . . . . 0.0 112.42 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -147.64 161.51 41.0 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.526 1.53 . . . . 0.0 110.525 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.0 p -152.95 165.34 35.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.849 1.26 . . . . 0.0 112.451 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.38 172.75 24.14 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.027 0.822 . . . . 0.0 114.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -125.67 170.28 11.68 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.0 86.93 2.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.565 2.346 . . . . 0.0 108.528 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -115.74 -18.49 10.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.084 0.954 . . . . 0.0 113.231 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.2 t -155.64 11.8 0.32 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.844 1.658 . . . . 0.0 113.658 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.94 -113.05 2.69 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.93 -30.77 20.94 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.121 2.547 . . . . 0.0 115.123 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.0 t 23.47 67.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 129.314 3.046 . . . . 0.0 113.751 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -174.58 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.661 1.985 . . . . 0.0 112.224 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.1 p -122.54 -173.52 2.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.913 2.085 . . . . 0.0 109.88 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.04 -178.35 3.26 Favored Glycine 0 CA--C 1.545 1.918 0 CA-C-O 122.297 0.943 . . . . 0.0 114.765 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 169.43 10.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.711 1.205 . . . . 0.0 112.314 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -148.21 116.95 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.392 1.077 . . . . 0.0 111.705 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.24 173.01 14.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.374 1.47 . . . . 0.0 111.288 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.61 127.82 9.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.417 1.087 . . . . 0.0 109.476 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.92 173.85 11.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.474 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.18 149.71 48.71 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -128.69 117.2 20.77 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.361 1.864 . . . . 0.0 111.78 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -69.06 104.91 2.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.916 1.686 . . . . 0.0 109.816 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.8 mtp -66.5 148.75 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.216 1.007 . . . . 0.0 110.569 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -24.63 63.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.272 1.029 . . . . 0.0 113.501 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t -69.58 -13.7 62.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.342 1.857 . . . . 0.0 114.494 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.34 12.34 48.82 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.677 1.132 . . . . 0.0 114.967 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -103.17 175.43 5.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.373 2.269 . . . . 0.0 110.088 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.1 m -138.25 110.29 7.28 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.033 -1.042 . . . . 0.0 112.715 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.4 tp -74.67 113.45 11.95 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.551 1.14 . . . . 0.0 112.936 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.0 102.68 2.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.36 1.933 . . . . 0.0 110.401 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.4 160.27 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.535 1.134 . . . . 0.0 110.591 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.436 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -142.08 153.31 44.07 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.387 0.675 . . . . 0.0 111.556 174.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -161.23 156.11 23.7 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.783 1.233 . . . . 0.0 110.834 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 t -168.63 138.44 2.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.788 1.235 . . . . 0.0 109.221 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.42 95.71 7.48 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.36 171.71 16.42 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.035 2.49 . . . . 0.0 111.628 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -150.15 140.87 22.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.024 1.33 . . . . 0.0 110.808 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.1 t70 64.19 110.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.262 2.625 . . . . 0.0 115.061 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -94.08 82.37 4.18 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.607 1.563 . . . . 0.0 111.429 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.12 -51.82 67.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.204 -0.935 . . . . 0.0 111.511 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -159.15 -43.15 0.06 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.183 2.193 . . . . 0.0 111.589 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -77.54 138.35 39.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.971 1.309 . . . . 0.0 112.735 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.1 m -77.15 172.57 13.03 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.797 0.808 . . . . 0.0 110.07 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -61.66 170.57 1.89 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.115 1.366 . . . . 0.0 112.121 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.447 ' CZ2' ' CE2' ' A' ' 135' ' ' TYR . 15.0 p-90 -114.09 157.98 21.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.7 0.8 . . . . 0.0 112.548 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -158.02 174.14 15.69 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.605 1.962 . . . . 0.0 110.12 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 154.96 133.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 129.221 3.009 . . . . 0.0 112.347 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.04 140.95 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.261 1.024 . . . . 0.0 109.015 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -133.35 149.32 51.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.801 1.24 . . . . 0.0 109.177 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.92 98.46 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.103 0.961 . . . . 0.0 109.024 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.19 99.94 0.2 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.402 1.081 . . . . 0.0 109.46 174.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.9 t -68.22 84.97 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.423 1.089 . . . . 0.0 110.86 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.98 -114.9 0.69 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.797 2.142 . . . . 0.0 110.302 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -150.35 123.34 8.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.965 1.306 . . . . 0.0 111.404 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.69 105.96 4.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.565 1.546 . . . . 0.0 112.48 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 167.22 3.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.416 1.086 . . . . 0.0 111.461 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.54 112.33 17.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.08 -0.388 . . . . 0.0 111.21 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.28 -179.44 6.94 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -51.85 -42.04 62.29 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.001 -1.062 . . . . 0.0 112.018 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.71 97.06 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.389 0.995 . . . . 0.0 113.798 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -65.01 -45.72 84.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.798 1.299 . . . . 0.0 111.297 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -57.54 -39.92 77.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.693 0.797 . . . . 0.0 110.99 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -67.09 -40.47 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.474 1.11 . . . . 0.0 112.221 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.67 -29.77 70.96 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.443 -1.411 . . . . 0.0 112.883 174.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -76.38 -55.6 5.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.211 1.405 . . . . 0.0 111.615 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.447 ' CE2' ' CZ2' ' A' ' 114' ' ' TRP . 10.8 m-85 -76.5 -26.91 55.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -126.85 -33.85 2.44 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.213 1.005 . . . . 0.0 113.444 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.38 -49.41 45.16 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.839 1.209 . . . . 0.0 112.527 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -166.58 73.63 1.14 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 126.133 1.773 . . . . 0.0 111.565 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 133.01 23.92 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.34 2.026 . . . . 0.0 112.127 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -112.15 -175.17 2.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.552 2.341 . . . . 0.0 111.832 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -134.34 139.56 45.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.146 2.179 . . . . 0.0 110.636 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.36 91.13 0.14 Allowed Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.771 0.714 . . . . 0.0 113.823 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.63 -47.31 19.61 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.81 -1.406 . . . . 0.0 113.438 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 p30 179.37 88.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.974 2.51 . . . . 0.0 112.062 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.19 148.23 6.63 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.48 -0.762 . . . . 0.0 114.255 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -77.54 145.19 37.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.712 1.205 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -153.2 141.37 20.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.271 1.429 . . . . 0.0 111.641 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -118.03 147.2 43.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.851 1.66 . . . . 0.0 111.207 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -149.82 166.45 29.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.309 1.044 . . . . 0.0 112.069 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -79.92 108.31 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.74 -32.76 74.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.61 14.16 4.9 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.52 -26.06 3.07 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.141 1.471 . . . . 0.0 114.704 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.2 10.78 1.27 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.423 -1.21 . . . . 0.0 115.469 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.75 165.5 26.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.534 1.667 . . . . 0.0 112.369 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.01 141.33 52.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.597 1.159 . . . . 0.0 108.947 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.0 157.68 37.24 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.601 0.76 . . . . 0.0 109.386 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.9 129.25 56.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.1 159.03 19.7 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 123.34 0.495 . . . . 0.0 112.467 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.39 156.05 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.842 1.657 . . . . 0.0 110.432 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -153.73 114.21 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.8 p -102.03 150.97 22.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.818 0.847 . . . . 0.0 110.425 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.31 156.14 45.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.029 1.731 . . . . 0.0 110.431 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.17 128.5 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.995 2.518 . . . . 0.0 112.908 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.86 -179.0 51.73 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 122.229 0.905 . . . . 0.0 114.244 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.32 80.83 1.36 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.414 1.885 . . . . 0.0 112.48 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.55 164.0 34.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.739 1.216 . . . . 0.0 112.802 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -153.54 -178.91 7.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.746 1.619 . . . . 0.0 113.636 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.0 ptm -102.11 166.62 10.51 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.896 2.079 . . . . 0.0 113.653 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -154.8 153.76 31.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.888 1.275 . . . . 0.0 109.955 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.8 mm -135.47 117.63 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.892 1.277 . . . . 0.0 110.114 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -112.89 111.94 23.05 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.867 -1.146 . . . . 0.0 111.503 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 10.0 pt -95.51 131.73 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 109.086 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.5 t -150.71 158.76 44.53 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.633 -0.667 . . . . 0.0 111.227 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.127 1.371 . . . . 0.0 112.185 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.74 -61.77 2.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.825 1.193 . . . . 0.0 112.87 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.56 -41.39 1.45 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.55 -25.56 8.97 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 125.423 1.487 . . . . 0.0 116.213 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 p -138.34 158.18 44.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.694 1.747 . . . . 0.0 111.447 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mm -136.2 165.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.774 -1.204 . . . . 0.0 110.382 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -170.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.881 1.273 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.4 -43.75 5.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 -29.56 6.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.18 1.371 . . . . 0.0 112.897 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.13 73.64 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.296 1.048 . . . . 0.0 111.491 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.4 m -86.53 -8.53 57.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.823 2.049 . . . . 0.0 114.345 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.63 131.36 45.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.47 1.108 . . . . 0.0 109.21 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.612 1.165 . . . . 0.0 109.163 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -54.61 -29.58 52.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.928 0.785 . . . . 0.0 112.988 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -58.28 -56.74 18.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 112.434 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.46 -44.62 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.893 0.877 . . . . 0.0 109.841 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -25.48 67.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.591 1.156 . . . . 0.0 113.472 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -74.72 -53.1 9.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.102 -1.624 . . . . 0.0 110.373 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -39.85 83.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 112.934 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.65 -33.36 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.339 0.972 . . . . 0.0 113.082 -174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.8 -36.59 42.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.498 0.719 . . . . 0.0 110.522 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.84 -44.14 97.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.814 0.846 . . . . 0.0 111.664 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -20.53 57.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.41 -28.76 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.327 1.851 . . . . 0.0 112.731 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.45 -143.47 4.04 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.681 2.086 . . . . 0.0 112.237 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -135.42 21.87 3.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.902 2.081 . . . . 0.0 112.8 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.03 125.98 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.009 1.724 . . . . 0.0 111.468 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.74 3.92 0.93 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.575 1.55 . . . . 0.0 114.508 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.51 111.72 7.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.839 2.056 . . . . 0.0 109.634 -175.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -138.4 176.82 8.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.962 1.705 . . . . 0.0 112.061 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -102.0 148.72 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.519 1.128 . . . . 0.0 111.426 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 97.74 3.34 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.58 1.952 . . . . 0.0 111.19 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.41 129.77 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.942 -1.099 . . . . 0.0 110.248 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.95 171.49 42.37 Favored Glycine 0 C--O 1.235 0.205 0 O-C-N 121.57 -0.706 . . . . 0.0 114.273 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.61 122.85 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 0.0 109.99 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.97 102.66 2.05 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.387 -1.445 . . . . 0.0 111.747 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -76.75 92.0 3.53 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.4 -0.813 . . . . 0.0 112.225 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -143.54 48.78 1.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.057 0.943 . . . . 0.0 111.586 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -109.8 -8.43 14.91 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.31 57.07 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.561 1.077 . . . . 0.0 115.558 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.44 134.68 6.98 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.129 1.347 . . . . 0.0 113.059 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.2 m -61.87 141.2 58.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.999 1.32 . . . . 0.0 110.816 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -104.68 163.49 12.45 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.472 -0.768 . . . . 0.0 111.343 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -143.41 102.0 3.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.022 1.329 . . . . 0.0 111.02 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.98 163.36 22.39 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.292 -0.88 . . . . 0.0 111.131 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.23 -60.65 1.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.126 1.371 . . . . 0.0 111.062 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -153.01 -173.84 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 111.096 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 147.96 35.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.44 1.496 . . . . 0.0 110.895 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -132.13 134.59 45.61 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.135 1.374 . . . . 0.0 110.568 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.48 157.9 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.204 2.202 . . . . 0.0 111.223 -174.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -127.13 -37.14 2.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.092 1.357 . . . . 0.0 112.924 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.3 t -133.46 92.97 3.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.25 121.19 2.1 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.344 0.973 . . . . 0.0 114.726 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.427 HG21 ' H ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -69.25 -179.04 1.46 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.11 1.764 . . . . 0.0 112.759 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.427 ' H ' HG21 ' A' ' 54' ' ' THR . 16.2 p -88.16 158.56 18.5 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.779 1.232 . . . . 0.0 111.673 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -155.49 -22.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.163 1.385 . . . . 0.0 112.608 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 m -128.13 161.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.712 2.005 . . . . 0.0 110.353 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 tt -91.92 135.26 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.302 1.441 . . . . 0.0 110.975 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.99 125.85 86.33 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 0.0 109.123 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.02 148.47 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.197 2.598 . . . . 0.0 111.043 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.48 -56.14 3.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.749 0.82 . . . . 0.0 112.309 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -119.2 134.97 54.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.094 1.358 . . . . 0.0 110.334 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.5 t -133.4 132.77 22.15 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.526 1.13 . . . . 0.0 111.484 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.56 164.28 35.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.807 3.005 . . . . 0.0 112.557 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 22.03 0.2 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.0 1.72 . . . . 0.0 115.381 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 p -146.7 23.53 1.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.528 1.531 . . . . 0.0 113.379 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -148.06 130.55 15.8 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.878 1.217 . . . . 0.0 112.607 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.04 179.17 5.79 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.365 1.079 . . . . 0.0 111.443 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 142.97 21.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.812 1.245 . . . . 0.0 109.588 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.8 mt -122.39 -178.05 3.79 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.584 1.154 . . . . 0.0 110.555 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -155.5 164.76 38.26 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.689 -1.257 . . . . 0.0 110.326 174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -142.65 174.54 10.55 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.093 0.957 . . . . 0.0 111.943 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.06 -171.55 12.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.385 1.469 . . . . 0.0 112.61 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -163.81 1.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.658 1.583 . . . . 0.0 114.484 -175.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.98 84.24 3.81 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.445 1.898 . . . . 0.0 112.253 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -77.32 -20.1 55.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.7 t -143.15 17.44 1.91 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.268 2.227 . . . . 0.0 112.042 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.93 89.77 Favored Glycine 0 CA--C 1.548 2.121 0 CA-C-O 117.85 -1.528 . . . . 0.0 114.317 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.47 -44.95 10.17 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.642 2.895 . . . . 0.0 112.68 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.269 0.4 OUTLIER 46.96 -168.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 128.101 2.561 . . . . 0.0 112.499 -175.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.09 -14.28 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.572 2.349 . . . . 0.0 116.239 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.57 -175.41 4.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.729 3.211 . . . . 0.0 109.252 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.48 -80.25 1.28 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.319 -0.711 . . . . 0.0 113.145 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.98 -174.45 2.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.465 1.506 . . . . 0.0 113.471 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.33 114.52 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.031 2.533 . . . . 0.0 110.742 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.05 177.13 10.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.275 1.43 . . . . 0.0 111.887 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.54 127.84 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.394 1.477 . . . . 0.0 109.059 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -132.36 159.9 37.87 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.805 0.842 . . . . 0.0 112.066 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.33 144.35 50.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.114 0.565 . . . . 0.0 111.29 -177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.61 121.9 41.29 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.485 1.514 . . . . 0.0 110.2 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.65 111.59 4.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.912 1.285 . . . . 0.0 110.354 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.7 mtp -72.32 142.68 48.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.745 1.218 . . . . 0.0 110.4 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.3 t -53.86 -33.7 57.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.433 1.093 . . . . 0.0 113.89 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -10.51 30.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.52 26.4 9.29 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.506 1.05 . . . . 0.0 114.291 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -117.73 177.53 4.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.383 1.873 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.5 m -140.21 106.19 5.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.9 1.28 . . . . 0.0 111.704 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.0 tp -74.95 118.83 18.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.182 0.993 . . . . 0.0 110.314 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.81 107.51 3.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.88 1.229 . . . . 0.0 113.521 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.67 158.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 112.533 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.43 168.86 18.81 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.241 1.016 . . . . 0.0 112.136 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 31' ' ' ILE . 47.0 p90 -171.68 150.31 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.633 1.573 . . . . 0.0 110.375 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.8 m -162.01 130.63 4.26 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.494 1.518 . . . . 0.0 107.355 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.1 t -107.04 128.45 26.05 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.438 -0.791 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.73 136.41 45.61 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.493 2.129 . . . . 0.0 111.258 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -38.68 -58.75 1.02 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.631 1.972 . . . . 0.0 113.17 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.99 121.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.7 2.0 . . . . 0.0 109.43 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 42.19 53.21 4.43 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.86 1.664 . . . . 0.0 113.536 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -60.16 -13.26 11.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.451 1.501 . . . . 0.0 114.737 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.93 34.02 22.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.02 1.728 . . . . 0.0 113.148 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 166.4 26.03 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.812 1.645 . . . . 0.0 111.806 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.5 p -67.67 161.06 26.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.744 0.783 . . . . 0.0 110.406 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -100.51 172.44 7.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.752 1.221 . . . . 0.0 111.461 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -121.69 144.92 48.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.922 1.289 . . . . 0.0 112.267 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -155.51 160.24 40.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.535 1.134 . . . . 0.0 110.474 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 173.7 132.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.167 2.987 . . . . 0.0 111.008 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.17 140.92 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.72 1.608 . . . . 0.0 109.794 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -135.61 158.57 44.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.304 1.441 . . . . 0.0 110.805 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.22 99.4 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.769 1.628 . . . . 0.0 108.088 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -65.32 103.77 0.85 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.144 -0.972 . . . . 0.0 109.67 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.1 t -68.79 83.43 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.634 -1.291 . . . . 0.0 111.347 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.76 -111.64 0.49 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 127.117 2.294 . . . . 0.0 111.502 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -146.26 135.84 23.12 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.89 1.676 . . . . 0.0 111.852 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -158.31 113.84 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.695 1.598 . . . . 0.0 112.15 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 165.63 24.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.165 0.586 . . . . 0.0 111.236 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.67 113.04 16.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.647 0.779 . . . . 0.0 110.37 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -158.88 -174.74 4.91 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.698 1.599 . . . . 0.0 112.839 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -50.61 -40.95 54.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.256 -0.902 . . . . 0.0 112.865 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.91 -39.91 56.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.246 0.93 . . . . 0.0 113.269 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.3 ttt -67.41 -57.79 5.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.41 1.084 . . . . 0.0 111.507 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -53.47 -34.91 59.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.38 0.991 . . . . 0.0 112.691 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -66.64 -46.81 74.57 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.206 1.002 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -25.75 66.9 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.502 -1.374 . . . . 0.0 113.122 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.35 -45.07 57.26 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.727 2.011 . . . . 0.0 113.11 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.69 -31.76 14.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -116.31 -20.95 9.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.897 1.279 . . . . 0.0 113.163 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.68 -63.85 2.25 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.568 1.556 . . . . 0.0 114.166 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -122.52 64.45 21.58 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.898 1.279 . . . . 0.0 112.161 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -60.65 122.66 11.6 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.999 2.466 . . . . 0.0 112.851 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.37 -171.9 2.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.405 1.482 . . . . 0.0 111.351 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -139.26 135.58 34.03 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.735 -1.228 . . . . 0.0 112.997 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.73 8.16 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.265 1.412 . . . . 0.0 110.697 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -130.65 56.71 1.76 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.043 1.337 . . . . 0.0 110.825 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.5 p30 40.41 65.06 0.82 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.506 2.322 . . . . 0.0 115.432 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.28 154.02 21.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.819 1.199 . . . . 0.0 113.158 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.441 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 42.6 m95 -70.01 142.33 52.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.17 . . . . 0.0 110.951 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -145.4 131.67 19.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.799 1.239 . . . . 0.0 111.929 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -107.24 141.88 37.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 112.147 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -148.37 157.74 43.67 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 123.336 1.541 . . . . 0.0 112.248 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.11 88.28 7.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.828 2.851 . . . . 0.0 106.436 175.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.1 tp -54.54 -27.84 41.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.594 1.557 . . . . 0.0 114.26 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.76 36.62 2.75 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -133.12 -20.32 2.17 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.1 2.96 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.579 1.085 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.47 176.68 8.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.378 1.871 . . . . 0.0 111.665 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -116.24 163.4 16.05 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.664 1.186 . . . . 0.0 111.127 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.174 0.988 . . . . 0.0 112.274 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -116.16 124.6 50.72 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 126.726 2.011 . . . . 0.0 108.144 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.21 149.26 18.58 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 119.095 0.861 . . . . 0.0 112.98 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.441 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -134.67 151.5 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.738 1.615 . . . . 0.0 108.919 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.9 tpp -156.45 109.01 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.722 1.609 . . . . 0.0 108.462 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.7 p -132.72 156.0 47.82 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.96 2.104 . . . . 0.0 110.037 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.9 p -158.21 -176.48 5.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.859 1.663 . . . . 0.0 110.882 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.82 34.98 14.03 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.855 1.662 . . . . 0.0 115.45 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 148.46 88.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.466 1.031 . . . . 0.0 113.274 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 44.8 55.64 5.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.17 2.588 . . . . 0.0 112.166 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.26 163.69 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.051 1.74 . . . . 0.0 113.804 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.453 ' HG3' ' H ' ' A' ' 169' ' ' MET . 1.8 tptp -159.09 -168.34 2.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.453 ' H ' ' HG3' ' A' ' 168' ' ' LYS . 19.7 ptm -121.31 149.5 42.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.058 1.743 . . . . 0.0 111.06 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -167.51 152.37 6.99 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.391 1.476 . . . . 0.0 109.177 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.75 122.0 64.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 123.579 0.752 . . . . 0.0 109.243 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 114.11 25.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 108.365 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.4 pt -99.66 134.83 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.086 0.554 . . . . 0.0 110.531 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p -155.88 165.06 37.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.711 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.961 1.304 . . . . 0.0 112.474 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.29 -36.41 13.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 110.926 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.22 169.22 2.21 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.805 0.812 . . . . 0.0 110.592 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.66 -40.01 2.57 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.7 p -131.51 155.79 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.678 1.591 . . . . 0.0 111.61 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mm -140.31 160.59 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.268 1.427 . . . . 0.0 110.283 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -66.73 -171.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.082 2.553 . . . . 0.0 111.67 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.34 -28.29 58.53 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.26 61.56 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.212 1.386 . . . . 0.0 112.929 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.72 -43.03 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.705 1.202 . . . . 0.0 111.799 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.3 p -85.48 -13.09 50.2 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.7 138.61 34.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.862 2.065 . . . . 0.0 110.021 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m -145.7 149.51 34.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.9 0.88 . . . . 0.0 109.618 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -52.7 -26.49 14.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.29 -51.31 64.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.168 0.987 . . . . 0.0 112.11 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.23 -39.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.35 -0.844 . . . . 0.0 110.776 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -23.98 67.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.314 1.046 . . . . 0.0 112.338 176.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.16 -54.22 13.83 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.352 -1.467 . . . . 0.0 109.021 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -44.75 78.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.373 1.069 . . . . 0.0 112.62 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.04 -35.91 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.331 0.969 . . . . 0.0 113.414 -175.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD13 ' HZ3' ' A' ' 30' ' ' LYS . 35.2 mt -84.93 -32.3 23.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 111.801 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.23 -23.01 66.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.269 0.627 . . . . 0.0 111.584 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -48.15 -25.91 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.36 1.864 . . . . 0.0 113.657 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.0 mt -52.3 -29.19 22.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.576 1.55 . . . . 0.0 112.317 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.53 -129.07 1.19 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.912 1.244 . . . . 0.0 113.75 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -139.73 34.16 2.0 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.425 2.69 . . . . 0.0 110.74 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.65 167.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 128.249 2.62 . . . . 0.0 112.816 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.6 p -68.24 -6.51 24.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.567 1.547 . . . . 0.0 115.043 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -68.76 104.78 2.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.387 1.475 . . . . 0.0 110.394 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HZ2' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -153.38 116.77 4.64 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 111.286 -177.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.433 HD13 ' CE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -131.25 133.55 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.891 0.877 . . . . 0.0 111.635 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.6 102.62 9.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.107 2.163 . . . . 0.0 113.843 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.02 121.33 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.571 -1.331 . . . . 0.0 109.96 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.83 33.81 Favored Glycine 0 N--CA 1.461 0.363 0 O-C-N 121.053 -1.029 . . . . 0.0 112.956 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.42 134.45 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.335 1.064 . . . . 0.0 113.817 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 2.6 m-20 -76.41 106.76 8.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.69 1.596 . . . . 0.0 113.148 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -84.06 104.27 13.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.683 1.23 . . . . 0.0 112.977 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -145.49 23.8 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.078 -1.014 . . . . 0.0 113.021 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.51 -9.52 54.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.496 1.519 . . . . 0.0 114.66 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.95 49.48 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.493 1.044 . . . . 0.0 115.148 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.62 110.66 0.91 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.833 1.682 . . . . 0.0 110.166 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -59.58 147.2 38.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.801 1.3 . . . . 0.0 110.906 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -117.3 161.41 19.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.53 0.732 . . . . 0.0 111.506 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -133.01 113.63 13.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.331 2.253 . . . . 0.0 111.996 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 115.64 15.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.599 1.159 . . . . 0.0 110.831 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -54.85 8.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.521 1.528 . . . . 0.0 110.259 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.74 -174.03 3.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.72 1.608 . . . . 0.0 111.825 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 144.67 28.22 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.53 1.532 . . . . 0.0 111.622 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.62 119.94 37.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.54 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.32 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 109.562 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -5.12 43.64 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.162 1.385 . . . . 0.0 113.833 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 p -73.56 -137.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.017 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.85 -84.55 0.91 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.446 1.022 . . . . 0.0 112.663 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -146.17 176.03 10.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.517 1.127 . . . . 0.0 112.193 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -77.74 158.36 29.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.38 1.472 . . . . 0.0 113.051 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -135.22 -34.14 0.87 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.688 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.0 176.84 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.855 2.062 . . . . 0.0 110.129 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -100.93 131.8 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.442 1.497 . . . . 0.0 110.987 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.26 131.61 52.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -63.63 177.68 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.165 3.243 . . . . 0.0 112.411 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -117.81 -36.68 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.839 1.256 . . . . 0.0 112.279 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.13 157.92 33.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.952 1.301 . . . . 0.0 111.72 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.99 97.44 7.92 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 124.747 1.219 . . . . 0.0 108.681 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.99 174.61 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.795 1.663 . . . . 0.0 110.54 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -63.2 165.49 7.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.45 0.7 . . . . 0.0 109.887 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 t 46.08 30.81 1.01 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.162 1.385 . . . . 0.0 113.14 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -145.26 158.68 43.77 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.916 1.686 . . . . 0.0 112.138 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -140.34 -173.84 3.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.707 1.242 . . . . 0.0 110.105 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.91 153.88 28.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.926 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.2 mt -139.26 155.16 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.796 1.238 . . . . 0.0 108.578 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.07 160.26 33.35 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.119 1.368 . . . . 0.0 108.747 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 m -151.26 170.1 20.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.439 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.82 -171.2 21.35 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -144.08 142.36 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.613 1.165 . . . . 0.0 109.789 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.98 78.43 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.812 2.045 . . . . 0.0 112.619 174.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.25 -16.31 63.91 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.14 22.56 0.95 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.233 1.813 . . . . 0.0 112.535 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.23 34.02 88.42 Favored Glycine 0 CA--C 1.555 2.534 0 CA-C-O 118.027 -1.429 . . . . 0.0 115.674 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.82 -34.47 30.59 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.705 3.603 . . . . 0.0 114.369 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.33 9.88 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.582 1.953 . . . . 0.0 112.521 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.49 -48.79 0.65 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.705 2.402 . . . . 0.0 112.693 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.5 p -153.24 122.24 6.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.098 1.759 . . . . 0.0 112.092 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.89 -128.72 9.59 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.637 1.108 . . . . 0.0 112.564 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.89 179.63 8.49 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.003 1.401 . . . . 0.0 113.25 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -151.88 121.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 127.357 2.263 . . . . 0.0 111.329 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.1 176.02 12.28 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.797 1.639 . . . . 0.0 110.389 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.46 116.97 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.541 1.136 . . . . 0.0 108.441 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -127.22 170.08 12.81 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.264 1.026 . . . . 0.0 112.651 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.91 157.72 45.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.97 112.38 14.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.136 1.774 . . . . 0.0 112.147 -175.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.3 104.09 1.41 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.297 1.839 . . . . 0.0 111.032 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.43 140.37 58.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.492 1.117 . . . . 0.0 110.111 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -57.62 -20.72 34.96 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -74.39 -10.02 59.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.258 1.423 . . . . 0.0 113.905 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.76 11.77 45.91 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.058 1.313 . . . . 0.0 114.837 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.12 174.56 6.26 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.261 1.824 . . . . 0.0 109.7 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m -143.64 109.52 5.25 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.951 -1.093 . . . . 0.0 112.588 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.56 121.5 21.66 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.068 -1.02 . . . . 0.0 111.627 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 110.7 3.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.868 1.223 . . . . 0.0 113.367 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.58 150.13 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.193 0.997 . . . . 0.0 112.21 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -135.65 152.16 50.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.115 1.366 . . . . 0.0 110.774 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CE2' HD13 ' A' ' 31' ' ' ILE . 23.7 p90 -164.69 158.45 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.374 1.07 . . . . 0.0 110.474 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 m -163.17 154.39 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.87 2.068 . . . . 0.0 108.181 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.66 100.1 37.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.37 173.98 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.767 2.311 . . . . 0.0 111.828 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -101.13 -24.69 14.24 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.58 159.3 30.11 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.243 0.929 . . . . 0.0 112.477 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -158.81 -51.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.346 1.458 . . . . 0.0 113.176 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -54.05 -40.06 66.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.735 1.614 . . . . 0.0 112.168 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.17 135.32 52.98 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.57 1.148 . . . . 0.0 111.185 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -77.76 107.96 10.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.365 1.466 . . . . 0.0 109.89 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.8 p -163.63 39.83 0.09 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.341 1.056 . . . . 0.0 113.619 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -80.91 145.36 31.33 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.85 -1.156 . . . . 0.0 112.675 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -92.18 140.44 29.62 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.301 1.44 . . . . 0.0 112.622 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -163.1 138.32 6.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -161.24 152.12 18.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.766 -0.584 . . . . 0.0 112.441 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.96 143.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 127.161 2.185 . . . . 0.0 110.119 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 150.13 45.18 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.178 1.791 . . . . 0.0 109.872 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.84 103.55 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.232 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -66.45 101.36 0.75 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.851 -1.156 . . . . 0.0 109.093 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 t -67.49 82.22 0.16 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.847 -1.158 . . . . 0.0 111.525 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.47 -107.25 0.32 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.088 2.28 . . . . 0.0 111.423 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -153.19 144.64 23.27 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.849 1.26 . . . . 0.0 111.903 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -165.34 116.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.966 1.706 . . . . 0.0 111.788 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.71 164.92 20.56 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.538 0.735 . . . . 0.0 111.732 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.41 118.73 22.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.329 -0.232 . . . . 0.0 110.58 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.63 -179.09 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.139 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -48.84 42.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.943 1.297 . . . . 0.0 112.715 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.0 -33.52 60.71 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.001 0.81 . . . . 0.0 113.515 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.6 ttp -67.44 -56.42 9.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.412 1.106 . . . . 0.0 111.455 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -49.47 -39.81 34.97 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.296 0.953 . . . . 0.0 111.997 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -66.07 -43.14 88.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.079 0.952 . . . . 0.0 112.202 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -17.91 64.92 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.022 -1.673 . . . . 0.0 113.918 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.5 mt -96.23 -24.84 16.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.376 1.47 . . . . 0.0 113.39 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.81 -32.99 11.07 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.945 -1.097 . . . . 0.0 112.928 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -118.13 -33.67 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 112.759 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.19 -21.23 71.83 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.408 1.004 . . . . 0.0 114.517 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -154.11 87.0 3.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.462 2.305 . . . . 0.0 108.374 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.36 108.9 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.086 1.857 . . . . 0.0 110.953 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -139.88 158.95 43.25 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -147.42 167.67 23.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.963 1.705 . . . . 0.0 112.637 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.36 111.31 0.48 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.129 0.871 . . . . 0.0 112.93 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.03 70.39 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.986 0.914 . . . . 0.0 111.434 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.0 92.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.952 2.501 . . . . 0.0 114.993 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.09 130.17 1.09 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.581 1.086 . . . . 0.0 112.362 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.434 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 5.7 m95 -58.81 123.96 18.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.641 1.177 . . . . 0.0 111.164 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -131.75 118.24 19.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.422 1.489 . . . . 0.0 111.553 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.37 142.85 46.31 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.347 1.059 . . . . 0.0 112.615 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.23 156.82 41.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.688 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -74.62 104.36 5.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.73 -22.68 58.23 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.18 35.68 2.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.753 1.644 . . . . 0.0 116.523 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -135.42 -24.54 1.38 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.57 -18.03 1.13 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.204 1.383 . . . . 0.0 114.391 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp -131.04 163.44 27.6 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.129 1.372 . . . . 0.0 112.523 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -102.3 136.72 41.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.289 1.436 . . . . 0.0 112.211 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -115.07 135.72 53.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.149 0.58 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.427 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.8 tptm -103.87 119.69 39.45 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.884 2.074 . . . . 0.0 110.468 176.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.18 146.87 18.62 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.354 1.454 . . . . 0.0 112.773 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.434 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 4.1 tp -124.15 157.05 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.096 1.759 . . . . 0.0 110.226 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.0 tpt -152.34 90.87 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.463 1.505 . . . . 0.0 109.086 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.7 p -82.45 152.24 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 111.471 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.1 t -127.94 163.47 24.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.204 1.002 . . . . 0.0 112.049 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 65.05 144.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.575 2.75 . . . . 0.0 113.133 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 38.8 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.479 1.527 0 C-N-CA 126.877 2.18 . . . . 0.0 113.34 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.539 ' HG2' ' HZ2' ' A' ' 30' ' ' LYS . 2.1 tm-20 -75.59 64.11 1.63 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.376 1.87 . . . . 0.0 109.599 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.5 111.7 23.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.202 1.801 . . . . 0.0 111.768 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.1 161.69 36.41 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 140.33 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 127.739 2.416 . . . . 0.0 110.295 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.6 157.12 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.708 1.603 . . . . 0.0 109.018 173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.6 mp -128.31 134.54 64.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 124.464 1.106 . . . . 0.0 109.697 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 109.11 13.26 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.318 2.247 . . . . 0.0 110.737 175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.7 pt -91.54 124.47 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.134 1.374 . . . . 0.0 110.183 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.4 p -155.69 170.52 21.85 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.315 1.446 . . . . 0.0 112.735 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.7 -38.12 70.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.19 0.596 . . . . 0.0 111.843 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.38 169.72 10.18 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 110.654 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.87 -27.64 19.66 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 113.231 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -146.6 160.54 42.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.99 1.716 . . . . 0.0 111.641 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -139.83 166.81 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.571 1.549 . . . . 0.0 110.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 pt -73.91 -170.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.917 2.487 . . . . 0.0 110.308 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.05 19.8 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 -10.48 73.91 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.75 1.167 . . . . 0.0 114.36 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.7 -45.69 35.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.56 1.144 . . . . 0.0 111.497 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -81.62 -7.31 59.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.947 1.299 . . . . 0.0 113.869 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.5 tp -59.81 144.19 49.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.822 1.249 . . . . 0.0 110.396 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.3 146.43 29.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.247 1.019 . . . . 0.0 110.082 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -55.79 -29.06 59.08 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -60.85 -57.32 13.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.44 -43.68 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.766 -0.584 . . . . 0.0 110.073 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -30.86 68.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 112.766 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -69.55 -47.27 64.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.986 1.715 . . . . 0.0 111.824 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -35.65 77.81 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.857 -1.152 . . . . 0.0 112.131 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -39.14 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.052 -1.03 . . . . 0.0 113.642 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -31.58 61.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.233 0.469 . . . . 0.0 111.79 175.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -70.22 -33.41 71.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.319 1.448 . . . . 0.0 112.27 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -46.63 -29.44 1.85 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.457 2.303 . . . . 0.0 114.208 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.57 -43.96 25.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.365 1.466 . . . . 0.0 110.94 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.39 -146.51 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.313 1.435 . . . . 0.0 112.626 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -118.81 16.49 13.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.888 1.675 . . . . 0.0 112.349 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 m -121.06 119.44 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.037 1.735 . . . . 0.0 111.281 -174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.1 p -73.32 28.87 0.07 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.307 1.443 . . . . 0.0 113.588 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -122.85 65.17 0.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 109.355 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -121.29 -178.88 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 112.384 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.4 141.67 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.729 1.612 . . . . 0.0 112.028 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 104.94 11.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.854 1.662 . . . . 0.0 110.338 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG12 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.12 142.87 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 124.257 1.023 . . . . 0.0 113.52 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.11 173.48 34.59 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.535 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mt -139.71 150.02 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.422 1.489 . . . . 0.0 110.613 -174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.39 118.09 31.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 110.617 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.73 103.69 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 0.0 111.922 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.58 7.97 2.82 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.823 1.249 . . . . 0.0 112.988 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 t -66.19 -16.26 63.84 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.62 16.73 28.21 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.595 1.093 . . . . 0.0 115.361 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.43 136.92 8.38 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.262 1.411 . . . . 0.0 112.886 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -67.36 141.63 57.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.437 1.495 . . . . 0.0 111.749 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.511 ' CH2' ' HB3' ' A' ' 37' ' ' ASN . 40.3 m0 -108.01 165.82 11.18 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.647 1.179 . . . . 0.0 112.179 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -146.55 98.8 3.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 111.997 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.29 139.77 58.8 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.019 -1.05 . . . . 0.0 110.428 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.4 -61.37 1.57 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.872 0.869 . . . . 0.0 110.187 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.63 -164.12 0.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.913 2.885 . . . . 0.0 108.892 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.85 134.77 20.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.206 1.803 . . . . 0.0 111.329 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -103.98 112.48 25.48 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.601 1.56 . . . . 0.0 109.376 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 130.81 55.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.543 1.537 . . . . 0.0 109.839 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -31.02 7.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.746 1.618 . . . . 0.0 113.258 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -141.8 91.85 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.241 1.016 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.17 125.94 3.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.8 1.667 . . . . 0.0 111.946 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -74.7 175.49 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.897 0.856 . . . . 0.0 111.775 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p -62.55 171.02 2.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.683 1.993 . . . . 0.0 113.122 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.34 -50.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.035 1.334 . . . . 0.0 109.785 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.9 164.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.476 1.51 . . . . 0.0 111.761 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 tp -71.88 134.25 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 110.452 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -91.79 114.2 61.21 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.696 1.198 . . . . 0.0 109.724 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.31 120.53 7.68 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.308 3.339 . . . . 0.0 111.422 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.51 -67.58 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.499 0.72 . . . . 0.0 112.402 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -97.33 132.61 42.89 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.547 0.739 . . . . 0.0 109.561 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.67 128.04 22.98 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.816 0.847 . . . . 0.0 111.099 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.77 149.64 38.13 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.028 3.152 . . . . 0.0 112.805 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.89 17.96 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -141.0 8.62 2.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.412 1.885 . . . . 0.0 113.946 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -145.59 134.44 22.43 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 119.885 1.22 . . . . 0.0 113.038 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.23 -176.36 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 110.992 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.02 157.22 41.39 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.409 -0.807 . . . . 0.0 112.187 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 170.78 14.29 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 123.608 0.763 . . . . 0.0 111.65 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.48 157.76 43.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.231 1.813 . . . . 0.0 109.885 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.7 m -145.39 160.52 41.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.154 1.782 . . . . 0.0 108.799 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.81 -179.57 16.88 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.615 1.102 . . . . 0.0 111.984 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -141.45 166.93 23.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.19 96.42 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.039 1.736 . . . . 0.0 110.14 176.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -75.3 -18.44 60.04 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.5 t -155.39 20.35 0.41 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.283 1.833 . . . . 0.0 113.363 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.18 36.83 86.04 Favored Glycine 0 CA--C 1.549 2.208 0 O-C-N 120.363 -1.461 . . . . 0.0 114.414 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -69.51 -39.11 7.4 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.429 2.753 . . . . 0.0 114.38 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -114.56 2.76 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.922 1.689 . . . . 0.0 113.265 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.78 -57.95 0.39 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.519 2.728 . . . . 0.0 113.109 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.6 p -149.81 123.76 9.36 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.861 2.065 . . . . 0.0 111.334 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.57 -139.64 14.67 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.625 1.107 . . . . 0.0 112.371 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -159.75 156.45 27.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 112.554 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 t -130.86 108.0 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.878 2.071 . . . . 0.0 108.891 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.89 178.62 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 111.128 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.76 120.7 5.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -125.97 161.56 27.23 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.312 1.045 . . . . 0.0 113.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.52 148.82 52.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -122.01 102.37 8.13 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.286 2.234 . . . . 0.0 112.094 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -69.06 117.88 11.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.471 1.508 . . . . 0.0 110.374 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.9 mtp -82.42 153.1 25.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 111.516 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 m -58.74 -16.59 17.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -73.87 -17.88 60.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 113.565 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.27 33.82 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.248 1.88 . . . . 0.0 114.937 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -78.78 168.21 20.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.734 1.267 . . . . 0.0 111.573 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.8 m -136.43 106.51 6.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.318 1.047 . . . . 0.0 112.332 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.47 111.48 4.72 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.674 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.405 ' CA ' ' HE3' ' A' ' 130' ' ' MET . . . -94.6 105.77 3.33 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 0.0 113.486 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.31 149.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 122.099 -0.648 . . . . 0.0 110.882 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 145.43 48.4 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.209 -0.932 . . . . 0.0 109.793 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.485 ' CG ' HG12 ' A' ' 33' ' ' VAL . 40.8 p90 -167.71 135.16 2.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 123.308 1.528 . . . . 0.0 114.234 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 m -150.51 130.62 13.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.768 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.21 90.9 42.85 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.51 -13.42 32.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.569 2.179 . . . . 0.0 112.818 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.7 t80 64.47 166.09 0.15 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.072 2.949 . . . . 0.0 113.396 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.52 110.24 2.24 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.067 -1.021 . . . . 0.0 111.744 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -150.48 -65.57 0.2 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 0.0 111.482 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -84.07 -12.23 55.44 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 61.97 70.84 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.736 2.014 . . . . 0.0 113.072 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 170.97 18.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.036 1.334 . . . . 0.0 113.349 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -68.19 164.57 20.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 111.809 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.67 151.21 23.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.859 0.864 . . . . 0.0 112.075 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -85.84 159.85 19.6 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.324 0.65 . . . . 0.0 110.249 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -161.45 171.03 18.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.951 1.3 . . . . 0.0 109.399 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 148.26 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.558 3.143 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.61 160.88 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.684 0.793 . . . . 0.0 109.847 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.25 158.07 26.66 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.56 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.479 ' HB ' ' CE2' ' A' ' 153' ' ' TYR . 34.1 mt -105.53 117.3 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -66.78 87.85 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.873 1.669 . . . . 0.0 110.189 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.5 t -73.02 81.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.0 110.949 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.62 -82.13 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.717 1.151 . . . . 0.0 112.938 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 177.8 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.38 2.672 . . . . 0.0 111.116 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -155.39 159.21 39.71 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.937 2.095 . . . . 0.0 109.338 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.16 173.86 10.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.123 2.169 . . . . 0.0 111.173 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.64 109.7 5.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.721 0.408 . . . . 0.0 111.863 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -163.68 -169.81 2.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 111.099 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.7 -48.88 69.11 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.442 -0.786 . . . . 0.0 110.707 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.54 50.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.422 1.01 . . . . 0.0 113.659 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.405 ' HE3' ' CA ' ' A' ' 99' ' ' GLY . 3.8 ttt -66.34 -63.63 1.03 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.739 0.815 . . . . 0.0 110.595 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.88 -34.1 62.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.999 0.92 . . . . 0.0 112.776 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.63 -40.09 95.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.681 1.592 . . . . 0.0 111.019 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -21.89 65.76 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.261 -1.525 . . . . 0.0 113.26 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.4 mt -82.15 -41.11 20.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.492 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 -34.69 14.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -113.11 -36.56 5.03 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.481 1.512 . . . . 0.0 112.128 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.81 -69.58 1.02 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.747 1.642 . . . . 0.0 112.487 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -171.13 75.57 0.54 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 125.437 1.495 . . . . 0.0 112.933 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.73 161.32 32.78 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.751 2.3 . . . . 0.0 113.86 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -126.53 177.19 6.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.125 2.17 . . . . 0.0 112.224 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -108.24 124.0 49.63 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.055 2.142 . . . . 0.0 111.584 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.64 101.96 2.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.493 1.52 . . . . 0.0 112.928 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -136.86 23.96 3.08 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 71.2 99.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.81 2.444 . . . . 0.0 113.386 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.96 139.41 2.66 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.691 1.615 . . . . 0.0 111.987 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -69.83 154.91 41.33 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 122.216 -0.579 . . . . 0.0 111.354 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -142.08 124.47 15.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.305 1.442 . . . . 0.0 111.694 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -121.79 138.64 54.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.231 2.212 . . . . 0.0 111.34 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 159.44 38.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.92 1.288 . . . . 0.0 111.694 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -81.63 86.6 6.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.091 1.356 . . . . 0.0 110.083 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 153' ' ' TYR . 7.3 tt -58.42 -52.51 65.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.456 1.502 . . . . 0.0 112.949 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.58 42.37 0.02 OUTLIER Glycine 0 CA--C 1.542 1.761 0 N-CA-C 118.584 2.194 . . . . 0.0 118.584 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.479 ' CE2' ' HB ' ' A' ' 119' ' ' ILE . 0.5 OUTLIER -150.05 5.01 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.642 1.721 . . . . 0.0 115.61 -176.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.87 -57.21 0.44 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.448 1.499 . . . . 0.0 112.496 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.84 176.24 7.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.824 0.85 . . . . 0.0 111.652 174.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.24 123.94 31.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.648 1.579 . . . . 0.0 109.999 175.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.2 156.02 19.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.58 130.96 39.12 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.762 1.225 . . . . 0.0 109.977 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -124.41 152.66 17.46 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 124.269 0.938 . . . . 0.0 113.588 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 141.24 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.278 1.431 . . . . 0.0 110.396 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.31 99.13 5.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.931 1.242 . . . . 0.0 110.931 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.59 53.86 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 0.0 111.89 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.5 m -123.06 129.02 50.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.674 1.989 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.64 68.15 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.842 2.857 . . . . 0.0 109.151 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.2 -90.46 0.02 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.38 1.943 . . . . 0.0 114.536 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -75.81 11.22 1.45 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.57 2.348 . . . . 0.0 114.802 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.37 170.28 16.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.69 1.596 . . . . 0.0 113.032 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 -167.99 1.89 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.1 ptm -114.05 164.12 14.25 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.858 2.063 . . . . 0.0 110.99 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -150.64 146.03 26.24 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.165 1.386 . . . . 0.0 110.009 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.0 mm -121.03 128.69 76.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.311 1.045 . . . . 0.0 108.726 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -115.58 114.55 25.09 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.504 1.522 . . . . 0.0 108.965 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 13.3 pt -111.07 134.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.59 1.156 . . . . 0.0 110.709 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.5 p -162.72 158.97 23.69 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.8 1.24 . . . . 0.0 110.79 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.248 1.419 . . . . 0.0 112.212 -175.043 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.46 -38.02 12.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.233 2.613 . . . . 0.0 110.623 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.75 166.85 5.05 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.024 0.916 . . . . 0.0 110.403 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.64 -42.17 1.99 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.93 1.729 . . . . 0.0 110.89 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.3 p -139.1 159.98 40.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.429 1.491 . . . . 0.0 111.932 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mm -142.11 162.9 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 111.402 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.5 pt -69.1 -169.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.072 2.149 . . . . 0.0 111.073 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.08 -25.84 23.87 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.28 -21.59 34.05 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.411 1.005 . . . . 0.0 113.355 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -44.1 70.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.444 1.122 . . . . 0.0 111.845 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.64 -11.67 59.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.018 1.327 . . . . 0.0 113.365 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -66.15 159.12 26.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.59 146.84 27.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.685 0.794 . . . . 0.0 109.916 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -55.52 -33.93 64.21 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.96 -47.77 79.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.456 1.103 . . . . 0.0 113.049 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.1 -45.94 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 110.439 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -41.3 66.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 111.426 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.67 -53.3 40.47 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.619 1.968 . . . . 0.0 112.317 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -27.12 41.84 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -35.82 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.181 1.355 . . . . 0.0 111.742 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.27 -23.91 37.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.208 1.003 . . . . 0.0 112.463 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.9 -33.77 22.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.645 1.578 . . . . 0.0 114.235 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -19.89 16.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 112.935 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tp -47.63 -40.69 20.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.457 2.303 . . . . 0.0 111.038 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.99 -161.67 10.53 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.412 1.958 . . . . 0.0 112.524 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -128.42 34.69 4.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.039 2.136 . . . . 0.0 111.168 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.3 163.11 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.057 2.143 . . . . 0.0 113.301 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.55 -14.43 61.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.482 1.513 . . . . 0.0 114.479 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.29 118.62 26.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.027 2.131 . . . . 0.0 111.184 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.37 165.7 21.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.844 0.858 . . . . 0.0 113.145 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -145.41 148.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.683 1.193 . . . . 0.0 113.005 176.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' H ' ' HG2' ' A' ' 168' ' ' LYS . . . -121.77 105.63 10.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.591 2.356 . . . . 0.0 112.603 174.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -115.7 144.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 108.75 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.61 170.54 22.56 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 118.195 0.452 . . . . 0.0 112.8 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.02 124.88 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.888 0.875 . . . . 0.0 111.528 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -71.2 109.34 5.18 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.348 -0.845 . . . . 0.0 111.902 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.87 102.68 14.55 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.656 1.217 . . . . 0.0 111.271 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.14 44.41 1.55 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.07 -1.019 . . . . 0.0 110.94 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -2.32 9.05 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.41 75.81 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.946 -1.096 . . . . 0.0 115.266 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.37 107.85 1.71 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.758 1.647 . . . . 0.0 111.509 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.2 m -67.74 116.75 8.79 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.638 1.219 . . . . 0.0 110.632 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -85.78 161.25 19.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.588 0.355 . . . . 0.0 111.916 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -138.01 104.12 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.448 1.899 . . . . 0.0 111.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.93 141.27 58.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.884 -1.135 . . . . 0.0 110.528 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.42 -47.45 3.78 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.195 1.398 . . . . 0.0 111.774 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -155.63 171.35 20.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.027 0.931 . . . . 0.0 112.13 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.13 135.33 30.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 0.0 111.604 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -115.16 129.01 56.55 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.333 1.453 . . . . 0.0 109.088 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -147.22 161.15 41.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.869 1.267 . . . . 0.0 112.452 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -120.94 -31.84 4.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.738 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.462 ' CB ' ' H ' ' A' ' 85' ' ' VAL . 83.2 p -60.19 130.97 49.3 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.712 1.205 . . . . 0.0 112.344 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 37.13 -100.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.285 1.898 . . . . 0.0 113.904 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -165.04 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.478 1.911 . . . . 0.0 108.244 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 p -137.31 164.9 27.45 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.411 2.284 . . . . 0.0 112.119 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -154.67 -38.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.523 1.529 . . . . 0.0 111.358 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -102.31 165.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.682 1.593 . . . . 0.0 112.24 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.5 tt -80.24 136.62 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.641 1.176 . . . . 0.0 110.957 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.22 107.08 36.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.907 0.883 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.14 113.96 3.03 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 124.322 3.348 . . . . 0.0 110.386 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.49 -46.61 87.66 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.641 -0.662 . . . . 0.0 112.024 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.78 145.31 29.93 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.954 0.797 . . . . 0.0 110.854 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.11 94.19 16.26 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 124.723 1.209 . . . . 0.0 108.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.15 173.94 13.65 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.268 1.978 . . . . 0.0 112.125 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.72 166.82 3.06 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.343 0.657 . . . . 0.0 112.103 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.26 8.5 t 43.07 38.19 1.41 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.076 1.75 . . . . 0.0 113.396 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -148.74 151.41 34.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.039 1.736 . . . . 0.0 111.592 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.12 -175.62 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.32 . . . . 0.0 109.373 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.75 145.16 19.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.964 1.305 . . . . 0.0 109.368 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.08 39.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.25 1.02 . . . . 0.0 110.082 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -139.45 169.2 18.19 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 109.793 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -154.49 -177.8 6.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.339 1.055 . . . . 0.0 110.722 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.11 -167.03 12.79 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.354 1.93 . . . . 0.0 110.903 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -135.71 -162.68 1.29 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -114.89 -14.78 11.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.117 2.167 . . . . 0.0 114.45 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.97 -64.31 0.51 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.998 1.719 . . . . 0.0 114.769 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 11.1 25.49 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.611 1.564 . . . . 0.0 112.495 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.85 77.18 0.13 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.035 1.303 . . . . 0.0 113.426 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.76 21.94 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.921 1 C-N-CA 126.301 4.667 . . . . 0.0 116.347 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -32.65 101.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 129.028 2.931 . . . . 0.0 113.203 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 38.45 -95.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.91 2.484 . . . . 0.0 111.455 -175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.7 p -143.43 154.99 44.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.921 2.488 . . . . 0.0 108.173 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.84 -130.04 9.67 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.774 -1.204 . . . . 0.0 111.601 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -159.79 175.85 12.64 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.729 1.211 . . . . 0.0 112.145 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.462 ' H ' ' CB ' ' A' ' 52' ' ' SER . 47.1 t -152.36 114.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.357 2.263 . . . . 0.0 112.719 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . . . -143.98 167.0 23.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.488 1.515 . . . . 0.0 110.448 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 122.95 10.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.255 1.422 . . . . 0.0 107.45 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -139.23 164.01 30.95 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 112.315 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.11 151.73 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -131.83 112.16 12.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.958 1.703 . . . . 0.0 110.937 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -65.91 105.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.252 1.421 . . . . 0.0 110.655 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -73.47 153.46 40.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.203 1.001 . . . . 0.0 110.998 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.5 p -59.63 -20.56 56.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -76.27 -4.45 42.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 114.058 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.1 6.3 71.84 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.293 1.425 . . . . 0.0 114.851 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.59 177.28 5.86 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.235 1.414 . . . . 0.0 111.293 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.9 m -133.48 112.0 11.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.323 1.049 . . . . 0.0 113.12 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 tp -73.45 122.84 22.78 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.66 108.57 3.14 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.0 154.76 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.337 0.589 . . . . 0.0 110.828 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.38 148.22 44.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.532 1.133 . . . . 0.0 108.924 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' A' ' 31' ' ' ILE . 21.3 p90 -162.17 147.05 12.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.234 1.016 . . . . 0.0 110.488 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.2 m -151.55 165.4 34.36 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.94 1.296 . . . . 0.0 108.379 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.51 96.68 23.39 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.67 -32.62 11.58 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.976 2.451 . . . . 0.0 114.718 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.6 t80 51.41 100.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 128.198 2.599 . . . . 0.0 115.618 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.77 -168.3 3.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.209 1.404 . . . . 0.0 110.742 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.0 154.69 3.95 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.221 1.409 . . . . 0.0 112.371 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -58.28 -31.37 67.39 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.234 1.014 . . . . 0.0 112.583 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 38.26 0.73 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.456 1.502 . . . . 0.0 113.89 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -129.51 155.98 44.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.657 1.583 . . . . 0.0 112.754 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 t -91.18 175.11 7.06 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.301 1.44 . . . . 0.0 110.444 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.62 156.63 48.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.023 1.729 . . . . 0.0 111.122 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -84.16 144.41 29.01 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.259 1.024 . . . . 0.0 112.547 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -153.45 150.93 29.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.472 0.653 . . . . 0.0 111.831 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.61 151.21 4.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.046 1.338 . . . . 0.0 111.079 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.0 135.55 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.261 1.824 . . . . 0.0 108.748 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -146.43 155.01 42.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.102 1.361 . . . . 0.0 109.872 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.16 107.16 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.396 1.478 . . . . 0.0 107.863 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.66 104.83 4.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.277 1.031 . . . . 0.0 109.22 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t -65.6 97.02 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.799 -1.188 . . . . 0.0 110.097 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.8 19.26 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 127.194 2.33 . . . . 0.0 110.317 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -126.93 129.85 48.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.107 1.763 . . . . 0.0 111.018 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.75 121.68 5.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.841 1.657 . . . . 0.0 111.563 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.59 175.36 5.66 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.483 1.113 . . . . 0.0 110.85 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.59 115.06 22.42 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.71 -0.619 . . . . 0.0 111.905 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -151.27 -174.53 4.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.441 1.096 . . . . 0.0 111.682 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.56 -51.7 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.512 1.125 . . . . 0.0 110.668 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.06 46.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.202 0.906 . . . . 0.0 113.83 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.7 ttt -66.04 -65.2 0.71 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.629 0.714 . . . . 0.0 110.185 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -54.14 -31.78 53.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.47 1.108 . . . . 0.0 112.683 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.47 -47.88 82.05 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.802 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -23.69 67.44 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.464 -1.397 . . . . 0.0 113.806 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.09 -18.17 53.81 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.431 1.492 . . . . 0.0 114.44 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.76 -31.33 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.905 1.282 . . . . 0.0 114.433 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.52 -5.74 13.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.0 2.12 . . . . 0.0 112.268 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.03 -88.68 0.46 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.244 1.878 . . . . 0.0 110.744 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -160.98 73.08 2.7 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.695 1.598 . . . . 0.0 111.692 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.26 177.63 8.37 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.731 2.287 . . . . 0.0 114.914 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -127.03 -178.24 4.34 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.231 2.212 . . . . 0.0 113.056 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 144.65 48.85 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.378 -1.451 . . . . 0.0 111.848 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.97 116.5 0.76 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.587 1.089 . . . . 0.0 111.952 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -115.46 68.78 0.72 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.348 1.459 . . . . 0.0 112.83 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 64.55 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.281 2.633 . . . . 0.0 113.758 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.78 142.11 3.48 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.982 1.277 . . . . 0.0 112.5 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -67.82 147.9 51.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.481 0.713 . . . . 0.0 111.951 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -148.41 122.82 9.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.706 1.602 . . . . 0.0 110.926 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.12 141.58 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.987 0.915 . . . . 0.0 111.633 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -146.01 148.85 33.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.352 0.596 . . . . 0.0 110.452 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.53 92.72 8.6 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.92 -32.16 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.99 21.97 5.46 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -128.44 20.43 6.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.875 1.338 . . . . 0.0 114.445 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.85 12.11 83.11 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.348 -0.845 . . . . 0.0 113.827 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.87 166.97 23.2 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.41 1.884 . . . . 0.0 111.633 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 169.74 13.2 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.26 1.424 . . . . 0.0 109.824 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.81 167.52 23.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.897 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 137.02 54.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.295 1.438 . . . . 0.0 108.253 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.06 141.36 15.83 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.536 0.589 . . . . 0.0 112.632 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.22 101.97 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.516 1.526 . . . . 0.0 111.089 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.5 tpt -96.63 105.08 17.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.982 1.264 . . . . 0.0 110.998 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.8 p -114.7 145.36 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.08 0.952 . . . . 0.0 111.449 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -137.86 139.56 39.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.865 1.666 . . . . 0.0 111.968 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.6 -179.29 0.11 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 130.344 3.458 . . . . 0.0 108.744 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.09 -12.86 45.92 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 115.077 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.21 11.28 0.91 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.76 1.624 . . . . 0.0 114.769 -175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.96 169.11 12.76 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.546 -1.346 . . . . 0.0 113.745 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 19.6 tptt -167.14 151.36 6.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 113.091 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.6 ptm -81.19 165.76 21.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -154.37 161.0 41.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.332 1.453 . . . . 0.0 110.782 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 mm -123.14 135.35 63.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -118.12 126.99 53.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.411 1.084 . . . . 0.0 108.289 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 14.5 pt -110.82 117.0 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -156.05 145.02 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.372 0.669 . . . . 0.0 112.322 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.509 1.924 . . . . 0.0 112.003 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.851 0.358 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -36.21 13.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.423 1.089 . . . . 0.0 111.34 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.81 5.26 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 121.451 0.643 . . . . 0.0 110.188 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.43 -27.64 19.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.8 1.191 . . . . 0.0 113.039 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 p -145.79 155.27 42.82 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.109 1.364 . . . . 0.0 111.532 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -135.15 162.25 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.1 1.36 . . . . 0.0 110.435 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -72.51 -165.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 127.837 2.455 . . . . 0.0 111.231 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.05 -24.78 26.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.39 -19.62 34.89 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.53 1.062 . . . . 0.0 114.185 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.38 75.19 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.296 1.048 . . . . 0.0 111.81 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -85.67 -7.85 58.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.733 1.613 . . . . 0.0 114.15 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.92 149.94 46.09 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.204 1.002 . . . . 0.0 111.582 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -145.06 145.62 31.52 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.396 1.078 . . . . 0.0 110.528 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -51.77 -37.94 53.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.452 1.101 . . . . 0.0 113.359 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -56.26 -48.51 76.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.416 1.007 . . . . 0.0 112.651 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -52.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.658 1.583 . . . . 0.0 109.238 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.42 -41.39 65.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.537 1.535 . . . . 0.0 111.848 -175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.42 -51.95 67.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.414 1.486 . . . . 0.0 111.216 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -38.32 89.35 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.337 -0.852 . . . . 0.0 112.086 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.89 -51.09 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 110.959 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.11 -33.98 76.63 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.52 -23.04 63.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.1 1.36 . . . . 0.0 113.404 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.47 -23.34 49.29 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.648 -1.282 . . . . 0.0 113.471 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.82 -39.57 77.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.162 2.185 . . . . 0.0 112.629 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.38 111.79 0.48 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.429 1.014 . . . . 0.0 112.537 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.44 55.67 0.16 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.576 1.951 . . . . 0.0 113.939 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.48 174.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 127.449 2.299 . . . . 0.0 111.026 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.49 56.71 1.44 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.92 -1.112 . . . . 0.0 112.526 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.89 108.09 1.93 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.346 2.258 . . . . 0.0 109.304 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.38 123.44 14.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.43 1.092 . . . . 0.0 110.065 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.67 142.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.9 111.17 17.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.582 1.953 . . . . 0.0 110.722 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -127.36 127.12 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.434 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.37 30.56 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.468 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 69' ' ' LEU . 2.6 mp -136.85 142.49 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.874 1.27 . . . . 0.0 110.6 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.16 111.7 22.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.052 1.741 . . . . 0.0 111.546 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.88 89.65 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.132 1.773 . . . . 0.0 111.741 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -132.1 7.66 4.32 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.914 0.886 . . . . 0.0 112.684 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t -81.29 -6.98 59.47 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.55 20.02 36.06 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.594 1.092 . . . . 0.0 115.527 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.74 121.56 2.81 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.499 1.523 . . . . 0.0 111.667 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -57.43 144.13 37.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.594 1.558 . . . . 0.0 111.446 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -107.66 168.06 9.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.246 0.618 . . . . 0.0 112.547 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.8 m -153.74 105.16 2.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.895 2.078 . . . . 0.0 109.787 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.0 139.4 56.33 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.651 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.01 -54.56 2.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.38 1.072 . . . . 0.0 112.349 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -153.53 171.15 19.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.17 0.988 . . . . 0.0 111.187 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 136.23 43.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.153 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -119.16 136.54 54.13 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.883 1.273 . . . . 0.0 110.286 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.96 145.26 12.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.643 1.577 . . . . 0.0 112.068 -176.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -115.61 -11.02 11.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.582 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -151.47 137.75 18.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.031 1.732 . . . . 0.0 112.128 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 39.1 3.17 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.017 0.818 . . . . 0.0 114.6 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 m -30.19 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.04 2.936 . . . . 0.0 113.158 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -71.94 162.81 28.91 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.282 -0.886 . . . . 0.0 112.732 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -132.61 5.88 4.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.159 0.983 . . . . 0.0 113.581 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.33 163.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.051 1.74 . . . . 0.0 112.523 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.81 123.44 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.867 1.267 . . . . 0.0 112.856 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.7 130.37 61.55 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -70.21 142.58 46.3 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.844 2.362 . . . . 0.0 109.696 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 62' ' ' PHE . 2.0 pm0 -85.2 -77.86 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.904 0.882 . . . . 0.0 110.59 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.4 ' H ' ' HG2' ' A' ' 61' ' ' GLU . 3.6 m-85 -100.86 149.25 24.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.632 1.173 . . . . 0.0 110.506 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.0 133.34 14.14 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.131 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.11 -151.69 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.257 3.972 . . . . 0.0 113.796 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -119.63 15.76 12.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.076 1.751 . . . . 0.0 113.678 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -141.61 18.24 2.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.882 1.673 . . . . 0.0 113.775 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -136.77 -173.3 3.4 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.974 1.309 . . . . 0.0 113.238 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.87 -178.49 6.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.492 1.517 . . . . 0.0 110.339 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -146.22 160.93 41.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.525 -0.734 . . . . 0.0 111.32 178.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mt -141.39 157.3 45.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.481 1.112 . . . . 0.0 109.562 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.67 159.04 43.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.191 1.796 . . . . 0.0 108.593 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 m -150.05 140.07 22.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 110.516 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.96 165.07 13.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.028 1.299 . . . . 0.0 114.272 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -134.15 130.64 37.6 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 113.773 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -79.72 52.9 1.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -92.74 -28.06 16.84 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.0 12.11 2.22 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.37 -88.15 0.23 Allowed Glycine 0 N--CA 1.473 1.138 0 O-C-N 120.692 -1.255 . . . . 0.0 114.734 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.24 -27.27 9.78 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.056 2.504 . . . . 0.0 112.81 -175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.275 87.9 t 43.18 -91.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.967 2.507 . . . . 0.0 113.574 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.89 13.8 0.47 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 83' ' ' GLY . 3.1 m -135.89 -172.02 3.01 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.552 2.341 . . . . 0.0 111.003 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.461 ' H ' HG23 ' A' ' 82' ' ' THR . . . -94.31 158.98 23.18 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.33 1.443 . . . . 0.0 115.445 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' H ' ' CG2' ' A' ' 104' ' ' VAL . . . -76.89 145.65 38.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.083 1.753 . . . . 0.0 113.038 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.6 t -150.35 111.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.988 1.315 . . . . 0.0 113.131 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -140.57 164.61 29.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.228 1.014 . . . . 0.0 112.016 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 124.31 10.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.439 1.096 . . . . 0.0 108.972 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -132.95 160.6 36.6 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.183 0.993 . . . . 0.0 113.186 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.51 149.0 44.5 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -127.58 114.41 17.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.827 2.051 . . . . 0.0 110.58 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -71.22 116.71 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 111.05 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.98 23.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.016 2.126 . . . . 0.0 111.491 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -19.7 30.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.74 1.65 22.36 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.97 39.64 11.43 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 125.403 1.478 . . . . 0.0 112.09 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.547 HD21 HG22 ' A' ' 119' ' ' ILE . 9.4 p-10 -137.59 170.59 15.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.008 2.523 . . . . 0.0 113.16 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.9 m -131.7 110.22 10.74 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.28 117.35 14.93 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.382 1.073 . . . . 0.0 110.384 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.43 117.16 5.78 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.08 0.847 . . . . 0.0 112.711 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.95 164.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.727 0.811 . . . . 0.0 110.832 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.05 161.37 38.97 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.243 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 14.9 p90 -166.59 160.44 15.15 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.718 1.207 . . . . 0.0 111.565 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 119.85 0.94 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.968 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.413 ' CG2' ' H ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -81.35 146.03 56.91 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -71.14 154.79 62.0 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.878 1.719 . . . . 0.0 109.712 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -147.95 135.93 21.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.819 1.647 . . . . 0.0 107.542 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.46 104.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.24 1.816 . . . . 0.0 115.259 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -57.25 -1.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.534 1.534 . . . . 0.0 114.79 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.0 -22.52 10.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.786 2.434 . . . . 0.0 112.426 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -144.61 157.78 44.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.408 2.283 . . . . 0.0 110.717 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.39 114.24 15.33 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.554 1.542 . . . . 0.0 111.034 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.9 p -169.29 127.08 0.96 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.435 1.494 . . . . 0.0 110.61 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -134.35 88.93 2.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.853 1.261 . . . . 0.0 110.729 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -72.81 143.25 47.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.626 0.77 . . . . 0.0 112.033 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -152.99 151.66 30.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.29 0.636 . . . . 0.0 109.914 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -167.52 138.04 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.37 1.468 . . . . 0.0 109.305 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.56 134.21 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.783 1.233 . . . . 0.0 109.187 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -152.41 155.49 37.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.41 1.084 . . . . 0.0 109.497 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.547 HG22 HD21 ' A' ' 96' ' ' ASN . 67.9 mt -109.37 101.72 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.03 99.25 0.63 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.134 -0.979 . . . . 0.0 109.39 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -66.1 87.15 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.231 1.015 . . . . 0.0 110.634 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.33 -134.33 3.32 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.512 2.482 . . . . 0.0 110.321 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -149.99 109.9 4.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.717 1.607 . . . . 0.0 111.33 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -144.53 120.7 10.82 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.223 1.809 . . . . 0.0 112.139 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 174.5 5.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.692 1.197 . . . . 0.0 110.771 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.61 114.47 20.32 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.566 . . . . 0.0 110.043 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.97 -165.85 1.59 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.847 1.659 . . . . 0.0 110.471 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.37 -50.4 30.76 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.971 1.308 . . . . 0.0 110.996 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.52 -27.77 54.79 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.427 1.013 . . . . 0.0 114.609 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.8 ttt -75.59 -61.3 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.041 0.921 . . . . 0.0 110.179 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -53.96 -32.24 53.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.903 1.281 . . . . 0.0 112.665 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.39 -42.97 99.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 107.478 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -30.37 70.2 Favored 'General case' 0 CA--C 1.559 1.315 0 O-C-N 120.769 -1.207 . . . . 0.0 108.034 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.2 mt -75.76 -37.52 59.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.672 1.589 . . . . 0.0 113.879 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -27.93 14.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.421 1.488 . . . . 0.0 114.766 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.4 -40.23 2.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.383 1.473 . . . . 0.0 112.225 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.6 -70.68 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.149 1.833 . . . . 0.0 112.401 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.46 73.38 4.33 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 142.48 63.34 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.997 1.798 . . . . 0.0 112.996 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -122.97 -178.92 4.09 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.898 2.079 . . . . 0.0 109.275 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.73 143.43 50.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.381 1.472 . . . . 0.0 112.472 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.23 101.53 2.8 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.368 1.461 . . . . 0.0 113.446 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.57 19.96 4.26 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 54.92 80.22 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.148 2.179 . . . . 0.0 113.234 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.34 165.84 23.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.029 1.299 . . . . 0.0 113.327 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.447 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 9.2 m95 -68.86 130.1 41.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.066 1.346 . . . . 0.0 111.586 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -139.48 118.8 12.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.63 1.172 . . . . 0.0 113.654 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.88 145.21 30.15 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.274 1.43 . . . . 0.0 109.541 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -143.84 156.39 44.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.9 1.28 . . . . 0.0 109.675 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.31 100.2 13.04 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.94 -31.94 63.38 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.69 30.7 6.7 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 119.302 2.481 . . . . 0.0 119.302 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -131.67 -21.86 2.45 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.96 -15.67 1.74 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 118.666 0.666 . . . . 0.0 114.632 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.26 171.57 13.16 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 126.169 1.788 . . . . 0.0 110.029 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.18 164.44 19.48 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.322 1.049 . . . . 0.0 110.637 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.96 164.15 31.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.464 1.126 . . . . 0.0 112.757 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -128.57 125.39 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.227 1.811 . . . . 0.0 108.473 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.96 153.27 17.69 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.533 1.54 . . . . 0.0 112.863 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.447 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -129.48 149.73 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.728 1.611 . . . . 0.0 109.687 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 6.6 tpt -150.2 119.06 6.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.247 1.819 . . . . 0.0 109.387 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.9 122.46 32.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.313 1.845 . . . . 0.0 111.472 -175.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.9 p -87.85 73.61 9.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.885 1.674 . . . . 0.0 112.397 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.45 17.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.227 1.011 . . . . 0.0 113.021 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.87 -7.41 88.0 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.89 1.233 . . . . 0.0 114.459 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -125.53 7.92 7.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.136 2.175 . . . . 0.0 113.721 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -128.59 174.31 9.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.18 1.392 . . . . 0.0 112.575 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.42 -178.55 6.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.965 1.706 . . . . 0.0 112.906 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.85 151.81 24.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.479 1.911 . . . . 0.0 109.983 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -162.26 148.1 13.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.269 1.428 . . . . 0.0 108.82 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.18 136.24 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.688 0.795 . . . . 0.0 108.94 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -121.46 124.58 44.81 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.296 1.039 . . . . 0.0 108.71 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 5.3 pt -94.99 145.53 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.778 0.831 . . . . 0.0 109.51 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.5 t -159.0 170.01 23.03 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.788 -0.57 . . . . 0.0 112.171 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.972 1.709 . . . . 0.0 112.682 177.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.351 0.119 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.49 -44.17 2.0 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.238 1.415 . . . . 0.0 111.239 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.15 -174.31 0.48 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.578 0.751 . . . . 0.0 110.469 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.36 -31.76 7.12 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.402 -1.436 . . . . 0.0 111.538 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 p -146.39 155.96 42.97 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.543 1.537 . . . . 0.0 110.902 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.7 mm -136.56 166.91 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 126.334 1.854 . . . . 0.0 109.815 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -165.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.731 1.613 . . . . 0.0 111.339 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.12 -32.84 23.99 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.96 -14.65 37.45 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.995 1.283 . . . . 0.0 113.8 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.31 63.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.49 1.145 . . . . 0.0 111.291 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -85.71 -9.89 56.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.627 1.571 . . . . 0.0 114.258 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.49 143.2 54.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.454 1.101 . . . . 0.0 110.119 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.2 143.12 24.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.641 0.776 . . . . 0.0 109.959 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.06 -32.6 68.17 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -54.78 -51.06 66.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.452 1.101 . . . . 0.0 113.02 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.03 -52.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.18 -39.96 64.02 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.89 1.276 . . . . 0.0 112.432 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -52.22 -63.99 0.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.334 2.254 . . . . 0.0 110.237 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -66.51 -23.01 66.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -46.1 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.702 1.137 . . . . 0.0 111.91 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -26.38 61.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.205 1.002 . . . . 0.0 111.412 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.46 -43.35 49.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.489 1.916 . . . . 0.0 113.861 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -23.57 2.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.977 1.711 . . . . 0.0 114.841 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.55 -31.0 70.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.607 2.363 . . . . 0.0 114.826 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.7 -160.29 9.13 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.63 2.538 . . . . 0.0 111.99 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -146.53 83.83 1.61 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.656 1.582 . . . . 0.0 112.005 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.74 145.26 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.914 1.686 . . . . 0.0 110.659 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 m -70.57 18.99 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 119.86 -1.775 . . . . 0.0 114.968 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.18 142.04 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.069 2.547 . . . . 0.0 111.559 -175.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.45 -172.46 3.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.767 1.627 . . . . 0.0 113.013 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.03 145.28 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 127.504 2.321 . . . . 0.0 112.335 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 168' ' ' LYS . . . -138.46 129.08 26.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 127.195 2.198 . . . . 0.0 111.819 175.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.43 144.98 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 120.26 1.391 . . . . 0.0 112.033 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.42 174.62 46.41 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.382 0.513 . . . . 0.0 114.382 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.75 114.73 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.247 1.819 . . . . 0.0 108.61 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.51 106.0 1.32 Allowed 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.403 -1.436 . . . . 0.0 110.966 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.411 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . 9.5 t-20 -82.03 92.95 6.88 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 123.519 1.628 . . . . 0.0 112.143 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.81 43.74 1.59 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.391 1.076 . . . . 0.0 110.525 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -2.22 16.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.295 1.838 . . . . 0.0 114.433 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.88 17.06 73.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.569 1.081 . . . . 0.0 115.046 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.19 129.35 5.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.949 1.737 . . . . 0.0 111.422 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -79.18 118.79 21.46 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 117.93 0.865 . . . . 0.0 109.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 37' ' ' ASN . 5.9 m0 -88.03 161.66 17.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 m -137.86 107.74 6.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.33 1.852 . . . . 0.0 110.618 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.57 156.01 31.24 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.069 -1.02 . . . . 0.0 111.461 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -57.98 1.2 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.098 1.359 . . . . 0.0 112.438 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -147.69 167.99 23.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.285 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.25 137.63 40.97 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.357 1.463 . . . . 0.0 110.705 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.71 134.08 50.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.246 1.419 . . . . 0.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 155.47 45.12 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.059 2.144 . . . . 0.0 110.419 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -119.95 -44.23 2.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.277 1.431 . . . . 0.0 111.624 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -121.46 97.36 5.47 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.022 1.329 . . . . 0.0 111.479 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.63 109.34 2.78 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.92 1.247 . . . . 0.0 112.662 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -64.68 179.66 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.575 1.15 . . . . 0.0 113.231 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -65.6 152.89 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.598 1.559 . . . . 0.0 113.141 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -147.25 -21.66 0.39 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.49 164.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.294 2.238 . . . . 0.0 111.954 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 tt -73.59 130.66 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.925 0.89 . . . . 0.0 109.95 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 tp -78.91 128.42 76.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.59 126.82 15.36 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.782 2.988 . . . . 0.0 111.067 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.55 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.296 -0.878 . . . . 0.0 112.531 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -109.72 143.83 38.96 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.449 1.1 . . . . 0.0 110.389 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.75 86.99 53.69 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.384 1.074 . . . . 0.0 109.192 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.98 136.93 16.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.061 2.507 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -46.94 146.73 1.56 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.786 1.235 . . . . 0.0 112.705 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.327 1.4 p 74.47 32.55 0.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.125 2.17 . . . . 0.0 111.996 -175.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -150.4 146.98 27.02 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.013 2.125 . . . . 0.0 110.799 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.65 -177.91 3.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.314 1.046 . . . . 0.0 109.588 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.75 142.8 19.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.529 0.732 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.32 -179.85 3.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.558 0.743 . . . . 0.0 110.433 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -159.01 159.33 34.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.905 1.682 . . . . 0.0 109.318 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -138.19 164.01 30.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.069 1.348 . . . . 0.0 110.89 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.94 -179.9 16.46 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.74 1.162 . . . . 0.0 113.398 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.37 31.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -116.58 50.16 1.09 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.159 1.783 . . . . 0.0 113.738 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.23 105.69 0.36 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.299 1.44 . . . . 0.0 113.036 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.9 m 58.85 7.19 0.74 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 127.739 2.416 . . . . 0.0 115.01 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.29 66.46 1.39 Allowed Glycine 0 CA--C 1.539 1.559 0 O-C-N 120.002 -1.686 . . . . 0.0 111.23 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 -53.32 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.596 3.53 . . . . 0.0 110.65 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -108.29 167.45 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.372 2.269 . . . . 0.0 106.709 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.12 -58.02 7.84 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.276 1.031 . . . . 0.0 111.817 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.5 p -143.86 148.64 35.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.473 1.909 . . . . 0.0 109.841 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.05 -120.56 14.03 Favored Glycine 0 CA--C 1.545 1.965 0 O-C-N 120.366 -1.459 . . . . 0.0 115.764 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -159.53 175.69 12.95 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.366 2.267 . . . . 0.0 112.662 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.6 t -140.86 123.99 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 127.982 2.513 . . . . 0.0 111.248 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -153.01 177.01 11.25 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.219 1.009 . . . . 0.0 111.875 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.7 125.71 11.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.345 1.458 . . . . 0.0 107.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -136.69 162.65 32.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.046 0.939 . . . . 0.0 110.52 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.11 150.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.454 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.88 123.49 40.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.534 1.534 . . . . 0.0 110.758 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.41 109.0 2.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.189 1.796 . . . . 0.0 110.881 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.0 mtp -71.63 155.36 40.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.67 0.788 . . . . 0.0 111.68 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -58.17 -30.46 66.43 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 113.164 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 1.26 11.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.909 1.684 . . . . 0.0 114.687 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.65 9.29 85.82 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.756 -1.215 . . . . 0.0 114.341 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -89.05 178.87 6.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.079 1.752 . . . . 0.0 109.819 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -142.58 110.25 5.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.398 -1.439 . . . . 0.0 111.488 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.3 tp -77.09 121.02 22.98 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.67 107.64 3.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.483 1.516 . . . . 0.0 112.857 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -80.06 168.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 122.273 1.035 . . . . 0.0 111.377 174.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.446 ' SD ' ' CZ3' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -146.46 157.54 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.606 1.962 . . . . 0.0 109.511 174.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -165.08 134.07 3.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.031 1.332 . . . . 0.0 108.374 175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.4 m -147.05 130.61 16.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.116 0.567 . . . . 0.0 110.165 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.3 132.54 42.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.902 -0.571 . . . . 0.0 111.203 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.61 161.35 46.37 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.773 2.315 . . . . 0.0 113.038 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.33 -21.86 9.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 113.325 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.23 165.51 20.36 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.935 0.874 . . . . 0.0 111.407 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -140.62 -48.29 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.18 2.192 . . . . 0.0 110.77 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -72.39 -35.4 68.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.387 1.075 . . . . 0.0 112.349 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 96.38 4.71 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.776 1.63 . . . . 0.0 111.821 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -67.13 112.36 4.4 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.09 0.956 . . . . 0.0 111.365 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -159.93 122.0 3.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.372 1.469 . . . . 0.0 109.328 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.15 155.21 50.49 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.92 0.888 . . . . 0.0 110.79 175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CZ3' ' SD ' ' A' ' 101' ' ' MET . 40.8 p-90 -84.38 152.93 23.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.635 0.774 . . . . 0.0 110.358 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -158.97 128.48 5.58 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 109.452 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.412 ' HB3' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -177.82 126.73 0.13 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.766 1.227 . . . . 0.0 111.12 -176.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.5 m -118.01 166.74 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.314 1.046 . . . . 0.0 111.927 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.91 158.17 43.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.107 0.963 . . . . 0.0 111.39 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.27 106.7 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.01 1.724 . . . . 0.0 107.195 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.39 99.13 2.87 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.055 -1.028 . . . . 0.0 108.954 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.4 t -65.63 88.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.822 -1.174 . . . . 0.0 110.911 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.47 -141.39 8.85 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.691 2.091 . . . . 0.0 110.633 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -128.81 124.02 34.32 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.956 1.702 . . . . 0.0 111.284 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -149.25 120.03 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.471 1.508 . . . . 0.0 111.383 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.61 170.6 10.43 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.322 0.649 . . . . 0.0 110.633 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.28 115.71 18.19 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.71 -178.4 7.26 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.909 1.284 . . . . 0.0 113.629 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -51.79 -41.04 61.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.349 1.46 . . . . 0.0 113.778 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.93 88.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.091 0.853 . . . . 0.0 112.75 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.7 ttm -64.68 -50.97 64.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.797 0.799 . . . . 0.0 110.437 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -61.11 -34.1 74.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.691 0.797 . . . . 0.0 112.769 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.74 -35.14 79.59 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.784 -1.198 . . . . 0.0 111.532 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -12.71 55.85 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.785 -1.197 . . . . 0.0 113.566 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 mt -91.69 -54.1 4.02 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.336 1.855 . . . . 0.0 109.318 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -75.37 -43.32 50.97 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.84 -35.4 7.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.818 1.247 . . . . 0.0 112.999 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -48.79 -69.33 1.01 Allowed Glycine 0 N--CA 1.47 0.911 0 C-N-CA 125.234 1.397 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -164.47 84.27 1.2 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.994 0.917 . . . . 0.0 111.591 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.78 143.92 38.17 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.914 1.743 . . . . 0.0 113.158 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 116' ' ' ASP . 2.3 m-85 -114.92 -168.57 1.4 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.397 1.479 . . . . 0.0 112.003 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.79 127.82 48.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.72 2.008 . . . . 0.0 111.787 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.85 96.02 0.64 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 125.04 1.305 . . . . 0.0 114.48 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.91 79.65 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.254 1.421 . . . . 0.0 111.748 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.7 p30 35.28 67.27 0.27 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.835 2.454 . . . . 0.0 115.363 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 135.6 3.48 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.374 0.987 . . . . 0.0 113.231 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -64.88 144.89 56.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.333 1.053 . . . . 0.0 111.646 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -145.36 135.67 24.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.556 1.142 . . . . 0.0 112.121 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -119.39 144.82 46.7 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 110.399 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -151.77 163.66 38.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.623 1.169 . . . . 0.0 110.894 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.32 91.78 7.38 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.35 -34.51 47.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.873 1.269 . . . . 0.0 113.871 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 115.58 39.05 0.94 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 118.037 1.975 . . . . 0.0 118.037 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -137.02 -32.78 0.78 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.87 -23.57 1.15 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.149 1.357 . . . . 0.0 114.006 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 173.09 6.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.478 1.911 . . . . 0.0 111.242 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -127.15 160.02 32.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.841 1.256 . . . . 0.0 110.509 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.34 39.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.366 0.603 . . . . 0.0 111.9 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.87 132.01 56.77 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.257 1.423 . . . . 0.0 107.293 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.75 153.79 16.67 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.106 0.86 . . . . 0.0 112.648 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 151.83 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.657 1.183 . . . . 0.0 111.766 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 21.1 tpp -147.43 91.88 2.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.656 1.583 . . . . 0.0 109.124 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.1 p -76.5 150.12 36.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 109.852 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 m -44.37 -69.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.312 1.845 . . . . 0.0 115.711 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -176.03 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.933 1.693 . . . . 0.0 112.398 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -47.15 89.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.212 0 C-N-CA 128.102 2.763 . . . . 0.0 115.432 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 45.5 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.078 2.151 . . . . 0.0 112.339 -175.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -143.43 159.42 42.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 113.426 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 2.2 mmtm -148.03 173.2 13.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.555 1.542 . . . . 0.0 113.922 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.3 ptm -99.49 154.56 18.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.994 1.717 . . . . 0.0 112.15 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -160.73 157.15 26.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.64 120.83 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.037 1.335 . . . . 0.0 109.573 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.43 101.64 12.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.407 1.083 . . . . 0.0 110.682 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 24.8 pt -91.66 133.33 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.134 0.574 . . . . 0.0 110.338 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.1 t -150.61 157.55 43.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.649 1.179 . . . . 0.0 111.386 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.608 1.163 . . . . 0.0 112.268 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -71.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.591 1.087 . . . . 0.0 111.263 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 170.35 179.23 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.659 3.584 . . . . 0.0 107.759 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.76 -34.6 1.63 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.863 -1.148 . . . . 0.0 113.691 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -135.04 146.43 48.97 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.891 1.346 . . . . 0.0 111.675 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.0 mm -136.05 177.83 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.278 1.831 . . . . 0.0 109.443 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.32 165.52 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.868 2.067 . . . . 0.0 110.755 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -28.95 65.14 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.186 -1.571 . . . . 0.0 115.068 -175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.87 -7.26 3.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.389 1.471 . . . . 0.0 114.108 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 -35.56 63.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.115 1.366 . . . . 0.0 113.848 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -120.73 -2.18 9.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.301 1.441 . . . . 0.0 113.971 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.7 tp -86.68 133.56 33.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.931 0.892 . . . . 0.0 112.012 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.7 m -144.75 -94.54 0.1 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.213 1.005 . . . . 0.0 110.16 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -158.68 -38.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.679 1.992 . . . . 0.0 110.804 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -52.81 -56.1 18.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.53 -47.16 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -43.3 68.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.533 1.133 . . . . 0.0 113.314 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.37 -62.08 1.84 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.361 2.264 . . . . 0.0 110.392 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -67.07 -30.46 70.52 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 117.803 -1.094 . . . . 0.0 113.658 176.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -52.26 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.212 1.369 . . . . 0.0 109.453 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -33.55 76.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.64 0.376 . . . . 0.0 111.685 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.47 -33.21 58.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 114.763 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -21.59 11.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.596 1.158 . . . . 0.0 113.829 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -48.49 -31.85 7.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.727 175.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.44 -146.07 4.45 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.693 0.663 . . . . 0.0 113.15 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -120.29 18.31 12.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.467 1.907 . . . . 0.0 113.124 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.87 -12.45 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.035 1.334 . . . . 0.0 113.803 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.11 19.89 4.06 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.485 2.314 . . . . 0.0 113.988 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -179.52 125.44 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.773 2.829 . . . . 0.0 108.765 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 24' ' ' LEU . 35.8 mmtt -137.62 -159.75 0.99 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.077 1.351 . . . . 0.0 109.812 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.37 152.36 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.438 1.895 . . . . 0.0 111.061 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.95 114.72 20.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.131 1.773 . . . . 0.0 108.592 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.75 133.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.449 1.5 . . . . 0.0 110.201 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.67 177.77 38.18 Favored Glycine 0 N--CA 1.454 -0.143 0 O-C-N 121.492 -0.755 . . . . 0.0 112.392 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.475 ' H ' HD13 ' A' ' 69' ' ' LEU . 1.1 mp -138.95 146.9 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.247 1.019 . . . . 0.0 110.471 -174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 106.83 19.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.293 1.837 . . . . 0.0 111.474 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.99 98.54 8.65 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.286 1.035 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -138.1 13.07 2.86 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -9.0 59.86 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.06 31.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 130.33 4.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.282 1.42 . . . . 0.0 112.217 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.1 m -62.25 141.51 58.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.94 1.696 . . . . 0.0 111.347 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -104.65 170.09 8.08 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.8 m -152.04 107.26 3.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.81 2.044 . . . . 0.0 110.555 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.18 152.33 45.64 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.855 -1.153 . . . . 0.0 109.807 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.11 -43.4 2.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.93 0.892 . . . . 0.0 112.357 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.76 -175.47 1.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.826 2.051 . . . . 0.0 110.578 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.45 139.03 18.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.421 . . . . 0.0 110.678 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.88 112.98 24.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.573 1.549 . . . . 0.0 109.174 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.73 150.52 35.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.189 2.195 . . . . 0.0 109.418 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.29 -43.58 2.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 111.089 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -137.32 111.91 8.73 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.029 1.332 . . . . 0.0 111.941 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.39 88.87 1.72 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 124.658 1.123 . . . . 0.0 111.99 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.6 m -81.16 99.17 8.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.229 1.012 . . . . 0.0 110.976 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 t -63.37 166.5 6.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -128.92 -4.01 5.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.848 1.659 . . . . 0.0 113.648 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.8 160.0 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.026 0.931 . . . . 0.0 112.564 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.35 126.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 112.793 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tt -86.33 119.72 71.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.866 1.266 . . . . 0.0 109.36 175.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 127.42 17.13 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 124.111 3.207 . . . . 0.0 111.438 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -79.44 -68.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.341 -0.849 . . . . 0.0 111.078 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.14 143.17 31.56 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.785 -0.572 . . . . 0.0 110.434 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.92 134.08 25.54 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 109.03 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.03 152.3 45.8 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.392 2.728 . . . . 0.0 111.858 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -65.38 17.04 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.856 2.462 . . . . 0.0 116.339 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -149.18 34.41 0.73 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 128.732 2.813 . . . . 0.0 111.162 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -153.46 163.86 39.21 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.414 -1.429 . . . . 0.0 112.201 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.05 175.02 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 111.401 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -144.68 159.74 42.33 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.338 0.655 . . . . 0.0 111.789 175.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.7 mt -139.21 158.81 43.52 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.784 1.234 . . . . 0.0 109.179 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 163.17 32.48 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.933 2.493 . . . . 0.0 108.019 175.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -151.04 178.26 9.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.214 1.806 . . . . 0.0 108.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.46 -177.51 31.62 Favored Glycine 0 N--CA 1.471 0.985 0 O-C-N 121.083 -1.011 . . . . 0.0 113.612 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.47 162.28 36.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -80.99 83.26 6.75 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.167 1.387 . . . . 0.0 111.634 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.59 -14.62 62.93 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -157.8 21.74 0.27 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.94 2.096 . . . . 0.0 113.406 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 66.55 39.6 93.97 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 120.078 -1.639 . . . . 0.0 113.032 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 94.2 Cg_endo -71.29 -44.54 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.728 3.618 . . . . 0.0 114.927 -175.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.1 154.77 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.138 1.775 . . . . 0.0 107.373 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.15 -48.42 70.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.44 -0.787 . . . . 0.0 111.5 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.97 145.1 23.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.749 2.42 . . . . 0.0 110.09 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.38 -118.31 5.82 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.692 -1.255 . . . . 0.0 115.37 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.83 168.49 19.5 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.328 2.251 . . . . 0.0 112.535 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -143.75 115.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.368 2.667 . . . . 0.0 111.784 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.33 178.98 9.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.916 1.686 . . . . 0.0 110.614 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.28 115.37 3.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.835 1.254 . . . . 0.0 108.24 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -122.68 170.94 9.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.549 1.139 . . . . 0.0 113.031 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.44 154.13 51.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -128.11 121.56 29.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.771 2.029 . . . . 0.0 112.376 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -74.03 104.75 4.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.445 1.898 . . . . 0.0 111.945 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 mtp -69.66 151.98 45.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.539 1.536 . . . . 0.0 113.02 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -30.65 65.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.483 1.513 . . . . 0.0 113.624 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -66.07 -13.73 60.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.588 1.155 . . . . 0.0 113.454 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.25 28.58 11.44 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.991 1.281 . . . . 0.0 114.175 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.37 168.75 10.34 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.757 1.623 . . . . 0.0 110.526 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.6 m -131.34 102.53 6.0 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.588 -1.32 . . . . 0.0 112.926 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 tp -73.66 124.56 26.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.818 -1.176 . . . . 0.0 112.188 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.07 102.46 2.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.729 1.157 . . . . 0.0 112.226 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.33 171.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.161 0.984 . . . . 0.0 111.955 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 2.3 ttp -144.67 144.78 31.41 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -161.06 142.27 11.68 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -158.15 154.45 27.45 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.074 1.349 . . . . 0.0 110.166 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.3 t -111.35 101.07 49.69 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.52 123.3 9.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.89 2.393 . . . . 0.0 111.046 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -77.91 -167.95 1.12 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.466 1.106 . . . . 0.0 110.822 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t0 79.39 -46.78 0.37 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.191 2.597 . . . . 0.0 113.046 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 67.21 -49.24 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.445 3.098 . . . . 0.0 114.063 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -28.84 64.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.775 2.03 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.88 86.31 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.311 1.444 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -74.92 98.27 3.53 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.925 1.69 . . . . 0.0 111.18 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -176.07 105.46 0.07 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.329 1.852 . . . . 0.0 110.378 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -129.59 150.63 50.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.398 1.079 . . . . 0.0 110.547 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -86.49 158.28 19.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.904 0.882 . . . . 0.0 111.908 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.481 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.5 p-90 -160.97 162.13 31.8 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.874 1.27 . . . . 0.0 110.63 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 170.74 139.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.087 2.555 . . . . 0.0 110.511 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.87 122.09 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.663 1.585 . . . . 0.0 108.663 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -127.72 162.37 26.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.491 2.316 . . . . 0.0 109.886 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.6 mt -108.38 121.25 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.895 1.678 . . . . 0.0 108.489 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -84.11 101.99 12.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 t -52.92 139.61 26.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.16 -0.962 . . . . 0.0 111.025 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.04 -118.56 4.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.788 1.185 . . . . 0.0 110.336 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -136.07 137.35 41.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.233 1.813 . . . . 0.0 111.259 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -159.52 117.67 2.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.882 1.273 . . . . 0.0 112.734 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 174.49 4.7 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.919 0.888 . . . . 0.0 111.25 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.54 121.79 31.3 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.799 -0.563 . . . . 0.0 110.004 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.71 177.07 10.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.95 0.9 . . . . 0.0 111.156 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -52.06 -45.35 64.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.002 0.921 . . . . 0.0 112.075 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.93 -50.06 63.37 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.725 0.679 . . . . 0.0 112.685 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.74 -55.97 28.27 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.461 0.63 . . . . 0.0 110.303 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -44.68 36.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 112.608 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.409 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 1.4 tt0 -69.36 -33.52 73.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.747 1.619 . . . . 0.0 108.944 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.58 -14.9 2.35 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.113 1.365 . . . . 0.0 113.456 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.1 mp -90.49 -21.73 21.7 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.232 1.413 . . . . 0.0 113.785 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -97.5 -42.57 7.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.446 2.298 . . . . 0.0 113.151 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.409 ' CE1' ' HG2' ' A' ' 132' ' ' GLU . 2.2 p90 -115.09 -26.87 7.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.4 -32.12 81.87 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.349 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 176.35 71.16 0.08 OUTLIER Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 130.117 3.367 . . . . 0.0 111.714 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.47 142.32 48.9 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.644 2.229 . . . . 0.0 113.266 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -129.45 177.79 6.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.247 1.819 . . . . 0.0 112.848 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -115.97 125.85 53.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.921 2.088 . . . . 0.0 111.059 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.5 109.89 1.32 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.401 1.477 . . . . 0.0 109.545 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -160.05 89.17 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.436 1.494 . . . . 0.0 110.24 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.81 101.34 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.385 2.674 . . . . 0.0 115.147 174.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.13 134.54 3.33 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.102 1.334 . . . . 0.0 111.686 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -64.43 145.43 56.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.713 0.805 . . . . 0.0 112.176 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.19 130.47 19.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 112.743 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 156.92 47.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.055 2.142 . . . . 0.0 111.216 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.6 19.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.021 1.728 . . . . 0.0 111.585 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -64.55 102.22 0.53 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.349 1.46 . . . . 0.0 109.387 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.94 -39.44 78.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.62 11.43 5.5 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -132.92 -34.11 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.131 1.466 . . . . 0.0 114.456 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 138.65 35.33 0.16 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.893 1.235 . . . . 0.0 113.98 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.82 163.46 37.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 110.591 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -136.25 103.82 5.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.333 1.853 . . . . 0.0 112.55 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.09 159.97 20.07 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.159 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.68 139.1 54.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.767 174.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.18 136.23 11.84 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.403 1.478 . . . . 0.0 113.292 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -116.12 138.9 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.166 1.386 . . . . 0.0 111.145 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.1 tpt -121.87 130.98 53.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.427 1.012 . . . . 0.0 109.317 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 47.2 p -137.24 144.12 42.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.444 1.098 . . . . 0.0 110.28 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.3 t -148.33 -174.05 4.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.247 1.419 . . . . 0.0 111.56 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.09 42.26 5.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.789 2.035 . . . . 0.0 113.966 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.83 73.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.906 1.241 . . . . 0.0 112.637 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 35.92 67.07 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.98 2.512 . . . . 0.0 113.866 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -139.12 172.81 12.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.777 0.831 . . . . 0.0 112.822 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.32 171.49 20.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 112.541 -175.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 142.16 28.01 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.218 1.007 . . . . 0.0 112.048 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -133.13 155.8 48.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.625 1.57 . . . . 0.0 109.827 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.91 125.41 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.847 1.259 . . . . 0.0 110.181 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -108.06 115.99 31.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.913 1.285 . . . . 0.0 110.113 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.42 129.76 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 0.0 110.157 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.5 m -171.65 172.09 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.025 1.33 . . . . 0.0 111.566 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.487 1.115 . . . . 0.0 113.008 178.072 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.52 -44.97 5.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 0.0 110.62 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.42 -59.87 2.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.35 -36.84 0.16 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 126.786 2.136 . . . . 0.0 117.517 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.2 p -138.16 151.75 48.04 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 110.918 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.71 162.42 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.457 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 pt -70.36 -169.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.554 1.942 . . . . 0.0 110.409 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.33 -22.08 17.72 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.79 11.43 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.623 1.106 . . . . 0.0 113.714 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.86 83.82 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.284 1.042 . . . . 0.0 111.856 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -80.74 -9.61 59.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.859 1.264 . . . . 0.0 113.698 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.4 159.23 21.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.748 1.219 . . . . 0.0 112.636 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.51 145.88 27.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.867 0.867 . . . . 0.0 109.846 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -56.32 -30.89 63.15 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -58.3 -52.96 63.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.061 0.944 . . . . 0.0 112.371 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.91 -46.56 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -40.65 60.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.425 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.07 -58.04 9.26 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.382 1.473 . . . . 0.0 112.116 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -23.78 61.51 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.85 -44.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.087 1.312 . . . . 0.0 111.227 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -28.96 61.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.142 0.977 . . . . 0.0 112.189 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.14 -39.25 34.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.142 1.377 . . . . 0.0 112.185 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -48.32 -24.82 1.32 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.716 2.406 . . . . 0.0 113.263 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 6.5 tt -48.92 -40.81 31.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.287 1.835 . . . . 0.0 111.689 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -153.39 -154.93 6.94 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.439 1.495 . . . . 0.0 112.819 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -141.23 76.16 1.53 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.028 1.731 . . . . 0.0 111.043 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.98 164.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 112.465 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.74 -39.24 80.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.781 1.232 . . . . 0.0 113.947 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.35 140.01 37.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 0.0 110.714 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -157.73 127.33 5.99 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.818 0.847 . . . . 0.0 110.308 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.62 139.13 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.004 0.921 . . . . 0.0 112.917 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.01 101.67 6.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.481 1.512 . . . . 0.0 113.462 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -107.81 118.24 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 120.259 -1.526 . . . . 0.0 109.695 174.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.86 155.56 23.82 Favored Glycine 0 N--CA 1.46 0.293 0 O-C-N 121.924 -0.485 . . . . 0.0 113.006 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.81 99.46 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.532 0.733 . . . . 0.0 111.637 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.36 102.99 0.26 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.878 1.271 . . . . 0.0 111.655 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -90.72 106.18 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.735 0.778 . . . . 0.0 112.877 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.266 31.3 tt0 -150.7 19.54 0.81 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.02 0.914 . . . . 0.0 111.278 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -5.1 20.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.258 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.76 17.44 51.9 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.525 1.536 . . . . 0.0 114.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.55 115.26 0.85 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.815 1.674 . . . . 0.0 111.377 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.7 m -55.52 148.53 15.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.066 1.347 . . . . 0.0 111.466 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -119.72 172.51 7.64 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.572 -0.705 . . . . 0.0 112.63 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -136.15 113.22 10.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.063 2.145 . . . . 0.0 111.458 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 105.65 3.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.839 0.856 . . . . 0.0 110.648 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -56.83 9.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.056 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.421 ' ND2' HH11 ' A' ' 125' ' ' ARG . 42.8 t30 -167.48 172.4 9.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.792 1.637 . . . . 0.0 111.549 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.65 135.41 34.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.78 2.032 . . . . 0.0 111.412 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -119.13 129.02 54.81 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.715 1.606 . . . . 0.0 110.107 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.72 126.28 21.93 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.36 2.264 . . . . 0.0 110.041 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.45 -16.92 19.95 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.202 1.401 . . . . 0.0 110.888 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -76.37 102.56 5.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.36 1.064 . . . . 0.0 110.151 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.94 -118.83 11.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.423 1.487 . . . . 0.0 113.654 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -136.72 -172.71 3.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.937 1.695 . . . . 0.0 111.148 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.96 167.17 20.13 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.574 1.949 . . . . 0.0 112.36 174.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -144.96 -45.55 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.87 0.868 . . . . 0.0 110.834 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.86 156.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.553 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.31 142.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.926 1.29 . . . . 0.0 111.134 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.68 128.96 41.98 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.412 1.085 . . . . 0.0 110.0 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.58 116.52 3.83 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 124.636 3.557 . . . . 0.0 112.033 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.45 -33.82 63.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -124.08 150.91 44.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.103 0.961 . . . . 0.0 112.188 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.8 t -138.64 96.12 9.69 Favored Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 124.876 1.27 . . . . 0.0 108.239 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 171.75 14.56 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.238 1.959 . . . . 0.0 111.421 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -64.82 174.98 1.63 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.665 -0.647 . . . . 0.0 110.615 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 14.6 t 49.15 24.66 0.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.56 1.544 . . . . 0.0 113.783 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -151.77 130.12 12.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.709 2.004 . . . . 0.0 110.826 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.29 -173.67 2.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.652 1.215 . . . . 0.0 109.643 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.33 162.46 40.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.606 1.162 . . . . 0.0 109.835 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.78 166.35 21.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.566 1.174 . . . . 0.0 108.162 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.85 161.13 43.15 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.134 1.373 . . . . 0.0 107.95 175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 49.5 m -155.42 146.03 22.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.12 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.84 -161.57 36.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.782 0.706 . . . . 0.0 111.774 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -145.26 174.79 10.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.193 1.397 . . . . 0.0 111.025 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -110.33 167.34 10.28 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.753 1.621 . . . . 0.0 110.639 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 153.22 -31.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 131.141 3.776 . . . . 0.0 112.515 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.21 17.4 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.34 -79.31 0.04 OUTLIER Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.492 -1.38 . . . . 0.0 113.417 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.77 12.16 2.51 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.148 3.232 . . . . 0.0 113.825 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.33 -28.24 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.009 1.323 . . . . 0.0 111.196 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.82 -6.59 11.03 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.796 2.438 . . . . 0.0 114.674 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.4 p -138.28 -154.24 0.52 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.236 1.814 . . . . 0.0 110.64 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.82 152.11 17.03 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.546 -1.346 . . . . 0.0 110.443 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 146.04 55.53 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.418 1.109 . . . . 0.0 112.281 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -147.63 135.17 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.732 2.013 . . . . 0.0 113.367 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -155.51 170.77 21.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.32 1.448 . . . . 0.0 110.803 174.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.06 114.98 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.226 1.41 . . . . 0.0 109.431 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -126.91 167.11 16.29 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.447 1.099 . . . . 0.0 112.24 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.54 154.15 44.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.12 0.568 . . . . 0.0 111.267 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.57 109.88 9.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.969 1.308 . . . . 0.0 113.337 -175.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -71.1 96.34 1.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.705 1.602 . . . . 0.0 111.03 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 151.7 45.09 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.836 -1.165 . . . . 0.0 111.339 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -16.36 15.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -70.34 1.33 5.06 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.657 1.983 . . . . 0.0 113.658 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.92 19.03 71.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.026 1.298 . . . . 0.0 114.013 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -121.3 175.81 5.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.035 1.734 . . . . 0.0 110.382 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -137.32 102.26 4.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.249 1.02 . . . . 0.0 112.956 -177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 tp -69.12 115.8 8.83 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.441 -0.787 . . . . 0.0 110.339 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.99 111.9 3.96 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.7 151.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.415 1.086 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -138.63 148.75 44.46 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.38 1.072 . . . . 0.0 110.002 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.7 p90 -157.21 159.57 37.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -164.46 150.57 10.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.1 t -108.73 98.59 29.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.04 162.07 41.57 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.588 1.526 . . . . 0.0 110.794 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -70.39 -174.62 0.87 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.661 1.185 . . . . 0.0 111.028 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -47.93 122.29 4.93 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.223 1.409 . . . . 0.0 112.71 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -55.26 109.42 0.54 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.675 1.19 . . . . 0.0 111.243 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -84.94 -49.17 8.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.479 0.712 . . . . 0.0 111.599 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -168.9 -50.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.45 1.5 . . . . 0.0 113.629 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -167.4 117.96 0.86 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.352 1.861 . . . . 0.0 109.545 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.67 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.268 1.827 . . . . 0.0 110.452 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.04 105.23 5.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.515 -0.74 . . . . 0.0 111.781 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -84.45 135.73 34.14 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.361 1.064 . . . . 0.0 113.128 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -151.4 125.56 9.3 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.128 0.971 . . . . 0.0 109.733 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.02 150.23 11.25 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.967 -1.083 . . . . 0.0 111.999 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.9 143.34 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.049 1.74 . . . . 0.0 110.138 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -135.47 126.48 27.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.42 1.488 . . . . 0.0 109.144 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.8 mt -93.27 100.04 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.237 1.015 . . . . 0.0 109.316 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -68.41 100.98 1.15 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.845 -1.159 . . . . 0.0 109.406 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 80.64 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.723 1.209 . . . . 0.0 111.132 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.35 -106.75 0.29 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.317 2.389 . . . . 0.0 111.22 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -156.56 150.3 24.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.369 1.868 . . . . 0.0 111.553 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -164.96 106.82 0.82 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.236 1.415 . . . . 0.0 113.877 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.421 HH11 ' ND2' ' A' ' 47' ' ' ASN . 0.2 OUTLIER -59.43 153.4 19.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.368 1.067 . . . . 0.0 111.182 174.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.96 10.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.741 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.39 -175.76 5.21 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.633 1.173 . . . . 0.0 111.471 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.0 -46.07 68.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.408 -1.432 . . . . 0.0 111.909 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.2 -31.59 62.38 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.555 1.074 . . . . 0.0 113.767 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.6 tpt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -48.11 -39.46 20.5 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.432 1.093 . . . . 0.0 112.453 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.36 -42.17 96.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.203 1.001 . . . . 0.0 111.598 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.84 68.51 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.288 -1.508 . . . . 0.0 113.462 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.3 mt -90.24 -7.85 52.48 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.06 -27.31 3.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.45 1.5 . . . . 0.0 114.116 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.49 -37.11 3.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.729 1.212 . . . . 0.0 111.706 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.27 -67.53 1.33 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.229 1.871 . . . . 0.0 113.168 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.53 67.88 0.29 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.822 1.649 . . . . 0.0 113.429 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.66 173.02 15.21 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.938 1.759 . . . . 0.0 115.207 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.92 173.18 10.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.163 1.785 . . . . 0.0 112.972 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -115.8 137.61 51.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.724 2.01 . . . . 0.0 112.042 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -138.1 116.65 1.34 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.722 1.153 . . . . 0.0 111.541 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -126.25 69.95 1.23 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.74 94.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.13 2.572 . . . . 0.0 113.898 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.01 139.74 2.75 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.753 1.644 . . . . 0.0 111.49 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -70.25 127.44 32.78 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -129.53 146.29 51.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.589 1.156 . . . . 0.0 111.634 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -142.33 137.77 30.78 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.452 1.501 . . . . 0.0 110.362 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 158.33 43.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.713 1.205 . . . . 0.0 110.892 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 94.08 1.02 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.714 1.206 . . . . 0.0 109.553 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tp -51.53 -36.33 44.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.329 1.451 . . . . 0.0 113.752 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 120.38 33.97 0.98 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.11 -32.28 0.79 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.07 -28.3 0.9 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.987 1.28 . . . . 0.0 114.344 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 175.14 5.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.824 2.05 . . . . 0.0 112.541 175.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -118.19 145.38 45.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.222 1.009 . . . . 0.0 112.164 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.88 147.7 45.66 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 130.89 53.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.426 1.89 . . . . 0.0 107.851 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -123.11 155.16 17.26 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 122.149 0.861 . . . . 0.0 112.951 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.1 131.02 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.067 1.747 . . . . 0.0 108.505 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.1 tpp -126.42 103.31 7.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.403 0.547 . . . . 0.0 109.529 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 68.9 p -98.73 141.32 31.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.142 1.377 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 89.58 1.2 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.47 -0.769 . . . . 0.0 111.812 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.18 30.23 0.17 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.701 1.2 . . . . 0.0 114.083 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.85 134.12 1.76 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.888 1.232 . . . . 0.0 112.419 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 43.45 59.82 2.86 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.439 1.496 . . . . 0.0 112.576 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -137.56 163.43 31.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.925 1.29 . . . . 0.0 112.024 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -163.26 144.85 9.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.5 ptm -77.61 160.49 28.5 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.157 1.783 . . . . 0.0 113.927 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -154.21 160.93 42.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.173 1.789 . . . . 0.0 109.477 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.7 mm -131.84 113.99 23.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 C-N-CA 125.126 1.37 . . . . 0.0 109.692 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -110.63 139.82 45.54 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.72 0.808 . . . . 0.0 110.891 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 10.2 pt -120.95 132.68 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.715 0.806 . . . . 0.0 109.731 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.2 p -148.05 161.47 41.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.329 . . . . 0.0 112.846 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.61 -50.41 70.23 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 117.748 -1.12 . . . . 0.0 111.488 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.7 -49.33 4.25 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.555 1.07 . . . . 0.0 113.266 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.56 -33.15 1.42 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.53 1.538 . . . . 0.0 116.694 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.1 p -138.61 146.57 41.91 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.445 2.122 . . . . 0.0 111.972 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.41 161.44 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.781 -1.2 . . . . 0.0 108.817 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 pt -75.05 177.55 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.487 1.915 . . . . 0.0 111.858 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.45 16.34 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.02 -18.18 40.18 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.148 1.356 . . . . 0.0 112.674 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.59 70.04 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.642 1.577 . . . . 0.0 113.632 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -112.32 -2.59 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.892 1.677 . . . . 0.0 113.311 174.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.76 148.84 32.83 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.338 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.91 146.83 27.29 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 0.0 110.047 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.39 -34.66 66.92 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.006 0.821 . . . . 0.0 112.763 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -59.43 -56.26 24.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.671 1.189 . . . . 0.0 113.018 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.25 -45.87 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.303 0.641 . . . . 0.0 111.026 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -55.22 -38.7 68.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.183 0.993 . . . . 0.0 111.95 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -52.25 -57.65 9.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.258 1.823 . . . . 0.0 111.705 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.05 60.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 176.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.82 -49.17 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.762 1.164 . . . . 0.0 110.838 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -21.76 65.93 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -24.84 22.84 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -20.03 62.56 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.282 1.033 . . . . 0.0 113.595 -175.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp -60.86 -30.16 69.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.843 1.257 . . . . 0.0 114.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 179.59 122.77 0.79 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.207 0.908 . . . . 0.0 112.11 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -70.59 93.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.608 1.563 . . . . 0.0 112.025 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.4 m -130.15 168.42 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.749 1.619 . . . . 0.0 112.273 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -56.66 -41.75 77.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.348 1.459 . . . . 0.0 113.777 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.42 156.32 43.68 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.011 2.124 . . . . 0.0 111.179 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.41 178.31 7.29 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.852 1.261 . . . . 0.0 111.673 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.406 HD13 ' CE1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -127.22 143.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.163 1.385 . . . . 0.0 111.491 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.98 100.22 6.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.592 1.957 . . . . 0.0 111.778 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.34 127.09 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.538 1.135 . . . . 0.0 109.918 174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.19 157.7 26.8 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.964 -0.636 . . . . 0.0 114.278 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.66 121.97 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.185 0.994 . . . . 0.0 110.229 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -74.1 105.12 5.17 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.363 -0.835 . . . . 0.0 110.689 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.62 91.95 4.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.223 1.809 . . . . 0.0 113.447 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.33 21.27 2.4 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.996 0.903 . . . . 0.0 112.392 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -7.07 54.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.698 1.599 . . . . 0.0 114.924 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.86 18.44 65.46 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.046 -1.034 . . . . 0.0 114.66 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.6 127.77 5.14 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.214 1.864 . . . . 0.0 110.736 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.3 m -69.4 131.01 44.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.73 0.765 . . . . 0.0 110.527 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.9 m0 -96.75 162.47 13.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.136 0.493 . . . . 0.0 111.954 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -138.83 107.46 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 127.1 2.16 . . . . 0.0 109.617 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 150.64 47.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.259 -0.9 . . . . 0.0 110.711 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -54.67 1.99 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.559 1.144 . . . . 0.0 111.993 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -156.92 172.22 19.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.974 0.91 . . . . 0.0 111.667 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.34 140.08 35.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.958 1.303 . . . . 0.0 111.841 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -118.65 127.44 53.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 109.659 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.4 119.56 39.82 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.217 1.807 . . . . 0.0 107.627 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -11.78 49.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.235 0.541 . . . . 0.0 111.295 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.01 114.25 7.43 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 108.961 -175.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.71 -165.88 53.87 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.228 0.918 . . . . 0.0 113.679 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 t -119.41 -170.75 1.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.665 1.586 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 163.06 22.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.709 1.604 . . . . 0.0 111.695 174.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -141.31 -44.46 0.37 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.093 0.957 . . . . 0.0 111.824 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.68 164.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.726 2.01 . . . . 0.0 111.421 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 tt -77.51 134.76 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.37 1.068 . . . . 0.0 112.032 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.83 128.98 52.2 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.148 0.979 . . . . 0.0 110.285 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.89 115.35 3.21 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 124.562 3.508 . . . . 0.0 112.14 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -62.65 -48.0 81.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -115.4 153.5 30.94 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.189 0.995 . . . . 0.0 111.577 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.75 88.87 13.59 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.434 1.094 . . . . 0.0 108.754 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.81 143.36 29.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.023 2.482 . . . . 0.0 111.336 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -48.88 153.98 0.78 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.526 1.13 . . . . 0.0 112.697 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 p 63.9 46.86 3.71 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.638 1.575 . . . . 0.0 110.047 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' A' ' 68' ' ' ALA . 17.4 ttmt -155.52 172.01 18.97 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.503 1.521 . . . . 0.0 111.09 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' H ' ' HG2' ' A' ' 67' ' ' LYS . . . -142.23 -176.67 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 108.77 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.5 144.98 9.38 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.34 -0.85 . . . . 0.0 110.619 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -117.36 170.15 8.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.893 1.33 . . . . 0.0 108.496 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.31 160.31 43.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.162 1.385 . . . . 0.0 107.708 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -147.38 148.12 31.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.832 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.8 -170.91 37.17 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.752 0.691 . . . . 0.0 112.165 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -176.68 4.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.853 1.661 . . . . 0.0 111.673 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.33 98.83 2.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.677 1.591 . . . . 0.0 112.671 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -99.67 -55.46 2.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.402 1.481 . . . . 0.0 111.91 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -146.66 14.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.72 -81.1 0.5 Allowed Glycine 0 N--CA 1.48 1.593 0 O-C-N 120.609 -1.307 . . . . 0.0 113.672 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.43 1.94 6.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.479 3.452 . . . . 0.0 113.1 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 p -56.58 -21.64 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 113.878 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.02 -5.48 22.11 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.958 2.503 . . . . 0.0 114.738 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 -151.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.772 1.629 . . . . 0.0 110.529 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -97.22 147.7 18.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.172 1.368 . . . . 0.0 109.888 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.43 151.94 42.86 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.114 0.957 . . . . 0.0 111.9 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -150.07 118.75 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.808 1.243 . . . . 0.0 112.946 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.42 160.0 43.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.529 1.532 . . . . 0.0 110.127 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 135.57 22.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -143.28 168.78 18.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 111.406 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.99 150.32 44.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.736 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -130.93 115.3 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.64 1.576 . . . . 0.0 110.373 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -73.7 104.08 4.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.382 1.473 . . . . 0.0 111.291 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -71.71 158.27 36.43 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.135 -0.978 . . . . 0.0 112.63 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -58.5 -24.97 61.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.831 1.252 . . . . 0.0 113.732 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 t -73.72 -3.24 27.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.998 1.319 . . . . 0.0 113.948 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.48 17.67 72.96 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.416 1.008 . . . . 0.0 114.265 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -102.83 163.18 12.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.594 1.558 . . . . 0.0 110.683 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -127.58 102.74 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.55 0.74 . . . . 0.0 112.982 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.72 116.45 12.11 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.418 -0.801 . . . . 0.0 110.855 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.09 104.16 3.1 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.306 1.431 . . . . 0.0 111.024 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.78 160.59 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 156.51 45.52 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.036 1.334 . . . . 0.0 110.261 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.406 ' CE1' HD13 ' A' ' 31' ' ' ILE . 10.7 p90 -166.96 155.25 9.83 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.501 1.521 . . . . 0.0 110.893 175.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.92 124.17 1.81 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.369 1.468 . . . . 0.0 110.38 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.1 t -81.73 131.99 56.0 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.16 173.27 8.75 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.501 2.134 . . . . 0.0 111.922 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.88 155.49 10.43 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.098 -1.001 . . . . 0.0 111.157 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.48 -66.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 128.355 2.662 . . . . 0.0 115.736 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -149.84 31.67 0.7 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.44 1.896 . . . . 0.0 112.235 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.49 -32.85 69.17 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.815 1.246 . . . . 0.0 114.154 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 61.23 82.12 0.17 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.664 1.986 . . . . 0.0 113.656 176.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.86 167.59 21.96 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.451 1.5 . . . . 0.0 112.097 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.6 m -57.59 143.99 39.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 110.955 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.11 152.25 24.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.674 0.79 . . . . 0.0 110.69 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -97.8 159.38 14.97 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -161.98 153.26 18.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.993 1.317 . . . . 0.0 109.494 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -174.47 104.18 0.1 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.122 1.369 . . . . 0.0 111.311 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.08 132.06 45.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.736 1.214 . . . . 0.0 108.507 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -140.48 160.98 38.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.118 1.367 . . . . 0.0 110.021 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 93.3 mt -118.65 112.5 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.498 1.519 . . . . 0.0 109.171 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.41 100.69 6.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -56.12 121.89 10.45 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.95 -1.094 . . . . 0.0 108.977 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.67 -140.46 15.41 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -128.41 132.09 48.48 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.391 1.476 . . . . 0.0 112.613 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -160.01 124.04 3.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.519 1.527 . . . . 0.0 112.238 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -179.28 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 111.459 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.83 109.19 19.57 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.842 -0.536 . . . . 0.0 111.154 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.89 -172.22 4.06 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 111.473 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.84 -47.51 31.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.893 0.877 . . . . 0.0 111.496 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.18 -47.44 55.3 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.402 1.001 . . . . 0.0 114.088 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.1 ttp -65.75 -52.23 52.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 111.276 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -56.31 -37.33 69.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.77 0.795 . . . . 0.0 112.767 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.42 -47.41 79.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.876 2.07 . . . . 0.0 110.049 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -26.98 69.08 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.696 1.135 . . . . 0.0 113.677 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mp -70.4 -49.19 51.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.955 1.302 . . . . 0.0 112.909 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.27 -29.54 13.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.24 -26.59 8.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.981 1.312 . . . . 0.0 112.156 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -63.83 4.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.449 1.5 . . . . 0.0 111.278 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -174.3 80.29 0.35 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.877 2.071 . . . . 0.0 111.331 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.22 154.2 66.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.134 1.89 . . . . 0.0 111.511 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -120.41 -164.58 1.11 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.576 1.95 . . . . 0.0 111.041 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.75 131.37 46.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.805 2.442 . . . . 0.0 111.509 -175.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -142.34 115.38 0.95 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.863 1.697 . . . . 0.0 111.054 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.78 -55.02 2.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 84.99 0.14 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 120.323 1.419 . . . . 0.0 111.398 174.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.26 163.86 24.01 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 122.0 0.778 . . . . 0.0 114.687 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.442 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 59.5 m95 -82.1 145.44 30.16 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.002 1.721 . . . . 0.0 111.983 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -161.12 123.42 3.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.217 1.407 . . . . 0.0 112.154 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.6 154.95 18.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.837 1.655 . . . . 0.0 111.651 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 145.81 24.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.794 1.237 . . . . 0.0 110.052 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -72.82 93.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -51.96 -36.88 50.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.085 1.354 . . . . 0.0 113.841 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.15 40.22 2.14 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.97 -32.48 0.96 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.73 -34.36 0.68 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.739 1.161 . . . . 0.0 113.548 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.31 172.63 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.168 1.787 . . . . 0.0 111.998 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -127.04 165.17 19.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.607 1.163 . . . . 0.0 110.603 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.48 163.6 39.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 146' ' ' TRP . 6.3 tptt -119.99 127.29 52.48 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.504 1.522 . . . . 0.0 108.153 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.36 146.76 17.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.815 0.721 . . . . 0.0 111.879 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.442 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -124.95 131.15 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 125.085 1.354 . . . . 0.0 109.313 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 125.89 36.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.07 0.85 . . . . 0.0 108.755 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 19.8 p -126.1 137.5 53.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.05 1.74 . . . . 0.0 111.783 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.6 p -129.93 128.93 43.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.111 2.164 . . . . 0.0 110.765 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.56 -54.4 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.412 1.885 . . . . 0.0 111.365 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.13 -49.08 0.2 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.735 1.16 . . . . 0.0 113.715 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.74 28.53 8.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.915 1.686 . . . . 0.0 112.778 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.55 159.67 23.14 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.276 1.43 . . . . 0.0 113.78 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.7 OUTLIER -150.92 168.91 23.07 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.46 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 7.1 ttp -102.78 138.07 40.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.729 1.612 . . . . 0.0 111.262 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -137.3 150.83 48.05 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.57 1.148 . . . . 0.0 109.689 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.1 mm -126.23 124.35 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.106 0.962 . . . . 0.0 109.286 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -112.96 106.96 15.34 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.029 -1.045 . . . . 0.0 110.439 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 17.3 pt -92.9 125.91 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.783 0.833 . . . . 0.0 109.933 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.2 p -155.59 149.36 25.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.219 1.808 . . . . 0.0 112.952 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.84 -0.059 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.08 -29.93 70.34 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.181 0.593 . . . . 0.0 111.405 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.01 128.67 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.717 1.607 . . . . 0.0 111.918 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.67 -15.05 9.79 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.42 1.962 . . . . 0.0 113.597 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p -167.37 162.79 14.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.149 2.58 . . . . 0.0 109.213 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.0 mt -140.24 172.56 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.557 1.143 . . . . 0.0 109.021 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -162.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 125.77 1.628 . . . . 0.0 110.317 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.7 60.2 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.4 -25.63 12.09 Favored Glycine 0 N--CA 1.488 2.13 0 O-C-N 123.951 0.782 . . . . 0.0 112.698 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.02 63.36 Favored 'General case' 0 CA--C 1.59 2.519 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -96.24 -3.76 43.57 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.571 1.548 . . . . 0.0 114.267 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.16 139.41 58.13 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.303 -0.873 . . . . 0.0 108.926 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.51 141.03 20.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.244 0.618 . . . . 0.0 110.403 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -55.75 -32.28 63.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -57.45 -49.06 77.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.746 1.218 . . . . 0.0 111.8 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -69.88 -50.42 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.476 1.11 . . . . 0.0 109.375 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -32.7 62.29 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.26 -61.28 2.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.201 1.8 . . . . 0.0 109.976 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -40.4 86.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.429 1.492 . . . . 0.0 112.677 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.16 -50.62 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.289 1.436 . . . . 0.0 111.613 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -35.24 65.76 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.1 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.36 -30.93 69.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.429 1.491 . . . . 0.0 113.267 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -55.78 -28.79 57.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.543 1.137 . . . . 0.0 113.633 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.57 -34.32 72.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.907 0.883 . . . . 0.0 111.991 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -173.39 116.11 0.59 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.123 1.344 . . . . 0.0 112.659 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -71.25 66.88 0.45 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.777 2.031 . . . . 0.0 112.32 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.51 175.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.856 2.462 . . . . 0.0 110.903 -175.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 m -72.03 55.8 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.476 1.91 . . . . 0.0 111.96 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.92 101.88 2.47 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.626 1.57 . . . . 0.0 110.712 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -141.72 121.71 13.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.67 1.588 . . . . 0.0 112.782 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 151.19 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.057 . . . . 0.0 110.852 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.15 101.99 4.14 Favored 'General case' 0 CA--C 1.573 1.837 0 C-N-CA 126.295 1.838 . . . . 0.0 111.317 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.78 132.92 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.306 1.442 . . . . 0.0 110.087 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.3 165.32 38.36 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -140.45 119.79 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.979 1.311 . . . . 0.0 112.378 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.75 115.91 7.84 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 121.381 -0.825 . . . . 0.0 111.08 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.05 85.32 4.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.482 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.96 13.67 5.76 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -76.27 -13.26 60.16 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 14.59 43.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.627 1.108 . . . . 0.0 115.437 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.33 126.09 3.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.387 1.47 . . . . 0.0 112.813 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.5 m -64.32 140.92 58.92 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.066 1.346 . . . . 0.0 111.253 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -106.57 171.95 7.08 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -150.55 110.82 4.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.134 1.773 . . . . 0.0 111.871 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.01 58.06 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 120.979 -1.076 . . . . 0.0 110.222 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.59 -46.26 4.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.397 0.679 . . . . 0.0 112.186 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.93 173.7 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.356 1.063 . . . . 0.0 111.244 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.03 128.77 23.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.105 0.962 . . . . 0.0 112.949 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.82 117.14 33.32 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.842 1.657 . . . . 0.0 110.32 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -116.92 129.95 56.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.076 1.75 . . . . 0.0 109.343 175.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.56 4.65 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -152.96 92.51 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.794 1.238 . . . . 0.0 110.215 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.07 19.33 0.28 Allowed Glycine 0 N--CA 1.475 1.28 0 N-CA-C 117.474 1.75 . . . . 0.0 117.474 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -40.04 113.77 0.38 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.143 2.177 . . . . 0.0 113.188 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 t -66.21 -179.67 0.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.783 1.633 . . . . 0.0 115.312 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.12 -9.71 3.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.077 1.751 . . . . 0.0 114.033 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -87.69 166.45 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.326 1.05 . . . . 0.0 112.581 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 tt -68.93 130.13 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.469 1.108 . . . . 0.0 112.63 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 tp -84.41 117.47 68.81 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.495 0.718 . . . . 0.0 109.769 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.03 119.96 6.9 Favored 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 122.758 2.305 . . . . 0.0 109.741 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.39 -64.25 1.2 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.935 0.894 . . . . 0.0 112.515 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -96.75 151.53 19.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.669 0.788 . . . . 0.0 109.963 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 132.93 9.63 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.007 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -71.55 -150.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 125.102 3.868 . . . . 0.0 112.914 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.96 15.13 9.25 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.939 1.696 . . . . 0.0 114.287 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -142.06 30.44 1.61 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.306 1.442 . . . . 0.0 112.752 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -146.1 -175.96 4.96 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.678 1.191 . . . . 0.0 113.077 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.26 173.78 11.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.112 1.365 . . . . 0.0 107.472 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.61 148.97 29.28 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.855 -1.153 . . . . 0.0 111.287 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.24 162.13 26.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.861 0.864 . . . . 0.0 111.266 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.38 163.52 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.272 1.429 . . . . 0.0 110.001 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.1 m -135.77 -166.53 1.87 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.4 1.48 . . . . 0.0 110.383 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.4 178.29 33.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.367 -0.833 . . . . 0.0 113.461 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -146.42 158.22 43.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.227 1.011 . . . . 0.0 112.481 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.49 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.695 2.398 . . . . 0.0 116.567 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -75.36 0.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.642 1.577 . . . . 0.0 112.686 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.6 m -87.71 -8.67 55.77 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.357 1.063 . . . . 0.0 112.253 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 80' ' ' VAL . . . -154.58 90.86 0.12 Allowed Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.53 35.23 0.43 Allowed 'Trans proline' 0 CA--C 1.578 2.721 1 C-N-CA 125.395 4.063 . . . . 0.0 111.098 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 78' ' ' GLY . 12.8 p -48.07 133.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 127.481 2.313 . . . . 0.0 111.245 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.07 0.59 3.46 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.584 1.554 . . . . 0.0 114.522 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -149.05 109.98 4.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.791 2.836 . . . . 0.0 108.814 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.63 -112.91 0.74 Allowed Glycine 0 CA--C 1.537 1.446 0 N-CA-C 119.661 2.624 . . . . 0.0 119.661 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -161.92 173.83 13.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.613 1.965 . . . . 0.0 112.091 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.48 113.94 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.898 1.279 . . . . 0.0 113.216 -175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.51 170.97 20.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 111.094 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.52 124.12 7.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.661 1.584 . . . . 0.0 108.757 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -128.49 163.8 24.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.661 1.184 . . . . 0.0 112.055 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.97 142.88 49.86 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -122.42 113.97 20.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.982 2.113 . . . . 0.0 111.151 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.42 108.32 2.33 Favored 'General case' 0 N--CA 1.382 -3.828 0 C-N-CA 124.836 1.255 . . . . 0.0 112.625 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.1 mtp -73.08 155.09 40.09 Favored 'General case' 0 CA--C 1.627 3.906 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -58.95 -23.62 61.75 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.61 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -67.98 -9.19 43.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.895 2.078 . . . . 0.0 114.178 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 8.06 68.71 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.71 1.148 . . . . 0.0 114.794 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.5 175.41 5.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.028 1.731 . . . . 0.0 110.412 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.84 104.06 6.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.963 -1.086 . . . . 0.0 112.314 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.2 tp -69.39 119.07 13.09 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 120.994 -1.066 . . . . 0.0 110.79 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 104.55 3.18 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.621 1.105 . . . . 0.0 111.065 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.15 162.46 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.211 0.529 . . . . 0.0 111.322 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.79 149.78 30.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.013 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.85 154.24 32.4 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.097 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -160.15 157.36 28.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.668 1.587 . . . . 0.0 107.377 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 95.33 47.84 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 121.327 -0.858 . . . . 0.0 109.211 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -69.98 162.34 42.57 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.9 1.733 . . . . 0.0 111.802 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -138.23 -45.34 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 111.047 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.5 157.96 30.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.969 2.108 . . . . 0.0 111.491 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -110.33 77.75 1.07 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.692 1.997 . . . . 0.0 110.954 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -66.89 -44.41 80.92 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.558 -0.714 . . . . 0.0 112.604 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -147.33 -44.49 0.17 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.919 1.288 . . . . 0.0 112.862 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -117.07 161.58 19.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.597 1.559 . . . . 0.0 111.631 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.6 m -75.13 -65.01 0.93 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -157.69 125.38 5.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 112.559 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -91.91 158.06 16.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.436 1.495 . . . . 0.0 112.377 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -165.1 126.79 2.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 110.064 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.98 91.07 1.02 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.33 150.8 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.538 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -142.97 135.07 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.241 1.416 . . . . 0.0 108.733 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.12 103.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.268 1.027 . . . . 0.0 109.651 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -69.91 96.73 1.04 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.7 t -63.63 99.68 0.24 Allowed 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.79 -124.02 3.16 Favored Glycine 0 CA--C 1.578 3.986 0 N-CA-C 104.518 -3.433 . . . . 0.0 104.518 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -141.85 116.54 9.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.854 0.827 . . . . 0.0 111.969 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -134.73 111.88 10.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.51 1.124 . . . . 0.0 112.996 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 167.3 5.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.608 1.163 . . . . 0.0 110.781 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.17 119.54 31.36 Favored 'General case' 1 N--CA 1.336 -6.145 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . 0.259 2.0 t70 -165.59 -177.04 4.19 Favored 'General case' 0 N--CA 1.522 3.153 0 O-C-N 127.602 3.064 . . . . 0.0 104.185 -163.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.46 -47.95 48.0 Favored 'General case' 1 CA--C 1.632 4.111 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.116 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.26 -31.46 34.56 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 121.849 2.113 . . . . 0.0 113.383 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.8 ttt -72.75 -58.56 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.386 0.674 . . . . 0.0 110.498 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -57.5 -31.18 65.76 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.82 -44.38 96.29 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.31 1.444 . . . . 0.0 109.704 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.47 -2.41 4.62 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.05 0.94 . . . . 0.0 113.471 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.7 mt -102.05 -45.87 5.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.662 1.585 . . . . 0.0 111.989 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -93.57 -23.4 18.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -121.25 -1.65 9.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.621 1.569 . . . . 0.0 111.974 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -121.98 72.91 0.37 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.591 2.043 . . . . 0.0 113.185 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.3 m120 73.58 68.66 0.27 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 127.005 2.122 . . . . 0.0 112.503 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.25 114.78 3.17 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.369 2.713 . . . . 0.0 111.749 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -124.78 162.59 23.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.42 1.888 . . . . 0.0 111.598 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.9 mtm105 -145.57 165.51 28.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.298 1.439 . . . . 0.0 112.008 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -134.32 -57.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.3 t0 48.81 69.36 0.58 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.643 1.977 . . . . 0.0 113.907 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.59 100.79 0.02 OUTLIER 'General case' 0 C--O 1.25 1.111 0 C-N-CA 129.213 3.005 . . . . 0.0 114.58 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.98 104.09 0.19 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -53.77 101.92 0.05 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 112.506 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -119.21 131.08 55.78 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.891 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.82 133.89 55.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.747 2.019 . . . . 0.0 109.846 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -140.4 157.51 45.42 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.262 0.553 . . . . 0.0 110.76 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -76.78 98.35 4.78 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.1 tp -57.66 -23.77 53.08 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.01 24.7 5.65 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-O 117.851 -1.527 . . . . 0.0 116.726 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -130.24 -27.56 2.21 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.813 1.807 . . . . 0.0 115.636 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.03 -33.01 1.05 Allowed Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.534 1.064 . . . . 0.0 113.83 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 172.7 6.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.741 1.616 . . . . 0.0 111.885 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.14 158.89 32.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 0.0 110.887 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 165.02 28.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.591 0.71 . . . . 0.0 111.144 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -128.14 136.79 51.63 Favored 'General case' 0 N--CA 1.396 -3.137 0 C-N-CA 124.826 1.25 . . . . 0.0 112.049 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.18 160.29 22.93 Favored Glycine 1 CA--C 1.618 6.518 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.44 156.94 41.0 Favored 'Isoleucine or valine' 1 CA--C 1.629 4.016 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.81 87.04 1.4 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.0 p -73.81 165.11 25.7 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.238 1.015 . . . . 0.0 110.704 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -128.46 -163.08 1.24 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.737 1.215 . . . . 0.0 112.042 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.62 7.07 4.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.534 2.333 . . . . 0.0 115.116 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.82 169.66 19.44 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.516 1.055 . . . . 0.0 110.732 -175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 65.6 -51.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.755 2.022 . . . . 0.0 114.568 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.98 163.44 7.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.568 2.347 . . . . 0.0 112.694 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -154.07 165.12 37.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 123.155 1.455 . . . . 0.0 114.524 -174.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.513 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 24.8 ptm -93.12 164.94 13.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.172 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -153.27 156.15 37.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.03 138.75 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.887 1.675 . . . . 0.0 109.145 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.44 117.74 23.54 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.103 1.361 . . . . 0.0 109.704 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.79 126.14 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.552 0.741 . . . . 0.0 110.17 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.7 t -152.53 158.84 43.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.577 0 C-N-CA 126.122 1.769 . . . . 0.0 111.134 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.01 -43.59 87.23 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.345 1.429 . . . . 0.0 111.72 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.63 165.81 11.79 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 110.597 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.71 -25.4 27.64 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.195 1.379 . . . . 0.0 112.573 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -149.19 151.63 34.65 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.522 1.661 . . . . 0.0 111.535 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 mm -144.12 158.9 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.743 1.217 . . . . 0.0 111.312 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.67 -173.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 127.502 2.321 . . . . 0.0 111.984 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.73 -22.34 3.45 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.0 -25.32 14.42 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.648 1.118 . . . . 0.0 114.144 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -36.87 75.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.158 0.979 . . . . 0.0 111.969 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -7.12 58.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.942 1.297 . . . . 0.0 113.619 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tt -64.67 156.4 30.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.382 1.473 . . . . 0.0 112.651 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -148.55 143.38 26.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.041 0.936 . . . . 0.0 110.116 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -56.25 -32.86 64.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.653 0.781 . . . . 0.0 113.104 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -55.52 -57.28 12.55 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.081 1.352 . . . . 0.0 112.342 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.19 -51.42 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.706 0.803 . . . . 0.0 109.892 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.44 -37.1 62.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.172 1.389 . . . . 0.0 113.615 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.26 -49.08 65.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.27 1.428 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -36.52 83.55 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.339 -0.851 . . . . 0.0 111.301 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.57 -53.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.802 1.241 . . . . 0.0 111.345 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -63.85 -34.93 79.04 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.98 -25.39 58.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -54.95 -26.81 38.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.342 1.428 . . . . 0.0 112.893 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp -88.18 -4.65 58.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.312 2.645 . . . . 0.0 114.606 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.24 102.17 0.16 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.718 1.152 . . . . 0.0 112.987 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.17 19.87 0.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.871 2.069 . . . . 0.0 113.782 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.15 174.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.705 2.402 . . . . 0.0 112.961 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 p -76.88 0.51 20.62 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.93 128.19 12.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.643 . . . . 0.0 111.928 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -141.65 166.11 25.63 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.19 146.02 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.969 1.708 . . . . 0.0 115.007 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.51 110.47 7.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.725 2.81 . . . . 0.0 109.404 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -116.12 125.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.31 157.71 30.31 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.178 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.48 ' H ' HD22 ' A' ' 69' ' ' LEU . 1.5 mp -139.19 117.58 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 0.0 111.572 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.89 102.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.421 -1.424 . . . . 0.0 111.746 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 87.16 3.38 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.88 1.272 . . . . 0.0 111.82 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -143.15 45.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.684 1.194 . . . . 0.0 111.295 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.47 1.3 29.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.014 1.325 . . . . 0.0 114.465 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.27 17.29 69.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.383 0.992 . . . . 0.0 115.139 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.16 131.76 4.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.945 1.736 . . . . 0.0 111.742 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -59.08 142.51 51.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.033 1.333 . . . . 0.0 111.194 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -104.68 167.16 9.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 111.505 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -152.58 102.49 2.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.269 2.227 . . . . 0.0 109.407 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 166.43 14.31 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.344 -0.848 . . . . 0.0 111.617 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -67.8 0.77 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.668 1.587 . . . . 0.0 110.432 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -156.66 -176.17 5.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.985 1.714 . . . . 0.0 110.995 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.85 37.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.97 1.708 . . . . 0.0 110.844 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -127.94 130.06 47.82 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.574 1.549 . . . . 0.0 109.684 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.16 137.44 34.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 128.485 2.714 . . . . 0.0 109.121 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -14.84 15.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.32 1.448 . . . . 0.0 112.324 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.81 99.08 3.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.642 1.977 . . . . 0.0 109.056 176.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.22 102.08 0.94 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 124.401 1.001 . . . . 0.0 112.807 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -65.94 -103.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.411 1.884 . . . . 0.0 110.914 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.6 p -150.51 172.67 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 111.916 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -148.75 -4.02 0.44 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.633 2.373 . . . . 0.0 113.125 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.81 166.86 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 127.416 2.287 . . . . 0.0 112.128 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.21 128.65 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.11 1.764 . . . . 0.0 112.576 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 tp -81.59 123.66 80.58 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 108.511 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -65.54 124.55 12.99 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.884 3.056 . . . . 0.0 110.827 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.07 -76.75 0.26 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.233 -0.917 . . . . 0.0 112.188 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.54 125.57 40.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.87 0.868 . . . . 0.0 110.28 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.78 121.98 26.46 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.228 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.94 179.21 6.51 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.179 3.252 . . . . 0.0 112.323 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -66.8 169.18 8.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.301 1.44 . . . . 0.0 112.64 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p 43.39 43.49 4.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.413 2.285 . . . . 0.0 115.016 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -144.49 177.58 8.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.608 1.963 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.08 -174.44 4.1 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.492 1.517 . . . . 0.0 108.324 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -156.27 154.17 30.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -129.35 163.72 25.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.771 0.829 . . . . 0.0 110.467 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.26 161.35 42.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.392 1.477 . . . . 0.0 109.502 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.6 m -147.02 178.49 8.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.296 1.438 . . . . 0.0 110.801 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.17 167.25 30.67 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.468 0.556 . . . . 0.0 113.471 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.94 -174.76 3.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.216 1.407 . . . . 0.0 112.971 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -64.54 56.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.457 3.103 . . . . 0.0 114.531 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -107.65 -11.72 15.39 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.688 1.595 . . . . 0.0 114.704 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.43 9.27 4.7 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.611 1.964 . . . . 0.0 112.94 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.33 29.96 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.511 -1.716 . . . . 0.0 115.656 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.38 -2.25 11.44 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 123.768 2.978 . . . . 0.0 114.922 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 p -54.02 146.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.07 -1.019 . . . . 0.0 108.715 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.95 8.09 6.62 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.95 1.3 . . . . 0.0 113.787 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.3 p -142.48 -171.71 3.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.921 2.088 . . . . 0.0 109.97 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.88 140.19 14.91 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.699 1.143 . . . . 0.0 111.236 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.46 128.87 38.43 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 117.999 0.899 . . . . 0.0 111.059 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.11 126.43 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.375 1.87 . . . . 0.0 111.986 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.8 167.39 25.74 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.338 1.455 . . . . 0.0 110.87 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 118.38 7.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.0 109.288 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -123.5 162.93 21.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.434 1.094 . . . . 0.0 112.55 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.23 145.76 50.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.972 0.909 . . . . 0.0 111.986 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.73 113.49 16.07 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.669 1.987 . . . . 0.0 110.89 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.96 122.11 16.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.847 1.259 . . . . 0.0 110.591 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.3 ttt -92.8 149.03 21.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.831 1.252 . . . . 0.0 111.017 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -22.71 16.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 t -72.01 -11.48 60.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.843 1.257 . . . . 0.0 113.789 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.49 4.87 60.59 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.672 1.606 . . . . 0.0 114.72 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -95.05 173.18 7.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.211 1.404 . . . . 0.0 110.769 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.8 m -137.16 104.37 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.961 1.304 . . . . 0.0 111.947 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.12 125.13 25.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.941 0.896 . . . . 0.0 110.346 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.67 104.84 2.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.19 1.376 . . . . 0.0 112.389 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.86 169.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.857 0.837 . . . . 0.0 112.175 175.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -149.0 147.48 28.61 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.189 1.396 . . . . 0.0 111.682 177.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -157.76 146.31 19.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.497 0.719 . . . . 0.0 112.088 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -153.31 122.04 6.4 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.482 0.713 . . . . 0.0 112.169 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.59 137.05 38.96 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.81 137.56 29.94 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.395 2.063 . . . . 0.0 112.741 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -94.29 -58.67 2.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.584 1.154 . . . . 0.0 110.309 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -127.21 10.15 6.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.997 1.319 . . . . 0.0 113.941 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.62 31.26 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.241 1.816 . . . . 0.0 112.704 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -20.46 64.87 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -66.96 -43.28 83.52 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.956 0.903 . . . . 0.0 112.473 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -174.44 163.07 3.62 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.16 2.984 . . . . 0.0 108.996 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 t 78.74 75.42 0.05 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.695 2.398 . . . . 0.0 111.547 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.39 140.03 50.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.091 1.356 . . . . 0.0 110.394 174.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -81.38 162.14 23.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.041 0.937 . . . . 0.0 112.229 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.49 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 4.8 p-90 -159.91 169.4 23.59 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.129 1.372 . . . . 0.0 110.928 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 t70 164.26 138.6 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 128.713 2.805 . . . . 0.0 112.265 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.42 128.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.344 1.858 . . . . 0.0 108.959 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -129.03 158.21 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.324 1.85 . . . . 0.0 110.234 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.2 mt -112.76 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.719 1.608 . . . . 0.0 108.383 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -70.49 102.78 2.29 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.724 -1.235 . . . . 0.0 110.136 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.2 t -67.01 90.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.79 -134.71 4.97 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.853 2.644 . . . . 0.0 109.629 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.26 124.7 26.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.042 1.337 . . . . 0.0 111.899 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -143.61 117.14 9.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.234 1.814 . . . . 0.0 110.868 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.24 165.94 18.97 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.142 0.428 . . . . 0.0 110.985 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.47 112.58 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.438 -0.789 . . . . 0.0 110.601 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -155.97 -172.84 4.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.365 1.466 . . . . 0.0 112.797 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -42.65 84.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.018 0.927 . . . . 0.0 110.868 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.7 -41.08 56.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.469 1.509 . . . . 0.0 112.887 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -64.83 0.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.501 1.12 . . . . 0.0 109.94 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -53.37 -34.35 57.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.201 1.001 . . . . 0.0 113.431 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -41.07 95.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.824 1.25 . . . . 0.0 111.388 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -21.71 66.69 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.484 -1.385 . . . . 0.0 112.386 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mt -85.3 -48.78 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.53 -33.25 31.89 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -114.66 -37.38 4.27 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.894 1.278 . . . . 0.0 112.708 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.64 -68.71 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.039 1.304 . . . . 0.0 112.479 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.77 79.0 1.8 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.99 153.38 72.56 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.06 175.91 8.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.136 2.174 . . . . 0.0 112.448 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -127.1 141.63 51.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.186 1.794 . . . . 0.0 110.826 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -141.46 108.56 0.55 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.561 1.076 . . . . 0.0 111.029 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -123.16 64.88 0.99 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.559 1.143 . . . . 0.0 112.264 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.04 95.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.619 2.368 . . . . 0.0 114.754 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.46 154.28 6.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.378 1.942 . . . . 0.0 112.405 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 63.1 m95 -77.18 144.74 38.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.274 1.03 . . . . 0.0 111.891 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -149.66 127.18 11.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.183 1.393 . . . . 0.0 112.364 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -120.67 152.46 38.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.234 1.814 . . . . 0.0 112.37 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -145.67 161.46 39.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.629 1.572 . . . . 0.0 110.636 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -75.04 98.76 3.71 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -57.84 7.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.935 1.294 . . . . 0.0 111.492 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.17 14.38 0.47 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -129.22 -16.58 3.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.56 -4.09 5.1 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.98 171.48 14.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.893 1.677 . . . . 0.0 110.801 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.71 161.19 31.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.019 . . . . 0.0 111.948 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.62 149.16 40.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.358 0.663 . . . . 0.0 111.815 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.8 OUTLIER -119.25 134.54 55.15 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.79 1.636 . . . . 0.0 108.988 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.27 136.44 12.62 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.097 1.332 . . . . 0.0 113.068 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -109.3 132.39 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.187 1.795 . . . . 0.0 108.691 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.88 105.97 11.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.746 0.818 . . . . 0.0 109.817 175.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 p -123.6 145.91 48.55 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.927 1.291 . . . . 0.0 110.562 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.7 p -140.46 -112.46 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.527 1.131 . . . . 0.0 110.504 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 52.38 13.48 0.3 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 120.833 1.651 . . . . 0.0 115.33 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 146.45 5.84 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.547 2.022 . . . . 0.0 110.779 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.23 38.4 29.21 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -144.83 170.87 15.29 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.562 1.545 . . . . 0.0 111.803 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -165.76 146.0 6.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.089 0.956 . . . . 0.0 112.99 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.62 144.87 45.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.506 1.922 . . . . 0.0 113.752 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -145.07 153.28 41.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.594 1.958 . . . . 0.0 109.83 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.0 mp -124.5 122.61 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.409 1.084 . . . . 0.0 109.963 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -100.1 132.14 45.64 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.985 0.914 . . . . 0.0 109.378 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 6.1 pt -116.85 133.07 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.724 0.81 . . . . 0.0 110.123 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.8 p -154.22 170.42 21.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.857 1.263 . . . . 0.0 112.798 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.027 0.441 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 mt -127.71 -53.33 1.34 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.279 1.832 . . . . 0.0 110.7 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.65 145.76 51.21 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 109.892 175.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.52 -38.86 1.82 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 127.111 2.291 . . . . 0.0 111.435 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -143.51 159.09 43.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.948 1.299 . . . . 0.0 112.374 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -139.19 169.83 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.42 1.888 . . . . 0.0 110.235 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.98 -166.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 127.854 2.462 . . . . 0.0 111.128 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.04 -16.58 13.29 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.64 -21.85 40.87 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.907 1.242 . . . . 0.0 114.068 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.12 86.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.567 1.183 . . . . 0.0 111.581 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -85.61 -15.69 41.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.906 1.283 . . . . 0.0 113.717 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 tt -61.14 150.06 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.205 1.002 . . . . 0.0 110.99 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -149.54 144.41 26.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.915 0.886 . . . . 0.0 109.132 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -50.91 -38.65 51.34 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 112.117 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -50.82 -53.32 33.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.408 1.083 . . . . 0.0 113.705 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.67 -47.42 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.97 -0.456 . . . . 0.0 110.171 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -35.74 65.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.327 1.451 . . . . 0.0 112.283 -176.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -64.13 -51.09 65.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.829 2.452 . . . . 0.0 110.67 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -35.22 79.6 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.674 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.67 -50.79 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.613 1.165 . . . . 0.0 111.702 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.15 -31.96 73.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 112.809 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.18 -9.11 59.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.075 -1.016 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -25.2 55.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.465 -1.397 . . . . 0.0 112.408 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -63.1 -39.59 95.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.826 2.05 . . . . 0.0 113.757 175.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.04 114.67 0.48 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.553 1.073 . . . . 0.0 113.499 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -76.41 42.6 0.28 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 128.635 2.774 . . . . 0.0 114.087 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.51 -177.42 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.906 2.082 . . . . 0.0 112.028 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 t -73.58 52.77 0.4 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.454 1.502 . . . . 0.0 112.578 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -168.19 130.66 1.47 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.13 2.572 . . . . 0.0 109.44 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' H ' ' NH1' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -154.9 160.75 41.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.564 1.946 . . . . 0.0 111.975 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -154.8 132.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.857 0.753 . . . . 0.0 112.416 174.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.74 115.7 22.5 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.603 1.961 . . . . 0.0 109.524 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 157.98 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.94 177.0 28.72 Favored Glycine 0 N--CA 1.451 -0.336 0 O-C-N 121.525 -0.734 . . . . 0.0 111.453 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -136.89 132.77 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.878 0.846 . . . . 0.0 111.631 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.42 104.92 16.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.374 1.47 . . . . 0.0 111.491 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -82.27 96.43 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.033 0.933 . . . . 0.0 112.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.06 13.44 5.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.813 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -3.34 54.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.609 1.564 . . . . 0.0 115.114 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 26.02 60.41 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.165 -0.96 . . . . 0.0 114.766 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.94 125.13 2.51 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.801 1.667 . . . . 0.0 111.44 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.0 m -64.23 141.42 58.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.028 0.931 . . . . 0.0 111.128 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -110.19 169.83 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.09 0.956 . . . . 0.0 111.708 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -144.14 101.2 3.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.074 1.35 . . . . 0.0 112.315 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 154.11 42.52 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.558 -1.339 . . . . 0.0 110.421 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.63 -54.28 2.57 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.237 1.415 . . . . 0.0 112.193 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -162.49 -171.93 2.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.106 1.762 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.7 145.37 30.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.658 1.583 . . . . 0.0 110.716 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -123.33 126.02 46.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.669 1.587 . . . . 0.0 110.119 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 137.04 46.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.827 2.451 . . . . 0.0 109.622 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -110.31 -43.3 3.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.191 1.796 . . . . 0.0 111.605 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -100.21 156.74 17.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 109.148 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.42 -171.39 19.93 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -145.19 166.15 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.97 1.308 . . . . 0.0 110.259 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 p -67.76 152.25 45.9 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -163.81 -30.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.958 1.703 . . . . 0.0 113.53 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.97 157.11 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.059 1.744 . . . . 0.0 111.49 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 tt -85.89 138.11 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.25 1.02 . . . . 0.0 112.11 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.88 131.76 42.23 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.222 1.409 . . . . 0.0 109.627 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.07 118.82 5.92 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.745 2.963 . . . . 0.0 110.926 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.11 -53.82 52.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.385 0.674 . . . . 0.0 112.475 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -119.94 136.62 54.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.208 1.003 . . . . 0.0 110.587 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.47 122.01 37.51 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.013 0.925 . . . . 0.0 110.609 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.64 171.0 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.684 2.923 . . . . 0.0 113.0 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -66.02 154.13 40.33 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.266 1.426 . . . . 0.0 112.742 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.7 t 36.87 56.03 1.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.099 2.16 . . . . 0.0 113.303 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -144.18 -178.49 5.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.95 1.3 . . . . 0.0 111.735 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.72 -178.79 6.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.069 0.937 . . . . 0.0 111.35 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.36 150.03 30.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 110.961 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.69 151.02 47.16 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.308 1.443 . . . . 0.0 108.486 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -127.98 159.84 33.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.573 1.549 . . . . 0.0 109.553 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.9 m -135.8 170.17 16.41 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.56 1.544 . . . . 0.0 109.931 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.434 ' H ' HD22 ' A' ' 24' ' ' LEU . . . 138.93 89.38 0.19 Allowed Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.527 1.06 . . . . 0.0 111.362 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.488 ' NH1' ' H ' ' A' ' 30' ' ' LYS . 52.2 ttt180 -142.18 137.38 30.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.926 1.29 . . . . 0.0 113.632 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 47.43 18.4 0.1 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.903 1.681 . . . . 0.0 114.065 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.29 106.62 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.658 2.383 . . . . 0.0 110.106 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 87.86 -0.71 0.47 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 129.077 2.951 . . . . 0.0 114.018 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.29 52.63 10.34 Favored Glycine 0 CA--C 1.543 1.841 0 C-N-CA 126.244 1.878 . . . . 0.0 112.972 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.69 -24.59 13.36 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.172 3.248 . . . . 0.0 113.419 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -146.93 157.95 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.813 1.645 . . . . 0.0 111.079 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.48 4.58 27.24 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.163 1.385 . . . . 0.0 114.328 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 t -125.64 -171.25 2.33 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.891 2.076 . . . . 0.0 111.903 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.12 179.89 49.62 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.175 1.369 . . . . 0.0 114.687 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.89 153.18 34.97 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.773 -0.84 . . . . 0.0 112.403 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -155.76 111.47 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.775 2.03 . . . . 0.0 107.858 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -156.43 167.51 30.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.483 1.135 . . . . 0.0 110.383 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.97 128.31 9.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.338 1.055 . . . . 0.0 108.824 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -127.2 165.02 20.4 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.028 0.931 . . . . 0.0 111.931 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.1 150.27 51.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.557 0.743 . . . . 0.0 112.481 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -125.57 114.8 19.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.971 1.308 . . . . 0.0 110.466 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -71.36 100.0 2.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.689 1.596 . . . . 0.0 110.539 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.0 mtp -64.86 146.64 54.62 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.951 -1.093 . . . . 0.0 112.028 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -57.51 -26.09 60.8 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -71.67 -4.72 28.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.702 1.201 . . . . 0.0 113.58 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.16 27.13 16.71 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.894 1.235 . . . . 0.0 114.457 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -117.57 166.46 12.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.623 1.569 . . . . 0.0 110.746 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 45.0 m -130.43 104.16 7.09 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.08 0.952 . . . . 0.0 112.44 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.8 tp -77.27 113.35 14.94 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.957 0.903 . . . . 0.0 110.033 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.87 111.4 4.21 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.749 1.642 . . . . 0.0 112.075 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.65 154.66 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 110.857 175.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.1 ttp -134.83 148.82 50.25 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.861 1.265 . . . . 0.0 110.035 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 12.4 p90 -153.97 142.46 20.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.367 0.667 . . . . 0.0 109.299 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 m -150.93 165.83 32.47 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.005 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 74' ' ' ARG . 95.2 t -119.78 142.2 32.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.314 1.046 . . . . 0.0 109.964 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD3' HD22 ' A' ' 113' ' ' ASN . 80.2 Cg_endo -72.12 -177.17 2.48 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.641 2.894 . . . . 0.0 112.706 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.26 31.06 0.82 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.046 1.338 . . . . 0.0 113.651 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 51.52 64.04 2.0 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.018 2.127 . . . . 0.0 113.781 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.43 152.5 50.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.69 1.196 . . . . 0.0 112.195 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.13 -30.08 69.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -67.26 112.46 4.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.578 1.551 . . . . 0.0 111.222 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -66.13 126.24 28.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.077 0.551 . . . . 0.0 111.635 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.13 24.42 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.355 1.062 . . . . 0.0 112.574 175.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.485 HD22 ' HD3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -68.01 146.86 53.13 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -175.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -93.22 137.34 32.64 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.987 1.715 . . . . 0.0 111.829 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -164.32 134.79 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.371 1.868 . . . . 0.0 108.394 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -156.16 151.74 27.03 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.333 1.053 . . . . 0.0 110.44 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.88 132.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.437 1.095 . . . . 0.0 110.33 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HE2' ' CE1' ' A' ' 120' ' ' TYR . 18.5 ttpt -144.76 158.61 43.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.872 0.869 . . . . 0.0 111.709 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.83 112.07 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.428 1.091 . . . . 0.0 110.47 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.464 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 27.0 m-85 -81.3 101.14 9.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -62.84 93.02 0.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.225 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.75 -138.78 8.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.401 2.429 . . . . 0.0 110.544 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -117.08 127.06 53.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.59 1.956 . . . . 0.0 111.778 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -148.73 108.05 3.94 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.2 168.81 18.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.13 0.972 . . . . 0.0 111.435 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.93 118.25 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.888 0.875 . . . . 0.0 111.37 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -161.88 -174.53 4.21 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.769 1.228 . . . . 0.0 112.114 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -48.73 -48.61 40.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.978 1.311 . . . . 0.0 111.556 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.51 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.31 0.957 . . . . 0.0 113.426 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.4 ttp -68.76 -49.31 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.238 1.019 . . . . 0.0 112.467 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.87 -39.27 68.49 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.488 0.585 . . . . 0.0 112.198 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -45.53 79.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.265 1.426 . . . . 0.0 111.199 175.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -21.94 66.69 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.336 -1.478 . . . . 0.0 113.716 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.91 -41.72 14.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.776 1.631 . . . . 0.0 112.824 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -88.95 -28.22 20.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -122.61 -32.07 3.63 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 112.313 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.85 -39.12 94.91 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.118 0.866 . . . . 0.0 113.431 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.53 75.38 9.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.15 120.72 8.0 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.415 2.077 . . . . 0.0 113.284 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.47 173.4 7.69 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.704 2.002 . . . . 0.0 112.369 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -139.83 140.02 36.47 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.565 1.946 . . . . 0.0 112.224 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -136.88 109.78 0.74 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.286 0.946 . . . . 0.0 114.188 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -87.28 -68.25 0.76 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.622 1.569 . . . . 0.0 112.44 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -173.12 114.97 0.26 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 0.0 112.089 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.37 160.17 8.67 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.704 1.145 . . . . 0.0 114.079 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.406 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 92.1 m95 -78.04 147.03 34.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.124 1.37 . . . . 0.0 112.5 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -150.61 127.6 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.664 1.585 . . . . 0.0 112.452 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.6 152.59 24.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.36 1.464 . . . . 0.0 112.37 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -158.65 169.91 23.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.868 1.267 . . . . 0.0 112.627 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -85.44 99.79 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.77 1.628 . . . . 0.0 107.807 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tp -60.88 -36.16 78.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.19 24.51 2.21 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -135.92 -29.12 1.04 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 119.157 1.479 . . . . 0.0 114.727 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 133.19 23.0 0.77 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.052 1.31 . . . . 0.0 114.66 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.2 162.63 37.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.224 1.512 . . . . 0.0 112.048 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 136.77 50.79 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.481 1.513 . . . . 0.0 108.875 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.45 168.48 14.16 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.006 0.922 . . . . 0.0 110.841 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 128.24 50.62 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.82 152.74 18.0 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.441 1.02 . . . . 0.0 112.02 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.406 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -133.65 145.96 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.236 178.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.9 tpt -154.88 100.85 2.24 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.337 1.055 . . . . 0.0 110.182 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -90.54 149.46 22.16 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 109.542 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -59.67 164.33 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.358 1.463 . . . . 0.0 112.867 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.68 129.85 40.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.756 0.823 . . . . 0.0 112.391 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.77 79.22 0.05 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.001 0.81 . . . . 0.0 112.091 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 67.97 -50.7 0.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.651 2.38 . . . . 0.0 115.322 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.52 169.86 7.01 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.475 1.91 . . . . 0.0 113.492 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -152.88 -177.56 6.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.987 1.715 . . . . 0.0 112.315 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 138.3 40.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.996 2.118 . . . . 0.0 112.288 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -146.42 156.29 43.19 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.345 1.458 . . . . 0.0 110.764 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.4 mm -131.9 125.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 110.283 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 112.76 19.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.311 1.044 . . . . 0.0 112.379 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.2 pt -97.63 132.11 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.721 1.608 . . . . 0.0 110.517 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 t -154.16 158.69 40.76 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.445 -0.784 . . . . 0.0 111.491 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.998 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -109.25 -62.61 1.46 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 112.38 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.21 29.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.0 1.72 . . . . 0.0 114.387 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.4 -5.6 10.22 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.021 1.772 . . . . 0.0 115.392 -175.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -167.49 162.18 14.29 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.304 2.642 . . . . 0.0 109.36 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -142.4 167.39 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.774 1.23 . . . . 0.0 109.901 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.03 -164.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 127.958 2.503 . . . . 0.0 110.045 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.04 -14.82 39.63 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -26.4 24.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.874 1.702 . . . . 0.0 113.571 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.53 81.34 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 118.373 1.086 . . . . 0.0 112.166 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -12.71 49.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.042 1.337 . . . . 0.0 113.842 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.36 129.73 41.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.857 1.263 . . . . 0.0 109.371 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -142.24 144.06 33.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.701 0.8 . . . . 0.0 109.319 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -54.96 -29.79 57.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.592 0.633 . . . . 0.0 112.381 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -58.63 -55.99 27.9 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 112.119 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -62.4 -47.04 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.9 63.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.005 1.322 . . . . 0.0 113.323 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -52.91 14.83 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 119.938 -1.726 . . . . 0.0 110.754 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -64.32 -38.93 92.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.117 1.767 . . . . 0.0 112.231 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.8 -34.45 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.429 1.092 . . . . 0.0 112.155 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.2 -40.55 37.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.258 1.423 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -72.45 -17.11 61.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -30.97 70.57 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.645 -1.284 . . . . 0.0 112.554 175.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 tp -72.59 -25.46 61.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 112.262 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.77 130.66 1.64 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.877 1.703 . . . . 0.0 111.759 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.68 43.56 0.09 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 128.479 2.712 . . . . 0.0 112.673 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.95 144.13 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.464 2.306 . . . . 0.0 111.243 -174.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.9 m -69.76 -29.23 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.477 -0.764 . . . . 0.0 112.997 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -71.81 82.02 0.89 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.922 1.689 . . . . 0.0 111.935 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.891 1.276 . . . . 0.0 111.493 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.18 130.98 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.646 1.178 . . . . 0.0 110.367 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.73 95.29 4.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.749 2.02 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -101.73 113.41 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.626 -1.296 . . . . 0.0 109.178 174.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.6 160.02 28.56 Favored Glycine 0 C--O 1.235 0.171 0 C-N-CA 120.857 -0.687 . . . . 0.0 114.745 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -135.61 130.97 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.193 1.397 . . . . 0.0 110.129 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 4.2 m-20 -86.7 104.4 16.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.344 1.058 . . . . 0.0 111.943 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -81.12 100.39 9.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.829 1.195 . . . . 0.0 112.102 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.64 21.49 2.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.197 0.999 . . . . 0.0 112.845 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -6.38 58.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.482 1.513 . . . . 0.0 114.621 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.53 22.82 55.51 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.384 0.992 . . . . 0.0 114.97 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.15 126.87 3.65 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.444 1.497 . . . . 0.0 112.275 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -58.6 143.95 44.56 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.464 1.106 . . . . 0.0 110.565 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -108.05 164.77 12.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.69 0.796 . . . . 0.0 111.858 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.1 m -149.9 104.15 3.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.141 1.776 . . . . 0.0 110.307 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.36 144.62 55.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.733 -1.229 . . . . 0.0 111.211 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -47.8 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.743 1.617 . . . . 0.0 113.149 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -157.73 171.33 20.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.497 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.64 128.67 25.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.894 1.277 . . . . 0.0 110.859 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -120.31 141.64 49.84 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.286 1.434 . . . . 0.0 110.373 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -154.22 155.73 35.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.527 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -120.15 -13.11 8.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.035 1.734 . . . . 0.0 111.093 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.4 m -143.04 131.23 21.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.649 1.98 . . . . 0.0 110.219 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 107.29 0.98 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.4 ' HB ' ' CA ' ' A' ' 78' ' ' GLY . 1.4 t -73.79 176.23 6.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.125 2.17 . . . . 0.0 111.378 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -69.13 163.14 25.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.452 1.12 . . . . 0.0 113.155 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.0 -29.74 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.986 1.314 . . . . 0.0 112.937 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.66 164.05 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.411 1.884 . . . . 0.0 110.233 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 tp -64.26 134.54 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.062 0.945 . . . . 0.0 110.786 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.29 109.56 34.37 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 108.295 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -61.46 123.47 12.82 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.032 3.154 . . . . 0.0 111.154 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.2 -59.56 2.51 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.346 -0.846 . . . . 0.0 112.483 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -105.22 144.73 31.6 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 110.697 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.44 124.46 17.11 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.595 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.17 170.48 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.072 2.514 . . . . 0.0 112.493 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -62.66 148.73 45.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.012 0.925 . . . . 0.0 111.133 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 p 53.9 42.86 31.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.808 1.643 . . . . 0.0 114.832 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -145.2 127.9 16.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.807 1.643 . . . . 0.0 112.723 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -84.64 176.1 8.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.978 0.911 . . . . 0.0 111.819 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 150.51 30.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.342 -0.849 . . . . 0.0 112.003 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 169.18 11.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.177 1.391 . . . . 0.0 112.128 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -145.7 160.65 41.41 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.87 164.65 33.04 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.725 1.61 . . . . 0.0 111.262 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.59 173.45 39.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.645 0.64 . . . . 0.0 113.703 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -141.66 141.12 33.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.442 1.897 . . . . 0.0 109.802 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -117.14 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 0.0 113.752 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t0 49.84 -91.18 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.681 2.392 . . . . 0.0 115.945 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.4 t -69.35 -10.14 56.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.701 2.001 . . . . 0.0 113.509 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.4 ' CA ' ' HB ' ' A' ' 54' ' ' THR . . . -79.02 -163.12 24.6 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.432 2.444 . . . . 0.0 116.011 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.92 -11.14 28.91 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.821 3.014 . . . . 0.0 113.985 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 p -141.49 167.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.278 1.831 . . . . 0.0 111.551 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.52 -14.63 19.9 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.858 1.263 . . . . 0.0 113.974 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.7 p -146.94 131.13 17.39 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 127.044 2.137 . . . . 0.0 112.961 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.77 161.18 34.37 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.838 2.637 . . . . 0.0 114.645 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.57 ' H ' ' CG2' ' A' ' 104' ' ' VAL . . . -134.42 107.78 7.78 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.115 -1.227 . . . . 0.0 111.521 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.08 112.87 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.505 1.922 . . . . 0.0 111.088 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.57 163.99 27.64 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.526 1.131 . . . . 0.0 111.18 175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.2 112.81 4.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.766 1.226 . . . . 0.0 108.635 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -122.64 165.17 16.92 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.969 1.308 . . . . 0.0 110.747 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.03 153.61 47.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.267 0.556 . . . . 0.0 111.511 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -127.96 112.9 15.18 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.967 1.307 . . . . 0.0 109.93 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.64 107.03 2.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.187 1.395 . . . . 0.0 110.329 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.15 144.92 50.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.212 1.405 . . . . 0.0 110.845 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.6 t -55.42 -27.33 47.21 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.175 0.99 . . . . 0.0 113.369 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -9.3 40.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.312 1.445 . . . . 0.0 114.837 174.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.12 55.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.872 1.225 . . . . 0.0 115.094 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.05 172.82 6.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.508 1.523 . . . . 0.0 110.445 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -136.33 108.36 7.18 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.312 1.045 . . . . 0.0 111.141 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 tp -73.75 125.87 29.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.013 -1.055 . . . . 0.0 109.091 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.88 99.12 1.93 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.9 162.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.786 0.803 . . . . 0.0 111.227 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -148.1 158.29 43.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.502 0.721 . . . . 0.0 111.322 174.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.435 ' CD2' ' HB ' ' A' ' 33' ' ' VAL . 45.8 p90 -160.3 162.72 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.928 1.291 . . . . 0.0 109.325 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.22 168.76 24.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.809 1.244 . . . . 0.0 109.108 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.57 ' CG2' ' H ' ' A' ' 84' ' ' ALA . 12.3 m -136.11 97.38 12.21 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 109.723 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.21 173.22 11.69 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.303 2.002 . . . . 0.0 110.865 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -69.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.794 -0.566 . . . . 0.0 111.817 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -170.46 147.23 2.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.142 1.777 . . . . 0.0 110.556 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.2 169.77 21.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.755 1.222 . . . . 0.0 111.383 174.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.54 -53.71 8.9 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.23 0.612 . . . . 0.0 111.682 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -161.5 22.28 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.32 -168.77 3.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.165 1.386 . . . . 0.0 112.957 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 t 63.49 23.16 13.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.321 2.248 . . . . 0.0 114.476 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -127.5 112.34 14.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.303 2.641 . . . . 0.0 111.524 -174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -86.23 157.55 19.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.679 1.191 . . . . 0.0 112.617 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.412 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 6.0 p-90 -160.94 148.32 15.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.762 0.825 . . . . 0.0 111.505 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -172.1 107.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.317 1.847 . . . . 0.0 111.699 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.6 t -116.36 137.24 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.683 0.793 . . . . 0.0 109.063 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -145.96 143.64 29.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.875 1.67 . . . . 0.0 110.484 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.409 ' H ' ' CD1' ' A' ' 151' ' ' LEU . 3.6 mp -81.88 153.42 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -122.62 96.34 4.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.247 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t -70.71 90.51 0.78 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.54 -1.35 . . . . 0.0 111.599 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.85 -112.57 0.52 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.31 1.909 . . . . 0.0 110.831 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -159.21 117.78 2.89 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.706 1.602 . . . . 0.0 110.513 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -140.04 108.6 5.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.241 1.416 . . . . 0.0 111.404 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.01 171.35 6.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.638 0.775 . . . . 0.0 111.153 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.77 113.67 22.12 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.728 -0.608 . . . . 0.0 110.651 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.09 -175.22 4.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.083 1.353 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.06 -45.04 21.38 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.827 1.251 . . . . 0.0 112.236 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.06 46.88 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.576 1.084 . . . . 0.0 114.397 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 ttp -70.02 -60.61 2.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.781 1.291 . . . . 0.0 109.63 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -53.54 -33.39 54.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.845 0.858 . . . . 0.0 113.241 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.22 -38.59 91.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.568 1.147 . . . . 0.0 110.837 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -23.61 66.78 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.329 -1.482 . . . . 0.0 112.458 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mt -84.01 -47.28 11.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.518 1.527 . . . . 0.0 111.345 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.18 -26.44 26.78 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -122.46 -38.88 2.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.681 1.192 . . . . 0.0 112.219 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.52 -55.95 24.48 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.737 1.161 . . . . 0.0 112.761 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -160.97 70.44 2.67 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.04 115.19 3.15 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.848 2.365 . . . . 0.0 112.99 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.21 -178.33 3.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.536 1.135 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.57 144.33 49.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.077 2.551 . . . . 0.0 111.022 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.45 108.29 0.63 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.853 1.216 . . . . 0.0 111.865 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -120.15 64.9 0.82 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.725 1.61 . . . . 0.0 114.094 -174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.94 96.03 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.923 2.089 . . . . 0.0 114.314 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.99 135.26 2.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.343 1.449 . . . . 0.0 112.017 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -66.41 144.63 56.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 111.371 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -143.6 131.2 21.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.363 1.065 . . . . 0.0 111.805 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -133.81 143.74 48.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.645 1.578 . . . . 0.0 112.346 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 161.98 40.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.462 1.505 . . . . 0.0 112.224 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -97.67 96.62 8.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.396 1.079 . . . . 0.0 108.886 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.409 ' CD1' ' H ' ' A' ' 119' ' ' ILE . 0.1 OUTLIER -53.54 -51.07 64.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.523 1.529 . . . . 0.0 112.014 -174.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.94 51.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.791 1.076 . . . . 0.0 115.791 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -135.44 -31.29 0.97 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -29.75 2.31 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.21 1.386 . . . . 0.0 113.321 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.61 172.14 6.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.904 1.682 . . . . 0.0 112.766 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -134.53 151.83 51.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.912 1.685 . . . . 0.0 109.782 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.54 152.99 51.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 133.71 49.1 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.504 1.521 . . . . 0.0 109.918 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.07 136.41 11.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.477 1.037 . . . . 0.0 112.591 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tp -108.24 149.81 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.091 1.757 . . . . 0.0 109.641 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.88 93.58 2.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.68 1.192 . . . . 0.0 110.707 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.9 p -91.88 161.62 14.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.247 1.019 . . . . 0.0 111.183 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.14 -26.52 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.734 1.214 . . . . 0.0 112.398 175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.33 114.86 9.83 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 110.911 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.03 -95.11 0.64 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.083 1.325 . . . . 0.0 113.078 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.01 64.15 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.45 1.5 . . . . 0.0 111.265 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.27 91.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.864 1.666 . . . . 0.0 113.977 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.462 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -156.66 168.84 26.19 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -174.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.462 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 17.8 ptm -135.31 160.47 38.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.227 2.611 . . . . 0.0 112.567 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -153.64 162.51 41.18 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.192 1.797 . . . . 0.0 109.558 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.1 mm -136.48 108.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -95.87 116.18 28.53 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 112.024 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.2 pt -103.67 132.19 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 0.0 111.101 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.7 p -155.48 170.96 20.73 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.284 -0.885 . . . . 0.0 112.643 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 118.528 -0.749 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp -69.75 -37.96 76.61 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.13 1.332 . . . . 0.0 112.115 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.65 171.54 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.85 -19.44 44.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.393 0.997 . . . . 0.0 113.659 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.8 p -163.38 156.99 19.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.784 2.834 . . . . 0.0 109.05 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -141.84 173.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.957 1.703 . . . . 0.0 109.065 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -167.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.558 1.543 . . . . 0.0 110.033 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.34 -40.2 11.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.72 -32.64 5.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.594 1.569 . . . . 0.0 113.083 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.588 1.194 . . . . 0.0 111.588 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.0 m -83.82 -6.54 59.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.607 1.963 . . . . 0.0 113.902 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 tt -66.27 138.09 57.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.578 1.151 . . . . 0.0 109.792 176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -141.79 142.17 33.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.863 0.865 . . . . 0.0 109.922 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -55.93 -32.45 63.82 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -56.62 -49.78 73.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.442 1.019 . . . . 0.0 112.771 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.11 -49.53 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.014 -0.429 . . . . 0.0 109.861 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -36.56 52.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.271 1.428 . . . . 0.0 112.222 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.92 -65.79 0.54 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.196 1.798 . . . . 0.0 111.211 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -65.05 -24.45 67.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 177.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.41 -46.6 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.707 1.203 . . . . 0.0 112.285 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -26.93 55.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.247 0.619 . . . . 0.0 112.063 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.21 -38.36 51.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.173 1.389 . . . . 0.0 113.714 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.45 -27.06 45.73 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.198 0.908 . . . . 0.0 113.039 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -52.72 -36.24 57.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.853 2.061 . . . . 0.0 113.7 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.98 115.75 0.49 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.773 1.178 . . . . 0.0 111.304 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.73 79.31 0.84 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.352 1.061 . . . . 0.0 111.28 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.87 174.28 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.557 1.943 . . . . 0.0 110.695 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -38.7 -61.42 0.72 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.162 2.185 . . . . 0.0 111.883 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -157.75 150.34 22.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.738 2.015 . . . . 0.0 110.034 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 -176.04 3.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 129.336 3.055 . . . . 0.0 110.361 -174.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.87 147.39 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.351 1.061 . . . . 0.0 112.11 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 110.96 11.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.27 1.828 . . . . 0.0 111.287 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.45 HG12 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -130.32 157.46 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 C-N-CA 125.189 1.396 . . . . 0.0 112.601 175.005 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 156.54 177.32 29.59 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -133.78 147.97 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.747 0.819 . . . . 0.0 110.46 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.79 102.07 13.79 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.926 -1.109 . . . . 0.0 112.049 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -82.16 98.61 8.79 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 113.124 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -133.91 10.61 3.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 113.44 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -5.36 35.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.22 42.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.855 1.217 . . . . 0.0 114.826 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.98 127.04 3.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.358 1.456 . . . . 0.0 112.328 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.7 m -57.8 142.03 46.99 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.361 1.065 . . . . 0.0 110.968 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.67 165.27 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.118 0.967 . . . . 0.0 111.938 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -142.01 99.85 3.61 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.118 1.767 . . . . 0.0 112.008 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.02 145.06 54.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.714 -1.241 . . . . 0.0 108.95 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -48.99 4.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.476 1.111 . . . . 0.0 111.733 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -176.6 176.03 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.818 2.047 . . . . 0.0 110.272 -174.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.65 40.61 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.089 1.755 . . . . 0.0 111.006 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -125.58 137.24 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.931 1.292 . . . . 0.0 110.364 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.57 42.22 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.151 1.78 . . . . 0.0 109.201 -175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 -23.13 3.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.87 68.11 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.073 1.416 . . . . 0.0 109.584 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.45 179.31 32.27 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.923 1.725 . . . . 0.0 110.969 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -141.98 162.31 35.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.311 1.444 . . . . 0.0 110.141 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 p -65.25 160.01 22.51 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.304 -0.873 . . . . 0.0 112.278 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.78 -19.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 161.8 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.462 1.905 . . . . 0.0 110.814 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.17 135.96 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.65 0.78 . . . . 0.0 110.038 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.8 tp -91.95 113.96 60.57 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.217 1.007 . . . . 0.0 108.393 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -66.45 125.48 13.98 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.624 2.883 . . . . 0.0 110.337 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -57.37 9.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.899 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.53 130.34 54.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.003 0.82 . . . . 0.0 111.164 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.81 121.76 49.82 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.367 1.067 . . . . 0.0 109.627 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.03 148.28 86.05 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.456 2.104 . . . . 0.0 111.285 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.5 155.4 5.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 175.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 t 40.6 55.32 2.94 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.597 1.559 . . . . 0.0 113.096 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -159.89 136.28 8.93 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.007 1.723 . . . . 0.0 111.895 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.35 177.49 5.82 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.43 1.092 . . . . 0.0 111.787 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.87 149.61 30.71 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.682 0.793 . . . . 0.0 111.912 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 171.31 7.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.731 1.212 . . . . 0.0 110.653 175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.2 158.16 37.13 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.638 1.975 . . . . 0.0 108.611 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -150.14 175.47 11.72 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.022 0.929 . . . . 0.0 111.118 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.02 172.73 29.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.886 0.755 . . . . 0.0 114.158 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -121.45 168.85 11.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.159 1.784 . . . . 0.0 113.378 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HZ1' ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -102.55 73.84 1.33 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.061 2.144 . . . . 0.0 110.774 -175.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.31 -17.78 11.73 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.1 9.68 0.51 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -117.91 -123.04 3.28 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -17.33 48.63 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.151 2.567 . . . . 0.0 113.934 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.309 8.6 p 48.11 22.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 127.927 2.491 . . . . 0.0 114.419 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.81 -83.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.319 2.248 . . . . 0.0 110.374 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.8 p -147.09 141.94 26.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.687 1.195 . . . . 0.0 113.512 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.479 ' C ' ' HZ1' ' A' ' 75' ' ' LYS . . . 61.05 171.12 0.74 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.532 1.539 . . . . 0.0 114.684 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.44 169.29 11.13 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.491 -1.593 . . . . 0.0 112.024 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.24 108.36 2.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 126.045 1.738 . . . . 0.0 110.837 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.83 179.83 7.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.122 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.18 138.47 17.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.206 1.003 . . . . 0.0 108.594 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.66 168.92 20.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.307 0.643 . . . . 0.0 111.359 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.49 30.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.785 0.803 . . . . 0.0 113.073 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -135.45 113.85 11.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.395 1.478 . . . . 0.0 110.099 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.1 115.02 7.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.923 1.289 . . . . 0.0 109.995 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.3 ttp -82.3 153.32 25.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.391 0.676 . . . . 0.0 112.029 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -59.15 -24.05 62.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.96 -7.73 43.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.547 1.539 . . . . 0.0 114.205 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.15 -1.45 73.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.407 1.479 . . . . 0.0 114.764 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.05 175.34 6.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.046 1.339 . . . . 0.0 111.184 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.7 m -136.7 115.24 11.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.266 1.427 . . . . 0.0 110.983 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 tp -81.49 126.15 31.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.03 117.35 5.28 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.412 1.006 . . . . 0.0 112.221 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -90.39 146.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.903 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -129.43 135.54 48.8 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.373 1.469 . . . . 0.0 109.879 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CG ' HG12 ' A' ' 33' ' ' VAL . 53.0 p90 -153.19 145.42 23.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.048 0.928 . . . . 0.0 113.013 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -151.04 149.72 29.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.277 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.76 95.26 49.12 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.16 -179.6 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.491 2.127 . . . . 0.0 110.609 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -62.11 171.37 1.8 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.488 1.115 . . . . 0.0 113.001 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -107.97 114.19 27.93 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.744 1.618 . . . . 0.0 111.547 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.65 173.93 11.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.151 1.781 . . . . 0.0 112.401 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.85 -37.73 80.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.438 1.495 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -59.15 128.84 39.19 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.844 1.258 . . . . 0.0 112.257 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -103.23 129.95 50.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.861 1.264 . . . . 0.0 109.252 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m 149.71 137.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 130.564 3.546 . . . . 0.0 110.829 -175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -134.56 159.61 40.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.377 1.871 . . . . 0.0 110.066 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.436 ' CZ3' ' HB2' ' A' ' 139' ' ' PRO . 50.9 m95 -97.22 147.04 24.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.335 1.054 . . . . 0.0 112.813 176.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -154.92 151.81 28.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.407 174.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -175.6 119.0 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.4 1.88 . . . . 0.0 110.186 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.88 137.7 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.056 1.743 . . . . 0.0 109.516 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -134.03 159.54 40.46 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 110.365 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.99 104.74 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.785 1.634 . . . . 0.0 108.548 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -76.33 106.52 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.321 1.448 . . . . 0.0 109.61 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -70.38 85.25 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.481 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.55 -122.47 1.35 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.508 2.004 . . . . 0.0 110.563 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -146.64 144.65 29.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.578 1.151 . . . . 0.0 111.101 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -150.49 122.95 8.46 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.139 1.376 . . . . 0.0 110.789 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.69 152.66 45.23 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.038 1.335 . . . . 0.0 109.873 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.444 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -80.81 115.26 20.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.483 -0.761 . . . . 0.0 109.289 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.9 p30 -156.79 -177.77 6.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.618 1.167 . . . . 0.0 113.012 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -53.75 -38.42 64.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.382 1.073 . . . . 0.0 112.73 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.93 -42.5 94.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.414 1.007 . . . . 0.0 112.378 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 ptm -60.72 -50.94 71.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.188 0.994 . . . . 0.0 110.383 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -57.9 -36.54 72.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.658 0.783 . . . . 0.0 112.226 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.65 -46.6 78.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 0.0 110.912 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -20.72 66.22 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.321 -1.487 . . . . 0.0 113.48 174.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.35 -17.17 37.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.867 2.467 . . . . 0.0 115.131 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.23 -23.44 4.89 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -123.83 -25.74 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.829 1.252 . . . . 0.0 111.968 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.28 -68.19 1.74 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.775 1.655 . . . . 0.0 113.579 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -141.62 55.02 4.58 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 98.1 Cg_endo -64.33 141.06 73.33 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 123.905 3.07 . . . . 0.0 113.966 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -124.07 174.73 7.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.643 1.977 . . . . 0.0 113.102 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -129.23 141.95 50.99 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.623 -1.298 . . . . 0.0 110.546 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.61 120.02 1.07 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -134.06 83.97 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.49 0.716 . . . . 0.0 111.705 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 m120 56.75 93.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.976 2.51 . . . . 0.0 114.478 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 148.56 140.6 3.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.918 1.723 . . . . 0.0 111.928 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -67.06 141.58 57.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.009 0.923 . . . . 0.0 111.849 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -144.3 140.96 29.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.907 1.283 . . . . 0.0 111.915 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -132.24 151.83 51.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 127.537 2.335 . . . . 0.0 110.506 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -150.86 157.56 43.06 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 110.638 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.63 88.33 3.92 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tp -50.01 -39.42 41.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.966 1.707 . . . . 0.0 114.314 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.38 1.61 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 117.767 1.867 . . . . 0.0 117.767 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -132.52 -32.93 1.28 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.09 -37.54 0.7 Allowed Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.665 1.126 . . . . 0.0 113.239 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.31 172.2 7.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.283 1.833 . . . . 0.0 111.112 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -133.13 156.32 47.66 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.544 1.538 . . . . 0.0 109.681 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.99 30.29 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.253 0.621 . . . . 0.0 110.902 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 134.7 53.17 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.726 1.21 . . . . 0.0 108.296 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.4 148.42 18.92 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.217 0.913 . . . . 0.0 112.421 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -121.65 113.86 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.734 1.214 . . . . 0.0 111.168 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.52 125.9 45.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.829 0.74 . . . . 0.0 109.385 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.3 p -123.63 159.87 28.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.205 1.802 . . . . 0.0 110.365 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.5 t -147.23 -73.63 0.21 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.11 -0.994 . . . . 0.0 112.376 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.33 106.79 0.48 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.79 1.236 . . . . 0.0 112.469 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.31 97.89 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 60.29 79.36 0.24 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.392 1.877 . . . . 0.0 113.274 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.03 86.14 0.24 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.134 1.373 . . . . 0.0 113.853 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 -170.62 3.06 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.1 ptm -155.4 169.48 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.04 1.336 . . . . 0.0 111.477 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -148.33 157.24 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.994 1.317 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 37.2 mm -123.7 123.01 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.833 1.253 . . . . 0.0 108.62 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -118.43 122.52 42.96 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.49 0.716 . . . . 0.0 110.289 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.2 pt -105.72 132.89 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.449 1.099 . . . . 0.0 108.829 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.7 p -150.93 163.71 38.06 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.316 0.647 . . . . 0.0 110.645 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.229 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.209 0.077 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.03 -33.37 59.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.745 0.818 . . . . 0.0 111.9 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.46 169.81 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.337 1.065 . . . . 0.0 110.982 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.6 -30.48 9.59 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.643 1.592 . . . . 0.0 111.567 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.5 p -144.87 146.08 31.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.656 1.728 . . . . 0.0 111.966 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -139.71 156.39 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.6 1.16 . . . . 0.0 110.839 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.21 163.32 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.431 1.493 . . . . 0.0 111.984 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.48 -29.43 58.74 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.48 -15.47 3.89 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.267 1.889 . . . . 0.0 112.327 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.99 -28.85 69.32 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.414 1.485 . . . . 0.0 114.115 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -119.88 3.25 11.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.898 1.679 . . . . 0.0 113.848 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -78.36 133.02 37.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.439 1.096 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.48 147.88 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.637 1.175 . . . . 0.0 109.196 175.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.16 -32.91 56.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.217 0.917 . . . . 0.0 113.202 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -60.99 -48.4 82.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.89 1.276 . . . . 0.0 113.509 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.07 -45.2 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 121.559 -0.713 . . . . 0.0 110.602 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.24 -37.59 62.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.956 1.303 . . . . 0.0 112.125 -176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -52.03 -67.2 0.27 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.436 2.295 . . . . 0.0 110.871 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -38.16 79.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.834 0.854 . . . . 0.0 112.056 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.2 -48.64 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.235 1.379 . . . . 0.0 111.435 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.18 -27.27 59.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.322 1.049 . . . . 0.0 113.44 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.37 -35.14 54.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 116.986 -1.483 . . . . 0.0 112.41 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -45.3 -27.77 0.71 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.71 2.804 . . . . 0.0 114.52 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -52.1 -37.03 52.72 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.963 0.905 . . . . 0.0 111.41 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.83 -164.34 10.33 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.073 2.273 . . . . 0.0 112.488 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -141.42 52.1 1.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.243 1.417 . . . . 0.0 112.586 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 m -136.01 169.46 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.413 1.485 . . . . 0.0 112.657 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 m -64.4 -2.97 2.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.265 1.826 . . . . 0.0 115.138 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.86 130.22 55.02 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.469 1.508 . . . . 0.0 109.071 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 138.37 20.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.007 1.323 . . . . 0.0 110.766 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.12 137.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.541 1.136 . . . . 0.0 112.194 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.27 116.49 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.549 2.339 . . . . 0.0 110.564 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.19 127.95 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 120.819 -1.176 . . . . 0.0 110.739 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.21 170.88 43.24 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 121.969 -0.457 . . . . 0.0 113.699 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.34 126.57 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.509 1.523 . . . . 0.0 110.108 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -77.53 108.0 10.38 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.523 -1.36 . . . . 0.0 112.125 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.89 93.73 9.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.211 1.404 . . . . 0.0 113.258 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.19 18.5 2.6 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 120.799 -1.188 . . . . 0.0 112.644 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 -7.8 59.5 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.5 7.61 71.95 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.657 1.123 . . . . 0.0 115.44 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.58 100.01 0.38 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.778 1.656 . . . . 0.0 111.891 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -52.18 124.44 13.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.784 2.033 . . . . 0.0 113.108 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.8 168.03 12.03 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.521 -0.737 . . . . 0.0 112.783 175.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -140.37 111.83 7.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.179 2.192 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.21 162.51 19.76 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.068 -1.02 . . . . 0.0 111.975 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.41 -64.56 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.628 1.171 . . . . 0.0 112.587 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -145.87 167.41 23.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.858 0.863 . . . . 0.0 111.533 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.3 134.46 31.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.816 1.247 . . . . 0.0 111.622 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -117.19 118.0 31.13 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.038 1.735 . . . . 0.0 109.749 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 118.86 25.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.372 2.269 . . . . 0.0 109.265 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.28 -30.54 11.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.206 1.403 . . . . 0.0 112.452 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -120.41 107.37 12.83 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.448 1.499 . . . . 0.0 108.447 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.99 123.09 3.35 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.524 1.059 . . . . 0.0 113.666 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -95.91 100.96 12.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.426 1.49 . . . . 0.0 109.515 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -67.68 168.99 10.22 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -138.92 0.32 1.96 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.936 1.695 . . . . 0.0 113.071 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.09 156.12 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.747 -1.221 . . . . 0.0 111.876 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.41 128.11 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.863 1.265 . . . . 0.0 112.537 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 tp -80.79 130.1 65.36 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 108.968 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 123.35 11.31 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.79 2.993 . . . . 0.0 111.184 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.65 -53.39 9.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.73 0.812 . . . . 0.0 112.96 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -114.58 157.35 23.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.165 0.986 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.71 87.98 11.04 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 124.024 0.93 . . . . 0.0 108.843 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.65 159.21 54.59 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.849 1.699 . . . . 0.0 111.183 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -58.47 158.49 7.46 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.718 -0.613 . . . . 0.0 111.035 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 6.9 p 58.17 42.47 22.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.223 1.409 . . . . 0.0 112.157 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -155.65 163.9 39.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.475 1.91 . . . . 0.0 111.762 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.06 -174.73 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.789 0.804 . . . . 0.0 109.422 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.52 154.52 28.75 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.542 -0.724 . . . . 0.0 111.425 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.15 164.42 28.07 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.901 0.881 . . . . 0.0 111.348 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.71 163.55 30.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.797 1.239 . . . . 0.0 109.698 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -131.01 172.36 12.17 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.3 1.84 . . . . 0.0 109.245 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.65 117.02 0.83 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-O 118.706 -1.052 . . . . 0.0 111.568 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -140.47 -172.37 3.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.253 1.421 . . . . 0.0 111.135 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.38 77.44 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.228 2.211 . . . . 0.0 113.304 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.87 -8.95 59.72 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.483 1.513 . . . . 0.0 112.99 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t -144.57 11.16 1.45 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.471 1.508 . . . . 0.0 114.448 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.42 40.78 47.21 Favored Glycine 0 CA--C 1.551 2.293 0 C-N-CA 125.294 1.426 . . . . 0.0 115.941 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.27 -32.44 16.45 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 124.242 3.295 . . . . 0.0 114.417 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -133.05 161.45 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.011 2.124 . . . . 0.0 109.94 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.48 -56.69 8.92 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.409 1.484 . . . . 0.0 112.578 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -158.6 140.9 14.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.804 2.042 . . . . 0.0 111.354 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.27 -169.25 51.65 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.359 1.457 . . . . 0.0 115.106 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.31 161.59 35.84 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.821 1.648 . . . . 0.0 114.14 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -155.37 119.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.609 1.963 . . . . 0.0 109.034 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -150.12 171.65 16.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.205 1.402 . . . . 0.0 109.119 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 127.67 6.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -131.1 165.09 24.03 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.007 0.923 . . . . 0.0 111.309 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.61 148.66 48.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -123.36 120.09 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.216 1.406 . . . . 0.0 110.528 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -71.73 102.35 2.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 0.0 110.23 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.4 mtp -66.11 152.35 44.91 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 0.0 111.893 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -56.57 -30.65 63.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.489 1.116 . . . . 0.0 113.423 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.4 p -65.27 -11.9 46.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.966 2.106 . . . . 0.0 115.157 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 18.8 41.89 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.519 1.057 . . . . 0.0 114.579 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -111.68 167.6 10.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.762 1.625 . . . . 0.0 110.804 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.1 m -128.94 101.06 5.9 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.233 -0.917 . . . . 0.0 112.767 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.64 116.34 11.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.749 0.82 . . . . 0.0 110.97 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.34 105.11 3.22 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.208 0.909 . . . . 0.0 111.876 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.04 156.32 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 0.0 110.152 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -136.57 162.85 31.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.759 1.224 . . . . 0.0 109.046 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -162.97 155.55 18.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.112 0.565 . . . . 0.0 111.022 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 t -153.53 164.01 38.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 110.645 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 m -105.02 146.64 33.06 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.493 1.117 . . . . 0.0 112.367 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.24 99.54 1.13 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.033 3.155 . . . . 0.0 112.055 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.64 26.79 0.74 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -126.25 82.54 2.08 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.174 -1.579 . . . . 0.0 111.478 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -59.6 -24.96 64.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.08 -30.76 68.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.071 1.348 . . . . 0.0 112.039 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -108.02 155.1 20.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.054 1.741 . . . . 0.0 110.386 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.94 155.92 17.68 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.309 -0.87 . . . . 0.0 111.013 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.2 m 55.15 -163.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.138 1.375 . . . . 0.0 112.326 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.36 149.53 52.0 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.512 -1.367 . . . . 0.0 110.216 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -84.38 142.54 30.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.331 1.452 . . . . 0.0 113.146 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.01 146.2 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -163.17 152.88 15.4 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.106 0.962 . . . . 0.0 112.957 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.9 140.84 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.031 0.932 . . . . 0.0 109.258 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -145.32 133.97 22.16 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.164 1.386 . . . . 0.0 109.387 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.3 mt -95.61 110.17 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 124.869 1.267 . . . . 0.0 108.496 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -76.21 96.26 3.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.3 p -55.69 119.42 5.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.82 -111.61 3.04 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 143.0 27.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.549 1.14 . . . . 0.0 112.281 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -158.87 117.53 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.657 1.583 . . . . 0.0 111.902 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 166.74 22.46 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.745 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 115.52 20.04 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.198 0.599 . . . . 0.0 110.535 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.21 -173.14 4.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.789 1.236 . . . . 0.0 111.872 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -50.73 -49.43 57.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.136 0.974 . . . . 0.0 111.732 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.73 -36.87 50.31 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.597 1.094 . . . . 0.0 113.683 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.72 -63.25 1.11 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.106 0.962 . . . . 0.0 110.425 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -51.61 -34.14 36.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.271 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -64.73 -47.86 76.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.645 1.178 . . . . 0.0 110.627 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.08 -25.25 66.93 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.11 -1.619 . . . . 0.0 113.401 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -83.48 -12.2 56.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.857 1.663 . . . . 0.0 114.941 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -124.16 -32.6 3.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.93 1.292 . . . . 0.0 114.094 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -114.87 -23.75 8.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.883 1.673 . . . . 0.0 112.778 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.93 -85.87 0.03 OUTLIER Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.251 1.881 . . . . 0.0 112.21 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -164.07 63.35 1.13 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.643 1.577 . . . . 0.0 112.15 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.15 178.32 7.45 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.896 2.398 . . . . 0.0 115.706 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.57 -171.07 2.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.539 1.936 . . . . 0.0 113.819 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -139.2 146.58 40.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.535 1.934 . . . . 0.0 111.365 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.65 -57.74 0.46 Allowed Glycine 0 N--CA 1.479 1.554 0 C-N-CA 124.503 1.049 . . . . 0.0 115.664 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.1 t0 52.86 68.62 0.8 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.826 1.651 . . . . 0.0 114.431 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.312 0.1 OUTLIER 40.95 69.05 0.37 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.122 2.169 . . . . 0.0 114.441 176.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 119.75 0.8 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.213 1.863 . . . . 0.0 111.496 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -57.78 132.89 54.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.159 0.983 . . . . 0.0 112.028 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -147.9 125.06 11.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.293 1.037 . . . . 0.0 112.364 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.01 137.47 49.99 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.895 1.678 . . . . 0.0 109.859 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 151.77 40.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.111 0.965 . . . . 0.0 110.877 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -74.53 93.94 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tp -48.62 -30.46 5.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.58 31.59 2.12 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.81 -27.36 1.15 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.45 -15.35 0.96 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.594 1.092 . . . . 0.0 114.675 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.49 171.64 13.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.647 1.579 . . . . 0.0 111.208 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.44 157.11 24.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.515 1.126 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -134.94 164.65 27.13 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.637 0.775 . . . . 0.0 109.447 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -133.2 122.8 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.924 1.69 . . . . 0.0 108.757 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.43 143.76 17.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.564 0.602 . . . . 0.0 113.19 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.11 143.84 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.514 1.526 . . . . 0.0 110.222 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 9.6 tpt -132.44 124.9 29.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.122 1.369 . . . . 0.0 109.458 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.9 p -128.96 135.53 49.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.933 0.893 . . . . 0.0 110.82 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -97.43 178.31 5.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.666 1.986 . . . . 0.0 112.135 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.05 -171.04 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.045 2.138 . . . . 0.0 112.132 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.66 174.67 45.25 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 47.43 21.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.472 1.909 . . . . 0.0 116.137 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.24 150.27 45.5 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.503 1.921 . . . . 0.0 113.079 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -164.63 154.41 13.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.053 1.341 . . . . 0.0 113.654 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.55 138.7 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.333 2.253 . . . . 0.0 112.448 174.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -143.11 161.45 38.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.22 1.808 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 mm -126.44 117.11 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.436 1.095 . . . . 0.0 109.96 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -96.24 117.16 30.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.534 1.134 . . . . 0.0 108.181 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 4.3 pt -109.88 130.9 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.31 142.93 2.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.736 0.814 . . . . 0.0 112.342 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.49 1.516 . . . . 0.0 113.435 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.831 0.348 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.02 -54.38 6.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.313 1.045 . . . . 0.0 113.372 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 142.95 33.56 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.343 0.592 . . . . 0.0 110.875 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.63 -21.81 13.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.249 1.88 . . . . 0.0 112.242 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -150.67 155.64 39.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.699 1.999 . . . . 0.0 112.005 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -140.82 167.91 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.93 1.692 . . . . 0.0 111.17 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -169.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.301 1.841 . . . . 0.0 111.04 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.72 -41.98 5.14 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.01 -32.55 5.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.161 1.362 . . . . 0.0 112.84 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 118.437 1.119 . . . . 0.0 111.608 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -85.39 -5.33 59.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.107 1.763 . . . . 0.0 113.778 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 HE22 ' A' ' 170' ' ' GLN . 5.0 tt -65.46 137.33 57.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.089 0.956 . . . . 0.0 109.914 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.55 146.01 35.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.322 1.049 . . . . 0.0 109.799 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -54.87 -32.8 61.18 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.888 0.767 . . . . 0.0 112.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -56.6 -56.45 21.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.452 1.101 . . . . 0.0 112.702 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.56 -49.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -19.17 26.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.237 1.415 . . . . 0.0 113.523 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -82.59 -47.92 11.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.973 2.109 . . . . 0.0 111.514 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -33.25 73.14 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.546 -1.346 . . . . 0.0 110.84 174.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -45.69 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.493 1.517 . . . . 0.0 112.821 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -33.53 68.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.819 0.448 . . . . 0.0 111.259 175.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.85 -23.04 58.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.77 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -47.38 -25.22 0.96 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.813 2.045 . . . . 0.0 113.19 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 tp -51.68 -27.11 10.63 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.164 1.786 . . . . 0.0 112.33 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.39 -136.08 2.17 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.919 1.724 . . . . 0.0 112.819 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -141.53 43.03 1.75 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 126.644 1.978 . . . . 0.0 113.2 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.69 159.12 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.233 1.813 . . . . 0.0 112.428 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.76 -26.56 59.86 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -69.43 82.87 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.962 1.305 . . . . 0.0 112.859 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 161.95 40.6 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.023 -1.048 . . . . 0.0 113.095 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.41 139.55 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 112.313 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.83 98.93 6.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.365 2.266 . . . . 0.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.33 159.3 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.796 -1.19 . . . . 0.0 110.881 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.3 -176.34 43.35 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-O 121.36 0.422 . . . . 0.0 112.079 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.39 144.7 29.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.022 0.929 . . . . 0.0 110.703 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.17 106.05 16.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.508 1.523 . . . . 0.0 112.006 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 p-10 -93.45 107.66 19.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.676 1.59 . . . . 0.0 111.963 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -136.84 10.27 3.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.302 1.441 . . . . 0.0 112.206 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -8.66 55.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.656 1.582 . . . . 0.0 115.13 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.05 28.38 41.63 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.611 1.101 . . . . 0.0 114.419 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.12 128.15 3.47 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.005 1.764 . . . . 0.0 111.206 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 m -58.22 147.6 29.89 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.315 1.446 . . . . 0.0 111.35 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 37' ' ' ASN . 45.9 m0 -110.72 173.48 6.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.875 -1.141 . . . . 0.0 112.966 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -153.63 98.78 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.573 1.549 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.67 137.34 45.96 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.005 -1.684 . . . . 0.0 110.603 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 -64.35 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.409 0.684 . . . . 0.0 111.224 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -154.26 -171.82 4.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.494 1.918 . . . . 0.0 110.885 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.23 134.77 29.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.033 1.333 . . . . 0.0 111.886 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -110.3 131.0 55.44 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.832 1.253 . . . . 0.0 109.915 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -153.0 162.29 41.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.069 1.348 . . . . 0.0 111.377 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -124.58 -56.67 1.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.143 1.377 . . . . 0.0 109.885 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.6 m -91.83 113.3 25.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.111 0.965 . . . . 0.0 110.559 177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.09 115.78 3.71 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -76.17 -179.76 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.911 1.284 . . . . 0.0 112.238 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.4 p -79.6 163.36 24.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 112.184 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.74 -35.65 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.981 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 160.25 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.59 1.956 . . . . 0.0 109.709 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 tt -80.32 133.89 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.85 0.86 . . . . 0.0 110.743 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.7 tp -80.88 128.33 71.83 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.05 163.77 27.45 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.347 2.031 . . . . 0.0 111.132 175.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -112.6 -66.05 1.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.514 1.126 . . . . 0.0 110.356 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.6 126.74 44.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.975 0.91 . . . . 0.0 109.819 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.32 129.91 24.45 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.593 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.26 -172.51 0.44 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.044 3.829 . . . . 0.0 113.204 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -82.06 153.01 26.35 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 119.685 -1.884 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.9 p 49.83 42.15 23.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.618 1.567 . . . . 0.0 114.736 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -156.0 122.6 5.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.067 1.747 . . . . 0.0 113.875 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -177.86 6.82 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.497 1.519 . . . . 0.0 114.125 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.27 152.37 41.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.244 1.418 . . . . 0.0 110.633 174.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 164.18 19.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -136.53 166.78 22.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.089 1.755 . . . . 0.0 110.539 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.6 p -138.71 168.5 19.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.297 1.439 . . . . 0.0 111.098 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 165.97 36.63 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.337 0.97 . . . . 0.0 111.569 174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -143.49 171.46 14.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.981 1.313 . . . . 0.0 112.082 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -94.87 80.84 3.72 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.267 1.427 . . . . 0.0 113.556 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -122.21 -11.72 8.38 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.74 13.73 1.35 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.761 1.224 . . . . 0.0 113.286 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.49 -95.46 0.3 Allowed Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.85 -1.156 . . . . 0.0 113.683 -176.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 81' ' ' ALA . 44.7 Cg_endo -74.87 -25.53 12.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.268 1.978 . . . . 0.0 113.507 -175.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.343 12.4 p 49.95 -1.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 130.189 3.395 . . . . 0.0 117.347 -176.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 79' ' ' PRO . . . -166.94 19.53 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 128.822 2.849 . . . . 0.0 113.317 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.43 -178.72 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.911 1.685 . . . . 0.0 111.591 -174.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.73 145.68 35.8 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.103 1.335 . . . . 0.0 114.382 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 151.95 40.23 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.321 1.048 . . . . 0.0 111.337 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.6 105.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.77 2.428 . . . . 0.0 110.59 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 102' ' ' PHE . . . -135.06 156.21 49.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.287 1.041 . . . . 0.0 110.897 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.29 111.65 5.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.517 1.127 . . . . 0.0 109.091 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -125.73 154.17 42.87 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.518 1.127 . . . . 0.0 112.074 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.88 140.6 50.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.274 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.66 110.36 19.05 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.712 1.205 . . . . 0.0 110.022 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.72 96.0 0.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.253 1.421 . . . . 0.0 110.41 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.4 ttt -62.95 146.91 51.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.038 1.735 . . . . 0.0 111.522 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 t -53.27 -23.65 9.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.648 1.179 . . . . 0.0 114.118 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 m -67.42 0.5 2.91 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.87 54.41 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.388 0.994 . . . . 0.0 112.125 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -124.15 166.52 15.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.486 1.914 . . . . 0.0 109.649 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.5 m -137.83 101.05 4.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.159 -0.963 . . . . 0.0 111.697 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -69.77 112.72 6.42 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.345 -0.847 . . . . 0.0 110.794 175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.5 102.97 2.99 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.705 1.145 . . . . 0.0 112.782 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.62 151.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.67 0.788 . . . . 0.0 111.699 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 6.3 ttp -134.54 150.65 50.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.385 1.474 . . . . 0.0 111.642 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CE2' ' HB1' ' A' ' 86' ' ' ALA . 4.6 p90 -162.34 151.37 15.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.341 1.057 . . . . 0.0 110.78 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -158.35 126.86 5.42 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 110.447 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.12 128.4 60.17 Favored Pre-proline 0 N--CA 1.48 1.049 0 O-C-N 121.209 -0.932 . . . . 0.0 111.2 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.79 167.59 25.34 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.802 3.002 . . . . 0.0 112.529 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.64 22.32 0.46 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.8 t70 87.18 126.98 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.101 2.96 . . . . 0.0 110.191 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.57 168.38 18.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.771 1.228 . . . . 0.0 111.669 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -58.26 -61.78 2.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.827 0.851 . . . . 0.0 111.02 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -168.77 90.6 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.811 1.644 . . . . 0.0 110.998 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.33 136.49 16.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.757 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -169.77 1.42 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.867 0.841 . . . . 0.0 110.615 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 131.11 35.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.726 1.21 . . . . 0.0 112.462 -175.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -97.67 131.16 44.48 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.078 0.951 . . . . 0.0 112.447 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.6 129.19 15.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.159 0.981 . . . . 0.0 109.941 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.73 107.76 1.52 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 m -115.83 161.5 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.368 0.667 . . . . 0.0 109.337 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -154.65 154.48 33.03 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.06 0.544 . . . . 0.0 111.367 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.439 ' H ' ' CD2' ' A' ' 151' ' ' LEU . 5.3 mp -107.66 110.19 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.991 0.916 . . . . 0.0 109.869 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.64 92.74 1.98 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.829 1.652 . . . . 0.0 109.919 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -68.78 81.08 0.29 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.567 -1.333 . . . . 0.0 111.497 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.13 -99.12 0.13 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.453 1.978 . . . . 0.0 112.354 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -165.33 104.19 0.74 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.911 1.684 . . . . 0.0 110.832 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -149.86 103.44 3.22 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 172.26 1.75 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.16 1.384 . . . . 0.0 112.386 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.39 119.96 19.3 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.62 -0.675 . . . . 0.0 112.184 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.62 -173.29 3.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.579 1.551 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -51.06 -52.98 38.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.427 1.091 . . . . 0.0 112.183 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.03 -31.05 64.48 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.769 0.7 . . . . 0.0 113.175 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.7 ttt -65.81 -64.45 0.86 Allowed 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -53.65 -33.67 56.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.026 0.93 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.48 -49.14 78.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.039 0.936 . . . . 0.0 109.195 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.54 -3.79 19.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.8 mt -102.78 -22.23 13.94 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.91 -25.24 9.52 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.959 -1.088 . . . . 0.0 113.671 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.56 0.85 8.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.408 1.483 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.99 71.63 0.3 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.401 1.953 . . . . 0.0 114.535 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.27 2.2 m120 85.49 57.49 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 130.203 3.401 . . . . 0.0 112.376 -175.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.91 125.0 14.47 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.763 2.976 . . . . 0.0 112.886 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.58 173.75 6.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.24 1.416 . . . . 0.0 112.82 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.06 142.84 51.43 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.119 1.767 . . . . 0.0 110.212 -174.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.09 118.07 1.66 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 121.658 0.588 . . . . 0.0 112.569 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -97.67 26.17 5.26 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.459 2.303 . . . . 0.0 114.528 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 77.12 94.86 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.235 2.614 . . . . 0.0 111.919 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 138.74 2.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.112 1.339 . . . . 0.0 112.862 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.456 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 22.4 m95 -64.59 130.81 45.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.487 1.515 . . . . 0.0 112.037 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -145.25 119.27 9.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.416 1.486 . . . . 0.0 112.114 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.91 143.02 27.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.546 1.138 . . . . 0.0 111.788 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.32 155.93 29.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.108 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 96.91 2.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.892 0.877 . . . . 0.0 108.923 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 2.7 tp -49.82 -49.97 46.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.458 1.103 . . . . 0.0 112.048 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.6 80.12 1.25 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.883 1.706 . . . . 0.0 114.733 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -168.92 -36.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.819 2.047 . . . . 0.0 111.688 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.07 -80.51 0.06 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.372 1.463 . . . . 0.0 113.058 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.07 -179.2 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.786 1.235 . . . . 0.0 112.837 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -117.29 145.35 44.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 0.0 112.169 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.34 172.32 13.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.069 0.938 . . . . 0.0 112.211 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -133.18 139.13 46.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.499 1.12 . . . . 0.0 110.263 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -122.55 164.46 15.56 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.233 1.397 . . . . 0.0 113.516 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.456 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 5.2 tp -139.23 95.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.18 99.04 10.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.861 -1.775 . . . . 0.0 112.351 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.71 132.68 56.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.436 1.094 . . . . 0.0 112.725 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 69.4 p -152.86 91.82 1.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.395 1.478 . . . . 0.0 112.711 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.9 52.5 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.511 -1.368 . . . . 0.0 111.57 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.8 125.94 1.44 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.252 17.5 pt-20 46.02 36.74 3.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.595 1.558 . . . . 0.0 114.195 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.21 162.46 18.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.085 2.154 . . . . 0.0 112.507 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.97 -172.68 4.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.541 1.536 . . . . 0.0 112.991 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -119.24 153.54 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.798 2.039 . . . . 0.0 111.883 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.461 HE22 HD13 ' A' ' 12' ' ' LEU . 31.4 tt0 -136.72 154.72 50.51 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.785 1.634 . . . . 0.0 110.468 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.68 120.19 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 109.731 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -112.08 111.06 21.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.581 1.552 . . . . 0.0 109.707 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 pt -97.23 144.3 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.882 1.273 . . . . 0.0 111.761 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.7 p -158.07 151.73 23.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.34 1.056 . . . . 0.0 112.535 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.679 1.591 . . . . 0.0 112.325 -176.138 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 159.0 12.26 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.935 0.894 . . . . 0.0 110.429 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.2 -9.13 56.07 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.261 0.934 . . . . 0.0 112.881 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -163.34 143.3 8.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.068 2.147 . . . . 0.0 110.375 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 70' ' ' LEU . 63.3 mt -143.75 160.78 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 125.377 1.471 . . . . 0.0 109.679 175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.02 -173.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 127.603 2.361 . . . . 0.0 112.008 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.28 -19.82 9.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -17.03 48.6 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.384 1.469 . . . . 0.0 112.435 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.69 67.87 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.617 1.167 . . . . 0.0 112.765 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -106.19 -2.8 22.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.261 1.824 . . . . 0.0 114.15 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.6 tp -67.11 138.65 57.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.954 1.302 . . . . 0.0 109.204 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.6 141.28 20.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.97 0.508 . . . . 0.0 110.984 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.59 -33.68 70.25 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.67 -47.45 76.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.143 1.377 . . . . 0.0 113.978 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.32 -54.28 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.653 1.181 . . . . 0.0 108.729 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.616 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.1 -33.77 27.63 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.04 1.736 . . . . 0.0 113.094 -175.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.44 -59.35 5.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.493 1.917 . . . . 0.0 110.88 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -35.76 81.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.921 1.689 . . . . 0.0 111.992 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.36 -45.8 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.129 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 32' ' ' ALA . 65.9 mt -64.42 -32.3 73.87 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 -19.78 60.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.581 1.152 . . . . 0.0 113.823 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -58.61 -32.51 69.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.859 -1.151 . . . . 0.0 111.645 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 56' ' ' ASP . 31.0 tp . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.301 1.441 . . . . 0.0 113.037 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.0 149.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.483 1.113 . . . . 0.0 111.468 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -125.79 110.12 13.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.144 1.378 . . . . 0.0 111.924 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.643 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.0 OUTLIER -120.83 118.55 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.001 1.32 . . . . 0.0 109.78 175.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 168.98 40.82 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.222 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.508 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.1 mp -135.31 130.72 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.0 109.576 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.4 105.02 8.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.283 1.033 . . . . 0.0 111.761 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -73.22 85.56 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.671 2.388 . . . . 0.0 111.955 175.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -137.53 46.08 2.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.823 -1.173 . . . . 0.0 111.38 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -2.45 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 175.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.71 24.28 62.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.365 0.983 . . . . 0.0 114.8 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.75 114.64 1.06 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.582 1.563 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -53.42 127.59 25.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.945 1.298 . . . . 0.0 111.289 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.548 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 53.7 m0 -91.38 157.37 17.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -137.9 109.56 7.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.951 1.701 . . . . 0.0 111.094 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -70.99 143.22 50.88 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.314 -0.866 . . . . 0.0 110.234 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -113.02 -47.35 3.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.343 1.457 . . . . 0.0 113.066 -178.122 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' H ' HD22 ' A' ' 46' ' ' LEU . 54.0 t30 -156.63 171.49 20.25 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.633 1.573 . . . . 0.0 111.199 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.59 121.82 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 111.869 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.43 ' H ' ' HB1' ' A' ' 126' ' ' ALA . 3.4 t80 -100.9 129.25 46.73 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 110.017 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 24.0 p90 -153.36 160.43 42.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.911 1.285 . . . . 0.0 112.018 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -116.43 -8.1 11.62 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.497 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 p -53.62 157.77 2.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.582 1.953 . . . . 0.0 112.79 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -35.16 -66.44 0.35 Allowed Glycine 0 N--CA 1.469 0.893 0 C-N-CA 127.96 2.695 . . . . 0.0 115.945 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.412 HG22 ' NE ' ' A' ' 74' ' ' ARG . 1.2 t -165.44 178.46 6.78 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.778 1.631 . . . . 0.0 111.492 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.9 171.39 8.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 111.648 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 24' ' ' LEU . 2.6 t0 -154.67 -28.21 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.832 -1.168 . . . . 0.0 113.294 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 24' ' ' LEU . 31.2 m -132.9 158.24 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.261 1.824 . . . . 0.0 110.832 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 tt -73.24 132.82 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.462 1.105 . . . . 0.0 111.654 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.01 122.26 82.95 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.377 1.071 . . . . 0.0 110.19 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.6 Cg_endo -64.77 114.87 2.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.359 3.373 . . . . 0.0 112.689 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.17 -55.16 17.71 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.58 153.64 30.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.456 1.102 . . . . 0.0 110.68 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.38 121.22 16.32 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.694 0.798 . . . . 0.0 111.592 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.94 162.06 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.716 2.277 . . . . 0.0 112.05 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -62.1 156.88 20.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.449 0.7 . . . . 0.0 112.172 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.2 p 41.78 49.44 3.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.37 1.868 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -141.24 -171.42 3.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.997 1.719 . . . . 0.0 111.361 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.14 -177.02 5.69 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.832 -1.167 . . . . 0.0 110.298 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -158.09 142.52 16.09 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.133 -0.979 . . . . 0.0 112.214 175.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -108.53 170.44 8.02 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.889 0.875 . . . . 0.0 110.735 176.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.643 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.5 t80 -152.15 165.71 33.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.473 1.509 . . . . 0.0 107.882 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.1 m -145.07 169.14 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.677 1.191 . . . . 0.0 109.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -157.54 7.19 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.314 0.483 . . . . 0.0 112.072 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.412 ' NE ' HG22 ' A' ' 54' ' ' THR . 10.4 ttp180 . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 125.59 1.556 . . . . 0.0 110.627 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 t -147.58 121.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.48 -1.387 . . . . 0.0 113.485 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -148.08 164.72 32.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.46 1.104 . . . . 0.0 111.212 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.18 110.2 4.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.647 1.179 . . . . 0.0 108.369 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.05 152.92 48.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.255 1.022 . . . . 0.0 112.069 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -115.78 148.96 39.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.435 -175.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 43.6 m-85 -122.83 124.24 42.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.961 1.304 . . . . 0.0 110.105 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.56 109.26 2.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 110.178 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.11 153.21 38.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.013 1.325 . . . . 0.0 111.17 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -63.87 -22.03 66.73 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.21 1.8 20.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.299 1.04 . . . . 0.0 113.781 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.76 19.52 70.45 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.663 1.125 . . . . 0.0 113.864 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -102.59 171.21 7.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 109.221 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.556 HG22 ' HB1' ' A' ' 89' ' ' ALA . 97.1 m -133.55 103.51 5.95 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.539 -1.351 . . . . 0.0 112.109 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.508 ' CD2' HG21 ' A' ' 35' ' ' ILE . 14.2 tp -69.75 126.65 30.36 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.297 -0.877 . . . . 0.0 110.345 174.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.23 107.47 3.06 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.18 165.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 117.632 0.716 . . . . 0.0 110.333 175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -151.41 140.75 21.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.232 177.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 27.6 p90 -153.34 160.04 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.662 0.744 . . . . 0.0 110.313 175.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -162.14 167.43 24.2 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.732 1.613 . . . . 0.0 109.19 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.42 106.64 57.08 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 123.011 2.474 . . . . 0.0 113.234 179.77 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 111.38 0.141 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -73.1 148.5 43.91 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.451 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.9 p-90 -148.04 169.43 19.96 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.519 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.9 t70 179.62 163.57 0.99 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 128.048 2.539 . . . . 0.0 110.379 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.548 HG11 ' SD ' ' A' ' 157' ' ' MET . 3.6 p -165.6 136.65 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.079 2.152 . . . . 0.0 109.252 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -152.42 156.6 39.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.87 1.268 . . . . 0.0 110.483 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.79 106.16 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.658 1.583 . . . . 0.0 107.767 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -74.69 98.74 3.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.273 1.029 . . . . 0.0 109.338 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.4 t -59.07 137.49 57.93 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.738 -1.226 . . . . 0.0 110.828 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.2 -117.42 5.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.496 1.522 . . . . 0.0 110.124 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 128.16 12.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.503 1.121 . . . . 0.0 111.253 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.37 114.72 10.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.068 1.347 . . . . 0.0 111.221 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.05 164.71 23.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 110.283 174.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.43 ' HB1' ' H ' ' A' ' 49' ' ' TYR . . . -80.95 109.0 15.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.903 -0.498 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.38 -173.28 4.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.202 1.401 . . . . 0.0 110.019 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.63 -43.29 56.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.002 0.921 . . . . 0.0 111.202 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -33.32 38.93 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.556 1.074 . . . . 0.0 114.329 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.1 ttt -70.51 -60.15 2.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.829 0.815 . . . . 0.0 110.452 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.42 ' HA ' HD12 ' A' ' 134' ' ' LEU . 74.0 t80 -56.94 -31.18 64.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.16 0.984 . . . . 0.0 113.632 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.33 -39.15 93.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 110.148 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -26.58 67.48 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.547 -1.346 . . . . 0.0 111.872 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 131' ' ' TYR . 3.6 mt -78.39 -43.41 27.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.236 1.414 . . . . 0.0 112.028 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.08 -28.32 16.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.62 -40.42 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.802 1.641 . . . . 0.0 111.707 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.63 -58.25 8.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.749 1.642 . . . . 0.0 111.572 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -178.75 88.29 0.22 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 127.225 2.21 . . . . 0.0 111.637 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.73 141.02 40.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.303 2.002 . . . . 0.0 111.234 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -112.83 173.75 6.23 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.37 1.468 . . . . 0.0 111.575 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.98 134.08 46.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.52 1.528 . . . . 0.0 110.718 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.22 106.85 0.7 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.436 1.017 . . . . 0.0 112.362 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -121.5 71.97 0.99 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.133 1.373 . . . . 0.0 111.117 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 59.61 101.09 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.692 2.797 . . . . 0.0 115.868 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.2 161.88 9.65 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.454 1.026 . . . . 0.0 114.593 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.523 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 m95 -78.55 150.65 32.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.725 1.21 . . . . 0.0 110.629 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -152.04 133.13 14.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.862 1.665 . . . . 0.0 110.718 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.8 146.13 49.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.31 1.444 . . . . 0.0 112.387 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -150.46 157.55 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.88 0.848 . . . . 0.0 112.123 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -80.53 92.98 5.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.486 1.514 . . . . 0.0 108.088 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 tp -52.51 -39.83 61.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.23 30.26 2.75 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.28 -22.61 1.97 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.448 1.624 . . . . 0.0 115.175 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.74 -21.56 1.82 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.265 1.412 . . . . 0.0 114.035 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 pp -124.1 173.52 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.731 1.612 . . . . 0.0 112.538 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -116.3 158.66 23.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.02 1.328 . . . . 0.0 111.336 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.548 ' SD ' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -131.31 155.03 47.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.584 0.354 . . . . 0.0 110.926 175.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.5 tppt? -126.16 127.47 45.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.545 1.938 . . . . 0.0 109.727 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.72 137.63 14.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 126.105 1.812 . . . . 0.0 112.812 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -117.13 146.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.496 1.118 . . . . 0.0 111.063 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.25 145.78 51.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.959 0.904 . . . . 0.0 109.352 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.42 HG23 ' CD1' ' A' ' 160' ' ' ILE . 42.0 p -144.03 126.62 15.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.171 1.388 . . . . 0.0 110.949 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m -89.07 178.52 6.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.002 2.121 . . . . 0.0 112.059 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.39 -178.7 0.18 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.95 2.5 . . . . 0.0 112.534 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 161.87 51.43 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.259 -0.901 . . . . 0.0 111.72 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 55.64 29.49 13.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.519 1.127 . . . . 0.0 112.792 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -126.53 144.56 50.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.115 1.766 . . . . 0.0 112.819 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.511 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 24.6 tptp -162.64 149.46 13.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.54 137.78 37.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.2 2.2 . . . . 0.0 112.682 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -135.6 157.33 47.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.876 1.67 . . . . 0.0 110.59 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 117' ' ' VAL . 13.3 mm -129.32 124.52 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.36 1.064 . . . . 0.0 110.769 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 131.99 54.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.425 1.49 . . . . 0.0 111.65 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.548 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 11.3 pt -118.23 134.26 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.813 1.645 . . . . 0.0 110.455 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.6 p -163.47 177.17 9.08 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.515 1.526 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.782 1.233 . . . . 0.0 111.919 -176.21 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.83 173.25 4.55 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.522 0.677 . . . . 0.0 110.388 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.63 -36.32 3.83 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.1 p -137.02 161.13 36.9 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.624 -1.515 . . . . 0.0 111.48 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 70' ' ' LEU . 36.1 mm -137.8 163.41 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.904 1.281 . . . . 0.0 110.416 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 pt -67.62 -170.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.893 2.077 . . . . 0.0 110.458 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.43 -28.15 4.9 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 119.722 -1.861 . . . . 0.0 115.932 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.2 69.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.465 1.031 . . . . 0.0 113.803 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.19 -42.06 39.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.524 1.13 . . . . 0.0 111.29 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -8.3 59.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.227 1.411 . . . . 0.0 114.106 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 17' ' ' LEU . 12.7 tp -59.83 143.79 50.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 0.0 110.305 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.25 150.74 31.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.527 1.131 . . . . 0.0 109.906 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -55.19 -26.68 40.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -62.05 -58.16 8.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.617 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.18 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.077 0.551 . . . . 0.0 109.73 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.37 -23.66 66.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.407 1.083 . . . . 0.0 113.456 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.24 -51.51 13.14 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.363 -1.461 . . . . 0.0 110.374 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -40.52 96.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 112.908 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -64.07 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.164 0.986 . . . . 0.0 112.857 -174.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 32' ' ' ALA . 69.4 mt -76.9 -31.86 57.02 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 110.891 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.43 -37.26 74.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.933 0.893 . . . . 0.0 111.921 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -19.89 47.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.028 1.331 . . . . 0.0 114.517 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 127.206 2.202 . . . . 0.0 113.336 175.062 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.947 0.404 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.5 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -133.19 142.02 43.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 125.196 1.398 . . . . 0.0 111.946 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -127.94 115.32 18.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.965 1.706 . . . . 0.0 109.684 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.2 p -131.75 128.76 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.873 1.269 . . . . 0.0 109.088 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.12 -179.53 40.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.523 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 3.4 mp -130.41 146.02 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.795 0.838 . . . . 0.0 111.543 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -96.7 109.41 22.06 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.296 -0.877 . . . . 0.0 111.63 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 91.61 6.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.078 0.951 . . . . 0.0 111.244 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.1 56.74 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.25 1.42 . . . . 0.0 109.697 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t -119.77 -45.63 2.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.194 1.397 . . . . 0.0 113.346 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 13.91 2.18 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.657 1.122 . . . . 0.0 115.878 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.33 146.57 17.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.093 1.33 . . . . 0.0 112.552 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 m -73.92 145.03 45.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.718 1.607 . . . . 0.0 110.589 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.453 ' CE2' HD11 ' A' ' 173' ' ' ILE . 22.0 m0 -112.52 166.49 11.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.666 -0.647 . . . . 0.0 112.573 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.9 m -143.62 109.43 5.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.19 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -69.24 151.31 46.44 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.818 -1.176 . . . . 0.0 111.232 175.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.54 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -106.91 -55.1 2.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.7 1.6 . . . . 0.0 111.6 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -160.9 -172.95 3.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.904 1.682 . . . . 0.0 110.829 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.02 137.76 29.5 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.103 1.361 . . . . 0.0 111.325 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -121.01 127.74 52.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.515 1.526 . . . . 0.0 110.151 178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.568 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -133.35 162.79 30.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 112.584 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -124.0 -43.98 2.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.673 1.589 . . . . 0.0 112.27 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.8 p -129.61 113.28 14.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.891 1.276 . . . . 0.0 112.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 114.9 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.332 1.444 . . . . 0.0 111.485 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.09 178.72 3.65 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.875 0.845 . . . . 0.0 112.001 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.02 162.78 1.75 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.576 1.95 . . . . 0.0 112.294 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.38 -32.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.104 -0.998 . . . . 0.0 112.22 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.08 169.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.986 2.114 . . . . 0.0 111.905 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -70.27 127.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.872 1.269 . . . . 0.0 112.801 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.74 129.78 60.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.62 146.53 79.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.501 2.8 . . . . 0.0 111.244 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.89 -53.08 3.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 112.417 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -122.08 143.94 49.22 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 110.44 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.684 HG21 HD22 ' A' ' 69' ' ' LEU . 49.9 t -136.27 130.14 18.11 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.644 1.177 . . . . 0.0 110.563 -174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.02 163.15 25.85 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.88 3.054 . . . . 0.0 112.562 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -70.07 14.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -140.24 15.68 2.42 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.09 1.756 . . . . 0.0 114.268 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.88 155.1 47.37 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.524 1.13 . . . . 0.0 112.522 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.23 -177.01 3.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.609 1.195 . . . . 0.0 112.159 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -152.77 154.22 34.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 175.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CD1' HD21 ' A' ' 17' ' ' LEU . 12.7 mt -138.11 167.22 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.283 1.433 . . . . 0.0 109.495 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.2 t80 -141.71 165.83 26.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.532 1.533 . . . . 0.0 109.966 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -145.99 169.1 19.32 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.35 1.06 . . . . 0.0 110.887 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.32 177.44 27.51 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.472 1.034 . . . . 0.0 111.109 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.574 1.15 . . . . 0.0 112.904 -176.62 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.06 113.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.773 2.029 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -148.31 176.6 10.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 111.542 175.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.48 118.66 5.13 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -126.04 160.71 29.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.053 0.941 . . . . 0.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -118.87 169.32 9.97 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.582 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -140.51 121.32 14.44 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.559 1.144 . . . . 0.0 110.943 -177.289 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.17 111.08 2.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.224 1.01 . . . . 0.0 109.223 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -72.2 153.87 41.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 111.034 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -58.01 -28.37 64.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -80.67 3.75 21.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.789 1.236 . . . . 0.0 114.306 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.28 -0.92 87.47 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.344 1.45 . . . . 0.0 114.516 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -78.58 178.65 7.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.61 1.564 . . . . 0.0 110.878 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.477 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 68.0 m -140.57 110.76 6.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.832 -1.168 . . . . 0.0 112.651 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 173' ' ' ILE . 27.1 tp -75.63 122.59 24.18 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.09 4.35 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 118.856 0.753 . . . . 0.0 112.471 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.41 160.99 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.294 1.047 . . . . 0.0 112.071 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.691 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -145.35 167.11 23.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.427 -0.796 . . . . 0.0 112.638 174.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 33' ' ' VAL . 45.1 p90 -169.48 158.6 8.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.026 1.331 . . . . 0.0 112.098 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 132.51 3.73 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.126 1.77 . . . . 0.0 108.381 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.93 138.15 26.31 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 119.096 0.862 . . . . 0.0 109.087 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.543 0.958 0 C-N-CA 122.765 2.31 . . . . 0.0 111.741 174.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 120.91 0.386 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -82.52 150.12 27.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.49 1.116 . . . . 0.0 112.161 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -161.44 149.01 14.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.799 1.64 . . . . 0.0 108.715 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -167.97 117.5 0.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.132 0.973 . . . . 0.0 110.871 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.44 HG11 HG21 ' A' ' 171' ' ' ILE . 46.3 t -118.12 135.2 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 123.007 0.523 . . . . 0.0 110.706 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -148.73 142.8 25.93 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.067 175.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.3 115.82 30.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -86.04 109.66 18.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.0 t -66.82 93.35 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.527 -1.358 . . . . 0.0 111.52 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.05 148.22 6.39 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 128.048 2.737 . . . . 0.0 111.796 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -48.13 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.68 2.392 . . . . 0.0 114.305 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -111.92 103.06 11.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.187 1.395 . . . . 0.0 112.978 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 162.49 14.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.419 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -79.08 114.44 18.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.39 -174.15 4.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.475 1.11 . . . . 0.0 111.676 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -51.12 -49.01 61.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.031 -1.043 . . . . 0.0 111.781 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -36.18 45.06 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.197 0.904 . . . . 0.0 113.673 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.4 ttt -67.49 -62.43 1.42 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.792 0.837 . . . . 0.0 110.045 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -55.03 -34.13 63.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -64.32 -39.27 93.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.464 1.506 . . . . 0.0 110.623 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -25.14 68.16 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.873 -1.142 . . . . 0.0 111.772 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 101' ' ' MET . 1.6 mt -84.43 -44.15 13.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.661 1.184 . . . . 0.0 112.551 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.97 -29.1 25.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.905 1.282 . . . . 0.0 114.359 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.99 -34.04 3.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.479 1.512 . . . . 0.0 113.714 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.31 61.22 3.13 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.504 2.002 . . . . 0.0 114.516 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.86 67.25 1.13 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 127.401 2.281 . . . . 0.0 110.817 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.82 149.01 92.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.236 2.624 . . . . 0.0 112.268 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -114.9 178.68 4.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.412 1.085 . . . . 0.0 111.843 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -128.08 135.61 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.002 1.321 . . . . 0.0 111.768 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.06 97.42 2.0 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.437 1.018 . . . . 0.0 113.055 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -65.48 -79.97 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.226 1.01 . . . . 0.0 111.665 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HA ' HG22 ' A' ' 162' ' ' THR . 8.7 p30 177.75 -16.82 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.913 2.085 . . . . 0.0 115.606 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.23 163.12 20.97 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 119.939 1.245 . . . . 0.0 113.452 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.458 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 79.9 m95 -72.34 147.5 46.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.27 0.628 . . . . 0.0 110.682 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -151.75 123.31 7.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.283 1.433 . . . . 0.0 111.626 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.36 143.7 41.74 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.469 1.508 . . . . 0.0 113.599 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.71 149.76 26.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.353 1.461 . . . . 0.0 112.655 174.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.7 97.88 9.39 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.483 1.513 . . . . 0.0 108.379 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -52.96 -52.46 58.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.924 1.689 . . . . 0.0 111.425 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.04 57.14 0.01 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.392 0.996 . . . . 0.0 115.499 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.22 -27.07 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 131.69 -9.78 5.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.903 1.239 . . . . 0.0 114.671 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.01 170.08 13.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.811 1.305 . . . . 0.0 112.547 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 ttp-105 -133.58 130.24 38.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.452 1.901 . . . . 0.0 110.265 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.472 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -111.59 139.82 46.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.663 0.385 . . . . 0.0 110.852 175.019 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.4 128.3 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.578 1.551 . . . . 0.0 109.128 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.7 153.88 16.76 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 123.83 0.729 . . . . 0.0 112.824 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.458 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -137.15 141.14 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.548 1.939 . . . . 0.0 108.199 175.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 115.4 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.045 1.738 . . . . 0.0 107.754 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 144' ' ' ASN . 11.4 p -109.0 170.44 8.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.7 p -70.76 167.71 18.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.428 1.091 . . . . 0.0 112.335 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.81 147.62 27.69 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.213 -0.93 . . . . 0.0 112.876 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.01 80.98 0.44 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.967 1.27 . . . . 0.0 113.698 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 50.22 39.02 18.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.848 1.659 . . . . 0.0 113.707 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -138.35 170.05 16.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.247 1.419 . . . . 0.0 111.436 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.429 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 5.2 tptt -156.01 -172.45 4.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.67 0.748 . . . . 0.0 111.609 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -118.25 157.43 27.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.187 2.195 . . . . 0.0 109.846 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -164.41 150.35 10.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.01 1.324 . . . . 0.0 110.034 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 24.8 mm -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.59 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -126.99 136.76 52.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.228 1.377 . . . . 0.0 112.375 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' MET . 32.0 pt -96.52 133.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -142.33 164.59 29.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.638 0.775 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.353 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.07 -179.67 1.29 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.89 0.876 . . . . 0.0 110.641 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.8 -38.65 3.07 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.572 -1.33 . . . . 0.0 111.702 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.7 p -137.06 160.01 40.22 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.674 -1.486 . . . . 0.0 111.793 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.478 HD11 HD12 ' A' ' 70' ' ' LEU . 36.9 mm -136.44 163.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.164 1.385 . . . . 0.0 110.082 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -70.65 -169.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.979 2.112 . . . . 0.0 110.423 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.63 -23.26 4.09 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.94 73.81 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.836 0.732 . . . . 0.0 113.784 -174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.06 40.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.695 1.198 . . . . 0.0 111.547 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -6.24 57.57 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.196 1.398 . . . . 0.0 113.714 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HD23 ' A' ' 17' ' ' LEU . 21.8 tp -57.94 142.75 45.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.104 1.761 . . . . 0.0 111.02 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -146.13 145.79 30.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.639 1.176 . . . . 0.0 109.713 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -55.74 -29.47 59.59 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -60.01 -55.71 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.682 1.193 . . . . 0.0 112.269 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.76 -44.35 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 122.006 -0.433 . . . . 0.0 109.845 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -59.31 -32.08 69.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.229 1.012 . . . . 0.0 113.207 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.81 -55.16 14.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.159 0.983 . . . . 0.0 110.373 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -35.02 74.6 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.718 -0.614 . . . . 0.0 112.034 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -45.26 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.115 0.871 . . . . 0.0 112.645 -176.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.54 -24.9 53.63 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.611 0.641 . . . . 0.0 110.764 174.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.41 -26.76 62.89 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.96 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -48.54 -25.27 1.63 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 120.925 1.693 . . . . 0.0 114.483 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' HH22 ' A' ' 74' ' ' ARG . 48.0 mt . . . . . 0 CA--C 1.551 1.013 0 C-N-CA 126.674 1.989 . . . . 0.0 115.799 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -136.89 123.27 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.266 1.427 . . . . 0.0 112.019 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -107.81 91.09 3.51 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.211 2.204 . . . . 0.0 110.943 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' CD2' ' A' ' 102' ' ' PHE . 2.8 p -89.72 126.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.579 -1.326 . . . . 0.0 110.675 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.69 167.2 37.72 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-O 121.776 0.654 . . . . 0.0 114.701 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -144.29 121.68 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -76.95 105.11 7.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.037 -1.039 . . . . 0.0 111.324 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.53 93.07 4.74 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.161 -0.962 . . . . 0.0 112.013 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -142.92 39.29 1.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.323 1.058 . . . . 0.0 111.82 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.74 -0.26 54.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.047 1.739 . . . . 0.0 114.815 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.6 14.24 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.268 0.937 . . . . 0.0 114.578 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.02 135.84 7.77 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.673 1.606 . . . . 0.0 112.463 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -67.18 134.07 51.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.48 1.112 . . . . 0.0 109.262 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -95.34 163.86 13.07 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -146.27 113.93 6.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.447 1.499 . . . . 0.0 111.035 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -74.36 135.77 42.48 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 -50.32 3.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.379 1.071 . . . . 0.0 111.83 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -156.35 171.93 19.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.207 1.003 . . . . 0.0 111.964 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.58 132.49 31.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.984 1.714 . . . . 0.0 111.469 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -116.62 122.64 45.19 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.553 1.541 . . . . 0.0 110.183 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -123.62 152.55 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.809 2.444 . . . . 0.0 110.44 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.91 -53.25 2.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.164 0.986 . . . . 0.0 110.25 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' H ' ' A' ' 85' ' ' VAL . 2.3 t -71.21 127.0 31.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.406 1.882 . . . . 0.0 109.581 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.31 -133.26 8.51 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.175 0.893 . . . . 0.0 112.736 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.06 -156.47 0.61 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.14 1.776 . . . . 0.0 109.585 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.88 166.83 1.34 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.373 3.069 . . . . 0.0 111.928 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.63 -29.42 0.11 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 24' ' ' LEU . 12.7 m -136.17 173.01 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.244 2.218 . . . . 0.0 112.049 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.97 128.2 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.603 1.161 . . . . 0.0 111.677 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 tp -85.09 132.29 46.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.33 122.3 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.901 3.067 . . . . 0.0 110.8 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.86 -59.39 3.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.798 0.839 . . . . 0.0 112.555 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -125.52 145.5 50.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.52 1.528 . . . . 0.0 110.169 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 69' ' ' LEU . 50.6 t -138.47 131.36 16.17 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.577 1.151 . . . . 0.0 108.936 -175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.42 163.97 24.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.782 2.988 . . . . 0.0 112.531 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.28 18.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -141.98 17.06 2.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.597 1.559 . . . . 0.0 114.173 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.438 1.472 . . . . 0.0 112.679 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.58 -176.6 5.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 122.425 1.107 . . . . 0.0 112.521 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -153.21 152.68 31.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.049 0.939 . . . . 0.0 111.592 175.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.638 ' CD1' HD21 ' A' ' 17' ' ' LEU . 10.6 mt -134.66 162.42 32.37 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.884 1.274 . . . . 0.0 111.111 174.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.28 163.91 31.49 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.066 1.346 . . . . 0.0 109.632 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 m -144.92 165.28 28.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.279 1.431 . . . . 0.0 110.164 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.68 162.88 33.79 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.41 1.481 . . . . 0.0 109.553 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.448 HH22 ' HB2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 125.984 1.714 . . . . 0.0 111.031 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.395 0.617 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.557 ' H ' ' HB3' ' A' ' 52' ' ' SER . 3.6 t -127.45 110.24 22.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 109.757 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -139.99 176.9 8.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 109.972 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.02 137.59 15.13 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.943 1.697 . . . . 0.0 106.498 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -143.12 162.03 36.63 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.268 0.627 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.639 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -126.71 136.79 52.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.755 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.7 m-85 -113.68 121.86 45.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 110.939 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -70.27 123.47 21.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.912 1.285 . . . . 0.0 110.211 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptm -97.1 155.09 16.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.552 0.615 . . . . 0.0 111.394 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.4 m -56.14 -22.47 28.69 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -2.03 20.87 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.767 1.227 . . . . 0.0 113.384 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.14 84.46 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.655 1.597 . . . . 0.0 114.638 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -100.45 171.38 7.78 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.443 1.097 . . . . 0.0 110.46 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.639 HG22 ' HB1' ' A' ' 89' ' ' ALA . 81.1 m -135.03 99.89 4.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.744 1.218 . . . . 0.0 111.621 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 173' ' ' ILE . 6.4 tp -69.59 113.75 7.16 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.414 -0.804 . . . . 0.0 111.42 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.6 107.84 3.54 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.264 1.411 . . . . 0.0 109.717 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -84.2 146.11 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 117.493 0.646 . . . . 0.0 111.045 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' HD13 ' A' ' 134' ' ' LEU . 13.9 tmm? -125.23 142.47 51.48 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.925 1.29 . . . . 0.0 110.568 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 32.9 p90 -151.27 158.92 44.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.107 174.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -158.06 175.24 14.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.47 100.05 50.92 Favored Pre-proline 0 N--CA 1.467 0.392 0 C-N-CA 126.51 1.924 . . . . 0.0 111.792 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.542 0.897 0 C-N-CA 122.699 2.266 . . . . 0.0 110.063 174.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -77.4 139.0 39.61 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.086 0.954 . . . . 0.0 112.98 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -161.83 149.27 14.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.489 1.916 . . . . 0.0 108.844 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -179.87 158.59 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.333 2.253 . . . . 0.0 111.263 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.67 147.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 127.766 2.427 . . . . 0.0 109.055 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -141.67 141.2 33.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.776 0.83 . . . . 0.0 109.635 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.6 mt -103.27 113.31 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.872 0.869 . . . . 0.0 108.693 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -82.42 111.0 18.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 t -65.42 87.51 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.015 -1.053 . . . . 0.0 111.476 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.93 164.58 11.92 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.938 2.685 . . . . 0.0 112.211 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -60.5 123.6 17.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.798 1.239 . . . . 0.0 111.778 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -133.6 104.28 6.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.589 1.555 . . . . 0.0 112.138 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.96 153.64 33.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.763 0.825 . . . . 0.0 110.634 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 117.58 21.33 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.721 0.408 . . . . 0.0 111.132 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.63 -176.8 6.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.082 1.753 . . . . 0.0 112.108 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.3 -47.23 25.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.33 1.452 . . . . 0.0 112.119 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.71 -46.99 80.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.102 0.858 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.4 ttp -60.22 -53.26 59.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.404 0.682 . . . . 0.0 110.684 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -53.35 -38.03 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.378 0.99 . . . . 0.0 113.078 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -43.54 95.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.699 1.2 . . . . 0.0 110.734 175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.59 -20.63 65.4 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.357 -1.464 . . . . 0.0 113.939 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 101' ' ' MET . 19.0 mt -92.52 -11.0 35.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.18 -35.09 3.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.011 1.324 . . . . 0.0 112.248 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -114.5 -25.55 8.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.186 1.395 . . . . 0.0 112.918 -175.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.5 -34.68 90.55 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.737 1.161 . . . . 0.0 113.752 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.09 83.44 5.6 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 126.018 1.727 . . . . 0.0 110.28 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.5 120.23 7.33 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.548 1.499 . . . . 0.0 112.325 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.76 165.02 22.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.811 1.244 . . . . 0.0 113.892 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -134.22 139.06 45.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.437 1.895 . . . . 0.0 111.531 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -127.02 110.43 1.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.907 1.241 . . . . 0.0 112.168 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -124.03 70.14 1.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.459 1.904 . . . . 0.0 113.364 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 50.76 60.3 3.97 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.05 2.14 . . . . 0.0 114.023 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -175.83 139.78 4.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.614 0.626 . . . . 0.0 113.92 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -63.43 135.46 56.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.031 1.332 . . . . 0.0 111.69 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -150.09 130.69 13.98 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.634 1.173 . . . . 0.0 111.672 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.66 158.5 25.39 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.118 1.767 . . . . 0.0 111.566 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.526 ' CE ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.52 161.57 39.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.0 1.32 . . . . 0.0 110.677 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.17 93.92 4.01 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.902 0.881 . . . . 0.0 108.799 174.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 149' ' ' LYS . 5.3 tp -47.43 -32.36 4.99 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.98 1.312 . . . . 0.0 113.984 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.54 32.26 2.36 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 117.396 1.718 . . . . 0.0 117.396 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.06 -28.69 1.16 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 148.77 -24.29 1.32 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.749 1.166 . . . . 0.0 114.504 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.46 175.5 5.43 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.634 1.973 . . . . 0.0 111.626 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -126.89 165.31 19.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.009 . . . . 0.0 112.222 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.714 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -145.94 156.91 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.428 177.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.86 129.22 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.713 1.605 . . . . 0.0 108.584 -177.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.11 144.56 18.48 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.407 0.527 . . . . 0.0 113.27 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -125.2 147.71 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.273 1.429 . . . . 0.0 109.762 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.547 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -140.46 117.38 11.08 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.6 1.16 . . . . 0.0 109.3 175.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 160' ' ' ILE . 7.9 p -122.18 147.75 45.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.641 1.176 . . . . 0.0 110.055 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -131.49 -178.31 4.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.586 1.954 . . . . 0.0 110.649 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 73.69 95.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.379 2.271 . . . . 0.0 113.302 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.42 -106.51 3.06 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.87 1.7 . . . . 0.0 114.355 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -115.78 17.72 15.99 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.631 2.373 . . . . 0.0 113.569 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.06 163.08 25.53 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.601 2.361 . . . . 0.0 115.021 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 31' ' ' ILE . 8.1 tptp -163.11 155.28 18.18 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.873 1.269 . . . . 0.0 114.34 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 136.39 33.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.118 2.567 . . . . 0.0 112.512 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -141.08 154.51 45.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.026 1.73 . . . . 0.0 110.221 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.01 120.55 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.529 1.132 . . . . 0.0 111.045 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -98.84 114.04 26.44 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.316 1.046 . . . . 0.0 109.482 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 157' ' ' MET . 7.5 pt -98.12 134.18 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.801 0.44 . . . . 0.0 109.828 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 92.8 p -156.37 167.35 30.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.408 1.483 . . . . 0.0 112.458 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.92 6.55 36.41 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.123 1.769 . . . . 0.0 113.128 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.99 -16.21 39.35 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.178 1.37 . . . . 0.0 115.502 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 p -146.04 162.97 36.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.158 1.479 . . . . 0.0 110.28 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 70' ' ' LEU . 26.5 mm -134.73 173.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 109.38 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 pt -85.4 -171.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 129.036 2.934 . . . . 0.0 110.461 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.96 -15.19 61.92 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.3 65.71 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 124.583 1.087 . . . . 0.0 113.62 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.18 81.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.144 1.378 . . . . 0.0 112.956 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -1.17 53.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 113.822 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.27 140.82 58.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.042 1.337 . . . . 0.0 110.491 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.84 145.75 26.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.116 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.61 -38.17 69.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.753 0.821 . . . . 0.0 113.134 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -56.62 -50.06 73.13 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.098 0.863 . . . . 0.0 112.783 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.81 -48.41 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.903 0.881 . . . . 0.0 110.587 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -56.24 -37.62 69.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 112.081 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -57.57 -55.82 29.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.447 1.899 . . . . 0.0 111.566 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -22.87 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.77 -52.3 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.514 1.506 . . . . 0.0 110.886 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.604 HD22 ' HB2' ' A' ' 32' ' ' ALA . 2.0 pp -61.72 -32.06 72.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.611 0.364 . . . . 0.0 111.721 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -85.68 -28.28 24.79 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -52.9 -21.18 3.99 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.761 2.024 . . . . 0.0 112.815 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 72' ' ' SER . 49.9 tp . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.453 1.901 . . . . 0.0 111.802 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.195 0.521 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -107.88 148.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.609 1.164 . . . . 0.0 110.73 175.03 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.604 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -134.04 100.04 4.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.925 1.69 . . . . 0.0 111.035 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 p -113.94 144.88 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.117 1.367 . . . . 0.0 107.396 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.36 167.27 36.5 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 118.418 0.554 . . . . 0.0 114.425 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.21 145.84 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.703 1.201 . . . . 0.0 110.872 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -107.68 104.25 13.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 111.472 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 3.5 p30 -89.12 116.95 27.76 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.377 1.471 . . . . 0.0 112.187 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -150.03 14.9 0.82 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.885 0.85 . . . . 0.0 112.182 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -78.55 -45.88 20.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.608 1.563 . . . . 0.0 114.356 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.63 16.82 1.43 Allowed Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.39 133.96 6.74 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.491 1.646 . . . . 0.0 113.006 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.7 m -69.93 122.11 18.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.236 1.414 . . . . 0.0 110.906 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.467 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 37.8 m0 -91.03 161.8 14.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.827 -0.546 . . . . 0.0 111.805 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 m -136.66 109.82 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.059 1.743 . . . . 0.0 111.088 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.9 114.14 4.9 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.914 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.728 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -75.95 -61.4 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.868 1.267 . . . . 0.0 111.385 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -159.9 169.88 22.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.985 1.314 . . . . 0.0 111.966 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.72 135.44 40.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.869 2.068 . . . . 0.0 111.047 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.451 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.3 t80 -120.71 130.61 54.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.453 1.501 . . . . 0.0 109.8 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -127.47 140.42 52.16 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.784 2.034 . . . . 0.0 109.838 -178.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -0.91 14.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.198 1.399 . . . . 0.0 113.842 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -80.23 -155.23 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.068 1.347 . . . . 0.0 109.781 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.78 -76.07 0.25 Allowed Glycine 0 N--CA 1.471 0.986 0 O-C-N 120.579 -1.326 . . . . 0.0 114.267 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -162.38 -178.14 6.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.349 1.46 . . . . 0.0 111.307 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 160.37 20.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.315 1.446 . . . . 0.0 113.69 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -141.81 -29.03 0.62 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.65 159.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.081 1.353 . . . . 0.0 111.787 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.9 tp -79.44 133.88 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.191 0.996 . . . . 0.0 109.583 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.0 tp -84.33 124.4 73.87 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.572 1.149 . . . . 0.0 109.642 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 69' ' ' LEU . 53.7 Cg_endo -64.74 120.09 7.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.706 3.604 . . . . 0.0 112.52 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.3 -55.19 23.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.41 150.62 36.11 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.728 1.211 . . . . 0.0 109.62 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.0 135.1 18.34 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.66 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -67.26 -164.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.702 2.935 . . . . 0.0 112.364 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -114.3 25.63 10.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.649 1.58 . . . . 0.0 113.712 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -149.44 8.36 0.7 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.279 1.431 . . . . 0.0 114.434 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -144.84 113.53 6.74 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.781 1.628 . . . . 0.0 114.459 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.01 174.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.748 1.219 . . . . 0.0 112.675 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -149.12 154.05 38.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.613 -0.679 . . . . 0.0 112.05 177.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.561 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -125.82 175.96 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.496 0.718 . . . . 0.0 112.42 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -147.64 161.51 41.0 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.526 1.53 . . . . 0.0 110.525 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD22 ' A' ' 24' ' ' LEU . 77.0 p -152.95 165.34 35.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.849 1.26 . . . . 0.0 112.451 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.38 172.75 24.14 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.027 0.822 . . . . 0.0 114.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.611 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -148.21 116.95 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.392 1.077 . . . . 0.0 111.705 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -151.24 173.01 14.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.374 1.47 . . . . 0.0 111.288 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.61 127.82 9.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.417 1.087 . . . . 0.0 109.476 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.92 173.85 11.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.474 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -136.18 149.71 48.71 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -128.69 117.2 20.77 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.361 1.864 . . . . 0.0 111.78 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -69.06 104.91 2.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.916 1.686 . . . . 0.0 109.816 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.8 mtp -66.5 148.75 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.216 1.007 . . . . 0.0 110.569 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -24.63 63.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.272 1.029 . . . . 0.0 113.501 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t -69.58 -13.7 62.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.342 1.857 . . . . 0.0 114.494 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.34 12.34 48.82 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.677 1.132 . . . . 0.0 114.967 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -103.17 175.43 5.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.373 2.269 . . . . 0.0 110.088 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.465 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 20.1 m -138.25 110.29 7.28 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.033 -1.042 . . . . 0.0 112.715 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.4 tp -74.67 113.45 11.95 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.551 1.14 . . . . 0.0 112.936 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.0 102.68 2.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.36 1.933 . . . . 0.0 110.401 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.4 160.27 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.535 1.134 . . . . 0.0 110.591 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -142.08 153.31 44.07 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.387 0.675 . . . . 0.0 111.556 174.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 16.4 p90 -161.23 156.11 23.7 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.783 1.233 . . . . 0.0 110.834 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 t -168.63 138.44 2.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.788 1.235 . . . . 0.0 109.221 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.42 95.71 7.48 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.537 0.65 0 C-N-CA 123.035 2.49 . . . . 0.0 111.628 178.326 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 p30 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.447 ' CZ2' ' CE2' ' A' ' 135' ' ' TYR . 15.0 p-90 -114.09 157.98 21.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.7 0.8 . . . . 0.0 112.548 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -158.02 174.14 15.69 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.605 1.962 . . . . 0.0 110.12 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 154.96 133.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 129.221 3.009 . . . . 0.0 112.347 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.04 140.95 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.261 1.024 . . . . 0.0 109.015 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -133.35 149.32 51.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.801 1.24 . . . . 0.0 109.177 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 155' ' ' LEU . 79.2 mt -110.92 98.46 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.103 0.961 . . . . 0.0 109.024 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.19 99.94 0.2 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.402 1.081 . . . . 0.0 109.46 174.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.9 t -68.22 84.97 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.423 1.089 . . . . 0.0 110.86 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.98 -114.9 0.69 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.797 2.142 . . . . 0.0 110.302 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -150.35 123.34 8.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.965 1.306 . . . . 0.0 111.404 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.69 105.96 4.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.565 1.546 . . . . 0.0 112.48 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.26 167.22 3.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.416 1.086 . . . . 0.0 111.461 174.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -80.54 112.33 17.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.08 -0.388 . . . . 0.0 111.21 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.28 -179.44 6.94 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -51.85 -42.04 62.29 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.001 -1.062 . . . . 0.0 112.018 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.71 97.06 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.389 0.995 . . . . 0.0 113.798 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 1.2 ppp? -65.01 -45.72 84.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.798 1.299 . . . . 0.0 111.297 174.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -57.54 -39.92 77.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.693 0.797 . . . . 0.0 110.99 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -67.09 -40.47 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.474 1.11 . . . . 0.0 112.221 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.67 -29.77 70.96 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.443 -1.411 . . . . 0.0 112.883 174.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -76.38 -55.6 5.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.211 1.405 . . . . 0.0 111.615 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.447 ' CE2' ' CZ2' ' A' ' 114' ' ' TRP . 10.8 m-85 -76.5 -26.91 55.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -126.85 -33.85 2.44 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.213 1.005 . . . . 0.0 113.444 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.38 -49.41 45.16 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.839 1.209 . . . . 0.0 112.527 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -166.58 73.63 1.14 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 126.133 1.773 . . . . 0.0 111.565 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 133.01 23.92 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.34 2.026 . . . . 0.0 112.127 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -112.15 -175.17 2.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.552 2.341 . . . . 0.0 111.832 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -134.34 139.56 45.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.146 2.179 . . . . 0.0 110.636 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.36 91.13 0.14 Allowed Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.771 0.714 . . . . 0.0 113.823 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.63 -47.31 19.61 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.81 -1.406 . . . . 0.0 113.438 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 p30 179.37 88.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.974 2.51 . . . . 0.0 112.062 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.19 148.23 6.63 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.48 -0.762 . . . . 0.0 114.255 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.401 ' CD2' ' HB ' ' A' ' 160' ' ' ILE . 85.9 m95 -77.54 145.19 37.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.712 1.205 . . . . 0.0 111.206 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -153.2 141.37 20.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.271 1.429 . . . . 0.0 111.641 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -118.03 147.2 43.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.851 1.66 . . . . 0.0 111.207 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -149.82 166.45 29.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.309 1.044 . . . . 0.0 112.069 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -79.92 108.31 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 157' ' ' MET . 10.3 tp -66.74 -32.76 74.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.61 14.16 4.9 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.52 -26.06 3.07 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.141 1.471 . . . . 0.0 114.704 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.2 10.78 1.27 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.423 -1.21 . . . . 0.0 115.469 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -138.75 165.5 26.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.534 1.667 . . . . 0.0 112.369 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.01 141.33 52.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.597 1.159 . . . . 0.0 108.947 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -126.0 157.68 37.24 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.601 0.76 . . . . 0.0 109.386 175.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.9 129.25 56.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.1 159.03 19.7 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 123.34 0.495 . . . . 0.0 112.467 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.705 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -140.39 156.05 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.842 1.657 . . . . 0.0 110.432 176.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -153.73 114.21 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.705 HG23 HD11 ' A' ' 160' ' ' ILE . 6.8 p -102.03 150.97 22.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.818 0.847 . . . . 0.0 110.425 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.31 156.14 45.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.029 1.731 . . . . 0.0 110.431 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.17 128.5 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.995 2.518 . . . . 0.0 112.908 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.86 -179.0 51.73 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 122.229 0.905 . . . . 0.0 114.244 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.32 80.83 1.36 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.414 1.885 . . . . 0.0 112.48 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.55 164.0 34.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.739 1.216 . . . . 0.0 112.802 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -153.54 -178.91 7.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.746 1.619 . . . . 0.0 113.636 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.433 ' SD ' ' HE3' ' A' ' 101' ' ' MET . 20.0 ptm -102.11 166.62 10.51 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.896 2.079 . . . . 0.0 113.653 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -154.8 153.76 31.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.888 1.275 . . . . 0.0 109.955 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.8 mm -135.47 117.63 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.892 1.277 . . . . 0.0 110.114 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -112.89 111.94 23.05 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.867 -1.146 . . . . 0.0 111.503 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.467 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.0 pt -95.51 131.73 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 109.086 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.5 t -150.71 158.76 44.53 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.633 -0.667 . . . . 0.0 111.227 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.127 1.371 . . . . 0.0 112.185 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.56 -41.39 1.45 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.55 -25.56 8.97 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 125.423 1.487 . . . . 0.0 116.213 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 p -138.34 158.18 44.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.694 1.747 . . . . 0.0 111.447 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mm -136.2 165.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.774 -1.204 . . . . 0.0 110.382 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -170.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.881 1.273 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.4 -43.75 5.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 -29.56 6.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.18 1.371 . . . . 0.0 112.897 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.13 73.64 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.296 1.048 . . . . 0.0 111.491 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.4 m -86.53 -8.53 57.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.823 2.049 . . . . 0.0 114.345 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.63 131.36 45.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.47 1.108 . . . . 0.0 109.21 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.612 1.165 . . . . 0.0 109.163 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -54.61 -29.58 52.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.928 0.785 . . . . 0.0 112.988 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -58.28 -56.74 18.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 112.434 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.46 -44.62 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.893 0.877 . . . . 0.0 109.841 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -62.25 -25.48 67.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.591 1.156 . . . . 0.0 113.472 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -74.72 -53.1 9.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.102 -1.624 . . . . 0.0 110.373 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -39.85 83.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 112.934 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.6 p -68.65 -33.36 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.339 0.972 . . . . 0.0 113.082 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 32' ' ' ALA . 82.5 mt -78.8 -36.59 42.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.498 0.719 . . . . 0.0 110.522 175.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.84 -44.14 97.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.814 0.846 . . . . 0.0 111.664 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -20.53 57.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 CA--C 1.542 0.665 0 C-N-CA 126.327 1.851 . . . . 0.0 112.731 174.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -102.0 148.72 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.519 1.128 . . . . 0.0 111.426 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -139.51 97.74 3.34 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.58 1.952 . . . . 0.0 111.19 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.6 p -107.41 129.77 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.942 -1.099 . . . . 0.0 110.248 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.95 171.49 42.37 Favored Glycine 0 C--O 1.235 0.205 0 O-C-N 121.57 -0.706 . . . . 0.0 114.273 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 98' ' ' LEU . 3.5 mp -139.61 122.85 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 0.0 109.99 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.97 102.66 2.05 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.387 -1.445 . . . . 0.0 111.747 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -76.75 92.0 3.53 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.4 -0.813 . . . . 0.0 112.225 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -143.54 48.78 1.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.057 0.943 . . . . 0.0 111.586 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -109.8 -8.43 14.91 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.31 57.07 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.561 1.077 . . . . 0.0 115.558 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.44 134.68 6.98 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.129 1.347 . . . . 0.0 113.059 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.2 m -61.87 141.2 58.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.999 1.32 . . . . 0.0 110.816 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 48.9 m0 -104.68 163.49 12.45 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.472 -0.768 . . . . 0.0 111.343 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -143.41 102.0 3.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.022 1.329 . . . . 0.0 111.02 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.98 163.36 22.39 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.292 -0.88 . . . . 0.0 111.131 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.23 -60.65 1.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.126 1.371 . . . . 0.0 111.062 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -153.01 -173.84 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 111.096 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 147.96 35.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.44 1.496 . . . . 0.0 110.895 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 2.8 t80 -132.13 134.59 45.61 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.135 1.374 . . . . 0.0 110.568 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -143.48 157.9 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.204 2.202 . . . . 0.0 111.223 -174.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -127.13 -37.14 2.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.092 1.357 . . . . 0.0 112.924 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.3 t -133.46 92.97 3.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.25 121.19 2.1 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.344 0.973 . . . . 0.0 114.726 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -179.04 1.46 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.11 1.764 . . . . 0.0 112.759 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -88.16 158.56 18.5 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.779 1.232 . . . . 0.0 111.673 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -155.49 -22.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.163 1.385 . . . . 0.0 112.608 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 m -128.13 161.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.712 2.005 . . . . 0.0 110.353 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 tt -91.92 135.26 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.302 1.441 . . . . 0.0 110.975 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.99 125.85 86.33 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 0.0 109.123 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG2' HD12 ' A' ' 69' ' ' LEU . 60.2 Cg_endo -64.02 148.47 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.197 2.598 . . . . 0.0 111.043 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.48 -56.14 3.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.749 0.82 . . . . 0.0 112.309 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -119.2 134.97 54.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.094 1.358 . . . . 0.0 110.334 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.965 HG21 HD13 ' A' ' 69' ' ' LEU . 92.5 t -133.4 132.77 22.15 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.526 1.13 . . . . 0.0 111.484 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.56 164.28 35.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.807 3.005 . . . . 0.0 112.557 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 22.03 0.2 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.0 1.72 . . . . 0.0 115.381 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 p -146.7 23.53 1.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.528 1.531 . . . . 0.0 113.379 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -148.06 130.55 15.8 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.878 1.217 . . . . 0.0 112.607 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.04 179.17 5.79 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.365 1.079 . . . . 0.0 111.443 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 HG21 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -153.66 142.97 21.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.812 1.245 . . . . 0.0 109.588 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 33' ' ' VAL . 4.8 mt -122.39 -178.05 3.79 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.584 1.154 . . . . 0.0 110.555 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -155.5 164.76 38.26 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.689 -1.257 . . . . 0.0 110.326 174.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.481 ' HA ' HG23 ' A' ' 31' ' ' ILE . 8.6 t -142.65 174.54 10.55 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.093 0.957 . . . . 0.0 111.943 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.06 -171.55 12.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.385 1.469 . . . . 0.0 112.61 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 125.658 1.583 . . . . 0.0 114.484 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.33 114.52 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.031 2.533 . . . . 0.0 110.742 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.05 177.13 10.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.275 1.43 . . . . 0.0 111.887 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.54 127.84 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.394 1.477 . . . . 0.0 109.059 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -132.36 159.9 37.87 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.805 0.842 . . . . 0.0 112.066 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -124.33 144.35 50.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.114 0.565 . . . . 0.0 111.29 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 21.8 m-85 -118.61 121.9 41.29 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.485 1.514 . . . . 0.0 110.2 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.65 111.59 4.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.912 1.285 . . . . 0.0 110.354 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.7 mtp -72.32 142.68 48.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.745 1.218 . . . . 0.0 110.4 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.3 t -53.86 -33.7 57.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.433 1.093 . . . . 0.0 113.89 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -10.51 30.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.52 26.4 9.29 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.506 1.05 . . . . 0.0 114.291 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -117.73 177.53 4.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.383 1.873 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.5 m -140.21 106.19 5.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.9 1.28 . . . . 0.0 111.704 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 35' ' ' ILE . 26.0 tp -74.95 118.83 18.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.182 0.993 . . . . 0.0 110.314 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.81 107.51 3.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.88 1.229 . . . . 0.0 113.521 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -89.67 158.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 112.533 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.43 168.86 18.81 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.241 1.016 . . . . 0.0 112.136 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 47.0 p90 -171.68 150.31 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.633 1.573 . . . . 0.0 110.375 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.8 m -162.01 130.63 4.26 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.494 1.518 . . . . 0.0 107.355 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.862 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.1 t -107.04 128.45 26.05 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.438 -0.791 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 122.493 2.129 . . . . 0.0 111.258 -179.32 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 p30 . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 121.435 0.636 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -121.69 144.92 48.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.922 1.289 . . . . 0.0 112.267 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -155.51 160.24 40.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.535 1.134 . . . . 0.0 110.474 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 173.7 132.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.167 2.987 . . . . 0.0 111.008 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.17 140.92 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.72 1.608 . . . . 0.0 109.794 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -135.61 158.57 44.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.304 1.441 . . . . 0.0 110.805 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.22 99.4 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.769 1.628 . . . . 0.0 108.088 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -65.32 103.77 0.85 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.144 -0.972 . . . . 0.0 109.67 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.1 t -68.79 83.43 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.634 -1.291 . . . . 0.0 111.347 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.76 -111.64 0.49 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 127.117 2.294 . . . . 0.0 111.502 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -146.26 135.84 23.12 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.89 1.676 . . . . 0.0 111.852 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -158.31 113.84 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.695 1.598 . . . . 0.0 112.15 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 165.63 24.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.165 0.586 . . . . 0.0 111.236 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.67 113.04 16.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.647 0.779 . . . . 0.0 110.37 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -158.88 -174.74 4.91 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.698 1.599 . . . . 0.0 112.839 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -50.61 -40.95 54.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.256 -0.902 . . . . 0.0 112.865 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.91 -39.91 56.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.246 0.93 . . . . 0.0 113.269 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.3 ttt -67.41 -57.79 5.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.41 1.084 . . . . 0.0 111.507 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -53.47 -34.91 59.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.38 0.991 . . . . 0.0 112.691 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -66.64 -46.81 74.57 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.206 1.002 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -25.75 66.9 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.502 -1.374 . . . . 0.0 113.122 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.35 -45.07 57.26 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.727 2.011 . . . . 0.0 113.11 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.69 -31.76 14.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -116.31 -20.95 9.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.897 1.279 . . . . 0.0 113.163 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.68 -63.85 2.25 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.568 1.556 . . . . 0.0 114.166 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -122.52 64.45 21.58 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.898 1.279 . . . . 0.0 112.161 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -60.65 122.66 11.6 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.999 2.466 . . . . 0.0 112.851 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.37 -171.9 2.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.405 1.482 . . . . 0.0 111.351 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -139.26 135.58 34.03 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.735 -1.228 . . . . 0.0 112.997 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.73 8.16 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.265 1.412 . . . . 0.0 110.697 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -130.65 56.71 1.76 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.043 1.337 . . . . 0.0 110.825 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.5 p30 40.41 65.06 0.82 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.506 2.322 . . . . 0.0 115.432 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.28 154.02 21.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.819 1.199 . . . . 0.0 113.158 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.46 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 42.6 m95 -70.01 142.33 52.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.17 . . . . 0.0 110.951 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -145.4 131.67 19.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.799 1.239 . . . . 0.0 111.929 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -107.24 141.88 37.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 112.147 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -148.37 157.74 43.67 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 123.336 1.541 . . . . 0.0 112.248 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -90.11 88.28 7.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.828 2.851 . . . . 0.0 106.436 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.475 HD13 ' SD ' ' A' ' 157' ' ' MET . 8.1 tp -54.54 -27.84 41.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.594 1.557 . . . . 0.0 114.26 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.76 36.62 2.75 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -133.12 -20.32 2.17 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.1 2.96 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.579 1.085 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.47 176.68 8.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.378 1.871 . . . . 0.0 111.665 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -116.24 163.4 16.05 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.664 1.186 . . . . 0.0 111.127 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.174 0.988 . . . . 0.0 112.274 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -116.16 124.6 50.72 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 126.726 2.011 . . . . 0.0 108.144 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.21 149.26 18.58 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 119.095 0.861 . . . . 0.0 112.98 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.46 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -134.67 151.5 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.738 1.615 . . . . 0.0 108.919 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.9 tpp -156.45 109.01 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.722 1.609 . . . . 0.0 108.462 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.7 p -132.72 156.0 47.82 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.96 2.104 . . . . 0.0 110.037 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.9 p -158.21 -176.48 5.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.859 1.663 . . . . 0.0 110.882 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.82 34.98 14.03 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.855 1.662 . . . . 0.0 115.45 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 148.46 88.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.466 1.031 . . . . 0.0 113.274 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 44.8 55.64 5.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.17 2.588 . . . . 0.0 112.166 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.26 163.69 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.051 1.74 . . . . 0.0 113.804 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.862 ' HE2' HG22 ' A' ' 104' ' ' VAL . 1.8 tptp -159.09 -168.34 2.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.518 ' H ' ' HG3' ' A' ' 168' ' ' LYS . 19.7 ptm -121.31 149.5 42.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.058 1.743 . . . . 0.0 111.06 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.514 ' C ' HD12 ' A' ' 171' ' ' ILE . 13.2 tt0 -167.51 152.37 6.99 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.391 1.476 . . . . 0.0 109.177 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 1.8 mp -122.75 122.0 64.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 123.579 0.752 . . . . 0.0 109.243 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 114.11 25.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 108.365 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 157' ' ' MET . 8.4 pt -99.66 134.83 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.086 0.554 . . . . 0.0 110.531 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p -155.88 165.06 37.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.711 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.961 1.304 . . . . 0.0 112.474 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 19' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.351 0.119 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.22 169.22 2.21 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.805 0.812 . . . . 0.0 110.592 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.66 -40.01 2.57 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.7 p -131.51 155.79 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.678 1.591 . . . . 0.0 111.61 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mm -140.31 160.59 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.268 1.427 . . . . 0.0 110.283 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.664 HD12 ' H ' ' A' ' 9' ' ' GLY . 1.2 pp -66.73 -171.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.082 2.553 . . . . 0.0 111.67 174.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.34 -28.29 58.53 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.664 ' H ' HD12 ' A' ' 7' ' ' ILE . . . 95.64 -16.26 61.56 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.212 1.386 . . . . 0.0 112.929 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.72 -43.03 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.705 1.202 . . . . 0.0 111.799 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 7' ' ' ILE . 92.3 p -85.48 -13.09 50.2 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.7 HD13 HD23 ' A' ' 17' ' ' LEU . 1.5 tp -53.7 138.61 34.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.862 2.065 . . . . 0.0 110.021 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.42 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.6 m -145.7 149.51 34.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.9 0.88 . . . . 0.0 109.618 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -52.7 -26.49 14.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.29 -51.31 64.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.168 0.987 . . . . 0.0 112.11 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.23 -39.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.35 -0.844 . . . . 0.0 110.776 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.7 HD23 HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.41 -23.98 67.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.314 1.046 . . . . 0.0 112.338 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.16 -54.22 13.83 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.352 -1.467 . . . . 0.0 109.021 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -55.78 -44.75 78.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.373 1.069 . . . . 0.0 112.62 175.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG23 HD22 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -63.04 -35.91 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.331 0.969 . . . . 0.0 113.414 -175.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 32' ' ' ALA . 35.2 mt -84.93 -32.3 23.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 111.801 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.23 -23.01 66.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.269 0.627 . . . . 0.0 111.584 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -48.15 -25.91 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.36 1.864 . . . . 0.0 113.657 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 125.576 1.55 . . . . 0.0 112.317 174.953 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HZ3' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.367 0.127 . . . . 0.0 111.286 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -131.25 133.55 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.891 0.877 . . . . 0.0 111.635 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -115.6 102.62 9.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.107 2.163 . . . . 0.0 113.843 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.609 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.1 p -114.02 121.33 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.571 -1.331 . . . . 0.0 109.96 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.83 33.81 Favored Glycine 0 N--CA 1.461 0.363 0 O-C-N 121.053 -1.029 . . . . 0.0 112.956 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 100' ' ' VAL . 2.2 mp -141.42 134.45 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.335 1.064 . . . . 0.0 113.817 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 2.6 m-20 -76.41 106.76 8.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.69 1.596 . . . . 0.0 113.148 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -84.06 104.27 13.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.683 1.23 . . . . 0.0 112.977 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -145.49 23.8 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.078 -1.014 . . . . 0.0 113.021 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.51 -9.52 54.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.496 1.519 . . . . 0.0 114.66 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.95 49.48 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.493 1.044 . . . . 0.0 115.148 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.62 110.66 0.91 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.833 1.682 . . . . 0.0 110.166 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -59.58 147.2 38.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.801 1.3 . . . . 0.0 110.906 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -117.3 161.41 19.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.53 0.732 . . . . 0.0 111.506 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -133.01 113.63 13.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.331 2.253 . . . . 0.0 111.996 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -75.41 115.64 15.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.599 1.159 . . . . 0.0 110.831 175.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -71.85 -54.85 8.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.521 1.528 . . . . 0.0 110.259 175.004 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.74 -174.03 3.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.72 1.608 . . . . 0.0 111.825 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 144.67 28.22 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.53 1.532 . . . . 0.0 111.622 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.62 119.94 37.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.54 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.32 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 109.562 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -5.12 43.64 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.162 1.385 . . . . 0.0 113.833 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 p -73.56 -137.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.017 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.85 -84.55 0.91 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.446 1.022 . . . . 0.0 112.663 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -146.17 176.03 10.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.517 1.127 . . . . 0.0 112.193 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -77.74 158.36 29.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.38 1.472 . . . . 0.0 113.051 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -135.22 -34.14 0.87 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.688 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 71' ' ' TYR . 19.7 m -132.0 176.84 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.855 2.062 . . . . 0.0 110.129 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -100.93 131.8 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.442 1.497 . . . . 0.0 110.987 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.26 131.61 52.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.656 ' HG2' HD12 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -63.63 177.68 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.165 3.243 . . . . 0.0 112.411 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -117.81 -36.68 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.839 1.256 . . . . 0.0 112.279 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.13 157.92 33.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.952 1.301 . . . . 0.0 111.72 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.99 97.44 7.92 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 124.747 1.219 . . . . 0.0 108.681 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.99 174.61 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.795 1.663 . . . . 0.0 110.54 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -63.2 165.49 7.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.45 0.7 . . . . 0.0 109.887 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 t 46.08 30.81 1.01 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.162 1.385 . . . . 0.0 113.14 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -145.26 158.68 43.77 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.916 1.686 . . . . 0.0 112.138 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -140.34 -173.84 3.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.707 1.242 . . . . 0.0 110.105 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -156.91 153.88 28.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.926 175.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 32' ' ' ALA . 14.2 mt -139.26 155.16 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.796 1.238 . . . . 0.0 108.578 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -129.07 160.26 33.35 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.119 1.368 . . . . 0.0 108.747 175.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 m -151.26 170.1 20.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.439 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.82 -171.2 21.35 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 124.613 1.165 . . . . 0.0 109.789 -177.078 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -151.88 121.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 127.357 2.263 . . . . 0.0 111.329 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.1 176.02 12.28 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.797 1.639 . . . . 0.0 110.389 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.46 116.97 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.541 1.136 . . . . 0.0 108.441 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 33' ' ' VAL . 10.7 p90 -127.22 170.08 12.81 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.264 1.026 . . . . 0.0 112.651 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.91 157.72 45.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.735 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -128.97 112.38 14.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.136 1.774 . . . . 0.0 112.147 -175.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.3 104.09 1.41 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.297 1.839 . . . . 0.0 111.032 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.43 140.37 58.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.492 1.117 . . . . 0.0 110.111 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -57.62 -20.72 34.96 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -74.39 -10.02 59.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.258 1.423 . . . . 0.0 113.905 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.76 11.77 45.91 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.058 1.313 . . . . 0.0 114.837 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.12 174.56 6.26 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.261 1.824 . . . . 0.0 109.7 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m -143.64 109.52 5.25 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.951 -1.093 . . . . 0.0 112.588 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 35' ' ' ILE . 48.7 tp -74.56 121.5 21.66 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.068 -1.02 . . . . 0.0 111.627 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 110.7 3.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.868 1.223 . . . . 0.0 113.367 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.4 p -86.58 150.13 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.193 0.997 . . . . 0.0 112.21 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.589 ' HB2' HD13 ' A' ' 134' ' ' LEU . 11.1 tmm? -135.65 152.16 50.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.115 1.366 . . . . 0.0 110.774 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.609 ' CE1' HG11 ' A' ' 33' ' ' VAL . 23.7 p90 -164.69 158.45 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.374 1.07 . . . . 0.0 110.474 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 m -163.17 154.39 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.87 2.068 . . . . 0.0 108.181 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.66 100.1 37.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 C-N-CA 122.767 2.311 . . . . 0.0 111.828 179.149 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.664 0.745 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -92.18 140.44 29.62 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.301 1.44 . . . . 0.0 112.622 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.539 ' CE3' HD11 ' A' ' 171' ' ' ILE . 6.8 p-90 -163.1 138.32 6.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -161.24 152.12 18.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.766 -0.584 . . . . 0.0 112.441 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 171' ' ' ILE . 10.9 t -143.96 143.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 127.161 2.185 . . . . 0.0 110.119 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 150.13 45.18 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.178 1.791 . . . . 0.0 109.872 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.84 103.55 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.232 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -66.45 101.36 0.75 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.851 -1.156 . . . . 0.0 109.093 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 t -67.49 82.22 0.16 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.847 -1.158 . . . . 0.0 111.525 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.47 -107.25 0.32 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.088 2.28 . . . . 0.0 111.423 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -153.19 144.64 23.27 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.849 1.26 . . . . 0.0 111.903 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -165.34 116.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.966 1.706 . . . . 0.0 111.788 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.71 164.92 20.56 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.538 0.735 . . . . 0.0 111.732 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.41 118.73 22.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.329 -0.232 . . . . 0.0 110.58 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.63 -179.09 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.139 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -48.84 42.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.943 1.297 . . . . 0.0 112.715 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.0 -33.52 60.71 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.001 0.81 . . . . 0.0 113.515 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.6 ttp -67.44 -56.42 9.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.412 1.106 . . . . 0.0 111.455 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -49.47 -39.81 34.97 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.296 0.953 . . . . 0.0 111.997 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -66.07 -43.14 88.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.079 0.952 . . . . 0.0 112.202 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -17.91 64.92 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.022 -1.673 . . . . 0.0 113.918 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 101' ' ' MET . 41.5 mt -96.23 -24.84 16.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.376 1.47 . . . . 0.0 113.39 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.81 -32.99 11.07 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.945 -1.097 . . . . 0.0 112.928 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -118.13 -33.67 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 112.759 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.19 -21.23 71.83 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.408 1.004 . . . . 0.0 114.517 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -154.11 87.0 3.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.462 2.305 . . . . 0.0 108.374 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.36 108.9 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.086 1.857 . . . . 0.0 110.953 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -139.88 158.95 43.25 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -147.42 167.67 23.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.963 1.705 . . . . 0.0 112.637 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.36 111.31 0.48 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.129 0.871 . . . . 0.0 112.93 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.03 70.39 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.986 0.914 . . . . 0.0 111.434 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.0 92.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.952 2.501 . . . . 0.0 114.993 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.09 130.17 1.09 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.581 1.086 . . . . 0.0 112.362 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.485 ' CE3' ' HG3' ' A' ' 158' ' ' LYS . 5.7 m95 -58.81 123.96 18.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.641 1.177 . . . . 0.0 111.164 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -131.75 118.24 19.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.422 1.489 . . . . 0.0 111.553 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.37 142.85 46.31 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.347 1.059 . . . . 0.0 112.615 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.23 156.82 41.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.688 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -74.62 104.36 5.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.73 -22.68 58.23 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.18 35.68 2.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.753 1.644 . . . . 0.0 116.523 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -135.42 -24.54 1.38 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.57 -18.03 1.13 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.204 1.383 . . . . 0.0 114.391 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 173' ' ' ILE . 1.2 pp -131.04 163.44 27.6 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.129 1.372 . . . . 0.0 112.523 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -102.3 136.72 41.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.289 1.436 . . . . 0.0 112.211 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB2' HG22 ' A' ' 173' ' ' ILE . 6.3 tmm? -115.07 135.72 53.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.149 0.58 . . . . 0.0 110.531 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.485 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.8 tptm -103.87 119.69 39.45 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.884 2.074 . . . . 0.0 110.468 176.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.18 146.87 18.62 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.354 1.454 . . . . 0.0 112.773 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 161' ' ' MET . 4.1 tp -124.15 157.05 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.096 1.759 . . . . 0.0 110.226 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.573 ' H ' HD12 ' A' ' 160' ' ' ILE . 7.0 tpt -152.34 90.87 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.463 1.505 . . . . 0.0 109.086 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.7 p -82.45 152.24 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 111.471 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.1 t -127.94 163.47 24.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.204 1.002 . . . . 0.0 112.049 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 65.05 144.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.575 2.75 . . . . 0.0 113.133 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 38.8 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.479 1.527 0 C-N-CA 126.877 2.18 . . . . 0.0 113.34 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.519 ' HG2' ' HZ3' ' A' ' 30' ' ' LYS . 2.1 tm-20 -75.59 64.11 1.63 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.376 1.87 . . . . 0.0 109.599 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.5 111.7 23.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.202 1.801 . . . . 0.0 111.768 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -159.1 161.69 36.41 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.421 ' N ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -121.99 140.33 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 127.739 2.416 . . . . 0.0 110.295 175.045 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.539 ' C ' HD12 ' A' ' 171' ' ' ILE . 25.5 tt0 -138.6 157.12 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.708 1.603 . . . . 0.0 109.018 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.539 HD11 ' CE3' ' A' ' 115' ' ' TRP . 1.6 mp -128.31 134.54 64.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 124.464 1.106 . . . . 0.0 109.697 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 109.11 13.26 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.318 2.247 . . . . 0.0 110.737 175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 155' ' ' LEU . 12.7 pt -91.54 124.47 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.134 1.374 . . . . 0.0 110.183 175.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.4 p -155.69 170.52 21.85 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.315 1.446 . . . . 0.0 112.735 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.38 169.72 10.18 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 110.654 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.87 -27.64 19.66 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 113.231 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -146.6 160.54 42.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.99 1.716 . . . . 0.0 111.641 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -139.83 166.81 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.571 1.549 . . . . 0.0 110.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 pt -73.91 -170.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.917 2.487 . . . . 0.0 110.308 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.05 19.8 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 -10.48 73.91 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.75 1.167 . . . . 0.0 114.36 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.7 -45.69 35.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.56 1.144 . . . . 0.0 111.497 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -81.62 -7.31 59.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.947 1.299 . . . . 0.0 113.869 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' ' 17' ' ' LEU . 20.5 tp -59.81 144.19 49.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.822 1.249 . . . . 0.0 110.396 174.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.3 146.43 29.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.247 1.019 . . . . 0.0 110.082 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -55.79 -29.06 59.08 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -60.85 -57.32 13.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.44 -43.68 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.766 -0.584 . . . . 0.0 110.073 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.601 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.36 -30.86 68.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 112.766 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -69.55 -47.27 64.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.986 1.715 . . . . 0.0 111.824 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -35.65 77.81 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.857 -1.152 . . . . 0.0 112.131 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -39.14 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.052 -1.03 . . . . 0.0 113.642 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -31.58 61.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.233 0.469 . . . . 0.0 111.79 175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -70.22 -33.41 71.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.319 1.448 . . . . 0.0 112.27 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -46.63 -29.44 1.85 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.457 2.303 . . . . 0.0 114.208 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD13 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 125.365 1.466 . . . . 0.0 110.94 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HE2' ' CD2' ' A' ' 24' ' ' LEU . 28.0 mmtm . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -121.4 141.67 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.729 1.612 . . . . 0.0 112.028 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 104.94 11.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.854 1.662 . . . . 0.0 110.338 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.12 142.87 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 124.257 1.023 . . . . 0.0 113.52 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.11 173.48 34.59 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.535 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 100' ' ' VAL . 3.1 mt -139.71 150.02 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.422 1.489 . . . . 0.0 110.613 -174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.39 118.09 31.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 110.617 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.549 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.73 103.69 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 0.0 111.922 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.58 7.97 2.82 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.823 1.249 . . . . 0.0 112.988 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 t -66.19 -16.26 63.84 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.62 16.73 28.21 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.595 1.093 . . . . 0.0 115.361 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.43 136.92 8.38 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.262 1.411 . . . . 0.0 112.886 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -67.36 141.63 57.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.437 1.495 . . . . 0.0 111.749 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.662 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 40.3 m0 -108.01 165.82 11.18 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.647 1.179 . . . . 0.0 112.179 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -146.55 98.8 3.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 111.997 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -63.29 139.77 58.8 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.019 -1.05 . . . . 0.0 110.428 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 91' ' ' TYR . 21.2 mt -93.4 -61.37 1.57 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.872 0.869 . . . . 0.0 110.187 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.63 -164.12 0.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.913 2.885 . . . . 0.0 108.892 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.85 134.77 20.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.206 1.803 . . . . 0.0 111.329 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -103.98 112.48 25.48 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.601 1.56 . . . . 0.0 109.376 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 130.81 55.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.543 1.537 . . . . 0.0 109.839 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -31.02 7.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.746 1.618 . . . . 0.0 113.258 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -141.8 91.85 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.241 1.016 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.17 125.94 3.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.8 1.667 . . . . 0.0 111.946 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -74.7 175.49 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.897 0.856 . . . . 0.0 111.775 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p -62.55 171.02 2.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.683 1.993 . . . . 0.0 113.122 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' OD1' HD13 ' A' ' 24' ' ' LEU . 1.2 t70 -152.34 -50.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.035 1.334 . . . . 0.0 109.785 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.9 164.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.476 1.51 . . . . 0.0 111.761 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 tp -71.88 134.25 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 110.452 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -91.79 114.2 61.21 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.696 1.198 . . . . 0.0 109.724 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.631 ' HG2' HD12 ' A' ' 69' ' ' LEU . 63.6 Cg_endo -66.31 120.53 7.68 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.308 3.339 . . . . 0.0 111.422 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.2 pt-20 -71.51 -67.58 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.499 0.72 . . . . 0.0 112.402 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -97.33 132.61 42.89 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.547 0.739 . . . . 0.0 109.561 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 t -129.67 128.04 22.98 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.816 0.847 . . . . 0.0 111.099 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.77 149.64 38.13 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.028 3.152 . . . . 0.0 112.805 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.89 17.96 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -141.0 8.62 2.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.412 1.885 . . . . 0.0 113.946 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -145.59 134.44 22.43 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 119.885 1.22 . . . . 0.0 113.038 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.23 -176.36 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 110.992 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -152.02 157.22 41.39 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.409 -0.807 . . . . 0.0 112.187 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.64 170.78 14.29 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 123.608 0.763 . . . . 0.0 111.65 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.48 157.76 43.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.231 1.813 . . . . 0.0 109.885 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.7 m -145.39 160.52 41.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.154 1.782 . . . . 0.0 108.799 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.81 -179.57 16.88 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.615 1.102 . . . . 0.0 111.984 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.552 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 103' ' ' SER . 15.4 t -130.86 108.0 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.878 2.071 . . . . 0.0 108.891 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.89 178.62 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 111.128 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.76 120.7 5.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -125.97 161.56 27.23 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.312 1.045 . . . . 0.0 113.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -131.52 148.82 52.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 24.4 m-85 -122.01 102.37 8.13 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.286 2.234 . . . . 0.0 112.094 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 46' ' ' LEU . 10.7 t80 -69.06 117.88 11.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.471 1.508 . . . . 0.0 110.374 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.9 mtp -82.42 153.1 25.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 111.516 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 m -58.74 -16.59 17.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -73.87 -17.88 60.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 113.565 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.27 33.82 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.248 1.88 . . . . 0.0 114.937 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -78.78 168.21 20.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.734 1.267 . . . . 0.0 111.573 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.71 HG22 ' HB1' ' A' ' 89' ' ' ALA . 23.8 m -136.43 106.51 6.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.318 1.047 . . . . 0.0 112.332 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 173' ' ' ILE . 16.4 tp -68.47 111.48 4.72 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.674 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 130' ' ' MET . . . -94.6 105.77 3.33 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 0.0 113.486 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -76.31 149.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 122.099 -0.648 . . . . 0.0 110.882 174.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.644 ' HB2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -122.72 145.43 48.4 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.209 -0.932 . . . . 0.0 109.793 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CG ' HG11 ' A' ' 33' ' ' VAL . 40.8 p90 -167.71 135.16 2.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 123.308 1.528 . . . . 0.0 114.234 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' VAL . 28.4 m -150.51 130.62 13.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.768 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.21 90.9 42.85 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 CA--C 1.541 0.855 0 C-N-CA 122.569 2.179 . . . . 0.0 112.818 -178.383 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.401 0.619 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -85.84 159.85 19.6 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.324 0.65 . . . . 0.0 110.249 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -161.45 171.03 18.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.951 1.3 . . . . 0.0 109.399 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 148.26 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.558 3.143 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.61 160.88 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.684 0.793 . . . . 0.0 109.847 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -161.25 158.07 26.66 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.56 176.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ ' ' A' ' 153' ' ' TYR . 34.1 mt -105.53 117.3 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -66.78 87.85 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.873 1.669 . . . . 0.0 110.189 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.5 t -73.02 81.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.0 110.949 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.62 -82.13 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.717 1.151 . . . . 0.0 112.938 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 177.8 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.38 2.672 . . . . 0.0 111.116 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -155.39 159.21 39.71 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.937 2.095 . . . . 0.0 109.338 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.16 173.86 10.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.123 2.169 . . . . 0.0 111.173 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.64 109.7 5.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.721 0.408 . . . . 0.0 111.863 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 130' ' ' MET . 2.4 t70 -163.68 -169.81 2.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 111.099 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.7 -48.88 69.11 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.442 -0.786 . . . . 0.0 110.707 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.54 50.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.422 1.01 . . . . 0.0 113.659 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.423 ' HE3' ' CA ' ' A' ' 99' ' ' GLY . 3.8 ttt -66.34 -63.63 1.03 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.739 0.815 . . . . 0.0 110.595 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.88 -34.1 62.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.999 0.92 . . . . 0.0 112.776 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.63 -40.09 95.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.681 1.592 . . . . 0.0 111.019 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -21.89 65.76 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.261 -1.525 . . . . 0.0 113.26 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 101' ' ' MET . 12.4 mt -82.15 -41.11 20.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.492 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 -34.69 14.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -113.11 -36.56 5.03 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.481 1.512 . . . . 0.0 112.128 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.81 -69.58 1.02 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.747 1.642 . . . . 0.0 112.487 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -171.13 75.57 0.54 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 125.437 1.495 . . . . 0.0 112.933 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.73 161.32 32.78 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.751 2.3 . . . . 0.0 113.86 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -126.53 177.19 6.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.125 2.17 . . . . 0.0 112.224 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -108.24 124.0 49.63 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.055 2.142 . . . . 0.0 111.584 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.64 101.96 2.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.493 1.52 . . . . 0.0 112.928 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -136.86 23.96 3.08 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 71.2 99.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.81 2.444 . . . . 0.0 113.386 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.96 139.41 2.66 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.691 1.615 . . . . 0.0 111.987 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -69.83 154.91 41.33 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 122.216 -0.579 . . . . 0.0 111.354 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -142.08 124.47 15.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.305 1.442 . . . . 0.0 111.694 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -121.79 138.64 54.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.231 2.212 . . . . 0.0 111.34 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 159.44 38.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.92 1.288 . . . . 0.0 111.694 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -81.63 86.6 6.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.091 1.356 . . . . 0.0 110.083 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.526 HD22 ' CE2' ' A' ' 153' ' ' TYR . 7.3 tt -58.42 -52.51 65.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.456 1.502 . . . . 0.0 112.949 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.58 42.37 0.02 OUTLIER Glycine 0 CA--C 1.542 1.761 0 N-CA-C 118.584 2.194 . . . . 0.0 118.584 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -150.05 5.01 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.642 1.721 . . . . 0.0 115.61 -176.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.87 -57.21 0.44 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.448 1.499 . . . . 0.0 112.496 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.84 176.24 7.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.824 0.85 . . . . 0.0 111.652 174.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.24 123.94 31.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.648 1.579 . . . . 0.0 109.999 175.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.613 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -88.2 156.02 19.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.58 130.96 39.12 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.762 1.225 . . . . 0.0 109.977 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -124.41 152.66 17.46 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 124.269 0.938 . . . . 0.0 113.588 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 141.24 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.278 1.431 . . . . 0.0 110.396 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.31 99.13 5.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.931 1.242 . . . . 0.0 110.931 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.59 53.86 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 0.0 111.89 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.5 m -123.06 129.02 50.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.674 1.989 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.64 68.15 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.842 2.857 . . . . 0.0 109.151 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.2 -90.46 0.02 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.38 1.943 . . . . 0.0 114.536 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -75.81 11.22 1.45 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.57 2.348 . . . . 0.0 114.802 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.37 170.28 16.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.69 1.596 . . . . 0.0 113.032 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 -167.99 1.89 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.1 ptm -114.05 164.12 14.25 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.858 2.063 . . . . 0.0 110.99 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -150.64 146.03 26.24 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.165 1.386 . . . . 0.0 110.009 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.0 mm -121.03 128.69 76.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.311 1.045 . . . . 0.0 108.726 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -115.58 114.55 25.09 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.504 1.522 . . . . 0.0 108.965 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.662 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 13.3 pt -111.07 134.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.59 1.156 . . . . 0.0 110.709 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.5 p -162.72 158.97 23.69 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.8 1.24 . . . . 0.0 110.79 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.248 1.419 . . . . 0.0 112.212 -175.043 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.75 166.85 5.05 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.024 0.916 . . . . 0.0 110.403 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.64 -42.17 1.99 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.93 1.729 . . . . 0.0 110.89 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.3 p -139.1 159.98 40.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.429 1.491 . . . . 0.0 111.932 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mm -142.11 162.9 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 111.402 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.5 pt -69.1 -169.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.072 2.149 . . . . 0.0 111.073 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.08 -25.84 23.87 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.28 -21.59 34.05 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.411 1.005 . . . . 0.0 113.355 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -44.1 70.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.444 1.122 . . . . 0.0 111.845 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.64 -11.67 59.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.018 1.327 . . . . 0.0 113.365 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD11 HD23 ' A' ' 17' ' ' LEU . 1.5 tt -66.15 159.12 26.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.59 146.84 27.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.685 0.794 . . . . 0.0 109.916 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -55.52 -33.93 64.21 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.96 -47.77 79.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.456 1.103 . . . . 0.0 113.049 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.1 -45.94 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 110.439 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.54 -41.3 66.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 111.426 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.67 -53.3 40.47 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.619 1.968 . . . . 0.0 112.317 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -27.12 41.84 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -35.82 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.181 1.355 . . . . 0.0 111.742 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -81.27 -23.91 37.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.208 1.003 . . . . 0.0 112.463 177.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.9 -33.77 22.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.645 1.578 . . . . 0.0 114.235 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -19.89 16.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 112.935 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 127.457 2.303 . . . . 0.0 111.038 174.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.564 ' HB2' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -145.41 148.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.683 1.193 . . . . 0.0 113.005 176.054 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.607 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -121.77 105.63 10.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.591 2.356 . . . . 0.0 112.603 174.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 102' ' ' PHE . 1.3 p -115.7 144.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 108.75 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.61 170.54 22.56 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 118.195 0.452 . . . . 0.0 112.8 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.02 124.88 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.888 0.875 . . . . 0.0 111.528 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -71.2 109.34 5.18 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.348 -0.845 . . . . 0.0 111.902 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.87 102.68 14.55 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.656 1.217 . . . . 0.0 111.271 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.14 44.41 1.55 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.07 -1.019 . . . . 0.0 110.94 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -2.32 9.05 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.41 75.81 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.946 -1.096 . . . . 0.0 115.266 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.37 107.85 1.71 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.758 1.647 . . . . 0.0 111.509 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.2 m -67.74 116.75 8.79 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.638 1.219 . . . . 0.0 110.632 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.443 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 8.7 m0 -85.78 161.25 19.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.588 0.355 . . . . 0.0 111.916 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -138.01 104.12 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.448 1.899 . . . . 0.0 111.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -65.93 141.27 58.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.884 -1.135 . . . . 0.0 110.528 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -106.42 -47.45 3.78 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.195 1.398 . . . . 0.0 111.774 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -155.63 171.35 20.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.027 0.931 . . . . 0.0 112.13 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.13 135.33 30.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 0.0 111.604 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.437 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.3 t80 -115.16 129.01 56.55 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.333 1.453 . . . . 0.0 109.088 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 18.8 p90 -147.22 161.15 41.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.869 1.267 . . . . 0.0 112.452 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -120.94 -31.84 4.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.738 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.49 ' CB ' ' H ' ' A' ' 85' ' ' VAL . 83.2 p -60.19 130.97 49.3 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.712 1.205 . . . . 0.0 112.344 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 37.13 -100.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.285 1.898 . . . . 0.0 113.904 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 55' ' ' THR . 2.1 t -165.04 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.478 1.911 . . . . 0.0 108.244 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 54' ' ' THR . 12.7 p -137.31 164.9 27.45 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.411 2.284 . . . . 0.0 112.119 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -154.67 -38.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.523 1.529 . . . . 0.0 111.358 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 3' ' ' ALA . 16.2 m -102.31 165.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.682 1.593 . . . . 0.0 112.24 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.5 tt -80.24 136.62 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.641 1.176 . . . . 0.0 110.957 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.22 107.08 36.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.907 0.883 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HG2' HD12 ' A' ' 69' ' ' LEU . 73.5 Cg_endo -67.14 113.96 3.03 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 124.322 3.348 . . . . 0.0 110.386 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.49 -46.61 87.66 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.641 -0.662 . . . . 0.0 112.024 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.78 145.31 29.93 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.954 0.797 . . . . 0.0 110.854 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.11 94.19 16.26 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 124.723 1.209 . . . . 0.0 108.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.15 173.94 13.65 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.268 1.978 . . . . 0.0 112.125 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.72 166.82 3.06 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.343 0.657 . . . . 0.0 112.103 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.26 8.5 t 43.07 38.19 1.41 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.076 1.75 . . . . 0.0 113.396 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -148.74 151.41 34.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.039 1.736 . . . . 0.0 111.592 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.12 -175.62 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.32 . . . . 0.0 109.373 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -156.75 145.16 19.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.964 1.305 . . . . 0.0 109.368 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' HB1' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -124.34 155.08 39.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.25 1.02 . . . . 0.0 110.082 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.461 ' CE1' HG23 ' A' ' 57' ' ' VAL . 2.3 t80 -139.45 169.2 18.19 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 109.793 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -154.49 -177.8 6.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.339 1.055 . . . . 0.0 110.722 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.11 -167.03 12.79 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.354 1.93 . . . . 0.0 110.903 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.978 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.49 ' H ' ' CB ' ' A' ' 52' ' ' SER . 47.1 t -152.36 114.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.357 2.263 . . . . 0.0 112.719 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -143.98 167.0 23.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.488 1.515 . . . . 0.0 110.448 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 122.95 10.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.255 1.422 . . . . 0.0 107.45 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -139.23 164.01 30.95 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 112.315 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 130' ' ' MET . . . -124.11 151.73 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.702 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 24.2 m-85 -131.83 112.16 12.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.958 1.703 . . . . 0.0 110.937 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -65.91 105.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.252 1.421 . . . . 0.0 110.655 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -73.47 153.46 40.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.203 1.001 . . . . 0.0 110.998 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.5 p -59.63 -20.56 56.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -76.27 -4.45 42.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 114.058 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.1 6.3 71.84 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.293 1.425 . . . . 0.0 114.851 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.59 177.28 5.86 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.235 1.414 . . . . 0.0 111.293 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.599 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 17.9 m -133.48 112.0 11.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.323 1.049 . . . . 0.0 113.12 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 tp -73.45 122.84 22.78 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.66 108.57 3.14 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.0 154.76 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.337 0.589 . . . . 0.0 110.828 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.526 ' CB ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -138.38 148.22 44.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.532 1.133 . . . . 0.0 108.924 175.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 21.3 p90 -162.17 147.05 12.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.234 1.016 . . . . 0.0 110.488 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 85' ' ' VAL . 24.2 m -151.55 165.4 34.36 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.94 1.296 . . . . 0.0 108.379 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.51 96.68 23.39 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.54 0.818 0 C-N-CA 122.976 2.451 . . . . 0.0 114.718 -175.018 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 121.86 0.838 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -84.16 144.41 29.01 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.259 1.024 . . . . 0.0 112.547 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -153.45 150.93 29.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.472 0.653 . . . . 0.0 111.831 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.61 151.21 4.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.046 1.338 . . . . 0.0 111.079 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.0 135.55 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.261 1.824 . . . . 0.0 108.748 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -146.43 155.01 42.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.102 1.361 . . . . 0.0 109.872 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.16 107.16 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.396 1.478 . . . . 0.0 107.863 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.66 104.83 4.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.277 1.031 . . . . 0.0 109.22 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t -65.6 97.02 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.799 -1.188 . . . . 0.0 110.097 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.8 19.26 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 127.194 2.33 . . . . 0.0 110.317 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -126.93 129.85 48.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.107 1.763 . . . . 0.0 111.018 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.75 121.68 5.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.841 1.657 . . . . 0.0 111.563 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.59 175.36 5.66 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.483 1.113 . . . . 0.0 110.85 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -84.59 115.06 22.42 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.71 -0.619 . . . . 0.0 111.905 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -151.27 -174.53 4.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.441 1.096 . . . . 0.0 111.682 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.56 -51.7 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.512 1.125 . . . . 0.0 110.668 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.06 46.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.202 0.906 . . . . 0.0 113.83 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 2.7 ttt -66.04 -65.2 0.71 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.629 0.714 . . . . 0.0 110.185 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -54.14 -31.78 53.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.47 1.108 . . . . 0.0 112.683 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.47 -47.88 82.05 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.802 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -23.69 67.44 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.464 -1.397 . . . . 0.0 113.806 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.526 HD13 ' CB ' ' A' ' 101' ' ' MET . 76.5 mt -79.09 -18.17 53.81 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.431 1.492 . . . . 0.0 114.44 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.76 -31.33 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.905 1.282 . . . . 0.0 114.433 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.52 -5.74 13.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.0 2.12 . . . . 0.0 112.268 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.03 -88.68 0.46 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.244 1.878 . . . . 0.0 110.744 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -160.98 73.08 2.7 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.695 1.598 . . . . 0.0 111.692 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.26 177.63 8.37 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.731 2.287 . . . . 0.0 114.914 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -127.03 -178.24 4.34 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.231 2.212 . . . . 0.0 113.056 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 144.65 48.85 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.378 -1.451 . . . . 0.0 111.848 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.97 116.5 0.76 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.587 1.089 . . . . 0.0 111.952 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -115.46 68.78 0.72 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.348 1.459 . . . . 0.0 112.83 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 64.55 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.281 2.633 . . . . 0.0 113.758 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.78 142.11 3.48 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.982 1.277 . . . . 0.0 112.5 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -67.82 147.9 51.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.481 0.713 . . . . 0.0 111.951 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -148.41 122.82 9.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.706 1.602 . . . . 0.0 110.926 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.12 141.58 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.987 0.915 . . . . 0.0 111.633 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -146.01 148.85 33.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.352 0.596 . . . . 0.0 110.452 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.53 92.72 8.6 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.494 HD13 ' SD ' ' A' ' 157' ' ' MET . 2.4 tp -51.92 -32.16 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.99 21.97 5.46 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -128.44 20.43 6.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.875 1.338 . . . . 0.0 114.445 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.85 12.11 83.11 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.348 -0.845 . . . . 0.0 113.827 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.87 166.97 23.2 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.41 1.884 . . . . 0.0 111.633 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 169.74 13.2 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.26 1.424 . . . . 0.0 109.824 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -145.81 167.52 23.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.897 175.003 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 137.02 54.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.295 1.438 . . . . 0.0 108.253 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.06 141.36 15.83 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.536 0.589 . . . . 0.0 112.632 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.22 101.97 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.516 1.526 . . . . 0.0 111.089 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.5 tpt -96.63 105.08 17.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.982 1.264 . . . . 0.0 110.998 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.8 p -114.7 145.36 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.08 0.952 . . . . 0.0 111.449 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -137.86 139.56 39.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.865 1.666 . . . . 0.0 111.968 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.6 -179.29 0.11 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 130.344 3.458 . . . . 0.0 108.744 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.09 -12.86 45.92 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 115.077 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.21 11.28 0.91 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.76 1.624 . . . . 0.0 114.769 -175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.96 169.11 12.76 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.546 -1.346 . . . . 0.0 113.745 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 19.6 tptt -167.14 151.36 6.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 113.091 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.6 ptm -81.19 165.76 21.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -154.37 161.0 41.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.332 1.453 . . . . 0.0 110.782 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 mm -123.14 135.35 63.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -118.12 126.99 53.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.411 1.084 . . . . 0.0 108.289 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 157' ' ' MET . 14.5 pt -110.82 117.0 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -156.05 145.02 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.372 0.669 . . . . 0.0 112.322 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.509 1.924 . . . . 0.0 112.003 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.81 5.26 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 121.451 0.643 . . . . 0.0 110.188 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.43 -27.64 19.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.8 1.191 . . . . 0.0 113.039 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 p -145.79 155.27 42.82 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.109 1.364 . . . . 0.0 111.532 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -135.15 162.25 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.1 1.36 . . . . 0.0 110.435 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -72.51 -165.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 127.837 2.455 . . . . 0.0 111.231 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.05 -24.78 26.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.39 -19.62 34.89 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.53 1.062 . . . . 0.0 114.185 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.38 75.19 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.296 1.048 . . . . 0.0 111.81 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -85.67 -7.85 58.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.733 1.613 . . . . 0.0 114.15 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HD23 ' A' ' 17' ' ' LEU . 10.2 tt -63.92 149.94 46.09 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.204 1.002 . . . . 0.0 111.582 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -145.06 145.62 31.52 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.396 1.078 . . . . 0.0 110.528 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -51.77 -37.94 53.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.452 1.101 . . . . 0.0 113.359 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -56.26 -48.51 76.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.416 1.007 . . . . 0.0 112.651 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -52.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.658 1.583 . . . . 0.0 109.238 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.719 HD13 HD23 ' A' ' 21' ' ' LEU . 2.0 tm? -53.42 -41.39 65.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.537 1.535 . . . . 0.0 111.848 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.42 -51.95 67.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.414 1.486 . . . . 0.0 111.216 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -38.32 89.35 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.337 -0.852 . . . . 0.0 112.086 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.89 -51.09 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 110.959 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.891 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.0 pp -67.11 -33.98 76.63 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.52 -23.04 63.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.1 1.36 . . . . 0.0 113.404 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.47 -23.34 49.29 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.648 -1.282 . . . . 0.0 113.471 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 57' ' ' VAL . 3.0 tm? . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 127.162 2.185 . . . . 0.0 112.629 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.67 142.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -175.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -120.9 111.17 17.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.582 1.953 . . . . 0.0 110.722 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 71' ' ' TYR . 2.0 p -127.36 127.12 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.434 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.37 30.56 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.468 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.713 HG21 HD21 ' A' ' 98' ' ' LEU . 2.6 mp -136.85 142.49 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.874 1.27 . . . . 0.0 110.6 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.16 111.7 22.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.052 1.741 . . . . 0.0 111.546 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.88 89.65 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.132 1.773 . . . . 0.0 111.741 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -132.1 7.66 4.32 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.914 0.886 . . . . 0.0 112.684 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t -81.29 -6.98 59.47 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.55 20.02 36.06 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.594 1.092 . . . . 0.0 115.527 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.74 121.56 2.81 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.499 1.523 . . . . 0.0 111.667 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -57.43 144.13 37.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.594 1.558 . . . . 0.0 111.446 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.447 ' HH2' HG22 ' A' ' 35' ' ' ILE . 44.5 m0 -107.66 168.06 9.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.246 0.618 . . . . 0.0 112.547 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.8 m -153.74 105.16 2.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.895 2.078 . . . . 0.0 109.787 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.0 139.4 56.33 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.651 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -110.01 -54.56 2.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.38 1.072 . . . . 0.0 112.349 -176.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -153.53 171.15 19.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.17 0.988 . . . . 0.0 111.187 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 136.23 43.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.153 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -119.16 136.54 54.13 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.883 1.273 . . . . 0.0 110.286 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -161.96 145.26 12.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.643 1.577 . . . . 0.0 112.068 -176.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -115.61 -11.02 11.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.582 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -151.47 137.75 18.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.031 1.732 . . . . 0.0 112.128 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 39.1 3.17 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.017 0.818 . . . . 0.0 114.6 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 m -30.19 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.04 2.936 . . . . 0.0 113.158 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -71.94 162.81 28.91 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.282 -0.886 . . . . 0.0 112.732 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -132.61 5.88 4.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.159 0.983 . . . . 0.0 113.581 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG23 ' CE1' ' A' ' 71' ' ' TYR . 5.8 m -106.33 163.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.051 1.74 . . . . 0.0 112.523 -177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.81 123.44 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.867 1.267 . . . . 0.0 112.856 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.7 130.37 61.55 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -70.21 142.58 46.3 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.844 2.362 . . . . 0.0 109.696 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -85.2 -77.86 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.904 0.882 . . . . 0.0 110.59 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -100.86 149.25 24.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.632 1.173 . . . . 0.0 110.506 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.0 133.34 14.14 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.131 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.11 -151.69 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.257 3.972 . . . . 0.0 113.796 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -119.63 15.76 12.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.076 1.751 . . . . 0.0 113.678 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -141.61 18.24 2.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.882 1.673 . . . . 0.0 113.775 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -136.77 -173.3 3.4 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.974 1.309 . . . . 0.0 113.238 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.87 -178.49 6.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.492 1.517 . . . . 0.0 110.339 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -146.22 160.93 41.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.525 -0.734 . . . . 0.0 111.32 178.223 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.465 HD11 HD11 ' A' ' 17' ' ' LEU . 5.0 mt -141.39 157.3 45.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.481 1.112 . . . . 0.0 109.562 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CE1' HG23 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -140.67 159.04 43.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.191 1.796 . . . . 0.0 108.593 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.1 m -150.05 140.07 22.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 110.516 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.96 165.07 13.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.028 1.299 . . . . 0.0 114.272 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 113.773 -175.554 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.6 t -150.35 111.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.988 1.315 . . . . 0.0 113.131 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -140.57 164.61 29.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.228 1.014 . . . . 0.0 112.016 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 124.31 10.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.439 1.096 . . . . 0.0 108.972 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -132.95 160.6 36.6 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.183 0.993 . . . . 0.0 113.186 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -122.51 149.0 44.5 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 29.7 m-85 -127.58 114.41 17.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.827 2.051 . . . . 0.0 110.58 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB2' HD22 ' A' ' 46' ' ' LEU . 18.9 t80 -71.22 116.71 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 111.05 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.98 23.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.016 2.126 . . . . 0.0 111.491 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -19.7 30.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.74 1.65 22.36 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.97 39.64 11.43 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 125.403 1.478 . . . . 0.0 112.09 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.462 HD22 HG21 ' A' ' 119' ' ' ILE . 9.4 p-10 -137.59 170.59 15.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.008 2.523 . . . . 0.0 113.16 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.502 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.9 m -131.7 110.22 10.74 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 35' ' ' ILE . 34.2 tp -73.28 117.35 14.93 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.382 1.073 . . . . 0.0 110.384 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.43 117.16 5.78 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.08 0.847 . . . . 0.0 112.711 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.95 164.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.727 0.811 . . . . 0.0 110.832 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.428 ' HG2' ' H ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -144.05 161.37 38.97 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.243 175.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 14.9 p90 -166.59 160.44 15.15 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.718 1.207 . . . . 0.0 111.565 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 119.85 0.94 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.968 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.35 146.03 56.91 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 N--CA 1.455 -0.779 0 C-N-CA 121.878 1.719 . . . . 0.0 109.712 175.245 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -72.81 143.25 47.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.626 0.77 . . . . 0.0 112.033 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -152.99 151.66 30.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.29 0.636 . . . . 0.0 109.914 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' A' ' 101' ' ' MET . 10.5 t0 -167.52 138.04 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.37 1.468 . . . . 0.0 109.305 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.56 134.21 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.783 1.233 . . . . 0.0 109.187 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HA ' HD11 ' A' ' 151' ' ' LEU . 5.5 tttp -152.41 155.49 37.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.41 1.084 . . . . 0.0 109.497 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.462 HG21 HD22 ' A' ' 96' ' ' ASN . 67.9 mt -109.37 101.72 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.03 99.25 0.63 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.134 -0.979 . . . . 0.0 109.39 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -66.1 87.15 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.231 1.015 . . . . 0.0 110.634 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.33 -134.33 3.32 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.512 2.482 . . . . 0.0 110.321 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -149.99 109.9 4.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.717 1.607 . . . . 0.0 111.33 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -144.53 120.7 10.82 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.223 1.809 . . . . 0.0 112.139 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 174.5 5.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.692 1.197 . . . . 0.0 110.771 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.61 114.47 20.32 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.566 . . . . 0.0 110.043 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.97 -165.85 1.59 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.847 1.659 . . . . 0.0 110.471 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.37 -50.4 30.76 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.971 1.308 . . . . 0.0 110.996 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.52 -27.77 54.79 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.427 1.013 . . . . 0.0 114.609 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.8 ttt -75.59 -61.3 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.041 0.921 . . . . 0.0 110.179 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -53.96 -32.24 53.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.903 1.281 . . . . 0.0 112.665 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.39 -42.97 99.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 107.478 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -30.37 70.2 Favored 'General case' 0 CA--C 1.559 1.315 0 O-C-N 120.769 -1.207 . . . . 0.0 108.034 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.2 mt -75.76 -37.52 59.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.672 1.589 . . . . 0.0 113.879 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -27.93 14.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.421 1.488 . . . . 0.0 114.766 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.4 -40.23 2.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.383 1.473 . . . . 0.0 112.225 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.6 -70.68 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.149 1.833 . . . . 0.0 112.401 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.46 73.38 4.33 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 142.48 63.34 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.997 1.798 . . . . 0.0 112.996 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -122.97 -178.92 4.09 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.898 2.079 . . . . 0.0 109.275 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.73 143.43 50.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.381 1.472 . . . . 0.0 112.472 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.23 101.53 2.8 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.368 1.461 . . . . 0.0 113.446 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.57 19.96 4.26 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 54.92 80.22 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.148 2.179 . . . . 0.0 113.234 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.34 165.84 23.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.029 1.299 . . . . 0.0 113.327 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.467 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 9.2 m95 -68.86 130.1 41.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.066 1.346 . . . . 0.0 111.586 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -139.48 118.8 12.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.63 1.172 . . . . 0.0 113.654 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.88 145.21 30.15 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.274 1.43 . . . . 0.0 109.541 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -143.84 156.39 44.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.9 1.28 . . . . 0.0 109.675 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.31 100.2 13.04 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 7.1 tp -55.94 -31.94 63.38 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.69 30.7 6.7 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 119.302 2.481 . . . . 0.0 119.302 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -131.67 -21.86 2.45 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.96 -15.67 1.74 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 118.666 0.666 . . . . 0.0 114.632 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.26 171.57 13.16 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 126.169 1.788 . . . . 0.0 110.029 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.18 164.44 19.48 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.322 1.049 . . . . 0.0 110.637 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.543 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.2 OUTLIER -143.96 164.15 31.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.464 1.126 . . . . 0.0 112.757 177.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -128.57 125.39 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.227 1.811 . . . . 0.0 108.473 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.96 153.27 17.69 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.533 1.54 . . . . 0.0 112.863 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -129.48 149.73 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.728 1.611 . . . . 0.0 109.687 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.557 ' N ' HD13 ' A' ' 160' ' ' ILE . 6.6 tpt -150.2 119.06 6.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.247 1.819 . . . . 0.0 109.387 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.535 HG23 HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -127.9 122.46 32.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.313 1.845 . . . . 0.0 111.472 -175.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.9 p -87.85 73.61 9.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.885 1.674 . . . . 0.0 112.397 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.45 17.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.227 1.011 . . . . 0.0 113.021 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.87 -7.41 88.0 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.89 1.233 . . . . 0.0 114.459 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -125.53 7.92 7.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.136 2.175 . . . . 0.0 113.721 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -128.59 174.31 9.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.18 1.392 . . . . 0.0 112.575 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.4 OUTLIER -161.42 -178.55 6.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.965 1.706 . . . . 0.0 112.906 -178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.437 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -106.85 151.81 24.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.479 1.911 . . . . 0.0 109.983 178.364 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.436 ' C ' HD12 ' A' ' 171' ' ' ILE . 28.7 tt0 -162.26 148.1 13.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.269 1.428 . . . . 0.0 108.82 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 170' ' ' GLN . 1.7 mp -123.18 136.24 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.688 0.795 . . . . 0.0 108.94 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -121.46 124.58 44.81 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.296 1.039 . . . . 0.0 108.71 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.543 HG22 ' HB3' ' A' ' 157' ' ' MET . 5.3 pt -94.99 145.53 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.778 0.831 . . . . 0.0 109.51 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.5 t -159.0 170.01 23.03 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.788 -0.57 . . . . 0.0 112.171 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.972 1.709 . . . . 0.0 112.682 177.93 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 111.239 0.089 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.15 -174.31 0.48 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.578 0.751 . . . . 0.0 110.469 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.36 -31.76 7.12 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.402 -1.436 . . . . 0.0 111.538 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 p -146.39 155.96 42.97 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.543 1.537 . . . . 0.0 110.902 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.496 HG13 HD23 ' A' ' 70' ' ' LEU . 41.7 mm -136.56 166.91 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 126.334 1.854 . . . . 0.0 109.815 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -165.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.731 1.613 . . . . 0.0 111.339 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -51.12 -32.84 23.99 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.96 -14.65 37.45 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.995 1.283 . . . . 0.0 113.8 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.31 63.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.49 1.145 . . . . 0.0 111.291 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -85.71 -9.89 56.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.627 1.571 . . . . 0.0 114.258 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.49 143.2 54.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.454 1.101 . . . . 0.0 110.119 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.2 143.12 24.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.641 0.776 . . . . 0.0 109.959 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.06 -32.6 68.17 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -54.78 -51.06 66.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.452 1.101 . . . . 0.0 113.02 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.03 -52.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.523 HD21 ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -53.18 -39.96 64.02 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.89 1.276 . . . . 0.0 112.432 -175.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -52.22 -63.99 0.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.334 2.254 . . . . 0.0 110.237 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -66.51 -23.01 66.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -46.1 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.702 1.137 . . . . 0.0 111.91 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.29 -26.38 61.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.205 1.002 . . . . 0.0 111.412 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.46 -43.35 49.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.489 1.916 . . . . 0.0 113.861 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -23.57 2.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.977 1.711 . . . . 0.0 114.841 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 127.607 2.363 . . . . 0.0 114.826 175.009 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.561 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -126.03 145.28 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 127.504 2.321 . . . . 0.0 112.335 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -138.46 129.08 26.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 127.195 2.198 . . . . 0.0 111.819 175.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 102' ' ' PHE . 2.4 t -129.43 144.98 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 120.26 1.391 . . . . 0.0 112.033 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.42 174.62 46.41 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.382 0.513 . . . . 0.0 114.382 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.53 HG21 HD21 ' A' ' 98' ' ' LEU . 3.3 mp -140.75 114.73 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.247 1.819 . . . . 0.0 108.61 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.51 106.0 1.32 Allowed 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.403 -1.436 . . . . 0.0 110.966 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . 9.5 t-20 -82.03 92.95 6.88 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 123.519 1.628 . . . . 0.0 112.143 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.81 43.74 1.59 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.391 1.076 . . . . 0.0 110.525 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -2.22 16.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.295 1.838 . . . . 0.0 114.433 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.88 17.06 73.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.569 1.081 . . . . 0.0 115.046 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.19 129.35 5.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.949 1.737 . . . . 0.0 111.422 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -79.18 118.79 21.46 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 117.93 0.865 . . . . 0.0 109.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.683 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 5.9 m0 -88.03 161.66 17.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 m -137.86 107.74 6.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.33 1.852 . . . . 0.0 110.618 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -64.57 156.01 31.24 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.069 -1.02 . . . . 0.0 111.461 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -57.98 1.2 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.098 1.359 . . . . 0.0 112.438 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -147.69 167.99 23.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.285 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.25 137.63 40.97 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.357 1.463 . . . . 0.0 110.705 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.522 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 t80 -126.71 134.08 50.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.246 1.419 . . . . 0.0 110.355 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -142.41 155.47 45.12 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.059 2.144 . . . . 0.0 110.419 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -119.95 -44.23 2.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.277 1.431 . . . . 0.0 111.624 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -121.46 97.36 5.47 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.022 1.329 . . . . 0.0 111.479 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.63 109.34 2.78 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.92 1.247 . . . . 0.0 112.662 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -64.68 179.66 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.575 1.15 . . . . 0.0 113.231 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -65.6 152.89 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.598 1.559 . . . . 0.0 113.141 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -147.25 -21.66 0.39 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.49 164.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.294 2.238 . . . . 0.0 111.954 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 tt -73.59 130.66 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.925 0.89 . . . . 0.0 109.95 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 tp -78.91 128.42 76.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.677 ' CG ' HD12 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -67.59 126.82 15.36 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.782 2.988 . . . . 0.0 111.067 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.55 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.296 -0.878 . . . . 0.0 112.531 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -109.72 143.83 38.96 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.449 1.1 . . . . 0.0 110.389 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.75 86.99 53.69 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.384 1.074 . . . . 0.0 109.192 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.98 136.93 16.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.061 2.507 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -46.94 146.73 1.56 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.786 1.235 . . . . 0.0 112.705 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.327 1.4 p 74.47 32.55 0.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.125 2.17 . . . . 0.0 111.996 -175.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 61.6 mttt -150.4 146.98 27.02 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.013 2.125 . . . . 0.0 110.799 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.65 -177.91 3.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.314 1.046 . . . . 0.0 109.588 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.677 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -155.75 142.8 19.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.529 0.732 . . . . 0.0 110.64 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -113.32 -179.85 3.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.558 0.743 . . . . 0.0 110.433 174.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -159.01 159.33 34.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.905 1.682 . . . . 0.0 109.318 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -138.19 164.01 30.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.069 1.348 . . . . 0.0 110.89 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.94 -179.9 16.46 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.74 1.162 . . . . 0.0 113.398 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 103' ' ' SER . 61.6 t -140.86 123.99 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 127.982 2.513 . . . . 0.0 111.248 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -153.01 177.01 11.25 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.219 1.009 . . . . 0.0 111.875 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.7 125.71 11.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.345 1.458 . . . . 0.0 107.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -136.69 162.65 32.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.046 0.939 . . . . 0.0 110.52 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -133.11 150.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.454 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.3 m-85 -124.88 123.49 40.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.534 1.534 . . . . 0.0 110.758 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.41 109.0 2.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.189 1.796 . . . . 0.0 110.881 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.0 mtp -71.63 155.36 40.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.67 0.788 . . . . 0.0 111.68 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -58.17 -30.46 66.43 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 113.164 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 1.26 11.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.909 1.684 . . . . 0.0 114.687 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.65 9.29 85.82 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.756 -1.215 . . . . 0.0 114.341 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -89.05 178.87 6.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.079 1.752 . . . . 0.0 109.819 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.61 HG22 ' HB1' ' A' ' 89' ' ' ALA . 28.8 m -142.58 110.25 5.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.398 -1.439 . . . . 0.0 111.488 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD21 HG21 ' A' ' 35' ' ' ILE . 27.3 tp -77.09 121.02 22.98 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.67 107.64 3.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.483 1.516 . . . . 0.0 112.857 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.06 168.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 122.273 1.035 . . . . 0.0 111.377 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.446 ' SD ' ' CZ3' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -146.46 157.54 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.606 1.962 . . . . 0.0 109.511 174.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 51.8 p90 -165.08 134.07 3.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.031 1.332 . . . . 0.0 108.374 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 85' ' ' VAL . 37.4 m -147.05 130.61 16.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.116 0.567 . . . . 0.0 110.165 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.3 132.54 42.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.902 -0.571 . . . . 0.0 111.203 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.542 0.881 0 C-N-CA 122.773 2.315 . . . . 0.0 113.038 177.047 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.421 0.629 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CZ3' ' SD ' ' A' ' 101' ' ' MET . 40.8 p-90 -84.38 152.93 23.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.635 0.774 . . . . 0.0 110.358 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -158.97 128.48 5.58 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 109.452 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -177.82 126.73 0.13 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.766 1.227 . . . . 0.0 111.12 -176.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.61 HG11 HG13 ' A' ' 171' ' ' ILE . 5.5 m -118.01 166.74 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.314 1.046 . . . . 0.0 111.927 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.91 158.17 43.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.107 0.963 . . . . 0.0 111.39 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.27 106.7 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.01 1.724 . . . . 0.0 107.195 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.39 99.13 2.87 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.055 -1.028 . . . . 0.0 108.954 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.4 t -65.63 88.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.822 -1.174 . . . . 0.0 110.911 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.47 -141.39 8.85 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.691 2.091 . . . . 0.0 110.633 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -128.81 124.02 34.32 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.956 1.702 . . . . 0.0 111.284 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -149.25 120.03 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.471 1.508 . . . . 0.0 111.383 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.61 170.6 10.43 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.322 0.649 . . . . 0.0 110.633 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.28 115.71 18.19 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.71 -178.4 7.26 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.909 1.284 . . . . 0.0 113.629 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -51.79 -41.04 61.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.349 1.46 . . . . 0.0 113.778 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.93 88.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.091 0.853 . . . . 0.0 112.75 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.7 ttm -64.68 -50.97 64.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.797 0.799 . . . . 0.0 110.437 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -61.11 -34.1 74.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.691 0.797 . . . . 0.0 112.769 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.74 -35.14 79.59 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.784 -1.198 . . . . 0.0 111.532 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -12.71 55.85 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.785 -1.197 . . . . 0.0 113.566 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 mt -91.69 -54.1 4.02 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.336 1.855 . . . . 0.0 109.318 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -75.37 -43.32 50.97 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.84 -35.4 7.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.818 1.247 . . . . 0.0 112.999 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -48.79 -69.33 1.01 Allowed Glycine 0 N--CA 1.47 0.911 0 C-N-CA 125.234 1.397 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -164.47 84.27 1.2 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.994 0.917 . . . . 0.0 111.591 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.78 143.92 38.17 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.914 1.743 . . . . 0.0 113.158 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' ASP . 2.3 m-85 -114.92 -168.57 1.4 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.397 1.479 . . . . 0.0 112.003 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.79 127.82 48.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.72 2.008 . . . . 0.0 111.787 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.85 96.02 0.64 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 125.04 1.305 . . . . 0.0 114.48 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.91 79.65 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.254 1.421 . . . . 0.0 111.748 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.7 p30 35.28 67.27 0.27 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.835 2.454 . . . . 0.0 115.363 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 135.6 3.48 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.374 0.987 . . . . 0.0 113.231 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -64.88 144.89 56.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.333 1.053 . . . . 0.0 111.646 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -145.36 135.67 24.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.556 1.142 . . . . 0.0 112.121 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -119.39 144.82 46.7 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 110.399 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -151.77 163.66 38.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.623 1.169 . . . . 0.0 110.894 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.32 91.78 7.38 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.35 -34.51 47.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.873 1.269 . . . . 0.0 113.871 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 115.58 39.05 0.94 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 118.037 1.975 . . . . 0.0 118.037 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -137.02 -32.78 0.78 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.87 -23.57 1.15 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.149 1.357 . . . . 0.0 114.006 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 173.09 6.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.478 1.911 . . . . 0.0 111.242 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -127.15 160.02 32.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.841 1.256 . . . . 0.0 110.509 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.499 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -145.41 161.34 39.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.366 0.603 . . . . 0.0 111.9 177.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.87 132.01 56.77 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.257 1.423 . . . . 0.0 107.293 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.75 153.79 16.67 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.106 0.86 . . . . 0.0 112.648 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.7 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.46 151.83 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.657 1.183 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 21.1 tpp -147.43 91.88 2.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.656 1.583 . . . . 0.0 109.124 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.7 HG23 HD11 ' A' ' 160' ' ' ILE . 3.1 p -76.5 150.12 36.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 109.852 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 m -44.37 -69.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.312 1.845 . . . . 0.0 115.711 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -176.03 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.933 1.693 . . . . 0.0 112.398 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -47.15 89.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.212 0 C-N-CA 128.102 2.763 . . . . 0.0 115.432 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 45.5 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.078 2.151 . . . . 0.0 112.339 -175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -143.43 159.42 42.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 113.426 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 2.2 mmtm -148.03 173.2 13.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.555 1.542 . . . . 0.0 113.922 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.3 ptm -99.49 154.56 18.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.994 1.717 . . . . 0.0 112.15 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -160.73 157.15 26.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.61 HG13 HG11 ' A' ' 117' ' ' VAL . 45.4 mm -123.64 120.83 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.037 1.335 . . . . 0.0 109.573 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.43 101.64 12.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.407 1.083 . . . . 0.0 110.682 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.683 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 24.8 pt -91.66 133.33 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.134 0.574 . . . . 0.0 110.338 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.1 t -150.61 157.55 43.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.649 1.179 . . . . 0.0 111.386 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.608 1.163 . . . . 0.0 112.268 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.576 0.227 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 170.35 179.23 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.659 3.584 . . . . 0.0 107.759 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.76 -34.6 1.63 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.863 -1.148 . . . . 0.0 113.691 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -135.04 146.43 48.97 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.891 1.346 . . . . 0.0 111.675 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' CD1' HD12 ' A' ' 70' ' ' LEU . 31.0 mm -136.05 177.83 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.278 1.831 . . . . 0.0 109.443 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.32 165.52 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.868 2.067 . . . . 0.0 110.755 176.152 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . . . -58.13 -28.95 65.14 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.186 -1.571 . . . . 0.0 115.068 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.87 -7.26 3.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.389 1.471 . . . . 0.0 114.108 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 -35.56 63.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.115 1.366 . . . . 0.0 113.848 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -120.73 -2.18 9.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.301 1.441 . . . . 0.0 113.971 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 17' ' ' LEU . 12.7 tp -86.68 133.56 33.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.931 0.892 . . . . 0.0 112.012 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.7 m -144.75 -94.54 0.1 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.213 1.005 . . . . 0.0 110.16 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -158.68 -38.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.679 1.992 . . . . 0.0 110.804 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -52.81 -56.1 18.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.53 -47.16 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.931 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.73 -43.3 68.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.533 1.133 . . . . 0.0 113.314 -176.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.37 -62.08 1.84 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.361 2.264 . . . . 0.0 110.392 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -67.07 -30.46 70.52 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 117.803 -1.094 . . . . 0.0 113.658 176.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -52.26 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.212 1.369 . . . . 0.0 109.453 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -64.63 -33.55 76.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.64 0.376 . . . . 0.0 111.685 -177.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.47 -33.21 58.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 114.763 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -21.59 11.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.596 1.158 . . . . 0.0 113.829 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.727 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HB2' HD12 ' A' ' 21' ' ' LEU . 35.8 mmtt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.37 152.36 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.438 1.895 . . . . 0.0 111.061 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.95 114.72 20.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.131 1.773 . . . . 0.0 108.592 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.4 p -121.75 133.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.449 1.5 . . . . 0.0 110.201 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.67 177.77 38.18 Favored Glycine 0 N--CA 1.454 -0.143 0 O-C-N 121.492 -0.755 . . . . 0.0 112.392 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.1 mp -138.95 146.9 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.247 1.019 . . . . 0.0 110.471 -174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 106.83 19.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.293 1.837 . . . . 0.0 111.474 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.99 98.54 8.65 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.286 1.035 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -138.1 13.07 2.86 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -9.0 59.86 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.06 31.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 130.33 4.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.282 1.42 . . . . 0.0 112.217 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.1 m -62.25 141.51 58.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.94 1.696 . . . . 0.0 111.347 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 46.4 m0 -104.65 170.09 8.08 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.8 m -152.04 107.26 3.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.81 2.044 . . . . 0.0 110.555 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.18 152.33 45.64 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.855 -1.153 . . . . 0.0 109.807 175.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.11 -43.4 2.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.93 0.892 . . . . 0.0 112.357 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.76 -175.47 1.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.826 2.051 . . . . 0.0 110.578 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.45 139.03 18.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.421 . . . . 0.0 110.678 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.88 112.98 24.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.573 1.549 . . . . 0.0 109.174 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.73 150.52 35.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.189 2.195 . . . . 0.0 109.418 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.29 -43.58 2.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 111.089 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -137.32 111.91 8.73 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.029 1.332 . . . . 0.0 111.941 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.39 88.87 1.72 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 124.658 1.123 . . . . 0.0 111.99 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.6 m -81.16 99.17 8.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.229 1.012 . . . . 0.0 110.976 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 71' ' ' TYR . 13.7 t -63.37 166.5 6.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -128.92 -4.01 5.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.848 1.659 . . . . 0.0 113.648 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' CE1' ' A' ' 71' ' ' TYR . 27.6 m -87.8 160.0 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.026 0.931 . . . . 0.0 112.564 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.35 126.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 112.793 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tt -86.33 119.72 71.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.866 1.266 . . . . 0.0 109.36 175.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 127.42 17.13 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 124.111 3.207 . . . . 0.0 111.438 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 2.3 pm0 -79.44 -68.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.341 -0.849 . . . . 0.0 111.078 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.14 143.17 31.56 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.785 -0.572 . . . . 0.0 110.434 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.92 134.08 25.54 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 109.03 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.03 152.3 45.8 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.392 2.728 . . . . 0.0 111.858 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -65.38 17.04 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.856 2.462 . . . . 0.0 116.339 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 3.0 p -149.18 34.41 0.73 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 128.732 2.813 . . . . 0.0 111.162 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -153.46 163.86 39.21 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.414 -1.429 . . . . 0.0 112.201 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.05 175.02 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 111.401 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -144.68 159.74 42.33 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.338 0.655 . . . . 0.0 111.789 175.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.74 ' CD1' HD21 ' A' ' 17' ' ' LEU . 17.7 mt -139.21 158.81 43.52 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.784 1.234 . . . . 0.0 109.179 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -138.29 163.17 32.48 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.933 2.493 . . . . 0.0 108.019 175.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -151.04 178.26 9.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.214 1.806 . . . . 0.0 108.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.46 -177.51 31.62 Favored Glycine 0 N--CA 1.471 0.985 0 O-C-N 121.083 -1.011 . . . . 0.0 113.612 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.138 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -143.75 115.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.368 2.667 . . . . 0.0 111.784 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -160.33 178.98 9.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.916 1.686 . . . . 0.0 110.614 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.28 115.37 3.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.835 1.254 . . . . 0.0 108.24 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -122.68 170.94 9.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.549 1.139 . . . . 0.0 113.031 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -134.44 154.13 51.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 40.8 m-85 -128.11 121.56 29.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.771 2.029 . . . . 0.0 112.376 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -74.03 104.75 4.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.445 1.898 . . . . 0.0 111.945 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 mtp -69.66 151.98 45.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.539 1.536 . . . . 0.0 113.02 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -30.65 65.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.483 1.513 . . . . 0.0 113.624 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -66.07 -13.73 60.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.588 1.155 . . . . 0.0 113.454 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.25 28.58 11.44 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.991 1.281 . . . . 0.0 114.175 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.37 168.75 10.34 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.757 1.623 . . . . 0.0 110.526 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.58 HG22 ' HB1' ' A' ' 89' ' ' ALA . 99.6 m -131.34 102.53 6.0 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.588 -1.32 . . . . 0.0 112.926 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 173' ' ' ILE . 9.9 tp -73.66 124.56 26.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.818 -1.176 . . . . 0.0 112.188 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.07 102.46 2.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.729 1.157 . . . . 0.0 112.226 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.3 p -66.33 171.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.161 0.984 . . . . 0.0 111.955 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 2.3 ttp -144.67 144.78 31.41 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.733 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 28.8 p90 -161.06 142.27 11.68 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -158.15 154.45 27.45 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.074 1.349 . . . . 0.0 110.166 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.3 t -111.35 101.07 49.69 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.455 -0.744 0 C-N-CA 122.89 2.393 . . . . 0.0 111.046 178.338 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -86.49 158.28 19.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.904 0.882 . . . . 0.0 111.908 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.504 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.5 p-90 -160.97 162.13 31.8 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.874 1.27 . . . . 0.0 110.63 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 170.74 139.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.087 2.555 . . . . 0.0 110.511 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.478 HG21 HG13 ' A' ' 171' ' ' ILE . 19.4 t -140.87 122.09 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.663 1.585 . . . . 0.0 108.663 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -127.72 162.37 26.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.491 2.316 . . . . 0.0 109.886 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.495 HG13 HD21 ' A' ' 151' ' ' LEU . 63.6 mt -108.38 121.25 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.895 1.678 . . . . 0.0 108.489 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -84.11 101.99 12.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 t -52.92 139.61 26.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.16 -0.962 . . . . 0.0 111.025 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.04 -118.56 4.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.788 1.185 . . . . 0.0 110.336 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -136.07 137.35 41.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.233 1.813 . . . . 0.0 111.259 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -159.52 117.67 2.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.882 1.273 . . . . 0.0 112.734 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 174.49 4.7 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.919 0.888 . . . . 0.0 111.25 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.54 121.79 31.3 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.799 -0.563 . . . . 0.0 110.004 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.71 177.07 10.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.95 0.9 . . . . 0.0 111.156 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -52.06 -45.35 64.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.002 0.921 . . . . 0.0 112.075 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.93 -50.06 63.37 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.725 0.679 . . . . 0.0 112.685 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.74 -55.97 28.27 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.461 0.63 . . . . 0.0 110.303 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -44.68 36.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 112.608 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 1.4 tt0 -69.36 -33.52 73.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.747 1.619 . . . . 0.0 108.944 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.58 -14.9 2.35 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.113 1.365 . . . . 0.0 113.456 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 101' ' ' MET . 6.1 mp -90.49 -21.73 21.7 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.232 1.413 . . . . 0.0 113.785 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -97.5 -42.57 7.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.446 2.298 . . . . 0.0 113.151 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' A' ' 132' ' ' GLU . 2.2 p90 -115.09 -26.87 7.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.4 -32.12 81.87 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.349 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 176.35 71.16 0.08 OUTLIER Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 130.117 3.367 . . . . 0.0 111.714 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.47 142.32 48.9 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.644 2.229 . . . . 0.0 113.266 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -129.45 177.79 6.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.247 1.819 . . . . 0.0 112.848 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -115.97 125.85 53.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.921 2.088 . . . . 0.0 111.059 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.5 109.89 1.32 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.401 1.477 . . . . 0.0 109.545 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -160.05 89.17 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.436 1.494 . . . . 0.0 110.24 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.81 101.34 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.385 2.674 . . . . 0.0 115.147 174.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.13 134.54 3.33 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.102 1.334 . . . . 0.0 111.686 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 72.4 m95 -64.43 145.43 56.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.713 0.805 . . . . 0.0 112.176 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.19 130.47 19.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 112.743 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 156.92 47.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.055 2.142 . . . . 0.0 111.216 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.6 19.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.021 1.728 . . . . 0.0 111.585 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -64.55 102.22 0.53 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.349 1.46 . . . . 0.0 109.387 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.495 HD21 HG13 ' A' ' 119' ' ' ILE . 3.9 tp -57.94 -39.44 78.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.62 11.43 5.5 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -132.92 -34.11 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.131 1.466 . . . . 0.0 114.456 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 138.65 35.33 0.16 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.893 1.235 . . . . 0.0 113.98 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 156' ' ' ARG . 0.2 OUTLIER -157.82 163.46 37.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 110.591 175.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.574 ' N ' HD12 ' A' ' 155' ' ' LEU . 90.0 mtt180 -136.25 103.82 5.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.333 1.853 . . . . 0.0 112.55 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.688 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -85.09 159.97 20.07 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.159 176.47 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -122.68 139.1 54.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.767 174.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 171' ' ' ILE . . . -119.18 136.23 11.84 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.403 1.478 . . . . 0.0 113.292 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.9 tp -116.12 138.9 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.166 1.386 . . . . 0.0 111.145 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.1 tpt -121.87 130.98 53.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.427 1.012 . . . . 0.0 109.317 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 47.2 p -137.24 144.12 42.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.444 1.098 . . . . 0.0 110.28 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.3 t -148.33 -174.05 4.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.247 1.419 . . . . 0.0 111.56 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.09 42.26 5.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.789 2.035 . . . . 0.0 113.966 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.83 73.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.906 1.241 . . . . 0.0 112.637 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 35.92 67.07 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.98 2.512 . . . . 0.0 113.866 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -139.12 172.81 12.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.777 0.831 . . . . 0.0 112.822 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.32 171.49 20.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 112.541 -175.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -90.35 142.16 28.01 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.218 1.007 . . . . 0.0 112.048 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -133.13 155.8 48.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.625 1.57 . . . . 0.0 109.827 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.478 HG13 HG21 ' A' ' 117' ' ' VAL . 41.5 mm -123.91 125.41 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.847 1.259 . . . . 0.0 110.181 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -108.06 115.99 31.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.913 1.285 . . . . 0.0 110.113 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.688 HG22 ' HB3' ' A' ' 157' ' ' MET . 15.1 pt -96.42 129.76 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 0.0 110.157 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.5 m -171.65 172.09 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.025 1.33 . . . . 0.0 111.566 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.487 1.115 . . . . 0.0 113.008 178.072 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.427 ' HB3' HG22 ' A' ' 20' ' ' VAL . 3.1 mm? . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.42 -59.87 2.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.35 -36.84 0.16 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 126.786 2.136 . . . . 0.0 117.517 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.2 p -138.16 151.75 48.04 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 110.918 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 70' ' ' LEU . 25.0 mm -132.71 162.42 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.457 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 pt -70.36 -169.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.554 1.942 . . . . 0.0 110.409 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.33 -22.08 17.72 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.79 11.43 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.623 1.106 . . . . 0.0 113.714 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.86 83.82 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.284 1.042 . . . . 0.0 111.856 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -80.74 -9.61 59.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.859 1.264 . . . . 0.0 113.698 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 17' ' ' LEU . 1.2 tt -64.4 159.23 21.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.748 1.219 . . . . 0.0 112.636 175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.51 145.88 27.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.867 0.867 . . . . 0.0 109.846 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -56.32 -30.89 63.15 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -58.3 -52.96 63.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.061 0.944 . . . . 0.0 112.371 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.91 -46.56 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -51.82 -40.65 60.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.425 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.07 -58.04 9.26 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.382 1.473 . . . . 0.0 112.116 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -23.78 61.51 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -66.85 -44.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.087 1.312 . . . . 0.0 111.227 -178.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -74.5 -28.96 61.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.142 0.977 . . . . 0.0 112.189 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.14 -39.25 34.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.142 1.377 . . . . 0.0 112.185 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -48.32 -24.82 1.32 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.716 2.406 . . . . 0.0 113.263 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.503 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 6.5 tt . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 126.287 1.835 . . . . 0.0 111.689 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.62 139.13 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.004 0.921 . . . . 0.0 112.917 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 70' ' ' LEU . . . -127.01 101.67 6.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.481 1.512 . . . . 0.0 113.462 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -107.81 118.24 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 120.259 -1.526 . . . . 0.0 109.695 174.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.86 155.56 23.82 Favored Glycine 0 N--CA 1.46 0.293 0 O-C-N 121.924 -0.485 . . . . 0.0 113.006 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.9 mp -133.81 99.46 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.532 0.733 . . . . 0.0 111.637 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.36 102.99 0.26 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.878 1.271 . . . . 0.0 111.655 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -90.72 106.18 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.735 0.778 . . . . 0.0 112.877 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.266 31.3 tt0 -150.7 19.54 0.81 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.02 0.914 . . . . 0.0 111.278 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -5.1 20.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.258 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.76 17.44 51.9 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.525 1.536 . . . . 0.0 114.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.55 115.26 0.85 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.815 1.674 . . . . 0.0 111.377 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.7 m -55.52 148.53 15.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.066 1.347 . . . . 0.0 111.466 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 10.8 m0 -119.72 172.51 7.64 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.572 -0.705 . . . . 0.0 112.63 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -136.15 113.22 10.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.063 2.145 . . . . 0.0 111.458 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -70.22 105.65 3.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.839 0.856 . . . . 0.0 110.648 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -66.26 -56.83 9.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.056 175.01 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -167.48 172.4 9.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.792 1.637 . . . . 0.0 111.549 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.65 135.41 34.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.78 2.032 . . . . 0.0 111.412 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.443 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.9 t80 -119.13 129.02 54.81 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.715 1.606 . . . . 0.0 110.107 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -138.72 126.28 21.93 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.36 2.264 . . . . 0.0 110.041 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.45 -16.92 19.95 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.202 1.401 . . . . 0.0 110.888 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -76.37 102.56 5.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.36 1.064 . . . . 0.0 110.151 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.94 -118.83 11.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.423 1.487 . . . . 0.0 113.654 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -136.72 -172.71 3.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.937 1.695 . . . . 0.0 111.148 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.517 HG23 ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -80.96 167.17 20.13 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.574 1.949 . . . . 0.0 112.36 174.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -144.96 -45.55 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.87 0.868 . . . . 0.0 110.834 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.86 156.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.553 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.31 142.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.926 1.29 . . . . 0.0 111.134 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.68 128.96 41.98 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.412 1.085 . . . . 0.0 110.0 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.58 116.52 3.83 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 124.636 3.557 . . . . 0.0 112.033 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.45 -33.82 63.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -124.08 150.91 44.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.103 0.961 . . . . 0.0 112.188 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.8 t -138.64 96.12 9.69 Favored Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 124.876 1.27 . . . . 0.0 108.239 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 171.75 14.56 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.238 1.959 . . . . 0.0 111.421 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -64.82 174.98 1.63 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.665 -0.647 . . . . 0.0 110.615 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 14.6 t 49.15 24.66 0.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.56 1.544 . . . . 0.0 113.783 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -151.77 130.12 12.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.709 2.004 . . . . 0.0 110.826 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.29 -173.67 2.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.652 1.215 . . . . 0.0 109.643 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.33 162.46 40.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.606 1.162 . . . . 0.0 109.835 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.62 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -131.78 166.35 21.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.566 1.174 . . . . 0.0 108.162 174.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.603 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.2 t80 -151.85 161.13 43.15 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.134 1.373 . . . . 0.0 107.95 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.503 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 49.5 m -155.42 146.03 22.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.12 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.84 -161.57 36.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.782 0.706 . . . . 0.0 111.774 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.193 1.397 . . . . 0.0 111.025 178.045 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -147.63 135.17 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.732 2.013 . . . . 0.0 113.367 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.51 170.77 21.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.32 1.448 . . . . 0.0 110.803 174.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.06 114.98 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.226 1.41 . . . . 0.0 109.431 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -126.91 167.11 16.29 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.447 1.099 . . . . 0.0 112.24 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -126.54 154.15 44.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.12 0.568 . . . . 0.0 111.267 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -133.57 109.88 9.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.969 1.308 . . . . 0.0 113.337 -175.004 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -71.1 96.34 1.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.705 1.602 . . . . 0.0 111.03 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 151.7 45.09 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.836 -1.165 . . . . 0.0 111.339 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -16.36 15.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -70.34 1.33 5.06 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.657 1.983 . . . . 0.0 113.658 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.92 19.03 71.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.026 1.298 . . . . 0.0 114.013 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -121.3 175.81 5.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.035 1.734 . . . . 0.0 110.382 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.594 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 97.2 m -137.32 102.26 4.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.249 1.02 . . . . 0.0 112.956 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 35' ' ' ILE . 20.5 tp -69.12 115.8 8.83 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.441 -0.787 . . . . 0.0 110.339 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.99 111.9 3.96 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.7 151.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.415 1.086 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.675 ' HB2' HD13 ' A' ' 134' ' ' LEU . 12.1 tmm? -138.63 148.75 44.46 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.38 1.072 . . . . 0.0 110.002 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.7 p90 -157.21 159.57 37.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -164.46 150.57 10.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.1 t -108.73 98.59 29.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.537 0.666 0 C-N-CA 121.588 1.526 . . . . 0.0 110.794 175.657 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 121.572 0.701 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -84.45 135.73 34.14 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.361 1.064 . . . . 0.0 113.128 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -151.4 125.56 9.3 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.128 0.971 . . . . 0.0 109.733 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.02 150.23 11.25 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.967 -1.083 . . . . 0.0 111.999 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.9 143.34 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.049 1.74 . . . . 0.0 110.138 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -135.47 126.48 27.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.42 1.488 . . . . 0.0 109.144 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.8 mt -93.27 100.04 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.237 1.015 . . . . 0.0 109.316 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -68.41 100.98 1.15 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.845 -1.159 . . . . 0.0 109.406 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 80.64 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.723 1.209 . . . . 0.0 111.132 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.35 -106.75 0.29 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.317 2.389 . . . . 0.0 111.22 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -156.56 150.3 24.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.369 1.868 . . . . 0.0 111.553 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -164.96 106.82 0.82 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.236 1.415 . . . . 0.0 113.877 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -59.43 153.4 19.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.368 1.067 . . . . 0.0 111.182 174.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -72.44 113.96 10.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.741 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.39 -175.76 5.21 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.633 1.173 . . . . 0.0 111.471 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.0 -46.07 68.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.408 -1.432 . . . . 0.0 111.909 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.2 -31.59 62.38 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.555 1.074 . . . . 0.0 113.767 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' HD11 ' A' ' 134' ' ' LEU . 12.6 tpt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -48.11 -39.46 20.5 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.432 1.093 . . . . 0.0 112.453 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.36 -42.17 96.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.203 1.001 . . . . 0.0 111.598 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.84 68.51 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.288 -1.508 . . . . 0.0 113.462 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 101' ' ' MET . 51.3 mt -90.24 -7.85 52.48 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.06 -27.31 3.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.45 1.5 . . . . 0.0 114.116 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.49 -37.11 3.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.729 1.212 . . . . 0.0 111.706 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.27 -67.53 1.33 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.229 1.871 . . . . 0.0 113.168 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.53 67.88 0.29 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.822 1.649 . . . . 0.0 113.429 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.66 173.02 15.21 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.938 1.759 . . . . 0.0 115.207 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.92 173.18 10.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.163 1.785 . . . . 0.0 112.972 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -115.8 137.61 51.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.724 2.01 . . . . 0.0 112.042 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -138.1 116.65 1.34 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.722 1.153 . . . . 0.0 111.541 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -126.25 69.95 1.23 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.74 94.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.13 2.572 . . . . 0.0 113.898 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.01 139.74 2.75 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.753 1.644 . . . . 0.0 111.49 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -70.25 127.44 32.78 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -129.53 146.29 51.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.589 1.156 . . . . 0.0 111.634 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -142.33 137.77 30.78 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.452 1.501 . . . . 0.0 110.362 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 158.33 43.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.713 1.205 . . . . 0.0 110.892 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 94.08 1.02 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.714 1.206 . . . . 0.0 109.553 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tp -51.53 -36.33 44.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.329 1.451 . . . . 0.0 113.752 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 120.38 33.97 0.98 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.11 -32.28 0.79 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.07 -28.3 0.9 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.987 1.28 . . . . 0.0 114.344 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 175.14 5.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.824 2.05 . . . . 0.0 112.541 175.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -118.19 145.38 45.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.222 1.009 . . . . 0.0 112.164 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.615 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -121.88 147.7 45.66 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 130.89 53.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.426 1.89 . . . . 0.0 107.851 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -123.11 155.16 17.26 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 122.149 0.861 . . . . 0.0 112.951 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.1 131.02 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.067 1.747 . . . . 0.0 108.505 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.1 tpp -126.42 103.31 7.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.403 0.547 . . . . 0.0 109.529 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 68.9 p -98.73 141.32 31.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.142 1.377 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 89.58 1.2 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.47 -0.769 . . . . 0.0 111.812 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.18 30.23 0.17 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.701 1.2 . . . . 0.0 114.083 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.85 134.12 1.76 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.888 1.232 . . . . 0.0 112.419 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 43.45 59.82 2.86 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.439 1.496 . . . . 0.0 112.576 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -137.56 163.43 31.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.925 1.29 . . . . 0.0 112.024 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 47.6 tptt -163.26 144.85 9.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.5 ptm -77.61 160.49 28.5 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.157 1.783 . . . . 0.0 113.927 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -154.21 160.93 42.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.173 1.789 . . . . 0.0 109.477 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.7 mm -131.84 113.99 23.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 C-N-CA 125.126 1.37 . . . . 0.0 109.692 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -110.63 139.82 45.54 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.72 0.808 . . . . 0.0 110.891 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' A' ' 157' ' ' MET . 10.2 pt -120.95 132.68 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.715 0.806 . . . . 0.0 109.731 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.2 p -148.05 161.47 41.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.329 . . . . 0.0 112.846 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.429 ' HB3' HG13 ' A' ' 20' ' ' VAL . 3.8 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 117.748 -1.12 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.7 -49.33 4.25 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.555 1.07 . . . . 0.0 113.266 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.56 -33.15 1.42 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.53 1.538 . . . . 0.0 116.694 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.1 p -138.61 146.57 41.91 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.445 2.122 . . . . 0.0 111.972 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.41 161.44 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.781 -1.2 . . . . 0.0 108.817 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 7' ' ' ILE . 4.7 pt -75.05 177.55 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.487 1.915 . . . . 0.0 111.858 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.45 16.34 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.02 -18.18 40.18 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.148 1.356 . . . . 0.0 112.674 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.59 70.04 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.642 1.577 . . . . 0.0 113.632 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -112.32 -2.59 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.892 1.677 . . . . 0.0 113.311 174.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD11 HD23 ' A' ' 17' ' ' LEU . 20.3 tp -78.76 148.84 32.83 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.338 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.91 146.83 27.29 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 0.0 110.047 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.39 -34.66 66.92 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.006 0.821 . . . . 0.0 112.763 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -59.43 -56.26 24.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.671 1.189 . . . . 0.0 113.018 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.25 -45.87 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.303 0.641 . . . . 0.0 111.026 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 12' ' ' LEU . 2.7 tm? -55.22 -38.7 68.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.183 0.993 . . . . 0.0 111.95 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -52.25 -57.65 9.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.258 1.823 . . . . 0.0 111.705 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.05 60.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 176.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 2' ' ' LEU . 8.0 t -65.82 -49.17 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.762 1.164 . . . . 0.0 110.838 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -67.0 -21.76 65.93 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -24.84 22.84 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -20.03 62.56 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.282 1.033 . . . . 0.0 113.595 -175.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD11 ' HD2' ' A' ' 30' ' ' LYS . 3.2 pp . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 124.843 1.257 . . . . 0.0 114.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.675 ' HD2' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.95 0.405 . . . . 0.0 111.673 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -127.22 143.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.163 1.385 . . . . 0.0 111.491 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.614 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -121.98 100.22 6.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.592 1.957 . . . . 0.0 111.778 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.5 p -110.34 127.09 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.538 1.135 . . . . 0.0 109.918 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.19 157.7 26.8 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.964 -0.636 . . . . 0.0 114.278 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.66 121.97 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.185 0.994 . . . . 0.0 110.229 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -74.1 105.12 5.17 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.363 -0.835 . . . . 0.0 110.689 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.62 91.95 4.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.223 1.809 . . . . 0.0 113.447 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.33 21.27 2.4 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.996 0.903 . . . . 0.0 112.392 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -7.07 54.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.698 1.599 . . . . 0.0 114.924 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.86 18.44 65.46 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.046 -1.034 . . . . 0.0 114.66 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.6 127.77 5.14 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.214 1.864 . . . . 0.0 110.736 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.3 m -69.4 131.01 44.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.73 0.765 . . . . 0.0 110.527 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.669 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 14.9 m0 -96.75 162.47 13.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.136 0.493 . . . . 0.0 111.954 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -138.83 107.46 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 127.1 2.16 . . . . 0.0 109.617 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 150.64 47.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.259 -0.9 . . . . 0.0 110.711 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -121.22 -54.67 1.99 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.559 1.144 . . . . 0.0 111.993 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -156.92 172.22 19.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.974 0.91 . . . . 0.0 111.667 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.34 140.08 35.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.958 1.303 . . . . 0.0 111.841 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 t80 -118.65 127.44 53.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 109.659 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.4 119.56 39.82 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.217 1.807 . . . . 0.0 107.627 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -11.78 49.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.235 0.541 . . . . 0.0 111.295 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.01 114.25 7.43 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 108.961 -175.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.71 -165.88 53.87 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.228 0.918 . . . . 0.0 113.679 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 t -119.41 -170.75 1.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.665 1.586 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 163.06 22.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.709 1.604 . . . . 0.0 111.695 174.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.438 ' OD2' HD13 ' A' ' 24' ' ' LEU . 19.1 t70 -141.31 -44.46 0.37 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.093 0.957 . . . . 0.0 111.824 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.68 164.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.726 2.01 . . . . 0.0 111.421 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 tt -77.51 134.76 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.37 1.068 . . . . 0.0 112.032 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.83 128.98 52.2 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.148 0.979 . . . . 0.0 110.285 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.663 ' HG2' HD12 ' A' ' 69' ' ' LEU . 52.9 Cg_endo -64.89 115.35 3.21 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 124.562 3.508 . . . . 0.0 112.14 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -62.65 -48.0 81.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -115.4 153.5 30.94 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.189 0.995 . . . . 0.0 111.577 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.75 88.87 13.59 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.434 1.094 . . . . 0.0 108.754 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.81 143.36 29.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.023 2.482 . . . . 0.0 111.336 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -48.88 153.98 0.78 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.526 1.13 . . . . 0.0 112.697 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 p 63.9 46.86 3.71 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.638 1.575 . . . . 0.0 110.047 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 68' ' ' ALA . 17.4 ttmt -155.52 172.01 18.97 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.503 1.521 . . . . 0.0 111.09 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' H ' ' HG2' ' A' ' 67' ' ' LYS . . . -142.23 -176.67 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 108.77 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -163.5 144.98 9.38 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.34 -0.85 . . . . 0.0 110.619 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.489 ' CD1' HD21 ' A' ' 17' ' ' LEU . 5.2 mt -117.36 170.15 8.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.893 1.33 . . . . 0.0 108.496 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.6 t80 -152.31 160.31 43.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.162 1.385 . . . . 0.0 107.708 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -147.38 148.12 31.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.832 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.8 -170.91 37.17 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.752 0.691 . . . . 0.0 112.165 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 125.853 1.661 . . . . 0.0 111.673 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -150.07 118.75 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.808 1.243 . . . . 0.0 112.946 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.42 160.0 43.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.529 1.532 . . . . 0.0 110.127 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' HB3' ' CE ' ' A' ' 130' ' ' MET . . . -146.32 135.57 22.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -143.28 168.78 18.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 111.406 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -123.99 150.32 44.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.736 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -130.93 115.3 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.64 1.576 . . . . 0.0 110.373 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.446 ' HB2' HD22 ' A' ' 46' ' ' LEU . 12.3 t80 -73.7 104.08 4.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.382 1.473 . . . . 0.0 111.291 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -71.71 158.27 36.43 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.135 -0.978 . . . . 0.0 112.63 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -58.5 -24.97 61.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.831 1.252 . . . . 0.0 113.732 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 t -73.72 -3.24 27.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.998 1.319 . . . . 0.0 113.948 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.48 17.67 72.96 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.416 1.008 . . . . 0.0 114.265 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -102.83 163.18 12.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.594 1.558 . . . . 0.0 110.683 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.61 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 86.8 m -127.58 102.74 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.55 0.74 . . . . 0.0 112.982 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 173' ' ' ILE . 27.1 tp -71.72 116.45 12.11 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.418 -0.801 . . . . 0.0 110.855 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.09 104.16 3.1 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.306 1.431 . . . . 0.0 111.024 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.78 160.59 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 156.51 45.52 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.036 1.334 . . . . 0.0 110.261 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 33' ' ' VAL . 10.7 p90 -166.96 155.25 9.83 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.501 1.521 . . . . 0.0 110.893 175.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.92 124.17 1.81 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.369 1.468 . . . . 0.0 110.38 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.1 t -81.73 131.99 56.0 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 122.501 2.134 . . . . 0.0 111.922 175.33 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.753 0.787 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -97.8 159.38 14.97 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -161.98 153.26 18.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.993 1.317 . . . . 0.0 109.494 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -174.47 104.18 0.1 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.122 1.369 . . . . 0.0 111.311 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.08 132.06 45.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.736 1.214 . . . . 0.0 108.507 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -140.48 160.98 38.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.118 1.367 . . . . 0.0 110.021 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 93.3 mt -118.65 112.5 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.498 1.519 . . . . 0.0 109.171 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.41 100.69 6.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -56.12 121.89 10.45 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.95 -1.094 . . . . 0.0 108.977 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.67 -140.46 15.41 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -128.41 132.09 48.48 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.391 1.476 . . . . 0.0 112.613 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -160.01 124.04 3.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.519 1.527 . . . . 0.0 112.238 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -179.28 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 111.459 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -87.83 109.19 19.57 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.842 -0.536 . . . . 0.0 111.154 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.89 -172.22 4.06 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 111.473 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.84 -47.51 31.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.893 0.877 . . . . 0.0 111.496 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.18 -47.44 55.3 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.402 1.001 . . . . 0.0 114.088 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.41 ' CE ' ' HB3' ' A' ' 87' ' ' ALA . 3.1 ttp -65.75 -52.23 52.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 111.276 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -56.31 -37.33 69.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.77 0.795 . . . . 0.0 112.767 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.42 -47.41 79.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.876 2.07 . . . . 0.0 110.049 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -26.98 69.08 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.696 1.135 . . . . 0.0 113.677 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mp -70.4 -49.19 51.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.955 1.302 . . . . 0.0 112.909 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.27 -29.54 13.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.24 -26.59 8.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.981 1.312 . . . . 0.0 112.156 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -63.83 4.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.449 1.5 . . . . 0.0 111.278 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -174.3 80.29 0.35 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.877 2.071 . . . . 0.0 111.331 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.22 154.2 66.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.134 1.89 . . . . 0.0 111.511 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -120.41 -164.58 1.11 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.576 1.95 . . . . 0.0 111.041 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.75 131.37 46.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.805 2.442 . . . . 0.0 111.509 -175.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -142.34 115.38 0.95 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.863 1.697 . . . . 0.0 111.054 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.78 -55.02 2.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 84.99 0.14 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 120.323 1.419 . . . . 0.0 111.398 174.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.26 163.86 24.01 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 122.0 0.778 . . . . 0.0 114.687 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.461 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 59.5 m95 -82.1 145.44 30.16 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.002 1.721 . . . . 0.0 111.983 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -161.12 123.42 3.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.217 1.407 . . . . 0.0 112.154 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.6 154.95 18.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.837 1.655 . . . . 0.0 111.651 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 145.81 24.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.794 1.237 . . . . 0.0 110.052 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -72.82 93.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -51.96 -36.88 50.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.085 1.354 . . . . 0.0 113.841 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.15 40.22 2.14 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.97 -32.48 0.96 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.73 -34.36 0.68 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.739 1.161 . . . . 0.0 113.548 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.31 172.63 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.168 1.787 . . . . 0.0 111.998 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -127.04 165.17 19.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.607 1.163 . . . . 0.0 110.603 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.59 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -152.48 163.6 39.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 174.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 146' ' ' TRP . 6.3 tptt -119.99 127.29 52.48 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.504 1.522 . . . . 0.0 108.153 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.36 146.76 17.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.815 0.721 . . . . 0.0 111.879 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.503 ' CD1' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -124.95 131.15 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 125.085 1.354 . . . . 0.0 109.313 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 125.89 36.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.07 0.85 . . . . 0.0 108.755 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.503 HG23 ' CD1' ' A' ' 160' ' ' ILE . 19.8 p -126.1 137.5 53.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.05 1.74 . . . . 0.0 111.783 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.6 p -129.93 128.93 43.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.111 2.164 . . . . 0.0 110.765 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.56 -54.4 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.412 1.885 . . . . 0.0 111.365 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.13 -49.08 0.2 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.735 1.16 . . . . 0.0 113.715 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.74 28.53 8.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.915 1.686 . . . . 0.0 112.778 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB1' ' OG1' ' A' ' 162' ' ' THR . . . -118.55 159.67 23.14 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.276 1.43 . . . . 0.0 113.78 -174.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.7 OUTLIER -150.92 168.91 23.07 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.421 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.46 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 7.1 ttp -102.78 138.07 40.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.729 1.612 . . . . 0.0 111.262 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -137.3 150.83 48.05 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.57 1.148 . . . . 0.0 109.689 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.408 HG23 ' SD ' ' A' ' 157' ' ' MET . 42.1 mm -126.23 124.35 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.106 0.962 . . . . 0.0 109.286 -175.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -112.96 106.96 15.34 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.029 -1.045 . . . . 0.0 110.439 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.669 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 17.3 pt -92.9 125.91 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.783 0.833 . . . . 0.0 109.933 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.2 p -155.59 149.36 25.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.219 1.808 . . . . 0.0 112.952 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.01 128.67 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.717 1.607 . . . . 0.0 111.918 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.67 -15.05 9.79 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.42 1.962 . . . . 0.0 113.597 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p -167.37 162.79 14.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.149 2.58 . . . . 0.0 109.213 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 70' ' ' LEU . 47.0 mt -140.24 172.56 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.557 1.143 . . . . 0.0 109.021 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -83.78 -162.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 125.77 1.628 . . . . 0.0 110.317 174.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.7 60.2 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.4 -25.63 12.09 Favored Glycine 0 N--CA 1.488 2.13 0 O-C-N 123.951 0.782 . . . . 0.0 112.698 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.02 63.36 Favored 'General case' 0 CA--C 1.59 2.519 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -96.24 -3.76 43.57 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.571 1.548 . . . . 0.0 114.267 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.16 139.41 58.13 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.303 -0.873 . . . . 0.0 108.926 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.51 141.03 20.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.244 0.618 . . . . 0.0 110.403 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -55.75 -32.28 63.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -57.45 -49.06 77.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.746 1.218 . . . . 0.0 111.8 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -69.88 -50.42 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.476 1.11 . . . . 0.0 109.375 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -55.13 -32.7 62.29 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.26 -61.28 2.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.201 1.8 . . . . 0.0 109.976 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -40.4 86.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.429 1.492 . . . . 0.0 112.677 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.16 -50.62 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.289 1.436 . . . . 0.0 111.613 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -73.43 -35.24 65.76 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.1 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.36 -30.93 69.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.429 1.491 . . . . 0.0 113.267 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -55.78 -28.79 57.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.543 1.137 . . . . 0.0 113.633 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 123.907 0.883 . . . . 0.0 111.991 177.272 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.644 ' CB ' HD11 ' A' ' 21' ' ' LEU . 2.7 pttm . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.485 HG23 ' HA ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.73 151.19 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.057 . . . . 0.0 110.852 178.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -141.15 101.99 4.14 Favored 'General case' 0 CA--C 1.573 1.837 0 C-N-CA 126.295 1.838 . . . . 0.0 111.317 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.466 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.4 p -114.78 132.92 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.306 1.442 . . . . 0.0 110.087 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.3 165.32 38.36 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -140.45 119.79 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.979 1.311 . . . . 0.0 112.378 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.75 115.91 7.84 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 121.381 -0.825 . . . . 0.0 111.08 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 2.7 p-10 -96.05 85.32 4.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.482 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.96 13.67 5.76 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -76.27 -13.26 60.16 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 14.59 43.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.627 1.108 . . . . 0.0 115.437 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.33 126.09 3.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.387 1.47 . . . . 0.0 112.813 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.5 m -64.32 140.92 58.92 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.066 1.346 . . . . 0.0 111.253 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 17.8 m0 -106.57 171.95 7.08 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -150.55 110.82 4.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.134 1.773 . . . . 0.0 111.871 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.01 58.06 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 120.979 -1.076 . . . . 0.0 110.222 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.59 -46.26 4.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.397 0.679 . . . . 0.0 112.186 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.93 173.7 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.356 1.063 . . . . 0.0 111.244 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.03 128.77 23.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.105 0.962 . . . . 0.0 112.949 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.82 117.14 33.32 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.842 1.657 . . . . 0.0 110.32 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 7.1 m-85 -116.92 129.95 56.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.076 1.75 . . . . 0.0 109.343 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.56 4.65 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -152.96 92.51 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.794 1.238 . . . . 0.0 110.215 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.07 19.33 0.28 Allowed Glycine 0 N--CA 1.475 1.28 0 N-CA-C 117.474 1.75 . . . . 0.0 117.474 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -40.04 113.77 0.38 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.143 2.177 . . . . 0.0 113.188 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.681 HG21 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 t -66.21 -179.67 0.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.783 1.633 . . . . 0.0 115.312 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.12 -9.71 3.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.077 1.751 . . . . 0.0 114.033 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -87.69 166.45 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.326 1.05 . . . . 0.0 112.581 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 tt -68.93 130.13 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.469 1.108 . . . . 0.0 112.63 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 60' ' ' PRO . 41.1 tp -84.41 117.47 68.81 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.495 0.718 . . . . 0.0 109.769 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.627 ' CG ' HD12 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -69.03 119.96 6.9 Favored 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 122.758 2.305 . . . . 0.0 109.741 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.39 -64.25 1.2 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.935 0.894 . . . . 0.0 112.515 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -96.75 151.53 19.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.669 0.788 . . . . 0.0 109.963 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 132.93 9.63 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.007 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -71.55 -150.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 125.102 3.868 . . . . 0.0 112.914 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.96 15.13 9.25 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.939 1.696 . . . . 0.0 114.287 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -142.06 30.44 1.61 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.306 1.442 . . . . 0.0 112.752 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -146.1 -175.96 4.96 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.678 1.191 . . . . 0.0 113.077 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.26 173.78 11.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.112 1.365 . . . . 0.0 107.472 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.627 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -150.61 148.97 29.28 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.855 -1.153 . . . . 0.0 111.287 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.24 162.13 26.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.861 0.864 . . . . 0.0 111.266 177.041 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 55' ' ' THR . 1.0 OUTLIER -141.38 163.52 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.272 1.429 . . . . 0.0 110.001 174.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 31' ' ' ILE . 55.1 m -135.77 -166.53 1.87 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.4 1.48 . . . . 0.0 110.383 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.4 178.29 33.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.367 -0.833 . . . . 0.0 113.461 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 124.227 1.011 . . . . 0.0 112.481 -175.901 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.48 113.94 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.898 1.279 . . . . 0.0 113.216 -175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . . . -155.51 170.97 20.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 111.094 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.52 124.12 7.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.661 1.584 . . . . 0.0 108.757 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -128.49 163.8 24.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.661 1.184 . . . . 0.0 112.055 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -121.97 142.88 49.86 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -122.42 113.97 20.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.982 2.113 . . . . 0.0 111.151 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.42 108.32 2.33 Favored 'General case' 0 N--CA 1.382 -3.828 0 C-N-CA 124.836 1.255 . . . . 0.0 112.625 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.1 mtp -73.08 155.09 40.09 Favored 'General case' 0 CA--C 1.627 3.906 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -58.95 -23.62 61.75 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.61 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -67.98 -9.19 43.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.895 2.078 . . . . 0.0 114.178 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 8.06 68.71 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.71 1.148 . . . . 0.0 114.794 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.5 175.41 5.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.028 1.731 . . . . 0.0 110.412 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 89' ' ' ALA . 91.8 m -130.84 104.06 6.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.963 -1.086 . . . . 0.0 112.314 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.649 HD22 HD13 ' A' ' 173' ' ' ILE . 47.2 tp -69.39 119.07 13.09 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 120.994 -1.066 . . . . 0.0 110.79 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 104.55 3.18 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.621 1.105 . . . . 0.0 111.065 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.15 162.46 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.211 0.529 . . . . 0.0 111.322 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.79 149.78 30.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.013 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CE2' HG11 ' A' ' 33' ' ' VAL . 45.3 p90 -154.85 154.24 32.4 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.097 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -160.15 157.36 28.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.668 1.587 . . . . 0.0 107.377 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.4 t -121.82 95.33 47.84 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 121.327 -0.858 . . . . 0.0 109.211 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 C-N-CA 121.9 1.733 . . . . 0.0 111.802 -178.146 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 123.346 1.546 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -91.91 158.06 16.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.436 1.495 . . . . 0.0 112.377 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -165.1 126.79 2.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 110.064 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.98 91.07 1.02 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.33 150.8 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.538 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -142.97 135.07 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.241 1.416 . . . . 0.0 108.733 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 155' ' ' LEU . 52.3 mt -100.12 103.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.268 1.027 . . . . 0.0 109.651 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -69.91 96.73 1.04 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.7 t -63.63 99.68 0.24 Allowed 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.79 -124.02 3.16 Favored Glycine 0 CA--C 1.578 3.986 0 N-CA-C 104.518 -3.433 . . . . 0.0 104.518 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -141.85 116.54 9.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.854 0.827 . . . . 0.0 111.969 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -134.73 111.88 10.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.51 1.124 . . . . 0.0 112.996 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 167.3 5.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.608 1.163 . . . . 0.0 110.781 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.17 119.54 31.36 Favored 'General case' 1 N--CA 1.336 -6.145 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . 0.259 2.0 t70 -165.59 -177.04 4.19 Favored 'General case' 0 N--CA 1.522 3.153 0 O-C-N 127.602 3.064 . . . . 0.0 104.185 -163.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.46 -47.95 48.0 Favored 'General case' 1 CA--C 1.632 4.111 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.116 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.26 -31.46 34.56 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 121.849 2.113 . . . . 0.0 113.383 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.8 ttt -72.75 -58.56 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.386 0.674 . . . . 0.0 110.498 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -57.5 -31.18 65.76 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.82 -44.38 96.29 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.31 1.444 . . . . 0.0 109.704 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.47 -2.41 4.62 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.05 0.94 . . . . 0.0 113.471 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.7 mt -102.05 -45.87 5.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.662 1.585 . . . . 0.0 111.989 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -93.57 -23.4 18.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -121.25 -1.65 9.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.621 1.569 . . . . 0.0 111.974 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -121.98 72.91 0.37 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.591 2.043 . . . . 0.0 113.185 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.3 m120 73.58 68.66 0.27 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 127.005 2.122 . . . . 0.0 112.503 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.25 114.78 3.17 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.369 2.713 . . . . 0.0 111.749 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -124.78 162.59 23.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.42 1.888 . . . . 0.0 111.598 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.9 mtm105 -145.57 165.51 28.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.298 1.439 . . . . 0.0 112.008 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -134.32 -57.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.3 t0 48.81 69.36 0.58 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.643 1.977 . . . . 0.0 113.907 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.59 100.79 0.02 OUTLIER 'General case' 0 C--O 1.25 1.111 0 C-N-CA 129.213 3.005 . . . . 0.0 114.58 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.98 104.09 0.19 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -53.77 101.92 0.05 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 112.506 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -119.21 131.08 55.78 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.891 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.82 133.89 55.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.747 2.019 . . . . 0.0 109.846 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -140.4 157.51 45.42 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.262 0.553 . . . . 0.0 110.76 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -76.78 98.35 4.78 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.1 tp -57.66 -23.77 53.08 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.01 24.7 5.65 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-O 117.851 -1.527 . . . . 0.0 116.726 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -130.24 -27.56 2.21 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.813 1.807 . . . . 0.0 115.636 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.03 -33.01 1.05 Allowed Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.534 1.064 . . . . 0.0 113.83 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -109.83 172.7 6.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.741 1.616 . . . . 0.0 111.885 174.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.14 158.89 32.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 0.0 110.887 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -143.49 165.02 28.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.591 0.71 . . . . 0.0 111.144 176.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -128.14 136.79 51.63 Favored 'General case' 0 N--CA 1.396 -3.137 0 C-N-CA 124.826 1.25 . . . . 0.0 112.049 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.18 160.29 22.93 Favored Glycine 1 CA--C 1.618 6.518 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.44 156.94 41.0 Favored 'Isoleucine or valine' 1 CA--C 1.629 4.016 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.81 87.04 1.4 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.0 p -73.81 165.11 25.7 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.238 1.015 . . . . 0.0 110.704 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -128.46 -163.08 1.24 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.737 1.215 . . . . 0.0 112.042 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.62 7.07 4.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.534 2.333 . . . . 0.0 115.116 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.82 169.66 19.44 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.516 1.055 . . . . 0.0 110.732 -175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 65.6 -51.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.755 2.022 . . . . 0.0 114.568 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.98 163.44 7.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.568 2.347 . . . . 0.0 112.694 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -154.07 165.12 37.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 123.155 1.455 . . . . 0.0 114.524 -174.359 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.485 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 24.8 ptm -93.12 164.94 13.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.172 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -153.27 156.15 37.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.03 138.75 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.887 1.675 . . . . 0.0 109.145 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.44 117.74 23.54 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.103 1.361 . . . . 0.0 109.704 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.649 HD13 HD22 ' A' ' 98' ' ' LEU . 22.7 pt -108.79 126.14 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.552 0.741 . . . . 0.0 110.17 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.7 t -152.53 158.84 43.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.577 0 C-N-CA 126.122 1.769 . . . . 0.0 111.134 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.63 165.81 11.79 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 110.597 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.71 -25.4 27.64 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.195 1.379 . . . . 0.0 112.573 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -149.19 151.63 34.65 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.522 1.661 . . . . 0.0 111.535 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.447 HD11 HD12 ' A' ' 70' ' ' LEU . 29.4 mm -144.12 158.9 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.743 1.217 . . . . 0.0 111.312 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.67 -173.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 127.502 2.321 . . . . 0.0 111.984 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.73 -22.34 3.45 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.0 -25.32 14.42 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.648 1.118 . . . . 0.0 114.144 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -36.87 75.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.158 0.979 . . . . 0.0 111.969 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -7.12 58.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.942 1.297 . . . . 0.0 113.619 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.413 HD11 HD23 ' A' ' 17' ' ' LEU . 2.8 tt -64.67 156.4 30.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.382 1.473 . . . . 0.0 112.651 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -148.55 143.38 26.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.041 0.936 . . . . 0.0 110.116 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -56.25 -32.86 64.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.653 0.781 . . . . 0.0 113.104 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -55.52 -57.28 12.55 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.081 1.352 . . . . 0.0 112.342 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.19 -51.42 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.706 0.803 . . . . 0.0 109.892 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.413 HD23 HD11 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -53.44 -37.1 62.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.172 1.389 . . . . 0.0 113.615 -174.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.26 -49.08 65.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.27 1.428 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -36.52 83.55 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.339 -0.851 . . . . 0.0 111.301 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.57 -53.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.802 1.241 . . . . 0.0 111.345 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.9 pp -63.85 -34.93 79.04 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.98 -25.39 58.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -54.95 -26.81 38.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.342 1.428 . . . . 0.0 112.893 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 128.312 2.645 . . . . 0.0 114.606 -178.121 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 tptt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.19 146.02 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.969 1.708 . . . . 0.0 115.007 -174.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -137.51 110.47 7.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.725 2.81 . . . . 0.0 109.404 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.3 p -116.12 125.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 175.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.31 157.71 30.31 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.178 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 98' ' ' LEU . 1.5 mp -139.19 117.58 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 0.0 111.572 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.89 102.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.421 -1.424 . . . . 0.0 111.746 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.419 ' HA ' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -76.76 87.16 3.38 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.88 1.272 . . . . 0.0 111.82 175.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -143.15 45.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.684 1.194 . . . . 0.0 111.295 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.47 1.3 29.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.014 1.325 . . . . 0.0 114.465 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.27 17.29 69.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.383 0.992 . . . . 0.0 115.139 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.16 131.76 4.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.945 1.736 . . . . 0.0 111.742 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -59.08 142.51 51.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.033 1.333 . . . . 0.0 111.194 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.419 ' CH2' ' HA ' ' A' ' 37' ' ' ASN . 45.7 m0 -104.68 167.16 9.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 111.505 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -152.58 102.49 2.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.269 2.227 . . . . 0.0 109.407 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 166.43 14.31 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.344 -0.848 . . . . 0.0 111.617 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -67.8 0.77 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.668 1.587 . . . . 0.0 110.432 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -156.66 -176.17 5.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.985 1.714 . . . . 0.0 110.995 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.85 37.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.97 1.708 . . . . 0.0 110.844 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -127.94 130.06 47.82 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.574 1.549 . . . . 0.0 109.684 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -140.16 137.44 34.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 128.485 2.714 . . . . 0.0 109.121 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -14.84 15.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.32 1.448 . . . . 0.0 112.324 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.81 99.08 3.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.642 1.977 . . . . 0.0 109.056 176.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.22 102.08 0.94 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 124.401 1.001 . . . . 0.0 112.807 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.434 HG23 ' CE1' ' A' ' 50' ' ' PHE . 97.1 m -65.94 -103.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.411 1.884 . . . . 0.0 110.914 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.6 p -150.51 172.67 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 111.916 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -148.75 -4.02 0.44 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.633 2.373 . . . . 0.0 113.125 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.81 166.86 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 127.416 2.287 . . . . 0.0 112.128 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.21 128.65 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.11 1.764 . . . . 0.0 112.576 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 tp -81.59 123.66 80.58 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 108.511 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 69' ' ' LEU . 65.6 Cg_endo -65.54 124.55 12.99 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.884 3.056 . . . . 0.0 110.827 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.07 -76.75 0.26 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.233 -0.917 . . . . 0.0 112.188 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.54 125.57 40.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.87 0.868 . . . . 0.0 110.28 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -123.78 121.98 26.46 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.228 -175.034 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.94 179.21 6.51 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.179 3.252 . . . . 0.0 112.323 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -66.8 169.18 8.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.301 1.44 . . . . 0.0 112.64 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p 43.39 43.49 4.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.413 2.285 . . . . 0.0 115.016 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -144.49 177.58 8.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.608 1.963 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.08 -174.44 4.1 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.492 1.517 . . . . 0.0 108.324 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.714 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -156.27 154.17 30.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.447 HD12 HD11 ' A' ' 6' ' ' ILE . 7.0 mt -129.35 163.72 25.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.771 0.829 . . . . 0.0 110.467 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -149.26 161.35 42.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.392 1.477 . . . . 0.0 109.502 174.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.6 m -147.02 178.49 8.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.296 1.438 . . . . 0.0 110.801 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.17 167.25 30.67 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.468 0.556 . . . . 0.0 113.471 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 125.216 1.407 . . . . 0.0 112.971 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 CA-C-O 120.257 0.075 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 103' ' ' SER . 76.6 t -143.11 126.43 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.375 1.87 . . . . 0.0 111.986 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -148.8 167.39 25.74 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.338 1.455 . . . . 0.0 110.87 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 118.38 7.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.0 109.288 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -123.5 162.93 21.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.434 1.094 . . . . 0.0 112.55 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -127.23 145.76 50.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.972 0.909 . . . . 0.0 111.986 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.73 113.49 16.07 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.669 1.987 . . . . 0.0 110.89 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.96 122.11 16.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.847 1.259 . . . . 0.0 110.591 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.3 ttt -92.8 149.03 21.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.831 1.252 . . . . 0.0 111.017 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -22.71 16.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 t -72.01 -11.48 60.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.843 1.257 . . . . 0.0 113.789 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.49 4.87 60.59 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.672 1.606 . . . . 0.0 114.72 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -95.05 173.18 7.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.211 1.404 . . . . 0.0 110.769 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.467 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 37.8 m -137.16 104.37 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.961 1.304 . . . . 0.0 111.947 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 35' ' ' ILE . 27.2 tp -67.12 125.13 25.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.941 0.896 . . . . 0.0 110.346 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.67 104.84 2.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.19 1.376 . . . . 0.0 112.389 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -74.86 169.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.857 0.837 . . . . 0.0 112.175 175.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -149.0 147.48 28.61 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.189 1.396 . . . . 0.0 111.682 177.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 p90 -157.76 146.31 19.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.497 0.719 . . . . 0.0 112.088 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' HG22 ' A' ' 85' ' ' VAL . 69.1 m -153.31 122.04 6.4 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.482 0.713 . . . . 0.0 112.169 174.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.59 137.05 38.96 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 CA--C 1.538 0.678 0 C-N-CA 122.395 2.063 . . . . 0.0 112.741 176.232 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.199 0.524 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -81.38 162.14 23.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.041 0.937 . . . . 0.0 112.229 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.521 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 4.8 p-90 -159.91 169.4 23.59 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.129 1.372 . . . . 0.0 110.928 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 t70 164.26 138.6 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 128.713 2.805 . . . . 0.0 112.265 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.42 128.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.344 1.858 . . . . 0.0 108.959 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -129.03 158.21 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.324 1.85 . . . . 0.0 110.234 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.2 mt -112.76 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.719 1.608 . . . . 0.0 108.383 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -70.49 102.78 2.29 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.724 -1.235 . . . . 0.0 110.136 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.2 t -67.01 90.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.79 -134.71 4.97 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.853 2.644 . . . . 0.0 109.629 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.26 124.7 26.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.042 1.337 . . . . 0.0 111.899 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -143.61 117.14 9.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.234 1.814 . . . . 0.0 110.868 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.24 165.94 18.97 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.142 0.428 . . . . 0.0 110.985 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.47 112.58 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.438 -0.789 . . . . 0.0 110.601 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -155.97 -172.84 4.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.365 1.466 . . . . 0.0 112.797 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -42.65 84.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.018 0.927 . . . . 0.0 110.868 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.7 -41.08 56.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.469 1.509 . . . . 0.0 112.887 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -64.83 0.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.501 1.12 . . . . 0.0 109.94 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -53.37 -34.35 57.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.201 1.001 . . . . 0.0 113.431 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -41.07 95.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.824 1.25 . . . . 0.0 111.388 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -21.71 66.69 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.484 -1.385 . . . . 0.0 112.386 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 101' ' ' MET . 6.3 mt -85.3 -48.78 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.53 -33.25 31.89 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -114.66 -37.38 4.27 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.894 1.278 . . . . 0.0 112.708 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.64 -68.71 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.039 1.304 . . . . 0.0 112.479 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.77 79.0 1.8 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.99 153.38 72.56 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.06 175.91 8.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.136 2.174 . . . . 0.0 112.448 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -127.1 141.63 51.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.186 1.794 . . . . 0.0 110.826 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -141.46 108.56 0.55 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.561 1.076 . . . . 0.0 111.029 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -123.16 64.88 0.99 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.559 1.143 . . . . 0.0 112.264 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.04 95.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.619 2.368 . . . . 0.0 114.754 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.46 154.28 6.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.378 1.942 . . . . 0.0 112.405 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 63.1 m95 -77.18 144.74 38.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.274 1.03 . . . . 0.0 111.891 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -149.66 127.18 11.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.183 1.393 . . . . 0.0 112.364 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -120.67 152.46 38.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.234 1.814 . . . . 0.0 112.37 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -145.67 161.46 39.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.629 1.572 . . . . 0.0 110.636 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -75.04 98.76 3.71 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -57.84 7.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.935 1.294 . . . . 0.0 111.492 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.17 14.38 0.47 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -129.22 -16.58 3.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.56 -4.09 5.1 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.98 171.48 14.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.893 1.677 . . . . 0.0 110.801 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.71 161.19 31.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.019 . . . . 0.0 111.948 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.578 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -141.62 149.16 40.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.358 0.663 . . . . 0.0 111.815 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.8 OUTLIER -119.25 134.54 55.15 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.79 1.636 . . . . 0.0 108.988 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.27 136.44 12.62 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.097 1.332 . . . . 0.0 113.068 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -109.3 132.39 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.187 1.795 . . . . 0.0 108.691 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.88 105.97 11.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.746 0.818 . . . . 0.0 109.817 175.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 p -123.6 145.91 48.55 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.927 1.291 . . . . 0.0 110.562 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.7 p -140.46 -112.46 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.527 1.131 . . . . 0.0 110.504 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 52.38 13.48 0.3 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 120.833 1.651 . . . . 0.0 115.33 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 146.45 5.84 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.547 2.022 . . . . 0.0 110.779 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.23 38.4 29.21 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -144.83 170.87 15.29 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.562 1.545 . . . . 0.0 111.803 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -165.76 146.0 6.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.089 0.956 . . . . 0.0 112.99 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.62 144.87 45.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.506 1.922 . . . . 0.0 113.752 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.536 ' C ' HD12 ' A' ' 171' ' ' ILE . 24.1 tt0 -145.07 153.28 41.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.594 1.958 . . . . 0.0 109.83 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.536 HD12 ' C ' ' A' ' 170' ' ' GLN . 2.0 mp -124.5 122.61 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.409 1.084 . . . . 0.0 109.963 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -100.1 132.14 45.64 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.985 0.914 . . . . 0.0 109.378 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.578 HG22 ' CB ' ' A' ' 157' ' ' MET . 6.1 pt -116.85 133.07 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.724 0.81 . . . . 0.0 110.123 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.8 p -154.22 170.42 21.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.857 1.263 . . . . 0.0 112.798 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.736 -0.173 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.65 145.76 51.21 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 109.892 175.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.52 -38.86 1.82 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 127.111 2.291 . . . . 0.0 111.435 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -143.51 159.09 43.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.948 1.299 . . . . 0.0 112.374 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -139.19 169.83 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.42 1.888 . . . . 0.0 110.235 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.98 -166.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 127.854 2.462 . . . . 0.0 111.128 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.04 -16.58 13.29 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.64 -21.85 40.87 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.907 1.242 . . . . 0.0 114.068 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.12 86.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.567 1.183 . . . . 0.0 111.581 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -85.61 -15.69 41.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.906 1.283 . . . . 0.0 113.717 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 tt -61.14 150.06 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.205 1.002 . . . . 0.0 110.99 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -149.54 144.41 26.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.915 0.886 . . . . 0.0 109.132 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -50.91 -38.65 51.34 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 112.117 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -50.82 -53.32 33.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.408 1.083 . . . . 0.0 113.705 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.67 -47.42 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.97 -0.456 . . . . 0.0 110.171 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -35.74 65.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.327 1.451 . . . . 0.0 112.283 -176.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -64.13 -51.09 65.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.829 2.452 . . . . 0.0 110.67 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -35.22 79.6 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.674 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.67 -50.79 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.613 1.165 . . . . 0.0 111.702 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 32' ' ' ALA . 4.5 pp -65.15 -31.96 73.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 112.809 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.18 -9.11 59.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.075 -1.016 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -25.2 55.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.465 -1.397 . . . . 0.0 112.408 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 126.826 2.05 . . . . 0.0 113.757 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.975 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -154.8 132.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.857 0.753 . . . . 0.0 112.416 174.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -122.74 115.7 22.5 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.603 1.961 . . . . 0.0 109.524 175.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 157.98 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.94 177.0 28.72 Favored Glycine 0 N--CA 1.451 -0.336 0 O-C-N 121.525 -0.734 . . . . 0.0 111.453 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -136.89 132.77 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.878 0.846 . . . . 0.0 111.631 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.42 104.92 16.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.374 1.47 . . . . 0.0 111.491 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -82.27 96.43 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.033 0.933 . . . . 0.0 112.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.06 13.44 5.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.813 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -3.34 54.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.609 1.564 . . . . 0.0 115.114 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 26.02 60.41 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.165 -0.96 . . . . 0.0 114.766 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.94 125.13 2.51 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.801 1.667 . . . . 0.0 111.44 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.0 m -64.23 141.42 58.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.028 0.931 . . . . 0.0 111.128 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.552 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 34.5 m0 -110.19 169.83 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.09 0.956 . . . . 0.0 111.708 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -144.14 101.2 3.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.074 1.35 . . . . 0.0 112.315 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 154.11 42.52 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.558 -1.339 . . . . 0.0 110.421 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -109.63 -54.28 2.57 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.237 1.415 . . . . 0.0 112.193 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 46' ' ' LEU . 5.8 p-10 -162.49 -171.93 2.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.106 1.762 . . . . 0.0 110.786 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.7 145.37 30.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.658 1.583 . . . . 0.0 110.716 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -123.33 126.02 46.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.669 1.587 . . . . 0.0 110.119 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 137.04 46.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.827 2.451 . . . . 0.0 109.622 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -110.31 -43.3 3.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.191 1.796 . . . . 0.0 111.605 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -100.21 156.74 17.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 109.148 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.42 -171.39 19.93 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -145.19 166.15 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.97 1.308 . . . . 0.0 110.259 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 p -67.76 152.25 45.9 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -163.81 -30.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.958 1.703 . . . . 0.0 113.53 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.97 157.11 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.059 1.744 . . . . 0.0 111.49 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 tt -85.89 138.11 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.25 1.02 . . . . 0.0 112.11 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.88 131.76 42.23 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.222 1.409 . . . . 0.0 109.627 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.07 118.82 5.92 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.745 2.963 . . . . 0.0 110.926 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.11 -53.82 52.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.385 0.674 . . . . 0.0 112.475 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -119.94 136.62 54.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.208 1.003 . . . . 0.0 110.587 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.47 122.01 37.51 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.013 0.925 . . . . 0.0 110.609 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.64 171.0 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.684 2.923 . . . . 0.0 113.0 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -66.02 154.13 40.33 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.266 1.426 . . . . 0.0 112.742 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.7 t 36.87 56.03 1.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.099 2.16 . . . . 0.0 113.303 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -144.18 -178.49 5.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.95 1.3 . . . . 0.0 111.735 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.72 -178.79 6.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.069 0.937 . . . . 0.0 111.35 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.36 150.03 30.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 110.961 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.69 151.02 47.16 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.308 1.443 . . . . 0.0 108.486 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -127.98 159.84 33.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.573 1.549 . . . . 0.0 109.553 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.9 m -135.8 170.17 16.41 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.56 1.544 . . . . 0.0 109.931 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' H ' HD22 ' A' ' 24' ' ' LEU . . . 138.93 89.38 0.19 Allowed Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.527 1.06 . . . . 0.0 111.362 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.657 ' NH1' HG11 ' A' ' 104' ' ' VAL . 52.2 ttt180 . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 124.926 1.29 . . . . 0.0 113.632 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.341 0.591 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -155.76 111.47 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.775 2.03 . . . . 0.0 107.858 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -156.43 167.51 30.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.483 1.135 . . . . 0.0 110.383 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.97 128.31 9.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.338 1.055 . . . . 0.0 108.824 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -127.2 165.02 20.4 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.028 0.931 . . . . 0.0 111.931 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -130.1 150.27 51.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.557 0.743 . . . . 0.0 112.481 -175.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -125.57 114.8 19.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.971 1.308 . . . . 0.0 110.466 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -71.36 100.0 2.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.689 1.596 . . . . 0.0 110.539 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.0 mtp -64.86 146.64 54.62 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.951 -1.093 . . . . 0.0 112.028 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -57.51 -26.09 60.8 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -71.67 -4.72 28.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.702 1.201 . . . . 0.0 113.58 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.16 27.13 16.71 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.894 1.235 . . . . 0.0 114.457 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -117.57 166.46 12.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.623 1.569 . . . . 0.0 110.746 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.518 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 45.0 m -130.43 104.16 7.09 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.08 0.952 . . . . 0.0 112.44 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 173' ' ' ILE . 13.8 tp -77.27 113.35 14.94 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.957 0.903 . . . . 0.0 110.033 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.87 111.4 4.21 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.749 1.642 . . . . 0.0 112.075 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.65 154.66 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 110.857 175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.1 ttp -134.83 148.82 50.25 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.861 1.265 . . . . 0.0 110.035 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 31' ' ' ILE . 12.4 p90 -153.97 142.46 20.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.367 0.667 . . . . 0.0 109.299 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 m -150.93 165.83 32.47 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.005 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.657 HG11 ' NH1' ' A' ' 74' ' ' ARG . 95.2 t -119.78 142.2 32.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.314 1.046 . . . . 0.0 109.964 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 80.2 Cg_endo . . . . . 0 CA--C 1.546 1.114 0 C-N-CA 123.641 2.894 . . . . 0.0 112.706 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.442 HD21 ' HD3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -93.22 137.34 32.64 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.987 1.715 . . . . 0.0 111.829 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -164.32 134.79 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.371 1.868 . . . . 0.0 108.394 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -156.16 151.74 27.03 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.333 1.053 . . . . 0.0 110.44 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.88 132.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.437 1.095 . . . . 0.0 110.33 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 120' ' ' TYR . 18.5 ttpt -144.76 158.61 43.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.872 0.869 . . . . 0.0 111.709 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.83 112.07 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.428 1.091 . . . . 0.0 110.47 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 27.0 m-85 -81.3 101.14 9.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -62.84 93.02 0.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.225 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.75 -138.78 8.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.401 2.429 . . . . 0.0 110.544 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -117.08 127.06 53.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.59 1.956 . . . . 0.0 111.778 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -148.73 108.05 3.94 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.2 168.81 18.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.13 0.972 . . . . 0.0 111.435 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.93 118.25 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.888 0.875 . . . . 0.0 111.37 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -161.88 -174.53 4.21 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.769 1.228 . . . . 0.0 112.114 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -48.73 -48.61 40.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.978 1.311 . . . . 0.0 111.556 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.51 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.31 0.957 . . . . 0.0 113.426 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.4 ttp -68.76 -49.31 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.238 1.019 . . . . 0.0 112.467 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.87 -39.27 68.49 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.488 0.585 . . . . 0.0 112.198 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -45.53 79.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.265 1.426 . . . . 0.0 111.199 175.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -21.94 66.69 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.336 -1.478 . . . . 0.0 113.716 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.91 -41.72 14.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.776 1.631 . . . . 0.0 112.824 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -88.95 -28.22 20.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -122.61 -32.07 3.63 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 112.313 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.85 -39.12 94.91 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.118 0.866 . . . . 0.0 113.431 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.53 75.38 9.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.15 120.72 8.0 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.415 2.077 . . . . 0.0 113.284 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.47 173.4 7.69 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.704 2.002 . . . . 0.0 112.369 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -139.83 140.02 36.47 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.565 1.946 . . . . 0.0 112.224 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -136.88 109.78 0.74 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.286 0.946 . . . . 0.0 114.188 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -87.28 -68.25 0.76 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.622 1.569 . . . . 0.0 112.44 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -173.12 114.97 0.26 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 0.0 112.089 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.37 160.17 8.67 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.704 1.145 . . . . 0.0 114.079 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.429 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 92.1 m95 -78.04 147.03 34.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.124 1.37 . . . . 0.0 112.5 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -150.61 127.6 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.664 1.585 . . . . 0.0 112.452 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.6 152.59 24.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.36 1.464 . . . . 0.0 112.37 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -158.65 169.91 23.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.868 1.267 . . . . 0.0 112.627 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -85.44 99.79 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.77 1.628 . . . . 0.0 107.807 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 5.8 tp -60.88 -36.16 78.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.19 24.51 2.21 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -135.92 -29.12 1.04 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 119.157 1.479 . . . . 0.0 114.727 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 133.19 23.0 0.77 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.052 1.31 . . . . 0.0 114.66 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.2 162.63 37.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.224 1.512 . . . . 0.0 112.048 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 136.77 50.79 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.481 1.513 . . . . 0.0 108.875 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.582 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -126.45 168.48 14.16 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.006 0.922 . . . . 0.0 110.841 175.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 128.24 50.62 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.82 152.74 18.0 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.441 1.02 . . . . 0.0 112.02 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.429 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -133.65 145.96 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.236 178.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.9 tpt -154.88 100.85 2.24 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.337 1.055 . . . . 0.0 110.182 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -90.54 149.46 22.16 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 109.542 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -59.67 164.33 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.358 1.463 . . . . 0.0 112.867 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . . . -55.68 129.85 40.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.756 0.823 . . . . 0.0 112.391 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.77 79.22 0.05 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.001 0.81 . . . . 0.0 112.091 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 67.97 -50.7 0.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.651 2.38 . . . . 0.0 115.322 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.52 169.86 7.01 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.475 1.91 . . . . 0.0 113.492 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -152.88 -177.56 6.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.987 1.715 . . . . 0.0 112.315 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 138.3 40.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.996 2.118 . . . . 0.0 112.288 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.443 ' O ' HD13 ' A' ' 171' ' ' ILE . 50.0 tt0 -146.42 156.29 43.19 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.345 1.458 . . . . 0.0 110.764 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 170' ' ' GLN . 14.4 mm -131.9 125.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 110.283 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 112.76 19.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.311 1.044 . . . . 0.0 112.379 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.582 HG22 ' CB ' ' A' ' 157' ' ' MET . 18.2 pt -97.63 132.11 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.721 1.608 . . . . 0.0 110.517 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 t -154.16 158.69 40.76 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.445 -0.784 . . . . 0.0 111.491 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.998 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.506 ' HB3' HG22 ' A' ' 20' ' ' VAL . 1.3 mm? . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.21 29.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.0 1.72 . . . . 0.0 114.387 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.4 -5.6 10.22 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.021 1.772 . . . . 0.0 115.392 -175.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -167.49 162.18 14.29 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.304 2.642 . . . . 0.0 109.36 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 70' ' ' LEU . 49.1 mt -142.4 167.39 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.774 1.23 . . . . 0.0 109.901 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.03 -164.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 127.958 2.503 . . . . 0.0 110.045 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.04 -14.82 39.63 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -26.4 24.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.874 1.702 . . . . 0.0 113.571 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.53 81.34 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 118.373 1.086 . . . . 0.0 112.166 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -12.71 49.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.042 1.337 . . . . 0.0 113.842 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.36 129.73 41.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.857 1.263 . . . . 0.0 109.371 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -142.24 144.06 33.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.701 0.8 . . . . 0.0 109.319 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -54.96 -29.79 57.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.592 0.633 . . . . 0.0 112.381 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -58.63 -55.99 27.9 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 112.119 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -62.4 -47.04 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.9 63.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.005 1.322 . . . . 0.0 113.323 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -52.91 14.83 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 119.938 -1.726 . . . . 0.0 110.754 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -64.32 -38.93 92.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.117 1.767 . . . . 0.0 112.231 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.8 -34.45 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.429 1.092 . . . . 0.0 112.155 -174.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 32' ' ' ALA . 97.2 mt -78.2 -40.55 37.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.258 1.423 . . . . 0.0 111.425 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -72.45 -17.11 61.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -30.97 70.57 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.645 -1.284 . . . . 0.0 112.554 175.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 112.262 177.574 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.597 0.237 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -133.18 130.98 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.646 1.178 . . . . 0.0 110.367 -177.451 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -116.73 95.29 4.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.749 2.02 . . . . 0.0 112.423 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -101.73 113.41 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.626 -1.296 . . . . 0.0 109.178 174.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.6 160.02 28.56 Favored Glycine 0 C--O 1.235 0.171 0 C-N-CA 120.857 -0.687 . . . . 0.0 114.745 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.495 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.8 mp -135.61 130.97 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.193 1.397 . . . . 0.0 110.129 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 4.2 m-20 -86.7 104.4 16.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.344 1.058 . . . . 0.0 111.943 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -81.12 100.39 9.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.829 1.195 . . . . 0.0 112.102 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.64 21.49 2.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.197 0.999 . . . . 0.0 112.845 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -6.38 58.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.482 1.513 . . . . 0.0 114.621 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.53 22.82 55.51 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.384 0.992 . . . . 0.0 114.97 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.15 126.87 3.65 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.444 1.497 . . . . 0.0 112.275 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -58.6 143.95 44.56 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.464 1.106 . . . . 0.0 110.565 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 50.7 m0 -108.05 164.77 12.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.69 0.796 . . . . 0.0 111.858 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.1 m -149.9 104.15 3.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.141 1.776 . . . . 0.0 110.307 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.36 144.62 55.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.733 -1.229 . . . . 0.0 111.211 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.549 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -107.56 -47.8 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.743 1.617 . . . . 0.0 113.149 -177.427 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.549 ' H ' HD22 ' A' ' 46' ' ' LEU . 61.7 t30 -157.73 171.33 20.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.497 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.64 128.67 25.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.894 1.277 . . . . 0.0 110.859 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -120.31 141.64 49.84 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.286 1.434 . . . . 0.0 110.373 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -154.22 155.73 35.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.527 177.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -120.15 -13.11 8.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.035 1.734 . . . . 0.0 111.093 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.4 m -143.04 131.23 21.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.649 1.98 . . . . 0.0 110.219 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 107.29 0.98 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 74' ' ' ARG . 1.4 t -73.79 176.23 6.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.125 2.17 . . . . 0.0 111.378 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -69.13 163.14 25.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.452 1.12 . . . . 0.0 113.155 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.0 -29.74 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.986 1.314 . . . . 0.0 112.937 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.66 164.05 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.411 1.884 . . . . 0.0 110.233 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 tp -64.26 134.54 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.062 0.945 . . . . 0.0 110.786 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.29 109.56 34.37 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 108.295 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HG2' HD12 ' A' ' 69' ' ' LEU . 50.7 Cg_endo -61.46 123.47 12.82 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.032 3.154 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.2 -59.56 2.51 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.346 -0.846 . . . . 0.0 112.483 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -105.22 144.73 31.6 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 110.697 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.44 124.46 17.11 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.595 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.17 170.48 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.072 2.514 . . . . 0.0 112.493 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -62.66 148.73 45.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.012 0.925 . . . . 0.0 111.133 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 p 53.9 42.86 31.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.808 1.643 . . . . 0.0 114.832 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -145.2 127.9 16.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.807 1.643 . . . . 0.0 112.723 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -84.64 176.1 8.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.978 0.911 . . . . 0.0 111.819 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.654 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -151.87 150.51 30.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.342 -0.849 . . . . 0.0 112.003 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -122.49 169.18 11.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.177 1.391 . . . . 0.0 112.128 177.051 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.627 ' HB3' HG13 ' A' ' 33' ' ' VAL . 2.4 t80 -145.7 160.65 41.41 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.436 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.87 164.65 33.04 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.725 1.61 . . . . 0.0 111.262 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.59 173.45 39.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.645 0.64 . . . . 0.0 113.703 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.637 ' O ' HG22 ' A' ' 54' ' ' THR . 22.7 tpt180 . . . . . 0 N--CA 1.477 0.91 0 C-N-CA 126.442 1.897 . . . . 0.0 109.802 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.778 0.323 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.08 112.87 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.505 1.922 . . . . 0.0 111.088 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -132.57 163.99 27.64 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.526 1.131 . . . . 0.0 111.18 175.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.2 112.81 4.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.766 1.226 . . . . 0.0 108.635 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -122.64 165.17 16.92 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.969 1.308 . . . . 0.0 110.747 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -129.03 153.61 47.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.267 0.556 . . . . 0.0 111.511 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.6 m-85 -127.96 112.9 15.18 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.967 1.307 . . . . 0.0 109.93 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 46' ' ' LEU . 10.5 t80 -67.64 107.03 2.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.187 1.395 . . . . 0.0 110.329 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.15 144.92 50.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.212 1.405 . . . . 0.0 110.845 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.6 t -55.42 -27.33 47.21 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.175 0.99 . . . . 0.0 113.369 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -9.3 40.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.312 1.445 . . . . 0.0 114.837 174.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.12 55.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.872 1.225 . . . . 0.0 115.094 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.05 172.82 6.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.508 1.523 . . . . 0.0 110.445 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HB1' ' A' ' 89' ' ' ALA . 40.8 m -136.33 108.36 7.18 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.312 1.045 . . . . 0.0 111.141 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 173' ' ' ILE . 9.1 tp -73.75 125.87 29.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.013 -1.055 . . . . 0.0 109.091 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.88 99.12 1.93 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.9 162.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.786 0.803 . . . . 0.0 111.227 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -148.1 158.29 43.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.502 0.721 . . . . 0.0 111.322 174.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 45.8 p90 -160.3 162.72 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.928 1.291 . . . . 0.0 109.325 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.22 168.76 24.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.809 1.244 . . . . 0.0 109.108 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.11 97.38 12.21 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 109.723 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 CA--C 1.541 0.836 0 C-N-CA 122.303 2.002 . . . . 0.0 110.865 175.022 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.443 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 122.017 0.913 . . . . 0.0 111.524 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -86.23 157.55 19.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.679 1.191 . . . . 0.0 112.617 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 6.0 p-90 -160.94 148.32 15.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.762 0.825 . . . . 0.0 111.505 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -172.1 107.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.317 1.847 . . . . 0.0 111.699 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 171' ' ' ILE . 23.6 t -116.36 137.24 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.683 0.793 . . . . 0.0 109.063 174.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' HA ' HD13 ' A' ' 151' ' ' LEU . 5.0 ttmt -145.96 143.64 29.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.875 1.67 . . . . 0.0 110.484 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.88 153.42 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -122.62 96.34 4.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.247 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t -70.71 90.51 0.78 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.54 -1.35 . . . . 0.0 111.599 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.85 -112.57 0.52 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.31 1.909 . . . . 0.0 110.831 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -159.21 117.78 2.89 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.706 1.602 . . . . 0.0 110.513 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -140.04 108.6 5.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.241 1.416 . . . . 0.0 111.404 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.01 171.35 6.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.638 0.775 . . . . 0.0 111.153 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.77 113.67 22.12 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.728 -0.608 . . . . 0.0 110.651 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.09 -175.22 4.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.083 1.353 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.06 -45.04 21.38 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.827 1.251 . . . . 0.0 112.236 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.06 46.88 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.576 1.084 . . . . 0.0 114.397 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 ttp -70.02 -60.61 2.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.781 1.291 . . . . 0.0 109.63 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -53.54 -33.39 54.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.845 0.858 . . . . 0.0 113.241 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.22 -38.59 91.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.568 1.147 . . . . 0.0 110.837 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -23.61 66.78 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.329 -1.482 . . . . 0.0 112.458 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mt -84.01 -47.28 11.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.518 1.527 . . . . 0.0 111.345 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.18 -26.44 26.78 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -122.46 -38.88 2.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.681 1.192 . . . . 0.0 112.219 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.52 -55.95 24.48 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.737 1.161 . . . . 0.0 112.761 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -160.97 70.44 2.67 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.04 115.19 3.15 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.848 2.365 . . . . 0.0 112.99 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.21 -178.33 3.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.536 1.135 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.57 144.33 49.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.077 2.551 . . . . 0.0 111.022 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.45 108.29 0.63 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.853 1.216 . . . . 0.0 111.865 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -120.15 64.9 0.82 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.725 1.61 . . . . 0.0 114.094 -174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.94 96.03 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.923 2.089 . . . . 0.0 114.314 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.99 135.26 2.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.343 1.449 . . . . 0.0 112.017 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -66.41 144.63 56.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 111.371 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -143.6 131.2 21.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.363 1.065 . . . . 0.0 111.805 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -133.81 143.74 48.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.645 1.578 . . . . 0.0 112.346 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 161.98 40.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.462 1.505 . . . . 0.0 112.224 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -97.67 96.62 8.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.396 1.079 . . . . 0.0 108.886 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -53.54 -51.07 64.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.523 1.529 . . . . 0.0 112.014 -174.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.94 51.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.791 1.076 . . . . 0.0 115.791 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -135.44 -31.29 0.97 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -29.75 2.31 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.21 1.386 . . . . 0.0 113.321 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.61 172.14 6.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.904 1.682 . . . . 0.0 112.766 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -134.53 151.83 51.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.912 1.685 . . . . 0.0 109.782 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.66 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.54 152.99 51.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 133.71 49.1 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.504 1.521 . . . . 0.0 109.918 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.07 136.41 11.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.477 1.037 . . . . 0.0 112.591 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tp -108.24 149.81 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.091 1.757 . . . . 0.0 109.641 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.88 93.58 2.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.68 1.192 . . . . 0.0 110.707 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.9 p -91.88 161.62 14.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.247 1.019 . . . . 0.0 111.183 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.14 -26.52 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.734 1.214 . . . . 0.0 112.398 175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.33 114.86 9.83 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 110.911 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.03 -95.11 0.64 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.083 1.325 . . . . 0.0 113.078 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.01 64.15 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.45 1.5 . . . . 0.0 111.265 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.27 91.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.864 1.666 . . . . 0.0 113.977 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.455 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -156.66 168.84 26.19 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -174.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.455 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 17.8 ptm -135.31 160.47 38.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.227 2.611 . . . . 0.0 112.567 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -153.64 162.51 41.18 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.192 1.797 . . . . 0.0 109.558 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 117' ' ' VAL . 11.1 mm -136.48 108.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -95.87 116.18 28.53 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 112.024 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.66 HG22 ' CB ' ' A' ' 157' ' ' MET . 8.2 pt -103.67 132.19 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 0.0 111.101 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.7 p -155.48 170.96 20.73 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.284 -0.885 . . . . 0.0 112.643 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.433 ' HB3' HG22 ' A' ' 20' ' ' VAL . 8.8 mp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.65 171.54 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.85 -19.44 44.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.393 0.997 . . . . 0.0 113.659 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.8 p -163.38 156.99 19.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.784 2.834 . . . . 0.0 109.05 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.505 HD11 HD12 ' A' ' 70' ' ' LEU . 64.8 mt -141.84 173.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.957 1.703 . . . . 0.0 109.065 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.11 -167.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.558 1.543 . . . . 0.0 110.033 174.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -46.34 -40.2 11.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.72 -32.64 5.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.594 1.569 . . . . 0.0 113.083 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.588 1.194 . . . . 0.0 111.588 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.0 m -83.82 -6.54 59.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.607 1.963 . . . . 0.0 113.902 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 13' ' ' THR . 4.6 tt -66.27 138.09 57.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.578 1.151 . . . . 0.0 109.792 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.2 m -141.79 142.17 33.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.863 0.865 . . . . 0.0 109.922 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -55.93 -32.45 63.82 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -56.62 -49.78 73.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.442 1.019 . . . . 0.0 112.771 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.11 -49.53 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.014 -0.429 . . . . 0.0 109.861 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.2 -36.56 52.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.271 1.428 . . . . 0.0 112.222 -178.173 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.92 -65.79 0.54 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.196 1.798 . . . . 0.0 111.211 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -65.05 -24.45 67.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 177.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.41 -46.6 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.707 1.203 . . . . 0.0 112.285 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -26.93 55.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.247 0.619 . . . . 0.0 112.063 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.21 -38.36 51.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.173 1.389 . . . . 0.0 113.714 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.45 -27.06 45.73 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.198 0.908 . . . . 0.0 113.039 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 126.853 2.061 . . . . 0.0 113.7 175.058 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -128.87 147.39 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.351 1.061 . . . . 0.0 112.11 -175.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 110.96 11.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.27 1.828 . . . . 0.0 111.287 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.783 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -130.32 157.46 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 C-N-CA 125.189 1.396 . . . . 0.0 112.601 175.005 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 156.54 177.32 29.59 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.2 mp -133.78 147.97 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.747 0.819 . . . . 0.0 110.46 -175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.79 102.07 13.79 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.926 -1.109 . . . . 0.0 112.049 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -82.16 98.61 8.79 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 113.124 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -133.91 10.61 3.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 113.44 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -5.36 35.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.22 42.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.855 1.217 . . . . 0.0 114.826 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.98 127.04 3.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.358 1.456 . . . . 0.0 112.328 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.7 m -57.8 142.03 46.99 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.361 1.065 . . . . 0.0 110.968 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.631 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 49.5 m0 -108.67 165.27 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.118 0.967 . . . . 0.0 111.938 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -142.01 99.85 3.61 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.118 1.767 . . . . 0.0 112.008 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -68.02 145.06 54.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.714 -1.241 . . . . 0.0 108.95 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.98 -48.99 4.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.476 1.111 . . . . 0.0 111.733 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.6 176.03 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.818 2.047 . . . . 0.0 110.272 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.65 40.61 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.089 1.755 . . . . 0.0 111.006 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -125.58 137.24 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.931 1.292 . . . . 0.0 110.364 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.57 42.22 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.151 1.78 . . . . 0.0 109.201 -175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 -23.13 3.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.87 68.11 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.073 1.416 . . . . 0.0 109.584 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.45 179.31 32.27 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.923 1.725 . . . . 0.0 110.969 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -141.98 162.31 35.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.311 1.444 . . . . 0.0 110.141 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 p -65.25 160.01 22.51 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.304 -0.873 . . . . 0.0 112.278 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.78 -19.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 161.8 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.462 1.905 . . . . 0.0 110.814 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.17 135.96 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.65 0.78 . . . . 0.0 110.038 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.8 tp -91.95 113.96 60.57 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.217 1.007 . . . . 0.0 108.393 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 69' ' ' LEU . 89.8 Cg_endo -66.45 125.48 13.98 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.624 2.883 . . . . 0.0 110.337 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -57.37 9.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.899 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.53 130.34 54.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.003 0.82 . . . . 0.0 111.164 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 69' ' ' LEU . 57.5 t -101.81 121.76 49.82 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.367 1.067 . . . . 0.0 109.627 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.03 148.28 86.05 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.456 2.104 . . . . 0.0 111.285 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.5 155.4 5.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 175.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 t 40.6 55.32 2.94 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.597 1.559 . . . . 0.0 113.096 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 3.6 ttmt -159.89 136.28 8.93 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.007 1.723 . . . . 0.0 111.895 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.35 177.49 5.82 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.43 1.092 . . . . 0.0 111.787 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 60' ' ' PRO . 2.2 pt? -149.87 149.61 30.71 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.682 0.793 . . . . 0.0 111.912 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.77 171.31 7.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.731 1.212 . . . . 0.0 110.653 175.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.2 158.16 37.13 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.638 1.975 . . . . 0.0 108.611 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -150.14 175.47 11.72 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.022 0.929 . . . . 0.0 111.118 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.02 172.73 29.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.886 0.755 . . . . 0.0 114.158 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 126.159 1.784 . . . . 0.0 113.378 -174.984 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 112.024 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.24 108.36 2.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 126.045 1.738 . . . . 0.0 110.837 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.83 179.83 7.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.122 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' A' ' 130' ' ' MET . . . -153.18 138.47 17.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.206 1.003 . . . . 0.0 108.594 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.66 168.92 20.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.307 0.643 . . . . 0.0 111.359 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.796 ' HB2' HH22 ' A' ' 124' ' ' ARG . . . -131.74 162.49 30.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.785 0.803 . . . . 0.0 113.073 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 31.3 m-85 -135.45 113.85 11.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.395 1.478 . . . . 0.0 110.099 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.1 115.02 7.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.923 1.289 . . . . 0.0 109.995 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.3 ttp -82.3 153.32 25.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.391 0.676 . . . . 0.0 112.029 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -59.15 -24.05 62.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.96 -7.73 43.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.547 1.539 . . . . 0.0 114.205 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.15 -1.45 73.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.407 1.479 . . . . 0.0 114.764 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.05 175.34 6.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.046 1.339 . . . . 0.0 111.184 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.538 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 7.7 m -136.7 115.24 11.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.266 1.427 . . . . 0.0 110.983 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.558 ' CD2' HG21 ' A' ' 35' ' ' ILE . 13.2 tp -81.49 126.15 31.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.03 117.35 5.28 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.412 1.006 . . . . 0.0 112.221 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -90.39 146.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.903 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -129.43 135.54 48.8 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.373 1.469 . . . . 0.0 109.879 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.783 ' CG ' HG11 ' A' ' 33' ' ' VAL . 53.0 p90 -153.19 145.42 23.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.048 0.928 . . . . 0.0 113.013 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -151.04 149.72 29.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.277 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.76 95.26 49.12 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 CA--C 1.541 0.862 0 C-N-CA 122.491 2.127 . . . . 0.0 110.609 176.262 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 121.136 0.493 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 139' ' ' PRO . 50.9 m95 -97.22 147.04 24.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.335 1.054 . . . . 0.0 112.813 176.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -154.92 151.81 28.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.407 174.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -175.6 119.0 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.4 1.88 . . . . 0.0 110.186 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 171' ' ' ILE . 13.7 p -119.88 137.7 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.056 1.743 . . . . 0.0 109.516 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -134.03 159.54 40.46 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 110.365 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.99 104.74 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.785 1.634 . . . . 0.0 108.548 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -76.33 106.52 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.321 1.448 . . . . 0.0 109.61 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -70.38 85.25 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.481 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.55 -122.47 1.35 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.508 2.004 . . . . 0.0 110.563 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -146.64 144.65 29.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.578 1.151 . . . . 0.0 111.101 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.796 HH22 ' HB2' ' A' ' 89' ' ' ALA . 20.2 ttp85 -150.49 122.95 8.46 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.139 1.376 . . . . 0.0 110.789 175.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.69 152.66 45.23 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.038 1.335 . . . . 0.0 109.873 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.81 115.26 20.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.483 -0.761 . . . . 0.0 109.289 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.9 p30 -156.79 -177.77 6.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.618 1.167 . . . . 0.0 113.012 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -53.75 -38.42 64.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.382 1.073 . . . . 0.0 112.73 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.93 -42.5 94.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.414 1.007 . . . . 0.0 112.378 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.425 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 1.5 ptm -60.72 -50.94 71.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.188 0.994 . . . . 0.0 110.383 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -57.9 -36.54 72.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.658 0.783 . . . . 0.0 112.226 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.65 -46.6 78.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 0.0 110.912 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -20.72 66.22 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.321 -1.487 . . . . 0.0 113.48 174.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.35 -17.17 37.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.867 2.467 . . . . 0.0 115.131 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.23 -23.44 4.89 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -123.83 -25.74 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.829 1.252 . . . . 0.0 111.968 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.28 -68.19 1.74 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.775 1.655 . . . . 0.0 113.579 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -141.62 55.02 4.58 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 98.1 Cg_endo -64.33 141.06 73.33 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 123.905 3.07 . . . . 0.0 113.966 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -124.07 174.73 7.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.643 1.977 . . . . 0.0 113.102 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -129.23 141.95 50.99 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.623 -1.298 . . . . 0.0 110.546 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.61 120.02 1.07 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -134.06 83.97 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.49 0.716 . . . . 0.0 111.705 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 m120 56.75 93.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.976 2.51 . . . . 0.0 114.478 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 148.56 140.6 3.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.918 1.723 . . . . 0.0 111.928 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -67.06 141.58 57.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.009 0.923 . . . . 0.0 111.849 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -144.3 140.96 29.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.907 1.283 . . . . 0.0 111.915 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -132.24 151.83 51.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 127.537 2.335 . . . . 0.0 110.506 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.614 ' HE3' HD12 ' A' ' 151' ' ' LEU . 1.8 pttt -150.86 157.56 43.06 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 110.638 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.63 88.33 3.92 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.614 HD12 ' HE3' ' A' ' 149' ' ' LYS . 1.7 tp -50.01 -39.42 41.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.966 1.707 . . . . 0.0 114.314 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.38 1.61 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 117.767 1.867 . . . . 0.0 117.767 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -132.52 -32.93 1.28 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.09 -37.54 0.7 Allowed Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.665 1.126 . . . . 0.0 113.239 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.31 172.2 7.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.283 1.833 . . . . 0.0 111.112 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -133.13 156.32 47.66 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.544 1.538 . . . . 0.0 109.681 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.653 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -133.22 162.99 30.29 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.253 0.621 . . . . 0.0 110.902 176.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 134.7 53.17 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.726 1.21 . . . . 0.0 108.296 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.4 148.42 18.92 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.217 0.913 . . . . 0.0 112.421 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -121.65 113.86 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.734 1.214 . . . . 0.0 111.168 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.52 125.9 45.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.829 0.74 . . . . 0.0 109.385 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.3 p -123.63 159.87 28.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.205 1.802 . . . . 0.0 110.365 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.5 t -147.23 -73.63 0.21 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.11 -0.994 . . . . 0.0 112.376 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.33 106.79 0.48 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.79 1.236 . . . . 0.0 112.469 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.31 97.89 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 60.29 79.36 0.24 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.392 1.877 . . . . 0.0 113.274 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.03 86.14 0.24 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.134 1.373 . . . . 0.0 113.853 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 -170.62 3.06 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.1 ptm -155.4 169.48 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.04 1.336 . . . . 0.0 111.477 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -148.33 157.24 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.994 1.317 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.551 HG21 HG21 ' A' ' 117' ' ' VAL . 37.2 mm -123.7 123.01 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.833 1.253 . . . . 0.0 108.62 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -118.43 122.52 42.96 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.49 0.716 . . . . 0.0 110.289 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 157' ' ' MET . 25.2 pt -105.72 132.89 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.449 1.099 . . . . 0.0 108.829 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.7 p -150.93 163.71 38.06 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.316 0.647 . . . . 0.0 110.645 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.229 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.46 169.81 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.337 1.065 . . . . 0.0 110.982 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.6 -30.48 9.59 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.643 1.592 . . . . 0.0 111.567 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.5 p -144.87 146.08 31.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.656 1.728 . . . . 0.0 111.966 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -139.71 156.39 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.6 1.16 . . . . 0.0 110.839 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.21 163.32 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.431 1.493 . . . . 0.0 111.984 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.48 -29.43 58.74 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.48 -15.47 3.89 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.267 1.889 . . . . 0.0 112.327 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.99 -28.85 69.32 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.414 1.485 . . . . 0.0 114.115 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -119.88 3.25 11.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.898 1.679 . . . . 0.0 113.848 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -78.36 133.02 37.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.439 1.096 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.48 147.88 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.637 1.175 . . . . 0.0 109.196 175.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.16 -32.91 56.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.217 0.917 . . . . 0.0 113.202 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -60.99 -48.4 82.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.89 1.276 . . . . 0.0 113.509 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.07 -45.2 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 121.559 -0.713 . . . . 0.0 110.602 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -53.24 -37.59 62.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.956 1.303 . . . . 0.0 112.125 -176.212 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -52.03 -67.2 0.27 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.436 2.295 . . . . 0.0 110.871 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -38.16 79.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.834 0.854 . . . . 0.0 112.056 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.2 -48.64 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.235 1.379 . . . . 0.0 111.435 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.663 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -75.18 -27.27 59.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.322 1.049 . . . . 0.0 113.44 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.37 -35.14 54.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 116.986 -1.483 . . . . 0.0 112.41 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -45.3 -27.77 0.71 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.71 2.804 . . . . 0.0 114.52 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 CA--C 1.55 0.967 0 C-N-CA 123.963 0.905 . . . . 0.0 111.41 175.044 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -132.12 137.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.541 1.136 . . . . 0.0 112.194 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB2' ' CB ' ' A' ' 21' ' ' LEU . . . -126.27 116.49 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.549 2.339 . . . . 0.0 110.564 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.19 127.95 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 120.819 -1.176 . . . . 0.0 110.739 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.21 170.88 43.24 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 121.969 -0.457 . . . . 0.0 113.699 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.34 126.57 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.509 1.523 . . . . 0.0 110.108 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -77.53 108.0 10.38 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.523 -1.36 . . . . 0.0 112.125 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.404 ' ND2' ' CE2' ' A' ' 43' ' ' TRP . 22.2 t-20 -86.89 93.73 9.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.211 1.404 . . . . 0.0 113.258 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.19 18.5 2.6 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 120.799 -1.188 . . . . 0.0 112.644 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 -7.8 59.5 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.5 7.61 71.95 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.657 1.123 . . . . 0.0 115.44 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.58 100.01 0.38 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.778 1.656 . . . . 0.0 111.891 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -52.18 124.44 13.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.784 2.033 . . . . 0.0 113.108 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.603 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 7.5 m0 -90.8 168.03 12.03 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.521 -0.737 . . . . 0.0 112.783 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -140.37 111.83 7.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.179 2.192 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -66.21 162.51 19.76 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.068 -1.02 . . . . 0.0 111.975 174.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -133.41 -64.56 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.628 1.171 . . . . 0.0 112.587 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -145.87 167.41 23.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.858 0.863 . . . . 0.0 111.533 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.3 134.46 31.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.816 1.247 . . . . 0.0 111.622 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -117.19 118.0 31.13 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.038 1.735 . . . . 0.0 109.749 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 118.86 25.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.372 2.269 . . . . 0.0 109.265 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.28 -30.54 11.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.206 1.403 . . . . 0.0 112.452 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -120.41 107.37 12.83 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.448 1.499 . . . . 0.0 108.447 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.99 123.09 3.35 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.524 1.059 . . . . 0.0 113.666 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -95.91 100.96 12.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.426 1.49 . . . . 0.0 109.515 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -67.68 168.99 10.22 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -138.92 0.32 1.96 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.936 1.695 . . . . 0.0 113.071 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG23 ' CE1' ' A' ' 71' ' ' TYR . 33.2 m -90.09 156.12 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.747 -1.221 . . . . 0.0 111.876 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.41 128.11 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.863 1.265 . . . . 0.0 112.537 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 tp -80.79 130.1 65.36 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 108.968 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.657 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.9 Cg_endo -65.51 123.35 11.31 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.79 2.993 . . . . 0.0 111.184 175.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.65 -53.39 9.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.73 0.812 . . . . 0.0 112.96 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -114.58 157.35 23.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.165 0.986 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.71 87.98 11.04 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 124.024 0.93 . . . . 0.0 108.843 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.65 159.21 54.59 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.849 1.699 . . . . 0.0 111.183 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -58.47 158.49 7.46 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.718 -0.613 . . . . 0.0 111.035 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 6.9 p 58.17 42.47 22.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.223 1.409 . . . . 0.0 112.157 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -155.65 163.9 39.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.475 1.91 . . . . 0.0 111.762 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.06 -174.73 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.789 0.804 . . . . 0.0 109.422 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -157.52 154.52 28.75 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.542 -0.724 . . . . 0.0 111.425 176.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mt -136.15 164.42 28.07 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.901 0.881 . . . . 0.0 111.348 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' A' ' 57' ' ' VAL . 1.2 t80 -136.71 163.55 30.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.797 1.239 . . . . 0.0 109.698 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -131.01 172.36 12.17 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.3 1.84 . . . . 0.0 109.245 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.65 117.02 0.83 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-O 118.706 -1.052 . . . . 0.0 111.568 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 93.1 mtm-85 . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 125.253 1.421 . . . . 0.0 111.135 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -155.37 119.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.609 1.963 . . . . 0.0 109.034 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.12 171.65 16.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.205 1.402 . . . . 0.0 109.119 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 127.67 6.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -131.1 165.09 24.03 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.007 0.923 . . . . 0.0 111.309 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -125.61 148.66 48.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.7 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 26.3 m-85 -123.36 120.09 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.216 1.406 . . . . 0.0 110.528 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.457 ' HB2' HD22 ' A' ' 46' ' ' LEU . 8.3 t80 -71.73 102.35 2.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 0.0 110.23 175.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.4 mtp -66.11 152.35 44.91 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 0.0 111.893 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -56.57 -30.65 63.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.489 1.116 . . . . 0.0 113.423 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.4 p -65.27 -11.9 46.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.966 2.106 . . . . 0.0 115.157 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 18.8 41.89 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.519 1.057 . . . . 0.0 114.579 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -111.68 167.6 10.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.762 1.625 . . . . 0.0 110.804 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.514 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 59.1 m -128.94 101.06 5.9 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.233 -0.917 . . . . 0.0 112.767 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 173' ' ' ILE . 9.6 tp -71.64 116.34 11.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.749 0.82 . . . . 0.0 110.97 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.34 105.11 3.22 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.208 0.909 . . . . 0.0 111.876 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.04 156.32 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 0.0 110.152 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.587 ' HB3' HD13 ' A' ' 134' ' ' LEU . 2.2 ppp? -136.57 162.85 31.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.759 1.224 . . . . 0.0 109.046 175.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -162.97 155.55 18.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.112 0.565 . . . . 0.0 111.022 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 t -153.53 164.01 38.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 110.645 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 m -105.02 146.64 33.06 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.493 1.117 . . . . 0.0 112.367 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 CA--C 1.541 0.841 0 C-N-CA 124.033 3.155 . . . . 0.0 112.055 176.341 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.343 0.592 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -84.38 142.54 30.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.331 1.452 . . . . 0.0 113.146 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.01 146.2 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -163.17 152.88 15.4 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.106 0.962 . . . . 0.0 112.957 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.563 ' O ' HD11 ' A' ' 151' ' ' LEU . 49.7 t -138.9 140.84 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.031 0.932 . . . . 0.0 109.258 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -145.32 133.97 22.16 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.164 1.386 . . . . 0.0 109.387 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.3 mt -95.61 110.17 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 124.869 1.267 . . . . 0.0 108.496 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -76.21 96.26 3.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.3 p -55.69 119.42 5.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.82 -111.61 3.04 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 143.0 27.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.549 1.14 . . . . 0.0 112.281 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -158.87 117.53 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.657 1.583 . . . . 0.0 111.902 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 166.74 22.46 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.745 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 115.52 20.04 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.198 0.599 . . . . 0.0 110.535 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.21 -173.14 4.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.789 1.236 . . . . 0.0 111.872 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -50.73 -49.43 57.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.136 0.974 . . . . 0.0 111.732 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.73 -36.87 50.31 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.597 1.094 . . . . 0.0 113.683 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.72 -63.25 1.11 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.106 0.962 . . . . 0.0 110.425 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -51.61 -34.14 36.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.271 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -64.73 -47.86 76.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.645 1.178 . . . . 0.0 110.627 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.08 -25.25 66.93 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.11 -1.619 . . . . 0.0 113.401 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 101' ' ' MET . 70.2 mt -83.48 -12.2 56.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.857 1.663 . . . . 0.0 114.941 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -124.16 -32.6 3.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.93 1.292 . . . . 0.0 114.094 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -114.87 -23.75 8.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.883 1.673 . . . . 0.0 112.778 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.93 -85.87 0.03 OUTLIER Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.251 1.881 . . . . 0.0 112.21 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -164.07 63.35 1.13 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.643 1.577 . . . . 0.0 112.15 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.15 178.32 7.45 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.896 2.398 . . . . 0.0 115.706 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.57 -171.07 2.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.539 1.936 . . . . 0.0 113.819 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -139.2 146.58 40.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.535 1.934 . . . . 0.0 111.365 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.65 -57.74 0.46 Allowed Glycine 0 N--CA 1.479 1.554 0 C-N-CA 124.503 1.049 . . . . 0.0 115.664 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.1 t0 52.86 68.62 0.8 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.826 1.651 . . . . 0.0 114.431 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.312 0.1 OUTLIER 40.95 69.05 0.37 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.122 2.169 . . . . 0.0 114.441 176.029 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 119.75 0.8 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.213 1.863 . . . . 0.0 111.496 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CZ3' ' HB ' ' A' ' 160' ' ' ILE . 8.2 m95 -57.78 132.89 54.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.159 0.983 . . . . 0.0 112.028 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -147.9 125.06 11.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.293 1.037 . . . . 0.0 112.364 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.01 137.47 49.99 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.895 1.678 . . . . 0.0 109.859 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 151.77 40.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.111 0.965 . . . . 0.0 110.877 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -74.53 93.94 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.682 HD13 ' SD ' ' A' ' 157' ' ' MET . 6.8 tp -48.62 -30.46 5.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.58 31.59 2.12 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.81 -27.36 1.15 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.45 -15.35 0.96 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.594 1.092 . . . . 0.0 114.675 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.49 171.64 13.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.647 1.579 . . . . 0.0 111.208 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.44 157.11 24.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.515 1.126 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -134.94 164.65 27.13 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.637 0.775 . . . . 0.0 109.447 174.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -133.2 122.8 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.924 1.69 . . . . 0.0 108.757 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.43 143.76 17.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.564 0.602 . . . . 0.0 113.19 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.4 ' HB ' ' CZ3' ' A' ' 146' ' ' TRP . 4.8 tp -122.11 143.84 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.514 1.526 . . . . 0.0 110.222 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 9.6 tpt -132.44 124.9 29.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.122 1.369 . . . . 0.0 109.458 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.9 p -128.96 135.53 49.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.933 0.893 . . . . 0.0 110.82 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -97.43 178.31 5.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.666 1.986 . . . . 0.0 112.135 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.05 -171.04 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.045 2.138 . . . . 0.0 112.132 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.66 174.67 45.25 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 47.43 21.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.472 1.909 . . . . 0.0 116.137 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.24 150.27 45.5 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.503 1.921 . . . . 0.0 113.079 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 39.3 tptt -164.63 154.41 13.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.053 1.341 . . . . 0.0 113.654 175.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.55 138.7 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.333 2.253 . . . . 0.0 112.448 174.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -143.11 161.45 38.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.22 1.808 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 mm -126.44 117.11 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.436 1.095 . . . . 0.0 109.96 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -96.24 117.16 30.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.534 1.134 . . . . 0.0 108.181 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.673 HD13 HD22 ' A' ' 98' ' ' LEU . 4.3 pt -109.88 130.9 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.31 142.93 2.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.736 0.814 . . . . 0.0 112.342 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.49 1.516 . . . . 0.0 113.435 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 142.95 33.56 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.343 0.592 . . . . 0.0 110.875 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.63 -21.81 13.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.249 1.88 . . . . 0.0 112.242 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -150.67 155.64 39.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.699 1.999 . . . . 0.0 112.005 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -140.82 167.91 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.93 1.692 . . . . 0.0 111.17 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -169.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.301 1.841 . . . . 0.0 111.04 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.72 -41.98 5.14 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.01 -32.55 5.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.161 1.362 . . . . 0.0 112.84 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 118.437 1.119 . . . . 0.0 111.608 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -85.39 -5.33 59.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.107 1.763 . . . . 0.0 113.778 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 13' ' ' THR . 5.0 tt -65.46 137.33 57.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.089 0.956 . . . . 0.0 109.914 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -141.55 146.01 35.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.322 1.049 . . . . 0.0 109.799 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -54.87 -32.8 61.18 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.888 0.767 . . . . 0.0 112.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -56.6 -56.45 21.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.452 1.101 . . . . 0.0 112.702 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.56 -49.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -57.83 -19.17 26.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.237 1.415 . . . . 0.0 113.523 -177.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -82.59 -47.92 11.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.973 2.109 . . . . 0.0 111.514 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -33.25 73.14 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.546 -1.346 . . . . 0.0 110.84 174.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -45.69 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.493 1.517 . . . . 0.0 112.821 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.5 OUTLIER -71.95 -33.53 68.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.819 0.448 . . . . 0.0 111.259 175.393 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.85 -23.04 58.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.77 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -47.38 -25.22 0.96 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.813 2.045 . . . . 0.0 113.19 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.51 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.7 tp . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 126.164 1.786 . . . . 0.0 112.33 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -134.41 139.55 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 112.313 177.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -117.83 98.93 6.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.365 2.266 . . . . 0.0 110.891 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 34' ' ' GLY . 14.0 p -125.33 159.3 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.796 -1.19 . . . . 0.0 110.881 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 33' ' ' VAL . . . 169.3 -176.34 43.35 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-O 121.36 0.422 . . . . 0.0 112.079 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.494 HG21 HD23 ' A' ' 98' ' ' LEU . 4.0 mp -138.39 144.7 29.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.022 0.929 . . . . 0.0 110.703 -175.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.17 106.05 16.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.508 1.523 . . . . 0.0 112.006 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.497 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 p-10 -93.45 107.66 19.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.676 1.59 . . . . 0.0 111.963 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -136.84 10.27 3.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.302 1.441 . . . . 0.0 112.206 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -8.66 55.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.656 1.582 . . . . 0.0 115.13 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.05 28.38 41.63 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.611 1.101 . . . . 0.0 114.419 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.12 128.15 3.47 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.005 1.764 . . . . 0.0 111.206 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 m -58.22 147.6 29.89 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.315 1.446 . . . . 0.0 111.35 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.712 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 45.9 m0 -110.72 173.48 6.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.875 -1.141 . . . . 0.0 112.966 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -153.63 98.78 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.573 1.549 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . . . -72.67 137.34 45.96 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.005 -1.684 . . . . 0.0 110.603 175.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.76 -64.35 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.409 0.684 . . . . 0.0 111.224 178.545 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -154.26 -171.82 4.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.494 1.918 . . . . 0.0 110.885 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.23 134.77 29.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.033 1.333 . . . . 0.0 111.886 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -110.3 131.0 55.44 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.832 1.253 . . . . 0.0 109.915 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 14.9 p90 -153.0 162.29 41.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.069 1.348 . . . . 0.0 111.377 174.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -124.58 -56.67 1.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.143 1.377 . . . . 0.0 109.885 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.6 m -91.83 113.3 25.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.111 0.965 . . . . 0.0 110.559 177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.09 115.78 3.71 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -76.17 -179.76 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.911 1.284 . . . . 0.0 112.238 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.4 p -79.6 163.36 24.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 112.184 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -154.74 -35.65 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.981 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 160.25 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.59 1.956 . . . . 0.0 109.709 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 tt -80.32 133.89 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.85 0.86 . . . . 0.0 110.743 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.7 tp -80.88 128.33 71.83 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.05 163.77 27.45 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.347 2.031 . . . . 0.0 111.132 175.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.9 pt-20 -112.6 -66.05 1.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.514 1.126 . . . . 0.0 110.356 178.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.6 126.74 44.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.975 0.91 . . . . 0.0 109.819 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -114.32 129.91 24.45 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.593 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.26 -172.51 0.44 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.044 3.829 . . . . 0.0 113.204 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -82.06 153.01 26.35 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 119.685 -1.884 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.9 p 49.83 42.15 23.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.618 1.567 . . . . 0.0 114.736 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -156.0 122.6 5.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.067 1.747 . . . . 0.0 113.875 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -177.86 6.82 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.497 1.519 . . . . 0.0 114.125 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -143.27 152.37 41.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.244 1.418 . . . . 0.0 110.633 174.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -123.52 164.18 19.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -136.53 166.78 22.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.089 1.755 . . . . 0.0 110.539 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.6 p -138.71 168.5 19.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.297 1.439 . . . . 0.0 111.098 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 165.97 36.63 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.337 0.97 . . . . 0.0 111.569 174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.981 1.313 . . . . 0.0 112.082 175.919 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.819 0 CA-C-O 121.193 0.52 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.6 105.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.77 2.428 . . . . 0.0 110.59 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -135.06 156.21 49.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.287 1.041 . . . . 0.0 110.897 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 134' ' ' LEU . . . -145.29 111.65 5.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.517 1.127 . . . . 0.0 109.091 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -125.73 154.17 42.87 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.518 1.127 . . . . 0.0 112.074 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.734 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -119.88 140.6 50.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.274 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.66 110.36 19.05 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.712 1.205 . . . . 0.0 110.022 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.618 ' HB2' HD11 ' A' ' 46' ' ' LEU . 11.2 t80 -68.72 96.0 0.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.253 1.421 . . . . 0.0 110.41 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.4 ttt -62.95 146.91 51.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.038 1.735 . . . . 0.0 111.522 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 t -53.27 -23.65 9.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.648 1.179 . . . . 0.0 114.118 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 m -67.42 0.5 2.91 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.87 54.41 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.388 0.994 . . . . 0.0 112.125 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -124.15 166.52 15.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.486 1.914 . . . . 0.0 109.649 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.734 HG22 ' HB1' ' A' ' 89' ' ' ALA . 10.5 m -137.83 101.05 4.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.159 -0.963 . . . . 0.0 111.697 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 HG21 ' A' ' 35' ' ' ILE . 13.1 tp -69.77 112.72 6.42 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.345 -0.847 . . . . 0.0 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.5 102.97 2.99 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.705 1.145 . . . . 0.0 112.782 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.62 151.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.67 0.788 . . . . 0.0 111.699 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.544 ' HB2' HD13 ' A' ' 134' ' ' LEU . 6.3 ttp -134.54 150.65 50.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.385 1.474 . . . . 0.0 111.642 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 4.6 p90 -162.34 151.37 15.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.341 1.057 . . . . 0.0 110.78 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -158.35 126.86 5.42 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 110.447 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.12 128.4 60.17 Favored Pre-proline 0 N--CA 1.48 1.049 0 O-C-N 121.209 -0.932 . . . . 0.0 111.2 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 C--N 1.355 0.875 0 C-N-CA 123.802 3.002 . . . . 0.0 112.529 176.28 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -97.67 131.16 44.48 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.078 0.951 . . . . 0.0 112.447 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.6 129.19 15.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.159 0.981 . . . . 0.0 109.941 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.73 107.76 1.52 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 m -115.83 161.5 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.368 0.667 . . . . 0.0 109.337 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.635 ' HA ' HD21 ' A' ' 151' ' ' LEU . 28.1 tttt -154.65 154.48 33.03 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.06 0.544 . . . . 0.0 111.367 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 151' ' ' LEU . 5.3 mp -107.66 110.19 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.991 0.916 . . . . 0.0 109.869 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.64 92.74 1.98 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.829 1.652 . . . . 0.0 109.919 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -68.78 81.08 0.29 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.567 -1.333 . . . . 0.0 111.497 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.13 -99.12 0.13 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.453 1.978 . . . . 0.0 112.354 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -165.33 104.19 0.74 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.911 1.684 . . . . 0.0 110.832 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -149.86 103.44 3.22 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 172.26 1.75 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.16 1.384 . . . . 0.0 112.386 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.39 119.96 19.3 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.62 -0.675 . . . . 0.0 112.184 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.62 -173.29 3.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.579 1.551 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -51.06 -52.98 38.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.427 1.091 . . . . 0.0 112.183 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.03 -31.05 64.48 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.769 0.7 . . . . 0.0 113.175 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.7 ttt -65.81 -64.45 0.86 Allowed 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -53.65 -33.67 56.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.026 0.93 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.48 -49.14 78.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.039 0.936 . . . . 0.0 109.195 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.54 -3.79 19.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 101' ' ' MET . 30.8 mt -102.78 -22.23 13.94 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.91 -25.24 9.52 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.959 -1.088 . . . . 0.0 113.671 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.56 0.85 8.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.408 1.483 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.99 71.63 0.3 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.401 1.953 . . . . 0.0 114.535 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.27 2.2 m120 85.49 57.49 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 130.203 3.401 . . . . 0.0 112.376 -175.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.91 125.0 14.47 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.763 2.976 . . . . 0.0 112.886 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.58 173.75 6.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.24 1.416 . . . . 0.0 112.82 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.06 142.84 51.43 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.119 1.767 . . . . 0.0 110.212 -174.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.09 118.07 1.66 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 121.658 0.588 . . . . 0.0 112.569 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -97.67 26.17 5.26 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.459 2.303 . . . . 0.0 114.528 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 77.12 94.86 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.235 2.614 . . . . 0.0 111.919 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 138.74 2.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.112 1.339 . . . . 0.0 112.862 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.469 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 22.4 m95 -64.59 130.81 45.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.487 1.515 . . . . 0.0 112.037 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -145.25 119.27 9.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.416 1.486 . . . . 0.0 112.114 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.91 143.02 27.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.546 1.138 . . . . 0.0 111.788 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.32 155.93 29.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.108 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 96.91 2.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.892 0.877 . . . . 0.0 108.923 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 118' ' ' LYS . 2.7 tp -49.82 -49.97 46.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.458 1.103 . . . . 0.0 112.048 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.6 80.12 1.25 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.883 1.706 . . . . 0.0 114.733 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -168.92 -36.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.819 2.047 . . . . 0.0 111.688 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.07 -80.51 0.06 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.372 1.463 . . . . 0.0 113.058 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.07 -179.2 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.786 1.235 . . . . 0.0 112.837 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -117.29 145.35 44.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 0.0 112.169 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.419 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.34 172.32 13.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.069 0.938 . . . . 0.0 112.211 -179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 18.4 ttpt -133.18 139.13 46.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.499 1.12 . . . . 0.0 110.263 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -122.55 164.46 15.56 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.233 1.397 . . . . 0.0 113.516 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.469 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 5.2 tp -139.23 95.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.18 99.04 10.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.861 -1.775 . . . . 0.0 112.351 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.71 132.68 56.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.436 1.094 . . . . 0.0 112.725 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 69.4 p -152.86 91.82 1.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.395 1.478 . . . . 0.0 112.711 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.9 52.5 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.511 -1.368 . . . . 0.0 111.57 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.8 125.94 1.44 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.252 17.5 pt-20 46.02 36.74 3.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.595 1.558 . . . . 0.0 114.195 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.21 162.46 18.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.085 2.154 . . . . 0.0 112.507 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.97 -172.68 4.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.541 1.536 . . . . 0.0 112.991 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -119.24 153.54 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.798 2.039 . . . . 0.0 111.883 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.438 HE22 HD13 ' A' ' 12' ' ' LEU . 31.4 tt0 -136.72 154.72 50.51 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.785 1.634 . . . . 0.0 110.468 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.68 120.19 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 109.731 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -112.08 111.06 21.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.581 1.552 . . . . 0.0 109.707 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.712 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 22.9 pt -97.23 144.3 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.882 1.273 . . . . 0.0 111.761 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.7 p -158.07 151.73 23.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.34 1.056 . . . . 0.0 112.535 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.679 1.591 . . . . 0.0 112.325 -176.138 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.21 -34.45 76.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.529 1.059 . . . . 0.0 112.75 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 159.0 12.26 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.935 0.894 . . . . 0.0 110.429 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.2 -9.13 56.07 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.261 0.934 . . . . 0.0 112.881 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -163.34 143.3 8.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.068 2.147 . . . . 0.0 110.375 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 70' ' ' LEU . 63.3 mt -143.75 160.78 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 125.377 1.471 . . . . 0.0 109.679 175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.02 -173.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 127.603 2.361 . . . . 0.0 112.008 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.28 -19.82 9.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -17.03 48.6 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.384 1.469 . . . . 0.0 112.435 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.69 67.87 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.617 1.167 . . . . 0.0 112.765 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -106.19 -2.8 22.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.261 1.824 . . . . 0.0 114.15 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.6 tp -67.11 138.65 57.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.954 1.302 . . . . 0.0 109.204 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.6 141.28 20.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.97 0.508 . . . . 0.0 110.984 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.59 -33.68 70.25 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.67 -47.45 76.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.143 1.377 . . . . 0.0 113.978 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.32 -54.28 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.653 1.181 . . . . 0.0 108.729 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.616 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.1 -33.77 27.63 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.04 1.736 . . . . 0.0 113.094 -175.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.44 -59.35 5.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.493 1.917 . . . . 0.0 110.88 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -35.76 81.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.921 1.689 . . . . 0.0 111.992 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.36 -45.8 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.129 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 32' ' ' ALA . 65.9 mt -64.42 -32.3 73.87 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 -19.78 60.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.581 1.152 . . . . 0.0 113.823 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -58.61 -32.51 69.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.859 -1.151 . . . . 0.0 111.645 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 56' ' ' ASP . 31.0 tp -58.44 -44.15 89.05 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.301 1.441 . . . . 0.0 113.037 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.67 150.45 10.01 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.414 1.007 . . . . 0.0 112.042 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -81.16 87.24 6.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.094 0.958 . . . . 0.0 111.07 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.54 158.26 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.932 1.693 . . . . 0.0 111.806 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.43 22.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.013 1.725 . . . . 0.0 114.249 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -141.7 120.26 12.48 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.524 1.529 . . . . 0.0 113.213 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -137.42 106.36 5.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.369 1.467 . . . . 0.0 109.703 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.0 149.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.483 1.113 . . . . 0.0 111.468 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -125.79 110.12 13.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.144 1.378 . . . . 0.0 111.924 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.643 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.0 OUTLIER -120.83 118.55 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.001 1.32 . . . . 0.0 109.78 175.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 168.98 40.82 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.222 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.508 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.1 mp -135.31 130.72 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.0 109.576 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.4 105.02 8.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.283 1.033 . . . . 0.0 111.761 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -73.22 85.56 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.671 2.388 . . . . 0.0 111.955 175.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -137.53 46.08 2.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.823 -1.173 . . . . 0.0 111.38 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -2.45 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 175.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.71 24.28 62.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.365 0.983 . . . . 0.0 114.8 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.75 114.64 1.06 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.582 1.563 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -53.42 127.59 25.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.945 1.298 . . . . 0.0 111.289 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.548 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 53.7 m0 -91.38 157.37 17.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -137.9 109.56 7.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.951 1.701 . . . . 0.0 111.094 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -70.99 143.22 50.88 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.314 -0.866 . . . . 0.0 110.234 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -113.02 -47.35 3.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.343 1.457 . . . . 0.0 113.066 -178.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' H ' HD22 ' A' ' 46' ' ' LEU . 54.0 t30 -156.63 171.49 20.25 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.633 1.573 . . . . 0.0 111.199 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.59 121.82 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 111.869 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.43 ' H ' ' HB1' ' A' ' 126' ' ' ALA . 3.4 t80 -100.9 129.25 46.73 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 110.017 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 24.0 p90 -153.36 160.43 42.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.911 1.285 . . . . 0.0 112.018 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -116.43 -8.1 11.62 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.497 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 p -53.62 157.77 2.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.582 1.953 . . . . 0.0 112.79 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -35.16 -66.44 0.35 Allowed Glycine 0 N--CA 1.469 0.893 0 C-N-CA 127.96 2.695 . . . . 0.0 115.945 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.412 HG22 ' NE ' ' A' ' 74' ' ' ARG . 1.2 t -165.44 178.46 6.78 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.778 1.631 . . . . 0.0 111.492 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.9 171.39 8.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 111.648 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 24' ' ' LEU . 2.6 t0 -154.67 -28.21 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.832 -1.168 . . . . 0.0 113.294 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 24' ' ' LEU . 31.2 m -132.9 158.24 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.261 1.824 . . . . 0.0 110.832 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 tt -73.24 132.82 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.462 1.105 . . . . 0.0 111.654 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.01 122.26 82.95 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.377 1.071 . . . . 0.0 110.19 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.6 Cg_endo -64.77 114.87 2.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.359 3.373 . . . . 0.0 112.689 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.17 -55.16 17.71 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.58 153.64 30.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.456 1.102 . . . . 0.0 110.68 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.38 121.22 16.32 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.694 0.798 . . . . 0.0 111.592 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.94 162.06 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.716 2.277 . . . . 0.0 112.05 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -62.1 156.88 20.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.449 0.7 . . . . 0.0 112.172 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.2 p 41.78 49.44 3.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.37 1.868 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -141.24 -171.42 3.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.997 1.719 . . . . 0.0 111.361 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.14 -177.02 5.69 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.832 -1.167 . . . . 0.0 110.298 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -158.09 142.52 16.09 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.133 -0.979 . . . . 0.0 112.214 175.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -108.53 170.44 8.02 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.889 0.875 . . . . 0.0 110.735 176.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.643 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.5 t80 -152.15 165.71 33.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.473 1.509 . . . . 0.0 107.882 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.1 m -145.07 169.14 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.677 1.191 . . . . 0.0 109.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -157.54 7.19 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.314 0.483 . . . . 0.0 112.072 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.412 ' NE ' HG22 ' A' ' 54' ' ' THR . 10.4 ttp180 -144.05 160.92 40.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.59 1.556 . . . . 0.0 110.627 175.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -112.53 -49.89 2.93 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.031 -1.043 . . . . 0.0 110.688 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 50.23 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.018 2.127 . . . . 0.0 113.832 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t -139.22 13.16 2.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.091 1.756 . . . . 0.0 113.108 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.71 -112.08 0.14 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.504 1.526 . . . . 0.0 112.669 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.12 -24.57 10.99 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 CA-C-N 120.057 1.928 . . . . 0.0 112.509 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 81' ' ' ALA . 4.0 t -150.71 176.99 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 127.475 2.31 . . . . 0.0 109.78 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.486 ' H ' HG12 ' A' ' 80' ' ' VAL . . . -84.53 -35.58 22.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.91 1.684 . . . . 0.0 112.873 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -142.86 138.51 30.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.48 1.912 . . . . 0.0 112.825 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 128.28 -142.37 13.46 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 127.913 2.673 . . . . 0.0 111.579 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . 177.16 145.22 0.1 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.025 2.53 . . . . 0.0 112.395 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 t -147.58 121.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.48 -1.387 . . . . 0.0 113.485 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -148.08 164.72 32.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.46 1.104 . . . . 0.0 111.212 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.18 110.2 4.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.647 1.179 . . . . 0.0 108.369 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.05 152.92 48.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.255 1.022 . . . . 0.0 112.069 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -115.78 148.96 39.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.435 -175.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 43.6 m-85 -122.83 124.24 42.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.961 1.304 . . . . 0.0 110.105 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.56 109.26 2.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 110.178 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.11 153.21 38.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.013 1.325 . . . . 0.0 111.17 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -63.87 -22.03 66.73 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.21 1.8 20.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.299 1.04 . . . . 0.0 113.781 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.76 19.52 70.45 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.663 1.125 . . . . 0.0 113.864 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -102.59 171.21 7.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 109.221 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.556 HG22 ' HB1' ' A' ' 89' ' ' ALA . 97.1 m -133.55 103.51 5.95 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.539 -1.351 . . . . 0.0 112.109 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.508 ' CD2' HG21 ' A' ' 35' ' ' ILE . 14.2 tp -69.75 126.65 30.36 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.297 -0.877 . . . . 0.0 110.345 174.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.23 107.47 3.06 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.18 165.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 117.632 0.716 . . . . 0.0 110.333 175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -151.41 140.75 21.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.232 177.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 27.6 p90 -153.34 160.04 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.662 0.744 . . . . 0.0 110.313 175.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -162.14 167.43 24.2 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.732 1.613 . . . . 0.0 109.19 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.42 106.64 57.08 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.25 -9.91 25.0 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.011 2.474 . . . . 0.0 113.234 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.66 12.5 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.575 2.75 . . . . 0.0 116.143 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -137.71 4.45 2.58 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.224 2.21 . . . . 0.0 114.183 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -130.67 61.25 1.62 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.016 1.727 . . . . 0.0 111.679 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -56.91 -19.21 16.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.243 1.017 . . . . 0.0 113.542 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -35.12 60.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.033 1.733 . . . . 0.0 112.842 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -136.57 175.27 9.76 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.309 1.444 . . . . 0.0 111.847 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.2 t -81.96 -173.95 4.78 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.91 0.862 . . . . 0.0 110.969 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.44 114.22 21.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.37 1.468 . . . . 0.0 111.38 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -73.1 148.5 43.91 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.451 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.9 p-90 -148.04 169.43 19.96 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.519 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.9 t70 179.62 163.57 0.99 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 128.048 2.539 . . . . 0.0 110.379 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.548 HG11 ' SD ' ' A' ' 157' ' ' MET . 3.6 p -165.6 136.65 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.079 2.152 . . . . 0.0 109.252 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -152.42 156.6 39.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.87 1.268 . . . . 0.0 110.483 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.79 106.16 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.658 1.583 . . . . 0.0 107.767 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -74.69 98.74 3.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.273 1.029 . . . . 0.0 109.338 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.4 t -59.07 137.49 57.93 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.738 -1.226 . . . . 0.0 110.828 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.2 -117.42 5.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.496 1.522 . . . . 0.0 110.124 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 128.16 12.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.503 1.121 . . . . 0.0 111.253 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.37 114.72 10.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.068 1.347 . . . . 0.0 111.221 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.05 164.71 23.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 110.283 174.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.43 ' HB1' ' H ' ' A' ' 49' ' ' TYR . . . -80.95 109.0 15.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.903 -0.498 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.38 -173.28 4.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.202 1.401 . . . . 0.0 110.019 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.63 -43.29 56.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.002 0.921 . . . . 0.0 111.202 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -33.32 38.93 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.556 1.074 . . . . 0.0 114.329 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.1 ttt -70.51 -60.15 2.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.829 0.815 . . . . 0.0 110.452 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.42 ' HA ' HD12 ' A' ' 134' ' ' LEU . 74.0 t80 -56.94 -31.18 64.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.16 0.984 . . . . 0.0 113.632 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.33 -39.15 93.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 110.148 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -26.58 67.48 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.547 -1.346 . . . . 0.0 111.872 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 131' ' ' TYR . 3.6 mt -78.39 -43.41 27.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.236 1.414 . . . . 0.0 112.028 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.08 -28.32 16.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.62 -40.42 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.802 1.641 . . . . 0.0 111.707 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.63 -58.25 8.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.749 1.642 . . . . 0.0 111.572 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -178.75 88.29 0.22 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 127.225 2.21 . . . . 0.0 111.637 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.73 141.02 40.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.303 2.002 . . . . 0.0 111.234 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -112.83 173.75 6.23 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.37 1.468 . . . . 0.0 111.575 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.98 134.08 46.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.52 1.528 . . . . 0.0 110.718 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.22 106.85 0.7 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.436 1.017 . . . . 0.0 112.362 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -121.5 71.97 0.99 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.133 1.373 . . . . 0.0 111.117 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 59.61 101.09 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.692 2.797 . . . . 0.0 115.868 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.2 161.88 9.65 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.454 1.026 . . . . 0.0 114.593 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.523 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 m95 -78.55 150.65 32.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.725 1.21 . . . . 0.0 110.629 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -152.04 133.13 14.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.862 1.665 . . . . 0.0 110.718 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.8 146.13 49.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.31 1.444 . . . . 0.0 112.387 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -150.46 157.55 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.88 0.848 . . . . 0.0 112.123 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -80.53 92.98 5.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.486 1.514 . . . . 0.0 108.088 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 tp -52.51 -39.83 61.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.23 30.26 2.75 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.28 -22.61 1.97 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.448 1.624 . . . . 0.0 115.175 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.74 -21.56 1.82 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.265 1.412 . . . . 0.0 114.035 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 pp -124.1 173.52 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.731 1.612 . . . . 0.0 112.538 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -116.3 158.66 23.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.02 1.328 . . . . 0.0 111.336 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.548 ' SD ' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -131.31 155.03 47.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.584 0.354 . . . . 0.0 110.926 175.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.5 tppt? -126.16 127.47 45.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.545 1.938 . . . . 0.0 109.727 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.72 137.63 14.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 126.105 1.812 . . . . 0.0 112.812 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -117.13 146.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.496 1.118 . . . . 0.0 111.063 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.25 145.78 51.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.959 0.904 . . . . 0.0 109.352 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.42 HG23 ' CD1' ' A' ' 160' ' ' ILE . 42.0 p -144.03 126.62 15.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.171 1.388 . . . . 0.0 110.949 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m -89.07 178.52 6.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.002 2.121 . . . . 0.0 112.059 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.39 -178.7 0.18 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.95 2.5 . . . . 0.0 112.534 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 161.87 51.43 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.259 -0.901 . . . . 0.0 111.72 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 55.64 29.49 13.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.519 1.127 . . . . 0.0 112.792 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -126.53 144.56 50.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.115 1.766 . . . . 0.0 112.819 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.511 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 24.6 tptp -162.64 149.46 13.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.54 137.78 37.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.2 2.2 . . . . 0.0 112.682 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -135.6 157.33 47.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.876 1.67 . . . . 0.0 110.59 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 117' ' ' VAL . 13.3 mm -129.32 124.52 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.36 1.064 . . . . 0.0 110.769 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 131.99 54.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.425 1.49 . . . . 0.0 111.65 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.548 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 11.3 pt -118.23 134.26 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.813 1.645 . . . . 0.0 110.455 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.6 p -163.47 177.17 9.08 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.515 1.526 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.782 1.233 . . . . 0.0 111.919 -176.21 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.734 0.302 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.83 -45.71 49.61 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.902 -1.124 . . . . 0.0 111.825 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.83 173.25 4.55 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.522 0.677 . . . . 0.0 110.388 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.63 -36.32 3.83 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.1 p -137.02 161.13 36.9 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.624 -1.515 . . . . 0.0 111.48 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 70' ' ' LEU . 36.1 mm -137.8 163.41 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.904 1.281 . . . . 0.0 110.416 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 pt -67.62 -170.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.893 2.077 . . . . 0.0 110.458 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.43 -28.15 4.9 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 119.722 -1.861 . . . . 0.0 115.932 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.2 69.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.465 1.031 . . . . 0.0 113.803 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.19 -42.06 39.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.524 1.13 . . . . 0.0 111.29 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -8.3 59.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.227 1.411 . . . . 0.0 114.106 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 17' ' ' LEU . 12.7 tp -59.83 143.79 50.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 0.0 110.305 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.25 150.74 31.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.527 1.131 . . . . 0.0 109.906 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -55.19 -26.68 40.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -62.05 -58.16 8.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.617 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.18 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.077 0.551 . . . . 0.0 109.73 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.37 -23.66 66.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.407 1.083 . . . . 0.0 113.456 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.24 -51.51 13.14 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.363 -1.461 . . . . 0.0 110.374 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -40.52 96.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 112.908 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -64.07 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.164 0.986 . . . . 0.0 112.857 -174.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 32' ' ' ALA . 69.4 mt -76.9 -31.86 57.02 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 110.891 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.43 -37.26 74.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.933 0.893 . . . . 0.0 111.921 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -19.89 47.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.028 1.331 . . . . 0.0 114.517 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.6 -34.67 72.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.206 2.202 . . . . 0.0 113.336 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.76 -153.84 7.57 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.951 2.215 . . . . 0.0 112.789 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -132.1 14.19 4.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.53 1.932 . . . . 0.0 113.186 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.76 129.95 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.615 1.966 . . . . 0.0 111.713 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -65.22 -4.42 5.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.98 1.312 . . . . 0.0 114.391 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.665 ' HB3' HG21 ' A' ' 82' ' ' THR . 3.3 mp0 -115.28 121.48 43.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.302 2.241 . . . . 0.0 108.119 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 -175.09 4.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.811 1.245 . . . . 0.0 111.497 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.5 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -133.19 142.02 43.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 125.196 1.398 . . . . 0.0 111.946 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -127.94 115.32 18.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.965 1.706 . . . . 0.0 109.684 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.2 p -131.75 128.76 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.873 1.269 . . . . 0.0 109.088 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.12 -179.53 40.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.523 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 3.4 mp -130.41 146.02 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.795 0.838 . . . . 0.0 111.543 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -96.7 109.41 22.06 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.296 -0.877 . . . . 0.0 111.63 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 91.61 6.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.078 0.951 . . . . 0.0 111.244 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.1 56.74 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.25 1.42 . . . . 0.0 109.697 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t -119.77 -45.63 2.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.194 1.397 . . . . 0.0 113.346 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 13.91 2.18 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.657 1.122 . . . . 0.0 115.878 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.33 146.57 17.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.093 1.33 . . . . 0.0 112.552 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 m -73.92 145.03 45.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.718 1.607 . . . . 0.0 110.589 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.453 ' CE2' HD11 ' A' ' 173' ' ' ILE . 22.0 m0 -112.52 166.49 11.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.666 -0.647 . . . . 0.0 112.573 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.9 m -143.62 109.43 5.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.19 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -69.24 151.31 46.44 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.818 -1.176 . . . . 0.0 111.232 175.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.54 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -106.91 -55.1 2.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.7 1.6 . . . . 0.0 111.6 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -160.9 -172.95 3.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.904 1.682 . . . . 0.0 110.829 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.02 137.76 29.5 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.103 1.361 . . . . 0.0 111.325 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -121.01 127.74 52.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.515 1.526 . . . . 0.0 110.151 178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.568 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -133.35 162.79 30.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 112.584 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -124.0 -43.98 2.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.673 1.589 . . . . 0.0 112.27 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.8 p -129.61 113.28 14.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.891 1.276 . . . . 0.0 112.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 114.9 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.332 1.444 . . . . 0.0 111.485 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.09 178.72 3.65 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.875 0.845 . . . . 0.0 112.001 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.02 162.78 1.75 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.576 1.95 . . . . 0.0 112.294 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.38 -32.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.104 -0.998 . . . . 0.0 112.22 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.08 169.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.986 2.114 . . . . 0.0 111.905 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -70.27 127.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.872 1.269 . . . . 0.0 112.801 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.74 129.78 60.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.62 146.53 79.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.501 2.8 . . . . 0.0 111.244 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.89 -53.08 3.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 112.417 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -122.08 143.94 49.22 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 110.44 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.684 HG21 HD22 ' A' ' 69' ' ' LEU . 49.9 t -136.27 130.14 18.11 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.644 1.177 . . . . 0.0 110.563 -174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.02 163.15 25.85 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.88 3.054 . . . . 0.0 112.562 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -70.07 14.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -140.24 15.68 2.42 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.09 1.756 . . . . 0.0 114.268 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.88 155.1 47.37 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.524 1.13 . . . . 0.0 112.522 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.23 -177.01 3.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.609 1.195 . . . . 0.0 112.159 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -152.77 154.22 34.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 175.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CD1' HD21 ' A' ' 17' ' ' LEU . 12.7 mt -138.11 167.22 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.283 1.433 . . . . 0.0 109.495 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.2 t80 -141.71 165.83 26.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.532 1.533 . . . . 0.0 109.966 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -145.99 169.1 19.32 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.35 1.06 . . . . 0.0 110.887 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.32 177.44 27.51 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.472 1.034 . . . . 0.0 111.109 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.38 176.79 8.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.574 1.15 . . . . 0.0 112.904 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -92.52 90.41 7.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.064 1.346 . . . . 0.0 110.873 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.17 -17.13 61.4 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -155.09 18.61 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.879 2.071 . . . . 0.0 112.79 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.68 39.31 93.7 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 120.33 -1.481 . . . . 0.0 113.85 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.73 -32.02 7.92 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 124.154 3.236 . . . . 0.0 115.931 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.63 160.3 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.669 1.987 . . . . 0.0 108.929 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.56 74.81 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.252 -0.905 . . . . 0.0 112.479 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.665 HG21 ' HB3' ' A' ' 29' ' ' GLN . 6.0 t -167.54 172.99 8.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.448 1.499 . . . . 0.0 111.845 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.05 -123.29 26.64 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.18 0.895 . . . . 0.0 111.968 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.12 179.13 7.11 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.311 1.844 . . . . 0.0 111.691 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.06 113.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.773 2.029 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -148.31 176.6 10.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 111.542 175.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.48 118.66 5.13 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -126.04 160.71 29.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.053 0.941 . . . . 0.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -118.87 169.32 9.97 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.582 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -140.51 121.32 14.44 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.559 1.144 . . . . 0.0 110.943 -177.289 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.17 111.08 2.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.224 1.01 . . . . 0.0 109.223 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -72.2 153.87 41.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 111.034 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -58.01 -28.37 64.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -80.67 3.75 21.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.789 1.236 . . . . 0.0 114.306 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.28 -0.92 87.47 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.344 1.45 . . . . 0.0 114.516 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -78.58 178.65 7.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.61 1.564 . . . . 0.0 110.878 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.477 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 68.0 m -140.57 110.76 6.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.832 -1.168 . . . . 0.0 112.651 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 173' ' ' ILE . 27.1 tp -75.63 122.59 24.18 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.09 4.35 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 118.856 0.753 . . . . 0.0 112.471 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.41 160.99 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.294 1.047 . . . . 0.0 112.071 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.691 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -145.35 167.11 23.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.427 -0.796 . . . . 0.0 112.638 174.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 33' ' ' VAL . 45.1 p90 -169.48 158.6 8.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.026 1.331 . . . . 0.0 112.098 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 132.51 3.73 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.126 1.77 . . . . 0.0 108.381 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.93 138.15 26.31 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 119.096 0.862 . . . . 0.0 109.087 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 178.34 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.765 2.31 . . . . 0.0 111.741 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.04 171.15 14.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.906 1.282 . . . . 0.0 111.122 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.25 102.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.93 1.292 . . . . 0.0 111.661 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -152.43 162.78 40.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.281 1.032 . . . . 0.0 112.875 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.67 -51.56 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.404 1.482 . . . . 0.0 111.694 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -80.4 131.45 35.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.637 1.175 . . . . 0.0 111.631 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -95.56 114.51 26.27 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.153 1.381 . . . . 0.0 110.51 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.5 p -149.05 143.02 25.8 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.522 1.129 . . . . 0.0 110.787 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.16 114.62 7.16 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.437 1.095 . . . . 0.0 110.845 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -82.52 150.12 27.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.49 1.116 . . . . 0.0 112.161 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -161.44 149.01 14.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.799 1.64 . . . . 0.0 108.715 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -167.97 117.5 0.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.132 0.973 . . . . 0.0 110.871 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.44 HG11 HG21 ' A' ' 171' ' ' ILE . 46.3 t -118.12 135.2 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 123.007 0.523 . . . . 0.0 110.706 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -148.73 142.8 25.93 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.067 175.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.3 115.82 30.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -86.04 109.66 18.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.0 t -66.82 93.35 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.527 -1.358 . . . . 0.0 111.52 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.05 148.22 6.39 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 128.048 2.737 . . . . 0.0 111.796 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -48.13 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.68 2.392 . . . . 0.0 114.305 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -111.92 103.06 11.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.187 1.395 . . . . 0.0 112.978 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 162.49 14.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.419 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -79.08 114.44 18.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.39 -174.15 4.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.475 1.11 . . . . 0.0 111.676 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -51.12 -49.01 61.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.031 -1.043 . . . . 0.0 111.781 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -36.18 45.06 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.197 0.904 . . . . 0.0 113.673 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.4 ttt -67.49 -62.43 1.42 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.792 0.837 . . . . 0.0 110.045 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -55.03 -34.13 63.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -64.32 -39.27 93.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.464 1.506 . . . . 0.0 110.623 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -25.14 68.16 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.873 -1.142 . . . . 0.0 111.772 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 101' ' ' MET . 1.6 mt -84.43 -44.15 13.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.661 1.184 . . . . 0.0 112.551 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.97 -29.1 25.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.905 1.282 . . . . 0.0 114.359 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.99 -34.04 3.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.479 1.512 . . . . 0.0 113.714 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.31 61.22 3.13 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.504 2.002 . . . . 0.0 114.516 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.86 67.25 1.13 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 127.401 2.281 . . . . 0.0 110.817 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.82 149.01 92.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.236 2.624 . . . . 0.0 112.268 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -114.9 178.68 4.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.412 1.085 . . . . 0.0 111.843 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -128.08 135.61 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.002 1.321 . . . . 0.0 111.768 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.06 97.42 2.0 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.437 1.018 . . . . 0.0 113.055 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -65.48 -79.97 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.226 1.01 . . . . 0.0 111.665 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HA ' HG22 ' A' ' 162' ' ' THR . 8.7 p30 177.75 -16.82 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.913 2.085 . . . . 0.0 115.606 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.23 163.12 20.97 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 119.939 1.245 . . . . 0.0 113.452 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.458 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 79.9 m95 -72.34 147.5 46.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.27 0.628 . . . . 0.0 110.682 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -151.75 123.31 7.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.283 1.433 . . . . 0.0 111.626 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.36 143.7 41.74 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.469 1.508 . . . . 0.0 113.599 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.71 149.76 26.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.353 1.461 . . . . 0.0 112.655 174.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.7 97.88 9.39 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.483 1.513 . . . . 0.0 108.379 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -52.96 -52.46 58.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.924 1.689 . . . . 0.0 111.425 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.04 57.14 0.01 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.392 0.996 . . . . 0.0 115.499 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.22 -27.07 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 131.69 -9.78 5.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.903 1.239 . . . . 0.0 114.671 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.01 170.08 13.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.811 1.305 . . . . 0.0 112.547 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 ttp-105 -133.58 130.24 38.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.452 1.901 . . . . 0.0 110.265 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.472 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -111.59 139.82 46.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.663 0.385 . . . . 0.0 110.852 175.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.4 128.3 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.578 1.551 . . . . 0.0 109.128 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.7 153.88 16.76 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 123.83 0.729 . . . . 0.0 112.824 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.458 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -137.15 141.14 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.548 1.939 . . . . 0.0 108.199 175.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 115.4 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.045 1.738 . . . . 0.0 107.754 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 144' ' ' ASN . 11.4 p -109.0 170.44 8.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.7 p -70.76 167.71 18.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.428 1.091 . . . . 0.0 112.335 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.81 147.62 27.69 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.213 -0.93 . . . . 0.0 112.876 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.01 80.98 0.44 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.967 1.27 . . . . 0.0 113.698 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 50.22 39.02 18.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.848 1.659 . . . . 0.0 113.707 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -138.35 170.05 16.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.247 1.419 . . . . 0.0 111.436 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.429 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 5.2 tptt -156.01 -172.45 4.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.67 0.748 . . . . 0.0 111.609 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -118.25 157.43 27.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.187 2.195 . . . . 0.0 109.846 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -164.41 150.35 10.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.01 1.324 . . . . 0.0 110.034 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 24.8 mm -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.59 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -126.99 136.76 52.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.228 1.377 . . . . 0.0 112.375 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' MET . 32.0 pt -96.52 133.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -142.33 164.59 29.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.638 0.775 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.353 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.308 0.099 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.09 -30.96 7.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.039 1.336 . . . . 0.0 112.718 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.07 -179.67 1.29 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.89 0.876 . . . . 0.0 110.641 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.8 -38.65 3.07 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.572 -1.33 . . . . 0.0 111.702 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.7 p -137.06 160.01 40.22 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.674 -1.486 . . . . 0.0 111.793 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.478 HD11 HD12 ' A' ' 70' ' ' LEU . 36.9 mm -136.44 163.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.164 1.385 . . . . 0.0 110.082 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -70.65 -169.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.979 2.112 . . . . 0.0 110.423 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.63 -23.26 4.09 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.94 73.81 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.836 0.732 . . . . 0.0 113.784 -174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.06 40.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.695 1.198 . . . . 0.0 111.547 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -6.24 57.57 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.196 1.398 . . . . 0.0 113.714 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HD23 ' A' ' 17' ' ' LEU . 21.8 tp -57.94 142.75 45.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.104 1.761 . . . . 0.0 111.02 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -146.13 145.79 30.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.639 1.176 . . . . 0.0 109.713 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -55.74 -29.47 59.59 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -60.01 -55.71 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.682 1.193 . . . . 0.0 112.269 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.76 -44.35 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 122.006 -0.433 . . . . 0.0 109.845 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -59.31 -32.08 69.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.229 1.012 . . . . 0.0 113.207 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.81 -55.16 14.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.159 0.983 . . . . 0.0 110.373 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -35.02 74.6 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.718 -0.614 . . . . 0.0 112.034 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -45.26 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.115 0.871 . . . . 0.0 112.645 -176.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.473 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.54 -24.9 53.63 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.611 0.641 . . . . 0.0 110.764 174.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.41 -26.76 62.89 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.96 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -48.54 -25.27 1.63 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 120.925 1.693 . . . . 0.0 114.483 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' HH22 ' A' ' 74' ' ' ARG . 48.0 mt -79.22 -9.32 59.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.674 1.989 . . . . 0.0 115.799 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.74 -154.17 8.5 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.297 1.904 . . . . 0.0 112.81 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -141.56 7.76 1.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.23 131.8 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.537 1.535 . . . . 0.0 113.883 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -66.56 1.69 1.62 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.94 103.37 7.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.416 1.886 . . . . 0.0 110.205 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -143.11 -173.99 4.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.279 1.832 . . . . 0.0 111.889 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -136.89 123.27 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.266 1.427 . . . . 0.0 112.019 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -107.81 91.09 3.51 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.211 2.204 . . . . 0.0 110.943 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' CD2' ' A' ' 102' ' ' PHE . 2.8 p -89.72 126.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.579 -1.326 . . . . 0.0 110.675 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.69 167.2 37.72 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-O 121.776 0.654 . . . . 0.0 114.701 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -144.29 121.68 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -76.95 105.11 7.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.037 -1.039 . . . . 0.0 111.324 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.53 93.07 4.74 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.161 -0.962 . . . . 0.0 112.013 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -142.92 39.29 1.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.323 1.058 . . . . 0.0 111.82 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.74 -0.26 54.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.047 1.739 . . . . 0.0 114.815 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.6 14.24 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.268 0.937 . . . . 0.0 114.578 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.02 135.84 7.77 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.673 1.606 . . . . 0.0 112.463 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -67.18 134.07 51.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.48 1.112 . . . . 0.0 109.262 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -95.34 163.86 13.07 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -146.27 113.93 6.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.447 1.499 . . . . 0.0 111.035 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -74.36 135.77 42.48 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 -50.32 3.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.379 1.071 . . . . 0.0 111.83 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -156.35 171.93 19.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.207 1.003 . . . . 0.0 111.964 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.58 132.49 31.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.984 1.714 . . . . 0.0 111.469 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -116.62 122.64 45.19 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.553 1.541 . . . . 0.0 110.183 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -123.62 152.55 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.809 2.444 . . . . 0.0 110.44 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.91 -53.25 2.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.164 0.986 . . . . 0.0 110.25 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' H ' ' A' ' 85' ' ' VAL . 2.3 t -71.21 127.0 31.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.406 1.882 . . . . 0.0 109.581 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.31 -133.26 8.51 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.175 0.893 . . . . 0.0 112.736 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.06 -156.47 0.61 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.14 1.776 . . . . 0.0 109.585 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.88 166.83 1.34 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.373 3.069 . . . . 0.0 111.928 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.63 -29.42 0.11 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 24' ' ' LEU . 12.7 m -136.17 173.01 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.244 2.218 . . . . 0.0 112.049 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.97 128.2 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.603 1.161 . . . . 0.0 111.677 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 tp -85.09 132.29 46.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.33 122.3 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.901 3.067 . . . . 0.0 110.8 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.86 -59.39 3.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.798 0.839 . . . . 0.0 112.555 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -125.52 145.5 50.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.52 1.528 . . . . 0.0 110.169 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 69' ' ' LEU . 50.6 t -138.47 131.36 16.17 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.577 1.151 . . . . 0.0 108.936 -175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.42 163.97 24.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.782 2.988 . . . . 0.0 112.531 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.28 18.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -141.98 17.06 2.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.597 1.559 . . . . 0.0 114.173 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.438 1.472 . . . . 0.0 112.679 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.58 -176.6 5.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 122.425 1.107 . . . . 0.0 112.521 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -153.21 152.68 31.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.049 0.939 . . . . 0.0 111.592 175.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.638 ' CD1' HD21 ' A' ' 17' ' ' LEU . 10.6 mt -134.66 162.42 32.37 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.884 1.274 . . . . 0.0 111.111 174.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.28 163.91 31.49 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.066 1.346 . . . . 0.0 109.632 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 m -144.92 165.28 28.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.279 1.431 . . . . 0.0 110.164 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.68 162.88 33.79 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.41 1.481 . . . . 0.0 109.553 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.448 HH22 ' HB2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -167.5 -160.7 0.37 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.984 1.714 . . . . 0.0 111.031 176.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -48.43 83.05 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 130.277 3.431 . . . . 0.0 113.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.63 -16.18 7.79 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -120.08 5.84 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.088 2.155 . . . . 0.0 111.006 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.7 26.82 Favored Glycine 0 CA--C 1.545 1.955 0 CA-C-O 117.401 -1.777 . . . . 0.0 115.966 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.76 -39.91 10.77 Favored 'Trans proline' 0 C--N 1.357 0.991 0 CA-C-N 121.838 2.819 . . . . 0.0 115.024 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.288 4.1 p 51.48 4.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 129.492 3.117 . . . . 0.0 116.986 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 1.22 2.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.979 2.112 . . . . 0.0 113.859 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -132.75 128.5 37.0 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.515 1.126 . . . . 0.0 110.932 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.473 ' H ' HG21 ' A' ' 104' ' ' VAL . . . -67.39 -74.48 0.56 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.547 1.07 . . . . 0.0 111.552 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -177.76 113.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.429 1.891 . . . . 0.0 110.397 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.557 ' H ' ' HB3' ' A' ' 52' ' ' SER . 3.6 t -127.45 110.24 22.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 109.757 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -139.99 176.9 8.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 109.972 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.02 137.59 15.13 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.943 1.697 . . . . 0.0 106.498 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -143.12 162.03 36.63 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.268 0.627 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.639 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -126.71 136.79 52.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.755 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.7 m-85 -113.68 121.86 45.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 110.939 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -70.27 123.47 21.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.912 1.285 . . . . 0.0 110.211 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptm -97.1 155.09 16.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.552 0.615 . . . . 0.0 111.394 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.4 m -56.14 -22.47 28.69 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -2.03 20.87 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.767 1.227 . . . . 0.0 113.384 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.14 84.46 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.655 1.597 . . . . 0.0 114.638 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -100.45 171.38 7.78 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.443 1.097 . . . . 0.0 110.46 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.639 HG22 ' HB1' ' A' ' 89' ' ' ALA . 81.1 m -135.03 99.89 4.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.744 1.218 . . . . 0.0 111.621 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 173' ' ' ILE . 6.4 tp -69.59 113.75 7.16 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.414 -0.804 . . . . 0.0 111.42 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.6 107.84 3.54 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.264 1.411 . . . . 0.0 109.717 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -84.2 146.11 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 117.493 0.646 . . . . 0.0 111.045 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' HD13 ' A' ' 134' ' ' LEU . 13.9 tmm? -125.23 142.47 51.48 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.925 1.29 . . . . 0.0 110.568 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 32.9 p90 -151.27 158.92 44.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.107 174.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -158.06 175.24 14.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG21 ' H ' ' A' ' 83' ' ' GLY . 27.9 m -113.47 100.05 50.92 Favored Pre-proline 0 N--CA 1.467 0.392 0 C-N-CA 126.51 1.924 . . . . 0.0 111.792 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.92 77.33 2.74 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.699 2.266 . . . . 0.0 110.063 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.91 -44.09 77.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.778 1.231 . . . . 0.0 111.838 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.47 105.95 0.29 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.975 1.31 . . . . 0.0 112.089 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -69.64 11.61 0.25 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.533 1.933 . . . . 0.0 114.671 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.9 -16.25 39.86 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.764 2.026 . . . . 0.0 114.428 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 19.8 t90 58.64 30.04 19.35 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.061 1.744 . . . . 0.0 114.345 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.46 172.87 12.66 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.839 -1.163 . . . . 0.0 113.707 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -50.81 111.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.165 2.186 . . . . 0.0 112.624 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.02 140.42 39.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -77.4 139.0 39.61 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.086 0.954 . . . . 0.0 112.98 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -161.83 149.27 14.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.489 1.916 . . . . 0.0 108.844 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -179.87 158.59 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.333 2.253 . . . . 0.0 111.263 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.67 147.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 127.766 2.427 . . . . 0.0 109.055 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -141.67 141.2 33.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.776 0.83 . . . . 0.0 109.635 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.6 mt -103.27 113.31 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.872 0.869 . . . . 0.0 108.693 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -82.42 111.0 18.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 t -65.42 87.51 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.015 -1.053 . . . . 0.0 111.476 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.93 164.58 11.92 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.938 2.685 . . . . 0.0 112.211 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -60.5 123.6 17.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.798 1.239 . . . . 0.0 111.778 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -133.6 104.28 6.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.589 1.555 . . . . 0.0 112.138 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.96 153.64 33.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.763 0.825 . . . . 0.0 110.634 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 117.58 21.33 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.721 0.408 . . . . 0.0 111.132 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.63 -176.8 6.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.082 1.753 . . . . 0.0 112.108 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.3 -47.23 25.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.33 1.452 . . . . 0.0 112.119 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.71 -46.99 80.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.102 0.858 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.4 ttp -60.22 -53.26 59.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.404 0.682 . . . . 0.0 110.684 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -53.35 -38.03 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.378 0.99 . . . . 0.0 113.078 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -43.54 95.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.699 1.2 . . . . 0.0 110.734 175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.59 -20.63 65.4 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.357 -1.464 . . . . 0.0 113.939 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 101' ' ' MET . 19.0 mt -92.52 -11.0 35.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.18 -35.09 3.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.011 1.324 . . . . 0.0 112.248 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -114.5 -25.55 8.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.186 1.395 . . . . 0.0 112.918 -175.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.5 -34.68 90.55 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.737 1.161 . . . . 0.0 113.752 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.09 83.44 5.6 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 126.018 1.727 . . . . 0.0 110.28 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.5 120.23 7.33 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.548 1.499 . . . . 0.0 112.325 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.76 165.02 22.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.811 1.244 . . . . 0.0 113.892 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -134.22 139.06 45.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.437 1.895 . . . . 0.0 111.531 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -127.02 110.43 1.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.907 1.241 . . . . 0.0 112.168 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -124.03 70.14 1.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.459 1.904 . . . . 0.0 113.364 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 50.76 60.3 3.97 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.05 2.14 . . . . 0.0 114.023 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -175.83 139.78 4.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.614 0.626 . . . . 0.0 113.92 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -63.43 135.46 56.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.031 1.332 . . . . 0.0 111.69 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -150.09 130.69 13.98 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.634 1.173 . . . . 0.0 111.672 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.66 158.5 25.39 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.118 1.767 . . . . 0.0 111.566 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.526 ' CE ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.52 161.57 39.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.0 1.32 . . . . 0.0 110.677 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.17 93.92 4.01 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.902 0.881 . . . . 0.0 108.799 174.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 149' ' ' LYS . 5.3 tp -47.43 -32.36 4.99 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.98 1.312 . . . . 0.0 113.984 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.54 32.26 2.36 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 117.396 1.718 . . . . 0.0 117.396 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.06 -28.69 1.16 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 148.77 -24.29 1.32 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.749 1.166 . . . . 0.0 114.504 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.46 175.5 5.43 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.634 1.973 . . . . 0.0 111.626 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -126.89 165.31 19.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.009 . . . . 0.0 112.222 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.714 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -145.94 156.91 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.428 177.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.86 129.22 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.713 1.605 . . . . 0.0 108.584 -177.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.11 144.56 18.48 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.407 0.527 . . . . 0.0 113.27 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -125.2 147.71 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.273 1.429 . . . . 0.0 109.762 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.547 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -140.46 117.38 11.08 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.6 1.16 . . . . 0.0 109.3 175.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 160' ' ' ILE . 7.9 p -122.18 147.75 45.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.641 1.176 . . . . 0.0 110.055 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -131.49 -178.31 4.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.586 1.954 . . . . 0.0 110.649 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 73.69 95.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.379 2.271 . . . . 0.0 113.302 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.42 -106.51 3.06 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.87 1.7 . . . . 0.0 114.355 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -115.78 17.72 15.99 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.631 2.373 . . . . 0.0 113.569 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.06 163.08 25.53 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.601 2.361 . . . . 0.0 115.021 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 31' ' ' ILE . 8.1 tptp -163.11 155.28 18.18 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.873 1.269 . . . . 0.0 114.34 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 136.39 33.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.118 2.567 . . . . 0.0 112.512 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -141.08 154.51 45.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.026 1.73 . . . . 0.0 110.221 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.01 120.55 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.529 1.132 . . . . 0.0 111.045 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -98.84 114.04 26.44 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.316 1.046 . . . . 0.0 109.482 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 157' ' ' MET . 7.5 pt -98.12 134.18 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.801 0.44 . . . . 0.0 109.828 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 92.8 p -156.37 167.35 30.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.408 1.483 . . . . 0.0 112.458 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 111.181 0.067 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mp -106.96 -83.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.203 1.401 . . . . 0.0 109.385 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.92 6.55 36.41 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.123 1.769 . . . . 0.0 113.128 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.99 -16.21 39.35 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.178 1.37 . . . . 0.0 115.502 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 p -146.04 162.97 36.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.158 1.479 . . . . 0.0 110.28 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 70' ' ' LEU . 26.5 mm -134.73 173.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 109.38 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 pt -85.4 -171.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 129.036 2.934 . . . . 0.0 110.461 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.96 -15.19 61.92 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.3 65.71 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 124.583 1.087 . . . . 0.0 113.62 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.18 81.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.144 1.378 . . . . 0.0 112.956 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -1.17 53.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 113.822 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.27 140.82 58.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.042 1.337 . . . . 0.0 110.491 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.84 145.75 26.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.116 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.61 -38.17 69.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.753 0.821 . . . . 0.0 113.134 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -56.62 -50.06 73.13 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.098 0.863 . . . . 0.0 112.783 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.81 -48.41 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.903 0.881 . . . . 0.0 110.587 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -56.24 -37.62 69.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 112.081 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -57.57 -55.82 29.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.447 1.899 . . . . 0.0 111.566 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -22.87 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.77 -52.3 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.514 1.506 . . . . 0.0 110.886 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.604 HD22 ' HB2' ' A' ' 32' ' ' ALA . 2.0 pp -61.72 -32.06 72.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.611 0.364 . . . . 0.0 111.721 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -85.68 -28.28 24.79 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -52.9 -21.18 3.99 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.761 2.024 . . . . 0.0 112.815 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 72' ' ' SER . 49.9 tp -48.41 -43.03 33.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.453 1.901 . . . . 0.0 111.802 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.08 142.44 6.88 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.76 1.171 . . . . 0.0 112.469 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -75.86 85.52 2.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.574 1.15 . . . . 0.0 111.898 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.18 173.91 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.154 2.182 . . . . 0.0 111.482 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.7 m -63.09 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.666 1.986 . . . . 0.0 112.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 56.98 -179.74 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.845 2.458 . . . . 0.0 112.921 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -177.68 5.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.791 1.636 . . . . 0.0 110.808 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -107.88 148.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.609 1.164 . . . . 0.0 110.73 175.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.604 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -134.04 100.04 4.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.925 1.69 . . . . 0.0 111.035 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 p -113.94 144.88 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.117 1.367 . . . . 0.0 107.396 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.36 167.27 36.5 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 118.418 0.554 . . . . 0.0 114.425 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.21 145.84 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.703 1.201 . . . . 0.0 110.872 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -107.68 104.25 13.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 111.472 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.41 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 3.5 p30 -89.12 116.95 27.76 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.377 1.471 . . . . 0.0 112.187 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -150.03 14.9 0.82 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.885 0.85 . . . . 0.0 112.182 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -78.55 -45.88 20.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.608 1.563 . . . . 0.0 114.356 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.63 16.82 1.43 Allowed Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.39 133.96 6.74 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.491 1.646 . . . . 0.0 113.006 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.7 m -69.93 122.11 18.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.236 1.414 . . . . 0.0 110.906 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.467 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 37.8 m0 -91.03 161.8 14.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.827 -0.546 . . . . 0.0 111.805 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 m -136.66 109.82 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.059 1.743 . . . . 0.0 111.088 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.9 114.14 4.9 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.914 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.728 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -75.95 -61.4 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.868 1.267 . . . . 0.0 111.385 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -159.9 169.88 22.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.985 1.314 . . . . 0.0 111.966 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.72 135.44 40.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.869 2.068 . . . . 0.0 111.047 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.451 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.3 t80 -120.71 130.61 54.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.453 1.501 . . . . 0.0 109.8 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -127.47 140.42 52.16 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.784 2.034 . . . . 0.0 109.838 -178.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -0.91 14.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.198 1.399 . . . . 0.0 113.842 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -80.23 -155.23 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.068 1.347 . . . . 0.0 109.781 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.78 -76.07 0.25 Allowed Glycine 0 N--CA 1.471 0.986 0 O-C-N 120.579 -1.326 . . . . 0.0 114.267 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -162.38 -178.14 6.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.349 1.46 . . . . 0.0 111.307 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 160.37 20.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.315 1.446 . . . . 0.0 113.69 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -141.81 -29.03 0.62 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.65 159.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.081 1.353 . . . . 0.0 111.787 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.9 tp -79.44 133.88 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.191 0.996 . . . . 0.0 109.583 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.0 tp -84.33 124.4 73.87 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.572 1.149 . . . . 0.0 109.642 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 69' ' ' LEU . 53.7 Cg_endo -64.74 120.09 7.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.706 3.604 . . . . 0.0 112.52 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.3 -55.19 23.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.41 150.62 36.11 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.728 1.211 . . . . 0.0 109.62 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.0 135.1 18.34 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.66 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -67.26 -164.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.702 2.935 . . . . 0.0 112.364 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -114.3 25.63 10.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.649 1.58 . . . . 0.0 113.712 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -149.44 8.36 0.7 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.279 1.431 . . . . 0.0 114.434 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -144.84 113.53 6.74 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.781 1.628 . . . . 0.0 114.459 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.01 174.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.748 1.219 . . . . 0.0 112.675 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -149.12 154.05 38.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.613 -0.679 . . . . 0.0 112.05 177.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.561 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -125.82 175.96 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.496 0.718 . . . . 0.0 112.42 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -147.64 161.51 41.0 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.526 1.53 . . . . 0.0 110.525 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD22 ' A' ' 24' ' ' LEU . 77.0 p -152.95 165.34 35.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.849 1.26 . . . . 0.0 112.451 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.38 172.75 24.14 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.027 0.822 . . . . 0.0 114.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -125.67 170.28 11.68 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.0 86.93 2.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.565 2.346 . . . . 0.0 108.528 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -115.74 -18.49 10.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.084 0.954 . . . . 0.0 113.231 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.2 t -155.64 11.8 0.32 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.844 1.658 . . . . 0.0 113.658 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.94 -113.05 2.69 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.93 -30.77 20.94 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.121 2.547 . . . . 0.0 115.123 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.0 t 23.47 67.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 129.314 3.046 . . . . 0.0 113.751 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -174.58 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.661 1.985 . . . . 0.0 112.224 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.1 p -122.54 -173.52 2.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.913 2.085 . . . . 0.0 109.88 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.04 -178.35 3.26 Favored Glycine 0 CA--C 1.545 1.918 0 CA-C-O 122.297 0.943 . . . . 0.0 114.765 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 169.43 10.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.711 1.205 . . . . 0.0 112.314 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -148.21 116.95 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.392 1.077 . . . . 0.0 111.705 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -151.24 173.01 14.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.374 1.47 . . . . 0.0 111.288 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.61 127.82 9.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.417 1.087 . . . . 0.0 109.476 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.92 173.85 11.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.474 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -136.18 149.71 48.71 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -128.69 117.2 20.77 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.361 1.864 . . . . 0.0 111.78 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -69.06 104.91 2.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.916 1.686 . . . . 0.0 109.816 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.8 mtp -66.5 148.75 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.216 1.007 . . . . 0.0 110.569 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -24.63 63.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.272 1.029 . . . . 0.0 113.501 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t -69.58 -13.7 62.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.342 1.857 . . . . 0.0 114.494 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.34 12.34 48.82 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.677 1.132 . . . . 0.0 114.967 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -103.17 175.43 5.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.373 2.269 . . . . 0.0 110.088 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.465 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 20.1 m -138.25 110.29 7.28 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.033 -1.042 . . . . 0.0 112.715 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.4 tp -74.67 113.45 11.95 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.551 1.14 . . . . 0.0 112.936 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.0 102.68 2.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.36 1.933 . . . . 0.0 110.401 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.4 160.27 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.535 1.134 . . . . 0.0 110.591 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -142.08 153.31 44.07 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.387 0.675 . . . . 0.0 111.556 174.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 16.4 p90 -161.23 156.11 23.7 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.783 1.233 . . . . 0.0 110.834 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 t -168.63 138.44 2.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.788 1.235 . . . . 0.0 109.221 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.42 95.71 7.48 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.36 171.71 16.42 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.035 2.49 . . . . 0.0 111.628 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -150.15 140.87 22.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.024 1.33 . . . . 0.0 110.808 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.1 t70 64.19 110.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.262 2.625 . . . . 0.0 115.061 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -94.08 82.37 4.18 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.607 1.563 . . . . 0.0 111.429 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.12 -51.82 67.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.204 -0.935 . . . . 0.0 111.511 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -159.15 -43.15 0.06 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.183 2.193 . . . . 0.0 111.589 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -77.54 138.35 39.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.971 1.309 . . . . 0.0 112.735 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.1 m -77.15 172.57 13.03 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.797 0.808 . . . . 0.0 110.07 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -61.66 170.57 1.89 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.115 1.366 . . . . 0.0 112.121 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.447 ' CZ2' ' CE2' ' A' ' 135' ' ' TYR . 15.0 p-90 -114.09 157.98 21.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.7 0.8 . . . . 0.0 112.548 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -158.02 174.14 15.69 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.605 1.962 . . . . 0.0 110.12 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 154.96 133.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 129.221 3.009 . . . . 0.0 112.347 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.04 140.95 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.261 1.024 . . . . 0.0 109.015 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -133.35 149.32 51.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.801 1.24 . . . . 0.0 109.177 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 155' ' ' LEU . 79.2 mt -110.92 98.46 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.103 0.961 . . . . 0.0 109.024 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.19 99.94 0.2 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.402 1.081 . . . . 0.0 109.46 174.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.9 t -68.22 84.97 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.423 1.089 . . . . 0.0 110.86 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.98 -114.9 0.69 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.797 2.142 . . . . 0.0 110.302 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -150.35 123.34 8.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.965 1.306 . . . . 0.0 111.404 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.69 105.96 4.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.565 1.546 . . . . 0.0 112.48 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.26 167.22 3.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.416 1.086 . . . . 0.0 111.461 174.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -80.54 112.33 17.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.08 -0.388 . . . . 0.0 111.21 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.28 -179.44 6.94 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -51.85 -42.04 62.29 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.001 -1.062 . . . . 0.0 112.018 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.71 97.06 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.389 0.995 . . . . 0.0 113.798 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 1.2 ppp? -65.01 -45.72 84.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.798 1.299 . . . . 0.0 111.297 174.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -57.54 -39.92 77.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.693 0.797 . . . . 0.0 110.99 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -67.09 -40.47 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.474 1.11 . . . . 0.0 112.221 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.67 -29.77 70.96 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.443 -1.411 . . . . 0.0 112.883 174.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -76.38 -55.6 5.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.211 1.405 . . . . 0.0 111.615 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.447 ' CE2' ' CZ2' ' A' ' 114' ' ' TRP . 10.8 m-85 -76.5 -26.91 55.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -126.85 -33.85 2.44 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.213 1.005 . . . . 0.0 113.444 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.38 -49.41 45.16 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.839 1.209 . . . . 0.0 112.527 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -166.58 73.63 1.14 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 126.133 1.773 . . . . 0.0 111.565 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 133.01 23.92 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.34 2.026 . . . . 0.0 112.127 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -112.15 -175.17 2.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.552 2.341 . . . . 0.0 111.832 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -134.34 139.56 45.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.146 2.179 . . . . 0.0 110.636 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.36 91.13 0.14 Allowed Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.771 0.714 . . . . 0.0 113.823 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.63 -47.31 19.61 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.81 -1.406 . . . . 0.0 113.438 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 p30 179.37 88.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.974 2.51 . . . . 0.0 112.062 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.19 148.23 6.63 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.48 -0.762 . . . . 0.0 114.255 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.401 ' CD2' ' HB ' ' A' ' 160' ' ' ILE . 85.9 m95 -77.54 145.19 37.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.712 1.205 . . . . 0.0 111.206 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -153.2 141.37 20.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.271 1.429 . . . . 0.0 111.641 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -118.03 147.2 43.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.851 1.66 . . . . 0.0 111.207 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -149.82 166.45 29.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.309 1.044 . . . . 0.0 112.069 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -79.92 108.31 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 157' ' ' MET . 10.3 tp -66.74 -32.76 74.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.61 14.16 4.9 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.52 -26.06 3.07 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.141 1.471 . . . . 0.0 114.704 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.2 10.78 1.27 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.423 -1.21 . . . . 0.0 115.469 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -138.75 165.5 26.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.534 1.667 . . . . 0.0 112.369 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.01 141.33 52.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.597 1.159 . . . . 0.0 108.947 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -126.0 157.68 37.24 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.601 0.76 . . . . 0.0 109.386 175.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.9 129.25 56.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.1 159.03 19.7 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 123.34 0.495 . . . . 0.0 112.467 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.705 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -140.39 156.05 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.842 1.657 . . . . 0.0 110.432 176.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -153.73 114.21 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.705 HG23 HD11 ' A' ' 160' ' ' ILE . 6.8 p -102.03 150.97 22.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.818 0.847 . . . . 0.0 110.425 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.31 156.14 45.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.029 1.731 . . . . 0.0 110.431 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.17 128.5 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.995 2.518 . . . . 0.0 112.908 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.86 -179.0 51.73 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 122.229 0.905 . . . . 0.0 114.244 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.32 80.83 1.36 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.414 1.885 . . . . 0.0 112.48 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.55 164.0 34.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.739 1.216 . . . . 0.0 112.802 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -153.54 -178.91 7.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.746 1.619 . . . . 0.0 113.636 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.433 ' SD ' ' HE3' ' A' ' 101' ' ' MET . 20.0 ptm -102.11 166.62 10.51 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.896 2.079 . . . . 0.0 113.653 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -154.8 153.76 31.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.888 1.275 . . . . 0.0 109.955 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.8 mm -135.47 117.63 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.892 1.277 . . . . 0.0 110.114 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -112.89 111.94 23.05 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.867 -1.146 . . . . 0.0 111.503 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.467 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.0 pt -95.51 131.73 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 109.086 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.5 t -150.71 158.76 44.53 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.633 -0.667 . . . . 0.0 111.227 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.127 1.371 . . . . 0.0 112.185 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.74 -61.77 2.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.825 1.193 . . . . 0.0 112.87 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.56 -41.39 1.45 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.55 -25.56 8.97 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 125.423 1.487 . . . . 0.0 116.213 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 p -138.34 158.18 44.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.694 1.747 . . . . 0.0 111.447 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mm -136.2 165.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.774 -1.204 . . . . 0.0 110.382 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -170.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.881 1.273 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.4 -43.75 5.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 -29.56 6.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.18 1.371 . . . . 0.0 112.897 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.13 73.64 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.296 1.048 . . . . 0.0 111.491 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.4 m -86.53 -8.53 57.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.823 2.049 . . . . 0.0 114.345 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.63 131.36 45.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.47 1.108 . . . . 0.0 109.21 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.612 1.165 . . . . 0.0 109.163 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -54.61 -29.58 52.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.928 0.785 . . . . 0.0 112.988 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -58.28 -56.74 18.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 112.434 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.46 -44.62 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.893 0.877 . . . . 0.0 109.841 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -62.25 -25.48 67.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.591 1.156 . . . . 0.0 113.472 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -74.72 -53.1 9.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.102 -1.624 . . . . 0.0 110.373 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -39.85 83.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 112.934 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.6 p -68.65 -33.36 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.339 0.972 . . . . 0.0 113.082 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 32' ' ' ALA . 82.5 mt -78.8 -36.59 42.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.498 0.719 . . . . 0.0 110.522 175.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.84 -44.14 97.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.814 0.846 . . . . 0.0 111.664 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -20.53 57.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.41 -28.76 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.327 1.851 . . . . 0.0 112.731 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.45 -143.47 4.04 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.681 2.086 . . . . 0.0 112.237 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -135.42 21.87 3.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.902 2.081 . . . . 0.0 112.8 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.03 125.98 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.009 1.724 . . . . 0.0 111.468 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.74 3.92 0.93 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.575 1.55 . . . . 0.0 114.508 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.51 111.72 7.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.839 2.056 . . . . 0.0 109.634 -175.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -138.4 176.82 8.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.962 1.705 . . . . 0.0 112.061 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -102.0 148.72 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.519 1.128 . . . . 0.0 111.426 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -139.51 97.74 3.34 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.58 1.952 . . . . 0.0 111.19 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.6 p -107.41 129.77 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.942 -1.099 . . . . 0.0 110.248 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.95 171.49 42.37 Favored Glycine 0 C--O 1.235 0.205 0 O-C-N 121.57 -0.706 . . . . 0.0 114.273 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 98' ' ' LEU . 3.5 mp -139.61 122.85 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 0.0 109.99 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.97 102.66 2.05 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.387 -1.445 . . . . 0.0 111.747 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -76.75 92.0 3.53 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.4 -0.813 . . . . 0.0 112.225 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -143.54 48.78 1.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.057 0.943 . . . . 0.0 111.586 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -109.8 -8.43 14.91 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.31 57.07 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.561 1.077 . . . . 0.0 115.558 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.44 134.68 6.98 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.129 1.347 . . . . 0.0 113.059 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.2 m -61.87 141.2 58.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.999 1.32 . . . . 0.0 110.816 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 48.9 m0 -104.68 163.49 12.45 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.472 -0.768 . . . . 0.0 111.343 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -143.41 102.0 3.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.022 1.329 . . . . 0.0 111.02 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.98 163.36 22.39 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.292 -0.88 . . . . 0.0 111.131 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.23 -60.65 1.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.126 1.371 . . . . 0.0 111.062 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -153.01 -173.84 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 111.096 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 147.96 35.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.44 1.496 . . . . 0.0 110.895 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 2.8 t80 -132.13 134.59 45.61 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.135 1.374 . . . . 0.0 110.568 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -143.48 157.9 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.204 2.202 . . . . 0.0 111.223 -174.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -127.13 -37.14 2.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.092 1.357 . . . . 0.0 112.924 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.3 t -133.46 92.97 3.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.25 121.19 2.1 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.344 0.973 . . . . 0.0 114.726 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -179.04 1.46 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.11 1.764 . . . . 0.0 112.759 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -88.16 158.56 18.5 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.779 1.232 . . . . 0.0 111.673 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -155.49 -22.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.163 1.385 . . . . 0.0 112.608 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 m -128.13 161.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.712 2.005 . . . . 0.0 110.353 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 tt -91.92 135.26 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.302 1.441 . . . . 0.0 110.975 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.99 125.85 86.33 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 0.0 109.123 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG2' HD12 ' A' ' 69' ' ' LEU . 60.2 Cg_endo -64.02 148.47 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.197 2.598 . . . . 0.0 111.043 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.48 -56.14 3.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.749 0.82 . . . . 0.0 112.309 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -119.2 134.97 54.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.094 1.358 . . . . 0.0 110.334 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.965 HG21 HD13 ' A' ' 69' ' ' LEU . 92.5 t -133.4 132.77 22.15 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.526 1.13 . . . . 0.0 111.484 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.56 164.28 35.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.807 3.005 . . . . 0.0 112.557 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 22.03 0.2 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.0 1.72 . . . . 0.0 115.381 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 p -146.7 23.53 1.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.528 1.531 . . . . 0.0 113.379 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -148.06 130.55 15.8 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.878 1.217 . . . . 0.0 112.607 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.04 179.17 5.79 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.365 1.079 . . . . 0.0 111.443 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 HG21 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -153.66 142.97 21.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.812 1.245 . . . . 0.0 109.588 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 33' ' ' VAL . 4.8 mt -122.39 -178.05 3.79 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.584 1.154 . . . . 0.0 110.555 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -155.5 164.76 38.26 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.689 -1.257 . . . . 0.0 110.326 174.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.481 ' HA ' HG23 ' A' ' 31' ' ' ILE . 8.6 t -142.65 174.54 10.55 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.093 0.957 . . . . 0.0 111.943 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.06 -171.55 12.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.385 1.469 . . . . 0.0 112.61 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -163.81 1.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.658 1.583 . . . . 0.0 114.484 -175.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.98 84.24 3.81 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.445 1.898 . . . . 0.0 112.253 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -77.32 -20.1 55.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.7 t -143.15 17.44 1.91 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.268 2.227 . . . . 0.0 112.042 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.93 89.77 Favored Glycine 0 CA--C 1.548 2.121 0 CA-C-O 117.85 -1.528 . . . . 0.0 114.317 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.47 -44.95 10.17 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.642 2.895 . . . . 0.0 112.68 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 81' ' ' ALA 0.269 0.4 OUTLIER 46.96 -168.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 128.101 2.561 . . . . 0.0 112.499 -175.043 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 80' ' ' VAL . . . 64.09 -14.28 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.572 2.349 . . . . 0.0 116.239 175.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.57 -175.41 4.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.729 3.211 . . . . 0.0 109.252 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.48 -80.25 1.28 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.319 -0.711 . . . . 0.0 113.145 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.98 -174.45 2.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.465 1.506 . . . . 0.0 113.471 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.33 114.52 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.031 2.533 . . . . 0.0 110.742 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.05 177.13 10.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.275 1.43 . . . . 0.0 111.887 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.54 127.84 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.394 1.477 . . . . 0.0 109.059 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -132.36 159.9 37.87 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.805 0.842 . . . . 0.0 112.066 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -124.33 144.35 50.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.114 0.565 . . . . 0.0 111.29 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 21.8 m-85 -118.61 121.9 41.29 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.485 1.514 . . . . 0.0 110.2 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.65 111.59 4.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.912 1.285 . . . . 0.0 110.354 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.7 mtp -72.32 142.68 48.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.745 1.218 . . . . 0.0 110.4 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.3 t -53.86 -33.7 57.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.433 1.093 . . . . 0.0 113.89 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -10.51 30.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.52 26.4 9.29 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.506 1.05 . . . . 0.0 114.291 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -117.73 177.53 4.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.383 1.873 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.5 m -140.21 106.19 5.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.9 1.28 . . . . 0.0 111.704 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 35' ' ' ILE . 26.0 tp -74.95 118.83 18.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.182 0.993 . . . . 0.0 110.314 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.81 107.51 3.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.88 1.229 . . . . 0.0 113.521 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -89.67 158.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 112.533 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.43 168.86 18.81 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.241 1.016 . . . . 0.0 112.136 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 47.0 p90 -171.68 150.31 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.633 1.573 . . . . 0.0 110.375 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.8 m -162.01 130.63 4.26 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.494 1.518 . . . . 0.0 107.355 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.862 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.1 t -107.04 128.45 26.05 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.438 -0.791 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.73 136.41 45.61 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.493 2.129 . . . . 0.0 111.258 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -38.68 -58.75 1.02 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.631 1.972 . . . . 0.0 113.17 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.99 121.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.7 2.0 . . . . 0.0 109.43 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 42.19 53.21 4.43 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.86 1.664 . . . . 0.0 113.536 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -60.16 -13.26 11.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.451 1.501 . . . . 0.0 114.737 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.93 34.02 22.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.02 1.728 . . . . 0.0 113.148 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 166.4 26.03 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.812 1.645 . . . . 0.0 111.806 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.5 p -67.67 161.06 26.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.744 0.783 . . . . 0.0 110.406 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -100.51 172.44 7.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.752 1.221 . . . . 0.0 111.461 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -121.69 144.92 48.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.922 1.289 . . . . 0.0 112.267 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -155.51 160.24 40.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.535 1.134 . . . . 0.0 110.474 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 173.7 132.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.167 2.987 . . . . 0.0 111.008 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.17 140.92 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.72 1.608 . . . . 0.0 109.794 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -135.61 158.57 44.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.304 1.441 . . . . 0.0 110.805 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.22 99.4 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.769 1.628 . . . . 0.0 108.088 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -65.32 103.77 0.85 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.144 -0.972 . . . . 0.0 109.67 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.1 t -68.79 83.43 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.634 -1.291 . . . . 0.0 111.347 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.76 -111.64 0.49 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 127.117 2.294 . . . . 0.0 111.502 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -146.26 135.84 23.12 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.89 1.676 . . . . 0.0 111.852 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -158.31 113.84 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.695 1.598 . . . . 0.0 112.15 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 165.63 24.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.165 0.586 . . . . 0.0 111.236 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.67 113.04 16.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.647 0.779 . . . . 0.0 110.37 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -158.88 -174.74 4.91 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.698 1.599 . . . . 0.0 112.839 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -50.61 -40.95 54.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.256 -0.902 . . . . 0.0 112.865 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.91 -39.91 56.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.246 0.93 . . . . 0.0 113.269 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.3 ttt -67.41 -57.79 5.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.41 1.084 . . . . 0.0 111.507 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -53.47 -34.91 59.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.38 0.991 . . . . 0.0 112.691 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -66.64 -46.81 74.57 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.206 1.002 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -25.75 66.9 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.502 -1.374 . . . . 0.0 113.122 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.35 -45.07 57.26 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.727 2.011 . . . . 0.0 113.11 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.69 -31.76 14.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -116.31 -20.95 9.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.897 1.279 . . . . 0.0 113.163 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.68 -63.85 2.25 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.568 1.556 . . . . 0.0 114.166 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -122.52 64.45 21.58 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.898 1.279 . . . . 0.0 112.161 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -60.65 122.66 11.6 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.999 2.466 . . . . 0.0 112.851 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.37 -171.9 2.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.405 1.482 . . . . 0.0 111.351 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -139.26 135.58 34.03 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.735 -1.228 . . . . 0.0 112.997 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.73 8.16 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.265 1.412 . . . . 0.0 110.697 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -130.65 56.71 1.76 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.043 1.337 . . . . 0.0 110.825 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.5 p30 40.41 65.06 0.82 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.506 2.322 . . . . 0.0 115.432 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.28 154.02 21.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.819 1.199 . . . . 0.0 113.158 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.46 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 42.6 m95 -70.01 142.33 52.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.17 . . . . 0.0 110.951 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -145.4 131.67 19.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.799 1.239 . . . . 0.0 111.929 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -107.24 141.88 37.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 112.147 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -148.37 157.74 43.67 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 123.336 1.541 . . . . 0.0 112.248 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -90.11 88.28 7.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.828 2.851 . . . . 0.0 106.436 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.475 HD13 ' SD ' ' A' ' 157' ' ' MET . 8.1 tp -54.54 -27.84 41.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.594 1.557 . . . . 0.0 114.26 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.76 36.62 2.75 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -133.12 -20.32 2.17 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.1 2.96 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.579 1.085 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.47 176.68 8.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.378 1.871 . . . . 0.0 111.665 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -116.24 163.4 16.05 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.664 1.186 . . . . 0.0 111.127 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.174 0.988 . . . . 0.0 112.274 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -116.16 124.6 50.72 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 126.726 2.011 . . . . 0.0 108.144 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.21 149.26 18.58 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 119.095 0.861 . . . . 0.0 112.98 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.46 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -134.67 151.5 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.738 1.615 . . . . 0.0 108.919 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.9 tpp -156.45 109.01 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.722 1.609 . . . . 0.0 108.462 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.7 p -132.72 156.0 47.82 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.96 2.104 . . . . 0.0 110.037 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.9 p -158.21 -176.48 5.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.859 1.663 . . . . 0.0 110.882 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.82 34.98 14.03 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.855 1.662 . . . . 0.0 115.45 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 148.46 88.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.466 1.031 . . . . 0.0 113.274 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 44.8 55.64 5.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.17 2.588 . . . . 0.0 112.166 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.26 163.69 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.051 1.74 . . . . 0.0 113.804 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.862 ' HE2' HG22 ' A' ' 104' ' ' VAL . 1.8 tptp -159.09 -168.34 2.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.518 ' H ' ' HG3' ' A' ' 168' ' ' LYS . 19.7 ptm -121.31 149.5 42.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.058 1.743 . . . . 0.0 111.06 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.514 ' C ' HD12 ' A' ' 171' ' ' ILE . 13.2 tt0 -167.51 152.37 6.99 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.391 1.476 . . . . 0.0 109.177 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 1.8 mp -122.75 122.0 64.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 123.579 0.752 . . . . 0.0 109.243 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 114.11 25.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 108.365 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 157' ' ' MET . 8.4 pt -99.66 134.83 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.086 0.554 . . . . 0.0 110.531 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p -155.88 165.06 37.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.711 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.961 1.304 . . . . 0.0 112.474 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -92.29 -36.41 13.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 110.926 175.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.22 169.22 2.21 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.805 0.812 . . . . 0.0 110.592 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.66 -40.01 2.57 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.7 p -131.51 155.79 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.678 1.591 . . . . 0.0 111.61 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mm -140.31 160.59 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.268 1.427 . . . . 0.0 110.283 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.664 HD12 ' H ' ' A' ' 9' ' ' GLY . 1.2 pp -66.73 -171.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.082 2.553 . . . . 0.0 111.67 174.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.34 -28.29 58.53 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.664 ' H ' HD12 ' A' ' 7' ' ' ILE . . . 95.64 -16.26 61.56 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.212 1.386 . . . . 0.0 112.929 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.72 -43.03 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.705 1.202 . . . . 0.0 111.799 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 7' ' ' ILE . 92.3 p -85.48 -13.09 50.2 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.7 HD13 HD23 ' A' ' 17' ' ' LEU . 1.5 tp -53.7 138.61 34.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.862 2.065 . . . . 0.0 110.021 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.42 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.6 m -145.7 149.51 34.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.9 0.88 . . . . 0.0 109.618 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -52.7 -26.49 14.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.29 -51.31 64.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.168 0.987 . . . . 0.0 112.11 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.23 -39.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.35 -0.844 . . . . 0.0 110.776 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.7 HD23 HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.41 -23.98 67.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.314 1.046 . . . . 0.0 112.338 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.16 -54.22 13.83 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.352 -1.467 . . . . 0.0 109.021 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -55.78 -44.75 78.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.373 1.069 . . . . 0.0 112.62 175.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG23 HD22 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -63.04 -35.91 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.331 0.969 . . . . 0.0 113.414 -175.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 32' ' ' ALA . 35.2 mt -84.93 -32.3 23.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 111.801 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.23 -23.01 66.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.269 0.627 . . . . 0.0 111.584 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -48.15 -25.91 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.36 1.864 . . . . 0.0 113.657 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.0 mt -52.3 -29.19 22.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.576 1.55 . . . . 0.0 112.317 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.53 -129.07 1.19 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.912 1.244 . . . . 0.0 113.75 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -139.73 34.16 2.0 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.425 2.69 . . . . 0.0 110.74 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.65 167.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 128.249 2.62 . . . . 0.0 112.816 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.6 p -68.24 -6.51 24.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.567 1.547 . . . . 0.0 115.043 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -68.76 104.78 2.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.387 1.475 . . . . 0.0 110.394 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HZ3' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -153.38 116.77 4.64 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 111.286 -177.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -131.25 133.55 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.891 0.877 . . . . 0.0 111.635 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -115.6 102.62 9.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.107 2.163 . . . . 0.0 113.843 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.609 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.1 p -114.02 121.33 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.571 -1.331 . . . . 0.0 109.96 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.83 33.81 Favored Glycine 0 N--CA 1.461 0.363 0 O-C-N 121.053 -1.029 . . . . 0.0 112.956 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 100' ' ' VAL . 2.2 mp -141.42 134.45 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.335 1.064 . . . . 0.0 113.817 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 2.6 m-20 -76.41 106.76 8.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.69 1.596 . . . . 0.0 113.148 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -84.06 104.27 13.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.683 1.23 . . . . 0.0 112.977 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -145.49 23.8 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.078 -1.014 . . . . 0.0 113.021 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.51 -9.52 54.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.496 1.519 . . . . 0.0 114.66 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.95 49.48 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.493 1.044 . . . . 0.0 115.148 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.62 110.66 0.91 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.833 1.682 . . . . 0.0 110.166 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -59.58 147.2 38.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.801 1.3 . . . . 0.0 110.906 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -117.3 161.41 19.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.53 0.732 . . . . 0.0 111.506 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -133.01 113.63 13.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.331 2.253 . . . . 0.0 111.996 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -75.41 115.64 15.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.599 1.159 . . . . 0.0 110.831 175.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -71.85 -54.85 8.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.521 1.528 . . . . 0.0 110.259 175.004 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.74 -174.03 3.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.72 1.608 . . . . 0.0 111.825 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 144.67 28.22 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.53 1.532 . . . . 0.0 111.622 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.62 119.94 37.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.54 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.32 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 109.562 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -5.12 43.64 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.162 1.385 . . . . 0.0 113.833 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 p -73.56 -137.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.017 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.85 -84.55 0.91 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.446 1.022 . . . . 0.0 112.663 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -146.17 176.03 10.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.517 1.127 . . . . 0.0 112.193 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -77.74 158.36 29.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.38 1.472 . . . . 0.0 113.051 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -135.22 -34.14 0.87 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.688 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 71' ' ' TYR . 19.7 m -132.0 176.84 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.855 2.062 . . . . 0.0 110.129 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -100.93 131.8 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.442 1.497 . . . . 0.0 110.987 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.26 131.61 52.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.656 ' HG2' HD12 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -63.63 177.68 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.165 3.243 . . . . 0.0 112.411 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -117.81 -36.68 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.839 1.256 . . . . 0.0 112.279 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.13 157.92 33.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.952 1.301 . . . . 0.0 111.72 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.99 97.44 7.92 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 124.747 1.219 . . . . 0.0 108.681 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.99 174.61 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.795 1.663 . . . . 0.0 110.54 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -63.2 165.49 7.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.45 0.7 . . . . 0.0 109.887 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 t 46.08 30.81 1.01 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.162 1.385 . . . . 0.0 113.14 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -145.26 158.68 43.77 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.916 1.686 . . . . 0.0 112.138 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -140.34 -173.84 3.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.707 1.242 . . . . 0.0 110.105 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -156.91 153.88 28.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.926 175.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 32' ' ' ALA . 14.2 mt -139.26 155.16 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.796 1.238 . . . . 0.0 108.578 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -129.07 160.26 33.35 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.119 1.368 . . . . 0.0 108.747 175.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 m -151.26 170.1 20.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.439 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.82 -171.2 21.35 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -144.08 142.36 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.613 1.165 . . . . 0.0 109.789 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.98 78.43 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.812 2.045 . . . . 0.0 112.619 174.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.25 -16.31 63.91 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.14 22.56 0.95 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.233 1.813 . . . . 0.0 112.535 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.23 34.02 88.42 Favored Glycine 0 CA--C 1.555 2.534 0 CA-C-O 118.027 -1.429 . . . . 0.0 115.674 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.82 -34.47 30.59 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.705 3.603 . . . . 0.0 114.369 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.33 9.88 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.582 1.953 . . . . 0.0 112.521 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.49 -48.79 0.65 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.705 2.402 . . . . 0.0 112.693 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.5 p -153.24 122.24 6.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.098 1.759 . . . . 0.0 112.092 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.89 -128.72 9.59 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.637 1.108 . . . . 0.0 112.564 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.89 179.63 8.49 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.003 1.401 . . . . 0.0 113.25 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -151.88 121.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 127.357 2.263 . . . . 0.0 111.329 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.1 176.02 12.28 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.797 1.639 . . . . 0.0 110.389 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.46 116.97 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.541 1.136 . . . . 0.0 108.441 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 33' ' ' VAL . 10.7 p90 -127.22 170.08 12.81 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.264 1.026 . . . . 0.0 112.651 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.91 157.72 45.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.735 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -128.97 112.38 14.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.136 1.774 . . . . 0.0 112.147 -175.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.3 104.09 1.41 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.297 1.839 . . . . 0.0 111.032 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.43 140.37 58.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.492 1.117 . . . . 0.0 110.111 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -57.62 -20.72 34.96 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -74.39 -10.02 59.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.258 1.423 . . . . 0.0 113.905 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.76 11.77 45.91 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.058 1.313 . . . . 0.0 114.837 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.12 174.56 6.26 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.261 1.824 . . . . 0.0 109.7 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m -143.64 109.52 5.25 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.951 -1.093 . . . . 0.0 112.588 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 35' ' ' ILE . 48.7 tp -74.56 121.5 21.66 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.068 -1.02 . . . . 0.0 111.627 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 110.7 3.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.868 1.223 . . . . 0.0 113.367 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.4 p -86.58 150.13 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.193 0.997 . . . . 0.0 112.21 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.589 ' HB2' HD13 ' A' ' 134' ' ' LEU . 11.1 tmm? -135.65 152.16 50.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.115 1.366 . . . . 0.0 110.774 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.609 ' CE1' HG11 ' A' ' 33' ' ' VAL . 23.7 p90 -164.69 158.45 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.374 1.07 . . . . 0.0 110.474 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 m -163.17 154.39 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.87 2.068 . . . . 0.0 108.181 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.66 100.1 37.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.37 173.98 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.767 2.311 . . . . 0.0 111.828 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -101.13 -24.69 14.24 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.58 159.3 30.11 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.243 0.929 . . . . 0.0 112.477 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -158.81 -51.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.346 1.458 . . . . 0.0 113.176 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -54.05 -40.06 66.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.735 1.614 . . . . 0.0 112.168 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.17 135.32 52.98 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.57 1.148 . . . . 0.0 111.185 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -77.76 107.96 10.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.365 1.466 . . . . 0.0 109.89 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.8 p -163.63 39.83 0.09 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.341 1.056 . . . . 0.0 113.619 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -80.91 145.36 31.33 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.85 -1.156 . . . . 0.0 112.675 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -92.18 140.44 29.62 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.301 1.44 . . . . 0.0 112.622 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.539 ' CE3' HD11 ' A' ' 171' ' ' ILE . 6.8 p-90 -163.1 138.32 6.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -161.24 152.12 18.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.766 -0.584 . . . . 0.0 112.441 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 171' ' ' ILE . 10.9 t -143.96 143.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 127.161 2.185 . . . . 0.0 110.119 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 150.13 45.18 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.178 1.791 . . . . 0.0 109.872 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.84 103.55 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.232 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -66.45 101.36 0.75 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.851 -1.156 . . . . 0.0 109.093 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 t -67.49 82.22 0.16 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.847 -1.158 . . . . 0.0 111.525 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.47 -107.25 0.32 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.088 2.28 . . . . 0.0 111.423 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -153.19 144.64 23.27 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.849 1.26 . . . . 0.0 111.903 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -165.34 116.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.966 1.706 . . . . 0.0 111.788 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.71 164.92 20.56 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.538 0.735 . . . . 0.0 111.732 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.41 118.73 22.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.329 -0.232 . . . . 0.0 110.58 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.63 -179.09 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.139 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -48.84 42.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.943 1.297 . . . . 0.0 112.715 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.0 -33.52 60.71 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.001 0.81 . . . . 0.0 113.515 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.6 ttp -67.44 -56.42 9.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.412 1.106 . . . . 0.0 111.455 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -49.47 -39.81 34.97 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.296 0.953 . . . . 0.0 111.997 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -66.07 -43.14 88.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.079 0.952 . . . . 0.0 112.202 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -17.91 64.92 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.022 -1.673 . . . . 0.0 113.918 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 101' ' ' MET . 41.5 mt -96.23 -24.84 16.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.376 1.47 . . . . 0.0 113.39 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.81 -32.99 11.07 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.945 -1.097 . . . . 0.0 112.928 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -118.13 -33.67 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 112.759 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.19 -21.23 71.83 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.408 1.004 . . . . 0.0 114.517 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -154.11 87.0 3.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.462 2.305 . . . . 0.0 108.374 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.36 108.9 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.086 1.857 . . . . 0.0 110.953 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -139.88 158.95 43.25 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -147.42 167.67 23.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.963 1.705 . . . . 0.0 112.637 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.36 111.31 0.48 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.129 0.871 . . . . 0.0 112.93 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.03 70.39 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.986 0.914 . . . . 0.0 111.434 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.0 92.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.952 2.501 . . . . 0.0 114.993 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.09 130.17 1.09 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.581 1.086 . . . . 0.0 112.362 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.485 ' CE3' ' HG3' ' A' ' 158' ' ' LYS . 5.7 m95 -58.81 123.96 18.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.641 1.177 . . . . 0.0 111.164 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -131.75 118.24 19.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.422 1.489 . . . . 0.0 111.553 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.37 142.85 46.31 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.347 1.059 . . . . 0.0 112.615 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.23 156.82 41.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.688 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -74.62 104.36 5.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.73 -22.68 58.23 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.18 35.68 2.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.753 1.644 . . . . 0.0 116.523 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -135.42 -24.54 1.38 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.57 -18.03 1.13 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.204 1.383 . . . . 0.0 114.391 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 173' ' ' ILE . 1.2 pp -131.04 163.44 27.6 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.129 1.372 . . . . 0.0 112.523 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -102.3 136.72 41.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.289 1.436 . . . . 0.0 112.211 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB2' HG22 ' A' ' 173' ' ' ILE . 6.3 tmm? -115.07 135.72 53.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.149 0.58 . . . . 0.0 110.531 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.485 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.8 tptm -103.87 119.69 39.45 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.884 2.074 . . . . 0.0 110.468 176.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.18 146.87 18.62 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.354 1.454 . . . . 0.0 112.773 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 161' ' ' MET . 4.1 tp -124.15 157.05 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.096 1.759 . . . . 0.0 110.226 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.573 ' H ' HD12 ' A' ' 160' ' ' ILE . 7.0 tpt -152.34 90.87 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.463 1.505 . . . . 0.0 109.086 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.7 p -82.45 152.24 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 111.471 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.1 t -127.94 163.47 24.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.204 1.002 . . . . 0.0 112.049 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 65.05 144.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.575 2.75 . . . . 0.0 113.133 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 38.8 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.479 1.527 0 C-N-CA 126.877 2.18 . . . . 0.0 113.34 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.519 ' HG2' ' HZ3' ' A' ' 30' ' ' LYS . 2.1 tm-20 -75.59 64.11 1.63 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.376 1.87 . . . . 0.0 109.599 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.5 111.7 23.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.202 1.801 . . . . 0.0 111.768 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -159.1 161.69 36.41 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.421 ' N ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -121.99 140.33 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 127.739 2.416 . . . . 0.0 110.295 175.045 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.539 ' C ' HD12 ' A' ' 171' ' ' ILE . 25.5 tt0 -138.6 157.12 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.708 1.603 . . . . 0.0 109.018 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.539 HD11 ' CE3' ' A' ' 115' ' ' TRP . 1.6 mp -128.31 134.54 64.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 124.464 1.106 . . . . 0.0 109.697 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 109.11 13.26 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.318 2.247 . . . . 0.0 110.737 175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 155' ' ' LEU . 12.7 pt -91.54 124.47 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.134 1.374 . . . . 0.0 110.183 175.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.4 p -155.69 170.52 21.85 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.315 1.446 . . . . 0.0 112.735 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.7 -38.12 70.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.19 0.596 . . . . 0.0 111.843 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.38 169.72 10.18 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 110.654 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.87 -27.64 19.66 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 113.231 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -146.6 160.54 42.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.99 1.716 . . . . 0.0 111.641 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -139.83 166.81 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.571 1.549 . . . . 0.0 110.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 pt -73.91 -170.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.917 2.487 . . . . 0.0 110.308 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.05 19.8 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 -10.48 73.91 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.75 1.167 . . . . 0.0 114.36 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.7 -45.69 35.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.56 1.144 . . . . 0.0 111.497 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -81.62 -7.31 59.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.947 1.299 . . . . 0.0 113.869 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' ' 17' ' ' LEU . 20.5 tp -59.81 144.19 49.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.822 1.249 . . . . 0.0 110.396 174.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.3 146.43 29.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.247 1.019 . . . . 0.0 110.082 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -55.79 -29.06 59.08 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -60.85 -57.32 13.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.44 -43.68 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.766 -0.584 . . . . 0.0 110.073 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.601 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.36 -30.86 68.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 112.766 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -69.55 -47.27 64.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.986 1.715 . . . . 0.0 111.824 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -35.65 77.81 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.857 -1.152 . . . . 0.0 112.131 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -39.14 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.052 -1.03 . . . . 0.0 113.642 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -31.58 61.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.233 0.469 . . . . 0.0 111.79 175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -70.22 -33.41 71.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.319 1.448 . . . . 0.0 112.27 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -46.63 -29.44 1.85 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.457 2.303 . . . . 0.0 114.208 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD13 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -47.57 -43.96 25.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.365 1.466 . . . . 0.0 110.94 174.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.39 -146.51 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.313 1.435 . . . . 0.0 112.626 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -118.81 16.49 13.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.888 1.675 . . . . 0.0 112.349 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 m -121.06 119.44 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.037 1.735 . . . . 0.0 111.281 -174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.1 p -73.32 28.87 0.07 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.307 1.443 . . . . 0.0 113.588 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -122.85 65.17 0.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 109.355 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HE2' ' CD2' ' A' ' 24' ' ' LEU . 28.0 mmtm -121.29 -178.88 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 112.384 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -121.4 141.67 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.729 1.612 . . . . 0.0 112.028 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 104.94 11.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.854 1.662 . . . . 0.0 110.338 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.12 142.87 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 124.257 1.023 . . . . 0.0 113.52 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.11 173.48 34.59 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.535 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 100' ' ' VAL . 3.1 mt -139.71 150.02 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.422 1.489 . . . . 0.0 110.613 -174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.39 118.09 31.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 110.617 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.549 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.73 103.69 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 0.0 111.922 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.58 7.97 2.82 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.823 1.249 . . . . 0.0 112.988 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 t -66.19 -16.26 63.84 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.62 16.73 28.21 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.595 1.093 . . . . 0.0 115.361 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.43 136.92 8.38 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.262 1.411 . . . . 0.0 112.886 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -67.36 141.63 57.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.437 1.495 . . . . 0.0 111.749 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.662 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 40.3 m0 -108.01 165.82 11.18 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.647 1.179 . . . . 0.0 112.179 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -146.55 98.8 3.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 111.997 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -63.29 139.77 58.8 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.019 -1.05 . . . . 0.0 110.428 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 91' ' ' TYR . 21.2 mt -93.4 -61.37 1.57 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.872 0.869 . . . . 0.0 110.187 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.63 -164.12 0.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.913 2.885 . . . . 0.0 108.892 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.85 134.77 20.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.206 1.803 . . . . 0.0 111.329 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -103.98 112.48 25.48 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.601 1.56 . . . . 0.0 109.376 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 130.81 55.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.543 1.537 . . . . 0.0 109.839 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -31.02 7.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.746 1.618 . . . . 0.0 113.258 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -141.8 91.85 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.241 1.016 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.17 125.94 3.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.8 1.667 . . . . 0.0 111.946 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -74.7 175.49 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.897 0.856 . . . . 0.0 111.775 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p -62.55 171.02 2.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.683 1.993 . . . . 0.0 113.122 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' OD1' HD13 ' A' ' 24' ' ' LEU . 1.2 t70 -152.34 -50.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.035 1.334 . . . . 0.0 109.785 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.9 164.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.476 1.51 . . . . 0.0 111.761 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 tp -71.88 134.25 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 110.452 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -91.79 114.2 61.21 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.696 1.198 . . . . 0.0 109.724 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.631 ' HG2' HD12 ' A' ' 69' ' ' LEU . 63.6 Cg_endo -66.31 120.53 7.68 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.308 3.339 . . . . 0.0 111.422 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.2 pt-20 -71.51 -67.58 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.499 0.72 . . . . 0.0 112.402 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -97.33 132.61 42.89 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.547 0.739 . . . . 0.0 109.561 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 t -129.67 128.04 22.98 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.816 0.847 . . . . 0.0 111.099 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.77 149.64 38.13 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.028 3.152 . . . . 0.0 112.805 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.89 17.96 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -141.0 8.62 2.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.412 1.885 . . . . 0.0 113.946 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -145.59 134.44 22.43 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 119.885 1.22 . . . . 0.0 113.038 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.23 -176.36 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 110.992 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -152.02 157.22 41.39 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.409 -0.807 . . . . 0.0 112.187 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.64 170.78 14.29 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 123.608 0.763 . . . . 0.0 111.65 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.48 157.76 43.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.231 1.813 . . . . 0.0 109.885 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.7 m -145.39 160.52 41.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.154 1.782 . . . . 0.0 108.799 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.81 -179.57 16.88 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.615 1.102 . . . . 0.0 111.984 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -141.45 166.93 23.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.19 96.42 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.039 1.736 . . . . 0.0 110.14 176.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -75.3 -18.44 60.04 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.5 t -155.39 20.35 0.41 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.283 1.833 . . . . 0.0 113.363 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.18 36.83 86.04 Favored Glycine 0 CA--C 1.549 2.208 0 O-C-N 120.363 -1.461 . . . . 0.0 114.414 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -69.51 -39.11 7.4 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.429 2.753 . . . . 0.0 114.38 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 84' ' ' ALA . 3.6 p -114.56 2.76 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.922 1.689 . . . . 0.0 113.265 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.78 -57.95 0.39 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.519 2.728 . . . . 0.0 113.109 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.6 p -149.81 123.76 9.36 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.861 2.065 . . . . 0.0 111.334 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.57 -139.64 14.67 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.625 1.107 . . . . 0.0 112.371 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HA ' HG11 ' A' ' 80' ' ' VAL . . . -159.75 156.45 27.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 112.554 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 103' ' ' SER . 15.4 t -130.86 108.0 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.878 2.071 . . . . 0.0 108.891 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.89 178.62 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 111.128 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.76 120.7 5.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -125.97 161.56 27.23 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.312 1.045 . . . . 0.0 113.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -131.52 148.82 52.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 24.4 m-85 -122.01 102.37 8.13 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.286 2.234 . . . . 0.0 112.094 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 46' ' ' LEU . 10.7 t80 -69.06 117.88 11.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.471 1.508 . . . . 0.0 110.374 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.9 mtp -82.42 153.1 25.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 111.516 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 m -58.74 -16.59 17.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -73.87 -17.88 60.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 113.565 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.27 33.82 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.248 1.88 . . . . 0.0 114.937 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -78.78 168.21 20.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.734 1.267 . . . . 0.0 111.573 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.71 HG22 ' HB1' ' A' ' 89' ' ' ALA . 23.8 m -136.43 106.51 6.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.318 1.047 . . . . 0.0 112.332 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 173' ' ' ILE . 16.4 tp -68.47 111.48 4.72 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.674 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 130' ' ' MET . . . -94.6 105.77 3.33 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 0.0 113.486 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -76.31 149.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 122.099 -0.648 . . . . 0.0 110.882 174.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.644 ' HB2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -122.72 145.43 48.4 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.209 -0.932 . . . . 0.0 109.793 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CG ' HG11 ' A' ' 33' ' ' VAL . 40.8 p90 -167.71 135.16 2.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 123.308 1.528 . . . . 0.0 114.234 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' VAL . 28.4 m -150.51 130.62 13.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.768 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.21 90.9 42.85 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.51 -13.42 32.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.569 2.179 . . . . 0.0 112.818 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.7 t80 64.47 166.09 0.15 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.072 2.949 . . . . 0.0 113.396 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.52 110.24 2.24 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.067 -1.021 . . . . 0.0 111.744 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -150.48 -65.57 0.2 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 0.0 111.482 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -84.07 -12.23 55.44 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 61.97 70.84 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.736 2.014 . . . . 0.0 113.072 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 170.97 18.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.036 1.334 . . . . 0.0 113.349 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -68.19 164.57 20.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 111.809 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.67 151.21 23.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.859 0.864 . . . . 0.0 112.075 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -85.84 159.85 19.6 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.324 0.65 . . . . 0.0 110.249 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -161.45 171.03 18.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.951 1.3 . . . . 0.0 109.399 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 148.26 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.558 3.143 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.61 160.88 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.684 0.793 . . . . 0.0 109.847 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -161.25 158.07 26.66 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.56 176.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ ' ' A' ' 153' ' ' TYR . 34.1 mt -105.53 117.3 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -66.78 87.85 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.873 1.669 . . . . 0.0 110.189 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.5 t -73.02 81.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.0 110.949 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.62 -82.13 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.717 1.151 . . . . 0.0 112.938 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 177.8 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.38 2.672 . . . . 0.0 111.116 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -155.39 159.21 39.71 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.937 2.095 . . . . 0.0 109.338 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.16 173.86 10.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.123 2.169 . . . . 0.0 111.173 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.64 109.7 5.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.721 0.408 . . . . 0.0 111.863 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 130' ' ' MET . 2.4 t70 -163.68 -169.81 2.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 111.099 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.7 -48.88 69.11 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.442 -0.786 . . . . 0.0 110.707 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.54 50.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.422 1.01 . . . . 0.0 113.659 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.423 ' HE3' ' CA ' ' A' ' 99' ' ' GLY . 3.8 ttt -66.34 -63.63 1.03 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.739 0.815 . . . . 0.0 110.595 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.88 -34.1 62.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.999 0.92 . . . . 0.0 112.776 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.63 -40.09 95.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.681 1.592 . . . . 0.0 111.019 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -21.89 65.76 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.261 -1.525 . . . . 0.0 113.26 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 101' ' ' MET . 12.4 mt -82.15 -41.11 20.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.492 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 -34.69 14.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -113.11 -36.56 5.03 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.481 1.512 . . . . 0.0 112.128 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.81 -69.58 1.02 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.747 1.642 . . . . 0.0 112.487 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -171.13 75.57 0.54 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 125.437 1.495 . . . . 0.0 112.933 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.73 161.32 32.78 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.751 2.3 . . . . 0.0 113.86 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -126.53 177.19 6.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.125 2.17 . . . . 0.0 112.224 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -108.24 124.0 49.63 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.055 2.142 . . . . 0.0 111.584 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.64 101.96 2.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.493 1.52 . . . . 0.0 112.928 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -136.86 23.96 3.08 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 71.2 99.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.81 2.444 . . . . 0.0 113.386 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.96 139.41 2.66 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.691 1.615 . . . . 0.0 111.987 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -69.83 154.91 41.33 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 122.216 -0.579 . . . . 0.0 111.354 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -142.08 124.47 15.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.305 1.442 . . . . 0.0 111.694 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -121.79 138.64 54.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.231 2.212 . . . . 0.0 111.34 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 159.44 38.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.92 1.288 . . . . 0.0 111.694 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -81.63 86.6 6.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.091 1.356 . . . . 0.0 110.083 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD22 ' CE2' ' A' ' 153' ' ' TYR . 7.3 tt -58.42 -52.51 65.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.456 1.502 . . . . 0.0 112.949 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.58 42.37 0.02 OUTLIER Glycine 0 CA--C 1.542 1.761 0 N-CA-C 118.584 2.194 . . . . 0.0 118.584 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -150.05 5.01 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.642 1.721 . . . . 0.0 115.61 -176.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.87 -57.21 0.44 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.448 1.499 . . . . 0.0 112.496 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.84 176.24 7.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.824 0.85 . . . . 0.0 111.652 174.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.24 123.94 31.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.648 1.579 . . . . 0.0 109.999 175.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.613 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -88.2 156.02 19.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.58 130.96 39.12 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.762 1.225 . . . . 0.0 109.977 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -124.41 152.66 17.46 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 124.269 0.938 . . . . 0.0 113.588 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 141.24 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.278 1.431 . . . . 0.0 110.396 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.31 99.13 5.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.931 1.242 . . . . 0.0 110.931 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.59 53.86 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 0.0 111.89 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.5 m -123.06 129.02 50.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.674 1.989 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.64 68.15 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.842 2.857 . . . . 0.0 109.151 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.2 -90.46 0.02 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.38 1.943 . . . . 0.0 114.536 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -75.81 11.22 1.45 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.57 2.348 . . . . 0.0 114.802 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.37 170.28 16.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.69 1.596 . . . . 0.0 113.032 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 -167.99 1.89 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.1 ptm -114.05 164.12 14.25 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.858 2.063 . . . . 0.0 110.99 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -150.64 146.03 26.24 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.165 1.386 . . . . 0.0 110.009 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.0 mm -121.03 128.69 76.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.311 1.045 . . . . 0.0 108.726 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -115.58 114.55 25.09 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.504 1.522 . . . . 0.0 108.965 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.662 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 13.3 pt -111.07 134.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.59 1.156 . . . . 0.0 110.709 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.5 p -162.72 158.97 23.69 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.8 1.24 . . . . 0.0 110.79 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.248 1.419 . . . . 0.0 112.212 -175.043 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.46 -38.02 12.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.233 2.613 . . . . 0.0 110.623 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.75 166.85 5.05 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.024 0.916 . . . . 0.0 110.403 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.64 -42.17 1.99 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.93 1.729 . . . . 0.0 110.89 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.3 p -139.1 159.98 40.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.429 1.491 . . . . 0.0 111.932 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mm -142.11 162.9 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 111.402 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.5 pt -69.1 -169.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.072 2.149 . . . . 0.0 111.073 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.08 -25.84 23.87 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.28 -21.59 34.05 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.411 1.005 . . . . 0.0 113.355 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -44.1 70.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.444 1.122 . . . . 0.0 111.845 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.64 -11.67 59.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.018 1.327 . . . . 0.0 113.365 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD11 HD23 ' A' ' 17' ' ' LEU . 1.5 tt -66.15 159.12 26.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.59 146.84 27.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.685 0.794 . . . . 0.0 109.916 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -55.52 -33.93 64.21 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.96 -47.77 79.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.456 1.103 . . . . 0.0 113.049 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.1 -45.94 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 110.439 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.54 -41.3 66.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 111.426 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.67 -53.3 40.47 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.619 1.968 . . . . 0.0 112.317 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -27.12 41.84 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -35.82 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.181 1.355 . . . . 0.0 111.742 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -81.27 -23.91 37.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.208 1.003 . . . . 0.0 112.463 177.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.9 -33.77 22.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.645 1.578 . . . . 0.0 114.235 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -19.89 16.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 112.935 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tp -47.63 -40.69 20.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.457 2.303 . . . . 0.0 111.038 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.99 -161.67 10.53 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.412 1.958 . . . . 0.0 112.524 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -128.42 34.69 4.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.039 2.136 . . . . 0.0 111.168 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.3 163.11 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.057 2.143 . . . . 0.0 113.301 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.55 -14.43 61.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.482 1.513 . . . . 0.0 114.479 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.29 118.62 26.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.027 2.131 . . . . 0.0 111.184 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.564 ' HB2' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -164.37 165.7 21.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.844 0.858 . . . . 0.0 113.145 -174.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -145.41 148.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.683 1.193 . . . . 0.0 113.005 176.054 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.607 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -121.77 105.63 10.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.591 2.356 . . . . 0.0 112.603 174.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 102' ' ' PHE . 1.3 p -115.7 144.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 108.75 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.61 170.54 22.56 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 118.195 0.452 . . . . 0.0 112.8 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.02 124.88 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.888 0.875 . . . . 0.0 111.528 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -71.2 109.34 5.18 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.348 -0.845 . . . . 0.0 111.902 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.87 102.68 14.55 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.656 1.217 . . . . 0.0 111.271 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.14 44.41 1.55 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.07 -1.019 . . . . 0.0 110.94 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -2.32 9.05 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.41 75.81 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.946 -1.096 . . . . 0.0 115.266 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.37 107.85 1.71 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.758 1.647 . . . . 0.0 111.509 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.2 m -67.74 116.75 8.79 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.638 1.219 . . . . 0.0 110.632 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.443 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 8.7 m0 -85.78 161.25 19.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.588 0.355 . . . . 0.0 111.916 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -138.01 104.12 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.448 1.899 . . . . 0.0 111.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -65.93 141.27 58.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.884 -1.135 . . . . 0.0 110.528 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -106.42 -47.45 3.78 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.195 1.398 . . . . 0.0 111.774 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -155.63 171.35 20.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.027 0.931 . . . . 0.0 112.13 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.13 135.33 30.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 0.0 111.604 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.437 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.3 t80 -115.16 129.01 56.55 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.333 1.453 . . . . 0.0 109.088 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 18.8 p90 -147.22 161.15 41.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.869 1.267 . . . . 0.0 112.452 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -120.94 -31.84 4.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.738 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.49 ' CB ' ' H ' ' A' ' 85' ' ' VAL . 83.2 p -60.19 130.97 49.3 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.712 1.205 . . . . 0.0 112.344 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 37.13 -100.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.285 1.898 . . . . 0.0 113.904 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 55' ' ' THR . 2.1 t -165.04 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.478 1.911 . . . . 0.0 108.244 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 54' ' ' THR . 12.7 p -137.31 164.9 27.45 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.411 2.284 . . . . 0.0 112.119 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -154.67 -38.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.523 1.529 . . . . 0.0 111.358 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 3' ' ' ALA . 16.2 m -102.31 165.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.682 1.593 . . . . 0.0 112.24 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.5 tt -80.24 136.62 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.641 1.176 . . . . 0.0 110.957 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.22 107.08 36.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.907 0.883 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HG2' HD12 ' A' ' 69' ' ' LEU . 73.5 Cg_endo -67.14 113.96 3.03 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 124.322 3.348 . . . . 0.0 110.386 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.49 -46.61 87.66 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.641 -0.662 . . . . 0.0 112.024 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.78 145.31 29.93 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.954 0.797 . . . . 0.0 110.854 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.11 94.19 16.26 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 124.723 1.209 . . . . 0.0 108.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.15 173.94 13.65 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.268 1.978 . . . . 0.0 112.125 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.72 166.82 3.06 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.343 0.657 . . . . 0.0 112.103 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.26 8.5 t 43.07 38.19 1.41 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.076 1.75 . . . . 0.0 113.396 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -148.74 151.41 34.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.039 1.736 . . . . 0.0 111.592 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.12 -175.62 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.32 . . . . 0.0 109.373 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -156.75 145.16 19.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.964 1.305 . . . . 0.0 109.368 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' HB1' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -124.34 155.08 39.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.25 1.02 . . . . 0.0 110.082 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.461 ' CE1' HG23 ' A' ' 57' ' ' VAL . 2.3 t80 -139.45 169.2 18.19 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 109.793 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -154.49 -177.8 6.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.339 1.055 . . . . 0.0 110.722 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.11 -167.03 12.79 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.354 1.93 . . . . 0.0 110.903 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -135.71 -162.68 1.29 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -114.89 -14.78 11.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.117 2.167 . . . . 0.0 114.45 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.97 -64.31 0.51 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.998 1.719 . . . . 0.0 114.769 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 11.1 25.49 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.611 1.564 . . . . 0.0 112.495 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.85 77.18 0.13 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.035 1.303 . . . . 0.0 113.426 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.76 21.94 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.921 1 C-N-CA 126.301 4.667 . . . . 0.0 116.347 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.461 HG21 HG21 ' A' ' 85' ' ' VAL . 8.9 p -32.65 101.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 129.028 2.931 . . . . 0.0 113.203 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 38.45 -95.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.91 2.484 . . . . 0.0 111.455 -175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.7 p -143.43 154.99 44.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.921 2.488 . . . . 0.0 108.173 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.84 -130.04 9.67 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.774 -1.204 . . . . 0.0 111.601 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -159.79 175.85 12.64 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.729 1.211 . . . . 0.0 112.145 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.49 ' H ' ' CB ' ' A' ' 52' ' ' SER . 47.1 t -152.36 114.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.357 2.263 . . . . 0.0 112.719 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -143.98 167.0 23.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.488 1.515 . . . . 0.0 110.448 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 122.95 10.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.255 1.422 . . . . 0.0 107.45 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -139.23 164.01 30.95 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 112.315 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 130' ' ' MET . . . -124.11 151.73 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.702 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 24.2 m-85 -131.83 112.16 12.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.958 1.703 . . . . 0.0 110.937 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -65.91 105.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.252 1.421 . . . . 0.0 110.655 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -73.47 153.46 40.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.203 1.001 . . . . 0.0 110.998 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.5 p -59.63 -20.56 56.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -76.27 -4.45 42.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 114.058 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.1 6.3 71.84 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.293 1.425 . . . . 0.0 114.851 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.59 177.28 5.86 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.235 1.414 . . . . 0.0 111.293 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.599 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 17.9 m -133.48 112.0 11.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.323 1.049 . . . . 0.0 113.12 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 tp -73.45 122.84 22.78 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.66 108.57 3.14 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.0 154.76 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.337 0.589 . . . . 0.0 110.828 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.526 ' CB ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -138.38 148.22 44.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.532 1.133 . . . . 0.0 108.924 175.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 21.3 p90 -162.17 147.05 12.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.234 1.016 . . . . 0.0 110.488 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 85' ' ' VAL . 24.2 m -151.55 165.4 34.36 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.94 1.296 . . . . 0.0 108.379 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.51 96.68 23.39 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.67 -32.62 11.58 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.976 2.451 . . . . 0.0 114.718 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.6 t80 51.41 100.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 128.198 2.599 . . . . 0.0 115.618 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.77 -168.3 3.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.209 1.404 . . . . 0.0 110.742 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.0 154.69 3.95 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.221 1.409 . . . . 0.0 112.371 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -58.28 -31.37 67.39 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.234 1.014 . . . . 0.0 112.583 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 38.26 0.73 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.456 1.502 . . . . 0.0 113.89 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -129.51 155.98 44.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.657 1.583 . . . . 0.0 112.754 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 t -91.18 175.11 7.06 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.301 1.44 . . . . 0.0 110.444 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.62 156.63 48.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.023 1.729 . . . . 0.0 111.122 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -84.16 144.41 29.01 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.259 1.024 . . . . 0.0 112.547 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -153.45 150.93 29.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.472 0.653 . . . . 0.0 111.831 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.61 151.21 4.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.046 1.338 . . . . 0.0 111.079 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.0 135.55 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.261 1.824 . . . . 0.0 108.748 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -146.43 155.01 42.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.102 1.361 . . . . 0.0 109.872 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.16 107.16 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.396 1.478 . . . . 0.0 107.863 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.66 104.83 4.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.277 1.031 . . . . 0.0 109.22 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t -65.6 97.02 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.799 -1.188 . . . . 0.0 110.097 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.8 19.26 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 127.194 2.33 . . . . 0.0 110.317 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -126.93 129.85 48.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.107 1.763 . . . . 0.0 111.018 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.75 121.68 5.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.841 1.657 . . . . 0.0 111.563 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.59 175.36 5.66 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.483 1.113 . . . . 0.0 110.85 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -84.59 115.06 22.42 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.71 -0.619 . . . . 0.0 111.905 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -151.27 -174.53 4.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.441 1.096 . . . . 0.0 111.682 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.56 -51.7 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.512 1.125 . . . . 0.0 110.668 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.06 46.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.202 0.906 . . . . 0.0 113.83 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 2.7 ttt -66.04 -65.2 0.71 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.629 0.714 . . . . 0.0 110.185 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -54.14 -31.78 53.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.47 1.108 . . . . 0.0 112.683 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.47 -47.88 82.05 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.802 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -23.69 67.44 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.464 -1.397 . . . . 0.0 113.806 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.526 HD13 ' CB ' ' A' ' 101' ' ' MET . 76.5 mt -79.09 -18.17 53.81 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.431 1.492 . . . . 0.0 114.44 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.76 -31.33 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.905 1.282 . . . . 0.0 114.433 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.52 -5.74 13.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.0 2.12 . . . . 0.0 112.268 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.03 -88.68 0.46 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.244 1.878 . . . . 0.0 110.744 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -160.98 73.08 2.7 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.695 1.598 . . . . 0.0 111.692 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.26 177.63 8.37 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.731 2.287 . . . . 0.0 114.914 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -127.03 -178.24 4.34 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.231 2.212 . . . . 0.0 113.056 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 144.65 48.85 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.378 -1.451 . . . . 0.0 111.848 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.97 116.5 0.76 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.587 1.089 . . . . 0.0 111.952 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -115.46 68.78 0.72 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.348 1.459 . . . . 0.0 112.83 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 64.55 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.281 2.633 . . . . 0.0 113.758 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.78 142.11 3.48 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.982 1.277 . . . . 0.0 112.5 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -67.82 147.9 51.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.481 0.713 . . . . 0.0 111.951 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -148.41 122.82 9.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.706 1.602 . . . . 0.0 110.926 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.12 141.58 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.987 0.915 . . . . 0.0 111.633 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -146.01 148.85 33.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.352 0.596 . . . . 0.0 110.452 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.53 92.72 8.6 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.494 HD13 ' SD ' ' A' ' 157' ' ' MET . 2.4 tp -51.92 -32.16 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.99 21.97 5.46 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -128.44 20.43 6.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.875 1.338 . . . . 0.0 114.445 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.85 12.11 83.11 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.348 -0.845 . . . . 0.0 113.827 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.87 166.97 23.2 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.41 1.884 . . . . 0.0 111.633 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 169.74 13.2 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.26 1.424 . . . . 0.0 109.824 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -145.81 167.52 23.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.897 175.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 137.02 54.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.295 1.438 . . . . 0.0 108.253 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.06 141.36 15.83 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.536 0.589 . . . . 0.0 112.632 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.22 101.97 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.516 1.526 . . . . 0.0 111.089 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.5 tpt -96.63 105.08 17.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.982 1.264 . . . . 0.0 110.998 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.8 p -114.7 145.36 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.08 0.952 . . . . 0.0 111.449 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -137.86 139.56 39.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.865 1.666 . . . . 0.0 111.968 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.6 -179.29 0.11 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 130.344 3.458 . . . . 0.0 108.744 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.09 -12.86 45.92 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 115.077 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.21 11.28 0.91 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.76 1.624 . . . . 0.0 114.769 -175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.96 169.11 12.76 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.546 -1.346 . . . . 0.0 113.745 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 19.6 tptt -167.14 151.36 6.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 113.091 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.6 ptm -81.19 165.76 21.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -154.37 161.0 41.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.332 1.453 . . . . 0.0 110.782 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 mm -123.14 135.35 63.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -118.12 126.99 53.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.411 1.084 . . . . 0.0 108.289 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 157' ' ' MET . 14.5 pt -110.82 117.0 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -156.05 145.02 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.372 0.669 . . . . 0.0 112.322 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.509 1.924 . . . . 0.0 112.003 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.851 0.358 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -36.21 13.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.423 1.089 . . . . 0.0 111.34 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.81 5.26 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 121.451 0.643 . . . . 0.0 110.188 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.43 -27.64 19.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.8 1.191 . . . . 0.0 113.039 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 p -145.79 155.27 42.82 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.109 1.364 . . . . 0.0 111.532 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -135.15 162.25 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.1 1.36 . . . . 0.0 110.435 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -72.51 -165.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 127.837 2.455 . . . . 0.0 111.231 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.05 -24.78 26.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.39 -19.62 34.89 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.53 1.062 . . . . 0.0 114.185 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.38 75.19 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.296 1.048 . . . . 0.0 111.81 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -85.67 -7.85 58.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.733 1.613 . . . . 0.0 114.15 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HD23 ' A' ' 17' ' ' LEU . 10.2 tt -63.92 149.94 46.09 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.204 1.002 . . . . 0.0 111.582 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -145.06 145.62 31.52 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.396 1.078 . . . . 0.0 110.528 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -51.77 -37.94 53.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.452 1.101 . . . . 0.0 113.359 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -56.26 -48.51 76.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.416 1.007 . . . . 0.0 112.651 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -52.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.658 1.583 . . . . 0.0 109.238 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.719 HD13 HD23 ' A' ' 21' ' ' LEU . 2.0 tm? -53.42 -41.39 65.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.537 1.535 . . . . 0.0 111.848 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.42 -51.95 67.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.414 1.486 . . . . 0.0 111.216 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -38.32 89.35 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.337 -0.852 . . . . 0.0 112.086 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.89 -51.09 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 110.959 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.891 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.0 pp -67.11 -33.98 76.63 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.52 -23.04 63.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.1 1.36 . . . . 0.0 113.404 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.47 -23.34 49.29 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.648 -1.282 . . . . 0.0 113.471 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 57' ' ' VAL . 3.0 tm? -57.82 -39.57 77.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.162 2.185 . . . . 0.0 112.629 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.38 111.79 0.48 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.429 1.014 . . . . 0.0 112.537 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.44 55.67 0.16 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.576 1.951 . . . . 0.0 113.939 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.48 174.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 127.449 2.299 . . . . 0.0 111.026 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.49 56.71 1.44 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.92 -1.112 . . . . 0.0 112.526 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.89 108.09 1.93 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.346 2.258 . . . . 0.0 109.304 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.38 123.44 14.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.43 1.092 . . . . 0.0 110.065 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.67 142.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -175.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -120.9 111.17 17.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.582 1.953 . . . . 0.0 110.722 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 71' ' ' TYR . 2.0 p -127.36 127.12 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.434 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.37 30.56 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.468 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.713 HG21 HD21 ' A' ' 98' ' ' LEU . 2.6 mp -136.85 142.49 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.874 1.27 . . . . 0.0 110.6 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.16 111.7 22.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.052 1.741 . . . . 0.0 111.546 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.88 89.65 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.132 1.773 . . . . 0.0 111.741 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -132.1 7.66 4.32 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.914 0.886 . . . . 0.0 112.684 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t -81.29 -6.98 59.47 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.55 20.02 36.06 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.594 1.092 . . . . 0.0 115.527 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.74 121.56 2.81 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.499 1.523 . . . . 0.0 111.667 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -57.43 144.13 37.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.594 1.558 . . . . 0.0 111.446 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.447 ' HH2' HG22 ' A' ' 35' ' ' ILE . 44.5 m0 -107.66 168.06 9.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.246 0.618 . . . . 0.0 112.547 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.8 m -153.74 105.16 2.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.895 2.078 . . . . 0.0 109.787 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.0 139.4 56.33 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.651 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -110.01 -54.56 2.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.38 1.072 . . . . 0.0 112.349 -176.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -153.53 171.15 19.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.17 0.988 . . . . 0.0 111.187 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 136.23 43.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.153 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -119.16 136.54 54.13 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.883 1.273 . . . . 0.0 110.286 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -161.96 145.26 12.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.643 1.577 . . . . 0.0 112.068 -176.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -115.61 -11.02 11.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.582 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -151.47 137.75 18.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.031 1.732 . . . . 0.0 112.128 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 39.1 3.17 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.017 0.818 . . . . 0.0 114.6 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 m -30.19 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.04 2.936 . . . . 0.0 113.158 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -71.94 162.81 28.91 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.282 -0.886 . . . . 0.0 112.732 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -132.61 5.88 4.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.159 0.983 . . . . 0.0 113.581 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG23 ' CE1' ' A' ' 71' ' ' TYR . 5.8 m -106.33 163.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.051 1.74 . . . . 0.0 112.523 -177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.81 123.44 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.867 1.267 . . . . 0.0 112.856 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.7 130.37 61.55 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -70.21 142.58 46.3 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.844 2.362 . . . . 0.0 109.696 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -85.2 -77.86 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.904 0.882 . . . . 0.0 110.59 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -100.86 149.25 24.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.632 1.173 . . . . 0.0 110.506 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.0 133.34 14.14 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.131 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.11 -151.69 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.257 3.972 . . . . 0.0 113.796 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -119.63 15.76 12.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.076 1.751 . . . . 0.0 113.678 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -141.61 18.24 2.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.882 1.673 . . . . 0.0 113.775 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -136.77 -173.3 3.4 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.974 1.309 . . . . 0.0 113.238 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.87 -178.49 6.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.492 1.517 . . . . 0.0 110.339 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -146.22 160.93 41.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.525 -0.734 . . . . 0.0 111.32 178.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.465 HD11 HD11 ' A' ' 17' ' ' LEU . 5.0 mt -141.39 157.3 45.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.481 1.112 . . . . 0.0 109.562 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CE1' HG23 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -140.67 159.04 43.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.191 1.796 . . . . 0.0 108.593 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.1 m -150.05 140.07 22.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 110.516 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.96 165.07 13.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.028 1.299 . . . . 0.0 114.272 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -134.15 130.64 37.6 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 113.773 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -79.72 52.9 1.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -92.74 -28.06 16.84 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.0 12.11 2.22 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.37 -88.15 0.23 Allowed Glycine 0 N--CA 1.473 1.138 0 O-C-N 120.692 -1.255 . . . . 0.0 114.734 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.24 -27.27 9.78 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.056 2.504 . . . . 0.0 112.81 -175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.275 87.9 t 43.18 -91.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.967 2.507 . . . . 0.0 113.574 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.89 13.8 0.47 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 83' ' ' GLY . 3.1 m -135.89 -172.02 3.01 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.552 2.341 . . . . 0.0 111.003 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.647 ' H ' HG22 ' A' ' 82' ' ' THR . . . -94.31 158.98 23.18 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.33 1.443 . . . . 0.0 115.445 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.65 38.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.083 1.753 . . . . 0.0 113.038 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.6 t -150.35 111.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.988 1.315 . . . . 0.0 113.131 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -140.57 164.61 29.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.228 1.014 . . . . 0.0 112.016 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 124.31 10.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.439 1.096 . . . . 0.0 108.972 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -132.95 160.6 36.6 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.183 0.993 . . . . 0.0 113.186 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -122.51 149.0 44.5 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 29.7 m-85 -127.58 114.41 17.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.827 2.051 . . . . 0.0 110.58 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB2' HD22 ' A' ' 46' ' ' LEU . 18.9 t80 -71.22 116.71 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 111.05 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.98 23.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.016 2.126 . . . . 0.0 111.491 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -19.7 30.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.74 1.65 22.36 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.97 39.64 11.43 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 125.403 1.478 . . . . 0.0 112.09 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.462 HD22 HG21 ' A' ' 119' ' ' ILE . 9.4 p-10 -137.59 170.59 15.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.008 2.523 . . . . 0.0 113.16 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.502 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.9 m -131.7 110.22 10.74 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 35' ' ' ILE . 34.2 tp -73.28 117.35 14.93 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.382 1.073 . . . . 0.0 110.384 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.43 117.16 5.78 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.08 0.847 . . . . 0.0 112.711 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.95 164.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.727 0.811 . . . . 0.0 110.832 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.428 ' HG2' ' H ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -144.05 161.37 38.97 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.243 175.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 14.9 p90 -166.59 160.44 15.15 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.718 1.207 . . . . 0.0 111.565 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 119.85 0.94 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.968 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.434 HG23 ' HA3' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -81.35 146.03 56.91 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -71.14 154.79 62.0 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.878 1.719 . . . . 0.0 109.712 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -147.95 135.93 21.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.819 1.647 . . . . 0.0 107.542 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.46 104.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.24 1.816 . . . . 0.0 115.259 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -57.25 -1.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.534 1.534 . . . . 0.0 114.79 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.0 -22.52 10.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.786 2.434 . . . . 0.0 112.426 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -144.61 157.78 44.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.408 2.283 . . . . 0.0 110.717 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.39 114.24 15.33 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.554 1.542 . . . . 0.0 111.034 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.9 p -169.29 127.08 0.96 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.435 1.494 . . . . 0.0 110.61 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -134.35 88.93 2.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.853 1.261 . . . . 0.0 110.729 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -72.81 143.25 47.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.626 0.77 . . . . 0.0 112.033 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -152.99 151.66 30.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.29 0.636 . . . . 0.0 109.914 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' A' ' 101' ' ' MET . 10.5 t0 -167.52 138.04 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.37 1.468 . . . . 0.0 109.305 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.56 134.21 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.783 1.233 . . . . 0.0 109.187 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HA ' HD11 ' A' ' 151' ' ' LEU . 5.5 tttp -152.41 155.49 37.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.41 1.084 . . . . 0.0 109.497 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.462 HG21 HD22 ' A' ' 96' ' ' ASN . 67.9 mt -109.37 101.72 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.03 99.25 0.63 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.134 -0.979 . . . . 0.0 109.39 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -66.1 87.15 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.231 1.015 . . . . 0.0 110.634 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.33 -134.33 3.32 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.512 2.482 . . . . 0.0 110.321 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -149.99 109.9 4.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.717 1.607 . . . . 0.0 111.33 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -144.53 120.7 10.82 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.223 1.809 . . . . 0.0 112.139 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 174.5 5.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.692 1.197 . . . . 0.0 110.771 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.61 114.47 20.32 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.566 . . . . 0.0 110.043 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.97 -165.85 1.59 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.847 1.659 . . . . 0.0 110.471 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.37 -50.4 30.76 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.971 1.308 . . . . 0.0 110.996 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.52 -27.77 54.79 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.427 1.013 . . . . 0.0 114.609 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.8 ttt -75.59 -61.3 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.041 0.921 . . . . 0.0 110.179 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -53.96 -32.24 53.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.903 1.281 . . . . 0.0 112.665 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.39 -42.97 99.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 107.478 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -30.37 70.2 Favored 'General case' 0 CA--C 1.559 1.315 0 O-C-N 120.769 -1.207 . . . . 0.0 108.034 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.2 mt -75.76 -37.52 59.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.672 1.589 . . . . 0.0 113.879 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -27.93 14.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.421 1.488 . . . . 0.0 114.766 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.4 -40.23 2.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.383 1.473 . . . . 0.0 112.225 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.6 -70.68 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.149 1.833 . . . . 0.0 112.401 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.46 73.38 4.33 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 142.48 63.34 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.997 1.798 . . . . 0.0 112.996 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -122.97 -178.92 4.09 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.898 2.079 . . . . 0.0 109.275 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.73 143.43 50.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.381 1.472 . . . . 0.0 112.472 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.23 101.53 2.8 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.368 1.461 . . . . 0.0 113.446 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.57 19.96 4.26 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 54.92 80.22 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.148 2.179 . . . . 0.0 113.234 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.34 165.84 23.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.029 1.299 . . . . 0.0 113.327 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.467 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 9.2 m95 -68.86 130.1 41.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.066 1.346 . . . . 0.0 111.586 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -139.48 118.8 12.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.63 1.172 . . . . 0.0 113.654 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.88 145.21 30.15 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.274 1.43 . . . . 0.0 109.541 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -143.84 156.39 44.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.9 1.28 . . . . 0.0 109.675 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.31 100.2 13.04 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 7.1 tp -55.94 -31.94 63.38 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.69 30.7 6.7 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 119.302 2.481 . . . . 0.0 119.302 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -131.67 -21.86 2.45 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.96 -15.67 1.74 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 118.666 0.666 . . . . 0.0 114.632 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.26 171.57 13.16 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 126.169 1.788 . . . . 0.0 110.029 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.18 164.44 19.48 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.322 1.049 . . . . 0.0 110.637 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.543 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.2 OUTLIER -143.96 164.15 31.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.464 1.126 . . . . 0.0 112.757 177.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -128.57 125.39 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.227 1.811 . . . . 0.0 108.473 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.96 153.27 17.69 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.533 1.54 . . . . 0.0 112.863 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -129.48 149.73 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.728 1.611 . . . . 0.0 109.687 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.557 ' N ' HD13 ' A' ' 160' ' ' ILE . 6.6 tpt -150.2 119.06 6.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.247 1.819 . . . . 0.0 109.387 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.535 HG23 HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -127.9 122.46 32.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.313 1.845 . . . . 0.0 111.472 -175.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.9 p -87.85 73.61 9.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.885 1.674 . . . . 0.0 112.397 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.45 17.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.227 1.011 . . . . 0.0 113.021 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.87 -7.41 88.0 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.89 1.233 . . . . 0.0 114.459 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -125.53 7.92 7.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.136 2.175 . . . . 0.0 113.721 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -128.59 174.31 9.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.18 1.392 . . . . 0.0 112.575 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.4 OUTLIER -161.42 -178.55 6.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.965 1.706 . . . . 0.0 112.906 -178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.437 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -106.85 151.81 24.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.479 1.911 . . . . 0.0 109.983 178.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.436 ' C ' HD12 ' A' ' 171' ' ' ILE . 28.7 tt0 -162.26 148.1 13.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.269 1.428 . . . . 0.0 108.82 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 170' ' ' GLN . 1.7 mp -123.18 136.24 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.688 0.795 . . . . 0.0 108.94 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -121.46 124.58 44.81 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.296 1.039 . . . . 0.0 108.71 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.543 HG22 ' HB3' ' A' ' 157' ' ' MET . 5.3 pt -94.99 145.53 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.778 0.831 . . . . 0.0 109.51 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.5 t -159.0 170.01 23.03 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.788 -0.57 . . . . 0.0 112.171 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.972 1.709 . . . . 0.0 112.682 177.93 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.351 0.119 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.49 -44.17 2.0 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.238 1.415 . . . . 0.0 111.239 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.15 -174.31 0.48 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.578 0.751 . . . . 0.0 110.469 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.36 -31.76 7.12 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.402 -1.436 . . . . 0.0 111.538 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 p -146.39 155.96 42.97 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.543 1.537 . . . . 0.0 110.902 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.496 HG13 HD23 ' A' ' 70' ' ' LEU . 41.7 mm -136.56 166.91 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 126.334 1.854 . . . . 0.0 109.815 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -165.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.731 1.613 . . . . 0.0 111.339 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -51.12 -32.84 23.99 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.96 -14.65 37.45 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.995 1.283 . . . . 0.0 113.8 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.31 63.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.49 1.145 . . . . 0.0 111.291 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -85.71 -9.89 56.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.627 1.571 . . . . 0.0 114.258 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.49 143.2 54.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.454 1.101 . . . . 0.0 110.119 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.2 143.12 24.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.641 0.776 . . . . 0.0 109.959 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.06 -32.6 68.17 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -54.78 -51.06 66.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.452 1.101 . . . . 0.0 113.02 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.03 -52.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.523 HD21 ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -53.18 -39.96 64.02 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.89 1.276 . . . . 0.0 112.432 -175.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -52.22 -63.99 0.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.334 2.254 . . . . 0.0 110.237 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -66.51 -23.01 66.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -46.1 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.702 1.137 . . . . 0.0 111.91 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.29 -26.38 61.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.205 1.002 . . . . 0.0 111.412 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.46 -43.35 49.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.489 1.916 . . . . 0.0 113.861 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -23.57 2.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.977 1.711 . . . . 0.0 114.841 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.55 -31.0 70.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.607 2.363 . . . . 0.0 114.826 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.7 -160.29 9.13 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.63 2.538 . . . . 0.0 111.99 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -146.53 83.83 1.61 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.656 1.582 . . . . 0.0 112.005 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.74 145.26 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.914 1.686 . . . . 0.0 110.659 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 m -70.57 18.99 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 119.86 -1.775 . . . . 0.0 114.968 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.18 142.04 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.069 2.547 . . . . 0.0 111.559 -175.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.45 -172.46 3.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.767 1.627 . . . . 0.0 113.013 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.561 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -126.03 145.28 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 127.504 2.321 . . . . 0.0 112.335 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -138.46 129.08 26.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 127.195 2.198 . . . . 0.0 111.819 175.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 102' ' ' PHE . 2.4 t -129.43 144.98 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 120.26 1.391 . . . . 0.0 112.033 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.42 174.62 46.41 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.382 0.513 . . . . 0.0 114.382 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.53 HG21 HD21 ' A' ' 98' ' ' LEU . 3.3 mp -140.75 114.73 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.247 1.819 . . . . 0.0 108.61 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.51 106.0 1.32 Allowed 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.403 -1.436 . . . . 0.0 110.966 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . 9.5 t-20 -82.03 92.95 6.88 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 123.519 1.628 . . . . 0.0 112.143 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.81 43.74 1.59 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.391 1.076 . . . . 0.0 110.525 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -2.22 16.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.295 1.838 . . . . 0.0 114.433 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.88 17.06 73.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.569 1.081 . . . . 0.0 115.046 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.19 129.35 5.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.949 1.737 . . . . 0.0 111.422 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -79.18 118.79 21.46 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 117.93 0.865 . . . . 0.0 109.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.683 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 5.9 m0 -88.03 161.66 17.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 m -137.86 107.74 6.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.33 1.852 . . . . 0.0 110.618 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -64.57 156.01 31.24 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.069 -1.02 . . . . 0.0 111.461 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -57.98 1.2 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.098 1.359 . . . . 0.0 112.438 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -147.69 167.99 23.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.285 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.25 137.63 40.97 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.357 1.463 . . . . 0.0 110.705 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.522 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 t80 -126.71 134.08 50.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.246 1.419 . . . . 0.0 110.355 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -142.41 155.47 45.12 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.059 2.144 . . . . 0.0 110.419 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -119.95 -44.23 2.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.277 1.431 . . . . 0.0 111.624 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -121.46 97.36 5.47 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.022 1.329 . . . . 0.0 111.479 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.63 109.34 2.78 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.92 1.247 . . . . 0.0 112.662 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -64.68 179.66 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.575 1.15 . . . . 0.0 113.231 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -65.6 152.89 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.598 1.559 . . . . 0.0 113.141 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -147.25 -21.66 0.39 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.49 164.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.294 2.238 . . . . 0.0 111.954 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 tt -73.59 130.66 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.925 0.89 . . . . 0.0 109.95 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 tp -78.91 128.42 76.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.677 ' CG ' HD12 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -67.59 126.82 15.36 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.782 2.988 . . . . 0.0 111.067 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.55 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.296 -0.878 . . . . 0.0 112.531 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -109.72 143.83 38.96 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.449 1.1 . . . . 0.0 110.389 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.75 86.99 53.69 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.384 1.074 . . . . 0.0 109.192 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.98 136.93 16.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.061 2.507 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -46.94 146.73 1.56 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.786 1.235 . . . . 0.0 112.705 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.327 1.4 p 74.47 32.55 0.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.125 2.17 . . . . 0.0 111.996 -175.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 61.6 mttt -150.4 146.98 27.02 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.013 2.125 . . . . 0.0 110.799 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.65 -177.91 3.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.314 1.046 . . . . 0.0 109.588 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.677 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -155.75 142.8 19.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.529 0.732 . . . . 0.0 110.64 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -113.32 -179.85 3.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.558 0.743 . . . . 0.0 110.433 174.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -159.01 159.33 34.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.905 1.682 . . . . 0.0 109.318 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -138.19 164.01 30.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.069 1.348 . . . . 0.0 110.89 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.94 -179.9 16.46 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.74 1.162 . . . . 0.0 113.398 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.37 31.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -116.58 50.16 1.09 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.159 1.783 . . . . 0.0 113.738 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.23 105.69 0.36 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.299 1.44 . . . . 0.0 113.036 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.9 m 58.85 7.19 0.74 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 127.739 2.416 . . . . 0.0 115.01 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.29 66.46 1.39 Allowed Glycine 0 CA--C 1.539 1.559 0 O-C-N 120.002 -1.686 . . . . 0.0 111.23 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 -53.32 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.596 3.53 . . . . 0.0 110.65 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -108.29 167.45 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.372 2.269 . . . . 0.0 106.709 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . . . -52.12 -58.02 7.84 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.276 1.031 . . . . 0.0 111.817 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.5 p -143.86 148.64 35.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.473 1.909 . . . . 0.0 109.841 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.05 -120.56 14.03 Favored Glycine 0 CA--C 1.545 1.965 0 O-C-N 120.366 -1.459 . . . . 0.0 115.764 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -159.53 175.69 12.95 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.366 2.267 . . . . 0.0 112.662 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 103' ' ' SER . 61.6 t -140.86 123.99 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 127.982 2.513 . . . . 0.0 111.248 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -153.01 177.01 11.25 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.219 1.009 . . . . 0.0 111.875 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.7 125.71 11.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.345 1.458 . . . . 0.0 107.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -136.69 162.65 32.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.046 0.939 . . . . 0.0 110.52 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -133.11 150.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.454 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.3 m-85 -124.88 123.49 40.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.534 1.534 . . . . 0.0 110.758 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.41 109.0 2.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.189 1.796 . . . . 0.0 110.881 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.0 mtp -71.63 155.36 40.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.67 0.788 . . . . 0.0 111.68 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -58.17 -30.46 66.43 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 113.164 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 1.26 11.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.909 1.684 . . . . 0.0 114.687 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.65 9.29 85.82 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.756 -1.215 . . . . 0.0 114.341 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -89.05 178.87 6.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.079 1.752 . . . . 0.0 109.819 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.61 HG22 ' HB1' ' A' ' 89' ' ' ALA . 28.8 m -142.58 110.25 5.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.398 -1.439 . . . . 0.0 111.488 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD21 HG21 ' A' ' 35' ' ' ILE . 27.3 tp -77.09 121.02 22.98 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.67 107.64 3.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.483 1.516 . . . . 0.0 112.857 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.06 168.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 122.273 1.035 . . . . 0.0 111.377 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.446 ' SD ' ' CZ3' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -146.46 157.54 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.606 1.962 . . . . 0.0 109.511 174.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 51.8 p90 -165.08 134.07 3.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.031 1.332 . . . . 0.0 108.374 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 85' ' ' VAL . 37.4 m -147.05 130.61 16.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.116 0.567 . . . . 0.0 110.165 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.3 132.54 42.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.902 -0.571 . . . . 0.0 111.203 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.61 161.35 46.37 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.773 2.315 . . . . 0.0 113.038 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -115.33 -21.86 9.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 113.325 177.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.23 165.51 20.36 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.935 0.874 . . . . 0.0 111.407 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -140.62 -48.29 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.18 2.192 . . . . 0.0 110.77 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -72.39 -35.4 68.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.387 1.075 . . . . 0.0 112.349 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 96.38 4.71 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.776 1.63 . . . . 0.0 111.821 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -67.13 112.36 4.4 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.09 0.956 . . . . 0.0 111.365 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -159.93 122.0 3.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.372 1.469 . . . . 0.0 109.328 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.15 155.21 50.49 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.92 0.888 . . . . 0.0 110.79 175.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CZ3' ' SD ' ' A' ' 101' ' ' MET . 40.8 p-90 -84.38 152.93 23.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.635 0.774 . . . . 0.0 110.358 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -158.97 128.48 5.58 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 109.452 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -177.82 126.73 0.13 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.766 1.227 . . . . 0.0 111.12 -176.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.61 HG11 HG13 ' A' ' 171' ' ' ILE . 5.5 m -118.01 166.74 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.314 1.046 . . . . 0.0 111.927 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.91 158.17 43.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.107 0.963 . . . . 0.0 111.39 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.27 106.7 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.01 1.724 . . . . 0.0 107.195 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.39 99.13 2.87 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.055 -1.028 . . . . 0.0 108.954 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.4 t -65.63 88.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.822 -1.174 . . . . 0.0 110.911 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.47 -141.39 8.85 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.691 2.091 . . . . 0.0 110.633 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -128.81 124.02 34.32 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.956 1.702 . . . . 0.0 111.284 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -149.25 120.03 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.471 1.508 . . . . 0.0 111.383 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.61 170.6 10.43 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.322 0.649 . . . . 0.0 110.633 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.28 115.71 18.19 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.71 -178.4 7.26 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.909 1.284 . . . . 0.0 113.629 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -51.79 -41.04 61.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.349 1.46 . . . . 0.0 113.778 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.93 88.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.091 0.853 . . . . 0.0 112.75 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.7 ttm -64.68 -50.97 64.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.797 0.799 . . . . 0.0 110.437 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -61.11 -34.1 74.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.691 0.797 . . . . 0.0 112.769 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.74 -35.14 79.59 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.784 -1.198 . . . . 0.0 111.532 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -12.71 55.85 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.785 -1.197 . . . . 0.0 113.566 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 mt -91.69 -54.1 4.02 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.336 1.855 . . . . 0.0 109.318 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -75.37 -43.32 50.97 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.84 -35.4 7.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.818 1.247 . . . . 0.0 112.999 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -48.79 -69.33 1.01 Allowed Glycine 0 N--CA 1.47 0.911 0 C-N-CA 125.234 1.397 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -164.47 84.27 1.2 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.994 0.917 . . . . 0.0 111.591 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.78 143.92 38.17 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.914 1.743 . . . . 0.0 113.158 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' ASP . 2.3 m-85 -114.92 -168.57 1.4 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.397 1.479 . . . . 0.0 112.003 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.79 127.82 48.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.72 2.008 . . . . 0.0 111.787 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.85 96.02 0.64 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 125.04 1.305 . . . . 0.0 114.48 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.91 79.65 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.254 1.421 . . . . 0.0 111.748 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.7 p30 35.28 67.27 0.27 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.835 2.454 . . . . 0.0 115.363 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 135.6 3.48 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.374 0.987 . . . . 0.0 113.231 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -64.88 144.89 56.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.333 1.053 . . . . 0.0 111.646 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -145.36 135.67 24.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.556 1.142 . . . . 0.0 112.121 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -119.39 144.82 46.7 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 110.399 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -151.77 163.66 38.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.623 1.169 . . . . 0.0 110.894 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.32 91.78 7.38 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.35 -34.51 47.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.873 1.269 . . . . 0.0 113.871 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 115.58 39.05 0.94 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 118.037 1.975 . . . . 0.0 118.037 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -137.02 -32.78 0.78 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.87 -23.57 1.15 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.149 1.357 . . . . 0.0 114.006 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 173.09 6.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.478 1.911 . . . . 0.0 111.242 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -127.15 160.02 32.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.841 1.256 . . . . 0.0 110.509 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.499 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -145.41 161.34 39.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.366 0.603 . . . . 0.0 111.9 177.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.87 132.01 56.77 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.257 1.423 . . . . 0.0 107.293 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.75 153.79 16.67 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.106 0.86 . . . . 0.0 112.648 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.7 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.46 151.83 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.657 1.183 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 21.1 tpp -147.43 91.88 2.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.656 1.583 . . . . 0.0 109.124 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.7 HG23 HD11 ' A' ' 160' ' ' ILE . 3.1 p -76.5 150.12 36.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 109.852 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 m -44.37 -69.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.312 1.845 . . . . 0.0 115.711 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -176.03 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.933 1.693 . . . . 0.0 112.398 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -47.15 89.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.212 0 C-N-CA 128.102 2.763 . . . . 0.0 115.432 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 45.5 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.078 2.151 . . . . 0.0 112.339 -175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -143.43 159.42 42.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 113.426 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 2.2 mmtm -148.03 173.2 13.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.555 1.542 . . . . 0.0 113.922 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.3 ptm -99.49 154.56 18.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.994 1.717 . . . . 0.0 112.15 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -160.73 157.15 26.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.61 HG13 HG11 ' A' ' 117' ' ' VAL . 45.4 mm -123.64 120.83 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.037 1.335 . . . . 0.0 109.573 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.43 101.64 12.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.407 1.083 . . . . 0.0 110.682 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.683 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 24.8 pt -91.66 133.33 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.134 0.574 . . . . 0.0 110.338 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.1 t -150.61 157.55 43.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.649 1.179 . . . . 0.0 111.386 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.608 1.163 . . . . 0.0 112.268 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -71.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.591 1.087 . . . . 0.0 111.263 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 170.35 179.23 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.659 3.584 . . . . 0.0 107.759 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.76 -34.6 1.63 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.863 -1.148 . . . . 0.0 113.691 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -135.04 146.43 48.97 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.891 1.346 . . . . 0.0 111.675 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' CD1' HD12 ' A' ' 70' ' ' LEU . 31.0 mm -136.05 177.83 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.278 1.831 . . . . 0.0 109.443 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.32 165.52 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.868 2.067 . . . . 0.0 110.755 176.152 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . . . -58.13 -28.95 65.14 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.186 -1.571 . . . . 0.0 115.068 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.87 -7.26 3.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.389 1.471 . . . . 0.0 114.108 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 -35.56 63.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.115 1.366 . . . . 0.0 113.848 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -120.73 -2.18 9.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.301 1.441 . . . . 0.0 113.971 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 17' ' ' LEU . 12.7 tp -86.68 133.56 33.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.931 0.892 . . . . 0.0 112.012 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.7 m -144.75 -94.54 0.1 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.213 1.005 . . . . 0.0 110.16 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -158.68 -38.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.679 1.992 . . . . 0.0 110.804 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -52.81 -56.1 18.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.53 -47.16 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.931 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.73 -43.3 68.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.533 1.133 . . . . 0.0 113.314 -176.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.37 -62.08 1.84 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.361 2.264 . . . . 0.0 110.392 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -67.07 -30.46 70.52 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 117.803 -1.094 . . . . 0.0 113.658 176.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -52.26 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.212 1.369 . . . . 0.0 109.453 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -64.63 -33.55 76.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.64 0.376 . . . . 0.0 111.685 -177.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.47 -33.21 58.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 114.763 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -21.59 11.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.596 1.158 . . . . 0.0 113.829 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -48.49 -31.85 7.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.727 175.028 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.44 -146.07 4.45 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.693 0.663 . . . . 0.0 113.15 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -120.29 18.31 12.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.467 1.907 . . . . 0.0 113.124 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.87 -12.45 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.035 1.334 . . . . 0.0 113.803 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.11 19.89 4.06 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.485 2.314 . . . . 0.0 113.988 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -179.52 125.44 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.773 2.829 . . . . 0.0 108.765 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HB2' HD12 ' A' ' 21' ' ' LEU . 35.8 mmtt -137.62 -159.75 0.99 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.077 1.351 . . . . 0.0 109.812 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.37 152.36 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.438 1.895 . . . . 0.0 111.061 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.95 114.72 20.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.131 1.773 . . . . 0.0 108.592 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.4 p -121.75 133.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.449 1.5 . . . . 0.0 110.201 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.67 177.77 38.18 Favored Glycine 0 N--CA 1.454 -0.143 0 O-C-N 121.492 -0.755 . . . . 0.0 112.392 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.1 mp -138.95 146.9 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.247 1.019 . . . . 0.0 110.471 -174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 106.83 19.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.293 1.837 . . . . 0.0 111.474 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.99 98.54 8.65 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.286 1.035 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -138.1 13.07 2.86 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -9.0 59.86 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.06 31.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 130.33 4.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.282 1.42 . . . . 0.0 112.217 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.1 m -62.25 141.51 58.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.94 1.696 . . . . 0.0 111.347 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 46.4 m0 -104.65 170.09 8.08 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.8 m -152.04 107.26 3.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.81 2.044 . . . . 0.0 110.555 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.18 152.33 45.64 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.855 -1.153 . . . . 0.0 109.807 175.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.11 -43.4 2.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.93 0.892 . . . . 0.0 112.357 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.76 -175.47 1.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.826 2.051 . . . . 0.0 110.578 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.45 139.03 18.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.421 . . . . 0.0 110.678 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.88 112.98 24.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.573 1.549 . . . . 0.0 109.174 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.73 150.52 35.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.189 2.195 . . . . 0.0 109.418 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.29 -43.58 2.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 111.089 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -137.32 111.91 8.73 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.029 1.332 . . . . 0.0 111.941 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.39 88.87 1.72 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 124.658 1.123 . . . . 0.0 111.99 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.6 m -81.16 99.17 8.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.229 1.012 . . . . 0.0 110.976 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 71' ' ' TYR . 13.7 t -63.37 166.5 6.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -128.92 -4.01 5.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.848 1.659 . . . . 0.0 113.648 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' CE1' ' A' ' 71' ' ' TYR . 27.6 m -87.8 160.0 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.026 0.931 . . . . 0.0 112.564 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.35 126.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 112.793 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tt -86.33 119.72 71.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.866 1.266 . . . . 0.0 109.36 175.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 127.42 17.13 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 124.111 3.207 . . . . 0.0 111.438 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 2.3 pm0 -79.44 -68.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.341 -0.849 . . . . 0.0 111.078 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.14 143.17 31.56 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.785 -0.572 . . . . 0.0 110.434 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.92 134.08 25.54 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 109.03 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.03 152.3 45.8 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.392 2.728 . . . . 0.0 111.858 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -65.38 17.04 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.856 2.462 . . . . 0.0 116.339 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 3.0 p -149.18 34.41 0.73 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 128.732 2.813 . . . . 0.0 111.162 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -153.46 163.86 39.21 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.414 -1.429 . . . . 0.0 112.201 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.05 175.02 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 111.401 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -144.68 159.74 42.33 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.338 0.655 . . . . 0.0 111.789 175.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.74 ' CD1' HD21 ' A' ' 17' ' ' LEU . 17.7 mt -139.21 158.81 43.52 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.784 1.234 . . . . 0.0 109.179 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -138.29 163.17 32.48 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.933 2.493 . . . . 0.0 108.019 175.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -151.04 178.26 9.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.214 1.806 . . . . 0.0 108.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.46 -177.51 31.62 Favored Glycine 0 N--CA 1.471 0.985 0 O-C-N 121.083 -1.011 . . . . 0.0 113.612 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.47 162.28 36.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -80.99 83.26 6.75 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.167 1.387 . . . . 0.0 111.634 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.59 -14.62 62.93 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -157.8 21.74 0.27 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.94 2.096 . . . . 0.0 113.406 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 66.55 39.6 93.97 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 120.078 -1.639 . . . . 0.0 113.032 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 94.2 Cg_endo -71.29 -44.54 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.728 3.618 . . . . 0.0 114.927 -175.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 84' ' ' ALA . 7.5 p -108.1 154.77 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.138 1.775 . . . . 0.0 107.373 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.15 -48.42 70.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.44 -0.787 . . . . 0.0 111.5 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.97 145.1 23.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.749 2.42 . . . . 0.0 110.09 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.38 -118.31 5.82 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.692 -1.255 . . . . 0.0 115.37 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 80' ' ' VAL . . . -163.83 168.49 19.5 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.328 2.251 . . . . 0.0 112.535 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -143.75 115.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.368 2.667 . . . . 0.0 111.784 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -160.33 178.98 9.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.916 1.686 . . . . 0.0 110.614 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.28 115.37 3.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.835 1.254 . . . . 0.0 108.24 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -122.68 170.94 9.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.549 1.139 . . . . 0.0 113.031 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -134.44 154.13 51.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 40.8 m-85 -128.11 121.56 29.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.771 2.029 . . . . 0.0 112.376 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -74.03 104.75 4.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.445 1.898 . . . . 0.0 111.945 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 mtp -69.66 151.98 45.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.539 1.536 . . . . 0.0 113.02 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -30.65 65.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.483 1.513 . . . . 0.0 113.624 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -66.07 -13.73 60.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.588 1.155 . . . . 0.0 113.454 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.25 28.58 11.44 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.991 1.281 . . . . 0.0 114.175 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.37 168.75 10.34 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.757 1.623 . . . . 0.0 110.526 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.58 HG22 ' HB1' ' A' ' 89' ' ' ALA . 99.6 m -131.34 102.53 6.0 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.588 -1.32 . . . . 0.0 112.926 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 173' ' ' ILE . 9.9 tp -73.66 124.56 26.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.818 -1.176 . . . . 0.0 112.188 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.07 102.46 2.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.729 1.157 . . . . 0.0 112.226 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.3 p -66.33 171.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.161 0.984 . . . . 0.0 111.955 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 2.3 ttp -144.67 144.78 31.41 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.733 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 28.8 p90 -161.06 142.27 11.68 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -158.15 154.45 27.45 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.074 1.349 . . . . 0.0 110.166 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.3 t -111.35 101.07 49.69 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.52 123.3 9.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.89 2.393 . . . . 0.0 111.046 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -77.91 -167.95 1.12 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.466 1.106 . . . . 0.0 110.822 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t0 79.39 -46.78 0.37 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.191 2.597 . . . . 0.0 113.046 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 67.21 -49.24 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.445 3.098 . . . . 0.0 114.063 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -28.84 64.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.775 2.03 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.88 86.31 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.311 1.444 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -74.92 98.27 3.53 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.925 1.69 . . . . 0.0 111.18 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -176.07 105.46 0.07 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.329 1.852 . . . . 0.0 110.378 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.59 150.63 50.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.398 1.079 . . . . 0.0 110.547 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -86.49 158.28 19.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.904 0.882 . . . . 0.0 111.908 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.504 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.5 p-90 -160.97 162.13 31.8 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.874 1.27 . . . . 0.0 110.63 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 170.74 139.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.087 2.555 . . . . 0.0 110.511 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.478 HG21 HG13 ' A' ' 171' ' ' ILE . 19.4 t -140.87 122.09 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.663 1.585 . . . . 0.0 108.663 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -127.72 162.37 26.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.491 2.316 . . . . 0.0 109.886 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.495 HG13 HD21 ' A' ' 151' ' ' LEU . 63.6 mt -108.38 121.25 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.895 1.678 . . . . 0.0 108.489 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -84.11 101.99 12.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 t -52.92 139.61 26.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.16 -0.962 . . . . 0.0 111.025 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.04 -118.56 4.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.788 1.185 . . . . 0.0 110.336 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -136.07 137.35 41.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.233 1.813 . . . . 0.0 111.259 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -159.52 117.67 2.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.882 1.273 . . . . 0.0 112.734 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 174.49 4.7 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.919 0.888 . . . . 0.0 111.25 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.54 121.79 31.3 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.799 -0.563 . . . . 0.0 110.004 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.71 177.07 10.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.95 0.9 . . . . 0.0 111.156 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -52.06 -45.35 64.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.002 0.921 . . . . 0.0 112.075 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.93 -50.06 63.37 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.725 0.679 . . . . 0.0 112.685 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.74 -55.97 28.27 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.461 0.63 . . . . 0.0 110.303 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -44.68 36.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 112.608 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 1.4 tt0 -69.36 -33.52 73.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.747 1.619 . . . . 0.0 108.944 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.58 -14.9 2.35 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.113 1.365 . . . . 0.0 113.456 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 101' ' ' MET . 6.1 mp -90.49 -21.73 21.7 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.232 1.413 . . . . 0.0 113.785 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -97.5 -42.57 7.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.446 2.298 . . . . 0.0 113.151 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' A' ' 132' ' ' GLU . 2.2 p90 -115.09 -26.87 7.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.4 -32.12 81.87 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.349 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 176.35 71.16 0.08 OUTLIER Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 130.117 3.367 . . . . 0.0 111.714 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.47 142.32 48.9 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.644 2.229 . . . . 0.0 113.266 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -129.45 177.79 6.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.247 1.819 . . . . 0.0 112.848 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -115.97 125.85 53.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.921 2.088 . . . . 0.0 111.059 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.5 109.89 1.32 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.401 1.477 . . . . 0.0 109.545 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -160.05 89.17 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.436 1.494 . . . . 0.0 110.24 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.81 101.34 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.385 2.674 . . . . 0.0 115.147 174.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.13 134.54 3.33 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.102 1.334 . . . . 0.0 111.686 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 72.4 m95 -64.43 145.43 56.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.713 0.805 . . . . 0.0 112.176 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.19 130.47 19.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 112.743 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 156.92 47.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.055 2.142 . . . . 0.0 111.216 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.6 19.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.021 1.728 . . . . 0.0 111.585 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -64.55 102.22 0.53 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.349 1.46 . . . . 0.0 109.387 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.495 HD21 HG13 ' A' ' 119' ' ' ILE . 3.9 tp -57.94 -39.44 78.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.62 11.43 5.5 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -132.92 -34.11 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.131 1.466 . . . . 0.0 114.456 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 138.65 35.33 0.16 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.893 1.235 . . . . 0.0 113.98 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 156' ' ' ARG . 0.2 OUTLIER -157.82 163.46 37.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 110.591 175.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.574 ' N ' HD12 ' A' ' 155' ' ' LEU . 90.0 mtt180 -136.25 103.82 5.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.333 1.853 . . . . 0.0 112.55 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.688 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -85.09 159.97 20.07 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.159 176.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -122.68 139.1 54.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.767 174.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 171' ' ' ILE . . . -119.18 136.23 11.84 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.403 1.478 . . . . 0.0 113.292 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.9 tp -116.12 138.9 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.166 1.386 . . . . 0.0 111.145 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.1 tpt -121.87 130.98 53.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.427 1.012 . . . . 0.0 109.317 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 47.2 p -137.24 144.12 42.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.444 1.098 . . . . 0.0 110.28 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.3 t -148.33 -174.05 4.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.247 1.419 . . . . 0.0 111.56 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.09 42.26 5.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.789 2.035 . . . . 0.0 113.966 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.83 73.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.906 1.241 . . . . 0.0 112.637 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 35.92 67.07 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.98 2.512 . . . . 0.0 113.866 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -139.12 172.81 12.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.777 0.831 . . . . 0.0 112.822 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.32 171.49 20.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 112.541 -175.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -90.35 142.16 28.01 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.218 1.007 . . . . 0.0 112.048 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -133.13 155.8 48.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.625 1.57 . . . . 0.0 109.827 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.478 HG13 HG21 ' A' ' 117' ' ' VAL . 41.5 mm -123.91 125.41 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.847 1.259 . . . . 0.0 110.181 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -108.06 115.99 31.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.913 1.285 . . . . 0.0 110.113 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.688 HG22 ' HB3' ' A' ' 157' ' ' MET . 15.1 pt -96.42 129.76 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 0.0 110.157 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.5 m -171.65 172.09 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.025 1.33 . . . . 0.0 111.566 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.487 1.115 . . . . 0.0 113.008 178.072 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.427 ' HB3' HG22 ' A' ' 20' ' ' VAL . 3.1 mm? -100.52 -44.97 5.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 0.0 110.62 -176.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.42 -59.87 2.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.35 -36.84 0.16 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 126.786 2.136 . . . . 0.0 117.517 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.2 p -138.16 151.75 48.04 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 110.918 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 70' ' ' LEU . 25.0 mm -132.71 162.42 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.457 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 pt -70.36 -169.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.554 1.942 . . . . 0.0 110.409 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.33 -22.08 17.72 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.79 11.43 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.623 1.106 . . . . 0.0 113.714 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.86 83.82 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.284 1.042 . . . . 0.0 111.856 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -80.74 -9.61 59.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.859 1.264 . . . . 0.0 113.698 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 17' ' ' LEU . 1.2 tt -64.4 159.23 21.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.748 1.219 . . . . 0.0 112.636 175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.51 145.88 27.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.867 0.867 . . . . 0.0 109.846 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -56.32 -30.89 63.15 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -58.3 -52.96 63.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.061 0.944 . . . . 0.0 112.371 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.91 -46.56 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -51.82 -40.65 60.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.425 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.07 -58.04 9.26 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.382 1.473 . . . . 0.0 112.116 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -23.78 61.51 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -66.85 -44.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.087 1.312 . . . . 0.0 111.227 -178.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -74.5 -28.96 61.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.142 0.977 . . . . 0.0 112.189 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.14 -39.25 34.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.142 1.377 . . . . 0.0 112.185 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -48.32 -24.82 1.32 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.716 2.406 . . . . 0.0 113.263 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.503 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 6.5 tt -48.92 -40.81 31.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.287 1.835 . . . . 0.0 111.689 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -153.39 -154.93 6.94 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.439 1.495 . . . . 0.0 112.819 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -141.23 76.16 1.53 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.028 1.731 . . . . 0.0 111.043 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.98 164.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 112.465 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.74 -39.24 80.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.781 1.232 . . . . 0.0 113.947 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.35 140.01 37.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 0.0 110.714 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -157.73 127.33 5.99 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.818 0.847 . . . . 0.0 110.308 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.62 139.13 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.004 0.921 . . . . 0.0 112.917 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 70' ' ' LEU . . . -127.01 101.67 6.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.481 1.512 . . . . 0.0 113.462 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -107.81 118.24 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 120.259 -1.526 . . . . 0.0 109.695 174.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.86 155.56 23.82 Favored Glycine 0 N--CA 1.46 0.293 0 O-C-N 121.924 -0.485 . . . . 0.0 113.006 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.9 mp -133.81 99.46 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.532 0.733 . . . . 0.0 111.637 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.36 102.99 0.26 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.878 1.271 . . . . 0.0 111.655 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -90.72 106.18 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.735 0.778 . . . . 0.0 112.877 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.266 31.3 tt0 -150.7 19.54 0.81 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.02 0.914 . . . . 0.0 111.278 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -5.1 20.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.258 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.76 17.44 51.9 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.525 1.536 . . . . 0.0 114.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.55 115.26 0.85 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.815 1.674 . . . . 0.0 111.377 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.7 m -55.52 148.53 15.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.066 1.347 . . . . 0.0 111.466 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 10.8 m0 -119.72 172.51 7.64 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.572 -0.705 . . . . 0.0 112.63 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -136.15 113.22 10.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.063 2.145 . . . . 0.0 111.458 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -70.22 105.65 3.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.839 0.856 . . . . 0.0 110.648 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -66.26 -56.83 9.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.056 175.01 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -167.48 172.4 9.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.792 1.637 . . . . 0.0 111.549 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.65 135.41 34.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.78 2.032 . . . . 0.0 111.412 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.443 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.9 t80 -119.13 129.02 54.81 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.715 1.606 . . . . 0.0 110.107 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -138.72 126.28 21.93 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.36 2.264 . . . . 0.0 110.041 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.45 -16.92 19.95 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.202 1.401 . . . . 0.0 110.888 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -76.37 102.56 5.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.36 1.064 . . . . 0.0 110.151 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.94 -118.83 11.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.423 1.487 . . . . 0.0 113.654 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -136.72 -172.71 3.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.937 1.695 . . . . 0.0 111.148 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.517 HG23 ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -80.96 167.17 20.13 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.574 1.949 . . . . 0.0 112.36 174.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -144.96 -45.55 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.87 0.868 . . . . 0.0 110.834 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.86 156.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.553 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.31 142.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.926 1.29 . . . . 0.0 111.134 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.68 128.96 41.98 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.412 1.085 . . . . 0.0 110.0 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.58 116.52 3.83 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 124.636 3.557 . . . . 0.0 112.033 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.45 -33.82 63.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -124.08 150.91 44.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.103 0.961 . . . . 0.0 112.188 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.8 t -138.64 96.12 9.69 Favored Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 124.876 1.27 . . . . 0.0 108.239 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 171.75 14.56 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.238 1.959 . . . . 0.0 111.421 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -64.82 174.98 1.63 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.665 -0.647 . . . . 0.0 110.615 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 14.6 t 49.15 24.66 0.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.56 1.544 . . . . 0.0 113.783 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -151.77 130.12 12.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.709 2.004 . . . . 0.0 110.826 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.29 -173.67 2.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.652 1.215 . . . . 0.0 109.643 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.33 162.46 40.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.606 1.162 . . . . 0.0 109.835 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.62 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -131.78 166.35 21.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.566 1.174 . . . . 0.0 108.162 174.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.603 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.2 t80 -151.85 161.13 43.15 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.134 1.373 . . . . 0.0 107.95 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.503 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 49.5 m -155.42 146.03 22.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.12 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.84 -161.57 36.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.782 0.706 . . . . 0.0 111.774 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -145.26 174.79 10.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.193 1.397 . . . . 0.0 111.025 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -110.33 167.34 10.28 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.753 1.621 . . . . 0.0 110.639 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 153.22 -31.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 131.141 3.776 . . . . 0.0 112.515 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.21 17.4 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.34 -79.31 0.04 OUTLIER Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.492 -1.38 . . . . 0.0 113.417 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.77 12.16 2.51 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.148 3.232 . . . . 0.0 113.825 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.33 -28.24 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.009 1.323 . . . . 0.0 111.196 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.82 -6.59 11.03 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.796 2.438 . . . . 0.0 114.674 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.4 p -138.28 -154.24 0.52 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.236 1.814 . . . . 0.0 110.64 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.82 152.11 17.03 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.546 -1.346 . . . . 0.0 110.443 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 146.04 55.53 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.418 1.109 . . . . 0.0 112.281 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -147.63 135.17 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.732 2.013 . . . . 0.0 113.367 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.51 170.77 21.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.32 1.448 . . . . 0.0 110.803 174.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.06 114.98 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.226 1.41 . . . . 0.0 109.431 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -126.91 167.11 16.29 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.447 1.099 . . . . 0.0 112.24 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -126.54 154.15 44.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.12 0.568 . . . . 0.0 111.267 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -133.57 109.88 9.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.969 1.308 . . . . 0.0 113.337 -175.004 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -71.1 96.34 1.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.705 1.602 . . . . 0.0 111.03 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 151.7 45.09 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.836 -1.165 . . . . 0.0 111.339 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -16.36 15.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -70.34 1.33 5.06 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.657 1.983 . . . . 0.0 113.658 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.92 19.03 71.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.026 1.298 . . . . 0.0 114.013 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -121.3 175.81 5.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.035 1.734 . . . . 0.0 110.382 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.594 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 97.2 m -137.32 102.26 4.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.249 1.02 . . . . 0.0 112.956 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 35' ' ' ILE . 20.5 tp -69.12 115.8 8.83 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.441 -0.787 . . . . 0.0 110.339 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.99 111.9 3.96 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.7 151.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.415 1.086 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.675 ' HB2' HD13 ' A' ' 134' ' ' LEU . 12.1 tmm? -138.63 148.75 44.46 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.38 1.072 . . . . 0.0 110.002 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.7 p90 -157.21 159.57 37.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -164.46 150.57 10.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.1 t -108.73 98.59 29.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.04 162.07 41.57 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.588 1.526 . . . . 0.0 110.794 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -70.39 -174.62 0.87 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.661 1.185 . . . . 0.0 111.028 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -47.93 122.29 4.93 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.223 1.409 . . . . 0.0 112.71 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -55.26 109.42 0.54 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.675 1.19 . . . . 0.0 111.243 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -84.94 -49.17 8.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.479 0.712 . . . . 0.0 111.599 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -168.9 -50.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.45 1.5 . . . . 0.0 113.629 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -167.4 117.96 0.86 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.352 1.861 . . . . 0.0 109.545 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.67 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.268 1.827 . . . . 0.0 110.452 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.04 105.23 5.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.515 -0.74 . . . . 0.0 111.781 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -84.45 135.73 34.14 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.361 1.064 . . . . 0.0 113.128 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -151.4 125.56 9.3 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.128 0.971 . . . . 0.0 109.733 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.02 150.23 11.25 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.967 -1.083 . . . . 0.0 111.999 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.9 143.34 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.049 1.74 . . . . 0.0 110.138 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -135.47 126.48 27.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.42 1.488 . . . . 0.0 109.144 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.8 mt -93.27 100.04 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.237 1.015 . . . . 0.0 109.316 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -68.41 100.98 1.15 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.845 -1.159 . . . . 0.0 109.406 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 80.64 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.723 1.209 . . . . 0.0 111.132 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.35 -106.75 0.29 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.317 2.389 . . . . 0.0 111.22 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -156.56 150.3 24.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.369 1.868 . . . . 0.0 111.553 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -164.96 106.82 0.82 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.236 1.415 . . . . 0.0 113.877 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -59.43 153.4 19.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.368 1.067 . . . . 0.0 111.182 174.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -72.44 113.96 10.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.741 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.39 -175.76 5.21 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.633 1.173 . . . . 0.0 111.471 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.0 -46.07 68.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.408 -1.432 . . . . 0.0 111.909 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.2 -31.59 62.38 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.555 1.074 . . . . 0.0 113.767 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' HD11 ' A' ' 134' ' ' LEU . 12.6 tpt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -48.11 -39.46 20.5 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.432 1.093 . . . . 0.0 112.453 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.36 -42.17 96.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.203 1.001 . . . . 0.0 111.598 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.84 68.51 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.288 -1.508 . . . . 0.0 113.462 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 101' ' ' MET . 51.3 mt -90.24 -7.85 52.48 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.06 -27.31 3.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.45 1.5 . . . . 0.0 114.116 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.49 -37.11 3.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.729 1.212 . . . . 0.0 111.706 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.27 -67.53 1.33 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.229 1.871 . . . . 0.0 113.168 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.53 67.88 0.29 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.822 1.649 . . . . 0.0 113.429 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.66 173.02 15.21 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.938 1.759 . . . . 0.0 115.207 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.92 173.18 10.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.163 1.785 . . . . 0.0 112.972 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -115.8 137.61 51.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.724 2.01 . . . . 0.0 112.042 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -138.1 116.65 1.34 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.722 1.153 . . . . 0.0 111.541 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -126.25 69.95 1.23 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.74 94.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.13 2.572 . . . . 0.0 113.898 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.01 139.74 2.75 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.753 1.644 . . . . 0.0 111.49 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -70.25 127.44 32.78 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -129.53 146.29 51.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.589 1.156 . . . . 0.0 111.634 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -142.33 137.77 30.78 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.452 1.501 . . . . 0.0 110.362 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 158.33 43.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.713 1.205 . . . . 0.0 110.892 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 94.08 1.02 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.714 1.206 . . . . 0.0 109.553 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tp -51.53 -36.33 44.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.329 1.451 . . . . 0.0 113.752 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 120.38 33.97 0.98 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.11 -32.28 0.79 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.07 -28.3 0.9 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.987 1.28 . . . . 0.0 114.344 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 175.14 5.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.824 2.05 . . . . 0.0 112.541 175.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -118.19 145.38 45.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.222 1.009 . . . . 0.0 112.164 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.615 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -121.88 147.7 45.66 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 130.89 53.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.426 1.89 . . . . 0.0 107.851 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -123.11 155.16 17.26 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 122.149 0.861 . . . . 0.0 112.951 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.1 131.02 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.067 1.747 . . . . 0.0 108.505 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.1 tpp -126.42 103.31 7.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.403 0.547 . . . . 0.0 109.529 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 68.9 p -98.73 141.32 31.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.142 1.377 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 89.58 1.2 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.47 -0.769 . . . . 0.0 111.812 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.18 30.23 0.17 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.701 1.2 . . . . 0.0 114.083 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.85 134.12 1.76 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.888 1.232 . . . . 0.0 112.419 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 43.45 59.82 2.86 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.439 1.496 . . . . 0.0 112.576 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -137.56 163.43 31.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.925 1.29 . . . . 0.0 112.024 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 47.6 tptt -163.26 144.85 9.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.5 ptm -77.61 160.49 28.5 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.157 1.783 . . . . 0.0 113.927 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -154.21 160.93 42.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.173 1.789 . . . . 0.0 109.477 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.7 mm -131.84 113.99 23.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 C-N-CA 125.126 1.37 . . . . 0.0 109.692 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -110.63 139.82 45.54 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.72 0.808 . . . . 0.0 110.891 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' A' ' 157' ' ' MET . 10.2 pt -120.95 132.68 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.715 0.806 . . . . 0.0 109.731 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.2 p -148.05 161.47 41.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.329 . . . . 0.0 112.846 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.429 ' HB3' HG13 ' A' ' 20' ' ' VAL . 3.8 mt -55.61 -50.41 70.23 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 117.748 -1.12 . . . . 0.0 111.488 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.7 -49.33 4.25 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.555 1.07 . . . . 0.0 113.266 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.56 -33.15 1.42 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.53 1.538 . . . . 0.0 116.694 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.1 p -138.61 146.57 41.91 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.445 2.122 . . . . 0.0 111.972 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.41 161.44 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.781 -1.2 . . . . 0.0 108.817 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 7' ' ' ILE . 4.7 pt -75.05 177.55 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.487 1.915 . . . . 0.0 111.858 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.45 16.34 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.02 -18.18 40.18 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.148 1.356 . . . . 0.0 112.674 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.59 70.04 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.642 1.577 . . . . 0.0 113.632 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -112.32 -2.59 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.892 1.677 . . . . 0.0 113.311 174.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD11 HD23 ' A' ' 17' ' ' LEU . 20.3 tp -78.76 148.84 32.83 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.338 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.91 146.83 27.29 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 0.0 110.047 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.39 -34.66 66.92 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.006 0.821 . . . . 0.0 112.763 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -59.43 -56.26 24.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.671 1.189 . . . . 0.0 113.018 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.25 -45.87 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.303 0.641 . . . . 0.0 111.026 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 12' ' ' LEU . 2.7 tm? -55.22 -38.7 68.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.183 0.993 . . . . 0.0 111.95 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -52.25 -57.65 9.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.258 1.823 . . . . 0.0 111.705 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.05 60.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 176.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 2' ' ' LEU . 8.0 t -65.82 -49.17 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.762 1.164 . . . . 0.0 110.838 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -67.0 -21.76 65.93 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -24.84 22.84 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -20.03 62.56 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.282 1.033 . . . . 0.0 113.595 -175.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD11 ' HD2' ' A' ' 30' ' ' LYS . 3.2 pp -60.86 -30.16 69.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.843 1.257 . . . . 0.0 114.031 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.564 ' N ' HD12 ' A' ' 24' ' ' LEU . . . 179.59 122.77 0.79 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.207 0.908 . . . . 0.0 112.11 -175.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -70.59 93.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.608 1.563 . . . . 0.0 112.025 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.4 m -130.15 168.42 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.749 1.619 . . . . 0.0 112.273 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -56.66 -41.75 77.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.348 1.459 . . . . 0.0 113.777 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.42 156.32 43.68 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.011 2.124 . . . . 0.0 111.179 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.675 ' HD2' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -139.41 178.31 7.29 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.852 1.261 . . . . 0.0 111.673 177.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -127.22 143.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.163 1.385 . . . . 0.0 111.491 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.614 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -121.98 100.22 6.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.592 1.957 . . . . 0.0 111.778 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.5 p -110.34 127.09 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.538 1.135 . . . . 0.0 109.918 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.19 157.7 26.8 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.964 -0.636 . . . . 0.0 114.278 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.66 121.97 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.185 0.994 . . . . 0.0 110.229 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -74.1 105.12 5.17 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.363 -0.835 . . . . 0.0 110.689 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.62 91.95 4.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.223 1.809 . . . . 0.0 113.447 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.33 21.27 2.4 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.996 0.903 . . . . 0.0 112.392 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -7.07 54.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.698 1.599 . . . . 0.0 114.924 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.86 18.44 65.46 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.046 -1.034 . . . . 0.0 114.66 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.6 127.77 5.14 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.214 1.864 . . . . 0.0 110.736 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.3 m -69.4 131.01 44.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.73 0.765 . . . . 0.0 110.527 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.669 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 14.9 m0 -96.75 162.47 13.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.136 0.493 . . . . 0.0 111.954 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -138.83 107.46 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 127.1 2.16 . . . . 0.0 109.617 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 150.64 47.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.259 -0.9 . . . . 0.0 110.711 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -121.22 -54.67 1.99 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.559 1.144 . . . . 0.0 111.993 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -156.92 172.22 19.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.974 0.91 . . . . 0.0 111.667 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.34 140.08 35.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.958 1.303 . . . . 0.0 111.841 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 t80 -118.65 127.44 53.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 109.659 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.4 119.56 39.82 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.217 1.807 . . . . 0.0 107.627 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -11.78 49.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.235 0.541 . . . . 0.0 111.295 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.01 114.25 7.43 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 108.961 -175.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.71 -165.88 53.87 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.228 0.918 . . . . 0.0 113.679 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 t -119.41 -170.75 1.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.665 1.586 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 163.06 22.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.709 1.604 . . . . 0.0 111.695 174.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.438 ' OD2' HD13 ' A' ' 24' ' ' LEU . 19.1 t70 -141.31 -44.46 0.37 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.093 0.957 . . . . 0.0 111.824 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.68 164.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.726 2.01 . . . . 0.0 111.421 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 tt -77.51 134.76 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.37 1.068 . . . . 0.0 112.032 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.83 128.98 52.2 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.148 0.979 . . . . 0.0 110.285 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.663 ' HG2' HD12 ' A' ' 69' ' ' LEU . 52.9 Cg_endo -64.89 115.35 3.21 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 124.562 3.508 . . . . 0.0 112.14 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -62.65 -48.0 81.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -115.4 153.5 30.94 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.189 0.995 . . . . 0.0 111.577 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.75 88.87 13.59 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.434 1.094 . . . . 0.0 108.754 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.81 143.36 29.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.023 2.482 . . . . 0.0 111.336 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -48.88 153.98 0.78 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.526 1.13 . . . . 0.0 112.697 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 p 63.9 46.86 3.71 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.638 1.575 . . . . 0.0 110.047 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 68' ' ' ALA . 17.4 ttmt -155.52 172.01 18.97 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.503 1.521 . . . . 0.0 111.09 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' H ' ' HG2' ' A' ' 67' ' ' LYS . . . -142.23 -176.67 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 108.77 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -163.5 144.98 9.38 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.34 -0.85 . . . . 0.0 110.619 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.489 ' CD1' HD21 ' A' ' 17' ' ' LEU . 5.2 mt -117.36 170.15 8.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.893 1.33 . . . . 0.0 108.496 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.6 t80 -152.31 160.31 43.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.162 1.385 . . . . 0.0 107.708 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -147.38 148.12 31.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.832 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.8 -170.91 37.17 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.752 0.691 . . . . 0.0 112.165 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -176.68 4.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.853 1.661 . . . . 0.0 111.673 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.33 98.83 2.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.677 1.591 . . . . 0.0 112.671 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -99.67 -55.46 2.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.402 1.481 . . . . 0.0 111.91 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -146.66 14.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.72 -81.1 0.5 Allowed Glycine 0 N--CA 1.48 1.593 0 O-C-N 120.609 -1.307 . . . . 0.0 113.672 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.43 1.94 6.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.479 3.452 . . . . 0.0 113.1 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 p -56.58 -21.64 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 113.878 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.02 -5.48 22.11 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.958 2.503 . . . . 0.0 114.738 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 -151.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.772 1.629 . . . . 0.0 110.529 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 104' ' ' VAL . . . -97.22 147.7 18.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.172 1.368 . . . . 0.0 109.888 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.43 151.94 42.86 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.114 0.957 . . . . 0.0 111.9 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -150.07 118.75 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.808 1.243 . . . . 0.0 112.946 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.42 160.0 43.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.529 1.532 . . . . 0.0 110.127 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' HB3' ' CE ' ' A' ' 130' ' ' MET . . . -146.32 135.57 22.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -143.28 168.78 18.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 111.406 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -123.99 150.32 44.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.736 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -130.93 115.3 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.64 1.576 . . . . 0.0 110.373 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.446 ' HB2' HD22 ' A' ' 46' ' ' LEU . 12.3 t80 -73.7 104.08 4.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.382 1.473 . . . . 0.0 111.291 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -71.71 158.27 36.43 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.135 -0.978 . . . . 0.0 112.63 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -58.5 -24.97 61.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.831 1.252 . . . . 0.0 113.732 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 t -73.72 -3.24 27.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.998 1.319 . . . . 0.0 113.948 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.48 17.67 72.96 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.416 1.008 . . . . 0.0 114.265 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -102.83 163.18 12.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.594 1.558 . . . . 0.0 110.683 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.61 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 86.8 m -127.58 102.74 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.55 0.74 . . . . 0.0 112.982 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 173' ' ' ILE . 27.1 tp -71.72 116.45 12.11 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.418 -0.801 . . . . 0.0 110.855 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.09 104.16 3.1 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.306 1.431 . . . . 0.0 111.024 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.78 160.59 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 156.51 45.52 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.036 1.334 . . . . 0.0 110.261 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 33' ' ' VAL . 10.7 p90 -166.96 155.25 9.83 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.501 1.521 . . . . 0.0 110.893 175.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.92 124.17 1.81 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.369 1.468 . . . . 0.0 110.38 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.445 ' HB ' ' HA3' ' A' ' 83' ' ' GLY . 34.1 t -81.73 131.99 56.0 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.16 173.27 8.75 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.501 2.134 . . . . 0.0 111.922 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.88 155.49 10.43 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.098 -1.001 . . . . 0.0 111.157 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.48 -66.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 128.355 2.662 . . . . 0.0 115.736 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -149.84 31.67 0.7 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.44 1.896 . . . . 0.0 112.235 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.49 -32.85 69.17 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.815 1.246 . . . . 0.0 114.154 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 61.23 82.12 0.17 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.664 1.986 . . . . 0.0 113.656 176.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.86 167.59 21.96 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.451 1.5 . . . . 0.0 112.097 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.6 m -57.59 143.99 39.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 110.955 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.11 152.25 24.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.674 0.79 . . . . 0.0 110.69 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -97.8 159.38 14.97 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -161.98 153.26 18.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.993 1.317 . . . . 0.0 109.494 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -174.47 104.18 0.1 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.122 1.369 . . . . 0.0 111.311 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.08 132.06 45.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.736 1.214 . . . . 0.0 108.507 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -140.48 160.98 38.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.118 1.367 . . . . 0.0 110.021 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 93.3 mt -118.65 112.5 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.498 1.519 . . . . 0.0 109.171 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.41 100.69 6.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -56.12 121.89 10.45 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.95 -1.094 . . . . 0.0 108.977 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.67 -140.46 15.41 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -128.41 132.09 48.48 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.391 1.476 . . . . 0.0 112.613 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -160.01 124.04 3.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.519 1.527 . . . . 0.0 112.238 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -179.28 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 111.459 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -87.83 109.19 19.57 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.842 -0.536 . . . . 0.0 111.154 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.89 -172.22 4.06 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 111.473 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.84 -47.51 31.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.893 0.877 . . . . 0.0 111.496 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.18 -47.44 55.3 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.402 1.001 . . . . 0.0 114.088 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.41 ' CE ' ' HB3' ' A' ' 87' ' ' ALA . 3.1 ttp -65.75 -52.23 52.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 111.276 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -56.31 -37.33 69.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.77 0.795 . . . . 0.0 112.767 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.42 -47.41 79.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.876 2.07 . . . . 0.0 110.049 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -26.98 69.08 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.696 1.135 . . . . 0.0 113.677 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mp -70.4 -49.19 51.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.955 1.302 . . . . 0.0 112.909 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.27 -29.54 13.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.24 -26.59 8.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.981 1.312 . . . . 0.0 112.156 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -63.83 4.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.449 1.5 . . . . 0.0 111.278 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -174.3 80.29 0.35 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.877 2.071 . . . . 0.0 111.331 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.22 154.2 66.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.134 1.89 . . . . 0.0 111.511 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -120.41 -164.58 1.11 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.576 1.95 . . . . 0.0 111.041 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.75 131.37 46.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.805 2.442 . . . . 0.0 111.509 -175.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -142.34 115.38 0.95 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.863 1.697 . . . . 0.0 111.054 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.78 -55.02 2.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 84.99 0.14 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 120.323 1.419 . . . . 0.0 111.398 174.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.26 163.86 24.01 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 122.0 0.778 . . . . 0.0 114.687 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.461 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 59.5 m95 -82.1 145.44 30.16 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.002 1.721 . . . . 0.0 111.983 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -161.12 123.42 3.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.217 1.407 . . . . 0.0 112.154 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.6 154.95 18.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.837 1.655 . . . . 0.0 111.651 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 145.81 24.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.794 1.237 . . . . 0.0 110.052 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -72.82 93.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -51.96 -36.88 50.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.085 1.354 . . . . 0.0 113.841 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.15 40.22 2.14 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.97 -32.48 0.96 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.73 -34.36 0.68 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.739 1.161 . . . . 0.0 113.548 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.31 172.63 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.168 1.787 . . . . 0.0 111.998 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -127.04 165.17 19.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.607 1.163 . . . . 0.0 110.603 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.59 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -152.48 163.6 39.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 174.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 146' ' ' TRP . 6.3 tptt -119.99 127.29 52.48 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.504 1.522 . . . . 0.0 108.153 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.36 146.76 17.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.815 0.721 . . . . 0.0 111.879 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.503 ' CD1' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -124.95 131.15 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 125.085 1.354 . . . . 0.0 109.313 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 125.89 36.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.07 0.85 . . . . 0.0 108.755 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.503 HG23 ' CD1' ' A' ' 160' ' ' ILE . 19.8 p -126.1 137.5 53.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.05 1.74 . . . . 0.0 111.783 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.6 p -129.93 128.93 43.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.111 2.164 . . . . 0.0 110.765 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.56 -54.4 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.412 1.885 . . . . 0.0 111.365 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.13 -49.08 0.2 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.735 1.16 . . . . 0.0 113.715 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.74 28.53 8.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.915 1.686 . . . . 0.0 112.778 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB1' ' OG1' ' A' ' 162' ' ' THR . . . -118.55 159.67 23.14 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.276 1.43 . . . . 0.0 113.78 -174.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.7 OUTLIER -150.92 168.91 23.07 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.421 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.46 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 7.1 ttp -102.78 138.07 40.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.729 1.612 . . . . 0.0 111.262 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -137.3 150.83 48.05 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.57 1.148 . . . . 0.0 109.689 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.408 HG23 ' SD ' ' A' ' 157' ' ' MET . 42.1 mm -126.23 124.35 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.106 0.962 . . . . 0.0 109.286 -175.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -112.96 106.96 15.34 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.029 -1.045 . . . . 0.0 110.439 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.669 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 17.3 pt -92.9 125.91 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.783 0.833 . . . . 0.0 109.933 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.2 p -155.59 149.36 25.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.219 1.808 . . . . 0.0 112.952 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.84 -0.059 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.08 -29.93 70.34 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.181 0.593 . . . . 0.0 111.405 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.01 128.67 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.717 1.607 . . . . 0.0 111.918 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.67 -15.05 9.79 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.42 1.962 . . . . 0.0 113.597 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p -167.37 162.79 14.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.149 2.58 . . . . 0.0 109.213 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 70' ' ' LEU . 47.0 mt -140.24 172.56 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.557 1.143 . . . . 0.0 109.021 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -83.78 -162.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 125.77 1.628 . . . . 0.0 110.317 174.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.7 60.2 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.4 -25.63 12.09 Favored Glycine 0 N--CA 1.488 2.13 0 O-C-N 123.951 0.782 . . . . 0.0 112.698 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.02 63.36 Favored 'General case' 0 CA--C 1.59 2.519 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -96.24 -3.76 43.57 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.571 1.548 . . . . 0.0 114.267 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.16 139.41 58.13 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.303 -0.873 . . . . 0.0 108.926 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.51 141.03 20.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.244 0.618 . . . . 0.0 110.403 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -55.75 -32.28 63.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -57.45 -49.06 77.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.746 1.218 . . . . 0.0 111.8 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -69.88 -50.42 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.476 1.11 . . . . 0.0 109.375 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -55.13 -32.7 62.29 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.26 -61.28 2.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.201 1.8 . . . . 0.0 109.976 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -40.4 86.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.429 1.492 . . . . 0.0 112.677 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.16 -50.62 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.289 1.436 . . . . 0.0 111.613 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -73.43 -35.24 65.76 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.1 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.36 -30.93 69.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.429 1.491 . . . . 0.0 113.267 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -55.78 -28.79 57.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.543 1.137 . . . . 0.0 113.633 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.57 -34.32 72.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.907 0.883 . . . . 0.0 111.991 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -173.39 116.11 0.59 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.123 1.344 . . . . 0.0 112.659 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -71.25 66.88 0.45 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.777 2.031 . . . . 0.0 112.32 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.51 175.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.856 2.462 . . . . 0.0 110.903 -175.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 m -72.03 55.8 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.476 1.91 . . . . 0.0 111.96 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.92 101.88 2.47 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.626 1.57 . . . . 0.0 110.712 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.644 ' CB ' HD11 ' A' ' 21' ' ' LEU . 2.7 pttm -141.72 121.71 13.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.67 1.588 . . . . 0.0 112.782 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.485 HG23 ' HA ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.73 151.19 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.057 . . . . 0.0 110.852 178.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -141.15 101.99 4.14 Favored 'General case' 0 CA--C 1.573 1.837 0 C-N-CA 126.295 1.838 . . . . 0.0 111.317 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.466 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.4 p -114.78 132.92 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.306 1.442 . . . . 0.0 110.087 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.3 165.32 38.36 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -140.45 119.79 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.979 1.311 . . . . 0.0 112.378 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.75 115.91 7.84 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 121.381 -0.825 . . . . 0.0 111.08 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 2.7 p-10 -96.05 85.32 4.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.482 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.96 13.67 5.76 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -76.27 -13.26 60.16 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 14.59 43.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.627 1.108 . . . . 0.0 115.437 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.33 126.09 3.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.387 1.47 . . . . 0.0 112.813 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.5 m -64.32 140.92 58.92 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.066 1.346 . . . . 0.0 111.253 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 17.8 m0 -106.57 171.95 7.08 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -150.55 110.82 4.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.134 1.773 . . . . 0.0 111.871 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.01 58.06 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 120.979 -1.076 . . . . 0.0 110.222 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.59 -46.26 4.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.397 0.679 . . . . 0.0 112.186 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.93 173.7 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.356 1.063 . . . . 0.0 111.244 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.03 128.77 23.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.105 0.962 . . . . 0.0 112.949 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.82 117.14 33.32 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.842 1.657 . . . . 0.0 110.32 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 7.1 m-85 -116.92 129.95 56.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.076 1.75 . . . . 0.0 109.343 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.56 4.65 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -152.96 92.51 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.794 1.238 . . . . 0.0 110.215 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.07 19.33 0.28 Allowed Glycine 0 N--CA 1.475 1.28 0 N-CA-C 117.474 1.75 . . . . 0.0 117.474 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -40.04 113.77 0.38 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.143 2.177 . . . . 0.0 113.188 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.681 HG21 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 t -66.21 -179.67 0.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.783 1.633 . . . . 0.0 115.312 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.12 -9.71 3.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.077 1.751 . . . . 0.0 114.033 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -87.69 166.45 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.326 1.05 . . . . 0.0 112.581 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 tt -68.93 130.13 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.469 1.108 . . . . 0.0 112.63 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 60' ' ' PRO . 41.1 tp -84.41 117.47 68.81 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.495 0.718 . . . . 0.0 109.769 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.627 ' CG ' HD12 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -69.03 119.96 6.9 Favored 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 122.758 2.305 . . . . 0.0 109.741 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.39 -64.25 1.2 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.935 0.894 . . . . 0.0 112.515 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -96.75 151.53 19.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.669 0.788 . . . . 0.0 109.963 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 132.93 9.63 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.007 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -71.55 -150.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 125.102 3.868 . . . . 0.0 112.914 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.96 15.13 9.25 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.939 1.696 . . . . 0.0 114.287 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -142.06 30.44 1.61 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.306 1.442 . . . . 0.0 112.752 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -146.1 -175.96 4.96 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.678 1.191 . . . . 0.0 113.077 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.26 173.78 11.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.112 1.365 . . . . 0.0 107.472 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.627 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -150.61 148.97 29.28 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.855 -1.153 . . . . 0.0 111.287 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.24 162.13 26.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.861 0.864 . . . . 0.0 111.266 177.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 55' ' ' THR . 1.0 OUTLIER -141.38 163.52 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.272 1.429 . . . . 0.0 110.001 174.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 31' ' ' ILE . 55.1 m -135.77 -166.53 1.87 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.4 1.48 . . . . 0.0 110.383 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.4 178.29 33.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.367 -0.833 . . . . 0.0 113.461 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -146.42 158.22 43.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.227 1.011 . . . . 0.0 112.481 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.49 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.695 2.398 . . . . 0.0 116.567 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -75.36 0.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.642 1.577 . . . . 0.0 112.686 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.6 m -87.71 -8.67 55.77 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.357 1.063 . . . . 0.0 112.253 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.58 90.86 0.12 Allowed Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.53 35.23 0.43 Allowed 'Trans proline' 0 CA--C 1.578 2.721 1 C-N-CA 125.395 4.063 . . . . 0.0 111.098 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -48.07 133.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 127.481 2.313 . . . . 0.0 111.245 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.07 0.59 3.46 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.584 1.554 . . . . 0.0 114.522 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -149.05 109.98 4.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.791 2.836 . . . . 0.0 108.814 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' HA3' HG21 ' A' ' 104' ' ' VAL . . . 44.63 -112.91 0.74 Allowed Glycine 0 CA--C 1.537 1.446 0 N-CA-C 119.661 2.624 . . . . 0.0 119.661 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -161.92 173.83 13.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.613 1.965 . . . . 0.0 112.091 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.48 113.94 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.898 1.279 . . . . 0.0 113.216 -175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . . . -155.51 170.97 20.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 111.094 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.52 124.12 7.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.661 1.584 . . . . 0.0 108.757 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -128.49 163.8 24.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.661 1.184 . . . . 0.0 112.055 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -121.97 142.88 49.86 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -122.42 113.97 20.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.982 2.113 . . . . 0.0 111.151 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.42 108.32 2.33 Favored 'General case' 0 N--CA 1.382 -3.828 0 C-N-CA 124.836 1.255 . . . . 0.0 112.625 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.1 mtp -73.08 155.09 40.09 Favored 'General case' 0 CA--C 1.627 3.906 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -58.95 -23.62 61.75 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.61 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -67.98 -9.19 43.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.895 2.078 . . . . 0.0 114.178 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 8.06 68.71 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.71 1.148 . . . . 0.0 114.794 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.5 175.41 5.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.028 1.731 . . . . 0.0 110.412 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 89' ' ' ALA . 91.8 m -130.84 104.06 6.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.963 -1.086 . . . . 0.0 112.314 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.649 HD22 HD13 ' A' ' 173' ' ' ILE . 47.2 tp -69.39 119.07 13.09 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 120.994 -1.066 . . . . 0.0 110.79 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 104.55 3.18 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.621 1.105 . . . . 0.0 111.065 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.15 162.46 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.211 0.529 . . . . 0.0 111.322 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.79 149.78 30.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.013 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CE2' HG11 ' A' ' 33' ' ' VAL . 45.3 p90 -154.85 154.24 32.4 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.097 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -160.15 157.36 28.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.668 1.587 . . . . 0.0 107.377 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.4 t -121.82 95.33 47.84 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 121.327 -0.858 . . . . 0.0 109.211 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -69.98 162.34 42.57 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.9 1.733 . . . . 0.0 111.802 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -138.23 -45.34 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 111.047 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.5 157.96 30.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.969 2.108 . . . . 0.0 111.491 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -110.33 77.75 1.07 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.692 1.997 . . . . 0.0 110.954 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -66.89 -44.41 80.92 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.558 -0.714 . . . . 0.0 112.604 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -147.33 -44.49 0.17 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.919 1.288 . . . . 0.0 112.862 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -117.07 161.58 19.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.597 1.559 . . . . 0.0 111.631 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.6 m -75.13 -65.01 0.93 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -157.69 125.38 5.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 112.559 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -91.91 158.06 16.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.436 1.495 . . . . 0.0 112.377 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -165.1 126.79 2.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 110.064 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.98 91.07 1.02 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.33 150.8 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.538 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -142.97 135.07 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.241 1.416 . . . . 0.0 108.733 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 155' ' ' LEU . 52.3 mt -100.12 103.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.268 1.027 . . . . 0.0 109.651 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -69.91 96.73 1.04 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.7 t -63.63 99.68 0.24 Allowed 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.79 -124.02 3.16 Favored Glycine 0 CA--C 1.578 3.986 0 N-CA-C 104.518 -3.433 . . . . 0.0 104.518 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -141.85 116.54 9.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.854 0.827 . . . . 0.0 111.969 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -134.73 111.88 10.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.51 1.124 . . . . 0.0 112.996 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 167.3 5.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.608 1.163 . . . . 0.0 110.781 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.17 119.54 31.36 Favored 'General case' 1 N--CA 1.336 -6.145 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . 0.259 2.0 t70 -165.59 -177.04 4.19 Favored 'General case' 0 N--CA 1.522 3.153 0 O-C-N 127.602 3.064 . . . . 0.0 104.185 -163.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.46 -47.95 48.0 Favored 'General case' 1 CA--C 1.632 4.111 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.116 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.26 -31.46 34.56 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 121.849 2.113 . . . . 0.0 113.383 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.8 ttt -72.75 -58.56 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.386 0.674 . . . . 0.0 110.498 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -57.5 -31.18 65.76 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.82 -44.38 96.29 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.31 1.444 . . . . 0.0 109.704 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.47 -2.41 4.62 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.05 0.94 . . . . 0.0 113.471 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.7 mt -102.05 -45.87 5.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.662 1.585 . . . . 0.0 111.989 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -93.57 -23.4 18.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -121.25 -1.65 9.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.621 1.569 . . . . 0.0 111.974 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -121.98 72.91 0.37 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.591 2.043 . . . . 0.0 113.185 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.3 m120 73.58 68.66 0.27 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 127.005 2.122 . . . . 0.0 112.503 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.25 114.78 3.17 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.369 2.713 . . . . 0.0 111.749 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -124.78 162.59 23.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.42 1.888 . . . . 0.0 111.598 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.9 mtm105 -145.57 165.51 28.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.298 1.439 . . . . 0.0 112.008 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -134.32 -57.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.3 t0 48.81 69.36 0.58 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.643 1.977 . . . . 0.0 113.907 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.59 100.79 0.02 OUTLIER 'General case' 0 C--O 1.25 1.111 0 C-N-CA 129.213 3.005 . . . . 0.0 114.58 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.98 104.09 0.19 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -53.77 101.92 0.05 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 112.506 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -119.21 131.08 55.78 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.891 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.82 133.89 55.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.747 2.019 . . . . 0.0 109.846 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -140.4 157.51 45.42 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.262 0.553 . . . . 0.0 110.76 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -76.78 98.35 4.78 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.1 tp -57.66 -23.77 53.08 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.01 24.7 5.65 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-O 117.851 -1.527 . . . . 0.0 116.726 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -130.24 -27.56 2.21 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.813 1.807 . . . . 0.0 115.636 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.03 -33.01 1.05 Allowed Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.534 1.064 . . . . 0.0 113.83 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -109.83 172.7 6.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.741 1.616 . . . . 0.0 111.885 174.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.14 158.89 32.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 0.0 110.887 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -143.49 165.02 28.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.591 0.71 . . . . 0.0 111.144 176.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -128.14 136.79 51.63 Favored 'General case' 0 N--CA 1.396 -3.137 0 C-N-CA 124.826 1.25 . . . . 0.0 112.049 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.18 160.29 22.93 Favored Glycine 1 CA--C 1.618 6.518 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.44 156.94 41.0 Favored 'Isoleucine or valine' 1 CA--C 1.629 4.016 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.81 87.04 1.4 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.0 p -73.81 165.11 25.7 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.238 1.015 . . . . 0.0 110.704 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -128.46 -163.08 1.24 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.737 1.215 . . . . 0.0 112.042 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.62 7.07 4.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.534 2.333 . . . . 0.0 115.116 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.82 169.66 19.44 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.516 1.055 . . . . 0.0 110.732 -175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 65.6 -51.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.755 2.022 . . . . 0.0 114.568 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.98 163.44 7.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.568 2.347 . . . . 0.0 112.694 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -154.07 165.12 37.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 123.155 1.455 . . . . 0.0 114.524 -174.359 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.485 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 24.8 ptm -93.12 164.94 13.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.172 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -153.27 156.15 37.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.03 138.75 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.887 1.675 . . . . 0.0 109.145 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.44 117.74 23.54 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.103 1.361 . . . . 0.0 109.704 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.649 HD13 HD22 ' A' ' 98' ' ' LEU . 22.7 pt -108.79 126.14 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.552 0.741 . . . . 0.0 110.17 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.7 t -152.53 158.84 43.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.577 0 C-N-CA 126.122 1.769 . . . . 0.0 111.134 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.01 -43.59 87.23 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.345 1.429 . . . . 0.0 111.72 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.63 165.81 11.79 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 110.597 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.71 -25.4 27.64 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.195 1.379 . . . . 0.0 112.573 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -149.19 151.63 34.65 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.522 1.661 . . . . 0.0 111.535 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.447 HD11 HD12 ' A' ' 70' ' ' LEU . 29.4 mm -144.12 158.9 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.743 1.217 . . . . 0.0 111.312 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.67 -173.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 127.502 2.321 . . . . 0.0 111.984 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.73 -22.34 3.45 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.0 -25.32 14.42 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.648 1.118 . . . . 0.0 114.144 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -36.87 75.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.158 0.979 . . . . 0.0 111.969 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -7.12 58.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.942 1.297 . . . . 0.0 113.619 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD11 HD23 ' A' ' 17' ' ' LEU . 2.8 tt -64.67 156.4 30.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.382 1.473 . . . . 0.0 112.651 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -148.55 143.38 26.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.041 0.936 . . . . 0.0 110.116 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -56.25 -32.86 64.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.653 0.781 . . . . 0.0 113.104 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -55.52 -57.28 12.55 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.081 1.352 . . . . 0.0 112.342 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.19 -51.42 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.706 0.803 . . . . 0.0 109.892 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.413 HD23 HD11 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -53.44 -37.1 62.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.172 1.389 . . . . 0.0 113.615 -174.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.26 -49.08 65.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.27 1.428 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -36.52 83.55 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.339 -0.851 . . . . 0.0 111.301 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.57 -53.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.802 1.241 . . . . 0.0 111.345 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.9 pp -63.85 -34.93 79.04 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.98 -25.39 58.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -54.95 -26.81 38.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.342 1.428 . . . . 0.0 112.893 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp -88.18 -4.65 58.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.312 2.645 . . . . 0.0 114.606 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.24 102.17 0.16 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.718 1.152 . . . . 0.0 112.987 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.17 19.87 0.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.871 2.069 . . . . 0.0 113.782 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.15 174.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.705 2.402 . . . . 0.0 112.961 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 p -76.88 0.51 20.62 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.93 128.19 12.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.643 . . . . 0.0 111.928 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -141.65 166.11 25.63 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.19 146.02 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.969 1.708 . . . . 0.0 115.007 -174.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -137.51 110.47 7.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.725 2.81 . . . . 0.0 109.404 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.3 p -116.12 125.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 175.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.31 157.71 30.31 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.178 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 98' ' ' LEU . 1.5 mp -139.19 117.58 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 0.0 111.572 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.89 102.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.421 -1.424 . . . . 0.0 111.746 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.419 ' HA ' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -76.76 87.16 3.38 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.88 1.272 . . . . 0.0 111.82 175.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -143.15 45.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.684 1.194 . . . . 0.0 111.295 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.47 1.3 29.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.014 1.325 . . . . 0.0 114.465 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.27 17.29 69.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.383 0.992 . . . . 0.0 115.139 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.16 131.76 4.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.945 1.736 . . . . 0.0 111.742 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -59.08 142.51 51.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.033 1.333 . . . . 0.0 111.194 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.419 ' CH2' ' HA ' ' A' ' 37' ' ' ASN . 45.7 m0 -104.68 167.16 9.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 111.505 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -152.58 102.49 2.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.269 2.227 . . . . 0.0 109.407 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 166.43 14.31 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.344 -0.848 . . . . 0.0 111.617 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -67.8 0.77 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.668 1.587 . . . . 0.0 110.432 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -156.66 -176.17 5.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.985 1.714 . . . . 0.0 110.995 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.85 37.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.97 1.708 . . . . 0.0 110.844 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -127.94 130.06 47.82 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.574 1.549 . . . . 0.0 109.684 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -140.16 137.44 34.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 128.485 2.714 . . . . 0.0 109.121 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -14.84 15.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.32 1.448 . . . . 0.0 112.324 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.81 99.08 3.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.642 1.977 . . . . 0.0 109.056 176.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.22 102.08 0.94 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 124.401 1.001 . . . . 0.0 112.807 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 HG23 ' CE1' ' A' ' 50' ' ' PHE . 97.1 m -65.94 -103.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.411 1.884 . . . . 0.0 110.914 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.6 p -150.51 172.67 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 111.916 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -148.75 -4.02 0.44 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.633 2.373 . . . . 0.0 113.125 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.81 166.86 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 127.416 2.287 . . . . 0.0 112.128 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.21 128.65 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.11 1.764 . . . . 0.0 112.576 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 tp -81.59 123.66 80.58 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 108.511 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 69' ' ' LEU . 65.6 Cg_endo -65.54 124.55 12.99 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.884 3.056 . . . . 0.0 110.827 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.07 -76.75 0.26 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.233 -0.917 . . . . 0.0 112.188 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.54 125.57 40.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.87 0.868 . . . . 0.0 110.28 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -123.78 121.98 26.46 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.228 -175.034 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.94 179.21 6.51 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.179 3.252 . . . . 0.0 112.323 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -66.8 169.18 8.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.301 1.44 . . . . 0.0 112.64 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p 43.39 43.49 4.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.413 2.285 . . . . 0.0 115.016 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -144.49 177.58 8.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.608 1.963 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.08 -174.44 4.1 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.492 1.517 . . . . 0.0 108.324 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.714 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -156.27 154.17 30.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.447 HD12 HD11 ' A' ' 6' ' ' ILE . 7.0 mt -129.35 163.72 25.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.771 0.829 . . . . 0.0 110.467 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -149.26 161.35 42.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.392 1.477 . . . . 0.0 109.502 174.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.6 m -147.02 178.49 8.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.296 1.438 . . . . 0.0 110.801 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.17 167.25 30.67 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.468 0.556 . . . . 0.0 113.471 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.94 -174.76 3.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.216 1.407 . . . . 0.0 112.971 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -64.54 56.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.457 3.103 . . . . 0.0 114.531 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -107.65 -11.72 15.39 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.688 1.595 . . . . 0.0 114.704 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.43 9.27 4.7 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.611 1.964 . . . . 0.0 112.94 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.33 29.96 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.511 -1.716 . . . . 0.0 115.656 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.38 -2.25 11.44 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 123.768 2.978 . . . . 0.0 114.922 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 p -54.02 146.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.07 -1.019 . . . . 0.0 108.715 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.95 8.09 6.62 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.95 1.3 . . . . 0.0 113.787 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.3 p -142.48 -171.71 3.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.921 2.088 . . . . 0.0 109.97 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.88 140.19 14.91 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.699 1.143 . . . . 0.0 111.236 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.46 128.87 38.43 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 117.999 0.899 . . . . 0.0 111.059 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 103' ' ' SER . 76.6 t -143.11 126.43 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.375 1.87 . . . . 0.0 111.986 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -148.8 167.39 25.74 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.338 1.455 . . . . 0.0 110.87 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 118.38 7.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.0 109.288 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -123.5 162.93 21.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.434 1.094 . . . . 0.0 112.55 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -127.23 145.76 50.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.972 0.909 . . . . 0.0 111.986 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.73 113.49 16.07 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.669 1.987 . . . . 0.0 110.89 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.96 122.11 16.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.847 1.259 . . . . 0.0 110.591 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.3 ttt -92.8 149.03 21.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.831 1.252 . . . . 0.0 111.017 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -22.71 16.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 t -72.01 -11.48 60.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.843 1.257 . . . . 0.0 113.789 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.49 4.87 60.59 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.672 1.606 . . . . 0.0 114.72 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -95.05 173.18 7.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.211 1.404 . . . . 0.0 110.769 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.467 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 37.8 m -137.16 104.37 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.961 1.304 . . . . 0.0 111.947 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 35' ' ' ILE . 27.2 tp -67.12 125.13 25.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.941 0.896 . . . . 0.0 110.346 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.67 104.84 2.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.19 1.376 . . . . 0.0 112.389 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -74.86 169.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.857 0.837 . . . . 0.0 112.175 175.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -149.0 147.48 28.61 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.189 1.396 . . . . 0.0 111.682 177.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 p90 -157.76 146.31 19.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.497 0.719 . . . . 0.0 112.088 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' HG22 ' A' ' 85' ' ' VAL . 69.1 m -153.31 122.04 6.4 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.482 0.713 . . . . 0.0 112.169 174.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.59 137.05 38.96 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.81 137.56 29.94 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.395 2.063 . . . . 0.0 112.741 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -94.29 -58.67 2.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.584 1.154 . . . . 0.0 110.309 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -127.21 10.15 6.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.997 1.319 . . . . 0.0 113.941 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.62 31.26 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.241 1.816 . . . . 0.0 112.704 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -20.46 64.87 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -66.96 -43.28 83.52 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.956 0.903 . . . . 0.0 112.473 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -174.44 163.07 3.62 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.16 2.984 . . . . 0.0 108.996 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 t 78.74 75.42 0.05 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.695 2.398 . . . . 0.0 111.547 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.39 140.03 50.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.091 1.356 . . . . 0.0 110.394 174.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -81.38 162.14 23.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.041 0.937 . . . . 0.0 112.229 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.521 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 4.8 p-90 -159.91 169.4 23.59 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.129 1.372 . . . . 0.0 110.928 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 t70 164.26 138.6 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 128.713 2.805 . . . . 0.0 112.265 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.42 128.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.344 1.858 . . . . 0.0 108.959 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -129.03 158.21 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.324 1.85 . . . . 0.0 110.234 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.2 mt -112.76 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.719 1.608 . . . . 0.0 108.383 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -70.49 102.78 2.29 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.724 -1.235 . . . . 0.0 110.136 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.2 t -67.01 90.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.79 -134.71 4.97 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.853 2.644 . . . . 0.0 109.629 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.26 124.7 26.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.042 1.337 . . . . 0.0 111.899 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -143.61 117.14 9.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.234 1.814 . . . . 0.0 110.868 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.24 165.94 18.97 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.142 0.428 . . . . 0.0 110.985 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.47 112.58 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.438 -0.789 . . . . 0.0 110.601 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -155.97 -172.84 4.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.365 1.466 . . . . 0.0 112.797 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -42.65 84.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.018 0.927 . . . . 0.0 110.868 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.7 -41.08 56.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.469 1.509 . . . . 0.0 112.887 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -64.83 0.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.501 1.12 . . . . 0.0 109.94 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -53.37 -34.35 57.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.201 1.001 . . . . 0.0 113.431 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -41.07 95.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.824 1.25 . . . . 0.0 111.388 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -21.71 66.69 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.484 -1.385 . . . . 0.0 112.386 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 101' ' ' MET . 6.3 mt -85.3 -48.78 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.53 -33.25 31.89 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -114.66 -37.38 4.27 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.894 1.278 . . . . 0.0 112.708 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.64 -68.71 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.039 1.304 . . . . 0.0 112.479 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.77 79.0 1.8 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.99 153.38 72.56 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.06 175.91 8.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.136 2.174 . . . . 0.0 112.448 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -127.1 141.63 51.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.186 1.794 . . . . 0.0 110.826 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -141.46 108.56 0.55 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.561 1.076 . . . . 0.0 111.029 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -123.16 64.88 0.99 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.559 1.143 . . . . 0.0 112.264 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.04 95.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.619 2.368 . . . . 0.0 114.754 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.46 154.28 6.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.378 1.942 . . . . 0.0 112.405 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 63.1 m95 -77.18 144.74 38.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.274 1.03 . . . . 0.0 111.891 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -149.66 127.18 11.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.183 1.393 . . . . 0.0 112.364 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -120.67 152.46 38.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.234 1.814 . . . . 0.0 112.37 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -145.67 161.46 39.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.629 1.572 . . . . 0.0 110.636 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -75.04 98.76 3.71 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -57.84 7.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.935 1.294 . . . . 0.0 111.492 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.17 14.38 0.47 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -129.22 -16.58 3.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.56 -4.09 5.1 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.98 171.48 14.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.893 1.677 . . . . 0.0 110.801 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.71 161.19 31.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.019 . . . . 0.0 111.948 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.578 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -141.62 149.16 40.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.358 0.663 . . . . 0.0 111.815 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.8 OUTLIER -119.25 134.54 55.15 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.79 1.636 . . . . 0.0 108.988 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.27 136.44 12.62 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.097 1.332 . . . . 0.0 113.068 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -109.3 132.39 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.187 1.795 . . . . 0.0 108.691 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.88 105.97 11.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.746 0.818 . . . . 0.0 109.817 175.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 p -123.6 145.91 48.55 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.927 1.291 . . . . 0.0 110.562 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.7 p -140.46 -112.46 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.527 1.131 . . . . 0.0 110.504 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 52.38 13.48 0.3 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 120.833 1.651 . . . . 0.0 115.33 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 146.45 5.84 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.547 2.022 . . . . 0.0 110.779 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.23 38.4 29.21 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -144.83 170.87 15.29 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.562 1.545 . . . . 0.0 111.803 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -165.76 146.0 6.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.089 0.956 . . . . 0.0 112.99 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.62 144.87 45.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.506 1.922 . . . . 0.0 113.752 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.536 ' C ' HD12 ' A' ' 171' ' ' ILE . 24.1 tt0 -145.07 153.28 41.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.594 1.958 . . . . 0.0 109.83 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.536 HD12 ' C ' ' A' ' 170' ' ' GLN . 2.0 mp -124.5 122.61 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.409 1.084 . . . . 0.0 109.963 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -100.1 132.14 45.64 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.985 0.914 . . . . 0.0 109.378 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.578 HG22 ' CB ' ' A' ' 157' ' ' MET . 6.1 pt -116.85 133.07 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.724 0.81 . . . . 0.0 110.123 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.8 p -154.22 170.42 21.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.857 1.263 . . . . 0.0 112.798 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.027 0.441 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 mt -127.71 -53.33 1.34 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.279 1.832 . . . . 0.0 110.7 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.65 145.76 51.21 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 109.892 175.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.52 -38.86 1.82 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 127.111 2.291 . . . . 0.0 111.435 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -143.51 159.09 43.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.948 1.299 . . . . 0.0 112.374 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -139.19 169.83 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.42 1.888 . . . . 0.0 110.235 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.98 -166.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 127.854 2.462 . . . . 0.0 111.128 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.04 -16.58 13.29 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.64 -21.85 40.87 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.907 1.242 . . . . 0.0 114.068 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.12 86.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.567 1.183 . . . . 0.0 111.581 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -85.61 -15.69 41.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.906 1.283 . . . . 0.0 113.717 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 tt -61.14 150.06 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.205 1.002 . . . . 0.0 110.99 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -149.54 144.41 26.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.915 0.886 . . . . 0.0 109.132 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -50.91 -38.65 51.34 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 112.117 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -50.82 -53.32 33.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.408 1.083 . . . . 0.0 113.705 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.67 -47.42 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.97 -0.456 . . . . 0.0 110.171 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -35.74 65.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.327 1.451 . . . . 0.0 112.283 -176.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -64.13 -51.09 65.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.829 2.452 . . . . 0.0 110.67 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -35.22 79.6 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.674 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.67 -50.79 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.613 1.165 . . . . 0.0 111.702 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 32' ' ' ALA . 4.5 pp -65.15 -31.96 73.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 112.809 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.18 -9.11 59.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.075 -1.016 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -25.2 55.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.465 -1.397 . . . . 0.0 112.408 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -63.1 -39.59 95.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.826 2.05 . . . . 0.0 113.757 175.218 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.04 114.67 0.48 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.553 1.073 . . . . 0.0 113.499 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -76.41 42.6 0.28 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 128.635 2.774 . . . . 0.0 114.087 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 29' ' ' GLN . 3.6 m -126.51 -177.42 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.906 2.082 . . . . 0.0 112.028 -174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 t -73.58 52.77 0.4 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.454 1.502 . . . . 0.0 112.578 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' HG3' HG23 ' A' ' 27' ' ' VAL . 1.3 pp0? -168.19 130.66 1.47 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.13 2.572 . . . . 0.0 109.44 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' H ' ' NH1' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -154.9 160.75 41.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.564 1.946 . . . . 0.0 111.975 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -154.8 132.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.857 0.753 . . . . 0.0 112.416 174.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -122.74 115.7 22.5 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.603 1.961 . . . . 0.0 109.524 175.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 157.98 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.94 177.0 28.72 Favored Glycine 0 N--CA 1.451 -0.336 0 O-C-N 121.525 -0.734 . . . . 0.0 111.453 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -136.89 132.77 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.878 0.846 . . . . 0.0 111.631 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.42 104.92 16.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.374 1.47 . . . . 0.0 111.491 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -82.27 96.43 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.033 0.933 . . . . 0.0 112.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.06 13.44 5.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.813 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -3.34 54.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.609 1.564 . . . . 0.0 115.114 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 26.02 60.41 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.165 -0.96 . . . . 0.0 114.766 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.94 125.13 2.51 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.801 1.667 . . . . 0.0 111.44 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.0 m -64.23 141.42 58.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.028 0.931 . . . . 0.0 111.128 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.552 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 34.5 m0 -110.19 169.83 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.09 0.956 . . . . 0.0 111.708 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -144.14 101.2 3.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.074 1.35 . . . . 0.0 112.315 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 154.11 42.52 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.558 -1.339 . . . . 0.0 110.421 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -109.63 -54.28 2.57 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.237 1.415 . . . . 0.0 112.193 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 46' ' ' LEU . 5.8 p-10 -162.49 -171.93 2.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.106 1.762 . . . . 0.0 110.786 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.7 145.37 30.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.658 1.583 . . . . 0.0 110.716 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -123.33 126.02 46.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.669 1.587 . . . . 0.0 110.119 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 137.04 46.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.827 2.451 . . . . 0.0 109.622 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -110.31 -43.3 3.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.191 1.796 . . . . 0.0 111.605 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -100.21 156.74 17.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 109.148 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.42 -171.39 19.93 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -145.19 166.15 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.97 1.308 . . . . 0.0 110.259 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 p -67.76 152.25 45.9 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -163.81 -30.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.958 1.703 . . . . 0.0 113.53 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.97 157.11 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.059 1.744 . . . . 0.0 111.49 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 tt -85.89 138.11 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.25 1.02 . . . . 0.0 112.11 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.88 131.76 42.23 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.222 1.409 . . . . 0.0 109.627 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.07 118.82 5.92 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.745 2.963 . . . . 0.0 110.926 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.11 -53.82 52.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.385 0.674 . . . . 0.0 112.475 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -119.94 136.62 54.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.208 1.003 . . . . 0.0 110.587 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.47 122.01 37.51 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.013 0.925 . . . . 0.0 110.609 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.64 171.0 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.684 2.923 . . . . 0.0 113.0 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -66.02 154.13 40.33 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.266 1.426 . . . . 0.0 112.742 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.7 t 36.87 56.03 1.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.099 2.16 . . . . 0.0 113.303 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -144.18 -178.49 5.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.95 1.3 . . . . 0.0 111.735 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.72 -178.79 6.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.069 0.937 . . . . 0.0 111.35 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.36 150.03 30.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 110.961 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.69 151.02 47.16 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.308 1.443 . . . . 0.0 108.486 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -127.98 159.84 33.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.573 1.549 . . . . 0.0 109.553 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.9 m -135.8 170.17 16.41 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.56 1.544 . . . . 0.0 109.931 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' H ' HD22 ' A' ' 24' ' ' LEU . . . 138.93 89.38 0.19 Allowed Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.527 1.06 . . . . 0.0 111.362 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.657 ' NH1' HG11 ' A' ' 104' ' ' VAL . 52.2 ttt180 -142.18 137.38 30.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.926 1.29 . . . . 0.0 113.632 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 47.43 18.4 0.1 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.903 1.681 . . . . 0.0 114.065 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.29 106.62 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.658 2.383 . . . . 0.0 110.106 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 87.86 -0.71 0.47 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 129.077 2.951 . . . . 0.0 114.018 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.29 52.63 10.34 Favored Glycine 0 CA--C 1.543 1.841 0 C-N-CA 126.244 1.878 . . . . 0.0 112.972 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.69 -24.59 13.36 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.172 3.248 . . . . 0.0 113.419 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -146.93 157.95 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.813 1.645 . . . . 0.0 111.079 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.48 4.58 27.24 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.163 1.385 . . . . 0.0 114.328 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 t -125.64 -171.25 2.33 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.891 2.076 . . . . 0.0 111.903 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.46 ' HA2' ' HE ' ' A' ' 74' ' ' ARG . . . -77.12 179.89 49.62 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.175 1.369 . . . . 0.0 114.687 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.89 153.18 34.97 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.773 -0.84 . . . . 0.0 112.403 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -155.76 111.47 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.775 2.03 . . . . 0.0 107.858 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -156.43 167.51 30.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.483 1.135 . . . . 0.0 110.383 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.97 128.31 9.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.338 1.055 . . . . 0.0 108.824 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -127.2 165.02 20.4 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.028 0.931 . . . . 0.0 111.931 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -130.1 150.27 51.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.557 0.743 . . . . 0.0 112.481 -175.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -125.57 114.8 19.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.971 1.308 . . . . 0.0 110.466 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -71.36 100.0 2.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.689 1.596 . . . . 0.0 110.539 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.0 mtp -64.86 146.64 54.62 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.951 -1.093 . . . . 0.0 112.028 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -57.51 -26.09 60.8 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -71.67 -4.72 28.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.702 1.201 . . . . 0.0 113.58 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.16 27.13 16.71 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.894 1.235 . . . . 0.0 114.457 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -117.57 166.46 12.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.623 1.569 . . . . 0.0 110.746 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.518 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 45.0 m -130.43 104.16 7.09 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.08 0.952 . . . . 0.0 112.44 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 173' ' ' ILE . 13.8 tp -77.27 113.35 14.94 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.957 0.903 . . . . 0.0 110.033 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.87 111.4 4.21 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.749 1.642 . . . . 0.0 112.075 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.65 154.66 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 110.857 175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.1 ttp -134.83 148.82 50.25 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.861 1.265 . . . . 0.0 110.035 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 31' ' ' ILE . 12.4 p90 -153.97 142.46 20.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.367 0.667 . . . . 0.0 109.299 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 m -150.93 165.83 32.47 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.005 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.657 HG11 ' NH1' ' A' ' 74' ' ' ARG . 95.2 t -119.78 142.2 32.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.314 1.046 . . . . 0.0 109.964 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 80.2 Cg_endo -72.12 -177.17 2.48 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.641 2.894 . . . . 0.0 112.706 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.26 31.06 0.82 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.046 1.338 . . . . 0.0 113.651 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 51.52 64.04 2.0 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.018 2.127 . . . . 0.0 113.781 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.43 152.5 50.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.69 1.196 . . . . 0.0 112.195 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.13 -30.08 69.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -67.26 112.46 4.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.578 1.551 . . . . 0.0 111.222 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -66.13 126.24 28.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.077 0.551 . . . . 0.0 111.635 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.13 24.42 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.355 1.062 . . . . 0.0 112.574 175.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.442 HD21 ' HD3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -68.01 146.86 53.13 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -175.009 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -93.22 137.34 32.64 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.987 1.715 . . . . 0.0 111.829 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -164.32 134.79 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.371 1.868 . . . . 0.0 108.394 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -156.16 151.74 27.03 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.333 1.053 . . . . 0.0 110.44 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.88 132.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.437 1.095 . . . . 0.0 110.33 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 120' ' ' TYR . 18.5 ttpt -144.76 158.61 43.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.872 0.869 . . . . 0.0 111.709 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.83 112.07 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.428 1.091 . . . . 0.0 110.47 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 27.0 m-85 -81.3 101.14 9.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -62.84 93.02 0.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.225 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.75 -138.78 8.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.401 2.429 . . . . 0.0 110.544 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -117.08 127.06 53.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.59 1.956 . . . . 0.0 111.778 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -148.73 108.05 3.94 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.2 168.81 18.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.13 0.972 . . . . 0.0 111.435 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.93 118.25 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.888 0.875 . . . . 0.0 111.37 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -161.88 -174.53 4.21 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.769 1.228 . . . . 0.0 112.114 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -48.73 -48.61 40.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.978 1.311 . . . . 0.0 111.556 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.51 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.31 0.957 . . . . 0.0 113.426 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.4 ttp -68.76 -49.31 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.238 1.019 . . . . 0.0 112.467 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.87 -39.27 68.49 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.488 0.585 . . . . 0.0 112.198 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -45.53 79.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.265 1.426 . . . . 0.0 111.199 175.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -21.94 66.69 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.336 -1.478 . . . . 0.0 113.716 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.91 -41.72 14.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.776 1.631 . . . . 0.0 112.824 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -88.95 -28.22 20.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -122.61 -32.07 3.63 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 112.313 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.85 -39.12 94.91 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.118 0.866 . . . . 0.0 113.431 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.53 75.38 9.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.15 120.72 8.0 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.415 2.077 . . . . 0.0 113.284 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.47 173.4 7.69 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.704 2.002 . . . . 0.0 112.369 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -139.83 140.02 36.47 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.565 1.946 . . . . 0.0 112.224 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -136.88 109.78 0.74 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.286 0.946 . . . . 0.0 114.188 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -87.28 -68.25 0.76 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.622 1.569 . . . . 0.0 112.44 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -173.12 114.97 0.26 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 0.0 112.089 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.37 160.17 8.67 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.704 1.145 . . . . 0.0 114.079 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.429 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 92.1 m95 -78.04 147.03 34.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.124 1.37 . . . . 0.0 112.5 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -150.61 127.6 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.664 1.585 . . . . 0.0 112.452 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.6 152.59 24.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.36 1.464 . . . . 0.0 112.37 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -158.65 169.91 23.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.868 1.267 . . . . 0.0 112.627 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -85.44 99.79 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.77 1.628 . . . . 0.0 107.807 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 5.8 tp -60.88 -36.16 78.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.19 24.51 2.21 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -135.92 -29.12 1.04 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 119.157 1.479 . . . . 0.0 114.727 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 133.19 23.0 0.77 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.052 1.31 . . . . 0.0 114.66 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.2 162.63 37.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.224 1.512 . . . . 0.0 112.048 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 136.77 50.79 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.481 1.513 . . . . 0.0 108.875 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.582 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -126.45 168.48 14.16 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.006 0.922 . . . . 0.0 110.841 175.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 128.24 50.62 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.82 152.74 18.0 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.441 1.02 . . . . 0.0 112.02 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.429 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -133.65 145.96 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.236 178.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.9 tpt -154.88 100.85 2.24 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.337 1.055 . . . . 0.0 110.182 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -90.54 149.46 22.16 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 109.542 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -59.67 164.33 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.358 1.463 . . . . 0.0 112.867 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . . . -55.68 129.85 40.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.756 0.823 . . . . 0.0 112.391 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.77 79.22 0.05 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.001 0.81 . . . . 0.0 112.091 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 67.97 -50.7 0.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.651 2.38 . . . . 0.0 115.322 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.52 169.86 7.01 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.475 1.91 . . . . 0.0 113.492 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -152.88 -177.56 6.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.987 1.715 . . . . 0.0 112.315 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 138.3 40.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.996 2.118 . . . . 0.0 112.288 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.443 ' O ' HD13 ' A' ' 171' ' ' ILE . 50.0 tt0 -146.42 156.29 43.19 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.345 1.458 . . . . 0.0 110.764 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 170' ' ' GLN . 14.4 mm -131.9 125.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 110.283 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 112.76 19.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.311 1.044 . . . . 0.0 112.379 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.582 HG22 ' CB ' ' A' ' 157' ' ' MET . 18.2 pt -97.63 132.11 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.721 1.608 . . . . 0.0 110.517 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 t -154.16 158.69 40.76 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.445 -0.784 . . . . 0.0 111.491 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.998 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' HB3' HG22 ' A' ' 20' ' ' VAL . 1.3 mm? -109.25 -62.61 1.46 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 112.38 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.21 29.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.0 1.72 . . . . 0.0 114.387 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.4 -5.6 10.22 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.021 1.772 . . . . 0.0 115.392 -175.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -167.49 162.18 14.29 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.304 2.642 . . . . 0.0 109.36 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 70' ' ' LEU . 49.1 mt -142.4 167.39 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.774 1.23 . . . . 0.0 109.901 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.03 -164.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 127.958 2.503 . . . . 0.0 110.045 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.04 -14.82 39.63 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -26.4 24.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.874 1.702 . . . . 0.0 113.571 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.53 81.34 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 118.373 1.086 . . . . 0.0 112.166 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -12.71 49.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.042 1.337 . . . . 0.0 113.842 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.36 129.73 41.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.857 1.263 . . . . 0.0 109.371 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -142.24 144.06 33.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.701 0.8 . . . . 0.0 109.319 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -54.96 -29.79 57.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.592 0.633 . . . . 0.0 112.381 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -58.63 -55.99 27.9 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 112.119 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -62.4 -47.04 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.9 63.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.005 1.322 . . . . 0.0 113.323 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -52.91 14.83 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 119.938 -1.726 . . . . 0.0 110.754 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -64.32 -38.93 92.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.117 1.767 . . . . 0.0 112.231 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.8 -34.45 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.429 1.092 . . . . 0.0 112.155 -174.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 32' ' ' ALA . 97.2 mt -78.2 -40.55 37.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.258 1.423 . . . . 0.0 111.425 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -72.45 -17.11 61.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -30.97 70.57 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.645 -1.284 . . . . 0.0 112.554 175.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 tp -72.59 -25.46 61.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 112.262 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.77 130.66 1.64 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.877 1.703 . . . . 0.0 111.759 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.68 43.56 0.09 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 128.479 2.712 . . . . 0.0 112.673 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.95 144.13 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.464 2.306 . . . . 0.0 111.243 -174.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.9 m -69.76 -29.23 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.477 -0.764 . . . . 0.0 112.997 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -71.81 82.02 0.89 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.922 1.689 . . . . 0.0 111.935 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.891 1.276 . . . . 0.0 111.493 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -133.18 130.98 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.646 1.178 . . . . 0.0 110.367 -177.451 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -116.73 95.29 4.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.749 2.02 . . . . 0.0 112.423 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -101.73 113.41 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.626 -1.296 . . . . 0.0 109.178 174.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.6 160.02 28.56 Favored Glycine 0 C--O 1.235 0.171 0 C-N-CA 120.857 -0.687 . . . . 0.0 114.745 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.495 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.8 mp -135.61 130.97 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.193 1.397 . . . . 0.0 110.129 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 4.2 m-20 -86.7 104.4 16.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.344 1.058 . . . . 0.0 111.943 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -81.12 100.39 9.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.829 1.195 . . . . 0.0 112.102 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.64 21.49 2.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.197 0.999 . . . . 0.0 112.845 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -6.38 58.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.482 1.513 . . . . 0.0 114.621 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.53 22.82 55.51 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.384 0.992 . . . . 0.0 114.97 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.15 126.87 3.65 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.444 1.497 . . . . 0.0 112.275 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -58.6 143.95 44.56 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.464 1.106 . . . . 0.0 110.565 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 50.7 m0 -108.05 164.77 12.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.69 0.796 . . . . 0.0 111.858 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.1 m -149.9 104.15 3.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.141 1.776 . . . . 0.0 110.307 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.36 144.62 55.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.733 -1.229 . . . . 0.0 111.211 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.549 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -107.56 -47.8 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.743 1.617 . . . . 0.0 113.149 -177.427 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.549 ' H ' HD22 ' A' ' 46' ' ' LEU . 61.7 t30 -157.73 171.33 20.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.497 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.64 128.67 25.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.894 1.277 . . . . 0.0 110.859 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -120.31 141.64 49.84 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.286 1.434 . . . . 0.0 110.373 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -154.22 155.73 35.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.527 177.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -120.15 -13.11 8.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.035 1.734 . . . . 0.0 111.093 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.4 m -143.04 131.23 21.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.649 1.98 . . . . 0.0 110.219 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 107.29 0.98 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 74' ' ' ARG . 1.4 t -73.79 176.23 6.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.125 2.17 . . . . 0.0 111.378 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -69.13 163.14 25.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.452 1.12 . . . . 0.0 113.155 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.0 -29.74 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.986 1.314 . . . . 0.0 112.937 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.66 164.05 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.411 1.884 . . . . 0.0 110.233 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 tp -64.26 134.54 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.062 0.945 . . . . 0.0 110.786 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.29 109.56 34.37 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 108.295 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HG2' HD12 ' A' ' 69' ' ' LEU . 50.7 Cg_endo -61.46 123.47 12.82 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.032 3.154 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.2 -59.56 2.51 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.346 -0.846 . . . . 0.0 112.483 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -105.22 144.73 31.6 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 110.697 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.44 124.46 17.11 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.595 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.17 170.48 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.072 2.514 . . . . 0.0 112.493 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -62.66 148.73 45.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.012 0.925 . . . . 0.0 111.133 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 p 53.9 42.86 31.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.808 1.643 . . . . 0.0 114.832 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -145.2 127.9 16.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.807 1.643 . . . . 0.0 112.723 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -84.64 176.1 8.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.978 0.911 . . . . 0.0 111.819 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.654 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -151.87 150.51 30.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.342 -0.849 . . . . 0.0 112.003 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -122.49 169.18 11.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.177 1.391 . . . . 0.0 112.128 177.051 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.627 ' HB3' HG13 ' A' ' 33' ' ' VAL . 2.4 t80 -145.7 160.65 41.41 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.436 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.87 164.65 33.04 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.725 1.61 . . . . 0.0 111.262 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.59 173.45 39.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.645 0.64 . . . . 0.0 113.703 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' O ' HG22 ' A' ' 54' ' ' THR . 22.7 tpt180 -141.66 141.12 33.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.442 1.897 . . . . 0.0 109.802 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -117.14 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 0.0 113.752 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t0 49.84 -91.18 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.681 2.392 . . . . 0.0 115.945 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.4 t -69.35 -10.14 56.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.701 2.001 . . . . 0.0 113.509 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.02 -163.12 24.6 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.432 2.444 . . . . 0.0 116.011 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.92 -11.14 28.91 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.821 3.014 . . . . 0.0 113.985 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 p -141.49 167.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.278 1.831 . . . . 0.0 111.551 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.52 -14.63 19.9 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.858 1.263 . . . . 0.0 113.974 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.7 p -146.94 131.13 17.39 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 127.044 2.137 . . . . 0.0 112.961 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.77 161.18 34.37 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.838 2.637 . . . . 0.0 114.645 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.579 ' H ' ' CG2' ' A' ' 104' ' ' VAL . . . -134.42 107.78 7.78 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.115 -1.227 . . . . 0.0 111.521 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.08 112.87 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.505 1.922 . . . . 0.0 111.088 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -132.57 163.99 27.64 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.526 1.131 . . . . 0.0 111.18 175.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.2 112.81 4.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.766 1.226 . . . . 0.0 108.635 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -122.64 165.17 16.92 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.969 1.308 . . . . 0.0 110.747 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -129.03 153.61 47.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.267 0.556 . . . . 0.0 111.511 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.6 m-85 -127.96 112.9 15.18 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.967 1.307 . . . . 0.0 109.93 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 46' ' ' LEU . 10.5 t80 -67.64 107.03 2.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.187 1.395 . . . . 0.0 110.329 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.15 144.92 50.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.212 1.405 . . . . 0.0 110.845 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.6 t -55.42 -27.33 47.21 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.175 0.99 . . . . 0.0 113.369 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -9.3 40.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.312 1.445 . . . . 0.0 114.837 174.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.12 55.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.872 1.225 . . . . 0.0 115.094 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.05 172.82 6.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.508 1.523 . . . . 0.0 110.445 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HB1' ' A' ' 89' ' ' ALA . 40.8 m -136.33 108.36 7.18 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.312 1.045 . . . . 0.0 111.141 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 173' ' ' ILE . 9.1 tp -73.75 125.87 29.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.013 -1.055 . . . . 0.0 109.091 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.88 99.12 1.93 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.9 162.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.786 0.803 . . . . 0.0 111.227 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -148.1 158.29 43.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.502 0.721 . . . . 0.0 111.322 174.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 45.8 p90 -160.3 162.72 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.928 1.291 . . . . 0.0 109.325 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.22 168.76 24.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.809 1.244 . . . . 0.0 109.108 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.579 ' CG2' ' H ' ' A' ' 84' ' ' ALA . 12.3 m -136.11 97.38 12.21 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 109.723 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.21 173.22 11.69 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.303 2.002 . . . . 0.0 110.865 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -69.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.794 -0.566 . . . . 0.0 111.817 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -170.46 147.23 2.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.142 1.777 . . . . 0.0 110.556 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.2 169.77 21.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.755 1.222 . . . . 0.0 111.383 174.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.54 -53.71 8.9 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.23 0.612 . . . . 0.0 111.682 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -161.5 22.28 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.32 -168.77 3.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.165 1.386 . . . . 0.0 112.957 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 t 63.49 23.16 13.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.321 2.248 . . . . 0.0 114.476 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.457 ' HB2' ' HE1' ' A' ' 161' ' ' MET . 16.7 p-10 -127.5 112.34 14.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.303 2.641 . . . . 0.0 111.524 -174.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -86.23 157.55 19.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.679 1.191 . . . . 0.0 112.617 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 6.0 p-90 -160.94 148.32 15.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.762 0.825 . . . . 0.0 111.505 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -172.1 107.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.317 1.847 . . . . 0.0 111.699 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 171' ' ' ILE . 23.6 t -116.36 137.24 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.683 0.793 . . . . 0.0 109.063 174.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' HA ' HD13 ' A' ' 151' ' ' LEU . 5.0 ttmt -145.96 143.64 29.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.875 1.67 . . . . 0.0 110.484 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.88 153.42 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -122.62 96.34 4.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.247 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t -70.71 90.51 0.78 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.54 -1.35 . . . . 0.0 111.599 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.85 -112.57 0.52 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.31 1.909 . . . . 0.0 110.831 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -159.21 117.78 2.89 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.706 1.602 . . . . 0.0 110.513 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -140.04 108.6 5.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.241 1.416 . . . . 0.0 111.404 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.01 171.35 6.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.638 0.775 . . . . 0.0 111.153 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.77 113.67 22.12 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.728 -0.608 . . . . 0.0 110.651 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.09 -175.22 4.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.083 1.353 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.06 -45.04 21.38 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.827 1.251 . . . . 0.0 112.236 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.06 46.88 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.576 1.084 . . . . 0.0 114.397 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 ttp -70.02 -60.61 2.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.781 1.291 . . . . 0.0 109.63 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -53.54 -33.39 54.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.845 0.858 . . . . 0.0 113.241 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.22 -38.59 91.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.568 1.147 . . . . 0.0 110.837 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -23.61 66.78 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.329 -1.482 . . . . 0.0 112.458 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mt -84.01 -47.28 11.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.518 1.527 . . . . 0.0 111.345 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.18 -26.44 26.78 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -122.46 -38.88 2.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.681 1.192 . . . . 0.0 112.219 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.52 -55.95 24.48 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.737 1.161 . . . . 0.0 112.761 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -160.97 70.44 2.67 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.04 115.19 3.15 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.848 2.365 . . . . 0.0 112.99 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.21 -178.33 3.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.536 1.135 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.57 144.33 49.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.077 2.551 . . . . 0.0 111.022 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.45 108.29 0.63 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.853 1.216 . . . . 0.0 111.865 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -120.15 64.9 0.82 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.725 1.61 . . . . 0.0 114.094 -174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.94 96.03 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.923 2.089 . . . . 0.0 114.314 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.99 135.26 2.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.343 1.449 . . . . 0.0 112.017 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -66.41 144.63 56.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 111.371 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -143.6 131.2 21.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.363 1.065 . . . . 0.0 111.805 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -133.81 143.74 48.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.645 1.578 . . . . 0.0 112.346 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 161.98 40.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.462 1.505 . . . . 0.0 112.224 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -97.67 96.62 8.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.396 1.079 . . . . 0.0 108.886 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -53.54 -51.07 64.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.523 1.529 . . . . 0.0 112.014 -174.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.94 51.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.791 1.076 . . . . 0.0 115.791 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -135.44 -31.29 0.97 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -29.75 2.31 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.21 1.386 . . . . 0.0 113.321 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.61 172.14 6.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.904 1.682 . . . . 0.0 112.766 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -134.53 151.83 51.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.912 1.685 . . . . 0.0 109.782 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.66 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.54 152.99 51.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 133.71 49.1 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.504 1.521 . . . . 0.0 109.918 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.07 136.41 11.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.477 1.037 . . . . 0.0 112.591 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tp -108.24 149.81 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.091 1.757 . . . . 0.0 109.641 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.457 ' HE1' ' HB2' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -144.88 93.58 2.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.68 1.192 . . . . 0.0 110.707 174.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.9 p -91.88 161.62 14.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.247 1.019 . . . . 0.0 111.183 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.14 -26.52 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.734 1.214 . . . . 0.0 112.398 175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.33 114.86 9.83 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 110.911 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.03 -95.11 0.64 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.083 1.325 . . . . 0.0 113.078 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.01 64.15 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.45 1.5 . . . . 0.0 111.265 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.27 91.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.864 1.666 . . . . 0.0 113.977 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.455 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -156.66 168.84 26.19 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -174.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.455 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 17.8 ptm -135.31 160.47 38.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.227 2.611 . . . . 0.0 112.567 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -153.64 162.51 41.18 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.192 1.797 . . . . 0.0 109.558 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 117' ' ' VAL . 11.1 mm -136.48 108.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -95.87 116.18 28.53 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 112.024 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.66 HG22 ' CB ' ' A' ' 157' ' ' MET . 8.2 pt -103.67 132.19 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 0.0 111.101 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.7 p -155.48 170.96 20.73 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.284 -0.885 . . . . 0.0 112.643 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 118.528 -0.749 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.433 ' HB3' HG22 ' A' ' 20' ' ' VAL . 8.8 mp -69.75 -37.96 76.61 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.13 1.332 . . . . 0.0 112.115 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.65 171.54 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.85 -19.44 44.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.393 0.997 . . . . 0.0 113.659 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.8 p -163.38 156.99 19.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.784 2.834 . . . . 0.0 109.05 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.505 HD11 HD12 ' A' ' 70' ' ' LEU . 64.8 mt -141.84 173.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.957 1.703 . . . . 0.0 109.065 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.11 -167.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.558 1.543 . . . . 0.0 110.033 174.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -46.34 -40.2 11.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.72 -32.64 5.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.594 1.569 . . . . 0.0 113.083 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.588 1.194 . . . . 0.0 111.588 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.0 m -83.82 -6.54 59.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.607 1.963 . . . . 0.0 113.902 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 13' ' ' THR . 4.6 tt -66.27 138.09 57.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.578 1.151 . . . . 0.0 109.792 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.2 m -141.79 142.17 33.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.863 0.865 . . . . 0.0 109.922 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -55.93 -32.45 63.82 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -56.62 -49.78 73.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.442 1.019 . . . . 0.0 112.771 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.11 -49.53 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.014 -0.429 . . . . 0.0 109.861 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.2 -36.56 52.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.271 1.428 . . . . 0.0 112.222 -178.173 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.92 -65.79 0.54 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.196 1.798 . . . . 0.0 111.211 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -65.05 -24.45 67.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 177.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.41 -46.6 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.707 1.203 . . . . 0.0 112.285 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -26.93 55.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.247 0.619 . . . . 0.0 112.063 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.21 -38.36 51.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.173 1.389 . . . . 0.0 113.714 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.45 -27.06 45.73 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.198 0.908 . . . . 0.0 113.039 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -52.72 -36.24 57.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.853 2.061 . . . . 0.0 113.7 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.98 115.75 0.49 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.773 1.178 . . . . 0.0 111.304 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.73 79.31 0.84 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.352 1.061 . . . . 0.0 111.28 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.87 174.28 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.557 1.943 . . . . 0.0 110.695 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -38.7 -61.42 0.72 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.162 2.185 . . . . 0.0 111.883 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -157.75 150.34 22.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.738 2.015 . . . . 0.0 110.034 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 -176.04 3.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 129.336 3.055 . . . . 0.0 110.361 -174.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -128.87 147.39 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.351 1.061 . . . . 0.0 112.11 -175.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 110.96 11.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.27 1.828 . . . . 0.0 111.287 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.783 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -130.32 157.46 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 C-N-CA 125.189 1.396 . . . . 0.0 112.601 175.005 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 156.54 177.32 29.59 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.2 mp -133.78 147.97 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.747 0.819 . . . . 0.0 110.46 -175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.79 102.07 13.79 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.926 -1.109 . . . . 0.0 112.049 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -82.16 98.61 8.79 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 113.124 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -133.91 10.61 3.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 113.44 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -5.36 35.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.22 42.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.855 1.217 . . . . 0.0 114.826 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.98 127.04 3.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.358 1.456 . . . . 0.0 112.328 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.7 m -57.8 142.03 46.99 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.361 1.065 . . . . 0.0 110.968 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.631 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 49.5 m0 -108.67 165.27 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.118 0.967 . . . . 0.0 111.938 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -142.01 99.85 3.61 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.118 1.767 . . . . 0.0 112.008 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -68.02 145.06 54.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.714 -1.241 . . . . 0.0 108.95 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.98 -48.99 4.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.476 1.111 . . . . 0.0 111.733 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.6 176.03 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.818 2.047 . . . . 0.0 110.272 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.65 40.61 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.089 1.755 . . . . 0.0 111.006 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -125.58 137.24 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.931 1.292 . . . . 0.0 110.364 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.57 42.22 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.151 1.78 . . . . 0.0 109.201 -175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 -23.13 3.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.87 68.11 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.073 1.416 . . . . 0.0 109.584 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.45 179.31 32.27 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.923 1.725 . . . . 0.0 110.969 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -141.98 162.31 35.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.311 1.444 . . . . 0.0 110.141 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 p -65.25 160.01 22.51 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.304 -0.873 . . . . 0.0 112.278 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.78 -19.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 161.8 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.462 1.905 . . . . 0.0 110.814 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.17 135.96 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.65 0.78 . . . . 0.0 110.038 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.8 tp -91.95 113.96 60.57 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.217 1.007 . . . . 0.0 108.393 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 69' ' ' LEU . 89.8 Cg_endo -66.45 125.48 13.98 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.624 2.883 . . . . 0.0 110.337 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -57.37 9.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.899 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.53 130.34 54.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.003 0.82 . . . . 0.0 111.164 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 69' ' ' LEU . 57.5 t -101.81 121.76 49.82 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.367 1.067 . . . . 0.0 109.627 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.03 148.28 86.05 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.456 2.104 . . . . 0.0 111.285 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.5 155.4 5.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 175.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 t 40.6 55.32 2.94 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.597 1.559 . . . . 0.0 113.096 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 3.6 ttmt -159.89 136.28 8.93 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.007 1.723 . . . . 0.0 111.895 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.35 177.49 5.82 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.43 1.092 . . . . 0.0 111.787 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 60' ' ' PRO . 2.2 pt? -149.87 149.61 30.71 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.682 0.793 . . . . 0.0 111.912 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.77 171.31 7.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.731 1.212 . . . . 0.0 110.653 175.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.2 158.16 37.13 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.638 1.975 . . . . 0.0 108.611 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -150.14 175.47 11.72 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.022 0.929 . . . . 0.0 111.118 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.02 172.73 29.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.886 0.755 . . . . 0.0 114.158 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -121.45 168.85 11.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.159 1.784 . . . . 0.0 113.378 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 73.84 1.33 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.061 2.144 . . . . 0.0 110.774 -175.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.31 -17.78 11.73 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.1 9.68 0.51 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -117.91 -123.04 3.28 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -17.33 48.63 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.151 2.567 . . . . 0.0 113.934 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.309 8.6 p 48.11 22.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 127.927 2.491 . . . . 0.0 114.419 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.81 -83.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.319 2.248 . . . . 0.0 110.374 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.8 p -147.09 141.94 26.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.687 1.195 . . . . 0.0 113.512 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.05 171.12 0.74 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.532 1.539 . . . . 0.0 114.684 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -122.44 169.29 11.13 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.491 -1.593 . . . . 0.0 112.024 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.24 108.36 2.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 126.045 1.738 . . . . 0.0 110.837 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.83 179.83 7.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.122 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' A' ' 130' ' ' MET . . . -153.18 138.47 17.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.206 1.003 . . . . 0.0 108.594 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.66 168.92 20.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.307 0.643 . . . . 0.0 111.359 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.796 ' HB2' HH22 ' A' ' 124' ' ' ARG . . . -131.74 162.49 30.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.785 0.803 . . . . 0.0 113.073 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 31.3 m-85 -135.45 113.85 11.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.395 1.478 . . . . 0.0 110.099 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.1 115.02 7.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.923 1.289 . . . . 0.0 109.995 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.3 ttp -82.3 153.32 25.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.391 0.676 . . . . 0.0 112.029 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -59.15 -24.05 62.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.96 -7.73 43.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.547 1.539 . . . . 0.0 114.205 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.15 -1.45 73.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.407 1.479 . . . . 0.0 114.764 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.05 175.34 6.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.046 1.339 . . . . 0.0 111.184 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.538 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 7.7 m -136.7 115.24 11.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.266 1.427 . . . . 0.0 110.983 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.558 ' CD2' HG21 ' A' ' 35' ' ' ILE . 13.2 tp -81.49 126.15 31.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.03 117.35 5.28 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.412 1.006 . . . . 0.0 112.221 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -90.39 146.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.903 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -129.43 135.54 48.8 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.373 1.469 . . . . 0.0 109.879 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.783 ' CG ' HG11 ' A' ' 33' ' ' VAL . 53.0 p90 -153.19 145.42 23.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.048 0.928 . . . . 0.0 113.013 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -151.04 149.72 29.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.277 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.76 95.26 49.12 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.16 -179.6 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.491 2.127 . . . . 0.0 110.609 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -62.11 171.37 1.8 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.488 1.115 . . . . 0.0 113.001 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -107.97 114.19 27.93 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.744 1.618 . . . . 0.0 111.547 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.65 173.93 11.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.151 1.781 . . . . 0.0 112.401 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.85 -37.73 80.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.438 1.495 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -59.15 128.84 39.19 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.844 1.258 . . . . 0.0 112.257 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -103.23 129.95 50.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.861 1.264 . . . . 0.0 109.252 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m 149.71 137.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 130.564 3.546 . . . . 0.0 110.829 -175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -134.56 159.61 40.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.377 1.871 . . . . 0.0 110.066 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 139' ' ' PRO . 50.9 m95 -97.22 147.04 24.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.335 1.054 . . . . 0.0 112.813 176.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -154.92 151.81 28.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.407 174.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -175.6 119.0 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.4 1.88 . . . . 0.0 110.186 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 171' ' ' ILE . 13.7 p -119.88 137.7 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.056 1.743 . . . . 0.0 109.516 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -134.03 159.54 40.46 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 110.365 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.99 104.74 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.785 1.634 . . . . 0.0 108.548 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -76.33 106.52 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.321 1.448 . . . . 0.0 109.61 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -70.38 85.25 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.481 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.55 -122.47 1.35 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.508 2.004 . . . . 0.0 110.563 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -146.64 144.65 29.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.578 1.151 . . . . 0.0 111.101 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.796 HH22 ' HB2' ' A' ' 89' ' ' ALA . 20.2 ttp85 -150.49 122.95 8.46 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.139 1.376 . . . . 0.0 110.789 175.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.69 152.66 45.23 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.038 1.335 . . . . 0.0 109.873 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.81 115.26 20.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.483 -0.761 . . . . 0.0 109.289 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.9 p30 -156.79 -177.77 6.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.618 1.167 . . . . 0.0 113.012 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -53.75 -38.42 64.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.382 1.073 . . . . 0.0 112.73 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.93 -42.5 94.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.414 1.007 . . . . 0.0 112.378 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.425 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 1.5 ptm -60.72 -50.94 71.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.188 0.994 . . . . 0.0 110.383 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -57.9 -36.54 72.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.658 0.783 . . . . 0.0 112.226 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.65 -46.6 78.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 0.0 110.912 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -20.72 66.22 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.321 -1.487 . . . . 0.0 113.48 174.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.35 -17.17 37.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.867 2.467 . . . . 0.0 115.131 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.23 -23.44 4.89 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -123.83 -25.74 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.829 1.252 . . . . 0.0 111.968 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.28 -68.19 1.74 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.775 1.655 . . . . 0.0 113.579 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -141.62 55.02 4.58 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 98.1 Cg_endo -64.33 141.06 73.33 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 123.905 3.07 . . . . 0.0 113.966 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -124.07 174.73 7.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.643 1.977 . . . . 0.0 113.102 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -129.23 141.95 50.99 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.623 -1.298 . . . . 0.0 110.546 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.61 120.02 1.07 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -134.06 83.97 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.49 0.716 . . . . 0.0 111.705 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 m120 56.75 93.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.976 2.51 . . . . 0.0 114.478 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 148.56 140.6 3.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.918 1.723 . . . . 0.0 111.928 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -67.06 141.58 57.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.009 0.923 . . . . 0.0 111.849 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -144.3 140.96 29.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.907 1.283 . . . . 0.0 111.915 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -132.24 151.83 51.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 127.537 2.335 . . . . 0.0 110.506 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.614 ' HE3' HD12 ' A' ' 151' ' ' LEU . 1.8 pttt -150.86 157.56 43.06 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 110.638 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.63 88.33 3.92 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.614 HD12 ' HE3' ' A' ' 149' ' ' LYS . 1.7 tp -50.01 -39.42 41.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.966 1.707 . . . . 0.0 114.314 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.38 1.61 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 117.767 1.867 . . . . 0.0 117.767 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -132.52 -32.93 1.28 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.09 -37.54 0.7 Allowed Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.665 1.126 . . . . 0.0 113.239 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.31 172.2 7.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.283 1.833 . . . . 0.0 111.112 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -133.13 156.32 47.66 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.544 1.538 . . . . 0.0 109.681 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.653 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -133.22 162.99 30.29 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.253 0.621 . . . . 0.0 110.902 176.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 134.7 53.17 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.726 1.21 . . . . 0.0 108.296 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.4 148.42 18.92 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.217 0.913 . . . . 0.0 112.421 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -121.65 113.86 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.734 1.214 . . . . 0.0 111.168 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.52 125.9 45.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.829 0.74 . . . . 0.0 109.385 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.3 p -123.63 159.87 28.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.205 1.802 . . . . 0.0 110.365 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.5 t -147.23 -73.63 0.21 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.11 -0.994 . . . . 0.0 112.376 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.33 106.79 0.48 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.79 1.236 . . . . 0.0 112.469 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.31 97.89 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 60.29 79.36 0.24 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.392 1.877 . . . . 0.0 113.274 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.03 86.14 0.24 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.134 1.373 . . . . 0.0 113.853 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 -170.62 3.06 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.1 ptm -155.4 169.48 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.04 1.336 . . . . 0.0 111.477 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -148.33 157.24 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.994 1.317 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.551 HG21 HG21 ' A' ' 117' ' ' VAL . 37.2 mm -123.7 123.01 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.833 1.253 . . . . 0.0 108.62 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -118.43 122.52 42.96 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.49 0.716 . . . . 0.0 110.289 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 157' ' ' MET . 25.2 pt -105.72 132.89 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.449 1.099 . . . . 0.0 108.829 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.7 p -150.93 163.71 38.06 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.316 0.647 . . . . 0.0 110.645 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.229 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.209 0.077 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.03 -33.37 59.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.745 0.818 . . . . 0.0 111.9 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.46 169.81 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.337 1.065 . . . . 0.0 110.982 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.6 -30.48 9.59 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.643 1.592 . . . . 0.0 111.567 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.5 p -144.87 146.08 31.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.656 1.728 . . . . 0.0 111.966 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -139.71 156.39 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.6 1.16 . . . . 0.0 110.839 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.21 163.32 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.431 1.493 . . . . 0.0 111.984 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.48 -29.43 58.74 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.48 -15.47 3.89 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.267 1.889 . . . . 0.0 112.327 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.99 -28.85 69.32 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.414 1.485 . . . . 0.0 114.115 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -119.88 3.25 11.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.898 1.679 . . . . 0.0 113.848 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -78.36 133.02 37.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.439 1.096 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.48 147.88 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.637 1.175 . . . . 0.0 109.196 175.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.16 -32.91 56.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.217 0.917 . . . . 0.0 113.202 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -60.99 -48.4 82.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.89 1.276 . . . . 0.0 113.509 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.07 -45.2 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 121.559 -0.713 . . . . 0.0 110.602 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -53.24 -37.59 62.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.956 1.303 . . . . 0.0 112.125 -176.212 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -52.03 -67.2 0.27 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.436 2.295 . . . . 0.0 110.871 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -38.16 79.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.834 0.854 . . . . 0.0 112.056 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.2 -48.64 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.235 1.379 . . . . 0.0 111.435 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.663 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -75.18 -27.27 59.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.322 1.049 . . . . 0.0 113.44 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.37 -35.14 54.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 116.986 -1.483 . . . . 0.0 112.41 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -45.3 -27.77 0.71 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.71 2.804 . . . . 0.0 114.52 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -52.1 -37.03 52.72 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.963 0.905 . . . . 0.0 111.41 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.83 -164.34 10.33 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.073 2.273 . . . . 0.0 112.488 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -141.42 52.1 1.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.243 1.417 . . . . 0.0 112.586 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 m -136.01 169.46 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.413 1.485 . . . . 0.0 112.657 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 m -64.4 -2.97 2.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.265 1.826 . . . . 0.0 115.138 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.86 130.22 55.02 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.469 1.508 . . . . 0.0 109.071 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 138.37 20.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.007 1.323 . . . . 0.0 110.766 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -132.12 137.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.541 1.136 . . . . 0.0 112.194 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB2' ' CB ' ' A' ' 21' ' ' LEU . . . -126.27 116.49 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.549 2.339 . . . . 0.0 110.564 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.19 127.95 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 120.819 -1.176 . . . . 0.0 110.739 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.21 170.88 43.24 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 121.969 -0.457 . . . . 0.0 113.699 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.34 126.57 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.509 1.523 . . . . 0.0 110.108 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -77.53 108.0 10.38 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.523 -1.36 . . . . 0.0 112.125 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.404 ' ND2' ' CE2' ' A' ' 43' ' ' TRP . 22.2 t-20 -86.89 93.73 9.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.211 1.404 . . . . 0.0 113.258 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.19 18.5 2.6 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 120.799 -1.188 . . . . 0.0 112.644 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 -7.8 59.5 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.5 7.61 71.95 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.657 1.123 . . . . 0.0 115.44 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.58 100.01 0.38 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.778 1.656 . . . . 0.0 111.891 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -52.18 124.44 13.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.784 2.033 . . . . 0.0 113.108 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.603 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 7.5 m0 -90.8 168.03 12.03 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.521 -0.737 . . . . 0.0 112.783 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -140.37 111.83 7.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.179 2.192 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -66.21 162.51 19.76 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.068 -1.02 . . . . 0.0 111.975 174.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -133.41 -64.56 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.628 1.171 . . . . 0.0 112.587 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -145.87 167.41 23.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.858 0.863 . . . . 0.0 111.533 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.3 134.46 31.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.816 1.247 . . . . 0.0 111.622 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -117.19 118.0 31.13 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.038 1.735 . . . . 0.0 109.749 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 118.86 25.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.372 2.269 . . . . 0.0 109.265 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.28 -30.54 11.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.206 1.403 . . . . 0.0 112.452 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -120.41 107.37 12.83 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.448 1.499 . . . . 0.0 108.447 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.99 123.09 3.35 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.524 1.059 . . . . 0.0 113.666 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -95.91 100.96 12.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.426 1.49 . . . . 0.0 109.515 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -67.68 168.99 10.22 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -138.92 0.32 1.96 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.936 1.695 . . . . 0.0 113.071 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG23 ' CE1' ' A' ' 71' ' ' TYR . 33.2 m -90.09 156.12 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.747 -1.221 . . . . 0.0 111.876 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.41 128.11 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.863 1.265 . . . . 0.0 112.537 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 tp -80.79 130.1 65.36 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 108.968 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.657 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.9 Cg_endo -65.51 123.35 11.31 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.79 2.993 . . . . 0.0 111.184 175.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.65 -53.39 9.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.73 0.812 . . . . 0.0 112.96 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -114.58 157.35 23.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.165 0.986 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.71 87.98 11.04 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 124.024 0.93 . . . . 0.0 108.843 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.65 159.21 54.59 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.849 1.699 . . . . 0.0 111.183 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -58.47 158.49 7.46 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.718 -0.613 . . . . 0.0 111.035 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 6.9 p 58.17 42.47 22.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.223 1.409 . . . . 0.0 112.157 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -155.65 163.9 39.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.475 1.91 . . . . 0.0 111.762 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.06 -174.73 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.789 0.804 . . . . 0.0 109.422 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -157.52 154.52 28.75 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.542 -0.724 . . . . 0.0 111.425 176.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mt -136.15 164.42 28.07 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.901 0.881 . . . . 0.0 111.348 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' A' ' 57' ' ' VAL . 1.2 t80 -136.71 163.55 30.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.797 1.239 . . . . 0.0 109.698 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -131.01 172.36 12.17 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.3 1.84 . . . . 0.0 109.245 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.65 117.02 0.83 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-O 118.706 -1.052 . . . . 0.0 111.568 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 93.1 mtm-85 -140.47 -172.37 3.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.253 1.421 . . . . 0.0 111.135 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.38 77.44 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.228 2.211 . . . . 0.0 113.304 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.87 -8.95 59.72 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.483 1.513 . . . . 0.0 112.99 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t -144.57 11.16 1.45 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.471 1.508 . . . . 0.0 114.448 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.42 40.78 47.21 Favored Glycine 0 CA--C 1.551 2.293 0 C-N-CA 125.294 1.426 . . . . 0.0 115.941 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.27 -32.44 16.45 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 124.242 3.295 . . . . 0.0 114.417 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -133.05 161.45 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.011 2.124 . . . . 0.0 109.94 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.48 -56.69 8.92 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.409 1.484 . . . . 0.0 112.578 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -158.6 140.9 14.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.804 2.042 . . . . 0.0 111.354 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.748 ' HA3' HG21 ' A' ' 104' ' ' VAL . . . 72.27 -169.25 51.65 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.359 1.457 . . . . 0.0 115.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . -137.31 161.59 35.84 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.821 1.648 . . . . 0.0 114.14 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -155.37 119.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.609 1.963 . . . . 0.0 109.034 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.12 171.65 16.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.205 1.402 . . . . 0.0 109.119 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 127.67 6.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -131.1 165.09 24.03 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.007 0.923 . . . . 0.0 111.309 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -125.61 148.66 48.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.7 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 26.3 m-85 -123.36 120.09 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.216 1.406 . . . . 0.0 110.528 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.457 ' HB2' HD22 ' A' ' 46' ' ' LEU . 8.3 t80 -71.73 102.35 2.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 0.0 110.23 175.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.4 mtp -66.11 152.35 44.91 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 0.0 111.893 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -56.57 -30.65 63.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.489 1.116 . . . . 0.0 113.423 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.4 p -65.27 -11.9 46.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.966 2.106 . . . . 0.0 115.157 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 18.8 41.89 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.519 1.057 . . . . 0.0 114.579 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -111.68 167.6 10.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.762 1.625 . . . . 0.0 110.804 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.514 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 59.1 m -128.94 101.06 5.9 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.233 -0.917 . . . . 0.0 112.767 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 173' ' ' ILE . 9.6 tp -71.64 116.34 11.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.749 0.82 . . . . 0.0 110.97 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.34 105.11 3.22 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.208 0.909 . . . . 0.0 111.876 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.04 156.32 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 0.0 110.152 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.587 ' HB3' HD13 ' A' ' 134' ' ' LEU . 2.2 ppp? -136.57 162.85 31.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.759 1.224 . . . . 0.0 109.046 175.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -162.97 155.55 18.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.112 0.565 . . . . 0.0 111.022 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 t -153.53 164.01 38.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 110.645 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.748 HG21 ' HA3' ' A' ' 83' ' ' GLY . 9.2 m -105.02 146.64 33.06 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.493 1.117 . . . . 0.0 112.367 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.24 99.54 1.13 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.033 3.155 . . . . 0.0 112.055 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.64 26.79 0.74 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -126.25 82.54 2.08 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.174 -1.579 . . . . 0.0 111.478 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -59.6 -24.96 64.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.08 -30.76 68.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.071 1.348 . . . . 0.0 112.039 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -108.02 155.1 20.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.054 1.741 . . . . 0.0 110.386 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.94 155.92 17.68 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.309 -0.87 . . . . 0.0 111.013 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.2 m 55.15 -163.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.138 1.375 . . . . 0.0 112.326 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.36 149.53 52.0 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.512 -1.367 . . . . 0.0 110.216 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -84.38 142.54 30.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.331 1.452 . . . . 0.0 113.146 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.01 146.2 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -163.17 152.88 15.4 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.106 0.962 . . . . 0.0 112.957 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.563 ' O ' HD11 ' A' ' 151' ' ' LEU . 49.7 t -138.9 140.84 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.031 0.932 . . . . 0.0 109.258 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -145.32 133.97 22.16 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.164 1.386 . . . . 0.0 109.387 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.3 mt -95.61 110.17 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 124.869 1.267 . . . . 0.0 108.496 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -76.21 96.26 3.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.3 p -55.69 119.42 5.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.82 -111.61 3.04 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 143.0 27.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.549 1.14 . . . . 0.0 112.281 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -158.87 117.53 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.657 1.583 . . . . 0.0 111.902 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 166.74 22.46 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.745 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 115.52 20.04 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.198 0.599 . . . . 0.0 110.535 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.21 -173.14 4.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.789 1.236 . . . . 0.0 111.872 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -50.73 -49.43 57.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.136 0.974 . . . . 0.0 111.732 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.73 -36.87 50.31 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.597 1.094 . . . . 0.0 113.683 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.72 -63.25 1.11 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.106 0.962 . . . . 0.0 110.425 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -51.61 -34.14 36.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.271 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -64.73 -47.86 76.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.645 1.178 . . . . 0.0 110.627 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.08 -25.25 66.93 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.11 -1.619 . . . . 0.0 113.401 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 101' ' ' MET . 70.2 mt -83.48 -12.2 56.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.857 1.663 . . . . 0.0 114.941 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -124.16 -32.6 3.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.93 1.292 . . . . 0.0 114.094 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -114.87 -23.75 8.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.883 1.673 . . . . 0.0 112.778 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.93 -85.87 0.03 OUTLIER Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.251 1.881 . . . . 0.0 112.21 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -164.07 63.35 1.13 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.643 1.577 . . . . 0.0 112.15 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.15 178.32 7.45 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.896 2.398 . . . . 0.0 115.706 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.57 -171.07 2.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.539 1.936 . . . . 0.0 113.819 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -139.2 146.58 40.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.535 1.934 . . . . 0.0 111.365 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.65 -57.74 0.46 Allowed Glycine 0 N--CA 1.479 1.554 0 C-N-CA 124.503 1.049 . . . . 0.0 115.664 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.1 t0 52.86 68.62 0.8 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.826 1.651 . . . . 0.0 114.431 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.312 0.1 OUTLIER 40.95 69.05 0.37 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.122 2.169 . . . . 0.0 114.441 176.029 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 119.75 0.8 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.213 1.863 . . . . 0.0 111.496 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CZ3' ' HB ' ' A' ' 160' ' ' ILE . 8.2 m95 -57.78 132.89 54.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.159 0.983 . . . . 0.0 112.028 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -147.9 125.06 11.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.293 1.037 . . . . 0.0 112.364 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.01 137.47 49.99 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.895 1.678 . . . . 0.0 109.859 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 151.77 40.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.111 0.965 . . . . 0.0 110.877 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -74.53 93.94 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.682 HD13 ' SD ' ' A' ' 157' ' ' MET . 6.8 tp -48.62 -30.46 5.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.58 31.59 2.12 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.81 -27.36 1.15 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.45 -15.35 0.96 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.594 1.092 . . . . 0.0 114.675 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.49 171.64 13.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.647 1.579 . . . . 0.0 111.208 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.44 157.11 24.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.515 1.126 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -134.94 164.65 27.13 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.637 0.775 . . . . 0.0 109.447 174.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -133.2 122.8 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.924 1.69 . . . . 0.0 108.757 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.43 143.76 17.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.564 0.602 . . . . 0.0 113.19 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.4 ' HB ' ' CZ3' ' A' ' 146' ' ' TRP . 4.8 tp -122.11 143.84 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.514 1.526 . . . . 0.0 110.222 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 9.6 tpt -132.44 124.9 29.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.122 1.369 . . . . 0.0 109.458 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.9 p -128.96 135.53 49.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.933 0.893 . . . . 0.0 110.82 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -97.43 178.31 5.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.666 1.986 . . . . 0.0 112.135 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.05 -171.04 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.045 2.138 . . . . 0.0 112.132 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.66 174.67 45.25 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 47.43 21.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.472 1.909 . . . . 0.0 116.137 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.24 150.27 45.5 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.503 1.921 . . . . 0.0 113.079 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 39.3 tptt -164.63 154.41 13.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.053 1.341 . . . . 0.0 113.654 175.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.55 138.7 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.333 2.253 . . . . 0.0 112.448 174.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -143.11 161.45 38.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.22 1.808 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 mm -126.44 117.11 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.436 1.095 . . . . 0.0 109.96 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -96.24 117.16 30.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.534 1.134 . . . . 0.0 108.181 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.673 HD13 HD22 ' A' ' 98' ' ' LEU . 4.3 pt -109.88 130.9 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.31 142.93 2.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.736 0.814 . . . . 0.0 112.342 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.49 1.516 . . . . 0.0 113.435 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.831 0.348 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.02 -54.38 6.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.313 1.045 . . . . 0.0 113.372 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 142.95 33.56 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.343 0.592 . . . . 0.0 110.875 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.63 -21.81 13.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.249 1.88 . . . . 0.0 112.242 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -150.67 155.64 39.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.699 1.999 . . . . 0.0 112.005 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -140.82 167.91 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.93 1.692 . . . . 0.0 111.17 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -169.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.301 1.841 . . . . 0.0 111.04 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.72 -41.98 5.14 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.01 -32.55 5.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.161 1.362 . . . . 0.0 112.84 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 118.437 1.119 . . . . 0.0 111.608 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -85.39 -5.33 59.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.107 1.763 . . . . 0.0 113.778 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 13' ' ' THR . 5.0 tt -65.46 137.33 57.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.089 0.956 . . . . 0.0 109.914 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -141.55 146.01 35.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.322 1.049 . . . . 0.0 109.799 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -54.87 -32.8 61.18 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.888 0.767 . . . . 0.0 112.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -56.6 -56.45 21.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.452 1.101 . . . . 0.0 112.702 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.56 -49.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -57.83 -19.17 26.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.237 1.415 . . . . 0.0 113.523 -177.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -82.59 -47.92 11.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.973 2.109 . . . . 0.0 111.514 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -33.25 73.14 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.546 -1.346 . . . . 0.0 110.84 174.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -45.69 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.493 1.517 . . . . 0.0 112.821 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.5 OUTLIER -71.95 -33.53 68.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.819 0.448 . . . . 0.0 111.259 175.393 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.85 -23.04 58.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.77 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -47.38 -25.22 0.96 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.813 2.045 . . . . 0.0 113.19 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.51 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.7 tp -51.68 -27.11 10.63 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.164 1.786 . . . . 0.0 112.33 175.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.39 -136.08 2.17 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.919 1.724 . . . . 0.0 112.819 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -141.53 43.03 1.75 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 126.644 1.978 . . . . 0.0 113.2 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.69 159.12 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.233 1.813 . . . . 0.0 112.428 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.76 -26.56 59.86 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -69.43 82.87 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.962 1.305 . . . . 0.0 112.859 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 161.95 40.6 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.023 -1.048 . . . . 0.0 113.095 -176.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -134.41 139.55 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 112.313 177.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -117.83 98.93 6.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.365 2.266 . . . . 0.0 110.891 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 34' ' ' GLY . 14.0 p -125.33 159.3 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.796 -1.19 . . . . 0.0 110.881 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 33' ' ' VAL . . . 169.3 -176.34 43.35 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-O 121.36 0.422 . . . . 0.0 112.079 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.494 HG21 HD23 ' A' ' 98' ' ' LEU . 4.0 mp -138.39 144.7 29.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.022 0.929 . . . . 0.0 110.703 -175.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.17 106.05 16.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.508 1.523 . . . . 0.0 112.006 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 p-10 -93.45 107.66 19.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.676 1.59 . . . . 0.0 111.963 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -136.84 10.27 3.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.302 1.441 . . . . 0.0 112.206 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -8.66 55.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.656 1.582 . . . . 0.0 115.13 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.05 28.38 41.63 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.611 1.101 . . . . 0.0 114.419 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.12 128.15 3.47 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.005 1.764 . . . . 0.0 111.206 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 m -58.22 147.6 29.89 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.315 1.446 . . . . 0.0 111.35 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.712 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 45.9 m0 -110.72 173.48 6.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.875 -1.141 . . . . 0.0 112.966 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -153.63 98.78 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.573 1.549 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . . . -72.67 137.34 45.96 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.005 -1.684 . . . . 0.0 110.603 175.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.76 -64.35 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.409 0.684 . . . . 0.0 111.224 178.545 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -154.26 -171.82 4.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.494 1.918 . . . . 0.0 110.885 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.23 134.77 29.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.033 1.333 . . . . 0.0 111.886 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -110.3 131.0 55.44 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.832 1.253 . . . . 0.0 109.915 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 14.9 p90 -153.0 162.29 41.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.069 1.348 . . . . 0.0 111.377 174.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -124.58 -56.67 1.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.143 1.377 . . . . 0.0 109.885 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.6 m -91.83 113.3 25.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.111 0.965 . . . . 0.0 110.559 177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.09 115.78 3.71 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.55 HG21 ' HB3' ' A' ' 76' ' ' ASP . 5.3 t -76.17 -179.76 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.911 1.284 . . . . 0.0 112.238 176.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.4 p -79.6 163.36 24.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 112.184 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -154.74 -35.65 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.981 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 160.25 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.59 1.956 . . . . 0.0 109.709 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 tt -80.32 133.89 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.85 0.86 . . . . 0.0 110.743 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.7 tp -80.88 128.33 71.83 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.05 163.77 27.45 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.347 2.031 . . . . 0.0 111.132 175.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.9 pt-20 -112.6 -66.05 1.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.514 1.126 . . . . 0.0 110.356 178.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.6 126.74 44.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.975 0.91 . . . . 0.0 109.819 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -114.32 129.91 24.45 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.593 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.26 -172.51 0.44 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.044 3.829 . . . . 0.0 113.204 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -82.06 153.01 26.35 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 119.685 -1.884 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.9 p 49.83 42.15 23.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.618 1.567 . . . . 0.0 114.736 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -156.0 122.6 5.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.067 1.747 . . . . 0.0 113.875 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -177.86 6.82 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.497 1.519 . . . . 0.0 114.125 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -143.27 152.37 41.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.244 1.418 . . . . 0.0 110.633 174.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -123.52 164.18 19.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -136.53 166.78 22.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.089 1.755 . . . . 0.0 110.539 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.6 p -138.71 168.5 19.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.297 1.439 . . . . 0.0 111.098 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 165.97 36.63 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.337 0.97 . . . . 0.0 111.569 174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -143.49 171.46 14.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.981 1.313 . . . . 0.0 112.082 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -94.87 80.84 3.72 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.267 1.427 . . . . 0.0 113.556 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.55 ' HB3' HG21 ' A' ' 54' ' ' THR . 1.4 t70 -122.21 -11.72 8.38 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.74 13.73 1.35 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.761 1.224 . . . . 0.0 113.286 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.49 -95.46 0.3 Allowed Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.85 -1.156 . . . . 0.0 113.683 -176.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.87 -25.53 12.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.268 1.978 . . . . 0.0 113.507 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.343 12.4 p 49.95 -1.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 130.189 3.395 . . . . 0.0 117.347 -176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.94 19.53 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 128.822 2.849 . . . . 0.0 113.317 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -144.43 -178.72 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.911 1.685 . . . . 0.0 111.591 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 82' ' ' THR . . . -73.73 145.68 35.8 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.103 1.335 . . . . 0.0 114.382 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 151.95 40.23 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.321 1.048 . . . . 0.0 111.337 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.6 105.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.77 2.428 . . . . 0.0 110.59 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -135.06 156.21 49.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.287 1.041 . . . . 0.0 110.897 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 134' ' ' LEU . . . -145.29 111.65 5.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.517 1.127 . . . . 0.0 109.091 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -125.73 154.17 42.87 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.518 1.127 . . . . 0.0 112.074 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.734 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -119.88 140.6 50.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.274 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.66 110.36 19.05 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.712 1.205 . . . . 0.0 110.022 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.618 ' HB2' HD11 ' A' ' 46' ' ' LEU . 11.2 t80 -68.72 96.0 0.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.253 1.421 . . . . 0.0 110.41 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.4 ttt -62.95 146.91 51.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.038 1.735 . . . . 0.0 111.522 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 t -53.27 -23.65 9.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.648 1.179 . . . . 0.0 114.118 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 m -67.42 0.5 2.91 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.87 54.41 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.388 0.994 . . . . 0.0 112.125 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -124.15 166.52 15.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.486 1.914 . . . . 0.0 109.649 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.734 HG22 ' HB1' ' A' ' 89' ' ' ALA . 10.5 m -137.83 101.05 4.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.159 -0.963 . . . . 0.0 111.697 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 HG21 ' A' ' 35' ' ' ILE . 13.1 tp -69.77 112.72 6.42 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.345 -0.847 . . . . 0.0 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.5 102.97 2.99 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.705 1.145 . . . . 0.0 112.782 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.62 151.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.67 0.788 . . . . 0.0 111.699 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.544 ' HB2' HD13 ' A' ' 134' ' ' LEU . 6.3 ttp -134.54 150.65 50.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.385 1.474 . . . . 0.0 111.642 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 4.6 p90 -162.34 151.37 15.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.341 1.057 . . . . 0.0 110.78 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -158.35 126.86 5.42 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 110.447 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.12 128.4 60.17 Favored Pre-proline 0 N--CA 1.48 1.049 0 O-C-N 121.209 -0.932 . . . . 0.0 111.2 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.79 167.59 25.34 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.802 3.002 . . . . 0.0 112.529 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.64 22.32 0.46 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.8 t70 87.18 126.98 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.101 2.96 . . . . 0.0 110.191 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.57 168.38 18.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.771 1.228 . . . . 0.0 111.669 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -58.26 -61.78 2.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.827 0.851 . . . . 0.0 111.02 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -168.77 90.6 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.811 1.644 . . . . 0.0 110.998 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.33 136.49 16.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.757 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -169.77 1.42 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.867 0.841 . . . . 0.0 110.615 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 131.11 35.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.726 1.21 . . . . 0.0 112.462 -175.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -97.67 131.16 44.48 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.078 0.951 . . . . 0.0 112.447 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.6 129.19 15.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.159 0.981 . . . . 0.0 109.941 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.73 107.76 1.52 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 m -115.83 161.5 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.368 0.667 . . . . 0.0 109.337 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.635 ' HA ' HD21 ' A' ' 151' ' ' LEU . 28.1 tttt -154.65 154.48 33.03 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.06 0.544 . . . . 0.0 111.367 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 151' ' ' LEU . 5.3 mp -107.66 110.19 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.991 0.916 . . . . 0.0 109.869 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.64 92.74 1.98 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.829 1.652 . . . . 0.0 109.919 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -68.78 81.08 0.29 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.567 -1.333 . . . . 0.0 111.497 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.13 -99.12 0.13 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.453 1.978 . . . . 0.0 112.354 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -165.33 104.19 0.74 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.911 1.684 . . . . 0.0 110.832 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -149.86 103.44 3.22 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 172.26 1.75 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.16 1.384 . . . . 0.0 112.386 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.39 119.96 19.3 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.62 -0.675 . . . . 0.0 112.184 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.62 -173.29 3.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.579 1.551 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -51.06 -52.98 38.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.427 1.091 . . . . 0.0 112.183 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.03 -31.05 64.48 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.769 0.7 . . . . 0.0 113.175 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.7 ttt -65.81 -64.45 0.86 Allowed 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -53.65 -33.67 56.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.026 0.93 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.48 -49.14 78.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.039 0.936 . . . . 0.0 109.195 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.54 -3.79 19.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 101' ' ' MET . 30.8 mt -102.78 -22.23 13.94 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.91 -25.24 9.52 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.959 -1.088 . . . . 0.0 113.671 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.56 0.85 8.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.408 1.483 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.99 71.63 0.3 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.401 1.953 . . . . 0.0 114.535 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.27 2.2 m120 85.49 57.49 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 130.203 3.401 . . . . 0.0 112.376 -175.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.91 125.0 14.47 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.763 2.976 . . . . 0.0 112.886 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.58 173.75 6.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.24 1.416 . . . . 0.0 112.82 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.06 142.84 51.43 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.119 1.767 . . . . 0.0 110.212 -174.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.09 118.07 1.66 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 121.658 0.588 . . . . 0.0 112.569 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -97.67 26.17 5.26 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.459 2.303 . . . . 0.0 114.528 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 77.12 94.86 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.235 2.614 . . . . 0.0 111.919 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 138.74 2.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.112 1.339 . . . . 0.0 112.862 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.469 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 22.4 m95 -64.59 130.81 45.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.487 1.515 . . . . 0.0 112.037 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -145.25 119.27 9.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.416 1.486 . . . . 0.0 112.114 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.91 143.02 27.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.546 1.138 . . . . 0.0 111.788 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.32 155.93 29.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.108 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 96.91 2.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.892 0.877 . . . . 0.0 108.923 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 118' ' ' LYS . 2.7 tp -49.82 -49.97 46.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.458 1.103 . . . . 0.0 112.048 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.6 80.12 1.25 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.883 1.706 . . . . 0.0 114.733 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -168.92 -36.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.819 2.047 . . . . 0.0 111.688 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.07 -80.51 0.06 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.372 1.463 . . . . 0.0 113.058 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.07 -179.2 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.786 1.235 . . . . 0.0 112.837 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -117.29 145.35 44.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 0.0 112.169 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.419 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.34 172.32 13.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.069 0.938 . . . . 0.0 112.211 -179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 18.4 ttpt -133.18 139.13 46.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.499 1.12 . . . . 0.0 110.263 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -122.55 164.46 15.56 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.233 1.397 . . . . 0.0 113.516 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.469 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 5.2 tp -139.23 95.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.18 99.04 10.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.861 -1.775 . . . . 0.0 112.351 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.71 132.68 56.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.436 1.094 . . . . 0.0 112.725 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 69.4 p -152.86 91.82 1.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.395 1.478 . . . . 0.0 112.711 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.9 52.5 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.511 -1.368 . . . . 0.0 111.57 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.8 125.94 1.44 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.252 17.5 pt-20 46.02 36.74 3.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.595 1.558 . . . . 0.0 114.195 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.21 162.46 18.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.085 2.154 . . . . 0.0 112.507 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.97 -172.68 4.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.541 1.536 . . . . 0.0 112.991 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -119.24 153.54 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.798 2.039 . . . . 0.0 111.883 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.438 HE22 HD13 ' A' ' 12' ' ' LEU . 31.4 tt0 -136.72 154.72 50.51 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.785 1.634 . . . . 0.0 110.468 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.68 120.19 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 109.731 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -112.08 111.06 21.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.581 1.552 . . . . 0.0 109.707 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.712 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 22.9 pt -97.23 144.3 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.882 1.273 . . . . 0.0 111.761 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.7 p -158.07 151.73 23.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.34 1.056 . . . . 0.0 112.535 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.679 1.591 . . . . 0.0 112.325 -176.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 159.0 12.26 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.935 0.894 . . . . 0.0 110.429 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.2 -9.13 56.07 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.261 0.934 . . . . 0.0 112.881 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -163.34 143.3 8.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.068 2.147 . . . . 0.0 110.375 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 70' ' ' LEU . 63.3 mt -143.75 160.78 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 125.377 1.471 . . . . 0.0 109.679 175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.02 -173.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 127.603 2.361 . . . . 0.0 112.008 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.28 -19.82 9.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -17.03 48.6 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.384 1.469 . . . . 0.0 112.435 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.69 67.87 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.617 1.167 . . . . 0.0 112.765 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -106.19 -2.8 22.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.261 1.824 . . . . 0.0 114.15 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.6 tp -67.11 138.65 57.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.954 1.302 . . . . 0.0 109.204 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.6 141.28 20.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.97 0.508 . . . . 0.0 110.984 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.59 -33.68 70.25 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.67 -47.45 76.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.143 1.377 . . . . 0.0 113.978 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.32 -54.28 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.653 1.181 . . . . 0.0 108.729 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.616 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.1 -33.77 27.63 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.04 1.736 . . . . 0.0 113.094 -175.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.44 -59.35 5.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.493 1.917 . . . . 0.0 110.88 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -35.76 81.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.921 1.689 . . . . 0.0 111.992 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.36 -45.8 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.129 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 32' ' ' ALA . 65.9 mt -64.42 -32.3 73.87 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 -19.78 60.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.581 1.152 . . . . 0.0 113.823 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -58.61 -32.51 69.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.859 -1.151 . . . . 0.0 111.645 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 56' ' ' ASP . 31.0 tp . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.301 1.441 . . . . 0.0 113.037 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.0 149.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.483 1.113 . . . . 0.0 111.468 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -125.79 110.12 13.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.144 1.378 . . . . 0.0 111.924 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.643 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.0 OUTLIER -120.83 118.55 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.001 1.32 . . . . 0.0 109.78 175.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 168.98 40.82 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.222 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.508 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.1 mp -135.31 130.72 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.0 109.576 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.4 105.02 8.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.283 1.033 . . . . 0.0 111.761 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -73.22 85.56 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.671 2.388 . . . . 0.0 111.955 175.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -137.53 46.08 2.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.823 -1.173 . . . . 0.0 111.38 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -2.45 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 175.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.71 24.28 62.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.365 0.983 . . . . 0.0 114.8 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.75 114.64 1.06 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.582 1.563 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -53.42 127.59 25.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.945 1.298 . . . . 0.0 111.289 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.548 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 53.7 m0 -91.38 157.37 17.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -137.9 109.56 7.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.951 1.701 . . . . 0.0 111.094 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -70.99 143.22 50.88 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.314 -0.866 . . . . 0.0 110.234 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -113.02 -47.35 3.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.343 1.457 . . . . 0.0 113.066 -178.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' H ' HD22 ' A' ' 46' ' ' LEU . 54.0 t30 -156.63 171.49 20.25 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.633 1.573 . . . . 0.0 111.199 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.59 121.82 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 111.869 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.43 ' H ' ' HB1' ' A' ' 126' ' ' ALA . 3.4 t80 -100.9 129.25 46.73 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 110.017 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 24.0 p90 -153.36 160.43 42.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.911 1.285 . . . . 0.0 112.018 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -116.43 -8.1 11.62 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.497 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 p -53.62 157.77 2.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.582 1.953 . . . . 0.0 112.79 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -35.16 -66.44 0.35 Allowed Glycine 0 N--CA 1.469 0.893 0 C-N-CA 127.96 2.695 . . . . 0.0 115.945 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.412 HG22 ' NE ' ' A' ' 74' ' ' ARG . 1.2 t -165.44 178.46 6.78 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.778 1.631 . . . . 0.0 111.492 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.9 171.39 8.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 111.648 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 24' ' ' LEU . 2.6 t0 -154.67 -28.21 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.832 -1.168 . . . . 0.0 113.294 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 24' ' ' LEU . 31.2 m -132.9 158.24 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.261 1.824 . . . . 0.0 110.832 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 tt -73.24 132.82 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.462 1.105 . . . . 0.0 111.654 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.01 122.26 82.95 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.377 1.071 . . . . 0.0 110.19 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.6 Cg_endo -64.77 114.87 2.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.359 3.373 . . . . 0.0 112.689 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.17 -55.16 17.71 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.58 153.64 30.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.456 1.102 . . . . 0.0 110.68 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.38 121.22 16.32 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.694 0.798 . . . . 0.0 111.592 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.94 162.06 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.716 2.277 . . . . 0.0 112.05 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -62.1 156.88 20.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.449 0.7 . . . . 0.0 112.172 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.2 p 41.78 49.44 3.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.37 1.868 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -141.24 -171.42 3.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.997 1.719 . . . . 0.0 111.361 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.14 -177.02 5.69 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.832 -1.167 . . . . 0.0 110.298 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -158.09 142.52 16.09 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.133 -0.979 . . . . 0.0 112.214 175.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -108.53 170.44 8.02 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.889 0.875 . . . . 0.0 110.735 176.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.643 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.5 t80 -152.15 165.71 33.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.473 1.509 . . . . 0.0 107.882 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.1 m -145.07 169.14 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.677 1.191 . . . . 0.0 109.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -157.54 7.19 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.314 0.483 . . . . 0.0 112.072 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.412 ' NE ' HG22 ' A' ' 54' ' ' THR . 10.4 ttp180 . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 125.59 1.556 . . . . 0.0 110.627 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 t -147.58 121.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.48 -1.387 . . . . 0.0 113.485 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -148.08 164.72 32.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.46 1.104 . . . . 0.0 111.212 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.18 110.2 4.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.647 1.179 . . . . 0.0 108.369 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.05 152.92 48.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.255 1.022 . . . . 0.0 112.069 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -115.78 148.96 39.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.435 -175.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 43.6 m-85 -122.83 124.24 42.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.961 1.304 . . . . 0.0 110.105 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.56 109.26 2.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 110.178 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.11 153.21 38.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.013 1.325 . . . . 0.0 111.17 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -63.87 -22.03 66.73 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.21 1.8 20.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.299 1.04 . . . . 0.0 113.781 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.76 19.52 70.45 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.663 1.125 . . . . 0.0 113.864 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -102.59 171.21 7.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 109.221 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.556 HG22 ' HB1' ' A' ' 89' ' ' ALA . 97.1 m -133.55 103.51 5.95 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.539 -1.351 . . . . 0.0 112.109 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.508 ' CD2' HG21 ' A' ' 35' ' ' ILE . 14.2 tp -69.75 126.65 30.36 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.297 -0.877 . . . . 0.0 110.345 174.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.23 107.47 3.06 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.18 165.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 117.632 0.716 . . . . 0.0 110.333 175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -151.41 140.75 21.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.232 177.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 27.6 p90 -153.34 160.04 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.662 0.744 . . . . 0.0 110.313 175.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -162.14 167.43 24.2 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.732 1.613 . . . . 0.0 109.19 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.42 106.64 57.08 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 123.011 2.474 . . . . 0.0 113.234 179.77 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 111.38 0.141 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -73.1 148.5 43.91 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.451 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.9 p-90 -148.04 169.43 19.96 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.519 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.9 t70 179.62 163.57 0.99 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 128.048 2.539 . . . . 0.0 110.379 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.548 HG11 ' SD ' ' A' ' 157' ' ' MET . 3.6 p -165.6 136.65 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.079 2.152 . . . . 0.0 109.252 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -152.42 156.6 39.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.87 1.268 . . . . 0.0 110.483 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.79 106.16 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.658 1.583 . . . . 0.0 107.767 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -74.69 98.74 3.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.273 1.029 . . . . 0.0 109.338 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.4 t -59.07 137.49 57.93 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.738 -1.226 . . . . 0.0 110.828 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.2 -117.42 5.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.496 1.522 . . . . 0.0 110.124 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 128.16 12.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.503 1.121 . . . . 0.0 111.253 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.37 114.72 10.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.068 1.347 . . . . 0.0 111.221 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.05 164.71 23.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 110.283 174.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.43 ' HB1' ' H ' ' A' ' 49' ' ' TYR . . . -80.95 109.0 15.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.903 -0.498 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.38 -173.28 4.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.202 1.401 . . . . 0.0 110.019 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.63 -43.29 56.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.002 0.921 . . . . 0.0 111.202 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -33.32 38.93 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.556 1.074 . . . . 0.0 114.329 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.1 ttt -70.51 -60.15 2.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.829 0.815 . . . . 0.0 110.452 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.42 ' HA ' HD12 ' A' ' 134' ' ' LEU . 74.0 t80 -56.94 -31.18 64.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.16 0.984 . . . . 0.0 113.632 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.33 -39.15 93.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 110.148 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -26.58 67.48 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.547 -1.346 . . . . 0.0 111.872 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 131' ' ' TYR . 3.6 mt -78.39 -43.41 27.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.236 1.414 . . . . 0.0 112.028 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.08 -28.32 16.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.62 -40.42 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.802 1.641 . . . . 0.0 111.707 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.63 -58.25 8.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.749 1.642 . . . . 0.0 111.572 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -178.75 88.29 0.22 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 127.225 2.21 . . . . 0.0 111.637 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.73 141.02 40.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.303 2.002 . . . . 0.0 111.234 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -112.83 173.75 6.23 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.37 1.468 . . . . 0.0 111.575 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.98 134.08 46.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.52 1.528 . . . . 0.0 110.718 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.22 106.85 0.7 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.436 1.017 . . . . 0.0 112.362 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -121.5 71.97 0.99 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.133 1.373 . . . . 0.0 111.117 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 59.61 101.09 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.692 2.797 . . . . 0.0 115.868 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.2 161.88 9.65 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.454 1.026 . . . . 0.0 114.593 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.523 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 m95 -78.55 150.65 32.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.725 1.21 . . . . 0.0 110.629 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -152.04 133.13 14.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.862 1.665 . . . . 0.0 110.718 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.8 146.13 49.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.31 1.444 . . . . 0.0 112.387 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -150.46 157.55 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.88 0.848 . . . . 0.0 112.123 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -80.53 92.98 5.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.486 1.514 . . . . 0.0 108.088 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 tp -52.51 -39.83 61.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.23 30.26 2.75 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.28 -22.61 1.97 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.448 1.624 . . . . 0.0 115.175 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.74 -21.56 1.82 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.265 1.412 . . . . 0.0 114.035 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 pp -124.1 173.52 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.731 1.612 . . . . 0.0 112.538 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -116.3 158.66 23.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.02 1.328 . . . . 0.0 111.336 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.548 ' SD ' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -131.31 155.03 47.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.584 0.354 . . . . 0.0 110.926 175.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.5 tppt? -126.16 127.47 45.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.545 1.938 . . . . 0.0 109.727 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.72 137.63 14.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 126.105 1.812 . . . . 0.0 112.812 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -117.13 146.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.496 1.118 . . . . 0.0 111.063 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.25 145.78 51.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.959 0.904 . . . . 0.0 109.352 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.42 HG23 ' CD1' ' A' ' 160' ' ' ILE . 42.0 p -144.03 126.62 15.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.171 1.388 . . . . 0.0 110.949 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m -89.07 178.52 6.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.002 2.121 . . . . 0.0 112.059 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.39 -178.7 0.18 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.95 2.5 . . . . 0.0 112.534 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 161.87 51.43 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.259 -0.901 . . . . 0.0 111.72 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 55.64 29.49 13.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.519 1.127 . . . . 0.0 112.792 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -126.53 144.56 50.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.115 1.766 . . . . 0.0 112.819 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.511 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 24.6 tptp -162.64 149.46 13.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.54 137.78 37.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.2 2.2 . . . . 0.0 112.682 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -135.6 157.33 47.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.876 1.67 . . . . 0.0 110.59 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 117' ' ' VAL . 13.3 mm -129.32 124.52 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.36 1.064 . . . . 0.0 110.769 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 131.99 54.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.425 1.49 . . . . 0.0 111.65 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.548 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 11.3 pt -118.23 134.26 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.813 1.645 . . . . 0.0 110.455 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.6 p -163.47 177.17 9.08 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.515 1.526 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.782 1.233 . . . . 0.0 111.919 -176.21 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.83 173.25 4.55 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.522 0.677 . . . . 0.0 110.388 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.63 -36.32 3.83 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.1 p -137.02 161.13 36.9 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.624 -1.515 . . . . 0.0 111.48 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 70' ' ' LEU . 36.1 mm -137.8 163.41 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.904 1.281 . . . . 0.0 110.416 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 pt -67.62 -170.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.893 2.077 . . . . 0.0 110.458 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.43 -28.15 4.9 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 119.722 -1.861 . . . . 0.0 115.932 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.2 69.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.465 1.031 . . . . 0.0 113.803 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.19 -42.06 39.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.524 1.13 . . . . 0.0 111.29 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -8.3 59.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.227 1.411 . . . . 0.0 114.106 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 17' ' ' LEU . 12.7 tp -59.83 143.79 50.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 0.0 110.305 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.25 150.74 31.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.527 1.131 . . . . 0.0 109.906 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -55.19 -26.68 40.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -62.05 -58.16 8.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.617 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.18 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.077 0.551 . . . . 0.0 109.73 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.37 -23.66 66.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.407 1.083 . . . . 0.0 113.456 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.24 -51.51 13.14 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.363 -1.461 . . . . 0.0 110.374 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -40.52 96.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 112.908 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -64.07 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.164 0.986 . . . . 0.0 112.857 -174.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 32' ' ' ALA . 69.4 mt -76.9 -31.86 57.02 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 110.891 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.43 -37.26 74.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.933 0.893 . . . . 0.0 111.921 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -19.89 47.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.028 1.331 . . . . 0.0 114.517 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 127.206 2.202 . . . . 0.0 113.336 175.062 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.947 0.404 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.5 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -133.19 142.02 43.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 125.196 1.398 . . . . 0.0 111.946 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -127.94 115.32 18.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.965 1.706 . . . . 0.0 109.684 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.2 p -131.75 128.76 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.873 1.269 . . . . 0.0 109.088 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.12 -179.53 40.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.523 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 3.4 mp -130.41 146.02 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.795 0.838 . . . . 0.0 111.543 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -96.7 109.41 22.06 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.296 -0.877 . . . . 0.0 111.63 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 91.61 6.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.078 0.951 . . . . 0.0 111.244 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.1 56.74 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.25 1.42 . . . . 0.0 109.697 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t -119.77 -45.63 2.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.194 1.397 . . . . 0.0 113.346 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 13.91 2.18 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.657 1.122 . . . . 0.0 115.878 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.33 146.57 17.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.093 1.33 . . . . 0.0 112.552 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 m -73.92 145.03 45.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.718 1.607 . . . . 0.0 110.589 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.453 ' CE2' HD11 ' A' ' 173' ' ' ILE . 22.0 m0 -112.52 166.49 11.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.666 -0.647 . . . . 0.0 112.573 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.9 m -143.62 109.43 5.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.19 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -69.24 151.31 46.44 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.818 -1.176 . . . . 0.0 111.232 175.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.54 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -106.91 -55.1 2.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.7 1.6 . . . . 0.0 111.6 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -160.9 -172.95 3.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.904 1.682 . . . . 0.0 110.829 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.02 137.76 29.5 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.103 1.361 . . . . 0.0 111.325 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -121.01 127.74 52.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.515 1.526 . . . . 0.0 110.151 178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.568 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -133.35 162.79 30.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 112.584 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -124.0 -43.98 2.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.673 1.589 . . . . 0.0 112.27 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.8 p -129.61 113.28 14.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.891 1.276 . . . . 0.0 112.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 114.9 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.332 1.444 . . . . 0.0 111.485 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.09 178.72 3.65 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.875 0.845 . . . . 0.0 112.001 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.02 162.78 1.75 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.576 1.95 . . . . 0.0 112.294 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.38 -32.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.104 -0.998 . . . . 0.0 112.22 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.08 169.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.986 2.114 . . . . 0.0 111.905 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -70.27 127.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.872 1.269 . . . . 0.0 112.801 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.74 129.78 60.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.62 146.53 79.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.501 2.8 . . . . 0.0 111.244 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.89 -53.08 3.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 112.417 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -122.08 143.94 49.22 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 110.44 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.684 HG21 HD22 ' A' ' 69' ' ' LEU . 49.9 t -136.27 130.14 18.11 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.644 1.177 . . . . 0.0 110.563 -174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.02 163.15 25.85 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.88 3.054 . . . . 0.0 112.562 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -70.07 14.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -140.24 15.68 2.42 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.09 1.756 . . . . 0.0 114.268 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.88 155.1 47.37 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.524 1.13 . . . . 0.0 112.522 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.23 -177.01 3.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.609 1.195 . . . . 0.0 112.159 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -152.77 154.22 34.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 175.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CD1' HD21 ' A' ' 17' ' ' LEU . 12.7 mt -138.11 167.22 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.283 1.433 . . . . 0.0 109.495 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.2 t80 -141.71 165.83 26.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.532 1.533 . . . . 0.0 109.966 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -145.99 169.1 19.32 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.35 1.06 . . . . 0.0 110.887 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.32 177.44 27.51 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.472 1.034 . . . . 0.0 111.109 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.574 1.15 . . . . 0.0 112.904 -176.62 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.06 113.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.773 2.029 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -148.31 176.6 10.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 111.542 175.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.48 118.66 5.13 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -126.04 160.71 29.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.053 0.941 . . . . 0.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -118.87 169.32 9.97 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.582 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -140.51 121.32 14.44 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.559 1.144 . . . . 0.0 110.943 -177.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.17 111.08 2.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.224 1.01 . . . . 0.0 109.223 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -72.2 153.87 41.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 111.034 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -58.01 -28.37 64.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -80.67 3.75 21.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.789 1.236 . . . . 0.0 114.306 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.28 -0.92 87.47 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.344 1.45 . . . . 0.0 114.516 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -78.58 178.65 7.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.61 1.564 . . . . 0.0 110.878 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.477 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 68.0 m -140.57 110.76 6.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.832 -1.168 . . . . 0.0 112.651 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 173' ' ' ILE . 27.1 tp -75.63 122.59 24.18 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.09 4.35 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 118.856 0.753 . . . . 0.0 112.471 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.41 160.99 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.294 1.047 . . . . 0.0 112.071 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.691 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -145.35 167.11 23.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.427 -0.796 . . . . 0.0 112.638 174.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 33' ' ' VAL . 45.1 p90 -169.48 158.6 8.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.026 1.331 . . . . 0.0 112.098 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 132.51 3.73 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.126 1.77 . . . . 0.0 108.381 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.93 138.15 26.31 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 119.096 0.862 . . . . 0.0 109.087 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.543 0.958 0 C-N-CA 122.765 2.31 . . . . 0.0 111.741 174.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 120.91 0.386 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -82.52 150.12 27.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.49 1.116 . . . . 0.0 112.161 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -161.44 149.01 14.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.799 1.64 . . . . 0.0 108.715 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -167.97 117.5 0.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.132 0.973 . . . . 0.0 110.871 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.44 HG11 HG21 ' A' ' 171' ' ' ILE . 46.3 t -118.12 135.2 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 123.007 0.523 . . . . 0.0 110.706 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -148.73 142.8 25.93 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.067 175.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.3 115.82 30.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -86.04 109.66 18.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.0 t -66.82 93.35 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.527 -1.358 . . . . 0.0 111.52 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.05 148.22 6.39 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 128.048 2.737 . . . . 0.0 111.796 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -48.13 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.68 2.392 . . . . 0.0 114.305 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -111.92 103.06 11.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.187 1.395 . . . . 0.0 112.978 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 162.49 14.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.419 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -79.08 114.44 18.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.39 -174.15 4.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.475 1.11 . . . . 0.0 111.676 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -51.12 -49.01 61.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.031 -1.043 . . . . 0.0 111.781 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -36.18 45.06 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.197 0.904 . . . . 0.0 113.673 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.4 ttt -67.49 -62.43 1.42 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.792 0.837 . . . . 0.0 110.045 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -55.03 -34.13 63.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -64.32 -39.27 93.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.464 1.506 . . . . 0.0 110.623 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -25.14 68.16 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.873 -1.142 . . . . 0.0 111.772 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 101' ' ' MET . 1.6 mt -84.43 -44.15 13.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.661 1.184 . . . . 0.0 112.551 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.97 -29.1 25.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.905 1.282 . . . . 0.0 114.359 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.99 -34.04 3.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.479 1.512 . . . . 0.0 113.714 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.31 61.22 3.13 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.504 2.002 . . . . 0.0 114.516 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.86 67.25 1.13 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 127.401 2.281 . . . . 0.0 110.817 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.82 149.01 92.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.236 2.624 . . . . 0.0 112.268 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -114.9 178.68 4.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.412 1.085 . . . . 0.0 111.843 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -128.08 135.61 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.002 1.321 . . . . 0.0 111.768 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.06 97.42 2.0 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.437 1.018 . . . . 0.0 113.055 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -65.48 -79.97 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.226 1.01 . . . . 0.0 111.665 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HA ' HG22 ' A' ' 162' ' ' THR . 8.7 p30 177.75 -16.82 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.913 2.085 . . . . 0.0 115.606 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.23 163.12 20.97 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 119.939 1.245 . . . . 0.0 113.452 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.458 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 79.9 m95 -72.34 147.5 46.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.27 0.628 . . . . 0.0 110.682 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -151.75 123.31 7.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.283 1.433 . . . . 0.0 111.626 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.36 143.7 41.74 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.469 1.508 . . . . 0.0 113.599 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.71 149.76 26.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.353 1.461 . . . . 0.0 112.655 174.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.7 97.88 9.39 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.483 1.513 . . . . 0.0 108.379 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -52.96 -52.46 58.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.924 1.689 . . . . 0.0 111.425 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.04 57.14 0.01 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.392 0.996 . . . . 0.0 115.499 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.22 -27.07 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 131.69 -9.78 5.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.903 1.239 . . . . 0.0 114.671 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.01 170.08 13.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.811 1.305 . . . . 0.0 112.547 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 ttp-105 -133.58 130.24 38.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.452 1.901 . . . . 0.0 110.265 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.472 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -111.59 139.82 46.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.663 0.385 . . . . 0.0 110.852 175.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.4 128.3 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.578 1.551 . . . . 0.0 109.128 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.7 153.88 16.76 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 123.83 0.729 . . . . 0.0 112.824 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.458 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -137.15 141.14 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.548 1.939 . . . . 0.0 108.199 175.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 115.4 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.045 1.738 . . . . 0.0 107.754 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 144' ' ' ASN . 11.4 p -109.0 170.44 8.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.7 p -70.76 167.71 18.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.428 1.091 . . . . 0.0 112.335 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.81 147.62 27.69 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.213 -0.93 . . . . 0.0 112.876 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.01 80.98 0.44 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.967 1.27 . . . . 0.0 113.698 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 50.22 39.02 18.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.848 1.659 . . . . 0.0 113.707 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -138.35 170.05 16.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.247 1.419 . . . . 0.0 111.436 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.429 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 5.2 tptt -156.01 -172.45 4.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.67 0.748 . . . . 0.0 111.609 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -118.25 157.43 27.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.187 2.195 . . . . 0.0 109.846 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -164.41 150.35 10.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.01 1.324 . . . . 0.0 110.034 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 24.8 mm -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.59 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -126.99 136.76 52.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.228 1.377 . . . . 0.0 112.375 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' MET . 32.0 pt -96.52 133.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -142.33 164.59 29.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.638 0.775 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.353 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.07 -179.67 1.29 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.89 0.876 . . . . 0.0 110.641 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.8 -38.65 3.07 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.572 -1.33 . . . . 0.0 111.702 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.7 p -137.06 160.01 40.22 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.674 -1.486 . . . . 0.0 111.793 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.478 HD11 HD12 ' A' ' 70' ' ' LEU . 36.9 mm -136.44 163.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.164 1.385 . . . . 0.0 110.082 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -70.65 -169.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.979 2.112 . . . . 0.0 110.423 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.63 -23.26 4.09 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.94 73.81 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.836 0.732 . . . . 0.0 113.784 -174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.06 40.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.695 1.198 . . . . 0.0 111.547 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -6.24 57.57 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.196 1.398 . . . . 0.0 113.714 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HD23 ' A' ' 17' ' ' LEU . 21.8 tp -57.94 142.75 45.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.104 1.761 . . . . 0.0 111.02 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -146.13 145.79 30.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.639 1.176 . . . . 0.0 109.713 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -55.74 -29.47 59.59 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -60.01 -55.71 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.682 1.193 . . . . 0.0 112.269 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.76 -44.35 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 122.006 -0.433 . . . . 0.0 109.845 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -59.31 -32.08 69.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.229 1.012 . . . . 0.0 113.207 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.81 -55.16 14.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.159 0.983 . . . . 0.0 110.373 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -35.02 74.6 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.718 -0.614 . . . . 0.0 112.034 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -45.26 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.115 0.871 . . . . 0.0 112.645 -176.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.54 -24.9 53.63 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.611 0.641 . . . . 0.0 110.764 174.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.41 -26.76 62.89 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.96 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -48.54 -25.27 1.63 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 120.925 1.693 . . . . 0.0 114.483 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' HH22 ' A' ' 74' ' ' ARG . 48.0 mt . . . . . 0 CA--C 1.551 1.013 0 C-N-CA 126.674 1.989 . . . . 0.0 115.799 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -136.89 123.27 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.266 1.427 . . . . 0.0 112.019 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -107.81 91.09 3.51 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.211 2.204 . . . . 0.0 110.943 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' CD2' ' A' ' 102' ' ' PHE . 2.8 p -89.72 126.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.579 -1.326 . . . . 0.0 110.675 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.69 167.2 37.72 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-O 121.776 0.654 . . . . 0.0 114.701 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -144.29 121.68 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -76.95 105.11 7.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.037 -1.039 . . . . 0.0 111.324 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.53 93.07 4.74 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.161 -0.962 . . . . 0.0 112.013 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -142.92 39.29 1.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.323 1.058 . . . . 0.0 111.82 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.74 -0.26 54.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.047 1.739 . . . . 0.0 114.815 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.6 14.24 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.268 0.937 . . . . 0.0 114.578 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.02 135.84 7.77 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.673 1.606 . . . . 0.0 112.463 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -67.18 134.07 51.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.48 1.112 . . . . 0.0 109.262 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -95.34 163.86 13.07 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -146.27 113.93 6.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.447 1.499 . . . . 0.0 111.035 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -74.36 135.77 42.48 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 -50.32 3.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.379 1.071 . . . . 0.0 111.83 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -156.35 171.93 19.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.207 1.003 . . . . 0.0 111.964 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.58 132.49 31.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.984 1.714 . . . . 0.0 111.469 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -116.62 122.64 45.19 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.553 1.541 . . . . 0.0 110.183 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -123.62 152.55 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.809 2.444 . . . . 0.0 110.44 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.91 -53.25 2.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.164 0.986 . . . . 0.0 110.25 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' H ' ' A' ' 85' ' ' VAL . 2.3 t -71.21 127.0 31.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.406 1.882 . . . . 0.0 109.581 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.31 -133.26 8.51 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.175 0.893 . . . . 0.0 112.736 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.06 -156.47 0.61 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.14 1.776 . . . . 0.0 109.585 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.88 166.83 1.34 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.373 3.069 . . . . 0.0 111.928 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.63 -29.42 0.11 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 24' ' ' LEU . 12.7 m -136.17 173.01 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.244 2.218 . . . . 0.0 112.049 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.97 128.2 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.603 1.161 . . . . 0.0 111.677 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 tp -85.09 132.29 46.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.33 122.3 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.901 3.067 . . . . 0.0 110.8 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.86 -59.39 3.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.798 0.839 . . . . 0.0 112.555 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -125.52 145.5 50.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.52 1.528 . . . . 0.0 110.169 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 69' ' ' LEU . 50.6 t -138.47 131.36 16.17 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.577 1.151 . . . . 0.0 108.936 -175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.42 163.97 24.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.782 2.988 . . . . 0.0 112.531 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.28 18.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -141.98 17.06 2.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.597 1.559 . . . . 0.0 114.173 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.438 1.472 . . . . 0.0 112.679 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.58 -176.6 5.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 122.425 1.107 . . . . 0.0 112.521 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -153.21 152.68 31.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.049 0.939 . . . . 0.0 111.592 175.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.638 ' CD1' HD21 ' A' ' 17' ' ' LEU . 10.6 mt -134.66 162.42 32.37 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.884 1.274 . . . . 0.0 111.111 174.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.28 163.91 31.49 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.066 1.346 . . . . 0.0 109.632 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 m -144.92 165.28 28.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.279 1.431 . . . . 0.0 110.164 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.68 162.88 33.79 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.41 1.481 . . . . 0.0 109.553 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.448 HH22 ' HB2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 125.984 1.714 . . . . 0.0 111.031 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.395 0.617 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.557 ' H ' ' HB3' ' A' ' 52' ' ' SER . 3.6 t -127.45 110.24 22.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 109.757 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -139.99 176.9 8.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 109.972 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.02 137.59 15.13 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.943 1.697 . . . . 0.0 106.498 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -143.12 162.03 36.63 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.268 0.627 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.639 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -126.71 136.79 52.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.755 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.7 m-85 -113.68 121.86 45.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 110.939 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -70.27 123.47 21.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.912 1.285 . . . . 0.0 110.211 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptm -97.1 155.09 16.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.552 0.615 . . . . 0.0 111.394 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.4 m -56.14 -22.47 28.69 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -2.03 20.87 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.767 1.227 . . . . 0.0 113.384 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.14 84.46 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.655 1.597 . . . . 0.0 114.638 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -100.45 171.38 7.78 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.443 1.097 . . . . 0.0 110.46 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.639 HG22 ' HB1' ' A' ' 89' ' ' ALA . 81.1 m -135.03 99.89 4.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.744 1.218 . . . . 0.0 111.621 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 173' ' ' ILE . 6.4 tp -69.59 113.75 7.16 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.414 -0.804 . . . . 0.0 111.42 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.6 107.84 3.54 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.264 1.411 . . . . 0.0 109.717 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -84.2 146.11 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 117.493 0.646 . . . . 0.0 111.045 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' HD13 ' A' ' 134' ' ' LEU . 13.9 tmm? -125.23 142.47 51.48 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.925 1.29 . . . . 0.0 110.568 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 32.9 p90 -151.27 158.92 44.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.107 174.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -158.06 175.24 14.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.47 100.05 50.92 Favored Pre-proline 0 N--CA 1.467 0.392 0 C-N-CA 126.51 1.924 . . . . 0.0 111.792 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.542 0.897 0 C-N-CA 122.699 2.266 . . . . 0.0 110.063 174.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -77.4 139.0 39.61 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.086 0.954 . . . . 0.0 112.98 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -161.83 149.27 14.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.489 1.916 . . . . 0.0 108.844 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -179.87 158.59 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.333 2.253 . . . . 0.0 111.263 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.67 147.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 127.766 2.427 . . . . 0.0 109.055 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -141.67 141.2 33.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.776 0.83 . . . . 0.0 109.635 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.6 mt -103.27 113.31 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.872 0.869 . . . . 0.0 108.693 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -82.42 111.0 18.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 t -65.42 87.51 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.015 -1.053 . . . . 0.0 111.476 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.93 164.58 11.92 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.938 2.685 . . . . 0.0 112.211 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -60.5 123.6 17.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.798 1.239 . . . . 0.0 111.778 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -133.6 104.28 6.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.589 1.555 . . . . 0.0 112.138 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.96 153.64 33.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.763 0.825 . . . . 0.0 110.634 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 117.58 21.33 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.721 0.408 . . . . 0.0 111.132 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.63 -176.8 6.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.082 1.753 . . . . 0.0 112.108 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.3 -47.23 25.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.33 1.452 . . . . 0.0 112.119 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.71 -46.99 80.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.102 0.858 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.4 ttp -60.22 -53.26 59.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.404 0.682 . . . . 0.0 110.684 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -53.35 -38.03 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.378 0.99 . . . . 0.0 113.078 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -43.54 95.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.699 1.2 . . . . 0.0 110.734 175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.59 -20.63 65.4 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.357 -1.464 . . . . 0.0 113.939 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 101' ' ' MET . 19.0 mt -92.52 -11.0 35.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.18 -35.09 3.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.011 1.324 . . . . 0.0 112.248 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -114.5 -25.55 8.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.186 1.395 . . . . 0.0 112.918 -175.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.5 -34.68 90.55 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.737 1.161 . . . . 0.0 113.752 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.09 83.44 5.6 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 126.018 1.727 . . . . 0.0 110.28 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.5 120.23 7.33 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.548 1.499 . . . . 0.0 112.325 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.76 165.02 22.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.811 1.244 . . . . 0.0 113.892 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -134.22 139.06 45.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.437 1.895 . . . . 0.0 111.531 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -127.02 110.43 1.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.907 1.241 . . . . 0.0 112.168 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -124.03 70.14 1.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.459 1.904 . . . . 0.0 113.364 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 50.76 60.3 3.97 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.05 2.14 . . . . 0.0 114.023 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -175.83 139.78 4.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.614 0.626 . . . . 0.0 113.92 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -63.43 135.46 56.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.031 1.332 . . . . 0.0 111.69 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -150.09 130.69 13.98 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.634 1.173 . . . . 0.0 111.672 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.66 158.5 25.39 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.118 1.767 . . . . 0.0 111.566 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.526 ' CE ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.52 161.57 39.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.0 1.32 . . . . 0.0 110.677 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.17 93.92 4.01 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.902 0.881 . . . . 0.0 108.799 174.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 149' ' ' LYS . 5.3 tp -47.43 -32.36 4.99 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.98 1.312 . . . . 0.0 113.984 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.54 32.26 2.36 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 117.396 1.718 . . . . 0.0 117.396 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.06 -28.69 1.16 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 148.77 -24.29 1.32 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.749 1.166 . . . . 0.0 114.504 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.46 175.5 5.43 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.634 1.973 . . . . 0.0 111.626 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -126.89 165.31 19.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.009 . . . . 0.0 112.222 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.714 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -145.94 156.91 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.428 177.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.86 129.22 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.713 1.605 . . . . 0.0 108.584 -177.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.11 144.56 18.48 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.407 0.527 . . . . 0.0 113.27 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -125.2 147.71 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.273 1.429 . . . . 0.0 109.762 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.547 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -140.46 117.38 11.08 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.6 1.16 . . . . 0.0 109.3 175.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 160' ' ' ILE . 7.9 p -122.18 147.75 45.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.641 1.176 . . . . 0.0 110.055 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -131.49 -178.31 4.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.586 1.954 . . . . 0.0 110.649 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 73.69 95.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.379 2.271 . . . . 0.0 113.302 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.42 -106.51 3.06 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.87 1.7 . . . . 0.0 114.355 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -115.78 17.72 15.99 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.631 2.373 . . . . 0.0 113.569 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.06 163.08 25.53 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.601 2.361 . . . . 0.0 115.021 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 31' ' ' ILE . 8.1 tptp -163.11 155.28 18.18 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.873 1.269 . . . . 0.0 114.34 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 136.39 33.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.118 2.567 . . . . 0.0 112.512 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -141.08 154.51 45.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.026 1.73 . . . . 0.0 110.221 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.01 120.55 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.529 1.132 . . . . 0.0 111.045 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -98.84 114.04 26.44 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.316 1.046 . . . . 0.0 109.482 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 157' ' ' MET . 7.5 pt -98.12 134.18 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.801 0.44 . . . . 0.0 109.828 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 92.8 p -156.37 167.35 30.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.408 1.483 . . . . 0.0 112.458 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.92 6.55 36.41 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.123 1.769 . . . . 0.0 113.128 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.99 -16.21 39.35 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.178 1.37 . . . . 0.0 115.502 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 p -146.04 162.97 36.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.158 1.479 . . . . 0.0 110.28 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 70' ' ' LEU . 26.5 mm -134.73 173.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 109.38 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 pt -85.4 -171.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 129.036 2.934 . . . . 0.0 110.461 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.96 -15.19 61.92 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.3 65.71 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 124.583 1.087 . . . . 0.0 113.62 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.18 81.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.144 1.378 . . . . 0.0 112.956 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -1.17 53.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 113.822 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.27 140.82 58.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.042 1.337 . . . . 0.0 110.491 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.84 145.75 26.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.116 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.61 -38.17 69.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.753 0.821 . . . . 0.0 113.134 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -56.62 -50.06 73.13 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.098 0.863 . . . . 0.0 112.783 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.81 -48.41 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.903 0.881 . . . . 0.0 110.587 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -56.24 -37.62 69.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 112.081 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -57.57 -55.82 29.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.447 1.899 . . . . 0.0 111.566 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -22.87 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.77 -52.3 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.514 1.506 . . . . 0.0 110.886 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.604 HD22 ' HB2' ' A' ' 32' ' ' ALA . 2.0 pp -61.72 -32.06 72.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.611 0.364 . . . . 0.0 111.721 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -85.68 -28.28 24.79 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -52.9 -21.18 3.99 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.761 2.024 . . . . 0.0 112.815 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 72' ' ' SER . 49.9 tp . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.453 1.901 . . . . 0.0 111.802 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.195 0.521 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -107.88 148.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.609 1.164 . . . . 0.0 110.73 175.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.604 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -134.04 100.04 4.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.925 1.69 . . . . 0.0 111.035 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 p -113.94 144.88 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.117 1.367 . . . . 0.0 107.396 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.36 167.27 36.5 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 118.418 0.554 . . . . 0.0 114.425 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.21 145.84 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.703 1.201 . . . . 0.0 110.872 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -107.68 104.25 13.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 111.472 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 3.5 p30 -89.12 116.95 27.76 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.377 1.471 . . . . 0.0 112.187 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -150.03 14.9 0.82 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.885 0.85 . . . . 0.0 112.182 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -78.55 -45.88 20.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.608 1.563 . . . . 0.0 114.356 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.63 16.82 1.43 Allowed Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.39 133.96 6.74 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.491 1.646 . . . . 0.0 113.006 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.7 m -69.93 122.11 18.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.236 1.414 . . . . 0.0 110.906 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.467 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 37.8 m0 -91.03 161.8 14.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.827 -0.546 . . . . 0.0 111.805 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 m -136.66 109.82 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.059 1.743 . . . . 0.0 111.088 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.9 114.14 4.9 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.914 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.728 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -75.95 -61.4 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.868 1.267 . . . . 0.0 111.385 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -159.9 169.88 22.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.985 1.314 . . . . 0.0 111.966 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.72 135.44 40.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.869 2.068 . . . . 0.0 111.047 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.451 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.3 t80 -120.71 130.61 54.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.453 1.501 . . . . 0.0 109.8 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -127.47 140.42 52.16 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.784 2.034 . . . . 0.0 109.838 -178.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -0.91 14.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.198 1.399 . . . . 0.0 113.842 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -80.23 -155.23 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.068 1.347 . . . . 0.0 109.781 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.78 -76.07 0.25 Allowed Glycine 0 N--CA 1.471 0.986 0 O-C-N 120.579 -1.326 . . . . 0.0 114.267 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -162.38 -178.14 6.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.349 1.46 . . . . 0.0 111.307 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 160.37 20.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.315 1.446 . . . . 0.0 113.69 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -141.81 -29.03 0.62 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.65 159.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.081 1.353 . . . . 0.0 111.787 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.9 tp -79.44 133.88 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.191 0.996 . . . . 0.0 109.583 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.0 tp -84.33 124.4 73.87 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.572 1.149 . . . . 0.0 109.642 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 69' ' ' LEU . 53.7 Cg_endo -64.74 120.09 7.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.706 3.604 . . . . 0.0 112.52 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.3 -55.19 23.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.41 150.62 36.11 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.728 1.211 . . . . 0.0 109.62 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.0 135.1 18.34 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.66 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -67.26 -164.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.702 2.935 . . . . 0.0 112.364 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -114.3 25.63 10.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.649 1.58 . . . . 0.0 113.712 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -149.44 8.36 0.7 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.279 1.431 . . . . 0.0 114.434 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -144.84 113.53 6.74 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.781 1.628 . . . . 0.0 114.459 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.01 174.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.748 1.219 . . . . 0.0 112.675 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -149.12 154.05 38.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.613 -0.679 . . . . 0.0 112.05 177.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.561 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -125.82 175.96 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.496 0.718 . . . . 0.0 112.42 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -147.64 161.51 41.0 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.526 1.53 . . . . 0.0 110.525 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD22 ' A' ' 24' ' ' LEU . 77.0 p -152.95 165.34 35.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.849 1.26 . . . . 0.0 112.451 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.38 172.75 24.14 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.027 0.822 . . . . 0.0 114.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -148.21 116.95 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.392 1.077 . . . . 0.0 111.705 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -151.24 173.01 14.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.374 1.47 . . . . 0.0 111.288 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.61 127.82 9.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.417 1.087 . . . . 0.0 109.476 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.92 173.85 11.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.474 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -136.18 149.71 48.71 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -128.69 117.2 20.77 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.361 1.864 . . . . 0.0 111.78 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -69.06 104.91 2.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.916 1.686 . . . . 0.0 109.816 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.8 mtp -66.5 148.75 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.216 1.007 . . . . 0.0 110.569 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -24.63 63.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.272 1.029 . . . . 0.0 113.501 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t -69.58 -13.7 62.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.342 1.857 . . . . 0.0 114.494 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.34 12.34 48.82 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.677 1.132 . . . . 0.0 114.967 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -103.17 175.43 5.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.373 2.269 . . . . 0.0 110.088 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.465 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 20.1 m -138.25 110.29 7.28 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.033 -1.042 . . . . 0.0 112.715 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.4 tp -74.67 113.45 11.95 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.551 1.14 . . . . 0.0 112.936 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.0 102.68 2.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.36 1.933 . . . . 0.0 110.401 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.4 160.27 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.535 1.134 . . . . 0.0 110.591 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -142.08 153.31 44.07 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.387 0.675 . . . . 0.0 111.556 174.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 16.4 p90 -161.23 156.11 23.7 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.783 1.233 . . . . 0.0 110.834 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 t -168.63 138.44 2.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.788 1.235 . . . . 0.0 109.221 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.42 95.71 7.48 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.537 0.65 0 C-N-CA 123.035 2.49 . . . . 0.0 111.628 178.326 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 p30 . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.447 ' CZ2' ' CE2' ' A' ' 135' ' ' TYR . 15.0 p-90 -114.09 157.98 21.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.7 0.8 . . . . 0.0 112.548 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -158.02 174.14 15.69 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.605 1.962 . . . . 0.0 110.12 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 154.96 133.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 129.221 3.009 . . . . 0.0 112.347 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.04 140.95 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.261 1.024 . . . . 0.0 109.015 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -133.35 149.32 51.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.801 1.24 . . . . 0.0 109.177 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 155' ' ' LEU . 79.2 mt -110.92 98.46 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.103 0.961 . . . . 0.0 109.024 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.19 99.94 0.2 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.402 1.081 . . . . 0.0 109.46 174.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.9 t -68.22 84.97 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.423 1.089 . . . . 0.0 110.86 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.98 -114.9 0.69 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.797 2.142 . . . . 0.0 110.302 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -150.35 123.34 8.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.965 1.306 . . . . 0.0 111.404 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.69 105.96 4.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.565 1.546 . . . . 0.0 112.48 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.26 167.22 3.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.416 1.086 . . . . 0.0 111.461 174.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -80.54 112.33 17.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.08 -0.388 . . . . 0.0 111.21 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.28 -179.44 6.94 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -51.85 -42.04 62.29 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.001 -1.062 . . . . 0.0 112.018 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.71 97.06 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.389 0.995 . . . . 0.0 113.798 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 1.2 ppp? -65.01 -45.72 84.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.798 1.299 . . . . 0.0 111.297 174.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -57.54 -39.92 77.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.693 0.797 . . . . 0.0 110.99 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -67.09 -40.47 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.474 1.11 . . . . 0.0 112.221 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.67 -29.77 70.96 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.443 -1.411 . . . . 0.0 112.883 174.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -76.38 -55.6 5.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.211 1.405 . . . . 0.0 111.615 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.447 ' CE2' ' CZ2' ' A' ' 114' ' ' TRP . 10.8 m-85 -76.5 -26.91 55.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -126.85 -33.85 2.44 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.213 1.005 . . . . 0.0 113.444 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.38 -49.41 45.16 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.839 1.209 . . . . 0.0 112.527 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -166.58 73.63 1.14 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 126.133 1.773 . . . . 0.0 111.565 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 133.01 23.92 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.34 2.026 . . . . 0.0 112.127 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -112.15 -175.17 2.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.552 2.341 . . . . 0.0 111.832 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -134.34 139.56 45.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.146 2.179 . . . . 0.0 110.636 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.36 91.13 0.14 Allowed Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.771 0.714 . . . . 0.0 113.823 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.63 -47.31 19.61 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.81 -1.406 . . . . 0.0 113.438 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 p30 179.37 88.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.974 2.51 . . . . 0.0 112.062 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.19 148.23 6.63 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.48 -0.762 . . . . 0.0 114.255 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.401 ' CD2' ' HB ' ' A' ' 160' ' ' ILE . 85.9 m95 -77.54 145.19 37.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.712 1.205 . . . . 0.0 111.206 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -153.2 141.37 20.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.271 1.429 . . . . 0.0 111.641 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -118.03 147.2 43.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.851 1.66 . . . . 0.0 111.207 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -149.82 166.45 29.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.309 1.044 . . . . 0.0 112.069 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -79.92 108.31 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 157' ' ' MET . 10.3 tp -66.74 -32.76 74.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.61 14.16 4.9 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.52 -26.06 3.07 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.141 1.471 . . . . 0.0 114.704 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.2 10.78 1.27 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.423 -1.21 . . . . 0.0 115.469 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -138.75 165.5 26.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.534 1.667 . . . . 0.0 112.369 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.01 141.33 52.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.597 1.159 . . . . 0.0 108.947 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -126.0 157.68 37.24 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.601 0.76 . . . . 0.0 109.386 175.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.9 129.25 56.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.1 159.03 19.7 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 123.34 0.495 . . . . 0.0 112.467 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.705 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -140.39 156.05 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.842 1.657 . . . . 0.0 110.432 176.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -153.73 114.21 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.705 HG23 HD11 ' A' ' 160' ' ' ILE . 6.8 p -102.03 150.97 22.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.818 0.847 . . . . 0.0 110.425 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.31 156.14 45.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.029 1.731 . . . . 0.0 110.431 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.17 128.5 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.995 2.518 . . . . 0.0 112.908 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.86 -179.0 51.73 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 122.229 0.905 . . . . 0.0 114.244 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.32 80.83 1.36 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.414 1.885 . . . . 0.0 112.48 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.55 164.0 34.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.739 1.216 . . . . 0.0 112.802 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -153.54 -178.91 7.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.746 1.619 . . . . 0.0 113.636 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.433 ' SD ' ' HE3' ' A' ' 101' ' ' MET . 20.0 ptm -102.11 166.62 10.51 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.896 2.079 . . . . 0.0 113.653 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -154.8 153.76 31.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.888 1.275 . . . . 0.0 109.955 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.8 mm -135.47 117.63 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.892 1.277 . . . . 0.0 110.114 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -112.89 111.94 23.05 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.867 -1.146 . . . . 0.0 111.503 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.467 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.0 pt -95.51 131.73 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 109.086 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.5 t -150.71 158.76 44.53 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.633 -0.667 . . . . 0.0 111.227 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.127 1.371 . . . . 0.0 112.185 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.56 -41.39 1.45 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.55 -25.56 8.97 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 125.423 1.487 . . . . 0.0 116.213 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 p -138.34 158.18 44.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.694 1.747 . . . . 0.0 111.447 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mm -136.2 165.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.774 -1.204 . . . . 0.0 110.382 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -170.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.881 1.273 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.4 -43.75 5.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 -29.56 6.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.18 1.371 . . . . 0.0 112.897 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.13 73.64 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.296 1.048 . . . . 0.0 111.491 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.4 m -86.53 -8.53 57.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.823 2.049 . . . . 0.0 114.345 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.63 131.36 45.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.47 1.108 . . . . 0.0 109.21 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.612 1.165 . . . . 0.0 109.163 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -54.61 -29.58 52.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.928 0.785 . . . . 0.0 112.988 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -58.28 -56.74 18.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 112.434 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.46 -44.62 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.893 0.877 . . . . 0.0 109.841 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -62.25 -25.48 67.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.591 1.156 . . . . 0.0 113.472 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -74.72 -53.1 9.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.102 -1.624 . . . . 0.0 110.373 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -39.85 83.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 112.934 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.6 p -68.65 -33.36 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.339 0.972 . . . . 0.0 113.082 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 32' ' ' ALA . 82.5 mt -78.8 -36.59 42.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.498 0.719 . . . . 0.0 110.522 175.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.84 -44.14 97.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.814 0.846 . . . . 0.0 111.664 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -20.53 57.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 CA--C 1.542 0.665 0 C-N-CA 126.327 1.851 . . . . 0.0 112.731 174.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -102.0 148.72 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.519 1.128 . . . . 0.0 111.426 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -139.51 97.74 3.34 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.58 1.952 . . . . 0.0 111.19 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.6 p -107.41 129.77 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.942 -1.099 . . . . 0.0 110.248 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.95 171.49 42.37 Favored Glycine 0 C--O 1.235 0.205 0 O-C-N 121.57 -0.706 . . . . 0.0 114.273 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 98' ' ' LEU . 3.5 mp -139.61 122.85 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 0.0 109.99 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.97 102.66 2.05 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.387 -1.445 . . . . 0.0 111.747 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -76.75 92.0 3.53 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.4 -0.813 . . . . 0.0 112.225 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -143.54 48.78 1.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.057 0.943 . . . . 0.0 111.586 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -109.8 -8.43 14.91 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.31 57.07 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.561 1.077 . . . . 0.0 115.558 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.44 134.68 6.98 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.129 1.347 . . . . 0.0 113.059 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.2 m -61.87 141.2 58.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.999 1.32 . . . . 0.0 110.816 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 48.9 m0 -104.68 163.49 12.45 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.472 -0.768 . . . . 0.0 111.343 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -143.41 102.0 3.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.022 1.329 . . . . 0.0 111.02 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.98 163.36 22.39 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.292 -0.88 . . . . 0.0 111.131 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.23 -60.65 1.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.126 1.371 . . . . 0.0 111.062 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -153.01 -173.84 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 111.096 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 147.96 35.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.44 1.496 . . . . 0.0 110.895 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 2.8 t80 -132.13 134.59 45.61 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.135 1.374 . . . . 0.0 110.568 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -143.48 157.9 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.204 2.202 . . . . 0.0 111.223 -174.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -127.13 -37.14 2.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.092 1.357 . . . . 0.0 112.924 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.3 t -133.46 92.97 3.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.25 121.19 2.1 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.344 0.973 . . . . 0.0 114.726 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -179.04 1.46 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.11 1.764 . . . . 0.0 112.759 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -88.16 158.56 18.5 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.779 1.232 . . . . 0.0 111.673 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -155.49 -22.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.163 1.385 . . . . 0.0 112.608 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 m -128.13 161.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.712 2.005 . . . . 0.0 110.353 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 tt -91.92 135.26 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.302 1.441 . . . . 0.0 110.975 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.99 125.85 86.33 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 0.0 109.123 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG2' HD12 ' A' ' 69' ' ' LEU . 60.2 Cg_endo -64.02 148.47 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.197 2.598 . . . . 0.0 111.043 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.48 -56.14 3.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.749 0.82 . . . . 0.0 112.309 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -119.2 134.97 54.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.094 1.358 . . . . 0.0 110.334 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.965 HG21 HD13 ' A' ' 69' ' ' LEU . 92.5 t -133.4 132.77 22.15 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.526 1.13 . . . . 0.0 111.484 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.56 164.28 35.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.807 3.005 . . . . 0.0 112.557 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 22.03 0.2 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.0 1.72 . . . . 0.0 115.381 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 p -146.7 23.53 1.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.528 1.531 . . . . 0.0 113.379 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -148.06 130.55 15.8 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.878 1.217 . . . . 0.0 112.607 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.04 179.17 5.79 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.365 1.079 . . . . 0.0 111.443 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 HG21 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -153.66 142.97 21.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.812 1.245 . . . . 0.0 109.588 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 33' ' ' VAL . 4.8 mt -122.39 -178.05 3.79 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.584 1.154 . . . . 0.0 110.555 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -155.5 164.76 38.26 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.689 -1.257 . . . . 0.0 110.326 174.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.481 ' HA ' HG23 ' A' ' 31' ' ' ILE . 8.6 t -142.65 174.54 10.55 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.093 0.957 . . . . 0.0 111.943 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.06 -171.55 12.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.385 1.469 . . . . 0.0 112.61 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 125.658 1.583 . . . . 0.0 114.484 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.33 114.52 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.031 2.533 . . . . 0.0 110.742 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.05 177.13 10.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.275 1.43 . . . . 0.0 111.887 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.54 127.84 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.394 1.477 . . . . 0.0 109.059 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -132.36 159.9 37.87 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.805 0.842 . . . . 0.0 112.066 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -124.33 144.35 50.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.114 0.565 . . . . 0.0 111.29 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 21.8 m-85 -118.61 121.9 41.29 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.485 1.514 . . . . 0.0 110.2 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.65 111.59 4.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.912 1.285 . . . . 0.0 110.354 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.7 mtp -72.32 142.68 48.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.745 1.218 . . . . 0.0 110.4 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.3 t -53.86 -33.7 57.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.433 1.093 . . . . 0.0 113.89 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -10.51 30.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.52 26.4 9.29 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.506 1.05 . . . . 0.0 114.291 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -117.73 177.53 4.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.383 1.873 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.5 m -140.21 106.19 5.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.9 1.28 . . . . 0.0 111.704 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 35' ' ' ILE . 26.0 tp -74.95 118.83 18.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.182 0.993 . . . . 0.0 110.314 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.81 107.51 3.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.88 1.229 . . . . 0.0 113.521 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -89.67 158.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 112.533 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.43 168.86 18.81 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.241 1.016 . . . . 0.0 112.136 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 47.0 p90 -171.68 150.31 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.633 1.573 . . . . 0.0 110.375 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.8 m -162.01 130.63 4.26 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.494 1.518 . . . . 0.0 107.355 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.862 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.1 t -107.04 128.45 26.05 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.438 -0.791 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 122.493 2.129 . . . . 0.0 111.258 -179.32 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 p30 . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 121.435 0.636 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -121.69 144.92 48.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.922 1.289 . . . . 0.0 112.267 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -155.51 160.24 40.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.535 1.134 . . . . 0.0 110.474 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 173.7 132.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.167 2.987 . . . . 0.0 111.008 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.17 140.92 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.72 1.608 . . . . 0.0 109.794 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -135.61 158.57 44.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.304 1.441 . . . . 0.0 110.805 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.22 99.4 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.769 1.628 . . . . 0.0 108.088 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -65.32 103.77 0.85 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.144 -0.972 . . . . 0.0 109.67 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.1 t -68.79 83.43 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.634 -1.291 . . . . 0.0 111.347 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.76 -111.64 0.49 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 127.117 2.294 . . . . 0.0 111.502 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -146.26 135.84 23.12 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.89 1.676 . . . . 0.0 111.852 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -158.31 113.84 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.695 1.598 . . . . 0.0 112.15 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 165.63 24.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.165 0.586 . . . . 0.0 111.236 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.67 113.04 16.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.647 0.779 . . . . 0.0 110.37 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -158.88 -174.74 4.91 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.698 1.599 . . . . 0.0 112.839 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -50.61 -40.95 54.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.256 -0.902 . . . . 0.0 112.865 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.91 -39.91 56.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.246 0.93 . . . . 0.0 113.269 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.3 ttt -67.41 -57.79 5.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.41 1.084 . . . . 0.0 111.507 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -53.47 -34.91 59.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.38 0.991 . . . . 0.0 112.691 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -66.64 -46.81 74.57 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.206 1.002 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -25.75 66.9 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.502 -1.374 . . . . 0.0 113.122 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.35 -45.07 57.26 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.727 2.011 . . . . 0.0 113.11 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.69 -31.76 14.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -116.31 -20.95 9.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.897 1.279 . . . . 0.0 113.163 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.68 -63.85 2.25 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.568 1.556 . . . . 0.0 114.166 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -122.52 64.45 21.58 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.898 1.279 . . . . 0.0 112.161 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -60.65 122.66 11.6 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.999 2.466 . . . . 0.0 112.851 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.37 -171.9 2.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.405 1.482 . . . . 0.0 111.351 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -139.26 135.58 34.03 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.735 -1.228 . . . . 0.0 112.997 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.73 8.16 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.265 1.412 . . . . 0.0 110.697 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -130.65 56.71 1.76 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.043 1.337 . . . . 0.0 110.825 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.5 p30 40.41 65.06 0.82 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.506 2.322 . . . . 0.0 115.432 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.28 154.02 21.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.819 1.199 . . . . 0.0 113.158 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.46 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 42.6 m95 -70.01 142.33 52.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.17 . . . . 0.0 110.951 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -145.4 131.67 19.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.799 1.239 . . . . 0.0 111.929 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -107.24 141.88 37.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 112.147 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -148.37 157.74 43.67 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 123.336 1.541 . . . . 0.0 112.248 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.502 ' H ' ' ND2' ' A' ' 150' ' ' ASN . 0.5 OUTLIER -90.11 88.28 7.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.828 2.851 . . . . 0.0 106.436 175.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.475 HD13 ' SD ' ' A' ' 157' ' ' MET . 8.1 tp -54.54 -27.84 41.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.594 1.557 . . . . 0.0 114.26 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.76 36.62 2.75 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -133.12 -20.32 2.17 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.1 2.96 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.579 1.085 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.47 176.68 8.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.378 1.871 . . . . 0.0 111.665 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -116.24 163.4 16.05 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.664 1.186 . . . . 0.0 111.127 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.174 0.988 . . . . 0.0 112.274 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -116.16 124.6 50.72 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 126.726 2.011 . . . . 0.0 108.144 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.21 149.26 18.58 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 119.095 0.861 . . . . 0.0 112.98 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.46 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -134.67 151.5 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.738 1.615 . . . . 0.0 108.919 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.9 tpp -156.45 109.01 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.722 1.609 . . . . 0.0 108.462 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.7 p -132.72 156.0 47.82 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.96 2.104 . . . . 0.0 110.037 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.9 p -158.21 -176.48 5.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.859 1.663 . . . . 0.0 110.882 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.82 34.98 14.03 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.855 1.662 . . . . 0.0 115.45 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 148.46 88.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.466 1.031 . . . . 0.0 113.274 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 44.8 55.64 5.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.17 2.588 . . . . 0.0 112.166 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.26 163.69 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.051 1.74 . . . . 0.0 113.804 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.862 ' HE2' HG22 ' A' ' 104' ' ' VAL . 1.8 tptp -159.09 -168.34 2.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.518 ' H ' ' HG3' ' A' ' 168' ' ' LYS . 19.7 ptm -121.31 149.5 42.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.058 1.743 . . . . 0.0 111.06 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.514 ' C ' HD12 ' A' ' 171' ' ' ILE . 13.2 tt0 -167.51 152.37 6.99 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.391 1.476 . . . . 0.0 109.177 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 1.8 mp -122.75 122.0 64.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 123.579 0.752 . . . . 0.0 109.243 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 114.11 25.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 108.365 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 157' ' ' MET . 8.4 pt -99.66 134.83 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.086 0.554 . . . . 0.0 110.531 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p -155.88 165.06 37.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.711 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.961 1.304 . . . . 0.0 112.474 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 19' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.351 0.119 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.22 169.22 2.21 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.805 0.812 . . . . 0.0 110.592 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.66 -40.01 2.57 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.7 p -131.51 155.79 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.678 1.591 . . . . 0.0 111.61 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mm -140.31 160.59 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.268 1.427 . . . . 0.0 110.283 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.664 HD12 ' H ' ' A' ' 9' ' ' GLY . 1.2 pp -66.73 -171.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.082 2.553 . . . . 0.0 111.67 174.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.34 -28.29 58.53 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.664 ' H ' HD12 ' A' ' 7' ' ' ILE . . . 95.64 -16.26 61.56 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.212 1.386 . . . . 0.0 112.929 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.72 -43.03 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.705 1.202 . . . . 0.0 111.799 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 7' ' ' ILE . 92.3 p -85.48 -13.09 50.2 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.7 HD13 HD23 ' A' ' 17' ' ' LEU . 1.5 tp -53.7 138.61 34.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.862 2.065 . . . . 0.0 110.021 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.42 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.6 m -145.7 149.51 34.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.9 0.88 . . . . 0.0 109.618 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -52.7 -26.49 14.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.29 -51.31 64.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.168 0.987 . . . . 0.0 112.11 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.23 -39.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.35 -0.844 . . . . 0.0 110.776 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.7 HD23 HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.41 -23.98 67.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.314 1.046 . . . . 0.0 112.338 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.16 -54.22 13.83 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.352 -1.467 . . . . 0.0 109.021 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -55.78 -44.75 78.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.373 1.069 . . . . 0.0 112.62 175.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG23 HD22 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -63.04 -35.91 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.331 0.969 . . . . 0.0 113.414 -175.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 32' ' ' ALA . 35.2 mt -84.93 -32.3 23.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 111.801 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.23 -23.01 66.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.269 0.627 . . . . 0.0 111.584 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -48.15 -25.91 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.36 1.864 . . . . 0.0 113.657 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 125.576 1.55 . . . . 0.0 112.317 174.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HZ3' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.367 0.127 . . . . 0.0 111.286 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -131.25 133.55 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.891 0.877 . . . . 0.0 111.635 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -115.6 102.62 9.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.107 2.163 . . . . 0.0 113.843 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.609 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.1 p -114.02 121.33 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.571 -1.331 . . . . 0.0 109.96 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.83 33.81 Favored Glycine 0 N--CA 1.461 0.363 0 O-C-N 121.053 -1.029 . . . . 0.0 112.956 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 100' ' ' VAL . 2.2 mp -141.42 134.45 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.335 1.064 . . . . 0.0 113.817 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 2.6 m-20 -76.41 106.76 8.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.69 1.596 . . . . 0.0 113.148 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -84.06 104.27 13.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.683 1.23 . . . . 0.0 112.977 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -145.49 23.8 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.078 -1.014 . . . . 0.0 113.021 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.51 -9.52 54.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.496 1.519 . . . . 0.0 114.66 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.95 49.48 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.493 1.044 . . . . 0.0 115.148 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.62 110.66 0.91 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.833 1.682 . . . . 0.0 110.166 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -59.58 147.2 38.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.801 1.3 . . . . 0.0 110.906 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -117.3 161.41 19.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.53 0.732 . . . . 0.0 111.506 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -133.01 113.63 13.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.331 2.253 . . . . 0.0 111.996 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -75.41 115.64 15.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.599 1.159 . . . . 0.0 110.831 175.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -71.85 -54.85 8.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.521 1.528 . . . . 0.0 110.259 175.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.74 -174.03 3.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.72 1.608 . . . . 0.0 111.825 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 144.67 28.22 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.53 1.532 . . . . 0.0 111.622 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.62 119.94 37.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.54 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.32 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 109.562 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -5.12 43.64 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.162 1.385 . . . . 0.0 113.833 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 p -73.56 -137.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.017 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.85 -84.55 0.91 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.446 1.022 . . . . 0.0 112.663 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -146.17 176.03 10.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.517 1.127 . . . . 0.0 112.193 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -77.74 158.36 29.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.38 1.472 . . . . 0.0 113.051 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -135.22 -34.14 0.87 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.688 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 71' ' ' TYR . 19.7 m -132.0 176.84 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.855 2.062 . . . . 0.0 110.129 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -100.93 131.8 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.442 1.497 . . . . 0.0 110.987 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.26 131.61 52.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.656 ' HG2' HD12 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -63.63 177.68 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.165 3.243 . . . . 0.0 112.411 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -117.81 -36.68 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.839 1.256 . . . . 0.0 112.279 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.13 157.92 33.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.952 1.301 . . . . 0.0 111.72 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.99 97.44 7.92 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 124.747 1.219 . . . . 0.0 108.681 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.99 174.61 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.795 1.663 . . . . 0.0 110.54 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -63.2 165.49 7.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.45 0.7 . . . . 0.0 109.887 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 t 46.08 30.81 1.01 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.162 1.385 . . . . 0.0 113.14 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -145.26 158.68 43.77 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.916 1.686 . . . . 0.0 112.138 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -140.34 -173.84 3.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.707 1.242 . . . . 0.0 110.105 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -156.91 153.88 28.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.926 175.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 32' ' ' ALA . 14.2 mt -139.26 155.16 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.796 1.238 . . . . 0.0 108.578 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -129.07 160.26 33.35 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.119 1.368 . . . . 0.0 108.747 175.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 m -151.26 170.1 20.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.439 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.82 -171.2 21.35 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 124.613 1.165 . . . . 0.0 109.789 -177.078 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -151.88 121.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 127.357 2.263 . . . . 0.0 111.329 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.1 176.02 12.28 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.797 1.639 . . . . 0.0 110.389 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.46 116.97 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.541 1.136 . . . . 0.0 108.441 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 33' ' ' VAL . 10.7 p90 -127.22 170.08 12.81 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.264 1.026 . . . . 0.0 112.651 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.91 157.72 45.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.735 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -128.97 112.38 14.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.136 1.774 . . . . 0.0 112.147 -175.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.3 104.09 1.41 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.297 1.839 . . . . 0.0 111.032 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.43 140.37 58.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.492 1.117 . . . . 0.0 110.111 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -57.62 -20.72 34.96 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -74.39 -10.02 59.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.258 1.423 . . . . 0.0 113.905 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.76 11.77 45.91 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.058 1.313 . . . . 0.0 114.837 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.12 174.56 6.26 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.261 1.824 . . . . 0.0 109.7 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m -143.64 109.52 5.25 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.951 -1.093 . . . . 0.0 112.588 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 35' ' ' ILE . 48.7 tp -74.56 121.5 21.66 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.068 -1.02 . . . . 0.0 111.627 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 110.7 3.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.868 1.223 . . . . 0.0 113.367 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.4 p -86.58 150.13 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.193 0.997 . . . . 0.0 112.21 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.589 ' HB2' HD13 ' A' ' 134' ' ' LEU . 11.1 tmm? -135.65 152.16 50.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.115 1.366 . . . . 0.0 110.774 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.609 ' CE1' HG11 ' A' ' 33' ' ' VAL . 23.7 p90 -164.69 158.45 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.374 1.07 . . . . 0.0 110.474 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 m -163.17 154.39 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.87 2.068 . . . . 0.0 108.181 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.66 100.1 37.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 C-N-CA 122.767 2.311 . . . . 0.0 111.828 179.149 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.664 0.745 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -92.18 140.44 29.62 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.301 1.44 . . . . 0.0 112.622 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.539 ' CE3' HD11 ' A' ' 171' ' ' ILE . 6.8 p-90 -163.1 138.32 6.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -161.24 152.12 18.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.766 -0.584 . . . . 0.0 112.441 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 171' ' ' ILE . 10.9 t -143.96 143.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 127.161 2.185 . . . . 0.0 110.119 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 150.13 45.18 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.178 1.791 . . . . 0.0 109.872 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.84 103.55 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.232 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -66.45 101.36 0.75 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.851 -1.156 . . . . 0.0 109.093 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 t -67.49 82.22 0.16 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.847 -1.158 . . . . 0.0 111.525 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.47 -107.25 0.32 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.088 2.28 . . . . 0.0 111.423 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -153.19 144.64 23.27 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.849 1.26 . . . . 0.0 111.903 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -165.34 116.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.966 1.706 . . . . 0.0 111.788 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.71 164.92 20.56 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.538 0.735 . . . . 0.0 111.732 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.41 118.73 22.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.329 -0.232 . . . . 0.0 110.58 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.63 -179.09 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.139 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -48.84 42.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.943 1.297 . . . . 0.0 112.715 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.0 -33.52 60.71 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.001 0.81 . . . . 0.0 113.515 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.6 ttp -67.44 -56.42 9.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.412 1.106 . . . . 0.0 111.455 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -49.47 -39.81 34.97 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.296 0.953 . . . . 0.0 111.997 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -66.07 -43.14 88.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.079 0.952 . . . . 0.0 112.202 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -17.91 64.92 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.022 -1.673 . . . . 0.0 113.918 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 101' ' ' MET . 41.5 mt -96.23 -24.84 16.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.376 1.47 . . . . 0.0 113.39 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.81 -32.99 11.07 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.945 -1.097 . . . . 0.0 112.928 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -118.13 -33.67 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 112.759 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.19 -21.23 71.83 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.408 1.004 . . . . 0.0 114.517 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -154.11 87.0 3.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.462 2.305 . . . . 0.0 108.374 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.36 108.9 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.086 1.857 . . . . 0.0 110.953 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -139.88 158.95 43.25 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -147.42 167.67 23.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.963 1.705 . . . . 0.0 112.637 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.36 111.31 0.48 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.129 0.871 . . . . 0.0 112.93 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.03 70.39 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.986 0.914 . . . . 0.0 111.434 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.0 92.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.952 2.501 . . . . 0.0 114.993 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.09 130.17 1.09 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.581 1.086 . . . . 0.0 112.362 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.485 ' CE3' ' HG3' ' A' ' 158' ' ' LYS . 5.7 m95 -58.81 123.96 18.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.641 1.177 . . . . 0.0 111.164 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -131.75 118.24 19.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.422 1.489 . . . . 0.0 111.553 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.37 142.85 46.31 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.347 1.059 . . . . 0.0 112.615 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.23 156.82 41.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.688 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -74.62 104.36 5.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.73 -22.68 58.23 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.18 35.68 2.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.753 1.644 . . . . 0.0 116.523 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -135.42 -24.54 1.38 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.57 -18.03 1.13 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.204 1.383 . . . . 0.0 114.391 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 173' ' ' ILE . 1.2 pp -131.04 163.44 27.6 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.129 1.372 . . . . 0.0 112.523 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -102.3 136.72 41.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.289 1.436 . . . . 0.0 112.211 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB2' HG22 ' A' ' 173' ' ' ILE . 6.3 tmm? -115.07 135.72 53.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.149 0.58 . . . . 0.0 110.531 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.485 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.8 tptm -103.87 119.69 39.45 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.884 2.074 . . . . 0.0 110.468 176.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.18 146.87 18.62 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.354 1.454 . . . . 0.0 112.773 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 161' ' ' MET . 4.1 tp -124.15 157.05 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.096 1.759 . . . . 0.0 110.226 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.573 ' H ' HD12 ' A' ' 160' ' ' ILE . 7.0 tpt -152.34 90.87 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.463 1.505 . . . . 0.0 109.086 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.7 p -82.45 152.24 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 111.471 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.1 t -127.94 163.47 24.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.204 1.002 . . . . 0.0 112.049 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 65.05 144.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.575 2.75 . . . . 0.0 113.133 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 38.8 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.479 1.527 0 C-N-CA 126.877 2.18 . . . . 0.0 113.34 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.519 ' HG2' ' HZ3' ' A' ' 30' ' ' LYS . 2.1 tm-20 -75.59 64.11 1.63 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.376 1.87 . . . . 0.0 109.599 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.5 111.7 23.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.202 1.801 . . . . 0.0 111.768 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -159.1 161.69 36.41 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.421 ' N ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -121.99 140.33 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 127.739 2.416 . . . . 0.0 110.295 175.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.539 ' C ' HD12 ' A' ' 171' ' ' ILE . 25.5 tt0 -138.6 157.12 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.708 1.603 . . . . 0.0 109.018 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.539 HD11 ' CE3' ' A' ' 115' ' ' TRP . 1.6 mp -128.31 134.54 64.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 124.464 1.106 . . . . 0.0 109.697 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 109.11 13.26 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.318 2.247 . . . . 0.0 110.737 175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 155' ' ' LEU . 12.7 pt -91.54 124.47 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.134 1.374 . . . . 0.0 110.183 175.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.4 p -155.69 170.52 21.85 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.315 1.446 . . . . 0.0 112.735 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.38 169.72 10.18 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 110.654 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.87 -27.64 19.66 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 113.231 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -146.6 160.54 42.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.99 1.716 . . . . 0.0 111.641 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -139.83 166.81 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.571 1.549 . . . . 0.0 110.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 pt -73.91 -170.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.917 2.487 . . . . 0.0 110.308 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.05 19.8 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 -10.48 73.91 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.75 1.167 . . . . 0.0 114.36 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.7 -45.69 35.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.56 1.144 . . . . 0.0 111.497 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -81.62 -7.31 59.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.947 1.299 . . . . 0.0 113.869 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' ' 17' ' ' LEU . 20.5 tp -59.81 144.19 49.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.822 1.249 . . . . 0.0 110.396 174.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.3 146.43 29.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.247 1.019 . . . . 0.0 110.082 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -55.79 -29.06 59.08 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -60.85 -57.32 13.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.44 -43.68 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.766 -0.584 . . . . 0.0 110.073 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.601 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.36 -30.86 68.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 112.766 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -69.55 -47.27 64.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.986 1.715 . . . . 0.0 111.824 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -35.65 77.81 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.857 -1.152 . . . . 0.0 112.131 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -39.14 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.052 -1.03 . . . . 0.0 113.642 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -31.58 61.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.233 0.469 . . . . 0.0 111.79 175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -70.22 -33.41 71.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.319 1.448 . . . . 0.0 112.27 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -46.63 -29.44 1.85 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.457 2.303 . . . . 0.0 114.208 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD13 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 125.365 1.466 . . . . 0.0 110.94 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HE2' ' CD2' ' A' ' 24' ' ' LEU . 28.0 mmtm . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -121.4 141.67 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.729 1.612 . . . . 0.0 112.028 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 104.94 11.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.854 1.662 . . . . 0.0 110.338 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.12 142.87 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 124.257 1.023 . . . . 0.0 113.52 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.11 173.48 34.59 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.535 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 100' ' ' VAL . 3.1 mt -139.71 150.02 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.422 1.489 . . . . 0.0 110.613 -174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.39 118.09 31.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 110.617 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.549 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.73 103.69 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 0.0 111.922 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.58 7.97 2.82 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.823 1.249 . . . . 0.0 112.988 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 t -66.19 -16.26 63.84 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.62 16.73 28.21 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.595 1.093 . . . . 0.0 115.361 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.43 136.92 8.38 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.262 1.411 . . . . 0.0 112.886 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -67.36 141.63 57.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.437 1.495 . . . . 0.0 111.749 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.662 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 40.3 m0 -108.01 165.82 11.18 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.647 1.179 . . . . 0.0 112.179 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -146.55 98.8 3.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 111.997 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -63.29 139.77 58.8 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.019 -1.05 . . . . 0.0 110.428 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 91' ' ' TYR . 21.2 mt -93.4 -61.37 1.57 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.872 0.869 . . . . 0.0 110.187 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.63 -164.12 0.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.913 2.885 . . . . 0.0 108.892 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.85 134.77 20.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.206 1.803 . . . . 0.0 111.329 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -103.98 112.48 25.48 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.601 1.56 . . . . 0.0 109.376 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 130.81 55.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.543 1.537 . . . . 0.0 109.839 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -31.02 7.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.746 1.618 . . . . 0.0 113.258 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -141.8 91.85 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.241 1.016 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.17 125.94 3.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.8 1.667 . . . . 0.0 111.946 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -74.7 175.49 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.897 0.856 . . . . 0.0 111.775 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p -62.55 171.02 2.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.683 1.993 . . . . 0.0 113.122 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' OD1' HD13 ' A' ' 24' ' ' LEU . 1.2 t70 -152.34 -50.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.035 1.334 . . . . 0.0 109.785 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.9 164.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.476 1.51 . . . . 0.0 111.761 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 tp -71.88 134.25 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 110.452 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -91.79 114.2 61.21 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.696 1.198 . . . . 0.0 109.724 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.631 ' HG2' HD12 ' A' ' 69' ' ' LEU . 63.6 Cg_endo -66.31 120.53 7.68 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.308 3.339 . . . . 0.0 111.422 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.2 pt-20 -71.51 -67.58 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.499 0.72 . . . . 0.0 112.402 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -97.33 132.61 42.89 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.547 0.739 . . . . 0.0 109.561 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 t -129.67 128.04 22.98 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.816 0.847 . . . . 0.0 111.099 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.77 149.64 38.13 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.028 3.152 . . . . 0.0 112.805 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.89 17.96 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -141.0 8.62 2.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.412 1.885 . . . . 0.0 113.946 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -145.59 134.44 22.43 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 119.885 1.22 . . . . 0.0 113.038 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.23 -176.36 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 110.992 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -152.02 157.22 41.39 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.409 -0.807 . . . . 0.0 112.187 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.64 170.78 14.29 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 123.608 0.763 . . . . 0.0 111.65 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.48 157.76 43.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.231 1.813 . . . . 0.0 109.885 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.7 m -145.39 160.52 41.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.154 1.782 . . . . 0.0 108.799 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.81 -179.57 16.88 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.615 1.102 . . . . 0.0 111.984 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 103' ' ' SER . 15.4 t -130.86 108.0 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.878 2.071 . . . . 0.0 108.891 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.89 178.62 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 111.128 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.76 120.7 5.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -125.97 161.56 27.23 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.312 1.045 . . . . 0.0 113.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -131.52 148.82 52.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 24.4 m-85 -122.01 102.37 8.13 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.286 2.234 . . . . 0.0 112.094 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 46' ' ' LEU . 10.7 t80 -69.06 117.88 11.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.471 1.508 . . . . 0.0 110.374 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.9 mtp -82.42 153.1 25.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 111.516 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 m -58.74 -16.59 17.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -73.87 -17.88 60.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 113.565 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.27 33.82 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.248 1.88 . . . . 0.0 114.937 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -78.78 168.21 20.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.734 1.267 . . . . 0.0 111.573 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.71 HG22 ' HB1' ' A' ' 89' ' ' ALA . 23.8 m -136.43 106.51 6.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.318 1.047 . . . . 0.0 112.332 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 173' ' ' ILE . 16.4 tp -68.47 111.48 4.72 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.674 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 130' ' ' MET . . . -94.6 105.77 3.33 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 0.0 113.486 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -76.31 149.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 122.099 -0.648 . . . . 0.0 110.882 174.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.644 ' HB2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -122.72 145.43 48.4 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.209 -0.932 . . . . 0.0 109.793 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CG ' HG11 ' A' ' 33' ' ' VAL . 40.8 p90 -167.71 135.16 2.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 123.308 1.528 . . . . 0.0 114.234 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' VAL . 28.4 m -150.51 130.62 13.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.768 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.21 90.9 42.85 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 CA--C 1.541 0.855 0 C-N-CA 122.569 2.179 . . . . 0.0 112.818 -178.383 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.401 0.619 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -85.84 159.85 19.6 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.324 0.65 . . . . 0.0 110.249 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -161.45 171.03 18.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.951 1.3 . . . . 0.0 109.399 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 148.26 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.558 3.143 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.61 160.88 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.684 0.793 . . . . 0.0 109.847 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -161.25 158.07 26.66 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.56 176.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ ' ' A' ' 153' ' ' TYR . 34.1 mt -105.53 117.3 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -66.78 87.85 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.873 1.669 . . . . 0.0 110.189 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.5 t -73.02 81.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.0 110.949 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.62 -82.13 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.717 1.151 . . . . 0.0 112.938 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 177.8 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.38 2.672 . . . . 0.0 111.116 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -155.39 159.21 39.71 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.937 2.095 . . . . 0.0 109.338 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.16 173.86 10.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.123 2.169 . . . . 0.0 111.173 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.64 109.7 5.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.721 0.408 . . . . 0.0 111.863 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 130' ' ' MET . 2.4 t70 -163.68 -169.81 2.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 111.099 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.7 -48.88 69.11 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.442 -0.786 . . . . 0.0 110.707 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.54 50.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.422 1.01 . . . . 0.0 113.659 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.423 ' HE3' ' CA ' ' A' ' 99' ' ' GLY . 3.8 ttt -66.34 -63.63 1.03 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.739 0.815 . . . . 0.0 110.595 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.88 -34.1 62.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.999 0.92 . . . . 0.0 112.776 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.63 -40.09 95.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.681 1.592 . . . . 0.0 111.019 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -21.89 65.76 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.261 -1.525 . . . . 0.0 113.26 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 101' ' ' MET . 12.4 mt -82.15 -41.11 20.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.492 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 -34.69 14.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -113.11 -36.56 5.03 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.481 1.512 . . . . 0.0 112.128 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.81 -69.58 1.02 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.747 1.642 . . . . 0.0 112.487 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -171.13 75.57 0.54 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 125.437 1.495 . . . . 0.0 112.933 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.73 161.32 32.78 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.751 2.3 . . . . 0.0 113.86 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -126.53 177.19 6.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.125 2.17 . . . . 0.0 112.224 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -108.24 124.0 49.63 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.055 2.142 . . . . 0.0 111.584 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.64 101.96 2.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.493 1.52 . . . . 0.0 112.928 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -136.86 23.96 3.08 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 71.2 99.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.81 2.444 . . . . 0.0 113.386 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.96 139.41 2.66 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.691 1.615 . . . . 0.0 111.987 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -69.83 154.91 41.33 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 122.216 -0.579 . . . . 0.0 111.354 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -142.08 124.47 15.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.305 1.442 . . . . 0.0 111.694 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -121.79 138.64 54.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.231 2.212 . . . . 0.0 111.34 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 159.44 38.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.92 1.288 . . . . 0.0 111.694 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -81.63 86.6 6.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.091 1.356 . . . . 0.0 110.083 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.526 HD22 ' CE2' ' A' ' 153' ' ' TYR . 7.3 tt -58.42 -52.51 65.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.456 1.502 . . . . 0.0 112.949 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.58 42.37 0.02 OUTLIER Glycine 0 CA--C 1.542 1.761 0 N-CA-C 118.584 2.194 . . . . 0.0 118.584 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -150.05 5.01 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.642 1.721 . . . . 0.0 115.61 -176.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.87 -57.21 0.44 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.448 1.499 . . . . 0.0 112.496 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.84 176.24 7.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.824 0.85 . . . . 0.0 111.652 174.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.24 123.94 31.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.648 1.579 . . . . 0.0 109.999 175.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.613 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -88.2 156.02 19.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.58 130.96 39.12 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.762 1.225 . . . . 0.0 109.977 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -124.41 152.66 17.46 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 124.269 0.938 . . . . 0.0 113.588 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 141.24 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.278 1.431 . . . . 0.0 110.396 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.31 99.13 5.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.931 1.242 . . . . 0.0 110.931 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.59 53.86 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 0.0 111.89 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.5 m -123.06 129.02 50.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.674 1.989 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.64 68.15 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.842 2.857 . . . . 0.0 109.151 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.2 -90.46 0.02 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.38 1.943 . . . . 0.0 114.536 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -75.81 11.22 1.45 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.57 2.348 . . . . 0.0 114.802 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.37 170.28 16.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.69 1.596 . . . . 0.0 113.032 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 -167.99 1.89 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.1 ptm -114.05 164.12 14.25 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.858 2.063 . . . . 0.0 110.99 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -150.64 146.03 26.24 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.165 1.386 . . . . 0.0 110.009 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.0 mm -121.03 128.69 76.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.311 1.045 . . . . 0.0 108.726 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -115.58 114.55 25.09 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.504 1.522 . . . . 0.0 108.965 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.662 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 13.3 pt -111.07 134.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.59 1.156 . . . . 0.0 110.709 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.5 p -162.72 158.97 23.69 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.8 1.24 . . . . 0.0 110.79 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.248 1.419 . . . . 0.0 112.212 -175.043 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.75 166.85 5.05 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.024 0.916 . . . . 0.0 110.403 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.64 -42.17 1.99 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.93 1.729 . . . . 0.0 110.89 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.3 p -139.1 159.98 40.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.429 1.491 . . . . 0.0 111.932 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mm -142.11 162.9 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 111.402 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.5 pt -69.1 -169.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.072 2.149 . . . . 0.0 111.073 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.08 -25.84 23.87 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.28 -21.59 34.05 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.411 1.005 . . . . 0.0 113.355 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -44.1 70.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.444 1.122 . . . . 0.0 111.845 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.64 -11.67 59.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.018 1.327 . . . . 0.0 113.365 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD11 HD23 ' A' ' 17' ' ' LEU . 1.5 tt -66.15 159.12 26.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.59 146.84 27.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.685 0.794 . . . . 0.0 109.916 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -55.52 -33.93 64.21 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.96 -47.77 79.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.456 1.103 . . . . 0.0 113.049 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.1 -45.94 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 110.439 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.54 -41.3 66.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 111.426 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.67 -53.3 40.47 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.619 1.968 . . . . 0.0 112.317 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -27.12 41.84 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -35.82 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.181 1.355 . . . . 0.0 111.742 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -81.27 -23.91 37.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.208 1.003 . . . . 0.0 112.463 177.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.9 -33.77 22.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.645 1.578 . . . . 0.0 114.235 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -19.89 16.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 112.935 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 127.457 2.303 . . . . 0.0 111.038 174.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.564 ' HB2' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -145.41 148.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.683 1.193 . . . . 0.0 113.005 176.054 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.607 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -121.77 105.63 10.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.591 2.356 . . . . 0.0 112.603 174.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 102' ' ' PHE . 1.3 p -115.7 144.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 108.75 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.61 170.54 22.56 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 118.195 0.452 . . . . 0.0 112.8 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.02 124.88 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.888 0.875 . . . . 0.0 111.528 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -71.2 109.34 5.18 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.348 -0.845 . . . . 0.0 111.902 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.87 102.68 14.55 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.656 1.217 . . . . 0.0 111.271 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.14 44.41 1.55 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.07 -1.019 . . . . 0.0 110.94 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -2.32 9.05 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.41 75.81 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.946 -1.096 . . . . 0.0 115.266 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.37 107.85 1.71 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.758 1.647 . . . . 0.0 111.509 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.2 m -67.74 116.75 8.79 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.638 1.219 . . . . 0.0 110.632 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.443 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 8.7 m0 -85.78 161.25 19.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.588 0.355 . . . . 0.0 111.916 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -138.01 104.12 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.448 1.899 . . . . 0.0 111.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -65.93 141.27 58.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.884 -1.135 . . . . 0.0 110.528 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -106.42 -47.45 3.78 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.195 1.398 . . . . 0.0 111.774 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -155.63 171.35 20.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.027 0.931 . . . . 0.0 112.13 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.13 135.33 30.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 0.0 111.604 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.437 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.3 t80 -115.16 129.01 56.55 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.333 1.453 . . . . 0.0 109.088 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 18.8 p90 -147.22 161.15 41.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.869 1.267 . . . . 0.0 112.452 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -120.94 -31.84 4.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.738 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.49 ' CB ' ' H ' ' A' ' 85' ' ' VAL . 83.2 p -60.19 130.97 49.3 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.712 1.205 . . . . 0.0 112.344 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 37.13 -100.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.285 1.898 . . . . 0.0 113.904 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 55' ' ' THR . 2.1 t -165.04 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.478 1.911 . . . . 0.0 108.244 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 54' ' ' THR . 12.7 p -137.31 164.9 27.45 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.411 2.284 . . . . 0.0 112.119 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -154.67 -38.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.523 1.529 . . . . 0.0 111.358 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 3' ' ' ALA . 16.2 m -102.31 165.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.682 1.593 . . . . 0.0 112.24 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.5 tt -80.24 136.62 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.641 1.176 . . . . 0.0 110.957 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.22 107.08 36.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.907 0.883 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HG2' HD12 ' A' ' 69' ' ' LEU . 73.5 Cg_endo -67.14 113.96 3.03 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 124.322 3.348 . . . . 0.0 110.386 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.49 -46.61 87.66 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.641 -0.662 . . . . 0.0 112.024 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.78 145.31 29.93 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.954 0.797 . . . . 0.0 110.854 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.11 94.19 16.26 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 124.723 1.209 . . . . 0.0 108.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.15 173.94 13.65 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.268 1.978 . . . . 0.0 112.125 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.72 166.82 3.06 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.343 0.657 . . . . 0.0 112.103 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.26 8.5 t 43.07 38.19 1.41 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.076 1.75 . . . . 0.0 113.396 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -148.74 151.41 34.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.039 1.736 . . . . 0.0 111.592 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.12 -175.62 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.32 . . . . 0.0 109.373 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -156.75 145.16 19.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.964 1.305 . . . . 0.0 109.368 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' HB1' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -124.34 155.08 39.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.25 1.02 . . . . 0.0 110.082 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.461 ' CE1' HG23 ' A' ' 57' ' ' VAL . 2.3 t80 -139.45 169.2 18.19 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 109.793 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -154.49 -177.8 6.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.339 1.055 . . . . 0.0 110.722 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.11 -167.03 12.79 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.354 1.93 . . . . 0.0 110.903 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.49 ' H ' ' CB ' ' A' ' 52' ' ' SER . 47.1 t -152.36 114.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.357 2.263 . . . . 0.0 112.719 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -143.98 167.0 23.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.488 1.515 . . . . 0.0 110.448 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 122.95 10.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.255 1.422 . . . . 0.0 107.45 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -139.23 164.01 30.95 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 112.315 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 130' ' ' MET . . . -124.11 151.73 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.702 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 24.2 m-85 -131.83 112.16 12.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.958 1.703 . . . . 0.0 110.937 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -65.91 105.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.252 1.421 . . . . 0.0 110.655 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -73.47 153.46 40.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.203 1.001 . . . . 0.0 110.998 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.5 p -59.63 -20.56 56.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -76.27 -4.45 42.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 114.058 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.1 6.3 71.84 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.293 1.425 . . . . 0.0 114.851 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.59 177.28 5.86 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.235 1.414 . . . . 0.0 111.293 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.599 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 17.9 m -133.48 112.0 11.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.323 1.049 . . . . 0.0 113.12 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 tp -73.45 122.84 22.78 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.66 108.57 3.14 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.0 154.76 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.337 0.589 . . . . 0.0 110.828 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.526 ' CB ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -138.38 148.22 44.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.532 1.133 . . . . 0.0 108.924 175.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 21.3 p90 -162.17 147.05 12.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.234 1.016 . . . . 0.0 110.488 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 85' ' ' VAL . 24.2 m -151.55 165.4 34.36 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.94 1.296 . . . . 0.0 108.379 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.51 96.68 23.39 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.54 0.818 0 C-N-CA 122.976 2.451 . . . . 0.0 114.718 -175.018 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 121.86 0.838 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -84.16 144.41 29.01 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.259 1.024 . . . . 0.0 112.547 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -153.45 150.93 29.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.472 0.653 . . . . 0.0 111.831 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.61 151.21 4.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.046 1.338 . . . . 0.0 111.079 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.0 135.55 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.261 1.824 . . . . 0.0 108.748 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -146.43 155.01 42.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.102 1.361 . . . . 0.0 109.872 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.16 107.16 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.396 1.478 . . . . 0.0 107.863 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.66 104.83 4.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.277 1.031 . . . . 0.0 109.22 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t -65.6 97.02 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.799 -1.188 . . . . 0.0 110.097 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.8 19.26 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 127.194 2.33 . . . . 0.0 110.317 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -126.93 129.85 48.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.107 1.763 . . . . 0.0 111.018 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.75 121.68 5.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.841 1.657 . . . . 0.0 111.563 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.59 175.36 5.66 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.483 1.113 . . . . 0.0 110.85 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -84.59 115.06 22.42 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.71 -0.619 . . . . 0.0 111.905 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -151.27 -174.53 4.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.441 1.096 . . . . 0.0 111.682 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.56 -51.7 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.512 1.125 . . . . 0.0 110.668 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.06 46.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.202 0.906 . . . . 0.0 113.83 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 2.7 ttt -66.04 -65.2 0.71 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.629 0.714 . . . . 0.0 110.185 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -54.14 -31.78 53.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.47 1.108 . . . . 0.0 112.683 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.47 -47.88 82.05 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.802 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -23.69 67.44 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.464 -1.397 . . . . 0.0 113.806 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.526 HD13 ' CB ' ' A' ' 101' ' ' MET . 76.5 mt -79.09 -18.17 53.81 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.431 1.492 . . . . 0.0 114.44 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.76 -31.33 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.905 1.282 . . . . 0.0 114.433 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.52 -5.74 13.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.0 2.12 . . . . 0.0 112.268 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.03 -88.68 0.46 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.244 1.878 . . . . 0.0 110.744 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -160.98 73.08 2.7 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.695 1.598 . . . . 0.0 111.692 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.26 177.63 8.37 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.731 2.287 . . . . 0.0 114.914 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -127.03 -178.24 4.34 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.231 2.212 . . . . 0.0 113.056 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 144.65 48.85 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.378 -1.451 . . . . 0.0 111.848 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.97 116.5 0.76 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.587 1.089 . . . . 0.0 111.952 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -115.46 68.78 0.72 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.348 1.459 . . . . 0.0 112.83 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 64.55 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.281 2.633 . . . . 0.0 113.758 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.78 142.11 3.48 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.982 1.277 . . . . 0.0 112.5 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -67.82 147.9 51.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.481 0.713 . . . . 0.0 111.951 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -148.41 122.82 9.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.706 1.602 . . . . 0.0 110.926 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.12 141.58 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.987 0.915 . . . . 0.0 111.633 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -146.01 148.85 33.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.352 0.596 . . . . 0.0 110.452 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.53 92.72 8.6 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.494 HD13 ' SD ' ' A' ' 157' ' ' MET . 2.4 tp -51.92 -32.16 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.99 21.97 5.46 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -128.44 20.43 6.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.875 1.338 . . . . 0.0 114.445 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.85 12.11 83.11 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.348 -0.845 . . . . 0.0 113.827 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.87 166.97 23.2 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.41 1.884 . . . . 0.0 111.633 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 169.74 13.2 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.26 1.424 . . . . 0.0 109.824 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -145.81 167.52 23.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.897 175.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 137.02 54.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.295 1.438 . . . . 0.0 108.253 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.06 141.36 15.83 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.536 0.589 . . . . 0.0 112.632 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.22 101.97 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.516 1.526 . . . . 0.0 111.089 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.5 tpt -96.63 105.08 17.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.982 1.264 . . . . 0.0 110.998 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.8 p -114.7 145.36 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.08 0.952 . . . . 0.0 111.449 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -137.86 139.56 39.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.865 1.666 . . . . 0.0 111.968 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.6 -179.29 0.11 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 130.344 3.458 . . . . 0.0 108.744 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.09 -12.86 45.92 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 115.077 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.21 11.28 0.91 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.76 1.624 . . . . 0.0 114.769 -175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.96 169.11 12.76 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.546 -1.346 . . . . 0.0 113.745 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 19.6 tptt -167.14 151.36 6.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 113.091 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.6 ptm -81.19 165.76 21.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -154.37 161.0 41.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.332 1.453 . . . . 0.0 110.782 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 mm -123.14 135.35 63.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -118.12 126.99 53.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.411 1.084 . . . . 0.0 108.289 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 157' ' ' MET . 14.5 pt -110.82 117.0 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -156.05 145.02 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.372 0.669 . . . . 0.0 112.322 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.509 1.924 . . . . 0.0 112.003 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.81 5.26 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 121.451 0.643 . . . . 0.0 110.188 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.43 -27.64 19.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.8 1.191 . . . . 0.0 113.039 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 p -145.79 155.27 42.82 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.109 1.364 . . . . 0.0 111.532 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -135.15 162.25 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.1 1.36 . . . . 0.0 110.435 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -72.51 -165.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 127.837 2.455 . . . . 0.0 111.231 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.05 -24.78 26.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.39 -19.62 34.89 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.53 1.062 . . . . 0.0 114.185 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.38 75.19 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.296 1.048 . . . . 0.0 111.81 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -85.67 -7.85 58.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.733 1.613 . . . . 0.0 114.15 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HD23 ' A' ' 17' ' ' LEU . 10.2 tt -63.92 149.94 46.09 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.204 1.002 . . . . 0.0 111.582 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -145.06 145.62 31.52 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.396 1.078 . . . . 0.0 110.528 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -51.77 -37.94 53.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.452 1.101 . . . . 0.0 113.359 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -56.26 -48.51 76.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.416 1.007 . . . . 0.0 112.651 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -52.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.658 1.583 . . . . 0.0 109.238 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.719 HD13 HD23 ' A' ' 21' ' ' LEU . 2.0 tm? -53.42 -41.39 65.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.537 1.535 . . . . 0.0 111.848 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.42 -51.95 67.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.414 1.486 . . . . 0.0 111.216 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -38.32 89.35 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.337 -0.852 . . . . 0.0 112.086 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.89 -51.09 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 110.959 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.891 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.0 pp -67.11 -33.98 76.63 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.52 -23.04 63.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.1 1.36 . . . . 0.0 113.404 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.47 -23.34 49.29 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.648 -1.282 . . . . 0.0 113.471 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 57' ' ' VAL . 3.0 tm? . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 127.162 2.185 . . . . 0.0 112.629 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.67 142.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -175.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -120.9 111.17 17.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.582 1.953 . . . . 0.0 110.722 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 71' ' ' TYR . 2.0 p -127.36 127.12 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.434 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.37 30.56 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.468 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.713 HG21 HD21 ' A' ' 98' ' ' LEU . 2.6 mp -136.85 142.49 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.874 1.27 . . . . 0.0 110.6 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.16 111.7 22.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.052 1.741 . . . . 0.0 111.546 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.88 89.65 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.132 1.773 . . . . 0.0 111.741 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -132.1 7.66 4.32 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.914 0.886 . . . . 0.0 112.684 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t -81.29 -6.98 59.47 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.55 20.02 36.06 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.594 1.092 . . . . 0.0 115.527 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.74 121.56 2.81 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.499 1.523 . . . . 0.0 111.667 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -57.43 144.13 37.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.594 1.558 . . . . 0.0 111.446 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.447 ' HH2' HG22 ' A' ' 35' ' ' ILE . 44.5 m0 -107.66 168.06 9.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.246 0.618 . . . . 0.0 112.547 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.8 m -153.74 105.16 2.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.895 2.078 . . . . 0.0 109.787 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.0 139.4 56.33 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.651 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -110.01 -54.56 2.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.38 1.072 . . . . 0.0 112.349 -176.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -153.53 171.15 19.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.17 0.988 . . . . 0.0 111.187 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 136.23 43.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.153 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -119.16 136.54 54.13 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.883 1.273 . . . . 0.0 110.286 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -161.96 145.26 12.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.643 1.577 . . . . 0.0 112.068 -176.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -115.61 -11.02 11.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.582 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -151.47 137.75 18.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.031 1.732 . . . . 0.0 112.128 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 39.1 3.17 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.017 0.818 . . . . 0.0 114.6 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 m -30.19 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.04 2.936 . . . . 0.0 113.158 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -71.94 162.81 28.91 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.282 -0.886 . . . . 0.0 112.732 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -132.61 5.88 4.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.159 0.983 . . . . 0.0 113.581 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG23 ' CE1' ' A' ' 71' ' ' TYR . 5.8 m -106.33 163.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.051 1.74 . . . . 0.0 112.523 -177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.81 123.44 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.867 1.267 . . . . 0.0 112.856 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.7 130.37 61.55 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -70.21 142.58 46.3 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.844 2.362 . . . . 0.0 109.696 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -85.2 -77.86 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.904 0.882 . . . . 0.0 110.59 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -100.86 149.25 24.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.632 1.173 . . . . 0.0 110.506 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.0 133.34 14.14 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.131 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.11 -151.69 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.257 3.972 . . . . 0.0 113.796 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -119.63 15.76 12.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.076 1.751 . . . . 0.0 113.678 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -141.61 18.24 2.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.882 1.673 . . . . 0.0 113.775 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -136.77 -173.3 3.4 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.974 1.309 . . . . 0.0 113.238 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.87 -178.49 6.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.492 1.517 . . . . 0.0 110.339 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -146.22 160.93 41.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.525 -0.734 . . . . 0.0 111.32 178.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.465 HD11 HD11 ' A' ' 17' ' ' LEU . 5.0 mt -141.39 157.3 45.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.481 1.112 . . . . 0.0 109.562 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CE1' HG23 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -140.67 159.04 43.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.191 1.796 . . . . 0.0 108.593 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.1 m -150.05 140.07 22.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 110.516 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.96 165.07 13.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.028 1.299 . . . . 0.0 114.272 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 113.773 -175.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.6 t -150.35 111.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.988 1.315 . . . . 0.0 113.131 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -140.57 164.61 29.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.228 1.014 . . . . 0.0 112.016 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 124.31 10.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.439 1.096 . . . . 0.0 108.972 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -132.95 160.6 36.6 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.183 0.993 . . . . 0.0 113.186 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -122.51 149.0 44.5 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 29.7 m-85 -127.58 114.41 17.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.827 2.051 . . . . 0.0 110.58 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB2' HD22 ' A' ' 46' ' ' LEU . 18.9 t80 -71.22 116.71 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 111.05 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.98 23.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.016 2.126 . . . . 0.0 111.491 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -19.7 30.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.74 1.65 22.36 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.97 39.64 11.43 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 125.403 1.478 . . . . 0.0 112.09 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.462 HD22 HG21 ' A' ' 119' ' ' ILE . 9.4 p-10 -137.59 170.59 15.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.008 2.523 . . . . 0.0 113.16 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.502 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.9 m -131.7 110.22 10.74 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 35' ' ' ILE . 34.2 tp -73.28 117.35 14.93 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.382 1.073 . . . . 0.0 110.384 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.43 117.16 5.78 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.08 0.847 . . . . 0.0 112.711 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.95 164.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.727 0.811 . . . . 0.0 110.832 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.428 ' HG2' ' H ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -144.05 161.37 38.97 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.243 175.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 14.9 p90 -166.59 160.44 15.15 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.718 1.207 . . . . 0.0 111.565 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 119.85 0.94 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.968 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.35 146.03 56.91 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 N--CA 1.455 -0.779 0 C-N-CA 121.878 1.719 . . . . 0.0 109.712 175.245 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -72.81 143.25 47.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.626 0.77 . . . . 0.0 112.033 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -152.99 151.66 30.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.29 0.636 . . . . 0.0 109.914 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' A' ' 101' ' ' MET . 10.5 t0 -167.52 138.04 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.37 1.468 . . . . 0.0 109.305 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.56 134.21 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.783 1.233 . . . . 0.0 109.187 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HA ' HD11 ' A' ' 151' ' ' LEU . 5.5 tttp -152.41 155.49 37.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.41 1.084 . . . . 0.0 109.497 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.462 HG21 HD22 ' A' ' 96' ' ' ASN . 67.9 mt -109.37 101.72 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.03 99.25 0.63 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.134 -0.979 . . . . 0.0 109.39 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -66.1 87.15 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.231 1.015 . . . . 0.0 110.634 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.33 -134.33 3.32 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.512 2.482 . . . . 0.0 110.321 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -149.99 109.9 4.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.717 1.607 . . . . 0.0 111.33 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -144.53 120.7 10.82 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.223 1.809 . . . . 0.0 112.139 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 174.5 5.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.692 1.197 . . . . 0.0 110.771 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.61 114.47 20.32 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.566 . . . . 0.0 110.043 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.97 -165.85 1.59 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.847 1.659 . . . . 0.0 110.471 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.37 -50.4 30.76 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.971 1.308 . . . . 0.0 110.996 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.52 -27.77 54.79 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.427 1.013 . . . . 0.0 114.609 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.8 ttt -75.59 -61.3 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.041 0.921 . . . . 0.0 110.179 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -53.96 -32.24 53.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.903 1.281 . . . . 0.0 112.665 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.39 -42.97 99.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 107.478 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -30.37 70.2 Favored 'General case' 0 CA--C 1.559 1.315 0 O-C-N 120.769 -1.207 . . . . 0.0 108.034 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.2 mt -75.76 -37.52 59.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.672 1.589 . . . . 0.0 113.879 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -27.93 14.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.421 1.488 . . . . 0.0 114.766 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.4 -40.23 2.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.383 1.473 . . . . 0.0 112.225 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.6 -70.68 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.149 1.833 . . . . 0.0 112.401 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.46 73.38 4.33 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 142.48 63.34 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.997 1.798 . . . . 0.0 112.996 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -122.97 -178.92 4.09 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.898 2.079 . . . . 0.0 109.275 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.73 143.43 50.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.381 1.472 . . . . 0.0 112.472 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.23 101.53 2.8 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.368 1.461 . . . . 0.0 113.446 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.57 19.96 4.26 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 54.92 80.22 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.148 2.179 . . . . 0.0 113.234 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.34 165.84 23.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.029 1.299 . . . . 0.0 113.327 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.467 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 9.2 m95 -68.86 130.1 41.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.066 1.346 . . . . 0.0 111.586 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -139.48 118.8 12.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.63 1.172 . . . . 0.0 113.654 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.88 145.21 30.15 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.274 1.43 . . . . 0.0 109.541 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -143.84 156.39 44.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.9 1.28 . . . . 0.0 109.675 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.31 100.2 13.04 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 7.1 tp -55.94 -31.94 63.38 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.69 30.7 6.7 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 119.302 2.481 . . . . 0.0 119.302 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -131.67 -21.86 2.45 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.96 -15.67 1.74 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 118.666 0.666 . . . . 0.0 114.632 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.26 171.57 13.16 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 126.169 1.788 . . . . 0.0 110.029 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.18 164.44 19.48 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.322 1.049 . . . . 0.0 110.637 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.543 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.2 OUTLIER -143.96 164.15 31.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.464 1.126 . . . . 0.0 112.757 177.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -128.57 125.39 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.227 1.811 . . . . 0.0 108.473 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.96 153.27 17.69 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.533 1.54 . . . . 0.0 112.863 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -129.48 149.73 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.728 1.611 . . . . 0.0 109.687 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.557 ' N ' HD13 ' A' ' 160' ' ' ILE . 6.6 tpt -150.2 119.06 6.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.247 1.819 . . . . 0.0 109.387 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.535 HG23 HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -127.9 122.46 32.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.313 1.845 . . . . 0.0 111.472 -175.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.9 p -87.85 73.61 9.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.885 1.674 . . . . 0.0 112.397 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.45 17.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.227 1.011 . . . . 0.0 113.021 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.87 -7.41 88.0 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.89 1.233 . . . . 0.0 114.459 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -125.53 7.92 7.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.136 2.175 . . . . 0.0 113.721 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -128.59 174.31 9.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.18 1.392 . . . . 0.0 112.575 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.4 OUTLIER -161.42 -178.55 6.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.965 1.706 . . . . 0.0 112.906 -178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.437 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -106.85 151.81 24.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.479 1.911 . . . . 0.0 109.983 178.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.436 ' C ' HD12 ' A' ' 171' ' ' ILE . 28.7 tt0 -162.26 148.1 13.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.269 1.428 . . . . 0.0 108.82 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 170' ' ' GLN . 1.7 mp -123.18 136.24 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.688 0.795 . . . . 0.0 108.94 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -121.46 124.58 44.81 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.296 1.039 . . . . 0.0 108.71 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.543 HG22 ' HB3' ' A' ' 157' ' ' MET . 5.3 pt -94.99 145.53 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.778 0.831 . . . . 0.0 109.51 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.5 t -159.0 170.01 23.03 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.788 -0.57 . . . . 0.0 112.171 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.972 1.709 . . . . 0.0 112.682 177.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 111.239 0.089 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.15 -174.31 0.48 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.578 0.751 . . . . 0.0 110.469 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.36 -31.76 7.12 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.402 -1.436 . . . . 0.0 111.538 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 p -146.39 155.96 42.97 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.543 1.537 . . . . 0.0 110.902 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.496 HG13 HD23 ' A' ' 70' ' ' LEU . 41.7 mm -136.56 166.91 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 126.334 1.854 . . . . 0.0 109.815 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -165.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.731 1.613 . . . . 0.0 111.339 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -51.12 -32.84 23.99 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.96 -14.65 37.45 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.995 1.283 . . . . 0.0 113.8 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.31 63.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.49 1.145 . . . . 0.0 111.291 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -85.71 -9.89 56.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.627 1.571 . . . . 0.0 114.258 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.49 143.2 54.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.454 1.101 . . . . 0.0 110.119 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.2 143.12 24.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.641 0.776 . . . . 0.0 109.959 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.06 -32.6 68.17 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -54.78 -51.06 66.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.452 1.101 . . . . 0.0 113.02 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.03 -52.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.523 HD21 ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -53.18 -39.96 64.02 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.89 1.276 . . . . 0.0 112.432 -175.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -52.22 -63.99 0.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.334 2.254 . . . . 0.0 110.237 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -66.51 -23.01 66.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -46.1 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.702 1.137 . . . . 0.0 111.91 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.29 -26.38 61.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.205 1.002 . . . . 0.0 111.412 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.46 -43.35 49.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.489 1.916 . . . . 0.0 113.861 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -23.57 2.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.977 1.711 . . . . 0.0 114.841 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 127.607 2.363 . . . . 0.0 114.826 175.009 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.561 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -126.03 145.28 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 127.504 2.321 . . . . 0.0 112.335 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -138.46 129.08 26.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 127.195 2.198 . . . . 0.0 111.819 175.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 102' ' ' PHE . 2.4 t -129.43 144.98 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 120.26 1.391 . . . . 0.0 112.033 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.42 174.62 46.41 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.382 0.513 . . . . 0.0 114.382 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.53 HG21 HD21 ' A' ' 98' ' ' LEU . 3.3 mp -140.75 114.73 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.247 1.819 . . . . 0.0 108.61 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.51 106.0 1.32 Allowed 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.403 -1.436 . . . . 0.0 110.966 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . 9.5 t-20 -82.03 92.95 6.88 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 123.519 1.628 . . . . 0.0 112.143 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.81 43.74 1.59 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.391 1.076 . . . . 0.0 110.525 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -2.22 16.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.295 1.838 . . . . 0.0 114.433 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.88 17.06 73.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.569 1.081 . . . . 0.0 115.046 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.19 129.35 5.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.949 1.737 . . . . 0.0 111.422 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -79.18 118.79 21.46 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 117.93 0.865 . . . . 0.0 109.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.683 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 5.9 m0 -88.03 161.66 17.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 m -137.86 107.74 6.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.33 1.852 . . . . 0.0 110.618 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -64.57 156.01 31.24 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.069 -1.02 . . . . 0.0 111.461 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -57.98 1.2 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.098 1.359 . . . . 0.0 112.438 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -147.69 167.99 23.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.285 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.25 137.63 40.97 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.357 1.463 . . . . 0.0 110.705 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.522 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 t80 -126.71 134.08 50.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.246 1.419 . . . . 0.0 110.355 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -142.41 155.47 45.12 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.059 2.144 . . . . 0.0 110.419 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -119.95 -44.23 2.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.277 1.431 . . . . 0.0 111.624 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -121.46 97.36 5.47 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.022 1.329 . . . . 0.0 111.479 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.63 109.34 2.78 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.92 1.247 . . . . 0.0 112.662 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -64.68 179.66 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.575 1.15 . . . . 0.0 113.231 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -65.6 152.89 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.598 1.559 . . . . 0.0 113.141 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -147.25 -21.66 0.39 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.49 164.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.294 2.238 . . . . 0.0 111.954 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 tt -73.59 130.66 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.925 0.89 . . . . 0.0 109.95 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 tp -78.91 128.42 76.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.677 ' CG ' HD12 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -67.59 126.82 15.36 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.782 2.988 . . . . 0.0 111.067 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.55 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.296 -0.878 . . . . 0.0 112.531 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -109.72 143.83 38.96 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.449 1.1 . . . . 0.0 110.389 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.75 86.99 53.69 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.384 1.074 . . . . 0.0 109.192 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.98 136.93 16.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.061 2.507 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -46.94 146.73 1.56 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.786 1.235 . . . . 0.0 112.705 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.327 1.4 p 74.47 32.55 0.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.125 2.17 . . . . 0.0 111.996 -175.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 61.6 mttt -150.4 146.98 27.02 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.013 2.125 . . . . 0.0 110.799 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.65 -177.91 3.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.314 1.046 . . . . 0.0 109.588 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.677 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -155.75 142.8 19.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.529 0.732 . . . . 0.0 110.64 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -113.32 -179.85 3.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.558 0.743 . . . . 0.0 110.433 174.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -159.01 159.33 34.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.905 1.682 . . . . 0.0 109.318 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -138.19 164.01 30.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.069 1.348 . . . . 0.0 110.89 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.94 -179.9 16.46 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.74 1.162 . . . . 0.0 113.398 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 103' ' ' SER . 61.6 t -140.86 123.99 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 127.982 2.513 . . . . 0.0 111.248 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -153.01 177.01 11.25 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.219 1.009 . . . . 0.0 111.875 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.7 125.71 11.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.345 1.458 . . . . 0.0 107.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -136.69 162.65 32.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.046 0.939 . . . . 0.0 110.52 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -133.11 150.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.454 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.3 m-85 -124.88 123.49 40.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.534 1.534 . . . . 0.0 110.758 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.41 109.0 2.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.189 1.796 . . . . 0.0 110.881 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.0 mtp -71.63 155.36 40.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.67 0.788 . . . . 0.0 111.68 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -58.17 -30.46 66.43 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 113.164 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 1.26 11.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.909 1.684 . . . . 0.0 114.687 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.65 9.29 85.82 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.756 -1.215 . . . . 0.0 114.341 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -89.05 178.87 6.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.079 1.752 . . . . 0.0 109.819 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.61 HG22 ' HB1' ' A' ' 89' ' ' ALA . 28.8 m -142.58 110.25 5.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.398 -1.439 . . . . 0.0 111.488 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD21 HG21 ' A' ' 35' ' ' ILE . 27.3 tp -77.09 121.02 22.98 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.67 107.64 3.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.483 1.516 . . . . 0.0 112.857 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.06 168.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 122.273 1.035 . . . . 0.0 111.377 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.446 ' SD ' ' CZ3' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -146.46 157.54 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.606 1.962 . . . . 0.0 109.511 174.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 51.8 p90 -165.08 134.07 3.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.031 1.332 . . . . 0.0 108.374 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 85' ' ' VAL . 37.4 m -147.05 130.61 16.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.116 0.567 . . . . 0.0 110.165 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.3 132.54 42.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.902 -0.571 . . . . 0.0 111.203 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.542 0.881 0 C-N-CA 122.773 2.315 . . . . 0.0 113.038 177.047 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.421 0.629 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CZ3' ' SD ' ' A' ' 101' ' ' MET . 40.8 p-90 -84.38 152.93 23.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.635 0.774 . . . . 0.0 110.358 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -158.97 128.48 5.58 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 109.452 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -177.82 126.73 0.13 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.766 1.227 . . . . 0.0 111.12 -176.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.61 HG11 HG13 ' A' ' 171' ' ' ILE . 5.5 m -118.01 166.74 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.314 1.046 . . . . 0.0 111.927 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.91 158.17 43.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.107 0.963 . . . . 0.0 111.39 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.27 106.7 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.01 1.724 . . . . 0.0 107.195 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.39 99.13 2.87 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.055 -1.028 . . . . 0.0 108.954 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.4 t -65.63 88.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.822 -1.174 . . . . 0.0 110.911 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.47 -141.39 8.85 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.691 2.091 . . . . 0.0 110.633 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -128.81 124.02 34.32 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.956 1.702 . . . . 0.0 111.284 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -149.25 120.03 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.471 1.508 . . . . 0.0 111.383 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.61 170.6 10.43 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.322 0.649 . . . . 0.0 110.633 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.28 115.71 18.19 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.71 -178.4 7.26 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.909 1.284 . . . . 0.0 113.629 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -51.79 -41.04 61.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.349 1.46 . . . . 0.0 113.778 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.93 88.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.091 0.853 . . . . 0.0 112.75 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.7 ttm -64.68 -50.97 64.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.797 0.799 . . . . 0.0 110.437 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -61.11 -34.1 74.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.691 0.797 . . . . 0.0 112.769 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.74 -35.14 79.59 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.784 -1.198 . . . . 0.0 111.532 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -12.71 55.85 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.785 -1.197 . . . . 0.0 113.566 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 mt -91.69 -54.1 4.02 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.336 1.855 . . . . 0.0 109.318 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -75.37 -43.32 50.97 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.84 -35.4 7.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.818 1.247 . . . . 0.0 112.999 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -48.79 -69.33 1.01 Allowed Glycine 0 N--CA 1.47 0.911 0 C-N-CA 125.234 1.397 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -164.47 84.27 1.2 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.994 0.917 . . . . 0.0 111.591 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.78 143.92 38.17 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.914 1.743 . . . . 0.0 113.158 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' ASP . 2.3 m-85 -114.92 -168.57 1.4 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.397 1.479 . . . . 0.0 112.003 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.79 127.82 48.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.72 2.008 . . . . 0.0 111.787 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.85 96.02 0.64 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 125.04 1.305 . . . . 0.0 114.48 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.91 79.65 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.254 1.421 . . . . 0.0 111.748 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.7 p30 35.28 67.27 0.27 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.835 2.454 . . . . 0.0 115.363 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 135.6 3.48 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.374 0.987 . . . . 0.0 113.231 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -64.88 144.89 56.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.333 1.053 . . . . 0.0 111.646 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -145.36 135.67 24.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.556 1.142 . . . . 0.0 112.121 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -119.39 144.82 46.7 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 110.399 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -151.77 163.66 38.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.623 1.169 . . . . 0.0 110.894 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.32 91.78 7.38 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.35 -34.51 47.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.873 1.269 . . . . 0.0 113.871 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 115.58 39.05 0.94 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 118.037 1.975 . . . . 0.0 118.037 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -137.02 -32.78 0.78 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.87 -23.57 1.15 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.149 1.357 . . . . 0.0 114.006 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 173.09 6.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.478 1.911 . . . . 0.0 111.242 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -127.15 160.02 32.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.841 1.256 . . . . 0.0 110.509 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.499 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -145.41 161.34 39.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.366 0.603 . . . . 0.0 111.9 177.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.87 132.01 56.77 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.257 1.423 . . . . 0.0 107.293 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.75 153.79 16.67 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.106 0.86 . . . . 0.0 112.648 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.7 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.46 151.83 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.657 1.183 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 21.1 tpp -147.43 91.88 2.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.656 1.583 . . . . 0.0 109.124 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.7 HG23 HD11 ' A' ' 160' ' ' ILE . 3.1 p -76.5 150.12 36.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 109.852 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 m -44.37 -69.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.312 1.845 . . . . 0.0 115.711 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -176.03 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.933 1.693 . . . . 0.0 112.398 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -47.15 89.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.212 0 C-N-CA 128.102 2.763 . . . . 0.0 115.432 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 45.5 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.078 2.151 . . . . 0.0 112.339 -175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -143.43 159.42 42.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 113.426 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 2.2 mmtm -148.03 173.2 13.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.555 1.542 . . . . 0.0 113.922 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.3 ptm -99.49 154.56 18.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.994 1.717 . . . . 0.0 112.15 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -160.73 157.15 26.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.61 HG13 HG11 ' A' ' 117' ' ' VAL . 45.4 mm -123.64 120.83 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.037 1.335 . . . . 0.0 109.573 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.43 101.64 12.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.407 1.083 . . . . 0.0 110.682 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.683 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 24.8 pt -91.66 133.33 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.134 0.574 . . . . 0.0 110.338 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.1 t -150.61 157.55 43.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.649 1.179 . . . . 0.0 111.386 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.608 1.163 . . . . 0.0 112.268 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.576 0.227 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 170.35 179.23 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.659 3.584 . . . . 0.0 107.759 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.76 -34.6 1.63 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.863 -1.148 . . . . 0.0 113.691 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -135.04 146.43 48.97 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.891 1.346 . . . . 0.0 111.675 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' CD1' HD12 ' A' ' 70' ' ' LEU . 31.0 mm -136.05 177.83 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.278 1.831 . . . . 0.0 109.443 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.32 165.52 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.868 2.067 . . . . 0.0 110.755 176.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . . . -58.13 -28.95 65.14 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.186 -1.571 . . . . 0.0 115.068 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.87 -7.26 3.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.389 1.471 . . . . 0.0 114.108 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 -35.56 63.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.115 1.366 . . . . 0.0 113.848 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -120.73 -2.18 9.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.301 1.441 . . . . 0.0 113.971 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 17' ' ' LEU . 12.7 tp -86.68 133.56 33.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.931 0.892 . . . . 0.0 112.012 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.7 m -144.75 -94.54 0.1 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.213 1.005 . . . . 0.0 110.16 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -158.68 -38.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.679 1.992 . . . . 0.0 110.804 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -52.81 -56.1 18.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.53 -47.16 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.931 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.73 -43.3 68.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.533 1.133 . . . . 0.0 113.314 -176.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.37 -62.08 1.84 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.361 2.264 . . . . 0.0 110.392 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -67.07 -30.46 70.52 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 117.803 -1.094 . . . . 0.0 113.658 176.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -52.26 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.212 1.369 . . . . 0.0 109.453 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -64.63 -33.55 76.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.64 0.376 . . . . 0.0 111.685 -177.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.47 -33.21 58.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 114.763 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -21.59 11.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.596 1.158 . . . . 0.0 113.829 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.727 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HB2' HD12 ' A' ' 21' ' ' LEU . 35.8 mmtt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.37 152.36 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.438 1.895 . . . . 0.0 111.061 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.95 114.72 20.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.131 1.773 . . . . 0.0 108.592 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.4 p -121.75 133.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.449 1.5 . . . . 0.0 110.201 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.67 177.77 38.18 Favored Glycine 0 N--CA 1.454 -0.143 0 O-C-N 121.492 -0.755 . . . . 0.0 112.392 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.1 mp -138.95 146.9 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.247 1.019 . . . . 0.0 110.471 -174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 106.83 19.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.293 1.837 . . . . 0.0 111.474 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.99 98.54 8.65 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.286 1.035 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -138.1 13.07 2.86 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -9.0 59.86 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.06 31.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 130.33 4.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.282 1.42 . . . . 0.0 112.217 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.1 m -62.25 141.51 58.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.94 1.696 . . . . 0.0 111.347 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 46.4 m0 -104.65 170.09 8.08 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.8 m -152.04 107.26 3.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.81 2.044 . . . . 0.0 110.555 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.18 152.33 45.64 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.855 -1.153 . . . . 0.0 109.807 175.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.11 -43.4 2.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.93 0.892 . . . . 0.0 112.357 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.76 -175.47 1.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.826 2.051 . . . . 0.0 110.578 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.45 139.03 18.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.421 . . . . 0.0 110.678 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.88 112.98 24.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.573 1.549 . . . . 0.0 109.174 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.73 150.52 35.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.189 2.195 . . . . 0.0 109.418 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.29 -43.58 2.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 111.089 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -137.32 111.91 8.73 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.029 1.332 . . . . 0.0 111.941 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.39 88.87 1.72 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 124.658 1.123 . . . . 0.0 111.99 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.6 m -81.16 99.17 8.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.229 1.012 . . . . 0.0 110.976 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 71' ' ' TYR . 13.7 t -63.37 166.5 6.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -128.92 -4.01 5.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.848 1.659 . . . . 0.0 113.648 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' CE1' ' A' ' 71' ' ' TYR . 27.6 m -87.8 160.0 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.026 0.931 . . . . 0.0 112.564 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.35 126.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 112.793 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tt -86.33 119.72 71.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.866 1.266 . . . . 0.0 109.36 175.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 127.42 17.13 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 124.111 3.207 . . . . 0.0 111.438 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 2.3 pm0 -79.44 -68.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.341 -0.849 . . . . 0.0 111.078 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.14 143.17 31.56 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.785 -0.572 . . . . 0.0 110.434 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.92 134.08 25.54 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 109.03 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.03 152.3 45.8 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.392 2.728 . . . . 0.0 111.858 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -65.38 17.04 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.856 2.462 . . . . 0.0 116.339 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 3.0 p -149.18 34.41 0.73 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 128.732 2.813 . . . . 0.0 111.162 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -153.46 163.86 39.21 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.414 -1.429 . . . . 0.0 112.201 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.05 175.02 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 111.401 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -144.68 159.74 42.33 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.338 0.655 . . . . 0.0 111.789 175.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.74 ' CD1' HD21 ' A' ' 17' ' ' LEU . 17.7 mt -139.21 158.81 43.52 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.784 1.234 . . . . 0.0 109.179 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -138.29 163.17 32.48 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.933 2.493 . . . . 0.0 108.019 175.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -151.04 178.26 9.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.214 1.806 . . . . 0.0 108.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.46 -177.51 31.62 Favored Glycine 0 N--CA 1.471 0.985 0 O-C-N 121.083 -1.011 . . . . 0.0 113.612 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.138 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -143.75 115.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.368 2.667 . . . . 0.0 111.784 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -160.33 178.98 9.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.916 1.686 . . . . 0.0 110.614 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.28 115.37 3.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.835 1.254 . . . . 0.0 108.24 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -122.68 170.94 9.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.549 1.139 . . . . 0.0 113.031 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -134.44 154.13 51.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 40.8 m-85 -128.11 121.56 29.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.771 2.029 . . . . 0.0 112.376 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -74.03 104.75 4.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.445 1.898 . . . . 0.0 111.945 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 mtp -69.66 151.98 45.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.539 1.536 . . . . 0.0 113.02 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -30.65 65.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.483 1.513 . . . . 0.0 113.624 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -66.07 -13.73 60.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.588 1.155 . . . . 0.0 113.454 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.25 28.58 11.44 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.991 1.281 . . . . 0.0 114.175 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.37 168.75 10.34 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.757 1.623 . . . . 0.0 110.526 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.58 HG22 ' HB1' ' A' ' 89' ' ' ALA . 99.6 m -131.34 102.53 6.0 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.588 -1.32 . . . . 0.0 112.926 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 173' ' ' ILE . 9.9 tp -73.66 124.56 26.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.818 -1.176 . . . . 0.0 112.188 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.07 102.46 2.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.729 1.157 . . . . 0.0 112.226 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.3 p -66.33 171.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.161 0.984 . . . . 0.0 111.955 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 2.3 ttp -144.67 144.78 31.41 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.733 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 28.8 p90 -161.06 142.27 11.68 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -158.15 154.45 27.45 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.074 1.349 . . . . 0.0 110.166 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.3 t -111.35 101.07 49.69 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.455 -0.744 0 C-N-CA 122.89 2.393 . . . . 0.0 111.046 178.338 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -86.49 158.28 19.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.904 0.882 . . . . 0.0 111.908 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.504 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.5 p-90 -160.97 162.13 31.8 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.874 1.27 . . . . 0.0 110.63 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 170.74 139.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.087 2.555 . . . . 0.0 110.511 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.478 HG21 HG13 ' A' ' 171' ' ' ILE . 19.4 t -140.87 122.09 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.663 1.585 . . . . 0.0 108.663 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -127.72 162.37 26.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.491 2.316 . . . . 0.0 109.886 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.495 HG13 HD21 ' A' ' 151' ' ' LEU . 63.6 mt -108.38 121.25 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.895 1.678 . . . . 0.0 108.489 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -84.11 101.99 12.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 t -52.92 139.61 26.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.16 -0.962 . . . . 0.0 111.025 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.04 -118.56 4.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.788 1.185 . . . . 0.0 110.336 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -136.07 137.35 41.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.233 1.813 . . . . 0.0 111.259 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -159.52 117.67 2.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.882 1.273 . . . . 0.0 112.734 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 174.49 4.7 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.919 0.888 . . . . 0.0 111.25 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.54 121.79 31.3 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.799 -0.563 . . . . 0.0 110.004 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.71 177.07 10.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.95 0.9 . . . . 0.0 111.156 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -52.06 -45.35 64.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.002 0.921 . . . . 0.0 112.075 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.93 -50.06 63.37 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.725 0.679 . . . . 0.0 112.685 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.74 -55.97 28.27 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.461 0.63 . . . . 0.0 110.303 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -44.68 36.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 112.608 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 1.4 tt0 -69.36 -33.52 73.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.747 1.619 . . . . 0.0 108.944 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.58 -14.9 2.35 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.113 1.365 . . . . 0.0 113.456 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 101' ' ' MET . 6.1 mp -90.49 -21.73 21.7 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.232 1.413 . . . . 0.0 113.785 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -97.5 -42.57 7.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.446 2.298 . . . . 0.0 113.151 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' A' ' 132' ' ' GLU . 2.2 p90 -115.09 -26.87 7.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.4 -32.12 81.87 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.349 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 176.35 71.16 0.08 OUTLIER Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 130.117 3.367 . . . . 0.0 111.714 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.47 142.32 48.9 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.644 2.229 . . . . 0.0 113.266 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -129.45 177.79 6.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.247 1.819 . . . . 0.0 112.848 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -115.97 125.85 53.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.921 2.088 . . . . 0.0 111.059 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.5 109.89 1.32 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.401 1.477 . . . . 0.0 109.545 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -160.05 89.17 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.436 1.494 . . . . 0.0 110.24 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.81 101.34 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.385 2.674 . . . . 0.0 115.147 174.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.13 134.54 3.33 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.102 1.334 . . . . 0.0 111.686 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 72.4 m95 -64.43 145.43 56.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.713 0.805 . . . . 0.0 112.176 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.19 130.47 19.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 112.743 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 156.92 47.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.055 2.142 . . . . 0.0 111.216 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.6 19.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.021 1.728 . . . . 0.0 111.585 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -64.55 102.22 0.53 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.349 1.46 . . . . 0.0 109.387 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.495 HD21 HG13 ' A' ' 119' ' ' ILE . 3.9 tp -57.94 -39.44 78.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.62 11.43 5.5 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -132.92 -34.11 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.131 1.466 . . . . 0.0 114.456 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 138.65 35.33 0.16 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.893 1.235 . . . . 0.0 113.98 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 156' ' ' ARG . 0.2 OUTLIER -157.82 163.46 37.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 110.591 175.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.574 ' N ' HD12 ' A' ' 155' ' ' LEU . 90.0 mtt180 -136.25 103.82 5.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.333 1.853 . . . . 0.0 112.55 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.688 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -85.09 159.97 20.07 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.159 176.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -122.68 139.1 54.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.767 174.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 171' ' ' ILE . . . -119.18 136.23 11.84 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.403 1.478 . . . . 0.0 113.292 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.9 tp -116.12 138.9 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.166 1.386 . . . . 0.0 111.145 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.1 tpt -121.87 130.98 53.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.427 1.012 . . . . 0.0 109.317 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 47.2 p -137.24 144.12 42.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.444 1.098 . . . . 0.0 110.28 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.3 t -148.33 -174.05 4.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.247 1.419 . . . . 0.0 111.56 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.09 42.26 5.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.789 2.035 . . . . 0.0 113.966 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.83 73.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.906 1.241 . . . . 0.0 112.637 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 35.92 67.07 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.98 2.512 . . . . 0.0 113.866 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -139.12 172.81 12.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.777 0.831 . . . . 0.0 112.822 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.32 171.49 20.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 112.541 -175.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -90.35 142.16 28.01 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.218 1.007 . . . . 0.0 112.048 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -133.13 155.8 48.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.625 1.57 . . . . 0.0 109.827 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.478 HG13 HG21 ' A' ' 117' ' ' VAL . 41.5 mm -123.91 125.41 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.847 1.259 . . . . 0.0 110.181 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -108.06 115.99 31.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.913 1.285 . . . . 0.0 110.113 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.688 HG22 ' HB3' ' A' ' 157' ' ' MET . 15.1 pt -96.42 129.76 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 0.0 110.157 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.5 m -171.65 172.09 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.025 1.33 . . . . 0.0 111.566 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.487 1.115 . . . . 0.0 113.008 178.072 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.427 ' HB3' HG22 ' A' ' 20' ' ' VAL . 3.1 mm? . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.42 -59.87 2.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.35 -36.84 0.16 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 126.786 2.136 . . . . 0.0 117.517 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.2 p -138.16 151.75 48.04 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 110.918 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 70' ' ' LEU . 25.0 mm -132.71 162.42 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.457 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 pt -70.36 -169.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.554 1.942 . . . . 0.0 110.409 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.33 -22.08 17.72 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.79 11.43 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.623 1.106 . . . . 0.0 113.714 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.86 83.82 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.284 1.042 . . . . 0.0 111.856 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -80.74 -9.61 59.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.859 1.264 . . . . 0.0 113.698 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 17' ' ' LEU . 1.2 tt -64.4 159.23 21.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.748 1.219 . . . . 0.0 112.636 175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.51 145.88 27.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.867 0.867 . . . . 0.0 109.846 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -56.32 -30.89 63.15 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -58.3 -52.96 63.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.061 0.944 . . . . 0.0 112.371 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.91 -46.56 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -51.82 -40.65 60.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.425 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.07 -58.04 9.26 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.382 1.473 . . . . 0.0 112.116 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -23.78 61.51 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -66.85 -44.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.087 1.312 . . . . 0.0 111.227 -178.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -74.5 -28.96 61.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.142 0.977 . . . . 0.0 112.189 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.14 -39.25 34.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.142 1.377 . . . . 0.0 112.185 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -48.32 -24.82 1.32 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.716 2.406 . . . . 0.0 113.263 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.503 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 6.5 tt . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 126.287 1.835 . . . . 0.0 111.689 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.62 139.13 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.004 0.921 . . . . 0.0 112.917 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 70' ' ' LEU . . . -127.01 101.67 6.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.481 1.512 . . . . 0.0 113.462 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -107.81 118.24 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 120.259 -1.526 . . . . 0.0 109.695 174.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.86 155.56 23.82 Favored Glycine 0 N--CA 1.46 0.293 0 O-C-N 121.924 -0.485 . . . . 0.0 113.006 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.9 mp -133.81 99.46 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.532 0.733 . . . . 0.0 111.637 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.36 102.99 0.26 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.878 1.271 . . . . 0.0 111.655 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -90.72 106.18 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.735 0.778 . . . . 0.0 112.877 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.266 31.3 tt0 -150.7 19.54 0.81 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.02 0.914 . . . . 0.0 111.278 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -5.1 20.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.258 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.76 17.44 51.9 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.525 1.536 . . . . 0.0 114.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.55 115.26 0.85 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.815 1.674 . . . . 0.0 111.377 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.7 m -55.52 148.53 15.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.066 1.347 . . . . 0.0 111.466 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 10.8 m0 -119.72 172.51 7.64 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.572 -0.705 . . . . 0.0 112.63 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -136.15 113.22 10.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.063 2.145 . . . . 0.0 111.458 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -70.22 105.65 3.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.839 0.856 . . . . 0.0 110.648 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -66.26 -56.83 9.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.056 175.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.402 ' ND2' HH11 ' A' ' 125' ' ' ARG . 42.8 t30 -167.48 172.4 9.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.792 1.637 . . . . 0.0 111.549 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.65 135.41 34.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.78 2.032 . . . . 0.0 111.412 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.443 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.9 t80 -119.13 129.02 54.81 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.715 1.606 . . . . 0.0 110.107 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -138.72 126.28 21.93 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.36 2.264 . . . . 0.0 110.041 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.45 -16.92 19.95 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.202 1.401 . . . . 0.0 110.888 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -76.37 102.56 5.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.36 1.064 . . . . 0.0 110.151 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.94 -118.83 11.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.423 1.487 . . . . 0.0 113.654 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -136.72 -172.71 3.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.937 1.695 . . . . 0.0 111.148 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.517 HG23 ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -80.96 167.17 20.13 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.574 1.949 . . . . 0.0 112.36 174.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -144.96 -45.55 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.87 0.868 . . . . 0.0 110.834 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.86 156.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.553 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.31 142.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.926 1.29 . . . . 0.0 111.134 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.68 128.96 41.98 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.412 1.085 . . . . 0.0 110.0 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.58 116.52 3.83 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 124.636 3.557 . . . . 0.0 112.033 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.45 -33.82 63.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -124.08 150.91 44.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.103 0.961 . . . . 0.0 112.188 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.8 t -138.64 96.12 9.69 Favored Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 124.876 1.27 . . . . 0.0 108.239 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 171.75 14.56 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.238 1.959 . . . . 0.0 111.421 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -64.82 174.98 1.63 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.665 -0.647 . . . . 0.0 110.615 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 14.6 t 49.15 24.66 0.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.56 1.544 . . . . 0.0 113.783 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -151.77 130.12 12.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.709 2.004 . . . . 0.0 110.826 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.29 -173.67 2.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.652 1.215 . . . . 0.0 109.643 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.33 162.46 40.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.606 1.162 . . . . 0.0 109.835 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.62 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -131.78 166.35 21.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.566 1.174 . . . . 0.0 108.162 174.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.603 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.2 t80 -151.85 161.13 43.15 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.134 1.373 . . . . 0.0 107.95 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.503 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 49.5 m -155.42 146.03 22.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.12 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.84 -161.57 36.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.782 0.706 . . . . 0.0 111.774 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.193 1.397 . . . . 0.0 111.025 178.045 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -147.63 135.17 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.732 2.013 . . . . 0.0 113.367 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.51 170.77 21.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.32 1.448 . . . . 0.0 110.803 174.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.06 114.98 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.226 1.41 . . . . 0.0 109.431 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -126.91 167.11 16.29 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.447 1.099 . . . . 0.0 112.24 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -126.54 154.15 44.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.12 0.568 . . . . 0.0 111.267 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -133.57 109.88 9.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.969 1.308 . . . . 0.0 113.337 -175.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -71.1 96.34 1.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.705 1.602 . . . . 0.0 111.03 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 151.7 45.09 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.836 -1.165 . . . . 0.0 111.339 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -16.36 15.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -70.34 1.33 5.06 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.657 1.983 . . . . 0.0 113.658 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.92 19.03 71.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.026 1.298 . . . . 0.0 114.013 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -121.3 175.81 5.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.035 1.734 . . . . 0.0 110.382 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.594 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 97.2 m -137.32 102.26 4.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.249 1.02 . . . . 0.0 112.956 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 35' ' ' ILE . 20.5 tp -69.12 115.8 8.83 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.441 -0.787 . . . . 0.0 110.339 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.99 111.9 3.96 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.7 151.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.415 1.086 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.675 ' HB2' HD13 ' A' ' 134' ' ' LEU . 12.1 tmm? -138.63 148.75 44.46 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.38 1.072 . . . . 0.0 110.002 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.7 p90 -157.21 159.57 37.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -164.46 150.57 10.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.1 t -108.73 98.59 29.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.537 0.666 0 C-N-CA 121.588 1.526 . . . . 0.0 110.794 175.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 121.572 0.701 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -84.45 135.73 34.14 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.361 1.064 . . . . 0.0 113.128 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -151.4 125.56 9.3 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.128 0.971 . . . . 0.0 109.733 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.02 150.23 11.25 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.967 -1.083 . . . . 0.0 111.999 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.9 143.34 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.049 1.74 . . . . 0.0 110.138 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -135.47 126.48 27.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.42 1.488 . . . . 0.0 109.144 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.8 mt -93.27 100.04 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.237 1.015 . . . . 0.0 109.316 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -68.41 100.98 1.15 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.845 -1.159 . . . . 0.0 109.406 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 80.64 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.723 1.209 . . . . 0.0 111.132 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.35 -106.75 0.29 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.317 2.389 . . . . 0.0 111.22 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -156.56 150.3 24.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.369 1.868 . . . . 0.0 111.553 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -164.96 106.82 0.82 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.236 1.415 . . . . 0.0 113.877 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -59.43 153.4 19.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.368 1.067 . . . . 0.0 111.182 174.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -72.44 113.96 10.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.741 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.39 -175.76 5.21 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.633 1.173 . . . . 0.0 111.471 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.0 -46.07 68.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.408 -1.432 . . . . 0.0 111.909 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.2 -31.59 62.38 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.555 1.074 . . . . 0.0 113.767 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' HD11 ' A' ' 134' ' ' LEU . 12.6 tpt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -48.11 -39.46 20.5 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.432 1.093 . . . . 0.0 112.453 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.36 -42.17 96.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.203 1.001 . . . . 0.0 111.598 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.84 68.51 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.288 -1.508 . . . . 0.0 113.462 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 101' ' ' MET . 51.3 mt -90.24 -7.85 52.48 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.06 -27.31 3.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.45 1.5 . . . . 0.0 114.116 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.49 -37.11 3.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.729 1.212 . . . . 0.0 111.706 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.27 -67.53 1.33 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.229 1.871 . . . . 0.0 113.168 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.53 67.88 0.29 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.822 1.649 . . . . 0.0 113.429 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.66 173.02 15.21 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.938 1.759 . . . . 0.0 115.207 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.92 173.18 10.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.163 1.785 . . . . 0.0 112.972 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -115.8 137.61 51.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.724 2.01 . . . . 0.0 112.042 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -138.1 116.65 1.34 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.722 1.153 . . . . 0.0 111.541 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -126.25 69.95 1.23 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.74 94.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.13 2.572 . . . . 0.0 113.898 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.01 139.74 2.75 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.753 1.644 . . . . 0.0 111.49 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -70.25 127.44 32.78 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -129.53 146.29 51.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.589 1.156 . . . . 0.0 111.634 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -142.33 137.77 30.78 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.452 1.501 . . . . 0.0 110.362 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 158.33 43.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.713 1.205 . . . . 0.0 110.892 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 94.08 1.02 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.714 1.206 . . . . 0.0 109.553 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tp -51.53 -36.33 44.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.329 1.451 . . . . 0.0 113.752 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 120.38 33.97 0.98 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.11 -32.28 0.79 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.07 -28.3 0.9 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.987 1.28 . . . . 0.0 114.344 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 175.14 5.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.824 2.05 . . . . 0.0 112.541 175.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -118.19 145.38 45.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.222 1.009 . . . . 0.0 112.164 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.615 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -121.88 147.7 45.66 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 130.89 53.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.426 1.89 . . . . 0.0 107.851 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -123.11 155.16 17.26 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 122.149 0.861 . . . . 0.0 112.951 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.1 131.02 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.067 1.747 . . . . 0.0 108.505 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.1 tpp -126.42 103.31 7.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.403 0.547 . . . . 0.0 109.529 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 68.9 p -98.73 141.32 31.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.142 1.377 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 89.58 1.2 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.47 -0.769 . . . . 0.0 111.812 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.18 30.23 0.17 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.701 1.2 . . . . 0.0 114.083 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.85 134.12 1.76 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.888 1.232 . . . . 0.0 112.419 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 43.45 59.82 2.86 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.439 1.496 . . . . 0.0 112.576 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -137.56 163.43 31.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.925 1.29 . . . . 0.0 112.024 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 47.6 tptt -163.26 144.85 9.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.5 ptm -77.61 160.49 28.5 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.157 1.783 . . . . 0.0 113.927 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -154.21 160.93 42.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.173 1.789 . . . . 0.0 109.477 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.7 mm -131.84 113.99 23.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 C-N-CA 125.126 1.37 . . . . 0.0 109.692 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -110.63 139.82 45.54 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.72 0.808 . . . . 0.0 110.891 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' A' ' 157' ' ' MET . 10.2 pt -120.95 132.68 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.715 0.806 . . . . 0.0 109.731 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.2 p -148.05 161.47 41.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.329 . . . . 0.0 112.846 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.429 ' HB3' HG13 ' A' ' 20' ' ' VAL . 3.8 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 117.748 -1.12 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.7 -49.33 4.25 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.555 1.07 . . . . 0.0 113.266 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.56 -33.15 1.42 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.53 1.538 . . . . 0.0 116.694 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.1 p -138.61 146.57 41.91 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.445 2.122 . . . . 0.0 111.972 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.41 161.44 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.781 -1.2 . . . . 0.0 108.817 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 7' ' ' ILE . 4.7 pt -75.05 177.55 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.487 1.915 . . . . 0.0 111.858 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.45 16.34 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.02 -18.18 40.18 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.148 1.356 . . . . 0.0 112.674 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.59 70.04 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.642 1.577 . . . . 0.0 113.632 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -112.32 -2.59 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.892 1.677 . . . . 0.0 113.311 174.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD11 HD23 ' A' ' 17' ' ' LEU . 20.3 tp -78.76 148.84 32.83 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.338 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.91 146.83 27.29 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 0.0 110.047 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.39 -34.66 66.92 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.006 0.821 . . . . 0.0 112.763 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -59.43 -56.26 24.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.671 1.189 . . . . 0.0 113.018 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.25 -45.87 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.303 0.641 . . . . 0.0 111.026 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 12' ' ' LEU . 2.7 tm? -55.22 -38.7 68.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.183 0.993 . . . . 0.0 111.95 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -52.25 -57.65 9.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.258 1.823 . . . . 0.0 111.705 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.05 60.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 176.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 2' ' ' LEU . 8.0 t -65.82 -49.17 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.762 1.164 . . . . 0.0 110.838 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -67.0 -21.76 65.93 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -24.84 22.84 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -20.03 62.56 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.282 1.033 . . . . 0.0 113.595 -175.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD11 ' HD2' ' A' ' 30' ' ' LYS . 3.2 pp . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 124.843 1.257 . . . . 0.0 114.031 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.675 ' HD2' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.95 0.405 . . . . 0.0 111.673 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -127.22 143.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.163 1.385 . . . . 0.0 111.491 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.614 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -121.98 100.22 6.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.592 1.957 . . . . 0.0 111.778 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.5 p -110.34 127.09 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.538 1.135 . . . . 0.0 109.918 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.19 157.7 26.8 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.964 -0.636 . . . . 0.0 114.278 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.66 121.97 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.185 0.994 . . . . 0.0 110.229 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -74.1 105.12 5.17 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.363 -0.835 . . . . 0.0 110.689 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.62 91.95 4.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.223 1.809 . . . . 0.0 113.447 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.33 21.27 2.4 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.996 0.903 . . . . 0.0 112.392 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -7.07 54.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.698 1.599 . . . . 0.0 114.924 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.86 18.44 65.46 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.046 -1.034 . . . . 0.0 114.66 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.6 127.77 5.14 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.214 1.864 . . . . 0.0 110.736 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.3 m -69.4 131.01 44.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.73 0.765 . . . . 0.0 110.527 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.669 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 14.9 m0 -96.75 162.47 13.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.136 0.493 . . . . 0.0 111.954 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -138.83 107.46 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 127.1 2.16 . . . . 0.0 109.617 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 150.64 47.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.259 -0.9 . . . . 0.0 110.711 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -121.22 -54.67 1.99 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.559 1.144 . . . . 0.0 111.993 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -156.92 172.22 19.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.974 0.91 . . . . 0.0 111.667 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.34 140.08 35.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.958 1.303 . . . . 0.0 111.841 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 t80 -118.65 127.44 53.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 109.659 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.4 119.56 39.82 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.217 1.807 . . . . 0.0 107.627 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -11.78 49.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.235 0.541 . . . . 0.0 111.295 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.01 114.25 7.43 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 108.961 -175.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.71 -165.88 53.87 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.228 0.918 . . . . 0.0 113.679 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 t -119.41 -170.75 1.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.665 1.586 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 163.06 22.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.709 1.604 . . . . 0.0 111.695 174.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.438 ' OD2' HD13 ' A' ' 24' ' ' LEU . 19.1 t70 -141.31 -44.46 0.37 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.093 0.957 . . . . 0.0 111.824 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.68 164.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.726 2.01 . . . . 0.0 111.421 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 tt -77.51 134.76 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.37 1.068 . . . . 0.0 112.032 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.83 128.98 52.2 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.148 0.979 . . . . 0.0 110.285 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.663 ' HG2' HD12 ' A' ' 69' ' ' LEU . 52.9 Cg_endo -64.89 115.35 3.21 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 124.562 3.508 . . . . 0.0 112.14 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -62.65 -48.0 81.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -115.4 153.5 30.94 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.189 0.995 . . . . 0.0 111.577 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.75 88.87 13.59 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.434 1.094 . . . . 0.0 108.754 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.81 143.36 29.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.023 2.482 . . . . 0.0 111.336 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -48.88 153.98 0.78 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.526 1.13 . . . . 0.0 112.697 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 p 63.9 46.86 3.71 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.638 1.575 . . . . 0.0 110.047 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 68' ' ' ALA . 17.4 ttmt -155.52 172.01 18.97 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.503 1.521 . . . . 0.0 111.09 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' H ' ' HG2' ' A' ' 67' ' ' LYS . . . -142.23 -176.67 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 108.77 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -163.5 144.98 9.38 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.34 -0.85 . . . . 0.0 110.619 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.489 ' CD1' HD21 ' A' ' 17' ' ' LEU . 5.2 mt -117.36 170.15 8.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.893 1.33 . . . . 0.0 108.496 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.6 t80 -152.31 160.31 43.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.162 1.385 . . . . 0.0 107.708 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -147.38 148.12 31.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.832 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.8 -170.91 37.17 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.752 0.691 . . . . 0.0 112.165 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 125.853 1.661 . . . . 0.0 111.673 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -150.07 118.75 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.808 1.243 . . . . 0.0 112.946 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.42 160.0 43.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.529 1.532 . . . . 0.0 110.127 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' HB3' ' CE ' ' A' ' 130' ' ' MET . . . -146.32 135.57 22.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -143.28 168.78 18.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 111.406 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -123.99 150.32 44.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.736 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -130.93 115.3 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.64 1.576 . . . . 0.0 110.373 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.446 ' HB2' HD22 ' A' ' 46' ' ' LEU . 12.3 t80 -73.7 104.08 4.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.382 1.473 . . . . 0.0 111.291 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -71.71 158.27 36.43 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.135 -0.978 . . . . 0.0 112.63 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -58.5 -24.97 61.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.831 1.252 . . . . 0.0 113.732 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 t -73.72 -3.24 27.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.998 1.319 . . . . 0.0 113.948 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.48 17.67 72.96 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.416 1.008 . . . . 0.0 114.265 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -102.83 163.18 12.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.594 1.558 . . . . 0.0 110.683 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.61 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 86.8 m -127.58 102.74 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.55 0.74 . . . . 0.0 112.982 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 173' ' ' ILE . 27.1 tp -71.72 116.45 12.11 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.418 -0.801 . . . . 0.0 110.855 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.09 104.16 3.1 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.306 1.431 . . . . 0.0 111.024 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.78 160.59 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 156.51 45.52 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.036 1.334 . . . . 0.0 110.261 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 33' ' ' VAL . 10.7 p90 -166.96 155.25 9.83 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.501 1.521 . . . . 0.0 110.893 175.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.92 124.17 1.81 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.369 1.468 . . . . 0.0 110.38 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.1 t -81.73 131.99 56.0 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 122.501 2.134 . . . . 0.0 111.922 175.33 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.753 0.787 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -97.8 159.38 14.97 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -161.98 153.26 18.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.993 1.317 . . . . 0.0 109.494 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -174.47 104.18 0.1 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.122 1.369 . . . . 0.0 111.311 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.08 132.06 45.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.736 1.214 . . . . 0.0 108.507 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -140.48 160.98 38.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.118 1.367 . . . . 0.0 110.021 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 93.3 mt -118.65 112.5 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.498 1.519 . . . . 0.0 109.171 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.41 100.69 6.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -56.12 121.89 10.45 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.95 -1.094 . . . . 0.0 108.977 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.67 -140.46 15.41 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -128.41 132.09 48.48 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.391 1.476 . . . . 0.0 112.613 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -160.01 124.04 3.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.519 1.527 . . . . 0.0 112.238 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -179.28 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 111.459 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -87.83 109.19 19.57 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.842 -0.536 . . . . 0.0 111.154 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.89 -172.22 4.06 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 111.473 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.84 -47.51 31.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.893 0.877 . . . . 0.0 111.496 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.18 -47.44 55.3 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.402 1.001 . . . . 0.0 114.088 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.41 ' CE ' ' HB3' ' A' ' 87' ' ' ALA . 3.1 ttp -65.75 -52.23 52.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 111.276 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -56.31 -37.33 69.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.77 0.795 . . . . 0.0 112.767 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.42 -47.41 79.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.876 2.07 . . . . 0.0 110.049 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -26.98 69.08 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.696 1.135 . . . . 0.0 113.677 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mp -70.4 -49.19 51.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.955 1.302 . . . . 0.0 112.909 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.27 -29.54 13.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.24 -26.59 8.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.981 1.312 . . . . 0.0 112.156 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -63.83 4.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.449 1.5 . . . . 0.0 111.278 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -174.3 80.29 0.35 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.877 2.071 . . . . 0.0 111.331 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.22 154.2 66.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.134 1.89 . . . . 0.0 111.511 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -120.41 -164.58 1.11 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.576 1.95 . . . . 0.0 111.041 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.75 131.37 46.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.805 2.442 . . . . 0.0 111.509 -175.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -142.34 115.38 0.95 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.863 1.697 . . . . 0.0 111.054 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.78 -55.02 2.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 84.99 0.14 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 120.323 1.419 . . . . 0.0 111.398 174.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.26 163.86 24.01 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 122.0 0.778 . . . . 0.0 114.687 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.461 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 59.5 m95 -82.1 145.44 30.16 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.002 1.721 . . . . 0.0 111.983 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -161.12 123.42 3.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.217 1.407 . . . . 0.0 112.154 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.6 154.95 18.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.837 1.655 . . . . 0.0 111.651 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 145.81 24.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.794 1.237 . . . . 0.0 110.052 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -72.82 93.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -51.96 -36.88 50.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.085 1.354 . . . . 0.0 113.841 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.15 40.22 2.14 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.97 -32.48 0.96 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.73 -34.36 0.68 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.739 1.161 . . . . 0.0 113.548 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.31 172.63 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.168 1.787 . . . . 0.0 111.998 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -127.04 165.17 19.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.607 1.163 . . . . 0.0 110.603 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.59 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -152.48 163.6 39.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 174.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 146' ' ' TRP . 6.3 tptt -119.99 127.29 52.48 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.504 1.522 . . . . 0.0 108.153 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.36 146.76 17.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.815 0.721 . . . . 0.0 111.879 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.503 ' CD1' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -124.95 131.15 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 125.085 1.354 . . . . 0.0 109.313 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 125.89 36.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.07 0.85 . . . . 0.0 108.755 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.503 HG23 ' CD1' ' A' ' 160' ' ' ILE . 19.8 p -126.1 137.5 53.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.05 1.74 . . . . 0.0 111.783 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.6 p -129.93 128.93 43.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.111 2.164 . . . . 0.0 110.765 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.56 -54.4 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.412 1.885 . . . . 0.0 111.365 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.13 -49.08 0.2 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.735 1.16 . . . . 0.0 113.715 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.74 28.53 8.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.915 1.686 . . . . 0.0 112.778 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB1' ' OG1' ' A' ' 162' ' ' THR . . . -118.55 159.67 23.14 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.276 1.43 . . . . 0.0 113.78 -174.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.7 OUTLIER -150.92 168.91 23.07 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.46 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 7.1 ttp -102.78 138.07 40.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.729 1.612 . . . . 0.0 111.262 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -137.3 150.83 48.05 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.57 1.148 . . . . 0.0 109.689 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.408 HG23 ' SD ' ' A' ' 157' ' ' MET . 42.1 mm -126.23 124.35 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.106 0.962 . . . . 0.0 109.286 -175.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -112.96 106.96 15.34 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.029 -1.045 . . . . 0.0 110.439 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.669 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 17.3 pt -92.9 125.91 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.783 0.833 . . . . 0.0 109.933 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.2 p -155.59 149.36 25.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.219 1.808 . . . . 0.0 112.952 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.01 128.67 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.717 1.607 . . . . 0.0 111.918 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.67 -15.05 9.79 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.42 1.962 . . . . 0.0 113.597 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p -167.37 162.79 14.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.149 2.58 . . . . 0.0 109.213 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 70' ' ' LEU . 47.0 mt -140.24 172.56 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.557 1.143 . . . . 0.0 109.021 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -83.78 -162.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 125.77 1.628 . . . . 0.0 110.317 174.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.7 60.2 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.4 -25.63 12.09 Favored Glycine 0 N--CA 1.488 2.13 0 O-C-N 123.951 0.782 . . . . 0.0 112.698 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.02 63.36 Favored 'General case' 0 CA--C 1.59 2.519 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -96.24 -3.76 43.57 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.571 1.548 . . . . 0.0 114.267 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.16 139.41 58.13 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.303 -0.873 . . . . 0.0 108.926 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.51 141.03 20.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.244 0.618 . . . . 0.0 110.403 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -55.75 -32.28 63.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -57.45 -49.06 77.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.746 1.218 . . . . 0.0 111.8 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -69.88 -50.42 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.476 1.11 . . . . 0.0 109.375 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -55.13 -32.7 62.29 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.26 -61.28 2.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.201 1.8 . . . . 0.0 109.976 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -40.4 86.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.429 1.492 . . . . 0.0 112.677 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.16 -50.62 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.289 1.436 . . . . 0.0 111.613 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -73.43 -35.24 65.76 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.1 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.36 -30.93 69.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.429 1.491 . . . . 0.0 113.267 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -55.78 -28.79 57.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.543 1.137 . . . . 0.0 113.633 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 123.907 0.883 . . . . 0.0 111.991 177.272 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.644 ' CB ' HD11 ' A' ' 21' ' ' LEU . 2.7 pttm . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.485 HG23 ' HA ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.73 151.19 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.057 . . . . 0.0 110.852 178.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -141.15 101.99 4.14 Favored 'General case' 0 CA--C 1.573 1.837 0 C-N-CA 126.295 1.838 . . . . 0.0 111.317 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.466 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.4 p -114.78 132.92 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.306 1.442 . . . . 0.0 110.087 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.3 165.32 38.36 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -140.45 119.79 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.979 1.311 . . . . 0.0 112.378 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.75 115.91 7.84 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 121.381 -0.825 . . . . 0.0 111.08 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -96.05 85.32 4.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.482 175.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.96 13.67 5.76 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -76.27 -13.26 60.16 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 14.59 43.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.627 1.108 . . . . 0.0 115.437 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.33 126.09 3.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.387 1.47 . . . . 0.0 112.813 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.5 m -64.32 140.92 58.92 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.066 1.346 . . . . 0.0 111.253 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 17.8 m0 -106.57 171.95 7.08 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -150.55 110.82 4.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.134 1.773 . . . . 0.0 111.871 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.01 58.06 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 120.979 -1.076 . . . . 0.0 110.222 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.59 -46.26 4.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.397 0.679 . . . . 0.0 112.186 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.93 173.7 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.356 1.063 . . . . 0.0 111.244 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.03 128.77 23.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.105 0.962 . . . . 0.0 112.949 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.82 117.14 33.32 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.842 1.657 . . . . 0.0 110.32 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 7.1 m-85 -116.92 129.95 56.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.076 1.75 . . . . 0.0 109.343 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.56 4.65 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -152.96 92.51 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.794 1.238 . . . . 0.0 110.215 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.07 19.33 0.28 Allowed Glycine 0 N--CA 1.475 1.28 0 N-CA-C 117.474 1.75 . . . . 0.0 117.474 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -40.04 113.77 0.38 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.143 2.177 . . . . 0.0 113.188 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.681 HG21 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 t -66.21 -179.67 0.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.783 1.633 . . . . 0.0 115.312 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.12 -9.71 3.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.077 1.751 . . . . 0.0 114.033 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -87.69 166.45 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.326 1.05 . . . . 0.0 112.581 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 tt -68.93 130.13 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.469 1.108 . . . . 0.0 112.63 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 60' ' ' PRO . 41.1 tp -84.41 117.47 68.81 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.495 0.718 . . . . 0.0 109.769 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.627 ' CG ' HD12 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -69.03 119.96 6.9 Favored 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 122.758 2.305 . . . . 0.0 109.741 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.39 -64.25 1.2 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.935 0.894 . . . . 0.0 112.515 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -96.75 151.53 19.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.669 0.788 . . . . 0.0 109.963 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 132.93 9.63 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.007 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -71.55 -150.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 125.102 3.868 . . . . 0.0 112.914 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.96 15.13 9.25 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.939 1.696 . . . . 0.0 114.287 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -142.06 30.44 1.61 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.306 1.442 . . . . 0.0 112.752 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -146.1 -175.96 4.96 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.678 1.191 . . . . 0.0 113.077 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.26 173.78 11.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.112 1.365 . . . . 0.0 107.472 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.627 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -150.61 148.97 29.28 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.855 -1.153 . . . . 0.0 111.287 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.24 162.13 26.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.861 0.864 . . . . 0.0 111.266 177.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 55' ' ' THR . 1.0 OUTLIER -141.38 163.52 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.272 1.429 . . . . 0.0 110.001 174.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 31' ' ' ILE . 55.1 m -135.77 -166.53 1.87 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.4 1.48 . . . . 0.0 110.383 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.4 178.29 33.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.367 -0.833 . . . . 0.0 113.461 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 124.227 1.011 . . . . 0.0 112.481 -175.901 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.48 113.94 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.898 1.279 . . . . 0.0 113.216 -175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . . . -155.51 170.97 20.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 111.094 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.52 124.12 7.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.661 1.584 . . . . 0.0 108.757 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -128.49 163.8 24.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.661 1.184 . . . . 0.0 112.055 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -121.97 142.88 49.86 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -122.42 113.97 20.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.982 2.113 . . . . 0.0 111.151 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.42 108.32 2.33 Favored 'General case' 0 N--CA 1.382 -3.828 0 C-N-CA 124.836 1.255 . . . . 0.0 112.625 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.1 mtp -73.08 155.09 40.09 Favored 'General case' 0 CA--C 1.627 3.906 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -58.95 -23.62 61.75 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.61 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -67.98 -9.19 43.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.895 2.078 . . . . 0.0 114.178 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 8.06 68.71 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.71 1.148 . . . . 0.0 114.794 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.5 175.41 5.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.028 1.731 . . . . 0.0 110.412 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 89' ' ' ALA . 91.8 m -130.84 104.06 6.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.963 -1.086 . . . . 0.0 112.314 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.649 HD22 HD13 ' A' ' 173' ' ' ILE . 47.2 tp -69.39 119.07 13.09 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 120.994 -1.066 . . . . 0.0 110.79 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 104.55 3.18 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.621 1.105 . . . . 0.0 111.065 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.15 162.46 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.211 0.529 . . . . 0.0 111.322 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.79 149.78 30.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.013 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CE2' HG11 ' A' ' 33' ' ' VAL . 45.3 p90 -154.85 154.24 32.4 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.097 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -160.15 157.36 28.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.668 1.587 . . . . 0.0 107.377 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.4 t -121.82 95.33 47.84 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 121.327 -0.858 . . . . 0.0 109.211 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 C-N-CA 121.9 1.733 . . . . 0.0 111.802 -178.146 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 123.346 1.546 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -91.91 158.06 16.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.436 1.495 . . . . 0.0 112.377 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -165.1 126.79 2.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 110.064 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.98 91.07 1.02 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.33 150.8 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.538 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -142.97 135.07 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.241 1.416 . . . . 0.0 108.733 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 155' ' ' LEU . 52.3 mt -100.12 103.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.268 1.027 . . . . 0.0 109.651 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -69.91 96.73 1.04 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.7 t -63.63 99.68 0.24 Allowed 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.79 -124.02 3.16 Favored Glycine 0 CA--C 1.578 3.986 0 N-CA-C 104.518 -3.433 . . . . 0.0 104.518 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -141.85 116.54 9.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.854 0.827 . . . . 0.0 111.969 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -134.73 111.88 10.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.51 1.124 . . . . 0.0 112.996 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 167.3 5.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.608 1.163 . . . . 0.0 110.781 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.17 119.54 31.36 Favored 'General case' 1 N--CA 1.336 -6.145 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . 0.259 2.0 t70 -165.59 -177.04 4.19 Favored 'General case' 0 N--CA 1.522 3.153 0 O-C-N 127.602 3.064 . . . . 0.0 104.185 -163.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.46 -47.95 48.0 Favored 'General case' 1 CA--C 1.632 4.111 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.116 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.26 -31.46 34.56 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 121.849 2.113 . . . . 0.0 113.383 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.8 ttt -72.75 -58.56 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.386 0.674 . . . . 0.0 110.498 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -57.5 -31.18 65.76 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.82 -44.38 96.29 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.31 1.444 . . . . 0.0 109.704 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.47 -2.41 4.62 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.05 0.94 . . . . 0.0 113.471 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.7 mt -102.05 -45.87 5.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.662 1.585 . . . . 0.0 111.989 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -93.57 -23.4 18.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -121.25 -1.65 9.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.621 1.569 . . . . 0.0 111.974 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -121.98 72.91 0.37 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.591 2.043 . . . . 0.0 113.185 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.3 m120 73.58 68.66 0.27 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 127.005 2.122 . . . . 0.0 112.503 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.25 114.78 3.17 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.369 2.713 . . . . 0.0 111.749 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -124.78 162.59 23.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.42 1.888 . . . . 0.0 111.598 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.9 mtm105 -145.57 165.51 28.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.298 1.439 . . . . 0.0 112.008 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -134.32 -57.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.3 t0 48.81 69.36 0.58 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.643 1.977 . . . . 0.0 113.907 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.59 100.79 0.02 OUTLIER 'General case' 0 C--O 1.25 1.111 0 C-N-CA 129.213 3.005 . . . . 0.0 114.58 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.98 104.09 0.19 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -53.77 101.92 0.05 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 112.506 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -119.21 131.08 55.78 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.891 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.82 133.89 55.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.747 2.019 . . . . 0.0 109.846 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -140.4 157.51 45.42 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.262 0.553 . . . . 0.0 110.76 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -76.78 98.35 4.78 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.1 tp -57.66 -23.77 53.08 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.01 24.7 5.65 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-O 117.851 -1.527 . . . . 0.0 116.726 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -130.24 -27.56 2.21 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.813 1.807 . . . . 0.0 115.636 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.03 -33.01 1.05 Allowed Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.534 1.064 . . . . 0.0 113.83 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -109.83 172.7 6.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.741 1.616 . . . . 0.0 111.885 174.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.14 158.89 32.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 0.0 110.887 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -143.49 165.02 28.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.591 0.71 . . . . 0.0 111.144 176.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -128.14 136.79 51.63 Favored 'General case' 0 N--CA 1.396 -3.137 0 C-N-CA 124.826 1.25 . . . . 0.0 112.049 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.18 160.29 22.93 Favored Glycine 1 CA--C 1.618 6.518 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.44 156.94 41.0 Favored 'Isoleucine or valine' 1 CA--C 1.629 4.016 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.81 87.04 1.4 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.0 p -73.81 165.11 25.7 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.238 1.015 . . . . 0.0 110.704 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -128.46 -163.08 1.24 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.737 1.215 . . . . 0.0 112.042 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.62 7.07 4.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.534 2.333 . . . . 0.0 115.116 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.82 169.66 19.44 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.516 1.055 . . . . 0.0 110.732 -175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 65.6 -51.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.755 2.022 . . . . 0.0 114.568 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.98 163.44 7.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.568 2.347 . . . . 0.0 112.694 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -154.07 165.12 37.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 123.155 1.455 . . . . 0.0 114.524 -174.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.485 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 24.8 ptm -93.12 164.94 13.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.172 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -153.27 156.15 37.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.03 138.75 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.887 1.675 . . . . 0.0 109.145 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.44 117.74 23.54 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.103 1.361 . . . . 0.0 109.704 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.649 HD13 HD22 ' A' ' 98' ' ' LEU . 22.7 pt -108.79 126.14 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.552 0.741 . . . . 0.0 110.17 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.7 t -152.53 158.84 43.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.577 0 C-N-CA 126.122 1.769 . . . . 0.0 111.134 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.63 165.81 11.79 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 110.597 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.71 -25.4 27.64 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.195 1.379 . . . . 0.0 112.573 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -149.19 151.63 34.65 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.522 1.661 . . . . 0.0 111.535 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.447 HD11 HD12 ' A' ' 70' ' ' LEU . 29.4 mm -144.12 158.9 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.743 1.217 . . . . 0.0 111.312 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.67 -173.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 127.502 2.321 . . . . 0.0 111.984 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.73 -22.34 3.45 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.0 -25.32 14.42 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.648 1.118 . . . . 0.0 114.144 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -36.87 75.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.158 0.979 . . . . 0.0 111.969 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -7.12 58.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.942 1.297 . . . . 0.0 113.619 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.413 HD11 HD23 ' A' ' 17' ' ' LEU . 2.8 tt -64.67 156.4 30.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.382 1.473 . . . . 0.0 112.651 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -148.55 143.38 26.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.041 0.936 . . . . 0.0 110.116 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -56.25 -32.86 64.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.653 0.781 . . . . 0.0 113.104 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -55.52 -57.28 12.55 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.081 1.352 . . . . 0.0 112.342 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.19 -51.42 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.706 0.803 . . . . 0.0 109.892 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.413 HD23 HD11 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -53.44 -37.1 62.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.172 1.389 . . . . 0.0 113.615 -174.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.26 -49.08 65.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.27 1.428 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -36.52 83.55 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.339 -0.851 . . . . 0.0 111.301 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.57 -53.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.802 1.241 . . . . 0.0 111.345 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.9 pp -63.85 -34.93 79.04 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.98 -25.39 58.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -54.95 -26.81 38.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.342 1.428 . . . . 0.0 112.893 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 128.312 2.645 . . . . 0.0 114.606 -178.121 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 tptt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.19 146.02 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.969 1.708 . . . . 0.0 115.007 -174.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -137.51 110.47 7.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.725 2.81 . . . . 0.0 109.404 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.3 p -116.12 125.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 175.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.31 157.71 30.31 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.178 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 98' ' ' LEU . 1.5 mp -139.19 117.58 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 0.0 111.572 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.89 102.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.421 -1.424 . . . . 0.0 111.746 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.419 ' HA ' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -76.76 87.16 3.38 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.88 1.272 . . . . 0.0 111.82 175.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -143.15 45.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.684 1.194 . . . . 0.0 111.295 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.47 1.3 29.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.014 1.325 . . . . 0.0 114.465 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.27 17.29 69.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.383 0.992 . . . . 0.0 115.139 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.16 131.76 4.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.945 1.736 . . . . 0.0 111.742 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -59.08 142.51 51.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.033 1.333 . . . . 0.0 111.194 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.419 ' CH2' ' HA ' ' A' ' 37' ' ' ASN . 45.7 m0 -104.68 167.16 9.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 111.505 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -152.58 102.49 2.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.269 2.227 . . . . 0.0 109.407 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 166.43 14.31 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.344 -0.848 . . . . 0.0 111.617 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -67.8 0.77 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.668 1.587 . . . . 0.0 110.432 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -156.66 -176.17 5.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.985 1.714 . . . . 0.0 110.995 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.85 37.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.97 1.708 . . . . 0.0 110.844 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -127.94 130.06 47.82 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.574 1.549 . . . . 0.0 109.684 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -140.16 137.44 34.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 128.485 2.714 . . . . 0.0 109.121 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -14.84 15.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.32 1.448 . . . . 0.0 112.324 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.81 99.08 3.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.642 1.977 . . . . 0.0 109.056 176.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.22 102.08 0.94 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 124.401 1.001 . . . . 0.0 112.807 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.434 HG23 ' CE1' ' A' ' 50' ' ' PHE . 97.1 m -65.94 -103.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.411 1.884 . . . . 0.0 110.914 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.6 p -150.51 172.67 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 111.916 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -148.75 -4.02 0.44 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.633 2.373 . . . . 0.0 113.125 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.81 166.86 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 127.416 2.287 . . . . 0.0 112.128 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.21 128.65 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.11 1.764 . . . . 0.0 112.576 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 tp -81.59 123.66 80.58 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 108.511 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 69' ' ' LEU . 65.6 Cg_endo -65.54 124.55 12.99 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.884 3.056 . . . . 0.0 110.827 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.07 -76.75 0.26 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.233 -0.917 . . . . 0.0 112.188 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.54 125.57 40.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.87 0.868 . . . . 0.0 110.28 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -123.78 121.98 26.46 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.228 -175.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.94 179.21 6.51 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.179 3.252 . . . . 0.0 112.323 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -66.8 169.18 8.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.301 1.44 . . . . 0.0 112.64 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p 43.39 43.49 4.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.413 2.285 . . . . 0.0 115.016 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -144.49 177.58 8.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.608 1.963 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.08 -174.44 4.1 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.492 1.517 . . . . 0.0 108.324 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.714 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -156.27 154.17 30.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.447 HD12 HD11 ' A' ' 6' ' ' ILE . 7.0 mt -129.35 163.72 25.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.771 0.829 . . . . 0.0 110.467 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -149.26 161.35 42.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.392 1.477 . . . . 0.0 109.502 174.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.6 m -147.02 178.49 8.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.296 1.438 . . . . 0.0 110.801 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.17 167.25 30.67 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.468 0.556 . . . . 0.0 113.471 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 125.216 1.407 . . . . 0.0 112.971 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 CA-C-O 120.257 0.075 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 103' ' ' SER . 76.6 t -143.11 126.43 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.375 1.87 . . . . 0.0 111.986 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -148.8 167.39 25.74 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.338 1.455 . . . . 0.0 110.87 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 118.38 7.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.0 109.288 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -123.5 162.93 21.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.434 1.094 . . . . 0.0 112.55 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -127.23 145.76 50.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.972 0.909 . . . . 0.0 111.986 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.73 113.49 16.07 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.669 1.987 . . . . 0.0 110.89 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.96 122.11 16.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.847 1.259 . . . . 0.0 110.591 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.3 ttt -92.8 149.03 21.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.831 1.252 . . . . 0.0 111.017 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -22.71 16.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 t -72.01 -11.48 60.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.843 1.257 . . . . 0.0 113.789 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.49 4.87 60.59 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.672 1.606 . . . . 0.0 114.72 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -95.05 173.18 7.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.211 1.404 . . . . 0.0 110.769 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.467 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 37.8 m -137.16 104.37 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.961 1.304 . . . . 0.0 111.947 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 35' ' ' ILE . 27.2 tp -67.12 125.13 25.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.941 0.896 . . . . 0.0 110.346 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.67 104.84 2.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.19 1.376 . . . . 0.0 112.389 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -74.86 169.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.857 0.837 . . . . 0.0 112.175 175.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -149.0 147.48 28.61 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.189 1.396 . . . . 0.0 111.682 177.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 p90 -157.76 146.31 19.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.497 0.719 . . . . 0.0 112.088 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' HG22 ' A' ' 85' ' ' VAL . 69.1 m -153.31 122.04 6.4 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.482 0.713 . . . . 0.0 112.169 174.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.59 137.05 38.96 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 CA--C 1.538 0.678 0 C-N-CA 122.395 2.063 . . . . 0.0 112.741 176.232 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.199 0.524 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -81.38 162.14 23.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.041 0.937 . . . . 0.0 112.229 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.521 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 4.8 p-90 -159.91 169.4 23.59 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.129 1.372 . . . . 0.0 110.928 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 t70 164.26 138.6 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 128.713 2.805 . . . . 0.0 112.265 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.42 128.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.344 1.858 . . . . 0.0 108.959 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -129.03 158.21 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.324 1.85 . . . . 0.0 110.234 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.2 mt -112.76 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.719 1.608 . . . . 0.0 108.383 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -70.49 102.78 2.29 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.724 -1.235 . . . . 0.0 110.136 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.2 t -67.01 90.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.79 -134.71 4.97 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.853 2.644 . . . . 0.0 109.629 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.26 124.7 26.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.042 1.337 . . . . 0.0 111.899 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -143.61 117.14 9.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.234 1.814 . . . . 0.0 110.868 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.24 165.94 18.97 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.142 0.428 . . . . 0.0 110.985 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.47 112.58 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.438 -0.789 . . . . 0.0 110.601 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -155.97 -172.84 4.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.365 1.466 . . . . 0.0 112.797 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -42.65 84.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.018 0.927 . . . . 0.0 110.868 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.7 -41.08 56.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.469 1.509 . . . . 0.0 112.887 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -64.83 0.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.501 1.12 . . . . 0.0 109.94 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -53.37 -34.35 57.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.201 1.001 . . . . 0.0 113.431 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -41.07 95.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.824 1.25 . . . . 0.0 111.388 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -21.71 66.69 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.484 -1.385 . . . . 0.0 112.386 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 101' ' ' MET . 6.3 mt -85.3 -48.78 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.53 -33.25 31.89 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -114.66 -37.38 4.27 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.894 1.278 . . . . 0.0 112.708 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.64 -68.71 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.039 1.304 . . . . 0.0 112.479 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.77 79.0 1.8 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.99 153.38 72.56 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.06 175.91 8.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.136 2.174 . . . . 0.0 112.448 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -127.1 141.63 51.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.186 1.794 . . . . 0.0 110.826 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -141.46 108.56 0.55 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.561 1.076 . . . . 0.0 111.029 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -123.16 64.88 0.99 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.559 1.143 . . . . 0.0 112.264 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.04 95.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.619 2.368 . . . . 0.0 114.754 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.46 154.28 6.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.378 1.942 . . . . 0.0 112.405 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 63.1 m95 -77.18 144.74 38.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.274 1.03 . . . . 0.0 111.891 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -149.66 127.18 11.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.183 1.393 . . . . 0.0 112.364 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -120.67 152.46 38.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.234 1.814 . . . . 0.0 112.37 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -145.67 161.46 39.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.629 1.572 . . . . 0.0 110.636 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -75.04 98.76 3.71 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -57.84 7.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.935 1.294 . . . . 0.0 111.492 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.17 14.38 0.47 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -129.22 -16.58 3.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.56 -4.09 5.1 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.98 171.48 14.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.893 1.677 . . . . 0.0 110.801 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.71 161.19 31.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.019 . . . . 0.0 111.948 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.578 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -141.62 149.16 40.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.358 0.663 . . . . 0.0 111.815 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.8 OUTLIER -119.25 134.54 55.15 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.79 1.636 . . . . 0.0 108.988 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.27 136.44 12.62 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.097 1.332 . . . . 0.0 113.068 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -109.3 132.39 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.187 1.795 . . . . 0.0 108.691 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.88 105.97 11.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.746 0.818 . . . . 0.0 109.817 175.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 p -123.6 145.91 48.55 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.927 1.291 . . . . 0.0 110.562 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.7 p -140.46 -112.46 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.527 1.131 . . . . 0.0 110.504 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 52.38 13.48 0.3 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 120.833 1.651 . . . . 0.0 115.33 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 146.45 5.84 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.547 2.022 . . . . 0.0 110.779 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.23 38.4 29.21 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -144.83 170.87 15.29 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.562 1.545 . . . . 0.0 111.803 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -165.76 146.0 6.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.089 0.956 . . . . 0.0 112.99 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.62 144.87 45.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.506 1.922 . . . . 0.0 113.752 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.536 ' C ' HD12 ' A' ' 171' ' ' ILE . 24.1 tt0 -145.07 153.28 41.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.594 1.958 . . . . 0.0 109.83 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.536 HD12 ' C ' ' A' ' 170' ' ' GLN . 2.0 mp -124.5 122.61 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.409 1.084 . . . . 0.0 109.963 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -100.1 132.14 45.64 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.985 0.914 . . . . 0.0 109.378 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.578 HG22 ' CB ' ' A' ' 157' ' ' MET . 6.1 pt -116.85 133.07 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.724 0.81 . . . . 0.0 110.123 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.8 p -154.22 170.42 21.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.857 1.263 . . . . 0.0 112.798 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.736 -0.173 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.65 145.76 51.21 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 109.892 175.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.52 -38.86 1.82 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 127.111 2.291 . . . . 0.0 111.435 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -143.51 159.09 43.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.948 1.299 . . . . 0.0 112.374 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -139.19 169.83 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.42 1.888 . . . . 0.0 110.235 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.98 -166.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 127.854 2.462 . . . . 0.0 111.128 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.04 -16.58 13.29 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.64 -21.85 40.87 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.907 1.242 . . . . 0.0 114.068 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.12 86.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.567 1.183 . . . . 0.0 111.581 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -85.61 -15.69 41.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.906 1.283 . . . . 0.0 113.717 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 tt -61.14 150.06 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.205 1.002 . . . . 0.0 110.99 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -149.54 144.41 26.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.915 0.886 . . . . 0.0 109.132 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -50.91 -38.65 51.34 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 112.117 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -50.82 -53.32 33.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.408 1.083 . . . . 0.0 113.705 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.67 -47.42 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.97 -0.456 . . . . 0.0 110.171 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -35.74 65.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.327 1.451 . . . . 0.0 112.283 -176.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -64.13 -51.09 65.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.829 2.452 . . . . 0.0 110.67 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -35.22 79.6 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.674 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.67 -50.79 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.613 1.165 . . . . 0.0 111.702 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 32' ' ' ALA . 4.5 pp -65.15 -31.96 73.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 112.809 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.18 -9.11 59.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.075 -1.016 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -25.2 55.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.465 -1.397 . . . . 0.0 112.408 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 126.826 2.05 . . . . 0.0 113.757 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.975 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -154.8 132.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.857 0.753 . . . . 0.0 112.416 174.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -122.74 115.7 22.5 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.603 1.961 . . . . 0.0 109.524 175.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 157.98 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.94 177.0 28.72 Favored Glycine 0 N--CA 1.451 -0.336 0 O-C-N 121.525 -0.734 . . . . 0.0 111.453 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -136.89 132.77 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.878 0.846 . . . . 0.0 111.631 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.42 104.92 16.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.374 1.47 . . . . 0.0 111.491 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -82.27 96.43 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.033 0.933 . . . . 0.0 112.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.06 13.44 5.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.813 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -3.34 54.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.609 1.564 . . . . 0.0 115.114 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 26.02 60.41 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.165 -0.96 . . . . 0.0 114.766 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.94 125.13 2.51 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.801 1.667 . . . . 0.0 111.44 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.0 m -64.23 141.42 58.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.028 0.931 . . . . 0.0 111.128 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.552 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 34.5 m0 -110.19 169.83 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.09 0.956 . . . . 0.0 111.708 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -144.14 101.2 3.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.074 1.35 . . . . 0.0 112.315 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 154.11 42.52 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.558 -1.339 . . . . 0.0 110.421 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -109.63 -54.28 2.57 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.237 1.415 . . . . 0.0 112.193 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 46' ' ' LEU . 5.8 p-10 -162.49 -171.93 2.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.106 1.762 . . . . 0.0 110.786 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.7 145.37 30.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.658 1.583 . . . . 0.0 110.716 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -123.33 126.02 46.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.669 1.587 . . . . 0.0 110.119 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 137.04 46.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.827 2.451 . . . . 0.0 109.622 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -110.31 -43.3 3.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.191 1.796 . . . . 0.0 111.605 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -100.21 156.74 17.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 109.148 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.42 -171.39 19.93 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -145.19 166.15 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.97 1.308 . . . . 0.0 110.259 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 p -67.76 152.25 45.9 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -163.81 -30.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.958 1.703 . . . . 0.0 113.53 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.97 157.11 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.059 1.744 . . . . 0.0 111.49 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 tt -85.89 138.11 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.25 1.02 . . . . 0.0 112.11 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.88 131.76 42.23 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.222 1.409 . . . . 0.0 109.627 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.07 118.82 5.92 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.745 2.963 . . . . 0.0 110.926 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.11 -53.82 52.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.385 0.674 . . . . 0.0 112.475 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -119.94 136.62 54.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.208 1.003 . . . . 0.0 110.587 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.47 122.01 37.51 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.013 0.925 . . . . 0.0 110.609 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.64 171.0 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.684 2.923 . . . . 0.0 113.0 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -66.02 154.13 40.33 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.266 1.426 . . . . 0.0 112.742 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.7 t 36.87 56.03 1.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.099 2.16 . . . . 0.0 113.303 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -144.18 -178.49 5.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.95 1.3 . . . . 0.0 111.735 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.72 -178.79 6.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.069 0.937 . . . . 0.0 111.35 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.36 150.03 30.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 110.961 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.69 151.02 47.16 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.308 1.443 . . . . 0.0 108.486 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -127.98 159.84 33.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.573 1.549 . . . . 0.0 109.553 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.9 m -135.8 170.17 16.41 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.56 1.544 . . . . 0.0 109.931 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' H ' HD22 ' A' ' 24' ' ' LEU . . . 138.93 89.38 0.19 Allowed Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.527 1.06 . . . . 0.0 111.362 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.657 ' NH1' HG11 ' A' ' 104' ' ' VAL . 52.2 ttt180 . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 124.926 1.29 . . . . 0.0 113.632 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.341 0.591 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -155.76 111.47 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.775 2.03 . . . . 0.0 107.858 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -156.43 167.51 30.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.483 1.135 . . . . 0.0 110.383 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.97 128.31 9.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.338 1.055 . . . . 0.0 108.824 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -127.2 165.02 20.4 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.028 0.931 . . . . 0.0 111.931 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -130.1 150.27 51.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.557 0.743 . . . . 0.0 112.481 -175.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -125.57 114.8 19.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.971 1.308 . . . . 0.0 110.466 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -71.36 100.0 2.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.689 1.596 . . . . 0.0 110.539 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.0 mtp -64.86 146.64 54.62 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.951 -1.093 . . . . 0.0 112.028 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -57.51 -26.09 60.8 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -71.67 -4.72 28.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.702 1.201 . . . . 0.0 113.58 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.16 27.13 16.71 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.894 1.235 . . . . 0.0 114.457 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -117.57 166.46 12.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.623 1.569 . . . . 0.0 110.746 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.518 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 45.0 m -130.43 104.16 7.09 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.08 0.952 . . . . 0.0 112.44 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 173' ' ' ILE . 13.8 tp -77.27 113.35 14.94 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.957 0.903 . . . . 0.0 110.033 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.87 111.4 4.21 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.749 1.642 . . . . 0.0 112.075 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.65 154.66 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 110.857 175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.1 ttp -134.83 148.82 50.25 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.861 1.265 . . . . 0.0 110.035 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 31' ' ' ILE . 12.4 p90 -153.97 142.46 20.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.367 0.667 . . . . 0.0 109.299 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 m -150.93 165.83 32.47 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.005 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.657 HG11 ' NH1' ' A' ' 74' ' ' ARG . 95.2 t -119.78 142.2 32.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.314 1.046 . . . . 0.0 109.964 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 80.2 Cg_endo . . . . . 0 CA--C 1.546 1.114 0 C-N-CA 123.641 2.894 . . . . 0.0 112.706 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.442 HD21 ' HD3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -93.22 137.34 32.64 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.987 1.715 . . . . 0.0 111.829 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -164.32 134.79 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.371 1.868 . . . . 0.0 108.394 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -156.16 151.74 27.03 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.333 1.053 . . . . 0.0 110.44 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.88 132.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.437 1.095 . . . . 0.0 110.33 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 120' ' ' TYR . 18.5 ttpt -144.76 158.61 43.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.872 0.869 . . . . 0.0 111.709 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.83 112.07 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.428 1.091 . . . . 0.0 110.47 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 27.0 m-85 -81.3 101.14 9.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -62.84 93.02 0.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.225 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.75 -138.78 8.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.401 2.429 . . . . 0.0 110.544 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -117.08 127.06 53.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.59 1.956 . . . . 0.0 111.778 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -148.73 108.05 3.94 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.2 168.81 18.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.13 0.972 . . . . 0.0 111.435 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.93 118.25 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.888 0.875 . . . . 0.0 111.37 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -161.88 -174.53 4.21 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.769 1.228 . . . . 0.0 112.114 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -48.73 -48.61 40.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.978 1.311 . . . . 0.0 111.556 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.51 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.31 0.957 . . . . 0.0 113.426 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.4 ttp -68.76 -49.31 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.238 1.019 . . . . 0.0 112.467 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.87 -39.27 68.49 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.488 0.585 . . . . 0.0 112.198 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -45.53 79.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.265 1.426 . . . . 0.0 111.199 175.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -21.94 66.69 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.336 -1.478 . . . . 0.0 113.716 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.91 -41.72 14.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.776 1.631 . . . . 0.0 112.824 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -88.95 -28.22 20.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -122.61 -32.07 3.63 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 112.313 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.85 -39.12 94.91 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.118 0.866 . . . . 0.0 113.431 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.53 75.38 9.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.15 120.72 8.0 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.415 2.077 . . . . 0.0 113.284 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.47 173.4 7.69 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.704 2.002 . . . . 0.0 112.369 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -139.83 140.02 36.47 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.565 1.946 . . . . 0.0 112.224 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -136.88 109.78 0.74 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.286 0.946 . . . . 0.0 114.188 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -87.28 -68.25 0.76 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.622 1.569 . . . . 0.0 112.44 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -173.12 114.97 0.26 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 0.0 112.089 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.37 160.17 8.67 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.704 1.145 . . . . 0.0 114.079 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.429 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 92.1 m95 -78.04 147.03 34.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.124 1.37 . . . . 0.0 112.5 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -150.61 127.6 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.664 1.585 . . . . 0.0 112.452 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.6 152.59 24.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.36 1.464 . . . . 0.0 112.37 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -158.65 169.91 23.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.868 1.267 . . . . 0.0 112.627 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -85.44 99.79 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.77 1.628 . . . . 0.0 107.807 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 5.8 tp -60.88 -36.16 78.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.19 24.51 2.21 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -135.92 -29.12 1.04 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 119.157 1.479 . . . . 0.0 114.727 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 133.19 23.0 0.77 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.052 1.31 . . . . 0.0 114.66 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.2 162.63 37.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.224 1.512 . . . . 0.0 112.048 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 136.77 50.79 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.481 1.513 . . . . 0.0 108.875 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.582 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -126.45 168.48 14.16 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.006 0.922 . . . . 0.0 110.841 175.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 128.24 50.62 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.82 152.74 18.0 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.441 1.02 . . . . 0.0 112.02 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.429 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -133.65 145.96 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.236 178.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.9 tpt -154.88 100.85 2.24 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.337 1.055 . . . . 0.0 110.182 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -90.54 149.46 22.16 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 109.542 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -59.67 164.33 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.358 1.463 . . . . 0.0 112.867 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . . . -55.68 129.85 40.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.756 0.823 . . . . 0.0 112.391 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.77 79.22 0.05 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.001 0.81 . . . . 0.0 112.091 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 67.97 -50.7 0.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.651 2.38 . . . . 0.0 115.322 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.52 169.86 7.01 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.475 1.91 . . . . 0.0 113.492 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -152.88 -177.56 6.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.987 1.715 . . . . 0.0 112.315 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 138.3 40.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.996 2.118 . . . . 0.0 112.288 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.443 ' O ' HD13 ' A' ' 171' ' ' ILE . 50.0 tt0 -146.42 156.29 43.19 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.345 1.458 . . . . 0.0 110.764 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 170' ' ' GLN . 14.4 mm -131.9 125.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 110.283 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 112.76 19.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.311 1.044 . . . . 0.0 112.379 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.582 HG22 ' CB ' ' A' ' 157' ' ' MET . 18.2 pt -97.63 132.11 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.721 1.608 . . . . 0.0 110.517 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 t -154.16 158.69 40.76 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.445 -0.784 . . . . 0.0 111.491 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.998 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.506 ' HB3' HG22 ' A' ' 20' ' ' VAL . 1.3 mm? . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.21 29.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.0 1.72 . . . . 0.0 114.387 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.4 -5.6 10.22 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.021 1.772 . . . . 0.0 115.392 -175.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -167.49 162.18 14.29 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.304 2.642 . . . . 0.0 109.36 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 70' ' ' LEU . 49.1 mt -142.4 167.39 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.774 1.23 . . . . 0.0 109.901 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.03 -164.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 127.958 2.503 . . . . 0.0 110.045 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.04 -14.82 39.63 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -26.4 24.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.874 1.702 . . . . 0.0 113.571 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.53 81.34 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 118.373 1.086 . . . . 0.0 112.166 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -12.71 49.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.042 1.337 . . . . 0.0 113.842 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.36 129.73 41.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.857 1.263 . . . . 0.0 109.371 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -142.24 144.06 33.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.701 0.8 . . . . 0.0 109.319 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -54.96 -29.79 57.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.592 0.633 . . . . 0.0 112.381 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -58.63 -55.99 27.9 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 112.119 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -62.4 -47.04 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.9 63.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.005 1.322 . . . . 0.0 113.323 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -52.91 14.83 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 119.938 -1.726 . . . . 0.0 110.754 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -64.32 -38.93 92.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.117 1.767 . . . . 0.0 112.231 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.8 -34.45 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.429 1.092 . . . . 0.0 112.155 -174.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 32' ' ' ALA . 97.2 mt -78.2 -40.55 37.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.258 1.423 . . . . 0.0 111.425 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -72.45 -17.11 61.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -30.97 70.57 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.645 -1.284 . . . . 0.0 112.554 175.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 112.262 177.574 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.597 0.237 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -133.18 130.98 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.646 1.178 . . . . 0.0 110.367 -177.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -116.73 95.29 4.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.749 2.02 . . . . 0.0 112.423 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -101.73 113.41 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.626 -1.296 . . . . 0.0 109.178 174.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.6 160.02 28.56 Favored Glycine 0 C--O 1.235 0.171 0 C-N-CA 120.857 -0.687 . . . . 0.0 114.745 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.495 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.8 mp -135.61 130.97 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.193 1.397 . . . . 0.0 110.129 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 4.2 m-20 -86.7 104.4 16.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.344 1.058 . . . . 0.0 111.943 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -81.12 100.39 9.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.829 1.195 . . . . 0.0 112.102 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.64 21.49 2.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.197 0.999 . . . . 0.0 112.845 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -6.38 58.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.482 1.513 . . . . 0.0 114.621 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.53 22.82 55.51 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.384 0.992 . . . . 0.0 114.97 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.15 126.87 3.65 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.444 1.497 . . . . 0.0 112.275 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -58.6 143.95 44.56 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.464 1.106 . . . . 0.0 110.565 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 50.7 m0 -108.05 164.77 12.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.69 0.796 . . . . 0.0 111.858 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.1 m -149.9 104.15 3.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.141 1.776 . . . . 0.0 110.307 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.36 144.62 55.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.733 -1.229 . . . . 0.0 111.211 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.549 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -107.56 -47.8 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.743 1.617 . . . . 0.0 113.149 -177.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.549 ' H ' HD22 ' A' ' 46' ' ' LEU . 61.7 t30 -157.73 171.33 20.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.497 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.64 128.67 25.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.894 1.277 . . . . 0.0 110.859 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -120.31 141.64 49.84 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.286 1.434 . . . . 0.0 110.373 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -154.22 155.73 35.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.527 177.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -120.15 -13.11 8.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.035 1.734 . . . . 0.0 111.093 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.4 m -143.04 131.23 21.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.649 1.98 . . . . 0.0 110.219 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 107.29 0.98 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 74' ' ' ARG . 1.4 t -73.79 176.23 6.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.125 2.17 . . . . 0.0 111.378 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -69.13 163.14 25.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.452 1.12 . . . . 0.0 113.155 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.0 -29.74 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.986 1.314 . . . . 0.0 112.937 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.66 164.05 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.411 1.884 . . . . 0.0 110.233 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 tp -64.26 134.54 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.062 0.945 . . . . 0.0 110.786 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.29 109.56 34.37 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 108.295 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HG2' HD12 ' A' ' 69' ' ' LEU . 50.7 Cg_endo -61.46 123.47 12.82 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.032 3.154 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.2 -59.56 2.51 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.346 -0.846 . . . . 0.0 112.483 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -105.22 144.73 31.6 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 110.697 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.44 124.46 17.11 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.595 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.17 170.48 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.072 2.514 . . . . 0.0 112.493 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -62.66 148.73 45.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.012 0.925 . . . . 0.0 111.133 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 p 53.9 42.86 31.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.808 1.643 . . . . 0.0 114.832 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -145.2 127.9 16.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.807 1.643 . . . . 0.0 112.723 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -84.64 176.1 8.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.978 0.911 . . . . 0.0 111.819 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.654 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -151.87 150.51 30.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.342 -0.849 . . . . 0.0 112.003 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -122.49 169.18 11.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.177 1.391 . . . . 0.0 112.128 177.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.627 ' HB3' HG13 ' A' ' 33' ' ' VAL . 2.4 t80 -145.7 160.65 41.41 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.436 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.87 164.65 33.04 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.725 1.61 . . . . 0.0 111.262 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.59 173.45 39.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.645 0.64 . . . . 0.0 113.703 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.637 ' O ' HG22 ' A' ' 54' ' ' THR . 22.7 tpt180 . . . . . 0 N--CA 1.477 0.91 0 C-N-CA 126.442 1.897 . . . . 0.0 109.802 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.778 0.323 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.08 112.87 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.505 1.922 . . . . 0.0 111.088 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -132.57 163.99 27.64 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.526 1.131 . . . . 0.0 111.18 175.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.2 112.81 4.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.766 1.226 . . . . 0.0 108.635 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -122.64 165.17 16.92 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.969 1.308 . . . . 0.0 110.747 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -129.03 153.61 47.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.267 0.556 . . . . 0.0 111.511 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.6 m-85 -127.96 112.9 15.18 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.967 1.307 . . . . 0.0 109.93 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 46' ' ' LEU . 10.5 t80 -67.64 107.03 2.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.187 1.395 . . . . 0.0 110.329 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.15 144.92 50.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.212 1.405 . . . . 0.0 110.845 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.6 t -55.42 -27.33 47.21 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.175 0.99 . . . . 0.0 113.369 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -9.3 40.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.312 1.445 . . . . 0.0 114.837 174.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.12 55.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.872 1.225 . . . . 0.0 115.094 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.05 172.82 6.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.508 1.523 . . . . 0.0 110.445 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HB1' ' A' ' 89' ' ' ALA . 40.8 m -136.33 108.36 7.18 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.312 1.045 . . . . 0.0 111.141 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 173' ' ' ILE . 9.1 tp -73.75 125.87 29.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.013 -1.055 . . . . 0.0 109.091 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.88 99.12 1.93 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.9 162.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.786 0.803 . . . . 0.0 111.227 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -148.1 158.29 43.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.502 0.721 . . . . 0.0 111.322 174.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 45.8 p90 -160.3 162.72 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.928 1.291 . . . . 0.0 109.325 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.22 168.76 24.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.809 1.244 . . . . 0.0 109.108 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.11 97.38 12.21 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 109.723 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 CA--C 1.541 0.836 0 C-N-CA 122.303 2.002 . . . . 0.0 110.865 175.022 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.457 ' HB2' ' HE1' ' A' ' 161' ' ' MET . 16.7 p-10 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 122.017 0.913 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -86.23 157.55 19.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.679 1.191 . . . . 0.0 112.617 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 6.0 p-90 -160.94 148.32 15.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.762 0.825 . . . . 0.0 111.505 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -172.1 107.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.317 1.847 . . . . 0.0 111.699 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 171' ' ' ILE . 23.6 t -116.36 137.24 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.683 0.793 . . . . 0.0 109.063 174.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' HA ' HD13 ' A' ' 151' ' ' LEU . 5.0 ttmt -145.96 143.64 29.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.875 1.67 . . . . 0.0 110.484 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.88 153.42 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -122.62 96.34 4.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.247 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t -70.71 90.51 0.78 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.54 -1.35 . . . . 0.0 111.599 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.85 -112.57 0.52 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.31 1.909 . . . . 0.0 110.831 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -159.21 117.78 2.89 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.706 1.602 . . . . 0.0 110.513 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -140.04 108.6 5.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.241 1.416 . . . . 0.0 111.404 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.01 171.35 6.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.638 0.775 . . . . 0.0 111.153 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.77 113.67 22.12 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.728 -0.608 . . . . 0.0 110.651 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.09 -175.22 4.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.083 1.353 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.06 -45.04 21.38 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.827 1.251 . . . . 0.0 112.236 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.06 46.88 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.576 1.084 . . . . 0.0 114.397 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 ttp -70.02 -60.61 2.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.781 1.291 . . . . 0.0 109.63 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -53.54 -33.39 54.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.845 0.858 . . . . 0.0 113.241 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.22 -38.59 91.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.568 1.147 . . . . 0.0 110.837 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -23.61 66.78 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.329 -1.482 . . . . 0.0 112.458 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mt -84.01 -47.28 11.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.518 1.527 . . . . 0.0 111.345 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.18 -26.44 26.78 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -122.46 -38.88 2.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.681 1.192 . . . . 0.0 112.219 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.52 -55.95 24.48 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.737 1.161 . . . . 0.0 112.761 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -160.97 70.44 2.67 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.04 115.19 3.15 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.848 2.365 . . . . 0.0 112.99 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.21 -178.33 3.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.536 1.135 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.57 144.33 49.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.077 2.551 . . . . 0.0 111.022 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.45 108.29 0.63 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.853 1.216 . . . . 0.0 111.865 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -120.15 64.9 0.82 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.725 1.61 . . . . 0.0 114.094 -174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.94 96.03 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.923 2.089 . . . . 0.0 114.314 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.99 135.26 2.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.343 1.449 . . . . 0.0 112.017 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -66.41 144.63 56.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 111.371 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -143.6 131.2 21.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.363 1.065 . . . . 0.0 111.805 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -133.81 143.74 48.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.645 1.578 . . . . 0.0 112.346 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 161.98 40.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.462 1.505 . . . . 0.0 112.224 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -97.67 96.62 8.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.396 1.079 . . . . 0.0 108.886 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -53.54 -51.07 64.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.523 1.529 . . . . 0.0 112.014 -174.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.94 51.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.791 1.076 . . . . 0.0 115.791 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -135.44 -31.29 0.97 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -29.75 2.31 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.21 1.386 . . . . 0.0 113.321 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.61 172.14 6.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.904 1.682 . . . . 0.0 112.766 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -134.53 151.83 51.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.912 1.685 . . . . 0.0 109.782 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.66 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.54 152.99 51.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 133.71 49.1 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.504 1.521 . . . . 0.0 109.918 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.07 136.41 11.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.477 1.037 . . . . 0.0 112.591 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tp -108.24 149.81 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.091 1.757 . . . . 0.0 109.641 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.457 ' HE1' ' HB2' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -144.88 93.58 2.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.68 1.192 . . . . 0.0 110.707 174.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.9 p -91.88 161.62 14.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.247 1.019 . . . . 0.0 111.183 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.14 -26.52 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.734 1.214 . . . . 0.0 112.398 175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.33 114.86 9.83 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 110.911 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.03 -95.11 0.64 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.083 1.325 . . . . 0.0 113.078 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.01 64.15 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.45 1.5 . . . . 0.0 111.265 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.27 91.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.864 1.666 . . . . 0.0 113.977 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.455 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -156.66 168.84 26.19 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -174.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.455 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 17.8 ptm -135.31 160.47 38.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.227 2.611 . . . . 0.0 112.567 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -153.64 162.51 41.18 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.192 1.797 . . . . 0.0 109.558 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 117' ' ' VAL . 11.1 mm -136.48 108.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -95.87 116.18 28.53 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 112.024 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.66 HG22 ' CB ' ' A' ' 157' ' ' MET . 8.2 pt -103.67 132.19 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 0.0 111.101 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.7 p -155.48 170.96 20.73 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.284 -0.885 . . . . 0.0 112.643 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.433 ' HB3' HG22 ' A' ' 20' ' ' VAL . 8.8 mp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.65 171.54 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.85 -19.44 44.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.393 0.997 . . . . 0.0 113.659 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.8 p -163.38 156.99 19.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.784 2.834 . . . . 0.0 109.05 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.505 HD11 HD12 ' A' ' 70' ' ' LEU . 64.8 mt -141.84 173.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.957 1.703 . . . . 0.0 109.065 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.11 -167.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.558 1.543 . . . . 0.0 110.033 174.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -46.34 -40.2 11.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.72 -32.64 5.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.594 1.569 . . . . 0.0 113.083 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.588 1.194 . . . . 0.0 111.588 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.0 m -83.82 -6.54 59.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.607 1.963 . . . . 0.0 113.902 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 13' ' ' THR . 4.6 tt -66.27 138.09 57.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.578 1.151 . . . . 0.0 109.792 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.2 m -141.79 142.17 33.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.863 0.865 . . . . 0.0 109.922 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -55.93 -32.45 63.82 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -56.62 -49.78 73.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.442 1.019 . . . . 0.0 112.771 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.11 -49.53 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.014 -0.429 . . . . 0.0 109.861 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.2 -36.56 52.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.271 1.428 . . . . 0.0 112.222 -178.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.92 -65.79 0.54 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.196 1.798 . . . . 0.0 111.211 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -65.05 -24.45 67.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 177.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.41 -46.6 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.707 1.203 . . . . 0.0 112.285 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -26.93 55.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.247 0.619 . . . . 0.0 112.063 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.21 -38.36 51.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.173 1.389 . . . . 0.0 113.714 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.45 -27.06 45.73 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.198 0.908 . . . . 0.0 113.039 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 126.853 2.061 . . . . 0.0 113.7 175.058 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -128.87 147.39 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.351 1.061 . . . . 0.0 112.11 -175.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 110.96 11.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.27 1.828 . . . . 0.0 111.287 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.783 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -130.32 157.46 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 C-N-CA 125.189 1.396 . . . . 0.0 112.601 175.005 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 156.54 177.32 29.59 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.2 mp -133.78 147.97 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.747 0.819 . . . . 0.0 110.46 -175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.79 102.07 13.79 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.926 -1.109 . . . . 0.0 112.049 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -82.16 98.61 8.79 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 113.124 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -133.91 10.61 3.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 113.44 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -5.36 35.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.22 42.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.855 1.217 . . . . 0.0 114.826 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.98 127.04 3.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.358 1.456 . . . . 0.0 112.328 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.7 m -57.8 142.03 46.99 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.361 1.065 . . . . 0.0 110.968 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.631 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 49.5 m0 -108.67 165.27 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.118 0.967 . . . . 0.0 111.938 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -142.01 99.85 3.61 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.118 1.767 . . . . 0.0 112.008 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -68.02 145.06 54.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.714 -1.241 . . . . 0.0 108.95 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.98 -48.99 4.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.476 1.111 . . . . 0.0 111.733 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -176.6 176.03 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.818 2.047 . . . . 0.0 110.272 -174.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.65 40.61 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.089 1.755 . . . . 0.0 111.006 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -125.58 137.24 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.931 1.292 . . . . 0.0 110.364 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.57 42.22 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.151 1.78 . . . . 0.0 109.201 -175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 -23.13 3.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.87 68.11 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.073 1.416 . . . . 0.0 109.584 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.45 179.31 32.27 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.923 1.725 . . . . 0.0 110.969 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -141.98 162.31 35.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.311 1.444 . . . . 0.0 110.141 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 p -65.25 160.01 22.51 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.304 -0.873 . . . . 0.0 112.278 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.78 -19.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 161.8 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.462 1.905 . . . . 0.0 110.814 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.17 135.96 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.65 0.78 . . . . 0.0 110.038 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.8 tp -91.95 113.96 60.57 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.217 1.007 . . . . 0.0 108.393 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 69' ' ' LEU . 89.8 Cg_endo -66.45 125.48 13.98 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.624 2.883 . . . . 0.0 110.337 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -57.37 9.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.899 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.53 130.34 54.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.003 0.82 . . . . 0.0 111.164 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 69' ' ' LEU . 57.5 t -101.81 121.76 49.82 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.367 1.067 . . . . 0.0 109.627 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.03 148.28 86.05 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.456 2.104 . . . . 0.0 111.285 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.5 155.4 5.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 175.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 t 40.6 55.32 2.94 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.597 1.559 . . . . 0.0 113.096 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 3.6 ttmt -159.89 136.28 8.93 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.007 1.723 . . . . 0.0 111.895 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.35 177.49 5.82 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.43 1.092 . . . . 0.0 111.787 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 60' ' ' PRO . 2.2 pt? -149.87 149.61 30.71 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.682 0.793 . . . . 0.0 111.912 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.77 171.31 7.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.731 1.212 . . . . 0.0 110.653 175.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.2 158.16 37.13 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.638 1.975 . . . . 0.0 108.611 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -150.14 175.47 11.72 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.022 0.929 . . . . 0.0 111.118 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.02 172.73 29.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.886 0.755 . . . . 0.0 114.158 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 126.159 1.784 . . . . 0.0 113.378 -174.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 112.024 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.24 108.36 2.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 126.045 1.738 . . . . 0.0 110.837 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.83 179.83 7.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.122 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' A' ' 130' ' ' MET . . . -153.18 138.47 17.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.206 1.003 . . . . 0.0 108.594 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.66 168.92 20.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.307 0.643 . . . . 0.0 111.359 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.796 ' HB2' HH22 ' A' ' 124' ' ' ARG . . . -131.74 162.49 30.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.785 0.803 . . . . 0.0 113.073 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 31.3 m-85 -135.45 113.85 11.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.395 1.478 . . . . 0.0 110.099 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.1 115.02 7.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.923 1.289 . . . . 0.0 109.995 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.3 ttp -82.3 153.32 25.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.391 0.676 . . . . 0.0 112.029 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -59.15 -24.05 62.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.96 -7.73 43.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.547 1.539 . . . . 0.0 114.205 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.15 -1.45 73.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.407 1.479 . . . . 0.0 114.764 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.05 175.34 6.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.046 1.339 . . . . 0.0 111.184 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.538 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 7.7 m -136.7 115.24 11.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.266 1.427 . . . . 0.0 110.983 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.558 ' CD2' HG21 ' A' ' 35' ' ' ILE . 13.2 tp -81.49 126.15 31.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.03 117.35 5.28 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.412 1.006 . . . . 0.0 112.221 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -90.39 146.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.903 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -129.43 135.54 48.8 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.373 1.469 . . . . 0.0 109.879 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.783 ' CG ' HG11 ' A' ' 33' ' ' VAL . 53.0 p90 -153.19 145.42 23.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.048 0.928 . . . . 0.0 113.013 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -151.04 149.72 29.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.277 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.76 95.26 49.12 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 CA--C 1.541 0.862 0 C-N-CA 122.491 2.127 . . . . 0.0 110.609 176.262 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 121.136 0.493 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 139' ' ' PRO . 50.9 m95 -97.22 147.04 24.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.335 1.054 . . . . 0.0 112.813 176.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -154.92 151.81 28.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.407 174.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -175.6 119.0 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.4 1.88 . . . . 0.0 110.186 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 171' ' ' ILE . 13.7 p -119.88 137.7 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.056 1.743 . . . . 0.0 109.516 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -134.03 159.54 40.46 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 110.365 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.99 104.74 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.785 1.634 . . . . 0.0 108.548 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -76.33 106.52 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.321 1.448 . . . . 0.0 109.61 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -70.38 85.25 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.481 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.55 -122.47 1.35 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.508 2.004 . . . . 0.0 110.563 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -146.64 144.65 29.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.578 1.151 . . . . 0.0 111.101 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.796 HH22 ' HB2' ' A' ' 89' ' ' ALA . 20.2 ttp85 -150.49 122.95 8.46 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.139 1.376 . . . . 0.0 110.789 175.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.69 152.66 45.23 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.038 1.335 . . . . 0.0 109.873 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.474 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -80.81 115.26 20.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.483 -0.761 . . . . 0.0 109.289 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.9 p30 -156.79 -177.77 6.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.618 1.167 . . . . 0.0 113.012 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -53.75 -38.42 64.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.382 1.073 . . . . 0.0 112.73 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.93 -42.5 94.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.414 1.007 . . . . 0.0 112.378 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.425 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 1.5 ptm -60.72 -50.94 71.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.188 0.994 . . . . 0.0 110.383 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -57.9 -36.54 72.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.658 0.783 . . . . 0.0 112.226 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.65 -46.6 78.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 0.0 110.912 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -20.72 66.22 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.321 -1.487 . . . . 0.0 113.48 174.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.35 -17.17 37.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.867 2.467 . . . . 0.0 115.131 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.23 -23.44 4.89 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -123.83 -25.74 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.829 1.252 . . . . 0.0 111.968 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.28 -68.19 1.74 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.775 1.655 . . . . 0.0 113.579 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -141.62 55.02 4.58 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 98.1 Cg_endo -64.33 141.06 73.33 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 123.905 3.07 . . . . 0.0 113.966 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -124.07 174.73 7.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.643 1.977 . . . . 0.0 113.102 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -129.23 141.95 50.99 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.623 -1.298 . . . . 0.0 110.546 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.61 120.02 1.07 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -134.06 83.97 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.49 0.716 . . . . 0.0 111.705 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 m120 56.75 93.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.976 2.51 . . . . 0.0 114.478 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 148.56 140.6 3.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.918 1.723 . . . . 0.0 111.928 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -67.06 141.58 57.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.009 0.923 . . . . 0.0 111.849 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -144.3 140.96 29.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.907 1.283 . . . . 0.0 111.915 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -132.24 151.83 51.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 127.537 2.335 . . . . 0.0 110.506 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.614 ' HE3' HD12 ' A' ' 151' ' ' LEU . 1.8 pttt -150.86 157.56 43.06 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 110.638 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.63 88.33 3.92 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.614 HD12 ' HE3' ' A' ' 149' ' ' LYS . 1.7 tp -50.01 -39.42 41.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.966 1.707 . . . . 0.0 114.314 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.38 1.61 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 117.767 1.867 . . . . 0.0 117.767 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -132.52 -32.93 1.28 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.09 -37.54 0.7 Allowed Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.665 1.126 . . . . 0.0 113.239 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.31 172.2 7.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.283 1.833 . . . . 0.0 111.112 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -133.13 156.32 47.66 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.544 1.538 . . . . 0.0 109.681 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.653 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -133.22 162.99 30.29 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.253 0.621 . . . . 0.0 110.902 176.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 134.7 53.17 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.726 1.21 . . . . 0.0 108.296 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.4 148.42 18.92 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.217 0.913 . . . . 0.0 112.421 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -121.65 113.86 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.734 1.214 . . . . 0.0 111.168 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.52 125.9 45.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.829 0.74 . . . . 0.0 109.385 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.3 p -123.63 159.87 28.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.205 1.802 . . . . 0.0 110.365 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.5 t -147.23 -73.63 0.21 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.11 -0.994 . . . . 0.0 112.376 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.33 106.79 0.48 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.79 1.236 . . . . 0.0 112.469 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.31 97.89 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 60.29 79.36 0.24 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.392 1.877 . . . . 0.0 113.274 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.03 86.14 0.24 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.134 1.373 . . . . 0.0 113.853 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 -170.62 3.06 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.1 ptm -155.4 169.48 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.04 1.336 . . . . 0.0 111.477 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -148.33 157.24 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.994 1.317 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.551 HG21 HG21 ' A' ' 117' ' ' VAL . 37.2 mm -123.7 123.01 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.833 1.253 . . . . 0.0 108.62 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -118.43 122.52 42.96 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.49 0.716 . . . . 0.0 110.289 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 157' ' ' MET . 25.2 pt -105.72 132.89 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.449 1.099 . . . . 0.0 108.829 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.7 p -150.93 163.71 38.06 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.316 0.647 . . . . 0.0 110.645 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.229 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.46 169.81 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.337 1.065 . . . . 0.0 110.982 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.6 -30.48 9.59 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.643 1.592 . . . . 0.0 111.567 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.5 p -144.87 146.08 31.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.656 1.728 . . . . 0.0 111.966 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -139.71 156.39 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.6 1.16 . . . . 0.0 110.839 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.21 163.32 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.431 1.493 . . . . 0.0 111.984 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.48 -29.43 58.74 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.48 -15.47 3.89 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.267 1.889 . . . . 0.0 112.327 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.99 -28.85 69.32 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.414 1.485 . . . . 0.0 114.115 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -119.88 3.25 11.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.898 1.679 . . . . 0.0 113.848 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -78.36 133.02 37.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.439 1.096 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.48 147.88 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.637 1.175 . . . . 0.0 109.196 175.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.16 -32.91 56.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.217 0.917 . . . . 0.0 113.202 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -60.99 -48.4 82.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.89 1.276 . . . . 0.0 113.509 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.07 -45.2 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 121.559 -0.713 . . . . 0.0 110.602 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -53.24 -37.59 62.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.956 1.303 . . . . 0.0 112.125 -176.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -52.03 -67.2 0.27 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.436 2.295 . . . . 0.0 110.871 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -38.16 79.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.834 0.854 . . . . 0.0 112.056 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.2 -48.64 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.235 1.379 . . . . 0.0 111.435 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.663 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -75.18 -27.27 59.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.322 1.049 . . . . 0.0 113.44 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.37 -35.14 54.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 116.986 -1.483 . . . . 0.0 112.41 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -45.3 -27.77 0.71 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.71 2.804 . . . . 0.0 114.52 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 CA--C 1.55 0.967 0 C-N-CA 123.963 0.905 . . . . 0.0 111.41 175.044 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -132.12 137.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.541 1.136 . . . . 0.0 112.194 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB2' ' CB ' ' A' ' 21' ' ' LEU . . . -126.27 116.49 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.549 2.339 . . . . 0.0 110.564 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.19 127.95 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 120.819 -1.176 . . . . 0.0 110.739 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.21 170.88 43.24 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 121.969 -0.457 . . . . 0.0 113.699 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.34 126.57 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.509 1.523 . . . . 0.0 110.108 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -77.53 108.0 10.38 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.523 -1.36 . . . . 0.0 112.125 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.89 93.73 9.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.211 1.404 . . . . 0.0 113.258 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.19 18.5 2.6 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 120.799 -1.188 . . . . 0.0 112.644 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 -7.8 59.5 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.5 7.61 71.95 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.657 1.123 . . . . 0.0 115.44 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.58 100.01 0.38 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.778 1.656 . . . . 0.0 111.891 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -52.18 124.44 13.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.784 2.033 . . . . 0.0 113.108 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.603 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 7.5 m0 -90.8 168.03 12.03 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.521 -0.737 . . . . 0.0 112.783 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -140.37 111.83 7.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.179 2.192 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -66.21 162.51 19.76 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.068 -1.02 . . . . 0.0 111.975 174.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -133.41 -64.56 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.628 1.171 . . . . 0.0 112.587 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -145.87 167.41 23.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.858 0.863 . . . . 0.0 111.533 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.3 134.46 31.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.816 1.247 . . . . 0.0 111.622 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -117.19 118.0 31.13 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.038 1.735 . . . . 0.0 109.749 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 118.86 25.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.372 2.269 . . . . 0.0 109.265 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.28 -30.54 11.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.206 1.403 . . . . 0.0 112.452 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -120.41 107.37 12.83 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.448 1.499 . . . . 0.0 108.447 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.99 123.09 3.35 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.524 1.059 . . . . 0.0 113.666 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -95.91 100.96 12.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.426 1.49 . . . . 0.0 109.515 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -67.68 168.99 10.22 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -138.92 0.32 1.96 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.936 1.695 . . . . 0.0 113.071 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG23 ' CE1' ' A' ' 71' ' ' TYR . 33.2 m -90.09 156.12 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.747 -1.221 . . . . 0.0 111.876 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.41 128.11 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.863 1.265 . . . . 0.0 112.537 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 tp -80.79 130.1 65.36 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 108.968 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.657 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.9 Cg_endo -65.51 123.35 11.31 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.79 2.993 . . . . 0.0 111.184 175.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.65 -53.39 9.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.73 0.812 . . . . 0.0 112.96 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -114.58 157.35 23.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.165 0.986 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.71 87.98 11.04 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 124.024 0.93 . . . . 0.0 108.843 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.65 159.21 54.59 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.849 1.699 . . . . 0.0 111.183 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -58.47 158.49 7.46 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.718 -0.613 . . . . 0.0 111.035 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 6.9 p 58.17 42.47 22.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.223 1.409 . . . . 0.0 112.157 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -155.65 163.9 39.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.475 1.91 . . . . 0.0 111.762 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.06 -174.73 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.789 0.804 . . . . 0.0 109.422 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -157.52 154.52 28.75 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.542 -0.724 . . . . 0.0 111.425 176.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mt -136.15 164.42 28.07 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.901 0.881 . . . . 0.0 111.348 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' A' ' 57' ' ' VAL . 1.2 t80 -136.71 163.55 30.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.797 1.239 . . . . 0.0 109.698 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -131.01 172.36 12.17 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.3 1.84 . . . . 0.0 109.245 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.65 117.02 0.83 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-O 118.706 -1.052 . . . . 0.0 111.568 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 93.1 mtm-85 . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 125.253 1.421 . . . . 0.0 111.135 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -155.37 119.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.609 1.963 . . . . 0.0 109.034 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.12 171.65 16.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.205 1.402 . . . . 0.0 109.119 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 127.67 6.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -131.1 165.09 24.03 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.007 0.923 . . . . 0.0 111.309 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -125.61 148.66 48.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.7 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 26.3 m-85 -123.36 120.09 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.216 1.406 . . . . 0.0 110.528 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.457 ' HB2' HD22 ' A' ' 46' ' ' LEU . 8.3 t80 -71.73 102.35 2.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 0.0 110.23 175.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.4 mtp -66.11 152.35 44.91 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 0.0 111.893 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -56.57 -30.65 63.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.489 1.116 . . . . 0.0 113.423 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.4 p -65.27 -11.9 46.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.966 2.106 . . . . 0.0 115.157 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 18.8 41.89 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.519 1.057 . . . . 0.0 114.579 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -111.68 167.6 10.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.762 1.625 . . . . 0.0 110.804 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.514 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 59.1 m -128.94 101.06 5.9 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.233 -0.917 . . . . 0.0 112.767 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 173' ' ' ILE . 9.6 tp -71.64 116.34 11.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.749 0.82 . . . . 0.0 110.97 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.34 105.11 3.22 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.208 0.909 . . . . 0.0 111.876 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.04 156.32 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 0.0 110.152 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.587 ' HB3' HD13 ' A' ' 134' ' ' LEU . 2.2 ppp? -136.57 162.85 31.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.759 1.224 . . . . 0.0 109.046 175.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -162.97 155.55 18.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.112 0.565 . . . . 0.0 111.022 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 t -153.53 164.01 38.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 110.645 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 m -105.02 146.64 33.06 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.493 1.117 . . . . 0.0 112.367 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 CA--C 1.541 0.841 0 C-N-CA 124.033 3.155 . . . . 0.0 112.055 176.341 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.343 0.592 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -84.38 142.54 30.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.331 1.452 . . . . 0.0 113.146 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.01 146.2 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -163.17 152.88 15.4 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.106 0.962 . . . . 0.0 112.957 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.563 ' O ' HD11 ' A' ' 151' ' ' LEU . 49.7 t -138.9 140.84 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.031 0.932 . . . . 0.0 109.258 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -145.32 133.97 22.16 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.164 1.386 . . . . 0.0 109.387 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.3 mt -95.61 110.17 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 124.869 1.267 . . . . 0.0 108.496 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -76.21 96.26 3.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.3 p -55.69 119.42 5.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.82 -111.61 3.04 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 143.0 27.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.549 1.14 . . . . 0.0 112.281 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -158.87 117.53 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.657 1.583 . . . . 0.0 111.902 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 166.74 22.46 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.745 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 115.52 20.04 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.198 0.599 . . . . 0.0 110.535 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.21 -173.14 4.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.789 1.236 . . . . 0.0 111.872 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -50.73 -49.43 57.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.136 0.974 . . . . 0.0 111.732 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.73 -36.87 50.31 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.597 1.094 . . . . 0.0 113.683 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.72 -63.25 1.11 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.106 0.962 . . . . 0.0 110.425 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -51.61 -34.14 36.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.271 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -64.73 -47.86 76.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.645 1.178 . . . . 0.0 110.627 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.08 -25.25 66.93 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.11 -1.619 . . . . 0.0 113.401 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 101' ' ' MET . 70.2 mt -83.48 -12.2 56.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.857 1.663 . . . . 0.0 114.941 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -124.16 -32.6 3.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.93 1.292 . . . . 0.0 114.094 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -114.87 -23.75 8.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.883 1.673 . . . . 0.0 112.778 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.93 -85.87 0.03 OUTLIER Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.251 1.881 . . . . 0.0 112.21 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -164.07 63.35 1.13 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.643 1.577 . . . . 0.0 112.15 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.15 178.32 7.45 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.896 2.398 . . . . 0.0 115.706 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.57 -171.07 2.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.539 1.936 . . . . 0.0 113.819 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -139.2 146.58 40.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.535 1.934 . . . . 0.0 111.365 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.65 -57.74 0.46 Allowed Glycine 0 N--CA 1.479 1.554 0 C-N-CA 124.503 1.049 . . . . 0.0 115.664 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.1 t0 52.86 68.62 0.8 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.826 1.651 . . . . 0.0 114.431 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.312 0.1 OUTLIER 40.95 69.05 0.37 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.122 2.169 . . . . 0.0 114.441 176.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 119.75 0.8 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.213 1.863 . . . . 0.0 111.496 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CZ3' ' HB ' ' A' ' 160' ' ' ILE . 8.2 m95 -57.78 132.89 54.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.159 0.983 . . . . 0.0 112.028 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -147.9 125.06 11.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.293 1.037 . . . . 0.0 112.364 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.01 137.47 49.99 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.895 1.678 . . . . 0.0 109.859 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 151.77 40.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.111 0.965 . . . . 0.0 110.877 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -74.53 93.94 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.682 HD13 ' SD ' ' A' ' 157' ' ' MET . 6.8 tp -48.62 -30.46 5.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.58 31.59 2.12 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.81 -27.36 1.15 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.45 -15.35 0.96 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.594 1.092 . . . . 0.0 114.675 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.49 171.64 13.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.647 1.579 . . . . 0.0 111.208 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.44 157.11 24.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.515 1.126 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -134.94 164.65 27.13 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.637 0.775 . . . . 0.0 109.447 174.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -133.2 122.8 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.924 1.69 . . . . 0.0 108.757 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.43 143.76 17.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.564 0.602 . . . . 0.0 113.19 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.4 ' HB ' ' CZ3' ' A' ' 146' ' ' TRP . 4.8 tp -122.11 143.84 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.514 1.526 . . . . 0.0 110.222 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 9.6 tpt -132.44 124.9 29.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.122 1.369 . . . . 0.0 109.458 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.9 p -128.96 135.53 49.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.933 0.893 . . . . 0.0 110.82 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -97.43 178.31 5.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.666 1.986 . . . . 0.0 112.135 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.05 -171.04 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.045 2.138 . . . . 0.0 112.132 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.66 174.67 45.25 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 47.43 21.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.472 1.909 . . . . 0.0 116.137 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.24 150.27 45.5 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.503 1.921 . . . . 0.0 113.079 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 39.3 tptt -164.63 154.41 13.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.053 1.341 . . . . 0.0 113.654 175.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.55 138.7 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.333 2.253 . . . . 0.0 112.448 174.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -143.11 161.45 38.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.22 1.808 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 mm -126.44 117.11 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.436 1.095 . . . . 0.0 109.96 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -96.24 117.16 30.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.534 1.134 . . . . 0.0 108.181 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.673 HD13 HD22 ' A' ' 98' ' ' LEU . 4.3 pt -109.88 130.9 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.31 142.93 2.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.736 0.814 . . . . 0.0 112.342 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.49 1.516 . . . . 0.0 113.435 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 142.95 33.56 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.343 0.592 . . . . 0.0 110.875 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.63 -21.81 13.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.249 1.88 . . . . 0.0 112.242 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -150.67 155.64 39.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.699 1.999 . . . . 0.0 112.005 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -140.82 167.91 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.93 1.692 . . . . 0.0 111.17 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -169.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.301 1.841 . . . . 0.0 111.04 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.72 -41.98 5.14 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.01 -32.55 5.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.161 1.362 . . . . 0.0 112.84 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 118.437 1.119 . . . . 0.0 111.608 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -85.39 -5.33 59.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.107 1.763 . . . . 0.0 113.778 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 13' ' ' THR . 5.0 tt -65.46 137.33 57.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.089 0.956 . . . . 0.0 109.914 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -141.55 146.01 35.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.322 1.049 . . . . 0.0 109.799 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -54.87 -32.8 61.18 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.888 0.767 . . . . 0.0 112.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -56.6 -56.45 21.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.452 1.101 . . . . 0.0 112.702 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.56 -49.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -57.83 -19.17 26.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.237 1.415 . . . . 0.0 113.523 -177.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -82.59 -47.92 11.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.973 2.109 . . . . 0.0 111.514 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -33.25 73.14 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.546 -1.346 . . . . 0.0 110.84 174.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -45.69 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.493 1.517 . . . . 0.0 112.821 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.5 OUTLIER -71.95 -33.53 68.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.819 0.448 . . . . 0.0 111.259 175.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.85 -23.04 58.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.77 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -47.38 -25.22 0.96 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.813 2.045 . . . . 0.0 113.19 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.51 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.7 tp . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 126.164 1.786 . . . . 0.0 112.33 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -134.41 139.55 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 112.313 177.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -117.83 98.93 6.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.365 2.266 . . . . 0.0 110.891 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 34' ' ' GLY . 14.0 p -125.33 159.3 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.796 -1.19 . . . . 0.0 110.881 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 33' ' ' VAL . . . 169.3 -176.34 43.35 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-O 121.36 0.422 . . . . 0.0 112.079 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.494 HG21 HD23 ' A' ' 98' ' ' LEU . 4.0 mp -138.39 144.7 29.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.022 0.929 . . . . 0.0 110.703 -175.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.17 106.05 16.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.508 1.523 . . . . 0.0 112.006 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.497 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 p-10 -93.45 107.66 19.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.676 1.59 . . . . 0.0 111.963 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -136.84 10.27 3.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.302 1.441 . . . . 0.0 112.206 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -8.66 55.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.656 1.582 . . . . 0.0 115.13 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.05 28.38 41.63 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.611 1.101 . . . . 0.0 114.419 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.12 128.15 3.47 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.005 1.764 . . . . 0.0 111.206 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 m -58.22 147.6 29.89 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.315 1.446 . . . . 0.0 111.35 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.712 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 45.9 m0 -110.72 173.48 6.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.875 -1.141 . . . . 0.0 112.966 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -153.63 98.78 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.573 1.549 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . . . -72.67 137.34 45.96 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.005 -1.684 . . . . 0.0 110.603 175.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.76 -64.35 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.409 0.684 . . . . 0.0 111.224 178.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -154.26 -171.82 4.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.494 1.918 . . . . 0.0 110.885 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.23 134.77 29.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.033 1.333 . . . . 0.0 111.886 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -110.3 131.0 55.44 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.832 1.253 . . . . 0.0 109.915 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 14.9 p90 -153.0 162.29 41.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.069 1.348 . . . . 0.0 111.377 174.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -124.58 -56.67 1.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.143 1.377 . . . . 0.0 109.885 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.6 m -91.83 113.3 25.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.111 0.965 . . . . 0.0 110.559 177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.09 115.78 3.71 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -76.17 -179.76 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.911 1.284 . . . . 0.0 112.238 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.4 p -79.6 163.36 24.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 112.184 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -154.74 -35.65 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.981 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 160.25 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.59 1.956 . . . . 0.0 109.709 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 tt -80.32 133.89 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.85 0.86 . . . . 0.0 110.743 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.7 tp -80.88 128.33 71.83 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.05 163.77 27.45 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.347 2.031 . . . . 0.0 111.132 175.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.9 pt-20 -112.6 -66.05 1.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.514 1.126 . . . . 0.0 110.356 178.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.6 126.74 44.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.975 0.91 . . . . 0.0 109.819 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -114.32 129.91 24.45 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.593 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.26 -172.51 0.44 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.044 3.829 . . . . 0.0 113.204 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -82.06 153.01 26.35 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 119.685 -1.884 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.9 p 49.83 42.15 23.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.618 1.567 . . . . 0.0 114.736 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -156.0 122.6 5.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.067 1.747 . . . . 0.0 113.875 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -177.86 6.82 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.497 1.519 . . . . 0.0 114.125 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -143.27 152.37 41.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.244 1.418 . . . . 0.0 110.633 174.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -123.52 164.18 19.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -136.53 166.78 22.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.089 1.755 . . . . 0.0 110.539 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.6 p -138.71 168.5 19.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.297 1.439 . . . . 0.0 111.098 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 165.97 36.63 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.337 0.97 . . . . 0.0 111.569 174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.981 1.313 . . . . 0.0 112.082 175.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.819 0 CA-C-O 121.193 0.52 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.6 105.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.77 2.428 . . . . 0.0 110.59 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -135.06 156.21 49.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.287 1.041 . . . . 0.0 110.897 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 134' ' ' LEU . . . -145.29 111.65 5.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.517 1.127 . . . . 0.0 109.091 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -125.73 154.17 42.87 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.518 1.127 . . . . 0.0 112.074 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.734 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -119.88 140.6 50.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.274 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.66 110.36 19.05 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.712 1.205 . . . . 0.0 110.022 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.618 ' HB2' HD11 ' A' ' 46' ' ' LEU . 11.2 t80 -68.72 96.0 0.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.253 1.421 . . . . 0.0 110.41 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.4 ttt -62.95 146.91 51.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.038 1.735 . . . . 0.0 111.522 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 t -53.27 -23.65 9.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.648 1.179 . . . . 0.0 114.118 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 m -67.42 0.5 2.91 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.87 54.41 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.388 0.994 . . . . 0.0 112.125 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -124.15 166.52 15.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.486 1.914 . . . . 0.0 109.649 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.734 HG22 ' HB1' ' A' ' 89' ' ' ALA . 10.5 m -137.83 101.05 4.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.159 -0.963 . . . . 0.0 111.697 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 HG21 ' A' ' 35' ' ' ILE . 13.1 tp -69.77 112.72 6.42 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.345 -0.847 . . . . 0.0 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.5 102.97 2.99 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.705 1.145 . . . . 0.0 112.782 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.62 151.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.67 0.788 . . . . 0.0 111.699 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.544 ' HB2' HD13 ' A' ' 134' ' ' LEU . 6.3 ttp -134.54 150.65 50.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.385 1.474 . . . . 0.0 111.642 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 4.6 p90 -162.34 151.37 15.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.341 1.057 . . . . 0.0 110.78 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -158.35 126.86 5.42 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 110.447 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.12 128.4 60.17 Favored Pre-proline 0 N--CA 1.48 1.049 0 O-C-N 121.209 -0.932 . . . . 0.0 111.2 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 C--N 1.355 0.875 0 C-N-CA 123.802 3.002 . . . . 0.0 112.529 176.28 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -97.67 131.16 44.48 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.078 0.951 . . . . 0.0 112.447 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.6 129.19 15.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.159 0.981 . . . . 0.0 109.941 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.73 107.76 1.52 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 m -115.83 161.5 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.368 0.667 . . . . 0.0 109.337 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.635 ' HA ' HD21 ' A' ' 151' ' ' LEU . 28.1 tttt -154.65 154.48 33.03 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.06 0.544 . . . . 0.0 111.367 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 151' ' ' LEU . 5.3 mp -107.66 110.19 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.991 0.916 . . . . 0.0 109.869 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.64 92.74 1.98 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.829 1.652 . . . . 0.0 109.919 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -68.78 81.08 0.29 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.567 -1.333 . . . . 0.0 111.497 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.13 -99.12 0.13 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.453 1.978 . . . . 0.0 112.354 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -165.33 104.19 0.74 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.911 1.684 . . . . 0.0 110.832 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -149.86 103.44 3.22 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 172.26 1.75 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.16 1.384 . . . . 0.0 112.386 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.39 119.96 19.3 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.62 -0.675 . . . . 0.0 112.184 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.62 -173.29 3.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.579 1.551 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -51.06 -52.98 38.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.427 1.091 . . . . 0.0 112.183 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.03 -31.05 64.48 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.769 0.7 . . . . 0.0 113.175 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.7 ttt -65.81 -64.45 0.86 Allowed 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -53.65 -33.67 56.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.026 0.93 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.48 -49.14 78.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.039 0.936 . . . . 0.0 109.195 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.54 -3.79 19.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 101' ' ' MET . 30.8 mt -102.78 -22.23 13.94 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.91 -25.24 9.52 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.959 -1.088 . . . . 0.0 113.671 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.56 0.85 8.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.408 1.483 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.99 71.63 0.3 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.401 1.953 . . . . 0.0 114.535 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.27 2.2 m120 85.49 57.49 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 130.203 3.401 . . . . 0.0 112.376 -175.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.91 125.0 14.47 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.763 2.976 . . . . 0.0 112.886 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.58 173.75 6.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.24 1.416 . . . . 0.0 112.82 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.06 142.84 51.43 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.119 1.767 . . . . 0.0 110.212 -174.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.09 118.07 1.66 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 121.658 0.588 . . . . 0.0 112.569 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -97.67 26.17 5.26 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.459 2.303 . . . . 0.0 114.528 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 77.12 94.86 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.235 2.614 . . . . 0.0 111.919 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 138.74 2.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.112 1.339 . . . . 0.0 112.862 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.469 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 22.4 m95 -64.59 130.81 45.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.487 1.515 . . . . 0.0 112.037 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -145.25 119.27 9.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.416 1.486 . . . . 0.0 112.114 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.91 143.02 27.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.546 1.138 . . . . 0.0 111.788 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.32 155.93 29.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.108 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 96.91 2.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.892 0.877 . . . . 0.0 108.923 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 118' ' ' LYS . 2.7 tp -49.82 -49.97 46.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.458 1.103 . . . . 0.0 112.048 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.6 80.12 1.25 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.883 1.706 . . . . 0.0 114.733 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -168.92 -36.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.819 2.047 . . . . 0.0 111.688 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.07 -80.51 0.06 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.372 1.463 . . . . 0.0 113.058 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.07 -179.2 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.786 1.235 . . . . 0.0 112.837 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -117.29 145.35 44.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 0.0 112.169 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.419 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.34 172.32 13.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.069 0.938 . . . . 0.0 112.211 -179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 18.4 ttpt -133.18 139.13 46.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.499 1.12 . . . . 0.0 110.263 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -122.55 164.46 15.56 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.233 1.397 . . . . 0.0 113.516 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.469 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 5.2 tp -139.23 95.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.18 99.04 10.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.861 -1.775 . . . . 0.0 112.351 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.71 132.68 56.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.436 1.094 . . . . 0.0 112.725 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 69.4 p -152.86 91.82 1.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.395 1.478 . . . . 0.0 112.711 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.9 52.5 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.511 -1.368 . . . . 0.0 111.57 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.8 125.94 1.44 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.252 17.5 pt-20 46.02 36.74 3.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.595 1.558 . . . . 0.0 114.195 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.21 162.46 18.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.085 2.154 . . . . 0.0 112.507 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.97 -172.68 4.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.541 1.536 . . . . 0.0 112.991 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -119.24 153.54 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.798 2.039 . . . . 0.0 111.883 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.438 HE22 HD13 ' A' ' 12' ' ' LEU . 31.4 tt0 -136.72 154.72 50.51 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.785 1.634 . . . . 0.0 110.468 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.68 120.19 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 109.731 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -112.08 111.06 21.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.581 1.552 . . . . 0.0 109.707 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.712 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 22.9 pt -97.23 144.3 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.882 1.273 . . . . 0.0 111.761 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.7 p -158.07 151.73 23.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.34 1.056 . . . . 0.0 112.535 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.679 1.591 . . . . 0.0 112.325 -176.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.21 -34.45 76.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.529 1.059 . . . . 0.0 112.75 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 159.0 12.26 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.935 0.894 . . . . 0.0 110.429 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.2 -9.13 56.07 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.261 0.934 . . . . 0.0 112.881 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -163.34 143.3 8.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.068 2.147 . . . . 0.0 110.375 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 70' ' ' LEU . 63.3 mt -143.75 160.78 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 125.377 1.471 . . . . 0.0 109.679 175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.02 -173.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 127.603 2.361 . . . . 0.0 112.008 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.28 -19.82 9.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -17.03 48.6 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.384 1.469 . . . . 0.0 112.435 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.69 67.87 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.617 1.167 . . . . 0.0 112.765 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -106.19 -2.8 22.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.261 1.824 . . . . 0.0 114.15 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.6 tp -67.11 138.65 57.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.954 1.302 . . . . 0.0 109.204 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.6 141.28 20.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.97 0.508 . . . . 0.0 110.984 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.59 -33.68 70.25 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.67 -47.45 76.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.143 1.377 . . . . 0.0 113.978 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.32 -54.28 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.653 1.181 . . . . 0.0 108.729 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.616 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.1 -33.77 27.63 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.04 1.736 . . . . 0.0 113.094 -175.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.44 -59.35 5.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.493 1.917 . . . . 0.0 110.88 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -35.76 81.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.921 1.689 . . . . 0.0 111.992 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.36 -45.8 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.129 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 32' ' ' ALA . 65.9 mt -64.42 -32.3 73.87 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 -19.78 60.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.581 1.152 . . . . 0.0 113.823 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -58.61 -32.51 69.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.859 -1.151 . . . . 0.0 111.645 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 56' ' ' ASP . 31.0 tp -58.44 -44.15 89.05 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.301 1.441 . . . . 0.0 113.037 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.67 150.45 10.01 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.414 1.007 . . . . 0.0 112.042 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -81.16 87.24 6.08 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.094 0.958 . . . . 0.0 111.07 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.54 158.26 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.932 1.693 . . . . 0.0 111.806 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.43 22.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.013 1.725 . . . . 0.0 114.249 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -141.7 120.26 12.48 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.524 1.529 . . . . 0.0 113.213 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -137.42 106.36 5.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.369 1.467 . . . . 0.0 109.703 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.0 149.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.483 1.113 . . . . 0.0 111.468 177.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -125.79 110.12 13.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.144 1.378 . . . . 0.0 111.924 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.643 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.0 OUTLIER -120.83 118.55 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.001 1.32 . . . . 0.0 109.78 175.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 168.98 40.82 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.222 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.508 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.1 mp -135.31 130.72 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.0 109.576 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.4 105.02 8.26 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.283 1.033 . . . . 0.0 111.761 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -73.22 85.56 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.671 2.388 . . . . 0.0 111.955 175.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -137.53 46.08 2.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.823 -1.173 . . . . 0.0 111.38 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -2.45 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 175.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.71 24.28 62.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.365 0.983 . . . . 0.0 114.8 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.75 114.64 1.06 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.582 1.563 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -53.42 127.59 25.49 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.945 1.298 . . . . 0.0 111.289 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.548 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 53.7 m0 -91.38 157.37 17.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -137.9 109.56 7.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.951 1.701 . . . . 0.0 111.094 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -70.99 143.22 50.88 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.314 -0.866 . . . . 0.0 110.234 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -113.02 -47.35 3.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.343 1.457 . . . . 0.0 113.066 -178.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' H ' HD22 ' A' ' 46' ' ' LEU . 54.0 t30 -156.63 171.49 20.25 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.633 1.573 . . . . 0.0 111.199 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.59 121.82 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 111.869 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.43 ' H ' ' HB1' ' A' ' 126' ' ' ALA . 3.4 t80 -100.9 129.25 46.73 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 110.017 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 24.0 p90 -153.36 160.43 42.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.911 1.285 . . . . 0.0 112.018 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -116.43 -8.1 11.62 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.497 174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 p -53.62 157.77 2.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.582 1.953 . . . . 0.0 112.79 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -35.16 -66.44 0.35 Allowed Glycine 0 N--CA 1.469 0.893 0 C-N-CA 127.96 2.695 . . . . 0.0 115.945 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.412 HG22 ' NE ' ' A' ' 74' ' ' ARG . 1.2 t -165.44 178.46 6.78 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.778 1.631 . . . . 0.0 111.492 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.9 171.39 8.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 111.648 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 24' ' ' LEU . 2.6 t0 -154.67 -28.21 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.832 -1.168 . . . . 0.0 113.294 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 24' ' ' LEU . 31.2 m -132.9 158.24 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.261 1.824 . . . . 0.0 110.832 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 tt -73.24 132.82 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.462 1.105 . . . . 0.0 111.654 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.01 122.26 82.95 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.377 1.071 . . . . 0.0 110.19 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.6 Cg_endo -64.77 114.87 2.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.359 3.373 . . . . 0.0 112.689 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.17 -55.16 17.71 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -115.58 153.64 30.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.456 1.102 . . . . 0.0 110.68 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.38 121.22 16.32 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.694 0.798 . . . . 0.0 111.592 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.94 162.06 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.716 2.277 . . . . 0.0 112.05 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -62.1 156.88 20.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.449 0.7 . . . . 0.0 112.172 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.2 p 41.78 49.44 3.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.37 1.868 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -141.24 -171.42 3.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.997 1.719 . . . . 0.0 111.361 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.14 -177.02 5.69 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.832 -1.167 . . . . 0.0 110.298 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -158.09 142.52 16.09 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.133 -0.979 . . . . 0.0 112.214 175.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -108.53 170.44 8.02 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.889 0.875 . . . . 0.0 110.735 176.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.643 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.5 t80 -152.15 165.71 33.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.473 1.509 . . . . 0.0 107.882 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.1 m -145.07 169.14 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.677 1.191 . . . . 0.0 109.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -157.54 7.19 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.314 0.483 . . . . 0.0 112.072 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.412 ' NE ' HG22 ' A' ' 54' ' ' THR . 10.4 ttp180 -144.05 160.92 40.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.59 1.556 . . . . 0.0 110.627 175.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -112.53 -49.89 2.93 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.031 -1.043 . . . . 0.0 110.688 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 50.23 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.018 2.127 . . . . 0.0 113.832 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t -139.22 13.16 2.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.091 1.756 . . . . 0.0 113.108 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.71 -112.08 0.14 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.504 1.526 . . . . 0.0 112.669 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.12 -24.57 10.99 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 CA-C-N 120.057 1.928 . . . . 0.0 112.509 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 81' ' ' ALA . 4.0 t -150.71 176.99 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 127.475 2.31 . . . . 0.0 109.78 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.486 ' H ' HG12 ' A' ' 80' ' ' VAL . . . -84.53 -35.58 22.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.91 1.684 . . . . 0.0 112.873 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -142.86 138.51 30.33 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.48 1.912 . . . . 0.0 112.825 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 128.28 -142.37 13.46 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 127.913 2.673 . . . . 0.0 111.579 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . 177.16 145.22 0.1 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.025 2.53 . . . . 0.0 112.395 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 t -147.58 121.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.48 -1.387 . . . . 0.0 113.485 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -148.08 164.72 32.98 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.46 1.104 . . . . 0.0 111.212 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.18 110.2 4.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.647 1.179 . . . . 0.0 108.369 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.05 152.92 48.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.255 1.022 . . . . 0.0 112.069 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -115.78 148.96 39.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.435 -175.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 43.6 m-85 -122.83 124.24 42.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.961 1.304 . . . . 0.0 110.105 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.56 109.26 2.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.655 1.182 . . . . 0.0 110.178 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.11 153.21 38.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.013 1.325 . . . . 0.0 111.17 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -63.87 -22.03 66.73 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.21 1.8 20.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.299 1.04 . . . . 0.0 113.781 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.76 19.52 70.45 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.663 1.125 . . . . 0.0 113.864 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -102.59 171.21 7.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 109.221 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.556 HG22 ' HB1' ' A' ' 89' ' ' ALA . 97.1 m -133.55 103.51 5.95 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.539 -1.351 . . . . 0.0 112.109 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.508 ' CD2' HG21 ' A' ' 35' ' ' ILE . 14.2 tp -69.75 126.65 30.36 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.297 -0.877 . . . . 0.0 110.345 174.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.23 107.47 3.06 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.18 165.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 117.632 0.716 . . . . 0.0 110.333 175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -151.41 140.75 21.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.232 177.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 27.6 p90 -153.34 160.04 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.662 0.744 . . . . 0.0 110.313 175.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -162.14 167.43 24.2 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.732 1.613 . . . . 0.0 109.19 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.42 106.64 57.08 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.25 -9.91 25.0 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.011 2.474 . . . . 0.0 113.234 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.66 12.5 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.575 2.75 . . . . 0.0 116.143 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -137.71 4.45 2.58 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.224 2.21 . . . . 0.0 114.183 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -130.67 61.25 1.62 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.016 1.727 . . . . 0.0 111.679 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -56.91 -19.21 16.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.243 1.017 . . . . 0.0 113.542 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -35.12 60.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.033 1.733 . . . . 0.0 112.842 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -136.57 175.27 9.76 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.309 1.444 . . . . 0.0 111.847 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.2 t -81.96 -173.95 4.78 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.91 0.862 . . . . 0.0 110.969 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.44 114.22 21.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.37 1.468 . . . . 0.0 111.38 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -73.1 148.5 43.91 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.451 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.9 p-90 -148.04 169.43 19.96 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.519 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.9 t70 179.62 163.57 0.99 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 128.048 2.539 . . . . 0.0 110.379 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.548 HG11 ' SD ' ' A' ' 157' ' ' MET . 3.6 p -165.6 136.65 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.079 2.152 . . . . 0.0 109.252 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -152.42 156.6 39.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.87 1.268 . . . . 0.0 110.483 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.79 106.16 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.658 1.583 . . . . 0.0 107.767 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -74.69 98.74 3.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.273 1.029 . . . . 0.0 109.338 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.4 t -59.07 137.49 57.93 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.738 -1.226 . . . . 0.0 110.828 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.2 -117.42 5.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.496 1.522 . . . . 0.0 110.124 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 128.16 12.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.503 1.121 . . . . 0.0 111.253 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.37 114.72 10.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.068 1.347 . . . . 0.0 111.221 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.05 164.71 23.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 110.283 174.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.43 ' HB1' ' H ' ' A' ' 49' ' ' TYR . . . -80.95 109.0 15.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.903 -0.498 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.38 -173.28 4.46 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.202 1.401 . . . . 0.0 110.019 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.63 -43.29 56.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.002 0.921 . . . . 0.0 111.202 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -33.32 38.93 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.556 1.074 . . . . 0.0 114.329 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.1 ttt -70.51 -60.15 2.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.829 0.815 . . . . 0.0 110.452 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.42 ' HA ' HD12 ' A' ' 134' ' ' LEU . 74.0 t80 -56.94 -31.18 64.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.16 0.984 . . . . 0.0 113.632 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.33 -39.15 93.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 110.148 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -26.58 67.48 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.547 -1.346 . . . . 0.0 111.872 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 131' ' ' TYR . 3.6 mt -78.39 -43.41 27.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.236 1.414 . . . . 0.0 112.028 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.08 -28.32 16.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.62 -40.42 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.802 1.641 . . . . 0.0 111.707 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.63 -58.25 8.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.749 1.642 . . . . 0.0 111.572 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -178.75 88.29 0.22 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 127.225 2.21 . . . . 0.0 111.637 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.73 141.02 40.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.303 2.002 . . . . 0.0 111.234 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -112.83 173.75 6.23 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.37 1.468 . . . . 0.0 111.575 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.98 134.08 46.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.52 1.528 . . . . 0.0 110.718 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -131.22 106.85 0.7 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.436 1.017 . . . . 0.0 112.362 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -121.5 71.97 0.99 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.133 1.373 . . . . 0.0 111.117 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 59.61 101.09 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.692 2.797 . . . . 0.0 115.868 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.2 161.88 9.65 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.454 1.026 . . . . 0.0 114.593 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.523 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 m95 -78.55 150.65 32.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.725 1.21 . . . . 0.0 110.629 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -152.04 133.13 14.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.862 1.665 . . . . 0.0 110.718 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -125.8 146.13 49.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.31 1.444 . . . . 0.0 112.387 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -150.46 157.55 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.88 0.848 . . . . 0.0 112.123 175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -80.53 92.98 5.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.486 1.514 . . . . 0.0 108.088 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 tp -52.51 -39.83 61.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.23 30.26 2.75 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.28 -22.61 1.97 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.448 1.624 . . . . 0.0 115.175 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.74 -21.56 1.82 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.265 1.412 . . . . 0.0 114.035 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 pp -124.1 173.52 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.731 1.612 . . . . 0.0 112.538 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -116.3 158.66 23.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.02 1.328 . . . . 0.0 111.336 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.548 ' SD ' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -131.31 155.03 47.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.584 0.354 . . . . 0.0 110.926 175.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.5 tppt? -126.16 127.47 45.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.545 1.938 . . . . 0.0 109.727 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.72 137.63 14.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 126.105 1.812 . . . . 0.0 112.812 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -117.13 146.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.496 1.118 . . . . 0.0 111.063 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.25 145.78 51.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.959 0.904 . . . . 0.0 109.352 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.42 HG23 ' CD1' ' A' ' 160' ' ' ILE . 42.0 p -144.03 126.62 15.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.171 1.388 . . . . 0.0 110.949 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m -89.07 178.52 6.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.002 2.121 . . . . 0.0 112.059 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.39 -178.7 0.18 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.95 2.5 . . . . 0.0 112.534 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 161.87 51.43 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 121.259 -0.901 . . . . 0.0 111.72 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 55.64 29.49 13.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.519 1.127 . . . . 0.0 112.792 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -126.53 144.56 50.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.115 1.766 . . . . 0.0 112.819 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.511 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 24.6 tptp -162.64 149.46 13.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.54 137.78 37.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.2 2.2 . . . . 0.0 112.682 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -135.6 157.33 47.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.876 1.67 . . . . 0.0 110.59 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 117' ' ' VAL . 13.3 mm -129.32 124.52 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.36 1.064 . . . . 0.0 110.769 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 131.99 54.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.425 1.49 . . . . 0.0 111.65 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.548 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 11.3 pt -118.23 134.26 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.813 1.645 . . . . 0.0 110.455 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.6 p -163.47 177.17 9.08 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.515 1.526 . . . . 0.0 110.809 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.782 1.233 . . . . 0.0 111.919 -176.21 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.734 0.302 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.83 -45.71 49.61 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.902 -1.124 . . . . 0.0 111.825 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.83 173.25 4.55 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.522 0.677 . . . . 0.0 110.388 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.63 -36.32 3.83 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.1 p -137.02 161.13 36.9 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.624 -1.515 . . . . 0.0 111.48 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 70' ' ' LEU . 36.1 mm -137.8 163.41 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.904 1.281 . . . . 0.0 110.416 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 pt -67.62 -170.84 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.893 2.077 . . . . 0.0 110.458 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.43 -28.15 4.9 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 119.722 -1.861 . . . . 0.0 115.932 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.2 69.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.465 1.031 . . . . 0.0 113.803 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.19 -42.06 39.05 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.524 1.13 . . . . 0.0 111.29 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -8.3 59.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.227 1.411 . . . . 0.0 114.106 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 17' ' ' LEU . 12.7 tp -59.83 143.79 50.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 0.0 110.305 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.25 150.74 31.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.527 1.131 . . . . 0.0 109.906 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -55.19 -26.68 40.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -62.05 -58.16 8.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.617 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.18 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.077 0.551 . . . . 0.0 109.73 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.37 -23.66 66.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.407 1.083 . . . . 0.0 113.456 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.24 -51.51 13.14 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.363 -1.461 . . . . 0.0 110.374 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -40.52 96.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.457 1.503 . . . . 0.0 112.908 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -64.07 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.164 0.986 . . . . 0.0 112.857 -174.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 32' ' ' ALA . 69.4 mt -76.9 -31.86 57.02 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 110.891 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -70.43 -37.26 74.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.933 0.893 . . . . 0.0 111.921 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -19.89 47.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.028 1.331 . . . . 0.0 114.517 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.6 -34.67 72.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.206 2.202 . . . . 0.0 113.336 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.76 -153.84 7.57 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.951 2.215 . . . . 0.0 112.789 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -132.1 14.19 4.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.53 1.932 . . . . 0.0 113.186 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.76 129.95 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.615 1.966 . . . . 0.0 111.713 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -65.22 -4.42 5.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.98 1.312 . . . . 0.0 114.391 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.665 ' HB3' HG21 ' A' ' 82' ' ' THR . 3.3 mp0 -115.28 121.48 43.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.302 2.241 . . . . 0.0 108.119 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 -175.09 4.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.811 1.245 . . . . 0.0 111.497 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.5 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -133.19 142.02 43.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 125.196 1.398 . . . . 0.0 111.946 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -127.94 115.32 18.37 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.965 1.706 . . . . 0.0 109.684 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.2 p -131.75 128.76 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.873 1.269 . . . . 0.0 109.088 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.12 -179.53 40.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.523 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 3.4 mp -130.41 146.02 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.795 0.838 . . . . 0.0 111.543 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -96.7 109.41 22.06 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.296 -0.877 . . . . 0.0 111.63 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 91.61 6.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.078 0.951 . . . . 0.0 111.244 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.1 56.74 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.25 1.42 . . . . 0.0 109.697 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t -119.77 -45.63 2.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.194 1.397 . . . . 0.0 113.346 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 13.91 2.18 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.657 1.122 . . . . 0.0 115.878 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.33 146.57 17.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.093 1.33 . . . . 0.0 112.552 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 m -73.92 145.03 45.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.718 1.607 . . . . 0.0 110.589 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.453 ' CE2' HD11 ' A' ' 173' ' ' ILE . 22.0 m0 -112.52 166.49 11.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.666 -0.647 . . . . 0.0 112.573 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.9 m -143.62 109.43 5.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.19 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -69.24 151.31 46.44 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.818 -1.176 . . . . 0.0 111.232 175.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.54 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -106.91 -55.1 2.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.7 1.6 . . . . 0.0 111.6 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -160.9 -172.95 3.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.904 1.682 . . . . 0.0 110.829 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.02 137.76 29.5 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.103 1.361 . . . . 0.0 111.325 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -121.01 127.74 52.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.515 1.526 . . . . 0.0 110.151 178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.568 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -133.35 162.79 30.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 112.584 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -124.0 -43.98 2.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.673 1.589 . . . . 0.0 112.27 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.8 p -129.61 113.28 14.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.891 1.276 . . . . 0.0 112.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 114.9 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.332 1.444 . . . . 0.0 111.485 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.09 178.72 3.65 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.875 0.845 . . . . 0.0 112.001 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.02 162.78 1.75 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.576 1.95 . . . . 0.0 112.294 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -146.38 -32.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.104 -0.998 . . . . 0.0 112.22 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.08 169.53 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.986 2.114 . . . . 0.0 111.905 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -70.27 127.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.872 1.269 . . . . 0.0 112.801 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.74 129.78 60.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.62 146.53 79.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.501 2.8 . . . . 0.0 111.244 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.89 -53.08 3.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 112.417 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -122.08 143.94 49.22 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 110.44 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.684 HG21 HD22 ' A' ' 69' ' ' LEU . 49.9 t -136.27 130.14 18.11 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.644 1.177 . . . . 0.0 110.563 -174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.02 163.15 25.85 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.88 3.054 . . . . 0.0 112.562 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -70.07 14.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -140.24 15.68 2.42 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.09 1.756 . . . . 0.0 114.268 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.88 155.1 47.37 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.524 1.13 . . . . 0.0 112.522 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.23 -177.01 3.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.609 1.195 . . . . 0.0 112.159 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -152.77 154.22 34.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 175.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CD1' HD21 ' A' ' 17' ' ' LEU . 12.7 mt -138.11 167.22 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.283 1.433 . . . . 0.0 109.495 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.2 t80 -141.71 165.83 26.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.532 1.533 . . . . 0.0 109.966 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -145.99 169.1 19.32 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.35 1.06 . . . . 0.0 110.887 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.32 177.44 27.51 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.472 1.034 . . . . 0.0 111.109 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.38 176.79 8.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.574 1.15 . . . . 0.0 112.904 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -92.52 90.41 7.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.064 1.346 . . . . 0.0 110.873 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.17 -17.13 61.4 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -155.09 18.61 0.43 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.879 2.071 . . . . 0.0 112.79 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.68 39.31 93.7 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 120.33 -1.481 . . . . 0.0 113.85 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.73 -32.02 7.92 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 124.154 3.236 . . . . 0.0 115.931 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.63 160.3 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.669 1.987 . . . . 0.0 108.929 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.56 74.81 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.252 -0.905 . . . . 0.0 112.479 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.665 HG21 ' HB3' ' A' ' 29' ' ' GLN . 6.0 t -167.54 172.99 8.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.448 1.499 . . . . 0.0 111.845 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.05 -123.29 26.64 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.18 0.895 . . . . 0.0 111.968 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.12 179.13 7.11 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.311 1.844 . . . . 0.0 111.691 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.06 113.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.773 2.029 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -148.31 176.6 10.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.058 0.943 . . . . 0.0 111.542 175.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.48 118.66 5.13 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -126.04 160.71 29.35 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.053 0.941 . . . . 0.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -118.87 169.32 9.97 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.582 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -140.51 121.32 14.44 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.559 1.144 . . . . 0.0 110.943 -177.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.17 111.08 2.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.224 1.01 . . . . 0.0 109.223 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -72.2 153.87 41.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.462 1.505 . . . . 0.0 111.034 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -58.01 -28.37 64.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -80.67 3.75 21.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.789 1.236 . . . . 0.0 114.306 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.28 -0.92 87.47 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.344 1.45 . . . . 0.0 114.516 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -78.58 178.65 7.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.61 1.564 . . . . 0.0 110.878 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.477 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 68.0 m -140.57 110.76 6.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.832 -1.168 . . . . 0.0 112.651 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 173' ' ' ILE . 27.1 tp -75.63 122.59 24.18 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.09 4.35 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 118.856 0.753 . . . . 0.0 112.471 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.41 160.99 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.294 1.047 . . . . 0.0 112.071 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.691 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -145.35 167.11 23.69 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.427 -0.796 . . . . 0.0 112.638 174.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 33' ' ' VAL . 45.1 p90 -169.48 158.6 8.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.026 1.331 . . . . 0.0 112.098 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.87 132.51 3.73 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.126 1.77 . . . . 0.0 108.381 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.93 138.15 26.31 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 119.096 0.862 . . . . 0.0 109.087 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 178.34 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.765 2.31 . . . . 0.0 111.741 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.04 171.15 14.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.906 1.282 . . . . 0.0 111.122 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.25 102.72 0.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.93 1.292 . . . . 0.0 111.661 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -152.43 162.78 40.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.281 1.032 . . . . 0.0 112.875 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.67 -51.56 14.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.404 1.482 . . . . 0.0 111.694 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -80.4 131.45 35.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.637 1.175 . . . . 0.0 111.631 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -95.56 114.51 26.27 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.153 1.381 . . . . 0.0 110.51 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.5 p -149.05 143.02 25.8 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.522 1.129 . . . . 0.0 110.787 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.16 114.62 7.16 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.437 1.095 . . . . 0.0 110.845 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -82.52 150.12 27.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.49 1.116 . . . . 0.0 112.161 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -161.44 149.01 14.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.799 1.64 . . . . 0.0 108.715 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -167.97 117.5 0.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.132 0.973 . . . . 0.0 110.871 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.44 HG11 HG21 ' A' ' 171' ' ' ILE . 46.3 t -118.12 135.2 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 123.007 0.523 . . . . 0.0 110.706 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -148.73 142.8 25.93 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.067 175.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.3 115.82 30.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -86.04 109.66 18.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 42.0 t -66.82 93.35 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.527 -1.358 . . . . 0.0 111.52 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.05 148.22 6.39 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 128.048 2.737 . . . . 0.0 111.796 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -48.13 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.68 2.392 . . . . 0.0 114.305 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -111.92 103.06 11.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.187 1.395 . . . . 0.0 112.978 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 162.49 14.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.419 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -79.08 114.44 18.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.39 -174.15 4.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.475 1.11 . . . . 0.0 111.676 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -51.12 -49.01 61.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.031 -1.043 . . . . 0.0 111.781 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.32 -36.18 45.06 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.197 0.904 . . . . 0.0 113.673 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.4 ttt -67.49 -62.43 1.42 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.792 0.837 . . . . 0.0 110.045 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -55.03 -34.13 63.24 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -64.32 -39.27 93.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.464 1.506 . . . . 0.0 110.623 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -25.14 68.16 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.873 -1.142 . . . . 0.0 111.772 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 101' ' ' MET . 1.6 mt -84.43 -44.15 13.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.661 1.184 . . . . 0.0 112.551 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.97 -29.1 25.34 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.905 1.282 . . . . 0.0 114.359 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.99 -34.04 3.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.479 1.512 . . . . 0.0 113.714 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.31 61.22 3.13 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.504 2.002 . . . . 0.0 114.516 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.86 67.25 1.13 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 127.401 2.281 . . . . 0.0 110.817 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.82 149.01 92.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.236 2.624 . . . . 0.0 112.268 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -114.9 178.68 4.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.412 1.085 . . . . 0.0 111.843 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -128.08 135.61 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.002 1.321 . . . . 0.0 111.768 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.06 97.42 2.0 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.437 1.018 . . . . 0.0 113.055 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -65.48 -79.97 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.226 1.01 . . . . 0.0 111.665 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HA ' HG22 ' A' ' 162' ' ' THR . 8.7 p30 177.75 -16.82 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.913 2.085 . . . . 0.0 115.606 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.23 163.12 20.97 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 119.939 1.245 . . . . 0.0 113.452 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.458 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 79.9 m95 -72.34 147.5 46.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.27 0.628 . . . . 0.0 110.682 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -151.75 123.31 7.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.283 1.433 . . . . 0.0 111.626 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.36 143.7 41.74 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.469 1.508 . . . . 0.0 113.599 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.71 149.76 26.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.353 1.461 . . . . 0.0 112.655 174.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.7 97.88 9.39 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.483 1.513 . . . . 0.0 108.379 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -52.96 -52.46 58.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.924 1.689 . . . . 0.0 111.425 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.04 57.14 0.01 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.392 0.996 . . . . 0.0 115.499 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.22 -27.07 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 131.69 -9.78 5.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.903 1.239 . . . . 0.0 114.671 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.01 170.08 13.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.811 1.305 . . . . 0.0 112.547 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 ttp-105 -133.58 130.24 38.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.452 1.901 . . . . 0.0 110.265 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.472 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -111.59 139.82 46.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.663 0.385 . . . . 0.0 110.852 175.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.4 128.3 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.578 1.551 . . . . 0.0 109.128 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.7 153.88 16.76 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 123.83 0.729 . . . . 0.0 112.824 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.458 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.3 OUTLIER -137.15 141.14 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.548 1.939 . . . . 0.0 108.199 175.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 115.4 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.045 1.738 . . . . 0.0 107.754 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 144' ' ' ASN . 11.4 p -109.0 170.44 8.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.338 0.655 . . . . 0.0 111.738 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.7 p -70.76 167.71 18.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.428 1.091 . . . . 0.0 112.335 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.81 147.62 27.69 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 121.213 -0.93 . . . . 0.0 112.876 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.01 80.98 0.44 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.967 1.27 . . . . 0.0 113.698 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 50.22 39.02 18.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.848 1.659 . . . . 0.0 113.707 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -138.35 170.05 16.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.247 1.419 . . . . 0.0 111.436 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.429 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 5.2 tptt -156.01 -172.45 4.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.67 0.748 . . . . 0.0 111.609 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -118.25 157.43 27.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.187 2.195 . . . . 0.0 109.846 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -164.41 150.35 10.64 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.01 1.324 . . . . 0.0 110.034 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 24.8 mm -130.84 131.5 64.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.59 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -126.99 136.76 52.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.228 1.377 . . . . 0.0 112.375 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' MET . 32.0 pt -96.52 133.88 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -142.33 164.59 29.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.638 0.775 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.353 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.308 0.099 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.09 -30.96 7.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.039 1.336 . . . . 0.0 112.718 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.07 -179.67 1.29 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.89 0.876 . . . . 0.0 110.641 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.8 -38.65 3.07 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.572 -1.33 . . . . 0.0 111.702 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.7 p -137.06 160.01 40.22 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.674 -1.486 . . . . 0.0 111.793 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.478 HD11 HD12 ' A' ' 70' ' ' LEU . 36.9 mm -136.44 163.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.164 1.385 . . . . 0.0 110.082 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -70.65 -169.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 126.979 2.112 . . . . 0.0 110.423 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.63 -23.26 4.09 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.94 73.81 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.836 0.732 . . . . 0.0 113.784 -174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.93 -42.06 40.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.695 1.198 . . . . 0.0 111.547 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.72 -6.24 57.57 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.196 1.398 . . . . 0.0 113.714 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HD23 ' A' ' 17' ' ' LEU . 21.8 tp -57.94 142.75 45.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.104 1.761 . . . . 0.0 111.02 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -146.13 145.79 30.63 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.639 1.176 . . . . 0.0 109.713 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -55.74 -29.47 59.59 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -60.01 -55.71 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.682 1.193 . . . . 0.0 112.269 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.76 -44.35 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 122.006 -0.433 . . . . 0.0 109.845 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -59.31 -32.08 69.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.229 1.012 . . . . 0.0 113.207 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.81 -55.16 14.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.159 0.983 . . . . 0.0 110.373 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -35.02 74.6 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.718 -0.614 . . . . 0.0 112.034 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -45.26 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.115 0.871 . . . . 0.0 112.645 -176.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.473 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -76.54 -24.9 53.63 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.611 0.641 . . . . 0.0 110.764 174.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.41 -26.76 62.89 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.96 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -48.54 -25.27 1.63 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 120.925 1.693 . . . . 0.0 114.483 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' HH22 ' A' ' 74' ' ' ARG . 48.0 mt -79.22 -9.32 59.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.674 1.989 . . . . 0.0 115.799 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.74 -154.17 8.5 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.297 1.904 . . . . 0.0 112.81 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -141.56 7.76 1.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.23 131.8 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.537 1.535 . . . . 0.0 113.883 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -66.56 1.69 1.62 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.94 103.37 7.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.416 1.886 . . . . 0.0 110.205 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -143.11 -173.99 4.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.279 1.832 . . . . 0.0 111.889 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -136.89 123.27 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.266 1.427 . . . . 0.0 112.019 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -107.81 91.09 3.51 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.211 2.204 . . . . 0.0 110.943 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG21 ' CD2' ' A' ' 102' ' ' PHE . 2.8 p -89.72 126.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.579 -1.326 . . . . 0.0 110.675 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.69 167.2 37.72 Favored Glycine 0 N--CA 1.462 0.373 0 CA-C-O 121.776 0.654 . . . . 0.0 114.701 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -144.29 121.68 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -76.95 105.11 7.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.037 -1.039 . . . . 0.0 111.324 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.53 93.07 4.74 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.161 -0.962 . . . . 0.0 112.013 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -142.92 39.29 1.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.323 1.058 . . . . 0.0 111.82 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.74 -0.26 54.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.047 1.739 . . . . 0.0 114.815 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.6 14.24 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.268 0.937 . . . . 0.0 114.578 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.02 135.84 7.77 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.673 1.606 . . . . 0.0 112.463 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -67.18 134.07 51.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.48 1.112 . . . . 0.0 109.262 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -95.34 163.86 13.07 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -146.27 113.93 6.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.447 1.499 . . . . 0.0 111.035 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -74.36 135.77 42.48 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 -50.32 3.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.379 1.071 . . . . 0.0 111.83 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -156.35 171.93 19.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.207 1.003 . . . . 0.0 111.964 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.58 132.49 31.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.984 1.714 . . . . 0.0 111.469 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -116.62 122.64 45.19 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.553 1.541 . . . . 0.0 110.183 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -123.62 152.55 41.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.809 2.444 . . . . 0.0 110.44 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.91 -53.25 2.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.164 0.986 . . . . 0.0 110.25 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' H ' ' A' ' 85' ' ' VAL . 2.3 t -71.21 127.0 31.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.406 1.882 . . . . 0.0 109.581 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.31 -133.26 8.51 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.175 0.893 . . . . 0.0 112.736 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.06 -156.47 0.61 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.14 1.776 . . . . 0.0 109.585 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.88 166.83 1.34 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.373 3.069 . . . . 0.0 111.928 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.63 -29.42 0.11 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 24' ' ' LEU . 12.7 m -136.17 173.01 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.244 2.218 . . . . 0.0 112.049 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.97 128.2 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.603 1.161 . . . . 0.0 111.677 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 tp -85.09 132.29 46.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.02 0.928 . . . . 0.0 109.297 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.33 122.3 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.901 3.067 . . . . 0.0 110.8 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.86 -59.39 3.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.798 0.839 . . . . 0.0 112.555 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -125.52 145.5 50.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.52 1.528 . . . . 0.0 110.169 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 69' ' ' LEU . 50.6 t -138.47 131.36 16.17 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 124.577 1.151 . . . . 0.0 108.936 -175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.42 163.97 24.22 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.782 2.988 . . . . 0.0 112.531 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.28 18.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -141.98 17.06 2.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.597 1.559 . . . . 0.0 114.173 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.438 1.472 . . . . 0.0 112.679 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.58 -176.6 5.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 122.425 1.107 . . . . 0.0 112.521 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -153.21 152.68 31.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.049 0.939 . . . . 0.0 111.592 175.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.638 ' CD1' HD21 ' A' ' 17' ' ' LEU . 10.6 mt -134.66 162.42 32.37 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.884 1.274 . . . . 0.0 111.111 174.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.28 163.91 31.49 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.066 1.346 . . . . 0.0 109.632 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 m -144.92 165.28 28.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.279 1.431 . . . . 0.0 110.164 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.68 162.88 33.79 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.41 1.481 . . . . 0.0 109.553 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.448 HH22 ' HB2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -167.5 -160.7 0.37 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.984 1.714 . . . . 0.0 111.031 176.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -48.43 83.05 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 130.277 3.431 . . . . 0.0 113.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.63 -16.18 7.79 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -120.08 5.84 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.088 2.155 . . . . 0.0 111.006 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.7 26.82 Favored Glycine 0 CA--C 1.545 1.955 0 CA-C-O 117.401 -1.777 . . . . 0.0 115.966 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.76 -39.91 10.77 Favored 'Trans proline' 0 C--N 1.357 0.991 0 CA-C-N 121.838 2.819 . . . . 0.0 115.024 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.288 4.1 p 51.48 4.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 129.492 3.117 . . . . 0.0 116.986 -175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 1.22 2.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.979 2.112 . . . . 0.0 113.859 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -132.75 128.5 37.0 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.515 1.126 . . . . 0.0 110.932 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.473 ' H ' HG21 ' A' ' 104' ' ' VAL . . . -67.39 -74.48 0.56 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.547 1.07 . . . . 0.0 111.552 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -177.76 113.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.429 1.891 . . . . 0.0 110.397 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.557 ' H ' ' HB3' ' A' ' 52' ' ' SER . 3.6 t -127.45 110.24 22.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 109.757 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -139.99 176.9 8.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 109.972 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.02 137.59 15.13 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.943 1.697 . . . . 0.0 106.498 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -143.12 162.03 36.63 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.268 0.627 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.639 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -126.71 136.79 52.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.755 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.7 m-85 -113.68 121.86 45.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 110.939 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -70.27 123.47 21.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.912 1.285 . . . . 0.0 110.211 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptm -97.1 155.09 16.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.552 0.615 . . . . 0.0 111.394 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.4 m -56.14 -22.47 28.69 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -2.03 20.87 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.767 1.227 . . . . 0.0 113.384 175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.14 84.46 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.655 1.597 . . . . 0.0 114.638 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -100.45 171.38 7.78 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.443 1.097 . . . . 0.0 110.46 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.639 HG22 ' HB1' ' A' ' 89' ' ' ALA . 81.1 m -135.03 99.89 4.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.744 1.218 . . . . 0.0 111.621 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 173' ' ' ILE . 6.4 tp -69.59 113.75 7.16 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.414 -0.804 . . . . 0.0 111.42 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.6 107.84 3.54 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.264 1.411 . . . . 0.0 109.717 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -84.2 146.11 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 117.493 0.646 . . . . 0.0 111.045 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' HD13 ' A' ' 134' ' ' LEU . 13.9 tmm? -125.23 142.47 51.48 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.925 1.29 . . . . 0.0 110.568 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 32.9 p90 -151.27 158.92 44.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.107 174.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -158.06 175.24 14.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG21 ' H ' ' A' ' 83' ' ' GLY . 27.9 m -113.47 100.05 50.92 Favored Pre-proline 0 N--CA 1.467 0.392 0 C-N-CA 126.51 1.924 . . . . 0.0 111.792 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.92 77.33 2.74 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.699 2.266 . . . . 0.0 110.063 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.91 -44.09 77.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.778 1.231 . . . . 0.0 111.838 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.47 105.95 0.29 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.975 1.31 . . . . 0.0 112.089 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -69.64 11.61 0.25 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.533 1.933 . . . . 0.0 114.671 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.9 -16.25 39.86 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.764 2.026 . . . . 0.0 114.428 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 19.8 t90 58.64 30.04 19.35 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.061 1.744 . . . . 0.0 114.345 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.46 172.87 12.66 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.839 -1.163 . . . . 0.0 113.707 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -50.81 111.06 0.49 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.165 2.186 . . . . 0.0 112.624 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.02 140.42 39.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -77.4 139.0 39.61 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.086 0.954 . . . . 0.0 112.98 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -161.83 149.27 14.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.489 1.916 . . . . 0.0 108.844 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -179.87 158.59 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.333 2.253 . . . . 0.0 111.263 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.67 147.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 127.766 2.427 . . . . 0.0 109.055 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -141.67 141.2 33.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.776 0.83 . . . . 0.0 109.635 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.6 mt -103.27 113.31 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.872 0.869 . . . . 0.0 108.693 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -82.42 111.0 18.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 t -65.42 87.51 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.015 -1.053 . . . . 0.0 111.476 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.93 164.58 11.92 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.938 2.685 . . . . 0.0 112.211 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -60.5 123.6 17.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.798 1.239 . . . . 0.0 111.778 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -133.6 104.28 6.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.589 1.555 . . . . 0.0 112.138 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.96 153.64 33.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.763 0.825 . . . . 0.0 110.634 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 117.58 21.33 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.721 0.408 . . . . 0.0 111.132 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.63 -176.8 6.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.082 1.753 . . . . 0.0 112.108 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.3 -47.23 25.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.33 1.452 . . . . 0.0 112.119 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.71 -46.99 80.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.102 0.858 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.4 ttp -60.22 -53.26 59.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.404 0.682 . . . . 0.0 110.684 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -53.35 -38.03 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.378 0.99 . . . . 0.0 113.078 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -43.54 95.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.699 1.2 . . . . 0.0 110.734 175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.59 -20.63 65.4 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.357 -1.464 . . . . 0.0 113.939 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 101' ' ' MET . 19.0 mt -92.52 -11.0 35.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.18 -35.09 3.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.011 1.324 . . . . 0.0 112.248 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -114.5 -25.55 8.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.186 1.395 . . . . 0.0 112.918 -175.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.5 -34.68 90.55 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.737 1.161 . . . . 0.0 113.752 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.09 83.44 5.6 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 126.018 1.727 . . . . 0.0 110.28 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.5 120.23 7.33 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.548 1.499 . . . . 0.0 112.325 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.76 165.02 22.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.811 1.244 . . . . 0.0 113.892 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -134.22 139.06 45.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.437 1.895 . . . . 0.0 111.531 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -127.02 110.43 1.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.907 1.241 . . . . 0.0 112.168 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -124.03 70.14 1.08 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.459 1.904 . . . . 0.0 113.364 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 50.76 60.3 3.97 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.05 2.14 . . . . 0.0 114.023 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -175.83 139.78 4.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.614 0.626 . . . . 0.0 113.92 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -63.43 135.46 56.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.031 1.332 . . . . 0.0 111.69 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -150.09 130.69 13.98 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.634 1.173 . . . . 0.0 111.672 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.66 158.5 25.39 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.118 1.767 . . . . 0.0 111.566 174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.526 ' CE ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.52 161.57 39.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.0 1.32 . . . . 0.0 110.677 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.17 93.92 4.01 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.902 0.881 . . . . 0.0 108.799 174.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 149' ' ' LYS . 5.3 tp -47.43 -32.36 4.99 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.98 1.312 . . . . 0.0 113.984 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.54 32.26 2.36 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 117.396 1.718 . . . . 0.0 117.396 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.06 -28.69 1.16 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 148.77 -24.29 1.32 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.749 1.166 . . . . 0.0 114.504 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.46 175.5 5.43 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.634 1.973 . . . . 0.0 111.626 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -126.89 165.31 19.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.009 . . . . 0.0 112.222 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.714 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -145.94 156.91 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.428 177.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.86 129.22 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.713 1.605 . . . . 0.0 108.584 -177.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.11 144.56 18.48 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.407 0.527 . . . . 0.0 113.27 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -125.2 147.71 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.273 1.429 . . . . 0.0 109.762 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.547 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -140.46 117.38 11.08 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.6 1.16 . . . . 0.0 109.3 175.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.594 HG23 HD11 ' A' ' 160' ' ' ILE . 7.9 p -122.18 147.75 45.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.641 1.176 . . . . 0.0 110.055 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -131.49 -178.31 4.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.586 1.954 . . . . 0.0 110.649 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 73.69 95.29 0.07 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.379 2.271 . . . . 0.0 113.302 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.42 -106.51 3.06 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.87 1.7 . . . . 0.0 114.355 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -115.78 17.72 15.99 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.631 2.373 . . . . 0.0 113.569 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.06 163.08 25.53 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.601 2.361 . . . . 0.0 115.021 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' A' ' 31' ' ' ILE . 8.1 tptp -163.11 155.28 18.18 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.873 1.269 . . . . 0.0 114.34 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 136.39 33.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.118 2.567 . . . . 0.0 112.512 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -141.08 154.51 45.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.026 1.73 . . . . 0.0 110.221 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 33.4 mm -124.01 120.55 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.529 1.132 . . . . 0.0 111.045 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -98.84 114.04 26.44 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.316 1.046 . . . . 0.0 109.482 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.714 HG22 ' HB3' ' A' ' 157' ' ' MET . 7.5 pt -98.12 134.18 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.801 0.44 . . . . 0.0 109.828 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 92.8 p -156.37 167.35 30.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.408 1.483 . . . . 0.0 112.458 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 111.181 0.067 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mp -106.96 -83.88 0.53 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.203 1.401 . . . . 0.0 109.385 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.92 6.55 36.41 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.123 1.769 . . . . 0.0 113.128 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.99 -16.21 39.35 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.178 1.37 . . . . 0.0 115.502 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 p -146.04 162.97 36.69 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.158 1.479 . . . . 0.0 110.28 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 70' ' ' LEU . 26.5 mm -134.73 173.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 109.38 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 pt -85.4 -171.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 129.036 2.934 . . . . 0.0 110.461 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.96 -15.19 61.92 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.3 65.71 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 124.583 1.087 . . . . 0.0 113.62 -175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.18 81.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.144 1.378 . . . . 0.0 112.956 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -1.17 53.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 113.822 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.27 140.82 58.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.042 1.337 . . . . 0.0 110.491 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.84 145.75 26.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.116 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.61 -38.17 69.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.753 0.821 . . . . 0.0 113.134 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -56.62 -50.06 73.13 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.098 0.863 . . . . 0.0 112.783 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.81 -48.41 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.903 0.881 . . . . 0.0 110.587 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -56.24 -37.62 69.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.495 1.118 . . . . 0.0 112.081 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -57.57 -55.82 29.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.447 1.899 . . . . 0.0 111.566 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -22.87 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.77 -52.3 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.514 1.506 . . . . 0.0 110.886 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.604 HD22 ' HB2' ' A' ' 32' ' ' ALA . 2.0 pp -61.72 -32.06 72.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.611 0.364 . . . . 0.0 111.721 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -85.68 -28.28 24.79 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -52.9 -21.18 3.99 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.761 2.024 . . . . 0.0 112.815 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 72' ' ' SER . 49.9 tp -48.41 -43.03 33.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.453 1.901 . . . . 0.0 111.802 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.08 142.44 6.88 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.76 1.171 . . . . 0.0 112.469 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -75.86 85.52 2.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.574 1.15 . . . . 0.0 111.898 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.18 173.91 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.154 2.182 . . . . 0.0 111.482 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.7 m -63.09 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.666 1.986 . . . . 0.0 112.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 56.98 -179.74 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.845 2.458 . . . . 0.0 112.921 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -177.68 5.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.791 1.636 . . . . 0.0 110.808 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -107.88 148.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.609 1.164 . . . . 0.0 110.73 175.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.604 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -134.04 100.04 4.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.925 1.69 . . . . 0.0 111.035 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 p -113.94 144.88 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.117 1.367 . . . . 0.0 107.396 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.36 167.27 36.5 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 118.418 0.554 . . . . 0.0 114.425 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.21 145.84 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.703 1.201 . . . . 0.0 110.872 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -107.68 104.25 13.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 111.472 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.41 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 3.5 p30 -89.12 116.95 27.76 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.377 1.471 . . . . 0.0 112.187 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -150.03 14.9 0.82 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.885 0.85 . . . . 0.0 112.182 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -78.55 -45.88 20.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.608 1.563 . . . . 0.0 114.356 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.63 16.82 1.43 Allowed Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.39 133.96 6.74 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.491 1.646 . . . . 0.0 113.006 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.7 m -69.93 122.11 18.66 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.236 1.414 . . . . 0.0 110.906 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.467 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 37.8 m0 -91.03 161.8 14.97 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.827 -0.546 . . . . 0.0 111.805 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 m -136.66 109.82 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.059 1.743 . . . . 0.0 111.088 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.9 114.14 4.9 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.914 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.728 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -75.95 -61.4 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.868 1.267 . . . . 0.0 111.385 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -159.9 169.88 22.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.985 1.314 . . . . 0.0 111.966 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.72 135.44 40.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.869 2.068 . . . . 0.0 111.047 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.451 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.3 t80 -120.71 130.61 54.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.453 1.501 . . . . 0.0 109.8 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -127.47 140.42 52.16 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.784 2.034 . . . . 0.0 109.838 -178.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -0.91 14.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.198 1.399 . . . . 0.0 113.842 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.9 p -80.23 -155.23 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.068 1.347 . . . . 0.0 109.781 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.78 -76.07 0.25 Allowed Glycine 0 N--CA 1.471 0.986 0 O-C-N 120.579 -1.326 . . . . 0.0 114.267 -175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -162.38 -178.14 6.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.349 1.46 . . . . 0.0 111.307 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 160.37 20.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.315 1.446 . . . . 0.0 113.69 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -141.81 -29.03 0.62 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.65 159.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.081 1.353 . . . . 0.0 111.787 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.9 tp -79.44 133.88 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.191 0.996 . . . . 0.0 109.583 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.0 tp -84.33 124.4 73.87 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.572 1.149 . . . . 0.0 109.642 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 69' ' ' LEU . 53.7 Cg_endo -64.74 120.09 7.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.706 3.604 . . . . 0.0 112.52 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.3 -55.19 23.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.41 150.62 36.11 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.728 1.211 . . . . 0.0 109.62 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.0 135.1 18.34 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.66 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -67.26 -164.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.702 2.935 . . . . 0.0 112.364 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -114.3 25.63 10.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.649 1.58 . . . . 0.0 113.712 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -149.44 8.36 0.7 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.279 1.431 . . . . 0.0 114.434 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -144.84 113.53 6.74 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.781 1.628 . . . . 0.0 114.459 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.01 174.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.748 1.219 . . . . 0.0 112.675 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -149.12 154.05 38.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.613 -0.679 . . . . 0.0 112.05 177.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.561 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -125.82 175.96 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.496 0.718 . . . . 0.0 112.42 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -147.64 161.51 41.0 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.526 1.53 . . . . 0.0 110.525 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD22 ' A' ' 24' ' ' LEU . 77.0 p -152.95 165.34 35.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.849 1.26 . . . . 0.0 112.451 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.38 172.75 24.14 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.027 0.822 . . . . 0.0 114.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -125.67 170.28 11.68 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.0 86.93 2.57 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.565 2.346 . . . . 0.0 108.528 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -115.74 -18.49 10.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.084 0.954 . . . . 0.0 113.231 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.2 t -155.64 11.8 0.32 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.844 1.658 . . . . 0.0 113.658 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.94 -113.05 2.69 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.93 -30.77 20.94 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.121 2.547 . . . . 0.0 115.123 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.0 t 23.47 67.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 129.314 3.046 . . . . 0.0 113.751 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -174.58 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.661 1.985 . . . . 0.0 112.224 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.1 p -122.54 -173.52 2.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.913 2.085 . . . . 0.0 109.88 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.04 -178.35 3.26 Favored Glycine 0 CA--C 1.545 1.918 0 CA-C-O 122.297 0.943 . . . . 0.0 114.765 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 169.43 10.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.711 1.205 . . . . 0.0 112.314 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -148.21 116.95 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.392 1.077 . . . . 0.0 111.705 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -151.24 173.01 14.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.374 1.47 . . . . 0.0 111.288 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.61 127.82 9.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.417 1.087 . . . . 0.0 109.476 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.92 173.85 11.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.474 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -136.18 149.71 48.71 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -128.69 117.2 20.77 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.361 1.864 . . . . 0.0 111.78 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -69.06 104.91 2.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.916 1.686 . . . . 0.0 109.816 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.8 mtp -66.5 148.75 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.216 1.007 . . . . 0.0 110.569 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -24.63 63.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.272 1.029 . . . . 0.0 113.501 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t -69.58 -13.7 62.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.342 1.857 . . . . 0.0 114.494 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.34 12.34 48.82 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.677 1.132 . . . . 0.0 114.967 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -103.17 175.43 5.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.373 2.269 . . . . 0.0 110.088 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.465 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 20.1 m -138.25 110.29 7.28 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.033 -1.042 . . . . 0.0 112.715 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.4 tp -74.67 113.45 11.95 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.551 1.14 . . . . 0.0 112.936 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.0 102.68 2.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.36 1.933 . . . . 0.0 110.401 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.4 160.27 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.535 1.134 . . . . 0.0 110.591 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -142.08 153.31 44.07 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.387 0.675 . . . . 0.0 111.556 174.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 16.4 p90 -161.23 156.11 23.7 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.783 1.233 . . . . 0.0 110.834 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 t -168.63 138.44 2.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.788 1.235 . . . . 0.0 109.221 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.42 95.71 7.48 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -72.36 171.71 16.42 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.035 2.49 . . . . 0.0 111.628 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -150.15 140.87 22.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.024 1.33 . . . . 0.0 110.808 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.1 t70 64.19 110.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.262 2.625 . . . . 0.0 115.061 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -94.08 82.37 4.18 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.607 1.563 . . . . 0.0 111.429 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.12 -51.82 67.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.204 -0.935 . . . . 0.0 111.511 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -159.15 -43.15 0.06 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.183 2.193 . . . . 0.0 111.589 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -77.54 138.35 39.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.971 1.309 . . . . 0.0 112.735 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.1 m -77.15 172.57 13.03 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.797 0.808 . . . . 0.0 110.07 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -61.66 170.57 1.89 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.115 1.366 . . . . 0.0 112.121 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.447 ' CZ2' ' CE2' ' A' ' 135' ' ' TYR . 15.0 p-90 -114.09 157.98 21.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.7 0.8 . . . . 0.0 112.548 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -158.02 174.14 15.69 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.605 1.962 . . . . 0.0 110.12 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 154.96 133.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 129.221 3.009 . . . . 0.0 112.347 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.04 140.95 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.261 1.024 . . . . 0.0 109.015 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -133.35 149.32 51.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.801 1.24 . . . . 0.0 109.177 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 155' ' ' LEU . 79.2 mt -110.92 98.46 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.103 0.961 . . . . 0.0 109.024 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.19 99.94 0.2 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.402 1.081 . . . . 0.0 109.46 174.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.9 t -68.22 84.97 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.423 1.089 . . . . 0.0 110.86 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.98 -114.9 0.69 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.797 2.142 . . . . 0.0 110.302 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -150.35 123.34 8.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.965 1.306 . . . . 0.0 111.404 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.69 105.96 4.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.565 1.546 . . . . 0.0 112.48 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.26 167.22 3.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.416 1.086 . . . . 0.0 111.461 174.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -80.54 112.33 17.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.08 -0.388 . . . . 0.0 111.21 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.28 -179.44 6.94 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -51.85 -42.04 62.29 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.001 -1.062 . . . . 0.0 112.018 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.71 97.06 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.389 0.995 . . . . 0.0 113.798 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 1.2 ppp? -65.01 -45.72 84.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.798 1.299 . . . . 0.0 111.297 174.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -57.54 -39.92 77.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.693 0.797 . . . . 0.0 110.99 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -67.09 -40.47 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.474 1.11 . . . . 0.0 112.221 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.67 -29.77 70.96 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.443 -1.411 . . . . 0.0 112.883 174.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -76.38 -55.6 5.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.211 1.405 . . . . 0.0 111.615 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.447 ' CE2' ' CZ2' ' A' ' 114' ' ' TRP . 10.8 m-85 -76.5 -26.91 55.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -126.85 -33.85 2.44 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.213 1.005 . . . . 0.0 113.444 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.38 -49.41 45.16 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.839 1.209 . . . . 0.0 112.527 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -166.58 73.63 1.14 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 126.133 1.773 . . . . 0.0 111.565 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 133.01 23.92 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.34 2.026 . . . . 0.0 112.127 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -112.15 -175.17 2.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.552 2.341 . . . . 0.0 111.832 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -134.34 139.56 45.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.146 2.179 . . . . 0.0 110.636 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.36 91.13 0.14 Allowed Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.771 0.714 . . . . 0.0 113.823 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.63 -47.31 19.61 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.81 -1.406 . . . . 0.0 113.438 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 p30 179.37 88.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.974 2.51 . . . . 0.0 112.062 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.19 148.23 6.63 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.48 -0.762 . . . . 0.0 114.255 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.401 ' CD2' ' HB ' ' A' ' 160' ' ' ILE . 85.9 m95 -77.54 145.19 37.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.712 1.205 . . . . 0.0 111.206 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -153.2 141.37 20.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.271 1.429 . . . . 0.0 111.641 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -118.03 147.2 43.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.851 1.66 . . . . 0.0 111.207 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -149.82 166.45 29.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.309 1.044 . . . . 0.0 112.069 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -79.92 108.31 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 157' ' ' MET . 10.3 tp -66.74 -32.76 74.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.61 14.16 4.9 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.52 -26.06 3.07 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.141 1.471 . . . . 0.0 114.704 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.2 10.78 1.27 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.423 -1.21 . . . . 0.0 115.469 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -138.75 165.5 26.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.534 1.667 . . . . 0.0 112.369 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.01 141.33 52.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.597 1.159 . . . . 0.0 108.947 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -126.0 157.68 37.24 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.601 0.76 . . . . 0.0 109.386 175.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.9 129.25 56.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.1 159.03 19.7 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 123.34 0.495 . . . . 0.0 112.467 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.705 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -140.39 156.05 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.842 1.657 . . . . 0.0 110.432 176.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -153.73 114.21 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.705 HG23 HD11 ' A' ' 160' ' ' ILE . 6.8 p -102.03 150.97 22.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.818 0.847 . . . . 0.0 110.425 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.31 156.14 45.98 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.029 1.731 . . . . 0.0 110.431 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.17 128.5 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.995 2.518 . . . . 0.0 112.908 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.86 -179.0 51.73 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 122.229 0.905 . . . . 0.0 114.244 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.32 80.83 1.36 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.414 1.885 . . . . 0.0 112.48 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.55 164.0 34.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.739 1.216 . . . . 0.0 112.802 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -153.54 -178.91 7.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.746 1.619 . . . . 0.0 113.636 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.433 ' SD ' ' HE3' ' A' ' 101' ' ' MET . 20.0 ptm -102.11 166.62 10.51 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.896 2.079 . . . . 0.0 113.653 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -154.8 153.76 31.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.888 1.275 . . . . 0.0 109.955 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.8 mm -135.47 117.63 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.892 1.277 . . . . 0.0 110.114 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -112.89 111.94 23.05 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.867 -1.146 . . . . 0.0 111.503 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.467 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.0 pt -95.51 131.73 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 109.086 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.5 t -150.71 158.76 44.53 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.633 -0.667 . . . . 0.0 111.227 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.127 1.371 . . . . 0.0 112.185 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.74 -61.77 2.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.825 1.193 . . . . 0.0 112.87 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.56 -41.39 1.45 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.55 -25.56 8.97 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 125.423 1.487 . . . . 0.0 116.213 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 p -138.34 158.18 44.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.694 1.747 . . . . 0.0 111.447 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mm -136.2 165.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.774 -1.204 . . . . 0.0 110.382 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -170.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.881 1.273 . . . . 0.0 110.764 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.4 -43.75 5.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 -29.56 6.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.18 1.371 . . . . 0.0 112.897 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.13 73.64 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.296 1.048 . . . . 0.0 111.491 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.4 m -86.53 -8.53 57.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.823 2.049 . . . . 0.0 114.345 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.63 131.36 45.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.47 1.108 . . . . 0.0 109.21 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.612 1.165 . . . . 0.0 109.163 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -54.61 -29.58 52.19 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.928 0.785 . . . . 0.0 112.988 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -58.28 -56.74 18.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 112.434 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.46 -44.62 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.893 0.877 . . . . 0.0 109.841 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -62.25 -25.48 67.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.591 1.156 . . . . 0.0 113.472 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -74.72 -53.1 9.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.102 -1.624 . . . . 0.0 110.373 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -39.85 83.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 112.934 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 17' ' ' LEU . 1.6 p -68.65 -33.36 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.339 0.972 . . . . 0.0 113.082 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 32' ' ' ALA . 82.5 mt -78.8 -36.59 42.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.498 0.719 . . . . 0.0 110.522 175.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.84 -44.14 97.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.814 0.846 . . . . 0.0 111.664 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -20.53 57.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.41 -28.76 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.327 1.851 . . . . 0.0 112.731 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.45 -143.47 4.04 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.681 2.086 . . . . 0.0 112.237 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -135.42 21.87 3.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.902 2.081 . . . . 0.0 112.8 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.03 125.98 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.009 1.724 . . . . 0.0 111.468 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.74 3.92 0.93 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.575 1.55 . . . . 0.0 114.508 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.51 111.72 7.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.839 2.056 . . . . 0.0 109.634 -175.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -138.4 176.82 8.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.962 1.705 . . . . 0.0 112.061 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -102.0 148.72 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.519 1.128 . . . . 0.0 111.426 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -139.51 97.74 3.34 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.58 1.952 . . . . 0.0 111.19 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.6 p -107.41 129.77 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 120.942 -1.099 . . . . 0.0 110.248 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.95 171.49 42.37 Favored Glycine 0 C--O 1.235 0.205 0 O-C-N 121.57 -0.706 . . . . 0.0 114.273 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.636 HG21 HD21 ' A' ' 98' ' ' LEU . 3.5 mp -139.61 122.85 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 0.0 109.99 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.97 102.66 2.05 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.387 -1.445 . . . . 0.0 111.747 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -76.75 92.0 3.53 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.4 -0.813 . . . . 0.0 112.225 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -143.54 48.78 1.43 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.057 0.943 . . . . 0.0 111.586 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -109.8 -8.43 14.91 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.31 57.07 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.561 1.077 . . . . 0.0 115.558 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.44 134.68 6.98 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.129 1.347 . . . . 0.0 113.059 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.2 m -61.87 141.2 58.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.999 1.32 . . . . 0.0 110.816 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 48.9 m0 -104.68 163.49 12.45 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.472 -0.768 . . . . 0.0 111.343 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -143.41 102.0 3.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.022 1.329 . . . . 0.0 111.02 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.98 163.36 22.39 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.292 -0.88 . . . . 0.0 111.131 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.23 -60.65 1.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.126 1.371 . . . . 0.0 111.062 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -153.01 -173.84 4.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 111.096 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 147.96 35.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.44 1.496 . . . . 0.0 110.895 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 2.8 t80 -132.13 134.59 45.61 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.135 1.374 . . . . 0.0 110.568 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -143.48 157.9 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.204 2.202 . . . . 0.0 111.223 -174.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -127.13 -37.14 2.09 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.092 1.357 . . . . 0.0 112.924 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.3 t -133.46 92.97 3.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.25 121.19 2.1 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.344 0.973 . . . . 0.0 114.726 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -179.04 1.46 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.11 1.764 . . . . 0.0 112.759 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -88.16 158.56 18.5 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.779 1.232 . . . . 0.0 111.673 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -155.49 -22.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.163 1.385 . . . . 0.0 112.608 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 m -128.13 161.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.712 2.005 . . . . 0.0 110.353 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 tt -91.92 135.26 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.302 1.441 . . . . 0.0 110.975 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.99 125.85 86.33 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 0.0 109.123 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG2' HD12 ' A' ' 69' ' ' LEU . 60.2 Cg_endo -64.02 148.47 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.197 2.598 . . . . 0.0 111.043 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.48 -56.14 3.14 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.749 0.82 . . . . 0.0 112.309 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -119.2 134.97 54.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.094 1.358 . . . . 0.0 110.334 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.965 HG21 HD13 ' A' ' 69' ' ' LEU . 92.5 t -133.4 132.77 22.15 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.526 1.13 . . . . 0.0 111.484 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.56 164.28 35.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.807 3.005 . . . . 0.0 112.557 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 22.03 0.2 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.0 1.72 . . . . 0.0 115.381 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 p -146.7 23.53 1.25 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.528 1.531 . . . . 0.0 113.379 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -148.06 130.55 15.8 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.878 1.217 . . . . 0.0 112.607 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.04 179.17 5.79 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.365 1.079 . . . . 0.0 111.443 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 HG21 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -153.66 142.97 21.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.812 1.245 . . . . 0.0 109.588 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 33' ' ' VAL . 4.8 mt -122.39 -178.05 3.79 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.584 1.154 . . . . 0.0 110.555 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -155.5 164.76 38.26 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.689 -1.257 . . . . 0.0 110.326 174.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.481 ' HA ' HG23 ' A' ' 31' ' ' ILE . 8.6 t -142.65 174.54 10.55 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.093 0.957 . . . . 0.0 111.943 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.06 -171.55 12.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.385 1.469 . . . . 0.0 112.61 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.02 -163.81 1.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.658 1.583 . . . . 0.0 114.484 -175.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.98 84.24 3.81 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.445 1.898 . . . . 0.0 112.253 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -77.32 -20.1 55.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.7 t -143.15 17.44 1.91 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.268 2.227 . . . . 0.0 112.042 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.84 38.93 89.77 Favored Glycine 0 CA--C 1.548 2.121 0 CA-C-O 117.85 -1.528 . . . . 0.0 114.317 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.47 -44.95 10.17 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.642 2.895 . . . . 0.0 112.68 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 81' ' ' ALA 0.269 0.4 OUTLIER 46.96 -168.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 128.101 2.561 . . . . 0.0 112.499 -175.043 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 80' ' ' VAL . . . 64.09 -14.28 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.572 2.349 . . . . 0.0 116.239 175.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.57 -175.41 4.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.729 3.211 . . . . 0.0 109.252 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.48 -80.25 1.28 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.319 -0.711 . . . . 0.0 113.145 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.98 -174.45 2.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.465 1.506 . . . . 0.0 113.471 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.33 114.52 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 128.031 2.533 . . . . 0.0 110.742 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.05 177.13 10.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.275 1.43 . . . . 0.0 111.887 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.54 127.84 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.394 1.477 . . . . 0.0 109.059 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -132.36 159.9 37.87 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.805 0.842 . . . . 0.0 112.066 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -124.33 144.35 50.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.114 0.565 . . . . 0.0 111.29 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 21.8 m-85 -118.61 121.9 41.29 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.485 1.514 . . . . 0.0 110.2 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.65 111.59 4.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.912 1.285 . . . . 0.0 110.354 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.7 mtp -72.32 142.68 48.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.745 1.218 . . . . 0.0 110.4 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.3 t -53.86 -33.7 57.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.433 1.093 . . . . 0.0 113.89 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -10.51 30.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.52 26.4 9.29 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.506 1.05 . . . . 0.0 114.291 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -117.73 177.53 4.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.383 1.873 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.5 m -140.21 106.19 5.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.9 1.28 . . . . 0.0 111.704 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 35' ' ' ILE . 26.0 tp -74.95 118.83 18.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.182 0.993 . . . . 0.0 110.314 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.81 107.51 3.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.88 1.229 . . . . 0.0 113.521 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -89.67 158.49 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 112.533 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.43 168.86 18.81 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.241 1.016 . . . . 0.0 112.136 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 47.0 p90 -171.68 150.31 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.633 1.573 . . . . 0.0 110.375 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.8 m -162.01 130.63 4.26 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.494 1.518 . . . . 0.0 107.355 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.862 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.1 t -107.04 128.45 26.05 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.438 -0.791 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.73 136.41 45.61 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.493 2.129 . . . . 0.0 111.258 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -38.68 -58.75 1.02 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.631 1.972 . . . . 0.0 113.17 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.99 121.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.7 2.0 . . . . 0.0 109.43 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 42.19 53.21 4.43 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.86 1.664 . . . . 0.0 113.536 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -60.16 -13.26 11.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.451 1.501 . . . . 0.0 114.737 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.93 34.02 22.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.02 1.728 . . . . 0.0 113.148 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 166.4 26.03 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.812 1.645 . . . . 0.0 111.806 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.5 p -67.67 161.06 26.71 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.744 0.783 . . . . 0.0 110.406 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -100.51 172.44 7.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.752 1.221 . . . . 0.0 111.461 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -121.69 144.92 48.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.922 1.289 . . . . 0.0 112.267 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -155.51 160.24 40.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.535 1.134 . . . . 0.0 110.474 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 t70 173.7 132.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.167 2.987 . . . . 0.0 111.008 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.17 140.92 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.72 1.608 . . . . 0.0 109.794 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -135.61 158.57 44.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.304 1.441 . . . . 0.0 110.805 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.22 99.4 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.769 1.628 . . . . 0.0 108.088 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -65.32 103.77 0.85 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.144 -0.972 . . . . 0.0 109.67 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.1 t -68.79 83.43 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.634 -1.291 . . . . 0.0 111.347 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.76 -111.64 0.49 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 127.117 2.294 . . . . 0.0 111.502 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -146.26 135.84 23.12 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.89 1.676 . . . . 0.0 111.852 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -158.31 113.84 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.695 1.598 . . . . 0.0 112.15 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 165.63 24.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.165 0.586 . . . . 0.0 111.236 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.67 113.04 16.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.647 0.779 . . . . 0.0 110.37 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -158.88 -174.74 4.91 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.698 1.599 . . . . 0.0 112.839 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -50.61 -40.95 54.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.256 -0.902 . . . . 0.0 112.865 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.91 -39.91 56.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.246 0.93 . . . . 0.0 113.269 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.3 ttt -67.41 -57.79 5.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.41 1.084 . . . . 0.0 111.507 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -53.47 -34.91 59.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.38 0.991 . . . . 0.0 112.691 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -66.64 -46.81 74.57 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.206 1.002 . . . . 0.0 111.384 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -25.75 66.9 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.502 -1.374 . . . . 0.0 113.122 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.35 -45.07 57.26 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.727 2.011 . . . . 0.0 113.11 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.69 -31.76 14.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -116.31 -20.95 9.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.897 1.279 . . . . 0.0 113.163 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.68 -63.85 2.25 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.568 1.556 . . . . 0.0 114.166 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -122.52 64.45 21.58 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.898 1.279 . . . . 0.0 112.161 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -60.65 122.66 11.6 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.999 2.466 . . . . 0.0 112.851 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.37 -171.9 2.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.405 1.482 . . . . 0.0 111.351 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -139.26 135.58 34.03 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.735 -1.228 . . . . 0.0 112.997 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.73 8.16 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.265 1.412 . . . . 0.0 110.697 175.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -130.65 56.71 1.76 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.043 1.337 . . . . 0.0 110.825 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.5 p30 40.41 65.06 0.82 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.506 2.322 . . . . 0.0 115.432 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.28 154.02 21.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.819 1.199 . . . . 0.0 113.158 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.46 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 42.6 m95 -70.01 142.33 52.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.17 . . . . 0.0 110.951 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -145.4 131.67 19.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.799 1.239 . . . . 0.0 111.929 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -107.24 141.88 37.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 112.147 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -148.37 157.74 43.67 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 123.336 1.541 . . . . 0.0 112.248 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.502 ' H ' ' ND2' ' A' ' 150' ' ' ASN . 0.5 OUTLIER -90.11 88.28 7.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.828 2.851 . . . . 0.0 106.436 175.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.475 HD13 ' SD ' ' A' ' 157' ' ' MET . 8.1 tp -54.54 -27.84 41.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.594 1.557 . . . . 0.0 114.26 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.76 36.62 2.75 Favored Glycine 0 CA--C 1.535 1.343 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -133.12 -20.32 2.17 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.1 2.96 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.579 1.085 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -132.47 176.68 8.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.378 1.871 . . . . 0.0 111.665 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -116.24 163.4 16.05 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.664 1.186 . . . . 0.0 111.127 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.174 0.988 . . . . 0.0 112.274 174.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -116.16 124.6 50.72 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 126.726 2.011 . . . . 0.0 108.144 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.21 149.26 18.58 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 119.095 0.861 . . . . 0.0 112.98 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.46 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -134.67 151.5 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.738 1.615 . . . . 0.0 108.919 176.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.9 tpp -156.45 109.01 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.722 1.609 . . . . 0.0 108.462 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.7 p -132.72 156.0 47.82 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.96 2.104 . . . . 0.0 110.037 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.9 p -158.21 -176.48 5.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.859 1.663 . . . . 0.0 110.882 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.82 34.98 14.03 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.855 1.662 . . . . 0.0 115.45 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 148.46 88.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.466 1.031 . . . . 0.0 113.274 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 44.8 55.64 5.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.17 2.588 . . . . 0.0 112.166 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.26 163.69 32.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.051 1.74 . . . . 0.0 113.804 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.862 ' HE2' HG22 ' A' ' 104' ' ' VAL . 1.8 tptp -159.09 -168.34 2.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.518 ' H ' ' HG3' ' A' ' 168' ' ' LYS . 19.7 ptm -121.31 149.5 42.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.058 1.743 . . . . 0.0 111.06 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.514 ' C ' HD12 ' A' ' 171' ' ' ILE . 13.2 tt0 -167.51 152.37 6.99 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.391 1.476 . . . . 0.0 109.177 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 1.8 mp -122.75 122.0 64.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 123.579 0.752 . . . . 0.0 109.243 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 114.11 25.74 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.08 1.352 . . . . 0.0 108.365 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 157' ' ' MET . 8.4 pt -99.66 134.83 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.086 0.554 . . . . 0.0 110.531 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p -155.88 165.06 37.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.711 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.961 1.304 . . . . 0.0 112.474 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -92.29 -36.41 13.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.932 0.893 . . . . 0.0 110.926 175.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.22 169.22 2.21 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 121.805 0.812 . . . . 0.0 110.592 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.66 -40.01 2.57 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.7 p -131.51 155.79 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.678 1.591 . . . . 0.0 111.61 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mm -140.31 160.59 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.268 1.427 . . . . 0.0 110.283 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.664 HD12 ' H ' ' A' ' 9' ' ' GLY . 1.2 pp -66.73 -171.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.082 2.553 . . . . 0.0 111.67 174.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.34 -28.29 58.53 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.664 ' H ' HD12 ' A' ' 7' ' ' ILE . . . 95.64 -16.26 61.56 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.212 1.386 . . . . 0.0 112.929 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.72 -43.03 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.705 1.202 . . . . 0.0 111.799 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 7' ' ' ILE . 92.3 p -85.48 -13.09 50.2 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.7 HD13 HD23 ' A' ' 17' ' ' LEU . 1.5 tp -53.7 138.61 34.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.862 2.065 . . . . 0.0 110.021 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.42 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.6 m -145.7 149.51 34.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.9 0.88 . . . . 0.0 109.618 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -52.7 -26.49 14.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.29 -51.31 64.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.168 0.987 . . . . 0.0 112.11 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.23 -39.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.35 -0.844 . . . . 0.0 110.776 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.7 HD23 HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -62.41 -23.98 67.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.314 1.046 . . . . 0.0 112.338 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.16 -54.22 13.83 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.352 -1.467 . . . . 0.0 109.021 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -55.78 -44.75 78.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.373 1.069 . . . . 0.0 112.62 175.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG23 HD22 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -63.04 -35.91 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.331 0.969 . . . . 0.0 113.414 -175.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 32' ' ' ALA . 35.2 mt -84.93 -32.3 23.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 111.801 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.23 -23.01 66.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.269 0.627 . . . . 0.0 111.584 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -48.15 -25.91 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.36 1.864 . . . . 0.0 113.657 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.0 mt -52.3 -29.19 22.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.576 1.55 . . . . 0.0 112.317 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.53 -129.07 1.19 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.912 1.244 . . . . 0.0 113.75 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -139.73 34.16 2.0 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.425 2.69 . . . . 0.0 110.74 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.65 167.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 128.249 2.62 . . . . 0.0 112.816 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.6 p -68.24 -6.51 24.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.567 1.547 . . . . 0.0 115.043 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -68.76 104.78 2.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.387 1.475 . . . . 0.0 110.394 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HZ3' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -153.38 116.77 4.64 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 111.286 -177.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -131.25 133.55 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.891 0.877 . . . . 0.0 111.635 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -115.6 102.62 9.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.107 2.163 . . . . 0.0 113.843 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.609 HG11 ' CE1' ' A' ' 102' ' ' PHE . 2.1 p -114.02 121.33 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.571 -1.331 . . . . 0.0 109.96 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.83 33.81 Favored Glycine 0 N--CA 1.461 0.363 0 O-C-N 121.053 -1.029 . . . . 0.0 112.956 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.717 HD11 ' HB ' ' A' ' 100' ' ' VAL . 2.2 mp -141.42 134.45 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.335 1.064 . . . . 0.0 113.817 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 2.6 m-20 -76.41 106.76 8.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.69 1.596 . . . . 0.0 113.148 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -84.06 104.27 13.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.683 1.23 . . . . 0.0 112.977 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -145.49 23.8 1.43 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.078 -1.014 . . . . 0.0 113.021 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.51 -9.52 54.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.496 1.519 . . . . 0.0 114.66 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.95 49.48 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.493 1.044 . . . . 0.0 115.148 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.62 110.66 0.91 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.833 1.682 . . . . 0.0 110.166 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.9 m -59.58 147.2 38.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.801 1.3 . . . . 0.0 110.906 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -117.3 161.41 19.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.53 0.732 . . . . 0.0 111.506 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -133.01 113.63 13.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.331 2.253 . . . . 0.0 111.996 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -75.41 115.64 15.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.599 1.159 . . . . 0.0 110.831 175.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -71.85 -54.85 8.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.521 1.528 . . . . 0.0 110.259 175.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.74 -174.03 3.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.72 1.608 . . . . 0.0 111.825 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 144.67 28.22 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.53 1.532 . . . . 0.0 111.622 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -116.62 119.94 37.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.54 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.32 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.565 1.546 . . . . 0.0 109.562 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -5.12 43.64 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.162 1.385 . . . . 0.0 113.833 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.1 p -73.56 -137.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.017 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.85 -84.55 0.91 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.446 1.022 . . . . 0.0 112.663 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -146.17 176.03 10.05 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.517 1.127 . . . . 0.0 112.193 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -77.74 158.36 29.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.38 1.472 . . . . 0.0 113.051 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -135.22 -34.14 0.87 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.688 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 71' ' ' TYR . 19.7 m -132.0 176.84 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.855 2.062 . . . . 0.0 110.129 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -100.93 131.8 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.442 1.497 . . . . 0.0 110.987 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.26 131.61 52.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.656 ' HG2' HD12 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -63.63 177.68 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.165 3.243 . . . . 0.0 112.411 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -117.81 -36.68 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.839 1.256 . . . . 0.0 112.279 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.13 157.92 33.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.952 1.301 . . . . 0.0 111.72 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.99 97.44 7.92 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 124.747 1.219 . . . . 0.0 108.681 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.99 174.61 12.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.795 1.663 . . . . 0.0 110.54 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -63.2 165.49 7.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.45 0.7 . . . . 0.0 109.887 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 t 46.08 30.81 1.01 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.162 1.385 . . . . 0.0 113.14 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -145.26 158.68 43.77 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.916 1.686 . . . . 0.0 112.138 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -140.34 -173.84 3.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.707 1.242 . . . . 0.0 110.105 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -156.91 153.88 28.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.926 175.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 32' ' ' ALA . 14.2 mt -139.26 155.16 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.796 1.238 . . . . 0.0 108.578 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -129.07 160.26 33.35 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.119 1.368 . . . . 0.0 108.747 175.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 m -151.26 170.1 20.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.439 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.82 -171.2 21.35 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -144.08 142.36 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.613 1.165 . . . . 0.0 109.789 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -64.98 78.43 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.812 2.045 . . . . 0.0 112.619 174.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.25 -16.31 63.91 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.14 22.56 0.95 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.233 1.813 . . . . 0.0 112.535 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.23 34.02 88.42 Favored Glycine 0 CA--C 1.555 2.534 0 CA-C-O 118.027 -1.429 . . . . 0.0 115.674 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.82 -34.47 30.59 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.705 3.603 . . . . 0.0 114.369 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.33 9.88 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.582 1.953 . . . . 0.0 112.521 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.49 -48.79 0.65 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.705 2.402 . . . . 0.0 112.693 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.5 p -153.24 122.24 6.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.098 1.759 . . . . 0.0 112.092 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.89 -128.72 9.59 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.637 1.108 . . . . 0.0 112.564 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.89 179.63 8.49 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.003 1.401 . . . . 0.0 113.25 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -151.88 121.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 127.357 2.263 . . . . 0.0 111.329 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.1 176.02 12.28 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.797 1.639 . . . . 0.0 110.389 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.46 116.97 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.541 1.136 . . . . 0.0 108.441 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 33' ' ' VAL . 10.7 p90 -127.22 170.08 12.81 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.264 1.026 . . . . 0.0 112.651 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.91 157.72 45.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.735 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -128.97 112.38 14.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.136 1.774 . . . . 0.0 112.147 -175.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.3 104.09 1.41 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.297 1.839 . . . . 0.0 111.032 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 ttp -65.43 140.37 58.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.492 1.117 . . . . 0.0 110.111 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 t -57.62 -20.72 34.96 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -74.39 -10.02 59.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.258 1.423 . . . . 0.0 113.905 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.76 11.77 45.91 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.058 1.313 . . . . 0.0 114.837 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.12 174.56 6.26 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.261 1.824 . . . . 0.0 109.7 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m -143.64 109.52 5.25 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.951 -1.093 . . . . 0.0 112.588 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 35' ' ' ILE . 48.7 tp -74.56 121.5 21.66 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.068 -1.02 . . . . 0.0 111.627 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 110.7 3.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.868 1.223 . . . . 0.0 113.367 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.717 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.4 p -86.58 150.13 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.193 0.997 . . . . 0.0 112.21 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.589 ' HB2' HD13 ' A' ' 134' ' ' LEU . 11.1 tmm? -135.65 152.16 50.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.115 1.366 . . . . 0.0 110.774 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.609 ' CE1' HG11 ' A' ' 33' ' ' VAL . 23.7 p90 -164.69 158.45 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.374 1.07 . . . . 0.0 110.474 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 m -163.17 154.39 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.87 2.068 . . . . 0.0 108.181 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.66 100.1 37.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.37 173.98 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.767 2.311 . . . . 0.0 111.828 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -101.13 -24.69 14.24 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.58 159.3 30.11 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.243 0.929 . . . . 0.0 112.477 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -158.81 -51.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.346 1.458 . . . . 0.0 113.176 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -54.05 -40.06 66.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.735 1.614 . . . . 0.0 112.168 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.17 135.32 52.98 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.57 1.148 . . . . 0.0 111.185 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -77.76 107.96 10.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.365 1.466 . . . . 0.0 109.89 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.8 p -163.63 39.83 0.09 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.341 1.056 . . . . 0.0 113.619 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -80.91 145.36 31.33 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.85 -1.156 . . . . 0.0 112.675 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -92.18 140.44 29.62 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.301 1.44 . . . . 0.0 112.622 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.539 ' CE3' HD11 ' A' ' 171' ' ' ILE . 6.8 p-90 -163.1 138.32 6.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -161.24 152.12 18.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.766 -0.584 . . . . 0.0 112.441 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 171' ' ' ILE . 10.9 t -143.96 143.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 127.161 2.185 . . . . 0.0 110.119 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 150.13 45.18 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.178 1.791 . . . . 0.0 109.872 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.84 103.55 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.232 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -66.45 101.36 0.75 Allowed 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.851 -1.156 . . . . 0.0 109.093 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 t -67.49 82.22 0.16 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.847 -1.158 . . . . 0.0 111.525 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.47 -107.25 0.32 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.088 2.28 . . . . 0.0 111.423 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -153.19 144.64 23.27 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.849 1.26 . . . . 0.0 111.903 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -165.34 116.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.966 1.706 . . . . 0.0 111.788 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.71 164.92 20.56 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.538 0.735 . . . . 0.0 111.732 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.41 118.73 22.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.329 -0.232 . . . . 0.0 110.58 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.63 -179.09 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.139 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.93 -48.84 42.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.943 1.297 . . . . 0.0 112.715 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.0 -33.52 60.71 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.001 0.81 . . . . 0.0 113.515 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.6 ttp -67.44 -56.42 9.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.412 1.106 . . . . 0.0 111.455 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -49.47 -39.81 34.97 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.296 0.953 . . . . 0.0 111.997 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -66.07 -43.14 88.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.079 0.952 . . . . 0.0 112.202 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -17.91 64.92 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.022 -1.673 . . . . 0.0 113.918 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 101' ' ' MET . 41.5 mt -96.23 -24.84 16.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.376 1.47 . . . . 0.0 113.39 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.81 -32.99 11.07 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.945 -1.097 . . . . 0.0 112.928 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -118.13 -33.67 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 112.759 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.19 -21.23 71.83 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.408 1.004 . . . . 0.0 114.517 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -154.11 87.0 3.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.462 2.305 . . . . 0.0 108.374 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.36 108.9 2.47 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.086 1.857 . . . . 0.0 110.953 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -139.88 158.95 43.25 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -147.42 167.67 23.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.963 1.705 . . . . 0.0 112.637 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.36 111.31 0.48 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.129 0.871 . . . . 0.0 112.93 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -92.03 70.39 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.986 0.914 . . . . 0.0 111.434 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.0 92.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.952 2.501 . . . . 0.0 114.993 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.09 130.17 1.09 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.581 1.086 . . . . 0.0 112.362 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.485 ' CE3' ' HG3' ' A' ' 158' ' ' LYS . 5.7 m95 -58.81 123.96 18.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.641 1.177 . . . . 0.0 111.164 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -131.75 118.24 19.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.422 1.489 . . . . 0.0 111.553 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.37 142.85 46.31 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.347 1.059 . . . . 0.0 112.615 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.23 156.82 41.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.688 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -74.62 104.36 5.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.73 -22.68 58.23 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.18 35.68 2.66 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.753 1.644 . . . . 0.0 116.523 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -135.42 -24.54 1.38 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.57 -18.03 1.13 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.204 1.383 . . . . 0.0 114.391 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 173' ' ' ILE . 1.2 pp -131.04 163.44 27.6 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.129 1.372 . . . . 0.0 112.523 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -102.3 136.72 41.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.289 1.436 . . . . 0.0 112.211 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB2' HG22 ' A' ' 173' ' ' ILE . 6.3 tmm? -115.07 135.72 53.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.149 0.58 . . . . 0.0 110.531 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.485 ' HG3' ' CE3' ' A' ' 146' ' ' TRP . 1.8 tptm -103.87 119.69 39.45 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.884 2.074 . . . . 0.0 110.468 176.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.18 146.87 18.62 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.354 1.454 . . . . 0.0 112.773 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 161' ' ' MET . 4.1 tp -124.15 157.05 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.096 1.759 . . . . 0.0 110.226 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.573 ' H ' HD12 ' A' ' 160' ' ' ILE . 7.0 tpt -152.34 90.87 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.463 1.505 . . . . 0.0 109.086 174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.7 p -82.45 152.24 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 111.471 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.1 t -127.94 163.47 24.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.204 1.002 . . . . 0.0 112.049 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 65.05 144.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.575 2.75 . . . . 0.0 113.133 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 38.8 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.479 1.527 0 C-N-CA 126.877 2.18 . . . . 0.0 113.34 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.519 ' HG2' ' HZ3' ' A' ' 30' ' ' LYS . 2.1 tm-20 -75.59 64.11 1.63 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.376 1.87 . . . . 0.0 109.599 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.5 111.7 23.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.202 1.801 . . . . 0.0 111.768 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -159.1 161.69 36.41 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.421 ' N ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -121.99 140.33 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 127.739 2.416 . . . . 0.0 110.295 175.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.539 ' C ' HD12 ' A' ' 171' ' ' ILE . 25.5 tt0 -138.6 157.12 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.708 1.603 . . . . 0.0 109.018 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.539 HD11 ' CE3' ' A' ' 115' ' ' TRP . 1.6 mp -128.31 134.54 64.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 C-N-CA 124.464 1.106 . . . . 0.0 109.697 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.75 109.11 13.26 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.318 2.247 . . . . 0.0 110.737 175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' A' ' 155' ' ' LEU . 12.7 pt -91.54 124.47 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.134 1.374 . . . . 0.0 110.183 175.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.4 p -155.69 170.52 21.85 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.315 1.446 . . . . 0.0 112.735 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.7 -38.12 70.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.19 0.596 . . . . 0.0 111.843 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.38 169.72 10.18 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.43 1.092 . . . . 0.0 110.654 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.87 -27.64 19.66 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 113.231 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -146.6 160.54 42.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.99 1.716 . . . . 0.0 111.641 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -139.83 166.81 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.571 1.549 . . . . 0.0 110.153 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 pt -73.91 -170.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.917 2.487 . . . . 0.0 110.308 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -20.05 19.8 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 -10.48 73.91 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.75 1.167 . . . . 0.0 114.36 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.7 -45.69 35.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.56 1.144 . . . . 0.0 111.497 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -81.62 -7.31 59.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.947 1.299 . . . . 0.0 113.869 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' ' 17' ' ' LEU . 20.5 tp -59.81 144.19 49.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.822 1.249 . . . . 0.0 110.396 174.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.3 146.43 29.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.247 1.019 . . . . 0.0 110.082 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -55.79 -29.06 59.08 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -60.85 -57.32 13.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.44 -43.68 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.766 -0.584 . . . . 0.0 110.073 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.601 HD21 ' CD1' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.36 -30.86 68.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 112.766 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -69.55 -47.27 64.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.986 1.715 . . . . 0.0 111.824 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -35.65 77.81 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.857 -1.152 . . . . 0.0 112.131 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -39.14 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.052 -1.03 . . . . 0.0 113.642 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -31.58 61.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.233 0.469 . . . . 0.0 111.79 175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -70.22 -33.41 71.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.319 1.448 . . . . 0.0 112.27 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -46.63 -29.44 1.85 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.457 2.303 . . . . 0.0 114.208 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD13 ' OD1' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -47.57 -43.96 25.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.365 1.466 . . . . 0.0 110.94 174.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.39 -146.51 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.313 1.435 . . . . 0.0 112.626 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -118.81 16.49 13.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.888 1.675 . . . . 0.0 112.349 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 m -121.06 119.44 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.037 1.735 . . . . 0.0 111.281 -174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.1 p -73.32 28.87 0.07 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.307 1.443 . . . . 0.0 113.588 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -122.85 65.17 0.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 109.355 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HE2' ' CD2' ' A' ' 24' ' ' LEU . 28.0 mmtm -121.29 -178.88 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 112.384 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -121.4 141.67 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.729 1.612 . . . . 0.0 112.028 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.19 104.94 11.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.854 1.662 . . . . 0.0 110.338 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.12 142.87 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 124.257 1.023 . . . . 0.0 113.52 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.11 173.48 34.59 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.535 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 100' ' ' VAL . 3.1 mt -139.71 150.02 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.422 1.489 . . . . 0.0 110.613 -174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.39 118.09 31.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 110.617 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.549 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.73 103.69 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 0.0 111.922 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.58 7.97 2.82 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.823 1.249 . . . . 0.0 112.988 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 t -66.19 -16.26 63.84 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.62 16.73 28.21 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.595 1.093 . . . . 0.0 115.361 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.43 136.92 8.38 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.262 1.411 . . . . 0.0 112.886 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -67.36 141.63 57.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.437 1.495 . . . . 0.0 111.749 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.662 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 40.3 m0 -108.01 165.82 11.18 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.647 1.179 . . . . 0.0 112.179 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -146.55 98.8 3.12 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 111.997 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -63.29 139.77 58.8 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.019 -1.05 . . . . 0.0 110.428 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 91' ' ' TYR . 21.2 mt -93.4 -61.37 1.57 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.872 0.869 . . . . 0.0 110.187 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.63 -164.12 0.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.913 2.885 . . . . 0.0 108.892 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.85 134.77 20.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.206 1.803 . . . . 0.0 111.329 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -103.98 112.48 25.48 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.601 1.56 . . . . 0.0 109.376 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 130.81 55.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.543 1.537 . . . . 0.0 109.839 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 -31.02 7.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.746 1.618 . . . . 0.0 113.258 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -141.8 91.85 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.241 1.016 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.17 125.94 3.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.8 1.667 . . . . 0.0 111.946 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -74.7 175.49 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.897 0.856 . . . . 0.0 111.775 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 p -62.55 171.02 2.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.683 1.993 . . . . 0.0 113.122 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' OD1' HD13 ' A' ' 24' ' ' LEU . 1.2 t70 -152.34 -50.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.035 1.334 . . . . 0.0 109.785 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.9 164.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.476 1.51 . . . . 0.0 111.761 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 tp -71.88 134.25 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 110.452 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -91.79 114.2 61.21 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.696 1.198 . . . . 0.0 109.724 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.631 ' HG2' HD12 ' A' ' 69' ' ' LEU . 63.6 Cg_endo -66.31 120.53 7.68 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.308 3.339 . . . . 0.0 111.422 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.2 pt-20 -71.51 -67.58 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.499 0.72 . . . . 0.0 112.402 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -97.33 132.61 42.89 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.547 0.739 . . . . 0.0 109.561 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 t -129.67 128.04 22.98 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.816 0.847 . . . . 0.0 111.099 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.77 149.64 38.13 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.028 3.152 . . . . 0.0 112.805 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.89 17.96 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -141.0 8.62 2.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.412 1.885 . . . . 0.0 113.946 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -145.59 134.44 22.43 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 119.885 1.22 . . . . 0.0 113.038 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.23 -176.36 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 110.992 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -152.02 157.22 41.39 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.409 -0.807 . . . . 0.0 112.187 175.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.601 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.64 170.78 14.29 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 123.608 0.763 . . . . 0.0 111.65 175.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.48 157.76 43.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.231 1.813 . . . . 0.0 109.885 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.7 m -145.39 160.52 41.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.154 1.782 . . . . 0.0 108.799 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.81 -179.57 16.88 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.615 1.102 . . . . 0.0 111.984 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -141.45 166.93 23.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.19 96.42 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.039 1.736 . . . . 0.0 110.14 176.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -75.3 -18.44 60.04 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.5 t -155.39 20.35 0.41 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.283 1.833 . . . . 0.0 113.363 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.18 36.83 86.04 Favored Glycine 0 CA--C 1.549 2.208 0 O-C-N 120.363 -1.461 . . . . 0.0 114.414 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -69.51 -39.11 7.4 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.429 2.753 . . . . 0.0 114.38 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 84' ' ' ALA . 3.6 p -114.56 2.76 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.922 1.689 . . . . 0.0 113.265 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.78 -57.95 0.39 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.519 2.728 . . . . 0.0 113.109 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.6 p -149.81 123.76 9.36 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.861 2.065 . . . . 0.0 111.334 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.57 -139.64 14.67 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.625 1.107 . . . . 0.0 112.371 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HA ' HG11 ' A' ' 80' ' ' VAL . . . -159.75 156.45 27.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 112.554 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 103' ' ' SER . 15.4 t -130.86 108.0 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.878 2.071 . . . . 0.0 108.891 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.89 178.62 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 111.128 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.76 120.7 5.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -125.97 161.56 27.23 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.312 1.045 . . . . 0.0 113.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -131.52 148.82 52.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 24.4 m-85 -122.01 102.37 8.13 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.286 2.234 . . . . 0.0 112.094 -175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 46' ' ' LEU . 10.7 t80 -69.06 117.88 11.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.471 1.508 . . . . 0.0 110.374 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.9 mtp -82.42 153.1 25.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 111.516 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 m -58.74 -16.59 17.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -73.87 -17.88 60.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 113.565 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.27 33.82 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 126.248 1.88 . . . . 0.0 114.937 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -78.78 168.21 20.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.734 1.267 . . . . 0.0 111.573 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.71 HG22 ' HB1' ' A' ' 89' ' ' ALA . 23.8 m -136.43 106.51 6.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.318 1.047 . . . . 0.0 112.332 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 173' ' ' ILE . 16.4 tp -68.47 111.48 4.72 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.674 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 130' ' ' MET . . . -94.6 105.77 3.33 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 0.0 113.486 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -76.31 149.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 122.099 -0.648 . . . . 0.0 110.882 174.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.644 ' HB2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -122.72 145.43 48.4 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.209 -0.932 . . . . 0.0 109.793 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.772 ' CG ' HG11 ' A' ' 33' ' ' VAL . 40.8 p90 -167.71 135.16 2.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 123.308 1.528 . . . . 0.0 114.234 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' VAL . 28.4 m -150.51 130.62 13.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.768 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.21 90.9 42.85 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.51 -13.42 32.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.569 2.179 . . . . 0.0 112.818 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.7 t80 64.47 166.09 0.15 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.072 2.949 . . . . 0.0 113.396 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.52 110.24 2.24 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.067 -1.021 . . . . 0.0 111.744 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -150.48 -65.57 0.2 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.997 1.319 . . . . 0.0 111.482 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -84.07 -12.23 55.44 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 61.97 70.84 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.736 2.014 . . . . 0.0 113.072 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.63 170.97 18.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.036 1.334 . . . . 0.0 113.349 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -68.19 164.57 20.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 111.809 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.67 151.21 23.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.859 0.864 . . . . 0.0 112.075 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -85.84 159.85 19.6 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.324 0.65 . . . . 0.0 110.249 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -161.45 171.03 18.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.951 1.3 . . . . 0.0 109.399 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 148.26 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.558 3.143 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.61 160.88 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.684 0.793 . . . . 0.0 109.847 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -161.25 158.07 26.66 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.56 176.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ ' ' A' ' 153' ' ' TYR . 34.1 mt -105.53 117.3 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -66.78 87.85 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.873 1.669 . . . . 0.0 110.189 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.5 t -73.02 81.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.0 110.949 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.62 -82.13 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.717 1.151 . . . . 0.0 112.938 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 177.8 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.38 2.672 . . . . 0.0 111.116 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -155.39 159.21 39.71 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.937 2.095 . . . . 0.0 109.338 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.16 173.86 10.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.123 2.169 . . . . 0.0 111.173 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.64 109.7 5.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.721 0.408 . . . . 0.0 111.863 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 130' ' ' MET . 2.4 t70 -163.68 -169.81 2.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 111.099 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -53.7 -48.88 69.11 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.442 -0.786 . . . . 0.0 110.707 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.54 50.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.422 1.01 . . . . 0.0 113.659 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.423 ' HE3' ' CA ' ' A' ' 99' ' ' GLY . 3.8 ttt -66.34 -63.63 1.03 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.739 0.815 . . . . 0.0 110.595 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.88 -34.1 62.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.999 0.92 . . . . 0.0 112.776 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.63 -40.09 95.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.681 1.592 . . . . 0.0 111.019 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -21.89 65.76 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.261 -1.525 . . . . 0.0 113.26 174.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 101' ' ' MET . 12.4 mt -82.15 -41.11 20.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.492 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 -34.69 14.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -113.11 -36.56 5.03 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.481 1.512 . . . . 0.0 112.128 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.81 -69.58 1.02 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.747 1.642 . . . . 0.0 112.487 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -171.13 75.57 0.54 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 125.437 1.495 . . . . 0.0 112.933 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.73 161.32 32.78 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.751 2.3 . . . . 0.0 113.86 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -126.53 177.19 6.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.125 2.17 . . . . 0.0 112.224 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -108.24 124.0 49.63 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.055 2.142 . . . . 0.0 111.584 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.64 101.96 2.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.493 1.52 . . . . 0.0 112.928 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -136.86 23.96 3.08 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 71.2 99.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.81 2.444 . . . . 0.0 113.386 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.96 139.41 2.66 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.691 1.615 . . . . 0.0 111.987 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -69.83 154.91 41.33 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 122.216 -0.579 . . . . 0.0 111.354 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -142.08 124.47 15.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.305 1.442 . . . . 0.0 111.694 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -121.79 138.64 54.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.231 2.212 . . . . 0.0 111.34 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 159.44 38.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.92 1.288 . . . . 0.0 111.694 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -81.63 86.6 6.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.091 1.356 . . . . 0.0 110.083 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD22 ' CE2' ' A' ' 153' ' ' TYR . 7.3 tt -58.42 -52.51 65.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.456 1.502 . . . . 0.0 112.949 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.58 42.37 0.02 OUTLIER Glycine 0 CA--C 1.542 1.761 0 N-CA-C 118.584 2.194 . . . . 0.0 118.584 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -150.05 5.01 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.642 1.721 . . . . 0.0 115.61 -176.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.87 -57.21 0.44 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.448 1.499 . . . . 0.0 112.496 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.84 176.24 7.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.824 0.85 . . . . 0.0 111.652 174.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.24 123.94 31.32 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.648 1.579 . . . . 0.0 109.999 175.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.613 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -88.2 156.02 19.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 174.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.58 130.96 39.12 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.762 1.225 . . . . 0.0 109.977 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -124.41 152.66 17.46 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 124.269 0.938 . . . . 0.0 113.588 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 141.24 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.278 1.431 . . . . 0.0 110.396 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.31 99.13 5.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.931 1.242 . . . . 0.0 110.931 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.59 53.86 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 0.0 111.89 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.5 m -123.06 129.02 50.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.674 1.989 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.64 68.15 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.842 2.857 . . . . 0.0 109.151 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.2 -90.46 0.02 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.38 1.943 . . . . 0.0 114.536 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -75.81 11.22 1.45 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.57 2.348 . . . . 0.0 114.802 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.37 170.28 16.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.69 1.596 . . . . 0.0 113.032 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 -167.99 1.89 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.1 ptm -114.05 164.12 14.25 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.858 2.063 . . . . 0.0 110.99 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -150.64 146.03 26.24 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.165 1.386 . . . . 0.0 110.009 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.0 mm -121.03 128.69 76.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.311 1.045 . . . . 0.0 108.726 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -115.58 114.55 25.09 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.504 1.522 . . . . 0.0 108.965 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.662 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 13.3 pt -111.07 134.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.59 1.156 . . . . 0.0 110.709 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.5 p -162.72 158.97 23.69 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.8 1.24 . . . . 0.0 110.79 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.248 1.419 . . . . 0.0 112.212 -175.043 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.46 -38.02 12.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.233 2.613 . . . . 0.0 110.623 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.75 166.85 5.05 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.024 0.916 . . . . 0.0 110.403 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.64 -42.17 1.99 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.93 1.729 . . . . 0.0 110.89 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.3 p -139.1 159.98 40.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.429 1.491 . . . . 0.0 111.932 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mm -142.11 162.9 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.993 1.317 . . . . 0.0 111.402 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.5 pt -69.1 -169.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.072 2.149 . . . . 0.0 111.073 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.08 -25.84 23.87 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.28 -21.59 34.05 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.411 1.005 . . . . 0.0 113.355 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -44.1 70.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.444 1.122 . . . . 0.0 111.845 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.64 -11.67 59.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.018 1.327 . . . . 0.0 113.365 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD11 HD23 ' A' ' 17' ' ' LEU . 1.5 tt -66.15 159.12 26.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.947 1.299 . . . . 0.0 112.839 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.59 146.84 27.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.685 0.794 . . . . 0.0 109.916 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -55.52 -33.93 64.21 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.96 -47.77 79.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.456 1.103 . . . . 0.0 113.049 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.1 -45.94 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 110.439 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.54 -41.3 66.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 111.426 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.67 -53.3 40.47 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.619 1.968 . . . . 0.0 112.317 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -27.12 41.84 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -35.82 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.181 1.355 . . . . 0.0 111.742 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -81.27 -23.91 37.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.208 1.003 . . . . 0.0 112.463 177.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.9 -33.77 22.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.645 1.578 . . . . 0.0 114.235 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -19.89 16.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 112.935 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tp -47.63 -40.69 20.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.457 2.303 . . . . 0.0 111.038 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.99 -161.67 10.53 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.412 1.958 . . . . 0.0 112.524 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -128.42 34.69 4.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.039 2.136 . . . . 0.0 111.168 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.3 163.11 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.057 2.143 . . . . 0.0 113.301 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.55 -14.43 61.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.482 1.513 . . . . 0.0 114.479 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.29 118.62 26.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.027 2.131 . . . . 0.0 111.184 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.564 ' HB2' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -164.37 165.7 21.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.844 0.858 . . . . 0.0 113.145 -174.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -145.41 148.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.683 1.193 . . . . 0.0 113.005 176.054 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.607 ' HB1' HD11 ' A' ' 70' ' ' LEU . . . -121.77 105.63 10.56 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.591 2.356 . . . . 0.0 112.603 174.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 102' ' ' PHE . 1.3 p -115.7 144.72 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 108.75 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.61 170.54 22.56 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 118.195 0.452 . . . . 0.0 112.8 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.02 124.88 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.888 0.875 . . . . 0.0 111.528 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -71.2 109.34 5.18 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.348 -0.845 . . . . 0.0 111.902 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -86.87 102.68 14.55 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.656 1.217 . . . . 0.0 111.271 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.14 44.41 1.55 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.07 -1.019 . . . . 0.0 110.94 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -2.32 9.05 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.41 75.81 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.946 -1.096 . . . . 0.0 115.266 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.37 107.85 1.71 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.758 1.647 . . . . 0.0 111.509 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.2 m -67.74 116.75 8.79 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.638 1.219 . . . . 0.0 110.632 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.443 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 8.7 m0 -85.78 161.25 19.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.588 0.355 . . . . 0.0 111.916 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -138.01 104.12 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.448 1.899 . . . . 0.0 111.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.702 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -65.93 141.27 58.28 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.884 -1.135 . . . . 0.0 110.528 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -106.42 -47.45 3.78 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.195 1.398 . . . . 0.0 111.774 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -155.63 171.35 20.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.027 0.931 . . . . 0.0 112.13 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.13 135.33 30.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 0.0 111.604 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.437 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.3 t80 -115.16 129.01 56.55 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.333 1.453 . . . . 0.0 109.088 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 18.8 p90 -147.22 161.15 41.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.869 1.267 . . . . 0.0 112.452 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -120.94 -31.84 4.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.738 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.49 ' CB ' ' H ' ' A' ' 85' ' ' VAL . 83.2 p -60.19 130.97 49.3 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.712 1.205 . . . . 0.0 112.344 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 37.13 -100.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.285 1.898 . . . . 0.0 113.904 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 55' ' ' THR . 2.1 t -165.04 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.478 1.911 . . . . 0.0 108.244 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.43 ' H ' HG23 ' A' ' 54' ' ' THR . 12.7 p -137.31 164.9 27.45 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.411 2.284 . . . . 0.0 112.119 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -154.67 -38.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.523 1.529 . . . . 0.0 111.358 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 3' ' ' ALA . 16.2 m -102.31 165.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.682 1.593 . . . . 0.0 112.24 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.5 tt -80.24 136.62 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.641 1.176 . . . . 0.0 110.957 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.22 107.08 36.14 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.907 0.883 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HG2' HD12 ' A' ' 69' ' ' LEU . 73.5 Cg_endo -67.14 113.96 3.03 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 124.322 3.348 . . . . 0.0 110.386 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.49 -46.61 87.66 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.641 -0.662 . . . . 0.0 112.024 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.78 145.31 29.93 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.954 0.797 . . . . 0.0 110.854 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.11 94.19 16.26 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 124.723 1.209 . . . . 0.0 108.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.15 173.94 13.65 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.268 1.978 . . . . 0.0 112.125 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.72 166.82 3.06 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.343 0.657 . . . . 0.0 112.103 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.26 8.5 t 43.07 38.19 1.41 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.076 1.75 . . . . 0.0 113.396 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -148.74 151.41 34.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.039 1.736 . . . . 0.0 111.592 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.12 -175.62 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.32 . . . . 0.0 109.373 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -156.75 145.16 19.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.964 1.305 . . . . 0.0 109.368 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD11 ' HB1' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -124.34 155.08 39.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.25 1.02 . . . . 0.0 110.082 174.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.461 ' CE1' HG23 ' A' ' 57' ' ' VAL . 2.3 t80 -139.45 169.2 18.19 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.794 1.238 . . . . 0.0 109.793 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -154.49 -177.8 6.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.339 1.055 . . . . 0.0 110.722 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.11 -167.03 12.79 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.354 1.93 . . . . 0.0 110.903 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -135.71 -162.68 1.29 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -114.89 -14.78 11.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.117 2.167 . . . . 0.0 114.45 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -39.97 -64.31 0.51 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.998 1.719 . . . . 0.0 114.769 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 11.1 25.49 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.611 1.564 . . . . 0.0 112.495 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.85 77.18 0.13 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.035 1.303 . . . . 0.0 113.426 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.76 21.94 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.921 1 C-N-CA 126.301 4.667 . . . . 0.0 116.347 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.461 HG21 HG21 ' A' ' 85' ' ' VAL . 8.9 p -32.65 101.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 129.028 2.931 . . . . 0.0 113.203 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 38.45 -95.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.91 2.484 . . . . 0.0 111.455 -175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.7 p -143.43 154.99 44.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.921 2.488 . . . . 0.0 108.173 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.84 -130.04 9.67 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.774 -1.204 . . . . 0.0 111.601 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -159.79 175.85 12.64 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.729 1.211 . . . . 0.0 112.145 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.49 ' H ' ' CB ' ' A' ' 52' ' ' SER . 47.1 t -152.36 114.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.357 2.263 . . . . 0.0 112.719 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 50' ' ' PHE . . . -143.98 167.0 23.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.488 1.515 . . . . 0.0 110.448 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 122.95 10.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.255 1.422 . . . . 0.0 107.45 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -139.23 164.01 30.95 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 112.315 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.636 ' HB2' ' HE1' ' A' ' 130' ' ' MET . . . -124.11 151.73 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.702 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 24.2 m-85 -131.83 112.16 12.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.958 1.703 . . . . 0.0 110.937 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -65.91 105.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.252 1.421 . . . . 0.0 110.655 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -73.47 153.46 40.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.203 1.001 . . . . 0.0 110.998 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.5 p -59.63 -20.56 56.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -76.27 -4.45 42.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 114.058 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.1 6.3 71.84 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.293 1.425 . . . . 0.0 114.851 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.59 177.28 5.86 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.235 1.414 . . . . 0.0 111.293 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.599 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 17.9 m -133.48 112.0 11.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.323 1.049 . . . . 0.0 113.12 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 tp -73.45 122.84 22.78 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.66 108.57 3.14 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.0 154.76 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.337 0.589 . . . . 0.0 110.828 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.526 ' CB ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -138.38 148.22 44.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.532 1.133 . . . . 0.0 108.924 175.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 21.3 p90 -162.17 147.05 12.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.234 1.016 . . . . 0.0 110.488 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 85' ' ' VAL . 24.2 m -151.55 165.4 34.36 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.94 1.296 . . . . 0.0 108.379 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.51 96.68 23.39 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.67 -32.62 11.58 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.976 2.451 . . . . 0.0 114.718 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.6 t80 51.41 100.6 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 128.198 2.599 . . . . 0.0 115.618 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.77 -168.3 3.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.209 1.404 . . . . 0.0 110.742 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.0 154.69 3.95 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.221 1.409 . . . . 0.0 112.371 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -58.28 -31.37 67.39 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.234 1.014 . . . . 0.0 112.583 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 38.26 0.73 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.456 1.502 . . . . 0.0 113.89 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -129.51 155.98 44.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.657 1.583 . . . . 0.0 112.754 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 t -91.18 175.11 7.06 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.301 1.44 . . . . 0.0 110.444 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.62 156.63 48.39 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.023 1.729 . . . . 0.0 111.122 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -84.16 144.41 29.01 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.259 1.024 . . . . 0.0 112.547 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -153.45 150.93 29.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.472 0.653 . . . . 0.0 111.831 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.61 151.21 4.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.046 1.338 . . . . 0.0 111.079 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.0 135.55 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.261 1.824 . . . . 0.0 108.748 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -146.43 155.01 42.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.102 1.361 . . . . 0.0 109.872 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.16 107.16 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.396 1.478 . . . . 0.0 107.863 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.66 104.83 4.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.277 1.031 . . . . 0.0 109.22 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t -65.6 97.02 0.29 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.799 -1.188 . . . . 0.0 110.097 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.8 19.26 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 127.194 2.33 . . . . 0.0 110.317 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -126.93 129.85 48.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.107 1.763 . . . . 0.0 111.018 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.75 121.68 5.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.841 1.657 . . . . 0.0 111.563 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.59 175.36 5.66 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.483 1.113 . . . . 0.0 110.85 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -84.59 115.06 22.42 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.71 -0.619 . . . . 0.0 111.905 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -151.27 -174.53 4.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.441 1.096 . . . . 0.0 111.682 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -52.56 -51.7 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.512 1.125 . . . . 0.0 110.668 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.06 46.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.202 0.906 . . . . 0.0 113.83 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 2.7 ttt -66.04 -65.2 0.71 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.629 0.714 . . . . 0.0 110.185 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -54.14 -31.78 53.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.47 1.108 . . . . 0.0 112.683 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.47 -47.88 82.05 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.802 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -23.69 67.44 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.464 -1.397 . . . . 0.0 113.806 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.526 HD13 ' CB ' ' A' ' 101' ' ' MET . 76.5 mt -79.09 -18.17 53.81 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.431 1.492 . . . . 0.0 114.44 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.76 -31.33 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.905 1.282 . . . . 0.0 114.433 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.52 -5.74 13.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.0 2.12 . . . . 0.0 112.268 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.03 -88.68 0.46 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.244 1.878 . . . . 0.0 110.744 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -160.98 73.08 2.7 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.695 1.598 . . . . 0.0 111.692 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.26 177.63 8.37 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.731 2.287 . . . . 0.0 114.914 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -127.03 -178.24 4.34 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.231 2.212 . . . . 0.0 113.056 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 144.65 48.85 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.378 -1.451 . . . . 0.0 111.848 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.97 116.5 0.76 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.587 1.089 . . . . 0.0 111.952 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -115.46 68.78 0.72 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.348 1.459 . . . . 0.0 112.83 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 64.55 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.281 2.633 . . . . 0.0 113.758 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.78 142.11 3.48 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.982 1.277 . . . . 0.0 112.5 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -67.82 147.9 51.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.481 0.713 . . . . 0.0 111.951 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -148.41 122.82 9.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.706 1.602 . . . . 0.0 110.926 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.12 141.58 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.987 0.915 . . . . 0.0 111.633 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -146.01 148.85 33.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.352 0.596 . . . . 0.0 110.452 174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.53 92.72 8.6 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.494 HD13 ' SD ' ' A' ' 157' ' ' MET . 2.4 tp -51.92 -32.16 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.99 21.97 5.46 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -128.44 20.43 6.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.875 1.338 . . . . 0.0 114.445 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.85 12.11 83.11 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.348 -0.845 . . . . 0.0 113.827 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.87 166.97 23.2 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.41 1.884 . . . . 0.0 111.633 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 169.74 13.2 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.26 1.424 . . . . 0.0 109.824 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -145.81 167.52 23.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.897 175.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 137.02 54.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.295 1.438 . . . . 0.0 108.253 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.06 141.36 15.83 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.536 0.589 . . . . 0.0 112.632 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.22 101.97 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.516 1.526 . . . . 0.0 111.089 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.5 tpt -96.63 105.08 17.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.982 1.264 . . . . 0.0 110.998 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.8 p -114.7 145.36 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.08 0.952 . . . . 0.0 111.449 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -137.86 139.56 39.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.865 1.666 . . . . 0.0 111.968 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 174.6 -179.29 0.11 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 130.344 3.458 . . . . 0.0 108.744 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.09 -12.86 45.92 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 115.077 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.21 11.28 0.91 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.76 1.624 . . . . 0.0 114.769 -175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.96 169.11 12.76 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.546 -1.346 . . . . 0.0 113.745 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 32' ' ' ALA . 19.6 tptt -167.14 151.36 6.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 113.091 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 20.6 ptm -81.19 165.76 21.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -154.37 161.0 41.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.332 1.453 . . . . 0.0 110.782 170.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 mm -123.14 135.35 63.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -118.12 126.99 53.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.411 1.084 . . . . 0.0 108.289 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 157' ' ' MET . 14.5 pt -110.82 117.0 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p -156.05 145.02 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.372 0.669 . . . . 0.0 112.322 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.509 1.924 . . . . 0.0 112.003 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.851 0.358 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -36.21 13.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.423 1.089 . . . . 0.0 111.34 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.81 5.26 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 121.451 0.643 . . . . 0.0 110.188 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.43 -27.64 19.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.8 1.191 . . . . 0.0 113.039 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.0 p -145.79 155.27 42.82 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.109 1.364 . . . . 0.0 111.532 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 mm -135.15 162.25 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.1 1.36 . . . . 0.0 110.435 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -72.51 -165.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 127.837 2.455 . . . . 0.0 111.231 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.05 -24.78 26.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.39 -19.62 34.89 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.53 1.062 . . . . 0.0 114.185 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.38 75.19 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.296 1.048 . . . . 0.0 111.81 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -85.67 -7.85 58.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.733 1.613 . . . . 0.0 114.15 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HD23 ' A' ' 17' ' ' LEU . 10.2 tt -63.92 149.94 46.09 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.204 1.002 . . . . 0.0 111.582 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -145.06 145.62 31.52 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.396 1.078 . . . . 0.0 110.528 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -51.77 -37.94 53.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.452 1.101 . . . . 0.0 113.359 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -56.26 -48.51 76.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.416 1.007 . . . . 0.0 112.651 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -52.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.658 1.583 . . . . 0.0 109.238 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.719 HD13 HD23 ' A' ' 21' ' ' LEU . 2.0 tm? -53.42 -41.39 65.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.537 1.535 . . . . 0.0 111.848 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.42 -51.95 67.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.414 1.486 . . . . 0.0 111.216 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -38.32 89.35 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.337 -0.852 . . . . 0.0 112.086 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.89 -51.09 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 110.959 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.891 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.0 pp -67.11 -33.98 76.63 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.52 -23.04 63.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.1 1.36 . . . . 0.0 113.404 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.47 -23.34 49.29 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.648 -1.282 . . . . 0.0 113.471 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 57' ' ' VAL . 3.0 tm? -57.82 -39.57 77.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.162 2.185 . . . . 0.0 112.629 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.38 111.79 0.48 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.429 1.014 . . . . 0.0 112.537 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.44 55.67 0.16 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.576 1.951 . . . . 0.0 113.939 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.48 174.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 127.449 2.299 . . . . 0.0 111.026 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.49 56.71 1.44 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.92 -1.112 . . . . 0.0 112.526 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.89 108.09 1.93 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.346 2.258 . . . . 0.0 109.304 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.38 123.44 14.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.43 1.092 . . . . 0.0 110.065 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.67 142.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -175.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -120.9 111.17 17.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.582 1.953 . . . . 0.0 110.722 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 71' ' ' TYR . 2.0 p -127.36 127.12 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.434 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.37 30.56 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.468 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.713 HG21 HD21 ' A' ' 98' ' ' LEU . 2.6 mp -136.85 142.49 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.874 1.27 . . . . 0.0 110.6 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.16 111.7 22.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.052 1.741 . . . . 0.0 111.546 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.88 89.65 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.132 1.773 . . . . 0.0 111.741 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -132.1 7.66 4.32 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.914 0.886 . . . . 0.0 112.684 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t -81.29 -6.98 59.47 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.55 20.02 36.06 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.594 1.092 . . . . 0.0 115.527 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.74 121.56 2.81 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.499 1.523 . . . . 0.0 111.667 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 m -57.43 144.13 37.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.594 1.558 . . . . 0.0 111.446 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.447 ' HH2' HG22 ' A' ' 35' ' ' ILE . 44.5 m0 -107.66 168.06 9.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.246 0.618 . . . . 0.0 112.547 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.8 m -153.74 105.16 2.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.895 2.078 . . . . 0.0 109.787 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.0 139.4 56.33 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.651 175.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -110.01 -54.56 2.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.38 1.072 . . . . 0.0 112.349 -176.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -153.53 171.15 19.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.17 0.988 . . . . 0.0 111.187 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 136.23 43.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.153 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -119.16 136.54 54.13 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.883 1.273 . . . . 0.0 110.286 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -161.96 145.26 12.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.643 1.577 . . . . 0.0 112.068 -176.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -115.61 -11.02 11.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.582 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -151.47 137.75 18.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.031 1.732 . . . . 0.0 112.128 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 39.1 3.17 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.017 0.818 . . . . 0.0 114.6 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 m -30.19 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.04 2.936 . . . . 0.0 113.158 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -71.94 162.81 28.91 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.282 -0.886 . . . . 0.0 112.732 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -132.61 5.88 4.02 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.159 0.983 . . . . 0.0 113.581 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG23 ' CE1' ' A' ' 71' ' ' TYR . 5.8 m -106.33 163.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.051 1.74 . . . . 0.0 112.523 -177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.81 123.44 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.867 1.267 . . . . 0.0 112.856 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.7 130.37 61.55 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -70.21 142.58 46.3 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.844 2.362 . . . . 0.0 109.696 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -85.2 -77.86 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.904 0.882 . . . . 0.0 110.59 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -100.86 149.25 24.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.632 1.173 . . . . 0.0 110.506 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.0 133.34 14.14 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.131 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.11 -151.69 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.257 3.972 . . . . 0.0 113.796 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -119.63 15.76 12.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.076 1.751 . . . . 0.0 113.678 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -141.61 18.24 2.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.882 1.673 . . . . 0.0 113.775 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -136.77 -173.3 3.4 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.974 1.309 . . . . 0.0 113.238 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.87 -178.49 6.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.492 1.517 . . . . 0.0 110.339 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -146.22 160.93 41.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.525 -0.734 . . . . 0.0 111.32 178.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.465 HD11 HD11 ' A' ' 17' ' ' LEU . 5.0 mt -141.39 157.3 45.36 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.481 1.112 . . . . 0.0 109.562 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CE1' HG23 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -140.67 159.04 43.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.191 1.796 . . . . 0.0 108.593 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.1 m -150.05 140.07 22.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 110.516 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.96 165.07 13.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.028 1.299 . . . . 0.0 114.272 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -134.15 130.64 37.6 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.859 1.264 . . . . 0.0 113.773 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -79.72 52.9 1.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -92.74 -28.06 16.84 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.0 12.11 2.22 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.37 -88.15 0.23 Allowed Glycine 0 N--CA 1.473 1.138 0 O-C-N 120.692 -1.255 . . . . 0.0 114.734 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.24 -27.27 9.78 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.056 2.504 . . . . 0.0 112.81 -175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.275 87.9 t 43.18 -91.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.967 2.507 . . . . 0.0 113.574 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.89 13.8 0.47 Allowed 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 83' ' ' GLY . 3.1 m -135.89 -172.02 3.01 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.552 2.341 . . . . 0.0 111.003 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.647 ' H ' HG22 ' A' ' 82' ' ' THR . . . -94.31 158.98 23.18 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.33 1.443 . . . . 0.0 115.445 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.65 38.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.083 1.753 . . . . 0.0 113.038 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.6 t -150.35 111.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.988 1.315 . . . . 0.0 113.131 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -140.57 164.61 29.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.228 1.014 . . . . 0.0 112.016 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 124.31 10.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.439 1.096 . . . . 0.0 108.972 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -132.95 160.6 36.6 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.183 0.993 . . . . 0.0 113.186 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -122.51 149.0 44.5 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 29.7 m-85 -127.58 114.41 17.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.827 2.051 . . . . 0.0 110.58 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB2' HD22 ' A' ' 46' ' ' LEU . 18.9 t80 -71.22 116.71 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 111.05 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.98 23.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.016 2.126 . . . . 0.0 111.491 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -19.7 30.42 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.74 1.65 22.36 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.97 39.64 11.43 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 125.403 1.478 . . . . 0.0 112.09 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.462 HD22 HG21 ' A' ' 119' ' ' ILE . 9.4 p-10 -137.59 170.59 15.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.008 2.523 . . . . 0.0 113.16 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.502 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 99.9 m -131.7 110.22 10.74 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 35' ' ' ILE . 34.2 tp -73.28 117.35 14.93 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.382 1.073 . . . . 0.0 110.384 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.43 117.16 5.78 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.08 0.847 . . . . 0.0 112.711 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.95 164.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.727 0.811 . . . . 0.0 110.832 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.428 ' HG2' ' H ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -144.05 161.37 38.97 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.642 1.177 . . . . 0.0 110.243 175.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 14.9 p90 -166.59 160.44 15.15 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.718 1.207 . . . . 0.0 111.565 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.2 119.85 0.94 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.968 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.434 HG23 ' HA3' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -81.35 146.03 56.91 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -71.14 154.79 62.0 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.878 1.719 . . . . 0.0 109.712 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -147.95 135.93 21.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.819 1.647 . . . . 0.0 107.542 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.46 104.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.24 1.816 . . . . 0.0 115.259 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -57.25 -1.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.534 1.534 . . . . 0.0 114.79 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.0 -22.52 10.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.786 2.434 . . . . 0.0 112.426 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -144.61 157.78 44.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.408 2.283 . . . . 0.0 110.717 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.39 114.24 15.33 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.554 1.542 . . . . 0.0 111.034 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.9 p -169.29 127.08 0.96 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.435 1.494 . . . . 0.0 110.61 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -134.35 88.93 2.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.853 1.261 . . . . 0.0 110.729 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -72.81 143.25 47.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.626 0.77 . . . . 0.0 112.033 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -152.99 151.66 30.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.29 0.636 . . . . 0.0 109.914 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' A' ' 101' ' ' MET . 10.5 t0 -167.52 138.04 2.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.37 1.468 . . . . 0.0 109.305 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.56 134.21 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.783 1.233 . . . . 0.0 109.187 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HA ' HD11 ' A' ' 151' ' ' LEU . 5.5 tttp -152.41 155.49 37.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.41 1.084 . . . . 0.0 109.497 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.462 HG21 HD22 ' A' ' 96' ' ' ASN . 67.9 mt -109.37 101.72 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -67.03 99.25 0.63 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.134 -0.979 . . . . 0.0 109.39 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -66.1 87.15 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.231 1.015 . . . . 0.0 110.634 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.33 -134.33 3.32 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.512 2.482 . . . . 0.0 110.321 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -149.99 109.9 4.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.717 1.607 . . . . 0.0 111.33 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -144.53 120.7 10.82 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.223 1.809 . . . . 0.0 112.139 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 174.5 5.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.692 1.197 . . . . 0.0 110.771 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.61 114.47 20.32 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.566 . . . . 0.0 110.043 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.97 -165.85 1.59 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.847 1.659 . . . . 0.0 110.471 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.37 -50.4 30.76 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.971 1.308 . . . . 0.0 110.996 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.52 -27.77 54.79 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.427 1.013 . . . . 0.0 114.609 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.8 ttt -75.59 -61.3 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.041 0.921 . . . . 0.0 110.179 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -53.96 -32.24 53.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.903 1.281 . . . . 0.0 112.665 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.39 -42.97 99.58 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 107.478 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -30.37 70.2 Favored 'General case' 0 CA--C 1.559 1.315 0 O-C-N 120.769 -1.207 . . . . 0.0 108.034 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.2 mt -75.76 -37.52 59.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.672 1.589 . . . . 0.0 113.879 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -27.93 14.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.421 1.488 . . . . 0.0 114.766 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.4 -40.23 2.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.383 1.473 . . . . 0.0 112.225 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.6 -70.68 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.149 1.833 . . . . 0.0 112.401 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.46 73.38 4.33 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 142.48 63.34 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.997 1.798 . . . . 0.0 112.996 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -122.97 -178.92 4.09 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.898 2.079 . . . . 0.0 109.275 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.73 143.43 50.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.381 1.472 . . . . 0.0 112.472 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.23 101.53 2.8 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.368 1.461 . . . . 0.0 113.446 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.57 19.96 4.26 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 54.92 80.22 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.148 2.179 . . . . 0.0 113.234 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.34 165.84 23.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.029 1.299 . . . . 0.0 113.327 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.467 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 9.2 m95 -68.86 130.1 41.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.066 1.346 . . . . 0.0 111.586 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -139.48 118.8 12.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.63 1.172 . . . . 0.0 113.654 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.88 145.21 30.15 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.274 1.43 . . . . 0.0 109.541 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -143.84 156.39 44.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.9 1.28 . . . . 0.0 109.675 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.31 100.2 13.04 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 7.1 tp -55.94 -31.94 63.38 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.69 30.7 6.7 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 119.302 2.481 . . . . 0.0 119.302 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -131.67 -21.86 2.45 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 145.96 -15.67 1.74 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 118.666 0.666 . . . . 0.0 114.632 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.26 171.57 13.16 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 126.169 1.788 . . . . 0.0 110.029 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.18 164.44 19.48 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.322 1.049 . . . . 0.0 110.637 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.543 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.2 OUTLIER -143.96 164.15 31.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.464 1.126 . . . . 0.0 112.757 177.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -128.57 125.39 38.15 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.227 1.811 . . . . 0.0 108.473 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.96 153.27 17.69 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.533 1.54 . . . . 0.0 112.863 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -129.48 149.73 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.728 1.611 . . . . 0.0 109.687 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.557 ' N ' HD13 ' A' ' 160' ' ' ILE . 6.6 tpt -150.2 119.06 6.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.247 1.819 . . . . 0.0 109.387 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.535 HG23 HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -127.9 122.46 32.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.313 1.845 . . . . 0.0 111.472 -175.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.9 p -87.85 73.61 9.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.885 1.674 . . . . 0.0 112.397 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.45 17.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.227 1.011 . . . . 0.0 113.021 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.87 -7.41 88.0 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.89 1.233 . . . . 0.0 114.459 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -125.53 7.92 7.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.136 2.175 . . . . 0.0 113.721 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -128.59 174.31 9.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.18 1.392 . . . . 0.0 112.575 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.4 OUTLIER -161.42 -178.55 6.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.965 1.706 . . . . 0.0 112.906 -178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.437 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -106.85 151.81 24.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.479 1.911 . . . . 0.0 109.983 178.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.436 ' C ' HD12 ' A' ' 171' ' ' ILE . 28.7 tt0 -162.26 148.1 13.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.269 1.428 . . . . 0.0 108.82 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 170' ' ' GLN . 1.7 mp -123.18 136.24 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.688 0.795 . . . . 0.0 108.94 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -121.46 124.58 44.81 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.296 1.039 . . . . 0.0 108.71 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.543 HG22 ' HB3' ' A' ' 157' ' ' MET . 5.3 pt -94.99 145.53 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.778 0.831 . . . . 0.0 109.51 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.5 t -159.0 170.01 23.03 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.788 -0.57 . . . . 0.0 112.171 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.972 1.709 . . . . 0.0 112.682 177.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.351 0.119 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.49 -44.17 2.0 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.238 1.415 . . . . 0.0 111.239 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.15 -174.31 0.48 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.578 0.751 . . . . 0.0 110.469 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.36 -31.76 7.12 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.402 -1.436 . . . . 0.0 111.538 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 p -146.39 155.96 42.97 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.543 1.537 . . . . 0.0 110.902 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.496 HG13 HD23 ' A' ' 70' ' ' LEU . 41.7 mm -136.56 166.91 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 126.334 1.854 . . . . 0.0 109.815 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -165.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.731 1.613 . . . . 0.0 111.339 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -51.12 -32.84 23.99 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.96 -14.65 37.45 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.995 1.283 . . . . 0.0 113.8 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.31 63.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.49 1.145 . . . . 0.0 111.291 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -85.71 -9.89 56.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.627 1.571 . . . . 0.0 114.258 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.49 143.2 54.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.454 1.101 . . . . 0.0 110.119 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.2 143.12 24.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.641 0.776 . . . . 0.0 109.959 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -58.06 -32.6 68.17 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -54.78 -51.06 66.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.452 1.101 . . . . 0.0 113.02 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.03 -52.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.523 HD21 ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -53.18 -39.96 64.02 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.89 1.276 . . . . 0.0 112.432 -175.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -52.22 -63.99 0.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.334 2.254 . . . . 0.0 110.237 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -66.51 -23.01 66.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.49 -46.1 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.702 1.137 . . . . 0.0 111.91 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.29 -26.38 61.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.205 1.002 . . . . 0.0 111.412 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.46 -43.35 49.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.489 1.916 . . . . 0.0 113.861 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -23.57 2.11 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.977 1.711 . . . . 0.0 114.841 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.55 -31.0 70.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.607 2.363 . . . . 0.0 114.826 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.7 -160.29 9.13 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.63 2.538 . . . . 0.0 111.99 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -146.53 83.83 1.61 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.656 1.582 . . . . 0.0 112.005 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.74 145.26 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.914 1.686 . . . . 0.0 110.659 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 m -70.57 18.99 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 119.86 -1.775 . . . . 0.0 114.968 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.18 142.04 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.069 2.547 . . . . 0.0 111.559 -175.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.45 -172.46 3.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.767 1.627 . . . . 0.0 113.013 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.561 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -126.03 145.28 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 127.504 2.321 . . . . 0.0 112.335 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -138.46 129.08 26.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 127.195 2.198 . . . . 0.0 111.819 175.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 102' ' ' PHE . 2.4 t -129.43 144.98 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 120.26 1.391 . . . . 0.0 112.033 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.42 174.62 46.41 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.382 0.513 . . . . 0.0 114.382 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.53 HG21 HD21 ' A' ' 98' ' ' LEU . 3.3 mp -140.75 114.73 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.247 1.819 . . . . 0.0 108.61 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.51 106.0 1.32 Allowed 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.403 -1.436 . . . . 0.0 110.966 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . 9.5 t-20 -82.03 92.95 6.88 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 123.519 1.628 . . . . 0.0 112.143 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.81 43.74 1.59 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.391 1.076 . . . . 0.0 110.525 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -2.22 16.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.295 1.838 . . . . 0.0 114.433 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.88 17.06 73.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.569 1.081 . . . . 0.0 115.046 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.19 129.35 5.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.949 1.737 . . . . 0.0 111.422 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -79.18 118.79 21.46 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 117.93 0.865 . . . . 0.0 109.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.683 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 5.9 m0 -88.03 161.66 17.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 m -137.86 107.74 6.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.33 1.852 . . . . 0.0 110.618 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -64.57 156.01 31.24 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.069 -1.02 . . . . 0.0 111.461 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -57.98 1.2 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.098 1.359 . . . . 0.0 112.438 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -147.69 167.99 23.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.285 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.25 137.63 40.97 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.357 1.463 . . . . 0.0 110.705 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.522 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 t80 -126.71 134.08 50.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.246 1.419 . . . . 0.0 110.355 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -142.41 155.47 45.12 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.059 2.144 . . . . 0.0 110.419 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -119.95 -44.23 2.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.277 1.431 . . . . 0.0 111.624 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -121.46 97.36 5.47 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.022 1.329 . . . . 0.0 111.479 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.63 109.34 2.78 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.92 1.247 . . . . 0.0 112.662 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -64.68 179.66 0.61 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.575 1.15 . . . . 0.0 113.231 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -65.6 152.89 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.598 1.559 . . . . 0.0 113.141 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -147.25 -21.66 0.39 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.49 164.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.294 2.238 . . . . 0.0 111.954 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 tt -73.59 130.66 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.925 0.89 . . . . 0.0 109.95 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.1 tp -78.91 128.42 76.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.677 ' CG ' HD12 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -67.59 126.82 15.36 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.782 2.988 . . . . 0.0 111.067 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.55 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.296 -0.878 . . . . 0.0 112.531 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -109.72 143.83 38.96 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.449 1.1 . . . . 0.0 110.389 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.75 86.99 53.69 Favored Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 124.384 1.074 . . . . 0.0 109.192 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.98 136.93 16.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.061 2.507 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -46.94 146.73 1.56 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.786 1.235 . . . . 0.0 112.705 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.327 1.4 p 74.47 32.55 0.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.125 2.17 . . . . 0.0 111.996 -175.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 61.6 mttt -150.4 146.98 27.02 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.013 2.125 . . . . 0.0 110.799 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.65 -177.91 3.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.314 1.046 . . . . 0.0 109.588 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.677 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -155.75 142.8 19.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.529 0.732 . . . . 0.0 110.64 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -113.32 -179.85 3.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.558 0.743 . . . . 0.0 110.433 174.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -159.01 159.33 34.64 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.905 1.682 . . . . 0.0 109.318 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -138.19 164.01 30.28 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.069 1.348 . . . . 0.0 110.89 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.94 -179.9 16.46 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.74 1.162 . . . . 0.0 113.398 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.53 162.37 31.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -116.58 50.16 1.09 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.159 1.783 . . . . 0.0 113.738 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.23 105.69 0.36 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.299 1.44 . . . . 0.0 113.036 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.9 m 58.85 7.19 0.74 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 127.739 2.416 . . . . 0.0 115.01 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.29 66.46 1.39 Allowed Glycine 0 CA--C 1.539 1.559 0 O-C-N 120.002 -1.686 . . . . 0.0 111.23 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 -53.32 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.596 3.53 . . . . 0.0 110.65 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -108.29 167.45 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.372 2.269 . . . . 0.0 106.709 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . . . -52.12 -58.02 7.84 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.276 1.031 . . . . 0.0 111.817 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.5 p -143.86 148.64 35.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.473 1.909 . . . . 0.0 109.841 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.05 -120.56 14.03 Favored Glycine 0 CA--C 1.545 1.965 0 O-C-N 120.366 -1.459 . . . . 0.0 115.764 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -159.53 175.69 12.95 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.366 2.267 . . . . 0.0 112.662 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 103' ' ' SER . 61.6 t -140.86 123.99 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 127.982 2.513 . . . . 0.0 111.248 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -153.01 177.01 11.25 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.219 1.009 . . . . 0.0 111.875 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.7 125.71 11.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.345 1.458 . . . . 0.0 107.692 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -136.69 162.65 32.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.046 0.939 . . . . 0.0 110.52 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -133.11 150.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.454 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.3 m-85 -124.88 123.49 40.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.534 1.534 . . . . 0.0 110.758 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.41 109.0 2.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.189 1.796 . . . . 0.0 110.881 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.0 mtp -71.63 155.36 40.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.67 0.788 . . . . 0.0 111.68 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.0 t -58.17 -30.46 66.43 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 113.164 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 1.26 11.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.909 1.684 . . . . 0.0 114.687 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.65 9.29 85.82 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.756 -1.215 . . . . 0.0 114.341 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -89.05 178.87 6.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.079 1.752 . . . . 0.0 109.819 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.61 HG22 ' HB1' ' A' ' 89' ' ' ALA . 28.8 m -142.58 110.25 5.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.398 -1.439 . . . . 0.0 111.488 175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD21 HG21 ' A' ' 35' ' ' ILE . 27.3 tp -77.09 121.02 22.98 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.67 107.64 3.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.483 1.516 . . . . 0.0 112.857 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.06 168.63 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 122.273 1.035 . . . . 0.0 111.377 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.446 ' SD ' ' CZ3' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -146.46 157.54 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.606 1.962 . . . . 0.0 109.511 174.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 51.8 p90 -165.08 134.07 3.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.031 1.332 . . . . 0.0 108.374 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 85' ' ' VAL . 37.4 m -147.05 130.61 16.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.116 0.567 . . . . 0.0 110.165 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.3 132.54 42.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.902 -0.571 . . . . 0.0 111.203 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.61 161.35 46.37 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.773 2.315 . . . . 0.0 113.038 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -115.33 -21.86 9.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 113.325 177.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.23 165.51 20.36 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.935 0.874 . . . . 0.0 111.407 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -140.62 -48.29 0.43 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.18 2.192 . . . . 0.0 110.77 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -72.39 -35.4 68.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.387 1.075 . . . . 0.0 112.349 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.08 96.38 4.71 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.776 1.63 . . . . 0.0 111.821 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -67.13 112.36 4.4 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.09 0.956 . . . . 0.0 111.365 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -159.93 122.0 3.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.372 1.469 . . . . 0.0 109.328 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.15 155.21 50.49 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.92 0.888 . . . . 0.0 110.79 175.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CZ3' ' SD ' ' A' ' 101' ' ' MET . 40.8 p-90 -84.38 152.93 23.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.635 0.774 . . . . 0.0 110.358 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -158.97 128.48 5.58 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 109.452 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -177.82 126.73 0.13 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.766 1.227 . . . . 0.0 111.12 -176.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.61 HG11 HG13 ' A' ' 171' ' ' ILE . 5.5 m -118.01 166.74 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.314 1.046 . . . . 0.0 111.927 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.91 158.17 43.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.107 0.963 . . . . 0.0 111.39 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.27 106.7 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.01 1.724 . . . . 0.0 107.195 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.39 99.13 2.87 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.055 -1.028 . . . . 0.0 108.954 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.4 t -65.63 88.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.822 -1.174 . . . . 0.0 110.911 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.47 -141.39 8.85 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.691 2.091 . . . . 0.0 110.633 -175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -128.81 124.02 34.32 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.956 1.702 . . . . 0.0 111.284 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -149.25 120.03 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.471 1.508 . . . . 0.0 111.383 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.61 170.6 10.43 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.322 0.649 . . . . 0.0 110.633 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -78.28 115.71 18.19 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.71 -178.4 7.26 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.909 1.284 . . . . 0.0 113.629 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -51.79 -41.04 61.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.349 1.46 . . . . 0.0 113.778 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.93 88.59 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.091 0.853 . . . . 0.0 112.75 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.7 ttm -64.68 -50.97 64.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.797 0.799 . . . . 0.0 110.437 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -61.11 -34.1 74.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.691 0.797 . . . . 0.0 112.769 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.74 -35.14 79.59 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.784 -1.198 . . . . 0.0 111.532 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -12.71 55.85 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.785 -1.197 . . . . 0.0 113.566 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 mt -91.69 -54.1 4.02 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.336 1.855 . . . . 0.0 109.318 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -75.37 -43.32 50.97 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.84 -35.4 7.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.818 1.247 . . . . 0.0 112.999 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -48.79 -69.33 1.01 Allowed Glycine 0 N--CA 1.47 0.911 0 C-N-CA 125.234 1.397 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -164.47 84.27 1.2 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.994 0.917 . . . . 0.0 111.591 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.78 143.92 38.17 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.914 1.743 . . . . 0.0 113.158 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' ASP . 2.3 m-85 -114.92 -168.57 1.4 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.397 1.479 . . . . 0.0 112.003 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -123.79 127.82 48.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.72 2.008 . . . . 0.0 111.787 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.85 96.02 0.64 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 125.04 1.305 . . . . 0.0 114.48 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.91 79.65 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.254 1.421 . . . . 0.0 111.748 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.7 p30 35.28 67.27 0.27 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.835 2.454 . . . . 0.0 115.363 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 135.6 3.48 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.374 0.987 . . . . 0.0 113.231 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -64.88 144.89 56.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.333 1.053 . . . . 0.0 111.646 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -145.36 135.67 24.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.556 1.142 . . . . 0.0 112.121 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -119.39 144.82 46.7 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 110.399 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -151.77 163.66 38.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.623 1.169 . . . . 0.0 110.894 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -83.32 91.78 7.38 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.35 -34.51 47.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.873 1.269 . . . . 0.0 113.871 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 115.58 39.05 0.94 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 118.037 1.975 . . . . 0.0 118.037 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -137.02 -32.78 0.78 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.87 -23.57 1.15 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.149 1.357 . . . . 0.0 114.006 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 173.09 6.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.478 1.911 . . . . 0.0 111.242 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -127.15 160.02 32.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.841 1.256 . . . . 0.0 110.509 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.499 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -145.41 161.34 39.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.366 0.603 . . . . 0.0 111.9 177.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.87 132.01 56.77 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.257 1.423 . . . . 0.0 107.293 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.75 153.79 16.67 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.106 0.86 . . . . 0.0 112.648 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.7 HD11 HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.46 151.83 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.657 1.183 . . . . 0.0 111.766 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 21.1 tpp -147.43 91.88 2.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.656 1.583 . . . . 0.0 109.124 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.7 HG23 HD11 ' A' ' 160' ' ' ILE . 3.1 p -76.5 150.12 36.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 109.852 174.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 m -44.37 -69.71 0.13 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.312 1.845 . . . . 0.0 115.711 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -176.03 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.933 1.693 . . . . 0.0 112.398 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -47.15 89.07 0.01 OUTLIER Glycine 0 CA--C 1.533 1.212 0 C-N-CA 128.102 2.763 . . . . 0.0 115.432 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 45.5 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.078 2.151 . . . . 0.0 112.339 -175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -143.43 159.42 42.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 113.426 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 2.2 mmtm -148.03 173.2 13.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.555 1.542 . . . . 0.0 113.922 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.3 ptm -99.49 154.56 18.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.994 1.717 . . . . 0.0 112.15 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -160.73 157.15 26.47 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.61 HG13 HG11 ' A' ' 117' ' ' VAL . 45.4 mm -123.64 120.83 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.037 1.335 . . . . 0.0 109.573 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.43 101.64 12.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.407 1.083 . . . . 0.0 110.682 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.683 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 24.8 pt -91.66 133.33 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.134 0.574 . . . . 0.0 110.338 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.1 t -150.61 157.55 43.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.649 1.179 . . . . 0.0 111.386 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.608 1.163 . . . . 0.0 112.268 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -71.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.591 1.087 . . . . 0.0 111.263 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 170.35 179.23 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.659 3.584 . . . . 0.0 107.759 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.76 -34.6 1.63 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.863 -1.148 . . . . 0.0 113.691 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.9 p -135.04 146.43 48.97 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.891 1.346 . . . . 0.0 111.675 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' CD1' HD12 ' A' ' 70' ' ' LEU . 31.0 mm -136.05 177.83 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.278 1.831 . . . . 0.0 109.443 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -108.32 165.52 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.868 2.067 . . . . 0.0 110.755 176.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' THR . . . -58.13 -28.95 65.14 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.186 -1.571 . . . . 0.0 115.068 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.87 -7.26 3.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.389 1.471 . . . . 0.0 114.108 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 -35.56 63.87 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.115 1.366 . . . . 0.0 113.848 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -120.73 -2.18 9.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.301 1.441 . . . . 0.0 113.971 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 17' ' ' LEU . 12.7 tp -86.68 133.56 33.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.931 0.892 . . . . 0.0 112.012 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.7 m -144.75 -94.54 0.1 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.213 1.005 . . . . 0.0 110.16 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -158.68 -38.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.679 1.992 . . . . 0.0 110.804 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -52.81 -56.1 18.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.53 -47.16 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.931 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -53.73 -43.3 68.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.533 1.133 . . . . 0.0 113.314 -176.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.37 -62.08 1.84 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.361 2.264 . . . . 0.0 110.392 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -67.07 -30.46 70.52 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 117.803 -1.094 . . . . 0.0 113.658 176.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -52.26 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.212 1.369 . . . . 0.0 109.453 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -64.63 -33.55 76.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.64 0.376 . . . . 0.0 111.685 -177.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.47 -33.21 58.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 114.763 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -21.59 11.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.596 1.158 . . . . 0.0 113.829 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -48.49 -31.85 7.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.727 175.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.44 -146.07 4.45 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.693 0.663 . . . . 0.0 113.15 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -120.29 18.31 12.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.467 1.907 . . . . 0.0 113.124 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.87 -12.45 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.035 1.334 . . . . 0.0 113.803 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.11 19.89 4.06 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.485 2.314 . . . . 0.0 113.988 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -179.52 125.44 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.773 2.829 . . . . 0.0 108.765 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HB2' HD12 ' A' ' 21' ' ' LEU . 35.8 mmtt -137.62 -159.75 0.99 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.077 1.351 . . . . 0.0 109.812 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.37 152.36 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.438 1.895 . . . . 0.0 111.061 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.95 114.72 20.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.131 1.773 . . . . 0.0 108.592 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.4 p -121.75 133.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.449 1.5 . . . . 0.0 110.201 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.67 177.77 38.18 Favored Glycine 0 N--CA 1.454 -0.143 0 O-C-N 121.492 -0.755 . . . . 0.0 112.392 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.1 mp -138.95 146.9 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.247 1.019 . . . . 0.0 110.471 -174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 106.83 19.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.293 1.837 . . . . 0.0 111.474 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.99 98.54 8.65 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.286 1.035 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -138.1 13.07 2.86 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -9.0 59.86 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.43 18.06 31.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 130.33 4.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.282 1.42 . . . . 0.0 112.217 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.1 m -62.25 141.51 58.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.94 1.696 . . . . 0.0 111.347 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 46.4 m0 -104.65 170.09 8.08 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.8 m -152.04 107.26 3.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.81 2.044 . . . . 0.0 110.555 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -68.18 152.33 45.64 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.855 -1.153 . . . . 0.0 109.807 175.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.11 -43.4 2.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.93 0.892 . . . . 0.0 112.357 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.76 -175.47 1.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.826 2.051 . . . . 0.0 110.578 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.45 139.03 18.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.421 . . . . 0.0 110.678 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -113.88 112.98 24.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.573 1.549 . . . . 0.0 109.174 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.73 150.52 35.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.189 2.195 . . . . 0.0 109.418 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.29 -43.58 2.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 111.089 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -137.32 111.91 8.73 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.029 1.332 . . . . 0.0 111.941 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.39 88.87 1.72 Allowed Glycine 0 N--CA 1.467 0.737 0 C-N-CA 124.658 1.123 . . . . 0.0 111.99 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.6 m -81.16 99.17 8.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.229 1.012 . . . . 0.0 110.976 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 71' ' ' TYR . 13.7 t -63.37 166.5 6.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -128.92 -4.01 5.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.848 1.659 . . . . 0.0 113.648 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' CE1' ' A' ' 71' ' ' TYR . 27.6 m -87.8 160.0 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.026 0.931 . . . . 0.0 112.564 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.35 126.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 112.793 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tt -86.33 119.72 71.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.866 1.266 . . . . 0.0 109.36 175.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.66 127.42 17.13 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 124.111 3.207 . . . . 0.0 111.438 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 2.3 pm0 -79.44 -68.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.341 -0.849 . . . . 0.0 111.078 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.14 143.17 31.56 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.785 -0.572 . . . . 0.0 110.434 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.92 134.08 25.54 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.503 1.121 . . . . 0.0 109.03 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.03 152.3 45.8 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.392 2.728 . . . . 0.0 111.858 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -65.38 17.04 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.856 2.462 . . . . 0.0 116.339 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 3.0 p -149.18 34.41 0.73 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 128.732 2.813 . . . . 0.0 111.162 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -153.46 163.86 39.21 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.414 -1.429 . . . . 0.0 112.201 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.05 175.02 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 111.401 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -144.68 159.74 42.33 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.338 0.655 . . . . 0.0 111.789 175.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.74 ' CD1' HD21 ' A' ' 17' ' ' LEU . 17.7 mt -139.21 158.81 43.52 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.784 1.234 . . . . 0.0 109.179 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -138.29 163.17 32.48 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.933 2.493 . . . . 0.0 108.019 175.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -151.04 178.26 9.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.214 1.806 . . . . 0.0 108.222 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.46 -177.51 31.62 Favored Glycine 0 N--CA 1.471 0.985 0 O-C-N 121.083 -1.011 . . . . 0.0 113.612 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.47 162.28 36.23 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -80.99 83.26 6.75 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.167 1.387 . . . . 0.0 111.634 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.59 -14.62 62.93 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -157.8 21.74 0.27 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.94 2.096 . . . . 0.0 113.406 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 79' ' ' PRO . . . 66.55 39.6 93.97 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 120.078 -1.639 . . . . 0.0 113.032 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 78' ' ' GLY . 94.2 Cg_endo -71.29 -44.54 1.1 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.728 3.618 . . . . 0.0 114.927 -175.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 84' ' ' ALA . 7.5 p -108.1 154.77 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.138 1.775 . . . . 0.0 107.373 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.15 -48.42 70.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.44 -0.787 . . . . 0.0 111.5 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.97 145.1 23.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.749 2.42 . . . . 0.0 110.09 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.38 -118.31 5.82 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.692 -1.255 . . . . 0.0 115.37 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 80' ' ' VAL . . . -163.83 168.49 19.5 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.328 2.251 . . . . 0.0 112.535 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -143.75 115.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.368 2.667 . . . . 0.0 111.784 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -160.33 178.98 9.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.916 1.686 . . . . 0.0 110.614 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.28 115.37 3.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.835 1.254 . . . . 0.0 108.24 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -122.68 170.94 9.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.549 1.139 . . . . 0.0 113.031 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -134.44 154.13 51.56 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 40.8 m-85 -128.11 121.56 29.9 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.771 2.029 . . . . 0.0 112.376 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -74.03 104.75 4.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.445 1.898 . . . . 0.0 111.945 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 mtp -69.66 151.98 45.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.539 1.536 . . . . 0.0 113.02 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -30.65 65.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.483 1.513 . . . . 0.0 113.624 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -66.07 -13.73 60.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.588 1.155 . . . . 0.0 113.454 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.25 28.58 11.44 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.991 1.281 . . . . 0.0 114.175 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.37 168.75 10.34 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.757 1.623 . . . . 0.0 110.526 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.58 HG22 ' HB1' ' A' ' 89' ' ' ALA . 99.6 m -131.34 102.53 6.0 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.588 -1.32 . . . . 0.0 112.926 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 173' ' ' ILE . 9.9 tp -73.66 124.56 26.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.818 -1.176 . . . . 0.0 112.188 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.07 102.46 2.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.729 1.157 . . . . 0.0 112.226 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' A' ' 35' ' ' ILE . 1.3 p -66.33 171.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.161 0.984 . . . . 0.0 111.955 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' A' ' 115' ' ' TRP . 2.3 ttp -144.67 144.78 31.41 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.733 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 28.8 p90 -161.06 142.27 11.68 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -158.15 154.45 27.45 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.074 1.349 . . . . 0.0 110.166 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.3 t -111.35 101.07 49.69 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.52 123.3 9.37 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.89 2.393 . . . . 0.0 111.046 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -77.91 -167.95 1.12 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.466 1.106 . . . . 0.0 110.822 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t0 79.39 -46.78 0.37 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.191 2.597 . . . . 0.0 113.046 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 67.21 -49.24 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.445 3.098 . . . . 0.0 114.063 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -28.84 64.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.775 2.03 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.88 86.31 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.311 1.444 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -74.92 98.27 3.53 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.925 1.69 . . . . 0.0 111.18 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -176.07 105.46 0.07 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.329 1.852 . . . . 0.0 110.378 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -129.59 150.63 50.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.398 1.079 . . . . 0.0 110.547 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -86.49 158.28 19.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.904 0.882 . . . . 0.0 111.908 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.504 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 2.5 p-90 -160.97 162.13 31.8 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.874 1.27 . . . . 0.0 110.63 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 170.74 139.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.087 2.555 . . . . 0.0 110.511 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.478 HG21 HG13 ' A' ' 171' ' ' ILE . 19.4 t -140.87 122.09 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.663 1.585 . . . . 0.0 108.663 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -127.72 162.37 26.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.491 2.316 . . . . 0.0 109.886 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.495 HG13 HD21 ' A' ' 151' ' ' LEU . 63.6 mt -108.38 121.25 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.895 1.678 . . . . 0.0 108.489 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -84.11 101.99 12.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 t -52.92 139.61 26.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.16 -0.962 . . . . 0.0 111.025 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.04 -118.56 4.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.788 1.185 . . . . 0.0 110.336 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -136.07 137.35 41.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.233 1.813 . . . . 0.0 111.259 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -159.52 117.67 2.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.882 1.273 . . . . 0.0 112.734 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 174.49 4.7 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.919 0.888 . . . . 0.0 111.25 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.54 121.79 31.3 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.799 -0.563 . . . . 0.0 110.004 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.71 177.07 10.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.95 0.9 . . . . 0.0 111.156 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -52.06 -45.35 64.71 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.002 0.921 . . . . 0.0 112.075 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.93 -50.06 63.37 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.725 0.679 . . . . 0.0 112.685 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.74 -55.97 28.27 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.461 0.63 . . . . 0.0 110.303 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -44.68 36.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 112.608 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 1.4 tt0 -69.36 -33.52 73.21 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.747 1.619 . . . . 0.0 108.944 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.58 -14.9 2.35 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.113 1.365 . . . . 0.0 113.456 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 101' ' ' MET . 6.1 mp -90.49 -21.73 21.7 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.232 1.413 . . . . 0.0 113.785 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -97.5 -42.57 7.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.446 2.298 . . . . 0.0 113.151 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' A' ' 132' ' ' GLU . 2.2 p90 -115.09 -26.87 7.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 174.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.4 -32.12 81.87 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.349 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 176.35 71.16 0.08 OUTLIER Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 130.117 3.367 . . . . 0.0 111.714 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.47 142.32 48.9 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.644 2.229 . . . . 0.0 113.266 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -129.45 177.79 6.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.247 1.819 . . . . 0.0 112.848 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -115.97 125.85 53.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.921 2.088 . . . . 0.0 111.059 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.5 109.89 1.32 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.401 1.477 . . . . 0.0 109.545 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -160.05 89.17 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.436 1.494 . . . . 0.0 110.24 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.81 101.34 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.385 2.674 . . . . 0.0 115.147 174.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.13 134.54 3.33 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.102 1.334 . . . . 0.0 111.686 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 72.4 m95 -64.43 145.43 56.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.713 0.805 . . . . 0.0 112.176 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.19 130.47 19.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.995 0.918 . . . . 0.0 112.743 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 156.92 47.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.055 2.142 . . . . 0.0 111.216 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.6 19.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.021 1.728 . . . . 0.0 111.585 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -64.55 102.22 0.53 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.349 1.46 . . . . 0.0 109.387 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.495 HD21 HG13 ' A' ' 119' ' ' ILE . 3.9 tp -57.94 -39.44 78.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.62 11.43 5.5 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -132.92 -34.11 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.131 1.466 . . . . 0.0 114.456 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 138.65 35.33 0.16 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.893 1.235 . . . . 0.0 113.98 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 156' ' ' ARG . 0.2 OUTLIER -157.82 163.46 37.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 110.591 175.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.574 ' N ' HD12 ' A' ' 155' ' ' LEU . 90.0 mtt180 -136.25 103.82 5.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.333 1.853 . . . . 0.0 112.55 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.688 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -85.09 159.97 20.07 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.159 176.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -122.68 139.1 54.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.767 174.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 171' ' ' ILE . . . -119.18 136.23 11.84 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.403 1.478 . . . . 0.0 113.292 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.9 tp -116.12 138.9 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.166 1.386 . . . . 0.0 111.145 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.1 tpt -121.87 130.98 53.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.427 1.012 . . . . 0.0 109.317 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 47.2 p -137.24 144.12 42.61 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.444 1.098 . . . . 0.0 110.28 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.3 t -148.33 -174.05 4.49 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.247 1.419 . . . . 0.0 111.56 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.09 42.26 5.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.789 2.035 . . . . 0.0 113.966 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.83 73.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.906 1.241 . . . . 0.0 112.637 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 35.92 67.07 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.98 2.512 . . . . 0.0 113.866 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -139.12 172.81 12.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.777 0.831 . . . . 0.0 112.822 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.32 171.49 20.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 112.541 -175.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -90.35 142.16 28.01 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.218 1.007 . . . . 0.0 112.048 174.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -133.13 155.8 48.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.625 1.57 . . . . 0.0 109.827 174.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.478 HG13 HG21 ' A' ' 117' ' ' VAL . 41.5 mm -123.91 125.41 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.847 1.259 . . . . 0.0 110.181 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -108.06 115.99 31.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.913 1.285 . . . . 0.0 110.113 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.688 HG22 ' HB3' ' A' ' 157' ' ' MET . 15.1 pt -96.42 129.76 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 0.0 110.157 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.5 m -171.65 172.09 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.025 1.33 . . . . 0.0 111.566 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.487 1.115 . . . . 0.0 113.008 178.072 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.427 ' HB3' HG22 ' A' ' 20' ' ' VAL . 3.1 mm? -100.52 -44.97 5.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 0.0 110.62 -176.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.42 -59.87 2.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.35 -36.84 0.16 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 126.786 2.136 . . . . 0.0 117.517 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.2 p -138.16 151.75 48.04 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 110.918 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 70' ' ' LEU . 25.0 mm -132.71 162.42 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.457 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 pt -70.36 -169.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.554 1.942 . . . . 0.0 110.409 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.33 -22.08 17.72 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.79 11.43 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.623 1.106 . . . . 0.0 113.714 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -42.86 83.82 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.284 1.042 . . . . 0.0 111.856 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -80.74 -9.61 59.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.859 1.264 . . . . 0.0 113.698 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 17' ' ' LEU . 1.2 tt -64.4 159.23 21.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.748 1.219 . . . . 0.0 112.636 175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.51 145.88 27.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.867 0.867 . . . . 0.0 109.846 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -56.32 -30.89 63.15 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -58.3 -52.96 63.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.061 0.944 . . . . 0.0 112.371 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.91 -46.56 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -51.82 -40.65 60.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.425 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.07 -58.04 9.26 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.382 1.473 . . . . 0.0 112.116 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -23.78 61.51 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -66.85 -44.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.087 1.312 . . . . 0.0 111.227 -178.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -74.5 -28.96 61.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.142 0.977 . . . . 0.0 112.189 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.14 -39.25 34.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.142 1.377 . . . . 0.0 112.185 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -48.32 -24.82 1.32 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.716 2.406 . . . . 0.0 113.263 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.503 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 6.5 tt -48.92 -40.81 31.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.287 1.835 . . . . 0.0 111.689 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -153.39 -154.93 6.94 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.439 1.495 . . . . 0.0 112.819 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -141.23 76.16 1.53 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.028 1.731 . . . . 0.0 111.043 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.98 164.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 112.465 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.74 -39.24 80.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.781 1.232 . . . . 0.0 113.947 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.35 140.01 37.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 0.0 110.714 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -157.73 127.33 5.99 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.818 0.847 . . . . 0.0 110.308 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -121.62 139.13 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.004 0.921 . . . . 0.0 112.917 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 70' ' ' LEU . . . -127.01 101.67 6.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.481 1.512 . . . . 0.0 113.462 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -107.81 118.24 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 120.259 -1.526 . . . . 0.0 109.695 174.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.86 155.56 23.82 Favored Glycine 0 N--CA 1.46 0.293 0 O-C-N 121.924 -0.485 . . . . 0.0 113.006 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.517 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.9 mp -133.81 99.46 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.532 0.733 . . . . 0.0 111.637 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.36 102.99 0.26 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.878 1.271 . . . . 0.0 111.655 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -90.72 106.18 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.735 0.778 . . . . 0.0 112.877 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.266 31.3 tt0 -150.7 19.54 0.81 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.02 0.914 . . . . 0.0 111.278 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -5.1 20.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.258 175.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.76 17.44 51.9 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.525 1.536 . . . . 0.0 114.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.55 115.26 0.85 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.815 1.674 . . . . 0.0 111.377 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.7 m -55.52 148.53 15.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.066 1.347 . . . . 0.0 111.466 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 10.8 m0 -119.72 172.51 7.64 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.572 -0.705 . . . . 0.0 112.63 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -136.15 113.22 10.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.063 2.145 . . . . 0.0 111.458 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -70.22 105.65 3.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.839 0.856 . . . . 0.0 110.648 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -66.26 -56.83 9.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.493 0.717 . . . . 0.0 111.056 175.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.402 ' ND2' HH11 ' A' ' 125' ' ' ARG . 42.8 t30 -167.48 172.4 9.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.792 1.637 . . . . 0.0 111.549 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.65 135.41 34.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.78 2.032 . . . . 0.0 111.412 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.443 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.9 t80 -119.13 129.02 54.81 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.715 1.606 . . . . 0.0 110.107 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -138.72 126.28 21.93 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.36 2.264 . . . . 0.0 110.041 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.45 -16.92 19.95 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.202 1.401 . . . . 0.0 110.888 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -76.37 102.56 5.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.36 1.064 . . . . 0.0 110.151 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.94 -118.83 11.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.423 1.487 . . . . 0.0 113.654 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 t -136.72 -172.71 3.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.937 1.695 . . . . 0.0 111.148 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.517 HG23 ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -80.96 167.17 20.13 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.574 1.949 . . . . 0.0 112.36 174.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -144.96 -45.55 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.87 0.868 . . . . 0.0 110.834 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.86 156.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.553 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.31 142.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.926 1.29 . . . . 0.0 111.134 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.68 128.96 41.98 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.412 1.085 . . . . 0.0 110.0 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.58 116.52 3.83 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 124.636 3.557 . . . . 0.0 112.033 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.45 -33.82 63.96 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -124.08 150.91 44.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.103 0.961 . . . . 0.0 112.188 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.8 t -138.64 96.12 9.69 Favored Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 124.876 1.27 . . . . 0.0 108.239 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 171.75 14.56 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.238 1.959 . . . . 0.0 111.421 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -64.82 174.98 1.63 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.665 -0.647 . . . . 0.0 110.615 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 14.6 t 49.15 24.66 0.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.56 1.544 . . . . 0.0 113.783 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -151.77 130.12 12.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.709 2.004 . . . . 0.0 110.826 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.29 -173.67 2.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.652 1.215 . . . . 0.0 109.643 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.33 162.46 40.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.606 1.162 . . . . 0.0 109.835 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.62 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -131.78 166.35 21.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.566 1.174 . . . . 0.0 108.162 174.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.603 ' HB3' HG13 ' A' ' 33' ' ' VAL . 3.2 t80 -151.85 161.13 43.15 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.134 1.373 . . . . 0.0 107.95 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.503 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 49.5 m -155.42 146.03 22.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.12 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.84 -161.57 36.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.782 0.706 . . . . 0.0 111.774 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -145.26 174.79 10.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.193 1.397 . . . . 0.0 111.025 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -110.33 167.34 10.28 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.753 1.621 . . . . 0.0 110.639 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 153.22 -31.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 131.141 3.776 . . . . 0.0 112.515 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.21 17.4 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.34 -79.31 0.04 OUTLIER Glycine 0 N--CA 1.477 1.39 0 O-C-N 120.492 -1.38 . . . . 0.0 113.417 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.77 12.16 2.51 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.148 3.232 . . . . 0.0 113.825 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.33 -28.24 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.009 1.323 . . . . 0.0 111.196 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.82 -6.59 11.03 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.796 2.438 . . . . 0.0 114.674 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.4 p -138.28 -154.24 0.52 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.236 1.814 . . . . 0.0 110.64 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.82 152.11 17.03 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.546 -1.346 . . . . 0.0 110.443 174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 146.04 55.53 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.418 1.109 . . . . 0.0 112.281 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -147.63 135.17 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.732 2.013 . . . . 0.0 113.367 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -155.51 170.77 21.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.32 1.448 . . . . 0.0 110.803 174.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.06 114.98 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.226 1.41 . . . . 0.0 109.431 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -126.91 167.11 16.29 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.447 1.099 . . . . 0.0 112.24 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -126.54 154.15 44.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.12 0.568 . . . . 0.0 111.267 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -133.57 109.88 9.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.969 1.308 . . . . 0.0 113.337 -175.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -71.1 96.34 1.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.705 1.602 . . . . 0.0 111.03 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 151.7 45.09 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.836 -1.165 . . . . 0.0 111.339 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -16.36 15.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 t -70.34 1.33 5.06 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.657 1.983 . . . . 0.0 113.658 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.92 19.03 71.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.026 1.298 . . . . 0.0 114.013 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -121.3 175.81 5.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.035 1.734 . . . . 0.0 110.382 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.594 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 97.2 m -137.32 102.26 4.75 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.249 1.02 . . . . 0.0 112.956 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 35' ' ' ILE . 20.5 tp -69.12 115.8 8.83 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.441 -0.787 . . . . 0.0 110.339 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.99 111.9 3.96 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.7 151.29 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.415 1.086 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.675 ' HB2' HD13 ' A' ' 134' ' ' LEU . 12.1 tmm? -138.63 148.75 44.46 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.38 1.072 . . . . 0.0 110.002 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.7 p90 -157.21 159.57 37.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.631 0.772 . . . . 0.0 111.477 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -164.46 150.57 10.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.1 t -108.73 98.59 29.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.04 162.07 41.57 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.588 1.526 . . . . 0.0 110.794 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -70.39 -174.62 0.87 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.661 1.185 . . . . 0.0 111.028 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -47.93 122.29 4.93 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.223 1.409 . . . . 0.0 112.71 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -55.26 109.42 0.54 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.675 1.19 . . . . 0.0 111.243 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -84.94 -49.17 8.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.479 0.712 . . . . 0.0 111.599 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -168.9 -50.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.45 1.5 . . . . 0.0 113.629 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -167.4 117.96 0.86 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.352 1.861 . . . . 0.0 109.545 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.67 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.268 1.827 . . . . 0.0 110.452 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.04 105.23 5.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.515 -0.74 . . . . 0.0 111.781 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -84.45 135.73 34.14 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.361 1.064 . . . . 0.0 113.128 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -151.4 125.56 9.3 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.128 0.971 . . . . 0.0 109.733 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.02 150.23 11.25 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.967 -1.083 . . . . 0.0 111.999 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.9 143.34 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.049 1.74 . . . . 0.0 110.138 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -135.47 126.48 27.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.42 1.488 . . . . 0.0 109.144 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.8 mt -93.27 100.04 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.237 1.015 . . . . 0.0 109.316 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -68.41 100.98 1.15 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.845 -1.159 . . . . 0.0 109.406 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 80.64 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.723 1.209 . . . . 0.0 111.132 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.35 -106.75 0.29 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 127.317 2.389 . . . . 0.0 111.22 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -156.56 150.3 24.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.369 1.868 . . . . 0.0 111.553 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -164.96 106.82 0.82 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.236 1.415 . . . . 0.0 113.877 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -59.43 153.4 19.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.368 1.067 . . . . 0.0 111.182 174.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -72.44 113.96 10.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.741 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -150.39 -175.76 5.21 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.633 1.173 . . . . 0.0 111.471 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.0 -46.07 68.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.408 -1.432 . . . . 0.0 111.909 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.2 -31.59 62.38 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.555 1.074 . . . . 0.0 113.767 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' HD11 ' A' ' 134' ' ' LEU . 12.6 tpt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -48.11 -39.46 20.5 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.432 1.093 . . . . 0.0 112.453 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.36 -42.17 96.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.203 1.001 . . . . 0.0 111.598 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.84 68.51 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.288 -1.508 . . . . 0.0 113.462 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 101' ' ' MET . 51.3 mt -90.24 -7.85 52.48 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.06 -27.31 3.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.45 1.5 . . . . 0.0 114.116 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.49 -37.11 3.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.729 1.212 . . . . 0.0 111.706 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.27 -67.53 1.33 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.229 1.871 . . . . 0.0 113.168 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.53 67.88 0.29 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.822 1.649 . . . . 0.0 113.429 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.66 173.02 15.21 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.938 1.759 . . . . 0.0 115.207 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.92 173.18 10.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.163 1.785 . . . . 0.0 112.972 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -115.8 137.61 51.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.724 2.01 . . . . 0.0 112.042 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -138.1 116.65 1.34 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.722 1.153 . . . . 0.0 111.541 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -126.25 69.95 1.23 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.74 94.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.13 2.572 . . . . 0.0 113.898 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.01 139.74 2.75 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.753 1.644 . . . . 0.0 111.49 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -70.25 127.44 32.78 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -129.53 146.29 51.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.589 1.156 . . . . 0.0 111.634 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -142.33 137.77 30.78 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.452 1.501 . . . . 0.0 110.362 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 158.33 43.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.713 1.205 . . . . 0.0 110.892 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 94.08 1.02 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.714 1.206 . . . . 0.0 109.553 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tp -51.53 -36.33 44.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.329 1.451 . . . . 0.0 113.752 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 120.38 33.97 0.98 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.11 -32.28 0.79 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.07 -28.3 0.9 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.987 1.28 . . . . 0.0 114.344 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 175.14 5.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.824 2.05 . . . . 0.0 112.541 175.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -118.19 145.38 45.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.222 1.009 . . . . 0.0 112.164 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.615 ' HB2' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -121.88 147.7 45.66 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 130.89 53.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.426 1.89 . . . . 0.0 107.851 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -123.11 155.16 17.26 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 122.149 0.861 . . . . 0.0 112.951 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.1 131.02 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.067 1.747 . . . . 0.0 108.505 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.1 tpp -126.42 103.31 7.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.403 0.547 . . . . 0.0 109.529 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 68.9 p -98.73 141.32 31.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.142 1.377 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.1 t -155.39 89.58 1.2 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.47 -0.769 . . . . 0.0 111.812 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.18 30.23 0.17 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.701 1.2 . . . . 0.0 114.083 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.85 134.12 1.76 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.888 1.232 . . . . 0.0 112.419 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 43.45 59.82 2.86 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.439 1.496 . . . . 0.0 112.576 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -137.56 163.43 31.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.925 1.29 . . . . 0.0 112.024 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 47.6 tptt -163.26 144.85 9.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 22.5 ptm -77.61 160.49 28.5 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.157 1.783 . . . . 0.0 113.927 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -154.21 160.93 42.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.173 1.789 . . . . 0.0 109.477 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 42.7 mm -131.84 113.99 23.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 C-N-CA 125.126 1.37 . . . . 0.0 109.692 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -110.63 139.82 45.54 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.72 0.808 . . . . 0.0 110.891 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.615 HG22 ' HB2' ' A' ' 157' ' ' MET . 10.2 pt -120.95 132.68 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.715 0.806 . . . . 0.0 109.731 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.2 p -148.05 161.47 41.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.024 1.329 . . . . 0.0 112.846 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.429 ' HB3' HG13 ' A' ' 20' ' ' VAL . 3.8 mt -55.61 -50.41 70.23 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 117.748 -1.12 . . . . 0.0 111.488 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.7 -49.33 4.25 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.555 1.07 . . . . 0.0 113.266 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.56 -33.15 1.42 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.53 1.538 . . . . 0.0 116.694 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.1 p -138.61 146.57 41.91 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.445 2.122 . . . . 0.0 111.972 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.41 161.44 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.781 -1.2 . . . . 0.0 108.817 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 7' ' ' ILE . 4.7 pt -75.05 177.55 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.487 1.915 . . . . 0.0 111.858 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.45 16.34 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.02 -18.18 40.18 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.148 1.356 . . . . 0.0 112.674 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.59 70.04 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.642 1.577 . . . . 0.0 113.632 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -112.32 -2.59 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.892 1.677 . . . . 0.0 113.311 174.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD11 HD23 ' A' ' 17' ' ' LEU . 20.3 tp -78.76 148.84 32.83 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.338 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.91 146.83 27.29 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 0.0 110.047 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.39 -34.66 66.92 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.006 0.821 . . . . 0.0 112.763 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -59.43 -56.26 24.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.671 1.189 . . . . 0.0 113.018 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.25 -45.87 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.303 0.641 . . . . 0.0 111.026 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 12' ' ' LEU . 2.7 tm? -55.22 -38.7 68.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.183 0.993 . . . . 0.0 111.95 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -52.25 -57.65 9.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.258 1.823 . . . . 0.0 111.705 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.05 60.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 176.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 2' ' ' LEU . 8.0 t -65.82 -49.17 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 119.762 1.164 . . . . 0.0 110.838 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -67.0 -21.76 65.93 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -24.84 22.84 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -20.03 62.56 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.282 1.033 . . . . 0.0 113.595 -175.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD11 ' HD2' ' A' ' 30' ' ' LYS . 3.2 pp -60.86 -30.16 69.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.843 1.257 . . . . 0.0 114.031 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.564 ' N ' HD12 ' A' ' 24' ' ' LEU . . . 179.59 122.77 0.79 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.207 0.908 . . . . 0.0 112.11 -175.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -70.59 93.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.608 1.563 . . . . 0.0 112.025 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.4 m -130.15 168.42 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.749 1.619 . . . . 0.0 112.273 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -56.66 -41.75 77.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.348 1.459 . . . . 0.0 113.777 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.42 156.32 43.68 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.011 2.124 . . . . 0.0 111.179 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.675 ' HD2' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -139.41 178.31 7.29 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.852 1.261 . . . . 0.0 111.673 177.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -127.22 143.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.163 1.385 . . . . 0.0 111.491 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.614 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -121.98 100.22 6.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.592 1.957 . . . . 0.0 111.778 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.5 p -110.34 127.09 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.538 1.135 . . . . 0.0 109.918 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.19 157.7 26.8 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.964 -0.636 . . . . 0.0 114.278 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.66 121.97 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.185 0.994 . . . . 0.0 110.229 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -74.1 105.12 5.17 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.363 -0.835 . . . . 0.0 110.689 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.62 91.95 4.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.223 1.809 . . . . 0.0 113.447 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.33 21.27 2.4 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.996 0.903 . . . . 0.0 112.392 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -7.07 54.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.698 1.599 . . . . 0.0 114.924 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.86 18.44 65.46 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.046 -1.034 . . . . 0.0 114.66 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.6 127.77 5.14 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.214 1.864 . . . . 0.0 110.736 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.3 m -69.4 131.01 44.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.73 0.765 . . . . 0.0 110.527 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.669 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 14.9 m0 -96.75 162.47 13.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.136 0.493 . . . . 0.0 111.954 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -138.83 107.46 5.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 127.1 2.16 . . . . 0.0 109.617 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 150.64 47.96 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.259 -0.9 . . . . 0.0 110.711 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -121.22 -54.67 1.99 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.559 1.144 . . . . 0.0 111.993 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -156.92 172.22 19.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.974 0.91 . . . . 0.0 111.667 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.34 140.08 35.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.958 1.303 . . . . 0.0 111.841 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 t80 -118.65 127.44 53.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 109.659 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.4 119.56 39.82 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.217 1.807 . . . . 0.0 107.627 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -11.78 49.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.235 0.541 . . . . 0.0 111.295 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.01 114.25 7.43 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 108.961 -175.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.71 -165.88 53.87 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.228 0.918 . . . . 0.0 113.679 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 t -119.41 -170.75 1.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.665 1.586 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.68 163.06 22.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.709 1.604 . . . . 0.0 111.695 174.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.438 ' OD2' HD13 ' A' ' 24' ' ' LEU . 19.1 t70 -141.31 -44.46 0.37 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.093 0.957 . . . . 0.0 111.824 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.68 164.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.726 2.01 . . . . 0.0 111.421 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 tt -77.51 134.76 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.37 1.068 . . . . 0.0 112.032 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.83 128.98 52.2 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.148 0.979 . . . . 0.0 110.285 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.663 ' HG2' HD12 ' A' ' 69' ' ' LEU . 52.9 Cg_endo -64.89 115.35 3.21 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 124.562 3.508 . . . . 0.0 112.14 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -62.65 -48.0 81.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -115.4 153.5 30.94 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.189 0.995 . . . . 0.0 111.577 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.75 88.87 13.59 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.434 1.094 . . . . 0.0 108.754 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.81 143.36 29.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.023 2.482 . . . . 0.0 111.336 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -48.88 153.98 0.78 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.526 1.13 . . . . 0.0 112.697 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 p 63.9 46.86 3.71 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.638 1.575 . . . . 0.0 110.047 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 68' ' ' ALA . 17.4 ttmt -155.52 172.01 18.97 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.503 1.521 . . . . 0.0 111.09 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' H ' ' HG2' ' A' ' 67' ' ' LYS . . . -142.23 -176.67 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.484 1.514 . . . . 0.0 108.77 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -163.5 144.98 9.38 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.34 -0.85 . . . . 0.0 110.619 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.489 ' CD1' HD21 ' A' ' 17' ' ' LEU . 5.2 mt -117.36 170.15 8.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.893 1.33 . . . . 0.0 108.496 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.6 t80 -152.31 160.31 43.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.162 1.385 . . . . 0.0 107.708 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -147.38 148.12 31.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.832 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.8 -170.91 37.17 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.752 0.691 . . . . 0.0 112.165 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -176.68 4.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.853 1.661 . . . . 0.0 111.673 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.33 98.83 2.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.677 1.591 . . . . 0.0 112.671 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -99.67 -55.46 2.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.402 1.481 . . . . 0.0 111.91 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -146.66 14.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.72 -81.1 0.5 Allowed Glycine 0 N--CA 1.48 1.593 0 O-C-N 120.609 -1.307 . . . . 0.0 113.672 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.43 1.94 6.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.479 3.452 . . . . 0.0 113.1 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 p -56.58 -21.64 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 113.878 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.02 -5.48 22.11 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.958 2.503 . . . . 0.0 114.738 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 -151.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.772 1.629 . . . . 0.0 110.529 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 104' ' ' VAL . . . -97.22 147.7 18.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.172 1.368 . . . . 0.0 109.888 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.43 151.94 42.86 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.114 0.957 . . . . 0.0 111.9 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -150.07 118.75 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.808 1.243 . . . . 0.0 112.946 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.42 160.0 43.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.529 1.532 . . . . 0.0 110.127 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' HB3' ' CE ' ' A' ' 130' ' ' MET . . . -146.32 135.57 22.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -143.28 168.78 18.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 111.406 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -123.99 150.32 44.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.736 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -130.93 115.3 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.64 1.576 . . . . 0.0 110.373 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.446 ' HB2' HD22 ' A' ' 46' ' ' LEU . 12.3 t80 -73.7 104.08 4.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.382 1.473 . . . . 0.0 111.291 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -71.71 158.27 36.43 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.135 -0.978 . . . . 0.0 112.63 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -58.5 -24.97 61.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.831 1.252 . . . . 0.0 113.732 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 t -73.72 -3.24 27.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.998 1.319 . . . . 0.0 113.948 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.48 17.67 72.96 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.416 1.008 . . . . 0.0 114.265 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -102.83 163.18 12.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.594 1.558 . . . . 0.0 110.683 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.61 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 86.8 m -127.58 102.74 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.55 0.74 . . . . 0.0 112.982 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 173' ' ' ILE . 27.1 tp -71.72 116.45 12.11 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.418 -0.801 . . . . 0.0 110.855 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.09 104.16 3.1 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.306 1.431 . . . . 0.0 111.024 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.78 160.59 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.624 0.726 . . . . 0.0 111.529 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 156.51 45.52 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.036 1.334 . . . . 0.0 110.261 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 33' ' ' VAL . 10.7 p90 -166.96 155.25 9.83 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.501 1.521 . . . . 0.0 110.893 175.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.92 124.17 1.81 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.369 1.468 . . . . 0.0 110.38 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.445 ' HB ' ' HA3' ' A' ' 83' ' ' GLY . 34.1 t -81.73 131.99 56.0 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.16 173.27 8.75 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.501 2.134 . . . . 0.0 111.922 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.88 155.49 10.43 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.098 -1.001 . . . . 0.0 111.157 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.48 -66.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 128.355 2.662 . . . . 0.0 115.736 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -149.84 31.67 0.7 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.44 1.896 . . . . 0.0 112.235 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.49 -32.85 69.17 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.815 1.246 . . . . 0.0 114.154 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 61.23 82.12 0.17 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.664 1.986 . . . . 0.0 113.656 176.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.86 167.59 21.96 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.451 1.5 . . . . 0.0 112.097 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.6 m -57.59 143.99 39.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 110.955 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.11 152.25 24.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.674 0.79 . . . . 0.0 110.69 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -97.8 159.38 14.97 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -161.98 153.26 18.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.993 1.317 . . . . 0.0 109.494 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -174.47 104.18 0.1 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.122 1.369 . . . . 0.0 111.311 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.08 132.06 45.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.736 1.214 . . . . 0.0 108.507 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -140.48 160.98 38.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.118 1.367 . . . . 0.0 110.021 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 93.3 mt -118.65 112.5 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.498 1.519 . . . . 0.0 109.171 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.41 100.69 6.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -56.12 121.89 10.45 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.95 -1.094 . . . . 0.0 108.977 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.67 -140.46 15.41 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -128.41 132.09 48.48 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.391 1.476 . . . . 0.0 112.613 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -160.01 124.04 3.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.519 1.527 . . . . 0.0 112.238 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -179.28 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 111.459 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 49' ' ' TYR . . . -87.83 109.19 19.57 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.842 -0.536 . . . . 0.0 111.154 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.89 -172.22 4.06 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 111.473 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.84 -47.51 31.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.893 0.877 . . . . 0.0 111.496 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.18 -47.44 55.3 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.402 1.001 . . . . 0.0 114.088 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.41 ' CE ' ' HB3' ' A' ' 87' ' ' ALA . 3.1 ttp -65.75 -52.23 52.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.017 0.927 . . . . 0.0 111.276 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -56.31 -37.33 69.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.77 0.795 . . . . 0.0 112.767 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.42 -47.41 79.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.876 2.07 . . . . 0.0 110.049 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -26.98 69.08 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.696 1.135 . . . . 0.0 113.677 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mp -70.4 -49.19 51.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.955 1.302 . . . . 0.0 112.909 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.27 -29.54 13.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.24 -26.59 8.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.981 1.312 . . . . 0.0 112.156 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -63.83 4.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.449 1.5 . . . . 0.0 111.278 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -174.3 80.29 0.35 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.877 2.071 . . . . 0.0 111.331 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.22 154.2 66.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.134 1.89 . . . . 0.0 111.511 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -120.41 -164.58 1.11 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.576 1.95 . . . . 0.0 111.041 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.75 131.37 46.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.805 2.442 . . . . 0.0 111.509 -175.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -142.34 115.38 0.95 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.863 1.697 . . . . 0.0 111.054 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.78 -55.02 2.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 84.99 0.14 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 120.323 1.419 . . . . 0.0 111.398 174.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.26 163.86 24.01 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 122.0 0.778 . . . . 0.0 114.687 175.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.461 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 59.5 m95 -82.1 145.44 30.16 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.002 1.721 . . . . 0.0 111.983 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -161.12 123.42 3.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.217 1.407 . . . . 0.0 112.154 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.6 154.95 18.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.837 1.655 . . . . 0.0 111.651 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.19 145.81 24.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.794 1.237 . . . . 0.0 110.052 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -72.82 93.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.9 tp -51.96 -36.88 50.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.085 1.354 . . . . 0.0 113.841 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.15 40.22 2.14 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.97 -32.48 0.96 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.73 -34.36 0.68 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.739 1.161 . . . . 0.0 113.548 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.31 172.63 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.168 1.787 . . . . 0.0 111.998 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -127.04 165.17 19.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.607 1.163 . . . . 0.0 110.603 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.59 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -152.48 163.6 39.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.663 0.744 . . . . 0.0 111.742 174.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 146' ' ' TRP . 6.3 tptt -119.99 127.29 52.48 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.504 1.522 . . . . 0.0 108.153 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.36 146.76 17.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.815 0.721 . . . . 0.0 111.879 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.503 ' CD1' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -124.95 131.15 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 125.085 1.354 . . . . 0.0 109.313 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 125.89 36.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.07 0.85 . . . . 0.0 108.755 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.503 HG23 ' CD1' ' A' ' 160' ' ' ILE . 19.8 p -126.1 137.5 53.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.05 1.74 . . . . 0.0 111.783 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.6 p -129.93 128.93 43.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.111 2.164 . . . . 0.0 110.765 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.56 -54.4 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.412 1.885 . . . . 0.0 111.365 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.13 -49.08 0.2 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.735 1.16 . . . . 0.0 113.715 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.74 28.53 8.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.915 1.686 . . . . 0.0 112.778 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB1' ' OG1' ' A' ' 162' ' ' THR . . . -118.55 159.67 23.14 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.276 1.43 . . . . 0.0 113.78 -174.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.7 OUTLIER -150.92 168.91 23.07 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -176.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.46 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 7.1 ttp -102.78 138.07 40.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.729 1.612 . . . . 0.0 111.262 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -137.3 150.83 48.05 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.57 1.148 . . . . 0.0 109.689 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.408 HG23 ' SD ' ' A' ' 157' ' ' MET . 42.1 mm -126.23 124.35 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.106 0.962 . . . . 0.0 109.286 -175.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -112.96 106.96 15.34 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.029 -1.045 . . . . 0.0 110.439 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.669 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 17.3 pt -92.9 125.91 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.783 0.833 . . . . 0.0 109.933 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 89.2 p -155.59 149.36 25.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.219 1.808 . . . . 0.0 112.952 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.84 -0.059 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.08 -29.93 70.34 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.181 0.593 . . . . 0.0 111.405 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.01 128.67 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.717 1.607 . . . . 0.0 111.918 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.67 -15.05 9.79 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.42 1.962 . . . . 0.0 113.597 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p -167.37 162.79 14.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.149 2.58 . . . . 0.0 109.213 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 70' ' ' LEU . 47.0 mt -140.24 172.56 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.557 1.143 . . . . 0.0 109.021 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -83.78 -162.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 125.77 1.628 . . . . 0.0 110.317 174.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.7 60.2 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.4 -25.63 12.09 Favored Glycine 0 N--CA 1.488 2.13 0 O-C-N 123.951 0.782 . . . . 0.0 112.698 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.02 63.36 Favored 'General case' 0 CA--C 1.59 2.519 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -96.24 -3.76 43.57 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.571 1.548 . . . . 0.0 114.267 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.16 139.41 58.13 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.303 -0.873 . . . . 0.0 108.926 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.51 141.03 20.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.244 0.618 . . . . 0.0 110.403 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -55.75 -32.28 63.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -57.45 -49.06 77.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.746 1.218 . . . . 0.0 111.8 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 t -69.88 -50.42 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.476 1.11 . . . . 0.0 109.375 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -55.13 -32.7 62.29 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.26 -61.28 2.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.201 1.8 . . . . 0.0 109.976 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -40.4 86.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.429 1.492 . . . . 0.0 112.677 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.16 -50.62 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.289 1.436 . . . . 0.0 111.613 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -73.43 -35.24 65.76 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.1 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.36 -30.93 69.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.429 1.491 . . . . 0.0 113.267 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -55.78 -28.79 57.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.543 1.137 . . . . 0.0 113.633 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.57 -34.32 72.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.907 0.883 . . . . 0.0 111.991 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -173.39 116.11 0.59 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.123 1.344 . . . . 0.0 112.659 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -71.25 66.88 0.45 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.777 2.031 . . . . 0.0 112.32 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.51 175.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.856 2.462 . . . . 0.0 110.903 -175.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 m -72.03 55.8 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.476 1.91 . . . . 0.0 111.96 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.92 101.88 2.47 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.626 1.57 . . . . 0.0 110.712 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.644 ' CB ' HD11 ' A' ' 21' ' ' LEU . 2.7 pttm -141.72 121.71 13.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.67 1.588 . . . . 0.0 112.782 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.485 HG23 ' HA ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.73 151.19 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.057 . . . . 0.0 110.852 178.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' N ' HD13 ' A' ' 31' ' ' ILE . . . -141.15 101.99 4.14 Favored 'General case' 0 CA--C 1.573 1.837 0 C-N-CA 126.295 1.838 . . . . 0.0 111.317 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.466 HG11 ' CE2' ' A' ' 102' ' ' PHE . 2.4 p -114.78 132.92 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.306 1.442 . . . . 0.0 110.087 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.3 165.32 38.36 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -140.45 119.79 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.979 1.311 . . . . 0.0 112.378 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -67.75 115.91 7.84 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 121.381 -0.825 . . . . 0.0 111.08 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -96.05 85.32 4.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.482 175.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.96 13.67 5.76 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -76.27 -13.26 60.16 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 14.59 43.09 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.627 1.108 . . . . 0.0 115.437 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.33 126.09 3.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.387 1.47 . . . . 0.0 112.813 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.5 m -64.32 140.92 58.92 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.066 1.346 . . . . 0.0 111.253 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 17.8 m0 -106.57 171.95 7.08 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.7 m -150.55 110.82 4.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.134 1.773 . . . . 0.0 111.871 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.01 58.06 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 120.979 -1.076 . . . . 0.0 110.222 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.59 -46.26 4.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.397 0.679 . . . . 0.0 112.186 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.93 173.7 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.356 1.063 . . . . 0.0 111.244 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.03 128.77 23.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.105 0.962 . . . . 0.0 112.949 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.82 117.14 33.32 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.842 1.657 . . . . 0.0 110.32 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 7.1 m-85 -116.92 129.95 56.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.076 1.75 . . . . 0.0 109.343 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.56 4.65 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -152.96 92.51 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.794 1.238 . . . . 0.0 110.215 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.07 19.33 0.28 Allowed Glycine 0 N--CA 1.475 1.28 0 N-CA-C 117.474 1.75 . . . . 0.0 117.474 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -40.04 113.77 0.38 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.143 2.177 . . . . 0.0 113.188 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.681 HG21 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 t -66.21 -179.67 0.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.783 1.633 . . . . 0.0 115.312 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.12 -9.71 3.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.077 1.751 . . . . 0.0 114.033 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -87.69 166.45 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.326 1.05 . . . . 0.0 112.581 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 tt -68.93 130.13 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.469 1.108 . . . . 0.0 112.63 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 60' ' ' PRO . 41.1 tp -84.41 117.47 68.81 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.495 0.718 . . . . 0.0 109.769 174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.627 ' CG ' HD12 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -69.03 119.96 6.9 Favored 'Trans proline' 0 CA--C 1.556 1.598 0 C-N-CA 122.758 2.305 . . . . 0.0 109.741 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.39 -64.25 1.2 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.935 0.894 . . . . 0.0 112.515 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -96.75 151.53 19.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.669 0.788 . . . . 0.0 109.963 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 132.93 9.63 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.007 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -71.55 -150.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 125.102 3.868 . . . . 0.0 112.914 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.96 15.13 9.25 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.939 1.696 . . . . 0.0 114.287 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -142.06 30.44 1.61 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.306 1.442 . . . . 0.0 112.752 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -146.1 -175.96 4.96 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.678 1.191 . . . . 0.0 113.077 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.26 173.78 11.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.112 1.365 . . . . 0.0 107.472 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.627 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -150.61 148.97 29.28 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.855 -1.153 . . . . 0.0 111.287 176.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.24 162.13 26.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.861 0.864 . . . . 0.0 111.266 177.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 55' ' ' THR . 1.0 OUTLIER -141.38 163.52 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.272 1.429 . . . . 0.0 110.001 174.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 31' ' ' ILE . 55.1 m -135.77 -166.53 1.87 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.4 1.48 . . . . 0.0 110.383 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.4 178.29 33.82 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.367 -0.833 . . . . 0.0 113.461 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -146.42 158.22 43.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.227 1.011 . . . . 0.0 112.481 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.49 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.695 2.398 . . . . 0.0 116.567 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -75.36 0.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.642 1.577 . . . . 0.0 112.686 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.6 m -87.71 -8.67 55.77 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.357 1.063 . . . . 0.0 112.253 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.58 90.86 0.12 Allowed Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.53 35.23 0.43 Allowed 'Trans proline' 0 CA--C 1.578 2.721 1 C-N-CA 125.395 4.063 . . . . 0.0 111.098 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -48.07 133.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 127.481 2.313 . . . . 0.0 111.245 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.07 0.59 3.46 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.584 1.554 . . . . 0.0 114.522 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -149.05 109.98 4.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.791 2.836 . . . . 0.0 108.814 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' HA3' HG21 ' A' ' 104' ' ' VAL . . . 44.63 -112.91 0.74 Allowed Glycine 0 CA--C 1.537 1.446 0 N-CA-C 119.661 2.624 . . . . 0.0 119.661 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -161.92 173.83 13.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.613 1.965 . . . . 0.0 112.091 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.48 113.94 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.898 1.279 . . . . 0.0 113.216 -175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . . . -155.51 170.97 20.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 111.094 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.52 124.12 7.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.661 1.584 . . . . 0.0 108.757 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -128.49 163.8 24.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.661 1.184 . . . . 0.0 112.055 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -121.97 142.88 49.86 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -122.42 113.97 20.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.982 2.113 . . . . 0.0 111.151 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.42 108.32 2.33 Favored 'General case' 0 N--CA 1.382 -3.828 0 C-N-CA 124.836 1.255 . . . . 0.0 112.625 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.1 mtp -73.08 155.09 40.09 Favored 'General case' 0 CA--C 1.627 3.906 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 t -58.95 -23.62 61.75 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.61 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -67.98 -9.19 43.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.895 2.078 . . . . 0.0 114.178 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 8.06 68.71 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.71 1.148 . . . . 0.0 114.794 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.5 175.41 5.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.028 1.731 . . . . 0.0 110.412 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 89' ' ' ALA . 91.8 m -130.84 104.06 6.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.963 -1.086 . . . . 0.0 112.314 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.649 HD22 HD13 ' A' ' 173' ' ' ILE . 47.2 tp -69.39 119.07 13.09 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 120.994 -1.066 . . . . 0.0 110.79 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 104.55 3.18 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.621 1.105 . . . . 0.0 111.065 174.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.15 162.46 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.211 0.529 . . . . 0.0 111.322 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.79 149.78 30.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.013 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' CE2' HG11 ' A' ' 33' ' ' VAL . 45.3 p90 -154.85 154.24 32.4 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.097 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -160.15 157.36 28.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.668 1.587 . . . . 0.0 107.377 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 168' ' ' LYS . 2.4 t -121.82 95.33 47.84 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 121.327 -0.858 . . . . 0.0 109.211 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -69.98 162.34 42.57 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.9 1.733 . . . . 0.0 111.802 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -138.23 -45.34 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 111.047 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.5 157.96 30.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.969 2.108 . . . . 0.0 111.491 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -110.33 77.75 1.07 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.692 1.997 . . . . 0.0 110.954 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -66.89 -44.41 80.92 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.558 -0.714 . . . . 0.0 112.604 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -147.33 -44.49 0.17 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.919 1.288 . . . . 0.0 112.862 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -117.07 161.58 19.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.597 1.559 . . . . 0.0 111.631 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.6 m -75.13 -65.01 0.93 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -157.69 125.38 5.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 112.559 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -91.91 158.06 16.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.436 1.495 . . . . 0.0 112.377 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -165.1 126.79 2.08 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 110.064 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.98 91.07 1.02 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.33 150.8 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.048 -1.032 . . . . 0.0 109.538 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -142.97 135.07 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.241 1.416 . . . . 0.0 108.733 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 155' ' ' LEU . 52.3 mt -100.12 103.45 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 124.268 1.027 . . . . 0.0 109.651 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -69.91 96.73 1.04 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.7 t -63.63 99.68 0.24 Allowed 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.79 -124.02 3.16 Favored Glycine 0 CA--C 1.578 3.986 0 N-CA-C 104.518 -3.433 . . . . 0.0 104.518 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.1 tttt -141.85 116.54 9.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.854 0.827 . . . . 0.0 111.969 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -134.73 111.88 10.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.51 1.124 . . . . 0.0 112.996 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 167.3 5.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.608 1.163 . . . . 0.0 110.781 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.17 119.54 31.36 Favored 'General case' 1 N--CA 1.336 -6.145 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 173.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . 0.259 2.0 t70 -165.59 -177.04 4.19 Favored 'General case' 0 N--CA 1.522 3.153 0 O-C-N 127.602 3.064 . . . . 0.0 104.185 -163.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.46 -47.95 48.0 Favored 'General case' 1 CA--C 1.632 4.111 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.116 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.26 -31.46 34.56 Favored Glycine 0 N--CA 1.48 1.586 0 CA-C-N 121.849 2.113 . . . . 0.0 113.383 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.8 ttt -72.75 -58.56 3.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.386 0.674 . . . . 0.0 110.498 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -57.5 -31.18 65.76 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.82 -44.38 96.29 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.31 1.444 . . . . 0.0 109.704 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -66.47 -2.41 4.62 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.05 0.94 . . . . 0.0 113.471 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.7 mt -102.05 -45.87 5.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.662 1.585 . . . . 0.0 111.989 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -93.57 -23.4 18.32 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -121.25 -1.65 9.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.621 1.569 . . . . 0.0 111.974 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -121.98 72.91 0.37 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.591 2.043 . . . . 0.0 113.185 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.3 m120 73.58 68.66 0.27 Allowed Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 127.005 2.122 . . . . 0.0 112.503 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.25 114.78 3.17 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.369 2.713 . . . . 0.0 111.749 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -124.78 162.59 23.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.42 1.888 . . . . 0.0 111.598 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.9 mtm105 -145.57 165.51 28.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.298 1.439 . . . . 0.0 112.008 -174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -134.32 -57.49 0.07 OUTLIER Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.3 t0 48.81 69.36 0.58 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 126.643 1.977 . . . . 0.0 113.907 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 57.59 100.79 0.02 OUTLIER 'General case' 0 C--O 1.25 1.111 0 C-N-CA 129.213 3.005 . . . . 0.0 114.58 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.98 104.09 0.19 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -53.77 101.92 0.05 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 112.506 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -119.21 131.08 55.78 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.891 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.82 133.89 55.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.747 2.019 . . . . 0.0 109.846 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -140.4 157.51 45.42 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.262 0.553 . . . . 0.0 110.76 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -76.78 98.35 4.78 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.1 tp -57.66 -23.77 53.08 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.01 24.7 5.65 Favored Glycine 0 C--N 1.357 1.745 0 CA-C-O 117.851 -1.527 . . . . 0.0 116.726 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -130.24 -27.56 2.21 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.813 1.807 . . . . 0.0 115.636 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.03 -33.01 1.05 Allowed Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.534 1.064 . . . . 0.0 113.83 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -109.83 172.7 6.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.741 1.616 . . . . 0.0 111.885 174.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.14 158.89 32.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 0.0 110.887 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -143.49 165.02 28.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.591 0.71 . . . . 0.0 111.144 176.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -128.14 136.79 51.63 Favored 'General case' 0 N--CA 1.396 -3.137 0 C-N-CA 124.826 1.25 . . . . 0.0 112.049 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.18 160.29 22.93 Favored Glycine 1 CA--C 1.618 6.518 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.44 156.94 41.0 Favored 'Isoleucine or valine' 1 CA--C 1.629 4.016 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.81 87.04 1.4 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.0 p -73.81 165.11 25.7 Favored 'General case' 0 C--O 1.254 1.313 0 C-N-CA 124.238 1.015 . . . . 0.0 110.704 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -128.46 -163.08 1.24 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.737 1.215 . . . . 0.0 112.042 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 74.62 7.07 4.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.534 2.333 . . . . 0.0 115.116 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.82 169.66 19.44 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.516 1.055 . . . . 0.0 110.732 -175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 65.6 -51.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.755 2.022 . . . . 0.0 114.568 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.98 163.44 7.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.568 2.347 . . . . 0.0 112.694 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -154.07 165.12 37.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 123.155 1.455 . . . . 0.0 114.524 -174.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.485 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 24.8 ptm -93.12 164.94 13.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.172 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -153.27 156.15 37.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.03 138.75 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.887 1.675 . . . . 0.0 109.145 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.44 117.74 23.54 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.103 1.361 . . . . 0.0 109.704 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.649 HD13 HD22 ' A' ' 98' ' ' LEU . 22.7 pt -108.79 126.14 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.552 0.741 . . . . 0.0 110.17 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.7 t -152.53 158.84 43.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.577 0 C-N-CA 126.122 1.769 . . . . 0.0 111.134 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.01 -43.59 87.23 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.345 1.429 . . . . 0.0 111.72 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.63 165.81 11.79 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 110.597 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.71 -25.4 27.64 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.195 1.379 . . . . 0.0 112.573 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -149.19 151.63 34.65 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.522 1.661 . . . . 0.0 111.535 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.447 HD11 HD12 ' A' ' 70' ' ' LEU . 29.4 mm -144.12 158.9 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.743 1.217 . . . . 0.0 111.312 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.67 -173.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 127.502 2.321 . . . . 0.0 111.984 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.73 -22.34 3.45 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.0 -25.32 14.42 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.648 1.118 . . . . 0.0 114.144 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -36.87 75.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.158 0.979 . . . . 0.0 111.969 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -7.12 58.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.942 1.297 . . . . 0.0 113.619 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD11 HD23 ' A' ' 17' ' ' LEU . 2.8 tt -64.67 156.4 30.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.382 1.473 . . . . 0.0 112.651 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -148.55 143.38 26.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.041 0.936 . . . . 0.0 110.116 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -56.25 -32.86 64.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.653 0.781 . . . . 0.0 113.104 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -55.52 -57.28 12.55 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.081 1.352 . . . . 0.0 112.342 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.19 -51.42 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.706 0.803 . . . . 0.0 109.892 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.413 HD23 HD11 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -53.44 -37.1 62.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.172 1.389 . . . . 0.0 113.615 -174.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.26 -49.08 65.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.27 1.428 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -36.52 83.55 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.339 -0.851 . . . . 0.0 111.301 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.57 -53.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.802 1.241 . . . . 0.0 111.345 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.417 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.9 pp -63.85 -34.93 79.04 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.98 -25.39 58.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -54.95 -26.81 38.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.342 1.428 . . . . 0.0 112.893 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp -88.18 -4.65 58.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.312 2.645 . . . . 0.0 114.606 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.24 102.17 0.16 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.718 1.152 . . . . 0.0 112.987 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.17 19.87 0.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.871 2.069 . . . . 0.0 113.782 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.15 174.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.705 2.402 . . . . 0.0 112.961 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 p -76.88 0.51 20.62 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.93 128.19 12.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.643 . . . . 0.0 111.928 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -141.65 166.11 25.63 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.19 146.02 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.969 1.708 . . . . 0.0 115.007 -174.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -137.51 110.47 7.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.725 2.81 . . . . 0.0 109.404 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 71' ' ' TYR . 1.3 p -116.12 125.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 175.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.31 157.71 30.31 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.178 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 98' ' ' LEU . 1.5 mp -139.19 117.58 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 0.0 111.572 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.89 102.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.421 -1.424 . . . . 0.0 111.746 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.419 ' HA ' ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -76.76 87.16 3.38 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.88 1.272 . . . . 0.0 111.82 175.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -143.15 45.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.684 1.194 . . . . 0.0 111.295 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.47 1.3 29.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.014 1.325 . . . . 0.0 114.465 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.27 17.29 69.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.383 0.992 . . . . 0.0 115.139 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.16 131.76 4.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.945 1.736 . . . . 0.0 111.742 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -59.08 142.51 51.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.033 1.333 . . . . 0.0 111.194 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.419 ' CH2' ' HA ' ' A' ' 37' ' ' ASN . 45.7 m0 -104.68 167.16 9.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 111.505 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -152.58 102.49 2.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.269 2.227 . . . . 0.0 109.407 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 166.43 14.31 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.344 -0.848 . . . . 0.0 111.617 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.79 -67.8 0.77 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.668 1.587 . . . . 0.0 110.432 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -156.66 -176.17 5.83 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.985 1.714 . . . . 0.0 110.995 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.85 37.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.97 1.708 . . . . 0.0 110.844 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -127.94 130.06 47.82 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.574 1.549 . . . . 0.0 109.684 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -140.16 137.44 34.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 128.485 2.714 . . . . 0.0 109.121 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -14.84 15.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.32 1.448 . . . . 0.0 112.324 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.81 99.08 3.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.642 1.977 . . . . 0.0 109.056 176.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.22 102.08 0.94 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 124.401 1.001 . . . . 0.0 112.807 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 HG23 ' CE1' ' A' ' 50' ' ' PHE . 97.1 m -65.94 -103.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.411 1.884 . . . . 0.0 110.914 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.6 p -150.51 172.67 15.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 111.916 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -148.75 -4.02 0.44 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.633 2.373 . . . . 0.0 113.125 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.81 166.86 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 127.416 2.287 . . . . 0.0 112.128 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.21 128.65 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.11 1.764 . . . . 0.0 112.576 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 tp -81.59 123.66 80.58 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 108.511 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 69' ' ' LEU . 65.6 Cg_endo -65.54 124.55 12.99 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.884 3.056 . . . . 0.0 110.827 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.07 -76.75 0.26 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.233 -0.917 . . . . 0.0 112.188 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.54 125.57 40.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.87 0.868 . . . . 0.0 110.28 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -123.78 121.98 26.46 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.228 -175.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -75.94 179.21 6.51 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.179 3.252 . . . . 0.0 112.323 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -66.8 169.18 8.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.301 1.44 . . . . 0.0 112.64 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p 43.39 43.49 4.35 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.413 2.285 . . . . 0.0 115.016 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -144.49 177.58 8.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.608 1.963 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.08 -174.44 4.1 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.492 1.517 . . . . 0.0 108.324 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.714 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -156.27 154.17 30.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.519 -0.738 . . . . 0.0 110.46 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.447 HD12 HD11 ' A' ' 6' ' ' ILE . 7.0 mt -129.35 163.72 25.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.771 0.829 . . . . 0.0 110.467 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -149.26 161.35 42.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.392 1.477 . . . . 0.0 109.502 174.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.6 m -147.02 178.49 8.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.296 1.438 . . . . 0.0 110.801 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.17 167.25 30.67 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.468 0.556 . . . . 0.0 113.471 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.94 -174.76 3.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.216 1.407 . . . . 0.0 112.971 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -64.54 56.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.457 3.103 . . . . 0.0 114.531 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -107.65 -11.72 15.39 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.688 1.595 . . . . 0.0 114.704 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.43 9.27 4.7 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.611 1.964 . . . . 0.0 112.94 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.33 29.96 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.511 -1.716 . . . . 0.0 115.656 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.38 -2.25 11.44 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 123.768 2.978 . . . . 0.0 114.922 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 p -54.02 146.4 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.07 -1.019 . . . . 0.0 108.715 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.95 8.09 6.62 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.95 1.3 . . . . 0.0 113.787 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.3 p -142.48 -171.71 3.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.921 2.088 . . . . 0.0 109.97 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.88 140.19 14.91 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.699 1.143 . . . . 0.0 111.236 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.46 128.87 38.43 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 117.999 0.899 . . . . 0.0 111.059 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 103' ' ' SER . 76.6 t -143.11 126.43 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.375 1.87 . . . . 0.0 111.986 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -148.8 167.39 25.74 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.338 1.455 . . . . 0.0 110.87 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 118.38 7.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.568 1.147 . . . . 0.0 109.288 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -123.5 162.93 21.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.434 1.094 . . . . 0.0 112.55 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -127.23 145.76 50.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.972 0.909 . . . . 0.0 111.986 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.73 113.49 16.07 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.669 1.987 . . . . 0.0 110.89 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.96 122.11 16.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.847 1.259 . . . . 0.0 110.591 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.3 ttt -92.8 149.03 21.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.831 1.252 . . . . 0.0 111.017 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.97 -22.71 16.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 t -72.01 -11.48 60.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.843 1.257 . . . . 0.0 113.789 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.49 4.87 60.59 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.672 1.606 . . . . 0.0 114.72 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -95.05 173.18 7.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.211 1.404 . . . . 0.0 110.769 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.467 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 37.8 m -137.16 104.37 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.961 1.304 . . . . 0.0 111.947 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 35' ' ' ILE . 27.2 tp -67.12 125.13 25.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.941 0.896 . . . . 0.0 110.346 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.67 104.84 2.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.19 1.376 . . . . 0.0 112.389 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -74.86 169.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.857 0.837 . . . . 0.0 112.175 175.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -149.0 147.48 28.61 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.189 1.396 . . . . 0.0 111.682 177.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 p90 -157.76 146.31 19.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.497 0.719 . . . . 0.0 112.088 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' HG22 ' A' ' 85' ' ' VAL . 69.1 m -153.31 122.04 6.4 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.482 0.713 . . . . 0.0 112.169 174.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.59 137.05 38.96 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.81 137.56 29.94 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.395 2.063 . . . . 0.0 112.741 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -94.29 -58.67 2.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.584 1.154 . . . . 0.0 110.309 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -127.21 10.15 6.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.997 1.319 . . . . 0.0 113.941 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.62 31.26 3.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.241 1.816 . . . . 0.0 112.704 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -20.46 64.87 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -66.96 -43.28 83.52 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.956 0.903 . . . . 0.0 112.473 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -174.44 163.07 3.62 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.16 2.984 . . . . 0.0 108.996 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 t 78.74 75.42 0.05 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.695 2.398 . . . . 0.0 111.547 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.39 140.03 50.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.091 1.356 . . . . 0.0 110.394 174.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -81.38 162.14 23.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.041 0.937 . . . . 0.0 112.229 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.521 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 4.8 p-90 -159.91 169.4 23.59 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.129 1.372 . . . . 0.0 110.928 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 t70 164.26 138.6 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 128.713 2.805 . . . . 0.0 112.265 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.42 128.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.344 1.858 . . . . 0.0 108.959 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -129.03 158.21 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.324 1.85 . . . . 0.0 110.234 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.2 mt -112.76 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.719 1.608 . . . . 0.0 108.383 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -70.49 102.78 2.29 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.724 -1.235 . . . . 0.0 110.136 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.2 t -67.01 90.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.79 -134.71 4.97 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.853 2.644 . . . . 0.0 109.629 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.26 124.7 26.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.042 1.337 . . . . 0.0 111.899 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -143.61 117.14 9.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.234 1.814 . . . . 0.0 110.868 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.24 165.94 18.97 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.142 0.428 . . . . 0.0 110.985 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.47 112.58 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.438 -0.789 . . . . 0.0 110.601 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -155.97 -172.84 4.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.365 1.466 . . . . 0.0 112.797 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -42.65 84.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.018 0.927 . . . . 0.0 110.868 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.7 -41.08 56.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.469 1.509 . . . . 0.0 112.887 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -64.83 0.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.501 1.12 . . . . 0.0 109.94 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -53.37 -34.35 57.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.201 1.001 . . . . 0.0 113.431 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -41.07 95.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.824 1.25 . . . . 0.0 111.388 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -21.71 66.69 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.484 -1.385 . . . . 0.0 112.386 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 101' ' ' MET . 6.3 mt -85.3 -48.78 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.53 -33.25 31.89 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -114.66 -37.38 4.27 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.894 1.278 . . . . 0.0 112.708 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.64 -68.71 1.55 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.039 1.304 . . . . 0.0 112.479 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.77 79.0 1.8 Allowed Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.99 153.38 72.56 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.06 175.91 8.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.136 2.174 . . . . 0.0 112.448 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -127.1 141.63 51.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.186 1.794 . . . . 0.0 110.826 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -141.46 108.56 0.55 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.561 1.076 . . . . 0.0 111.029 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -123.16 64.88 0.99 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.559 1.143 . . . . 0.0 112.264 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.04 95.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.619 2.368 . . . . 0.0 114.754 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.46 154.28 6.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.378 1.942 . . . . 0.0 112.405 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 158' ' ' LYS . 63.1 m95 -77.18 144.74 38.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.274 1.03 . . . . 0.0 111.891 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -149.66 127.18 11.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.183 1.393 . . . . 0.0 112.364 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -120.67 152.46 38.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.234 1.814 . . . . 0.0 112.37 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -145.67 161.46 39.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.629 1.572 . . . . 0.0 110.636 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -75.04 98.76 3.71 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -57.84 7.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.935 1.294 . . . . 0.0 111.492 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.17 14.38 0.47 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -129.22 -16.58 3.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.56 -4.09 5.1 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.98 171.48 14.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.893 1.677 . . . . 0.0 110.801 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.71 161.19 31.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.019 . . . . 0.0 111.948 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.578 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -141.62 149.16 40.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.358 0.663 . . . . 0.0 111.815 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 0.8 OUTLIER -119.25 134.54 55.15 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.79 1.636 . . . . 0.0 108.988 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.27 136.44 12.62 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.097 1.332 . . . . 0.0 113.068 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 tp -109.3 132.39 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.187 1.795 . . . . 0.0 108.691 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.88 105.97 11.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.746 0.818 . . . . 0.0 109.817 175.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 p -123.6 145.91 48.55 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.927 1.291 . . . . 0.0 110.562 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.7 p -140.46 -112.46 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.527 1.131 . . . . 0.0 110.504 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 52.38 13.48 0.3 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 120.833 1.651 . . . . 0.0 115.33 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 146.45 5.84 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.547 2.022 . . . . 0.0 110.779 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.23 38.4 29.21 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -144.83 170.87 15.29 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.562 1.545 . . . . 0.0 111.803 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -165.76 146.0 6.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.089 0.956 . . . . 0.0 112.99 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.62 144.87 45.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.506 1.922 . . . . 0.0 113.752 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.536 ' C ' HD12 ' A' ' 171' ' ' ILE . 24.1 tt0 -145.07 153.28 41.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.594 1.958 . . . . 0.0 109.83 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.536 HD12 ' C ' ' A' ' 170' ' ' GLN . 2.0 mp -124.5 122.61 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.409 1.084 . . . . 0.0 109.963 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -100.1 132.14 45.64 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.985 0.914 . . . . 0.0 109.378 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.578 HG22 ' CB ' ' A' ' 157' ' ' MET . 6.1 pt -116.85 133.07 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.724 0.81 . . . . 0.0 110.123 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.8 p -154.22 170.42 21.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.857 1.263 . . . . 0.0 112.798 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.027 0.441 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 mt -127.71 -53.33 1.34 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.279 1.832 . . . . 0.0 110.7 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.65 145.76 51.21 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.858 0.837 . . . . 0.0 109.892 175.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.52 -38.86 1.82 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 127.111 2.291 . . . . 0.0 111.435 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -143.51 159.09 43.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.948 1.299 . . . . 0.0 112.374 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -139.19 169.83 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.42 1.888 . . . . 0.0 110.235 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.98 -166.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 127.854 2.462 . . . . 0.0 111.128 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.04 -16.58 13.29 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.64 -21.85 40.87 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.907 1.242 . . . . 0.0 114.068 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.12 86.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.567 1.183 . . . . 0.0 111.581 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -85.61 -15.69 41.7 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.906 1.283 . . . . 0.0 113.717 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 tt -61.14 150.06 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.205 1.002 . . . . 0.0 110.99 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -149.54 144.41 26.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.915 0.886 . . . . 0.0 109.132 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -50.91 -38.65 51.34 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.863 0.865 . . . . 0.0 112.117 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -50.82 -53.32 33.07 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.408 1.083 . . . . 0.0 113.705 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.67 -47.42 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.97 -0.456 . . . . 0.0 110.171 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -35.74 65.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.327 1.451 . . . . 0.0 112.283 -176.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -64.13 -51.09 65.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.829 2.452 . . . . 0.0 110.67 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -35.22 79.6 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.674 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.67 -50.79 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.613 1.165 . . . . 0.0 111.702 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 32' ' ' ALA . 4.5 pp -65.15 -31.96 73.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 112.809 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.18 -9.11 59.04 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.075 -1.016 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -25.2 55.13 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.465 -1.397 . . . . 0.0 112.408 175.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -63.1 -39.59 95.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.826 2.05 . . . . 0.0 113.757 175.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.04 114.67 0.48 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.553 1.073 . . . . 0.0 113.499 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -76.41 42.6 0.28 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 128.635 2.774 . . . . 0.0 114.087 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 29' ' ' GLN . 3.6 m -126.51 -177.42 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.906 2.082 . . . . 0.0 112.028 -174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 t -73.58 52.77 0.4 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.454 1.502 . . . . 0.0 112.578 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' HG3' HG23 ' A' ' 27' ' ' VAL . 1.3 pp0? -168.19 130.66 1.47 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.13 2.572 . . . . 0.0 109.44 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' H ' ' NH1' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -154.9 160.75 41.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.564 1.946 . . . . 0.0 111.975 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -154.8 132.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.857 0.753 . . . . 0.0 112.416 174.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 21' ' ' LEU . . . -122.74 115.7 22.5 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.603 1.961 . . . . 0.0 109.524 175.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 157.98 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.94 177.0 28.72 Favored Glycine 0 N--CA 1.451 -0.336 0 O-C-N 121.525 -0.734 . . . . 0.0 111.453 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -136.89 132.77 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.878 0.846 . . . . 0.0 111.631 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.42 104.92 16.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.374 1.47 . . . . 0.0 111.491 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -82.27 96.43 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.033 0.933 . . . . 0.0 112.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.06 13.44 5.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.813 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.97 -3.34 54.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.609 1.564 . . . . 0.0 115.114 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 26.02 60.41 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.165 -0.96 . . . . 0.0 114.766 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.94 125.13 2.51 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.801 1.667 . . . . 0.0 111.44 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.0 m -64.23 141.42 58.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.028 0.931 . . . . 0.0 111.128 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.552 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 34.5 m0 -110.19 169.83 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.09 0.956 . . . . 0.0 111.708 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -144.14 101.2 3.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.074 1.35 . . . . 0.0 112.315 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 154.11 42.52 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.558 -1.339 . . . . 0.0 110.421 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -109.63 -54.28 2.57 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.237 1.415 . . . . 0.0 112.193 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 46' ' ' LEU . 5.8 p-10 -162.49 -171.93 2.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.106 1.762 . . . . 0.0 110.786 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.7 145.37 30.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.658 1.583 . . . . 0.0 110.716 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -123.33 126.02 46.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.669 1.587 . . . . 0.0 110.119 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 137.04 46.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.827 2.451 . . . . 0.0 109.622 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -110.31 -43.3 3.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.191 1.796 . . . . 0.0 111.605 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -100.21 156.74 17.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 109.148 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.42 -171.39 19.93 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 m -145.19 166.15 26.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.97 1.308 . . . . 0.0 110.259 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 p -67.76 152.25 45.9 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -163.81 -30.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.958 1.703 . . . . 0.0 113.53 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.97 157.11 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.059 1.744 . . . . 0.0 111.49 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 tt -85.89 138.11 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.25 1.02 . . . . 0.0 112.11 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.88 131.76 42.23 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.222 1.409 . . . . 0.0 109.627 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.07 118.82 5.92 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.745 2.963 . . . . 0.0 110.926 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.11 -53.82 52.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.385 0.674 . . . . 0.0 112.475 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -119.94 136.62 54.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.208 1.003 . . . . 0.0 110.587 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.47 122.01 37.51 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.013 0.925 . . . . 0.0 110.609 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.64 171.0 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.684 2.923 . . . . 0.0 113.0 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -66.02 154.13 40.33 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.266 1.426 . . . . 0.0 112.742 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.7 t 36.87 56.03 1.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.099 2.16 . . . . 0.0 113.303 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -144.18 -178.49 5.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.95 1.3 . . . . 0.0 111.735 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.72 -178.79 6.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.069 0.937 . . . . 0.0 111.35 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.36 150.03 30.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 110.961 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.69 151.02 47.16 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.308 1.443 . . . . 0.0 108.486 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -127.98 159.84 33.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.573 1.549 . . . . 0.0 109.553 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.9 m -135.8 170.17 16.41 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.56 1.544 . . . . 0.0 109.931 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' H ' HD22 ' A' ' 24' ' ' LEU . . . 138.93 89.38 0.19 Allowed Glycine 0 N--CA 1.467 0.705 0 C-N-CA 124.527 1.06 . . . . 0.0 111.362 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.657 ' NH1' HG11 ' A' ' 104' ' ' VAL . 52.2 ttt180 -142.18 137.38 30.78 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.926 1.29 . . . . 0.0 113.632 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 47.43 18.4 0.1 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.903 1.681 . . . . 0.0 114.065 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.29 106.62 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.658 2.383 . . . . 0.0 110.106 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 87.86 -0.71 0.47 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 129.077 2.951 . . . . 0.0 114.018 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.29 52.63 10.34 Favored Glycine 0 CA--C 1.543 1.841 0 C-N-CA 126.244 1.878 . . . . 0.0 112.972 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.69 -24.59 13.36 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.172 3.248 . . . . 0.0 113.419 -175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -146.93 157.95 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.813 1.645 . . . . 0.0 111.079 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.48 4.58 27.24 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.163 1.385 . . . . 0.0 114.328 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 t -125.64 -171.25 2.33 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.891 2.076 . . . . 0.0 111.903 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.46 ' HA2' ' HE ' ' A' ' 74' ' ' ARG . . . -77.12 179.89 49.62 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.175 1.369 . . . . 0.0 114.687 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.89 153.18 34.97 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.773 -0.84 . . . . 0.0 112.403 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -155.76 111.47 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.775 2.03 . . . . 0.0 107.858 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -156.43 167.51 30.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.483 1.135 . . . . 0.0 110.383 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.97 128.31 9.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.338 1.055 . . . . 0.0 108.824 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -127.2 165.02 20.4 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.028 0.931 . . . . 0.0 111.931 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -130.1 150.27 51.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.557 0.743 . . . . 0.0 112.481 -175.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -125.57 114.8 19.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.971 1.308 . . . . 0.0 110.466 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -71.36 100.0 2.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.689 1.596 . . . . 0.0 110.539 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.0 mtp -64.86 146.64 54.62 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.951 -1.093 . . . . 0.0 112.028 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -57.51 -26.09 60.8 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -71.67 -4.72 28.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.702 1.201 . . . . 0.0 113.58 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.16 27.13 16.71 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.894 1.235 . . . . 0.0 114.457 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -117.57 166.46 12.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.623 1.569 . . . . 0.0 110.746 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.518 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 45.0 m -130.43 104.16 7.09 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.08 0.952 . . . . 0.0 112.44 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 173' ' ' ILE . 13.8 tp -77.27 113.35 14.94 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.957 0.903 . . . . 0.0 110.033 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.87 111.4 4.21 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.749 1.642 . . . . 0.0 112.075 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.65 154.66 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 110.857 175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.1 ttp -134.83 148.82 50.25 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.861 1.265 . . . . 0.0 110.035 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 31' ' ' ILE . 12.4 p90 -153.97 142.46 20.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.367 0.667 . . . . 0.0 109.299 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 m -150.93 165.83 32.47 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.005 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.657 HG11 ' NH1' ' A' ' 74' ' ' ARG . 95.2 t -119.78 142.2 32.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.314 1.046 . . . . 0.0 109.964 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 164' ' ' ALA . 80.2 Cg_endo -72.12 -177.17 2.48 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.641 2.894 . . . . 0.0 112.706 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.26 31.06 0.82 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.046 1.338 . . . . 0.0 113.651 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 51.52 64.04 2.0 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.018 2.127 . . . . 0.0 113.781 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.43 152.5 50.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.69 1.196 . . . . 0.0 112.195 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.13 -30.08 69.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -67.26 112.46 4.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.578 1.551 . . . . 0.0 111.222 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -66.13 126.24 28.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.077 0.551 . . . . 0.0 111.635 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.13 24.42 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.355 1.062 . . . . 0.0 112.574 175.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.442 HD21 ' HD3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -68.01 146.86 53.13 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -175.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -93.22 137.34 32.64 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.987 1.715 . . . . 0.0 111.829 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -164.32 134.79 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.371 1.868 . . . . 0.0 108.394 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -156.16 151.74 27.03 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.333 1.053 . . . . 0.0 110.44 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.88 132.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.437 1.095 . . . . 0.0 110.33 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 120' ' ' TYR . 18.5 ttpt -144.76 158.61 43.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.872 0.869 . . . . 0.0 111.709 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.83 112.07 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.428 1.091 . . . . 0.0 110.47 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 27.0 m-85 -81.3 101.14 9.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -62.84 93.02 0.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.225 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.75 -138.78 8.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.401 2.429 . . . . 0.0 110.544 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -117.08 127.06 53.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.59 1.956 . . . . 0.0 111.778 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -148.73 108.05 3.94 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.2 168.81 18.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.13 0.972 . . . . 0.0 111.435 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.93 118.25 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.888 0.875 . . . . 0.0 111.37 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -161.88 -174.53 4.21 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.769 1.228 . . . . 0.0 112.114 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -48.73 -48.61 40.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.978 1.311 . . . . 0.0 111.556 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.51 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.31 0.957 . . . . 0.0 113.426 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.4 ttp -68.76 -49.31 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.238 1.019 . . . . 0.0 112.467 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.87 -39.27 68.49 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.488 0.585 . . . . 0.0 112.198 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -45.53 79.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.265 1.426 . . . . 0.0 111.199 175.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -21.94 66.69 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.336 -1.478 . . . . 0.0 113.716 174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.7 mp -85.91 -41.72 14.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.776 1.631 . . . . 0.0 112.824 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -88.95 -28.22 20.41 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -122.61 -32.07 3.63 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 112.313 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.85 -39.12 94.91 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.118 0.866 . . . . 0.0 113.431 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.53 75.38 9.43 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.15 120.72 8.0 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.415 2.077 . . . . 0.0 113.284 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.47 173.4 7.69 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.704 2.002 . . . . 0.0 112.369 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -139.83 140.02 36.47 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.565 1.946 . . . . 0.0 112.224 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -136.88 109.78 0.74 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.286 0.946 . . . . 0.0 114.188 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -87.28 -68.25 0.76 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.622 1.569 . . . . 0.0 112.44 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -173.12 114.97 0.26 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 0.0 112.089 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 136.37 160.17 8.67 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.704 1.145 . . . . 0.0 114.079 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.429 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 92.1 m95 -78.04 147.03 34.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.124 1.37 . . . . 0.0 112.5 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -150.61 127.6 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.664 1.585 . . . . 0.0 112.452 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.6 152.59 24.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.36 1.464 . . . . 0.0 112.37 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -158.65 169.91 23.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.868 1.267 . . . . 0.0 112.627 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -85.44 99.79 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.77 1.628 . . . . 0.0 107.807 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 157' ' ' MET . 5.8 tp -60.88 -36.16 78.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.19 24.51 2.21 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -135.92 -29.12 1.04 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 119.157 1.479 . . . . 0.0 114.727 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 133.19 23.0 0.77 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.052 1.31 . . . . 0.0 114.66 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.2 162.63 37.6 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.224 1.512 . . . . 0.0 112.048 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 136.77 50.79 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.481 1.513 . . . . 0.0 108.875 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.582 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -126.45 168.48 14.16 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.006 0.922 . . . . 0.0 110.841 175.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 128.24 50.62 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.82 152.74 18.0 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.441 1.02 . . . . 0.0 112.02 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.429 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 0.0 OUTLIER -133.65 145.96 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.236 178.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.9 tpt -154.88 100.85 2.24 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.337 1.055 . . . . 0.0 110.182 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -90.54 149.46 22.16 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 109.542 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 80.2 p -59.67 164.33 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.358 1.463 . . . . 0.0 112.867 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . . . -55.68 129.85 40.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.756 0.823 . . . . 0.0 112.391 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.77 79.22 0.05 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.001 0.81 . . . . 0.0 112.091 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 67.97 -50.7 0.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.651 2.38 . . . . 0.0 115.322 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.52 169.86 7.01 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.475 1.91 . . . . 0.0 113.492 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -152.88 -177.56 6.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.987 1.715 . . . . 0.0 112.315 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 138.3 40.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.996 2.118 . . . . 0.0 112.288 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.443 ' O ' HD13 ' A' ' 171' ' ' ILE . 50.0 tt0 -146.42 156.29 43.19 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.345 1.458 . . . . 0.0 110.764 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 170' ' ' GLN . 14.4 mm -131.9 125.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 110.283 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 112.76 19.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.311 1.044 . . . . 0.0 112.379 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.582 HG22 ' CB ' ' A' ' 157' ' ' MET . 18.2 pt -97.63 132.11 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.721 1.608 . . . . 0.0 110.517 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 t -154.16 158.69 40.76 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.445 -0.784 . . . . 0.0 111.491 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.998 174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' HB3' HG22 ' A' ' 20' ' ' VAL . 1.3 mm? -109.25 -62.61 1.46 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 112.38 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.21 29.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.0 1.72 . . . . 0.0 114.387 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.4 -5.6 10.22 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.021 1.772 . . . . 0.0 115.392 -175.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 p -167.49 162.18 14.29 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.304 2.642 . . . . 0.0 109.36 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 70' ' ' LEU . 49.1 mt -142.4 167.39 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.774 1.23 . . . . 0.0 109.901 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.03 -164.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 127.958 2.503 . . . . 0.0 110.045 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.04 -14.82 39.63 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -26.4 24.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.874 1.702 . . . . 0.0 113.571 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.53 81.34 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 118.373 1.086 . . . . 0.0 112.166 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -12.71 49.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.042 1.337 . . . . 0.0 113.842 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -63.36 129.73 41.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.857 1.263 . . . . 0.0 109.371 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -142.24 144.06 33.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.701 0.8 . . . . 0.0 109.319 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -54.96 -29.79 57.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.592 0.633 . . . . 0.0 112.381 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -58.63 -55.99 27.9 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 112.119 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -62.4 -47.04 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.9 63.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.005 1.322 . . . . 0.0 113.323 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -52.91 14.83 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 119.938 -1.726 . . . . 0.0 110.754 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -64.32 -38.93 92.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.117 1.767 . . . . 0.0 112.231 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.8 -34.45 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.429 1.092 . . . . 0.0 112.155 -174.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 32' ' ' ALA . 97.2 mt -78.2 -40.55 37.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.258 1.423 . . . . 0.0 111.425 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -72.45 -17.11 61.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -30.97 70.57 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.645 -1.284 . . . . 0.0 112.554 175.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 tp -72.59 -25.46 61.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 112.262 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.77 130.66 1.64 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.877 1.703 . . . . 0.0 111.759 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.68 43.56 0.09 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 128.479 2.712 . . . . 0.0 112.673 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.95 144.13 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.464 2.306 . . . . 0.0 111.243 -174.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.9 m -69.76 -29.23 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.477 -0.764 . . . . 0.0 112.997 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -71.81 82.02 0.89 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.922 1.689 . . . . 0.0 111.935 175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.891 1.276 . . . . 0.0 111.493 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -133.18 130.98 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.646 1.178 . . . . 0.0 110.367 -177.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -116.73 95.29 4.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.749 2.02 . . . . 0.0 112.423 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -101.73 113.41 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.626 -1.296 . . . . 0.0 109.178 174.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.6 160.02 28.56 Favored Glycine 0 C--O 1.235 0.171 0 C-N-CA 120.857 -0.687 . . . . 0.0 114.745 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.495 HG21 ' CD2' ' A' ' 98' ' ' LEU . 1.8 mp -135.61 130.97 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.193 1.397 . . . . 0.0 110.129 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 4.2 m-20 -86.7 104.4 16.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.344 1.058 . . . . 0.0 111.943 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -81.12 100.39 9.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.829 1.195 . . . . 0.0 112.102 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.64 21.49 2.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.197 0.999 . . . . 0.0 112.845 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -6.38 58.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.482 1.513 . . . . 0.0 114.621 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.53 22.82 55.51 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.384 0.992 . . . . 0.0 114.97 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.15 126.87 3.65 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.444 1.497 . . . . 0.0 112.275 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.0 m -58.6 143.95 44.56 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.464 1.106 . . . . 0.0 110.565 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 50.7 m0 -108.05 164.77 12.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.69 0.796 . . . . 0.0 111.858 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.1 m -149.9 104.15 3.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.141 1.776 . . . . 0.0 110.307 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -67.36 144.62 55.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.733 -1.229 . . . . 0.0 111.211 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.549 HD22 ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -107.56 -47.8 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.743 1.617 . . . . 0.0 113.149 -177.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.549 ' H ' HD22 ' A' ' 46' ' ' LEU . 61.7 t30 -157.73 171.33 20.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.497 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.64 128.67 25.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.894 1.277 . . . . 0.0 110.859 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -120.31 141.64 49.84 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.286 1.434 . . . . 0.0 110.373 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -154.22 155.73 35.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.527 177.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -120.15 -13.11 8.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.035 1.734 . . . . 0.0 111.093 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.4 m -143.04 131.23 21.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.649 1.98 . . . . 0.0 110.219 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 107.29 0.98 Allowed Glycine 0 CA--C 1.541 1.676 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 74' ' ' ARG . 1.4 t -73.79 176.23 6.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.125 2.17 . . . . 0.0 111.378 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -69.13 163.14 25.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.452 1.12 . . . . 0.0 113.155 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.0 -29.74 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.986 1.314 . . . . 0.0 112.937 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.66 164.05 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.411 1.884 . . . . 0.0 110.233 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 tp -64.26 134.54 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.062 0.945 . . . . 0.0 110.786 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.29 109.56 34.37 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 108.295 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HG2' HD12 ' A' ' 69' ' ' LEU . 50.7 Cg_endo -61.46 123.47 12.82 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.032 3.154 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.2 -59.56 2.51 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.346 -0.846 . . . . 0.0 112.483 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -105.22 144.73 31.6 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 110.697 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.44 124.46 17.11 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.595 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.17 170.48 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.072 2.514 . . . . 0.0 112.493 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -62.66 148.73 45.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.012 0.925 . . . . 0.0 111.133 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 p 53.9 42.86 31.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.808 1.643 . . . . 0.0 114.832 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -145.2 127.9 16.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.807 1.643 . . . . 0.0 112.723 175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 36' ' ' ASP . . . -84.64 176.1 8.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.978 0.911 . . . . 0.0 111.819 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.654 HD12 ' HG2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -151.87 150.51 30.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.342 -0.849 . . . . 0.0 112.003 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -122.49 169.18 11.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.177 1.391 . . . . 0.0 112.128 177.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.627 ' HB3' HG13 ' A' ' 33' ' ' VAL . 2.4 t80 -145.7 160.65 41.41 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.436 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.87 164.65 33.04 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.725 1.61 . . . . 0.0 111.262 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.59 173.45 39.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.645 0.64 . . . . 0.0 113.703 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' O ' HG22 ' A' ' 54' ' ' THR . 22.7 tpt180 -141.66 141.12 33.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.442 1.897 . . . . 0.0 109.802 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -117.14 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 0.0 113.752 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t0 49.84 -91.18 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.681 2.392 . . . . 0.0 115.945 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.4 t -69.35 -10.14 56.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.701 2.001 . . . . 0.0 113.509 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.02 -163.12 24.6 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.432 2.444 . . . . 0.0 116.011 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.92 -11.14 28.91 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.821 3.014 . . . . 0.0 113.985 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 p -141.49 167.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.278 1.831 . . . . 0.0 111.551 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.52 -14.63 19.9 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.858 1.263 . . . . 0.0 113.974 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.7 p -146.94 131.13 17.39 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 127.044 2.137 . . . . 0.0 112.961 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.77 161.18 34.37 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.838 2.637 . . . . 0.0 114.645 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.579 ' H ' ' CG2' ' A' ' 104' ' ' VAL . . . -134.42 107.78 7.78 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.115 -1.227 . . . . 0.0 111.521 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.08 112.87 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.505 1.922 . . . . 0.0 111.088 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -132.57 163.99 27.64 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.526 1.131 . . . . 0.0 111.18 175.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.2 112.81 4.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.766 1.226 . . . . 0.0 108.635 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -122.64 165.17 16.92 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.969 1.308 . . . . 0.0 110.747 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -129.03 153.61 47.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.267 0.556 . . . . 0.0 111.511 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 35.6 m-85 -127.96 112.9 15.18 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.967 1.307 . . . . 0.0 109.93 -175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 46' ' ' LEU . 10.5 t80 -67.64 107.03 2.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.187 1.395 . . . . 0.0 110.329 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.15 144.92 50.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.212 1.405 . . . . 0.0 110.845 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.6 t -55.42 -27.33 47.21 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.175 0.99 . . . . 0.0 113.369 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -9.3 40.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.312 1.445 . . . . 0.0 114.837 174.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.12 55.92 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.872 1.225 . . . . 0.0 115.094 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.05 172.82 6.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.508 1.523 . . . . 0.0 110.445 175.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HB1' ' A' ' 89' ' ' ALA . 40.8 m -136.33 108.36 7.18 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.312 1.045 . . . . 0.0 111.141 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 173' ' ' ILE . 9.1 tp -73.75 125.87 29.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.013 -1.055 . . . . 0.0 109.091 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.88 99.12 1.93 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.9 162.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.786 0.803 . . . . 0.0 111.227 177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -148.1 158.29 43.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.502 0.721 . . . . 0.0 111.322 174.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 45.8 p90 -160.3 162.72 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.928 1.291 . . . . 0.0 109.325 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.22 168.76 24.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.809 1.244 . . . . 0.0 109.108 175.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.579 ' CG2' ' H ' ' A' ' 84' ' ' ALA . 12.3 m -136.11 97.38 12.21 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 125.257 1.423 . . . . 0.0 109.723 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.21 173.22 11.69 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.303 2.002 . . . . 0.0 110.865 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -69.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.794 -0.566 . . . . 0.0 111.817 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -170.46 147.23 2.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.142 1.777 . . . . 0.0 110.556 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.2 169.77 21.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.755 1.222 . . . . 0.0 111.383 174.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.54 -53.71 8.9 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.23 0.612 . . . . 0.0 111.682 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -161.5 22.28 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.69 1.996 . . . . 0.0 113.972 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.32 -168.77 3.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.165 1.386 . . . . 0.0 112.957 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 t 63.49 23.16 13.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.321 2.248 . . . . 0.0 114.476 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.457 ' HB2' ' HE1' ' A' ' 161' ' ' MET . 16.7 p-10 -127.5 112.34 14.84 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.303 2.641 . . . . 0.0 111.524 -174.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -86.23 157.55 19.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.679 1.191 . . . . 0.0 112.617 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 6.0 p-90 -160.94 148.32 15.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.762 0.825 . . . . 0.0 111.505 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -172.1 107.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.317 1.847 . . . . 0.0 111.699 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 171' ' ' ILE . 23.6 t -116.36 137.24 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.683 0.793 . . . . 0.0 109.063 174.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' HA ' HD13 ' A' ' 151' ' ' LEU . 5.0 ttmt -145.96 143.64 29.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.875 1.67 . . . . 0.0 110.484 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.88 153.42 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -122.62 96.34 4.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.247 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t -70.71 90.51 0.78 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.54 -1.35 . . . . 0.0 111.599 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.85 -112.57 0.52 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.31 1.909 . . . . 0.0 110.831 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -159.21 117.78 2.89 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.706 1.602 . . . . 0.0 110.513 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -140.04 108.6 5.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.241 1.416 . . . . 0.0 111.404 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.01 171.35 6.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.638 0.775 . . . . 0.0 111.153 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.77 113.67 22.12 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.728 -0.608 . . . . 0.0 110.651 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.09 -175.22 4.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.083 1.353 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.06 -45.04 21.38 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.827 1.251 . . . . 0.0 112.236 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.06 46.88 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.576 1.084 . . . . 0.0 114.397 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 ttp -70.02 -60.61 2.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.781 1.291 . . . . 0.0 109.63 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -53.54 -33.39 54.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.845 0.858 . . . . 0.0 113.241 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.22 -38.59 91.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.568 1.147 . . . . 0.0 110.837 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -23.61 66.78 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.329 -1.482 . . . . 0.0 112.458 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mt -84.01 -47.28 11.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.518 1.527 . . . . 0.0 111.345 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.18 -26.44 26.78 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -122.46 -38.88 2.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.681 1.192 . . . . 0.0 112.219 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.52 -55.95 24.48 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.737 1.161 . . . . 0.0 112.761 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -160.97 70.44 2.67 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.04 115.19 3.15 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.848 2.365 . . . . 0.0 112.99 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.21 -178.33 3.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.536 1.135 . . . . 0.0 112.539 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.57 144.33 49.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.077 2.551 . . . . 0.0 111.022 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.45 108.29 0.63 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.853 1.216 . . . . 0.0 111.865 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -120.15 64.9 0.82 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.725 1.61 . . . . 0.0 114.094 -174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.94 96.03 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.923 2.089 . . . . 0.0 114.314 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.99 135.26 2.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.343 1.449 . . . . 0.0 112.017 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -66.41 144.63 56.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 111.371 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -143.6 131.2 21.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.363 1.065 . . . . 0.0 111.805 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -133.81 143.74 48.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.645 1.578 . . . . 0.0 112.346 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 161.98 40.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.462 1.505 . . . . 0.0 112.224 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -97.67 96.62 8.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.396 1.079 . . . . 0.0 108.886 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -53.54 -51.07 64.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.523 1.529 . . . . 0.0 112.014 -174.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.94 51.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.791 1.076 . . . . 0.0 115.791 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -135.44 -31.29 0.97 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -29.75 2.31 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.21 1.386 . . . . 0.0 113.321 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.61 172.14 6.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.904 1.682 . . . . 0.0 112.766 175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -134.53 151.83 51.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.912 1.685 . . . . 0.0 109.782 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.66 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.54 152.99 51.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 133.71 49.1 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.504 1.521 . . . . 0.0 109.918 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -119.07 136.41 11.99 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.477 1.037 . . . . 0.0 112.591 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tp -108.24 149.81 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.091 1.757 . . . . 0.0 109.641 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.457 ' HE1' ' HB2' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -144.88 93.58 2.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.68 1.192 . . . . 0.0 110.707 174.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.9 p -91.88 161.62 14.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.247 1.019 . . . . 0.0 111.183 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.14 -26.52 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.734 1.214 . . . . 0.0 112.398 175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.33 114.86 9.83 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 110.911 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.03 -95.11 0.64 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.083 1.325 . . . . 0.0 113.078 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.01 64.15 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.45 1.5 . . . . 0.0 111.265 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.27 91.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.864 1.666 . . . . 0.0 113.977 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.455 ' HD3' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -156.66 168.84 26.19 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -174.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.455 ' H ' ' HD3' ' A' ' 168' ' ' LYS . 17.8 ptm -135.31 160.47 38.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.227 2.611 . . . . 0.0 112.567 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -153.64 162.51 41.18 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.192 1.797 . . . . 0.0 109.558 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 117' ' ' VAL . 11.1 mm -136.48 108.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -95.87 116.18 28.53 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 112.024 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.66 HG22 ' CB ' ' A' ' 157' ' ' MET . 8.2 pt -103.67 132.19 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 0.0 111.101 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.7 p -155.48 170.96 20.73 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.284 -0.885 . . . . 0.0 112.643 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 118.528 -0.749 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.433 ' HB3' HG22 ' A' ' 20' ' ' VAL . 8.8 mp -69.75 -37.96 76.61 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.13 1.332 . . . . 0.0 112.115 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.65 171.54 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.85 -19.44 44.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.393 0.997 . . . . 0.0 113.659 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.8 p -163.38 156.99 19.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.784 2.834 . . . . 0.0 109.05 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.505 HD11 HD12 ' A' ' 70' ' ' LEU . 64.8 mt -141.84 173.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.957 1.703 . . . . 0.0 109.065 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.11 -167.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.558 1.543 . . . . 0.0 110.033 174.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . . . -46.34 -40.2 11.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.72 -32.64 5.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.594 1.569 . . . . 0.0 113.083 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.588 1.194 . . . . 0.0 111.588 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.0 m -83.82 -6.54 59.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.607 1.963 . . . . 0.0 113.902 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 13' ' ' THR . 4.6 tt -66.27 138.09 57.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.578 1.151 . . . . 0.0 109.792 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.2 m -141.79 142.17 33.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.863 0.865 . . . . 0.0 109.922 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -55.93 -32.45 63.82 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -56.62 -49.78 73.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.442 1.019 . . . . 0.0 112.771 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.11 -49.53 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.014 -0.429 . . . . 0.0 109.861 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.2 -36.56 52.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.271 1.428 . . . . 0.0 112.222 -178.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.92 -65.79 0.54 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.196 1.798 . . . . 0.0 111.211 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -65.05 -24.45 67.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 177.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -64.41 -46.6 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.707 1.203 . . . . 0.0 112.285 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -26.93 55.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.247 0.619 . . . . 0.0 112.063 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.21 -38.36 51.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.173 1.389 . . . . 0.0 113.714 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.45 -27.06 45.73 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.198 0.908 . . . . 0.0 113.039 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -52.72 -36.24 57.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.853 2.061 . . . . 0.0 113.7 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.98 115.75 0.49 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.773 1.178 . . . . 0.0 111.304 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.73 79.31 0.84 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.352 1.061 . . . . 0.0 111.28 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.87 174.28 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.557 1.943 . . . . 0.0 110.695 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -38.7 -61.42 0.72 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.162 2.185 . . . . 0.0 111.883 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -157.75 150.34 22.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.738 2.015 . . . . 0.0 110.034 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 -176.04 3.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 129.336 3.055 . . . . 0.0 110.361 -174.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -128.87 147.39 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.351 1.061 . . . . 0.0 112.11 -175.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 110.96 11.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.27 1.828 . . . . 0.0 111.287 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.783 HG11 ' CG ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -130.32 157.46 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 C-N-CA 125.189 1.396 . . . . 0.0 112.601 175.005 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 156.54 177.32 29.59 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 98' ' ' LEU . 2.2 mp -133.78 147.97 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.747 0.819 . . . . 0.0 110.46 -175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.79 102.07 13.79 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.926 -1.109 . . . . 0.0 112.049 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -82.16 98.61 8.79 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 113.124 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -133.91 10.61 3.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 113.44 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -5.36 35.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.14 22.22 42.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.855 1.217 . . . . 0.0 114.826 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.98 127.04 3.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.358 1.456 . . . . 0.0 112.328 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.7 m -57.8 142.03 46.99 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.361 1.065 . . . . 0.0 110.968 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.631 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 49.5 m0 -108.67 165.27 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.118 0.967 . . . . 0.0 111.938 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -142.01 99.85 3.61 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.118 1.767 . . . . 0.0 112.008 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . . . -68.02 145.06 54.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.714 -1.241 . . . . 0.0 108.95 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -99.98 -48.99 4.47 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.476 1.111 . . . . 0.0 111.733 179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -176.6 176.03 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.818 2.047 . . . . 0.0 110.272 -174.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.01 148.65 40.61 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.089 1.755 . . . . 0.0 111.006 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -125.58 137.24 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.931 1.292 . . . . 0.0 110.364 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.57 42.22 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.151 1.78 . . . . 0.0 109.201 -175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 -23.13 3.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.87 68.11 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.073 1.416 . . . . 0.0 109.584 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.45 179.31 32.27 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.923 1.725 . . . . 0.0 110.969 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.4 m -141.98 162.31 35.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.311 1.444 . . . . 0.0 110.141 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 p -65.25 160.01 22.51 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.304 -0.873 . . . . 0.0 112.278 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.78 -19.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 161.8 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.462 1.905 . . . . 0.0 110.814 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.17 135.96 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.65 0.78 . . . . 0.0 110.038 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.8 tp -91.95 113.96 60.57 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.217 1.007 . . . . 0.0 108.393 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 69' ' ' LEU . 89.8 Cg_endo -66.45 125.48 13.98 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.624 2.883 . . . . 0.0 110.337 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -57.37 9.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.899 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.53 130.34 54.87 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.003 0.82 . . . . 0.0 111.164 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 69' ' ' LEU . 57.5 t -101.81 121.76 49.82 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.367 1.067 . . . . 0.0 109.627 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.03 148.28 86.05 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.456 2.104 . . . . 0.0 111.285 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.5 155.4 5.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 175.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 t 40.6 55.32 2.94 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.597 1.559 . . . . 0.0 113.096 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 3.6 ttmt -159.89 136.28 8.93 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.007 1.723 . . . . 0.0 111.895 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.35 177.49 5.82 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.43 1.092 . . . . 0.0 111.787 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 60' ' ' PRO . 2.2 pt? -149.87 149.61 30.71 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.682 0.793 . . . . 0.0 111.912 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.77 171.31 7.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.731 1.212 . . . . 0.0 110.653 175.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.2 158.16 37.13 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.638 1.975 . . . . 0.0 108.611 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -150.14 175.47 11.72 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.022 0.929 . . . . 0.0 111.118 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.02 172.73 29.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.886 0.755 . . . . 0.0 114.158 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -121.45 168.85 11.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.159 1.784 . . . . 0.0 113.378 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 73.84 1.33 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.061 2.144 . . . . 0.0 110.774 -175.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.31 -17.78 11.73 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.1 9.68 0.51 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -117.91 -123.04 3.28 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -17.33 48.63 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.151 2.567 . . . . 0.0 113.934 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.309 8.6 p 48.11 22.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 127.927 2.491 . . . . 0.0 114.419 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.81 -83.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.319 2.248 . . . . 0.0 110.374 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.8 p -147.09 141.94 26.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.687 1.195 . . . . 0.0 113.512 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.05 171.12 0.74 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.532 1.539 . . . . 0.0 114.684 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -122.44 169.29 11.13 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.491 -1.593 . . . . 0.0 112.024 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.24 108.36 2.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 126.045 1.738 . . . . 0.0 110.837 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.83 179.83 7.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.122 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' A' ' 130' ' ' MET . . . -153.18 138.47 17.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.206 1.003 . . . . 0.0 108.594 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.66 168.92 20.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.307 0.643 . . . . 0.0 111.359 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.796 ' HB2' HH22 ' A' ' 124' ' ' ARG . . . -131.74 162.49 30.37 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.785 0.803 . . . . 0.0 113.073 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 31.3 m-85 -135.45 113.85 11.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.395 1.478 . . . . 0.0 110.099 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.1 115.02 7.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.923 1.289 . . . . 0.0 109.995 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.3 ttp -82.3 153.32 25.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.391 0.676 . . . . 0.0 112.029 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -59.15 -24.05 62.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.96 -7.73 43.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.547 1.539 . . . . 0.0 114.205 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.15 -1.45 73.64 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.407 1.479 . . . . 0.0 114.764 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.05 175.34 6.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.046 1.339 . . . . 0.0 111.184 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.538 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 7.7 m -136.7 115.24 11.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.266 1.427 . . . . 0.0 110.983 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.558 ' CD2' HG21 ' A' ' 35' ' ' ILE . 13.2 tp -81.49 126.15 31.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.03 117.35 5.28 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.412 1.006 . . . . 0.0 112.221 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -90.39 146.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.903 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -129.43 135.54 48.8 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.373 1.469 . . . . 0.0 109.879 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.783 ' CG ' HG11 ' A' ' 33' ' ' VAL . 53.0 p90 -153.19 145.42 23.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.048 0.928 . . . . 0.0 113.013 175.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -151.04 149.72 29.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.277 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.76 95.26 49.12 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.16 -179.6 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.491 2.127 . . . . 0.0 110.609 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -62.11 171.37 1.8 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.488 1.115 . . . . 0.0 113.001 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -107.97 114.19 27.93 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.744 1.618 . . . . 0.0 111.547 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.65 173.93 11.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.151 1.781 . . . . 0.0 112.401 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.85 -37.73 80.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.438 1.495 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -59.15 128.84 39.19 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.844 1.258 . . . . 0.0 112.257 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -103.23 129.95 50.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.861 1.264 . . . . 0.0 109.252 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m 149.71 137.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 130.564 3.546 . . . . 0.0 110.829 -175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -134.56 159.61 40.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.377 1.871 . . . . 0.0 110.066 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 139' ' ' PRO . 50.9 m95 -97.22 147.04 24.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.335 1.054 . . . . 0.0 112.813 176.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -154.92 151.81 28.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.407 174.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -175.6 119.0 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.4 1.88 . . . . 0.0 110.186 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 171' ' ' ILE . 13.7 p -119.88 137.7 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.056 1.743 . . . . 0.0 109.516 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -134.03 159.54 40.46 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 110.365 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.99 104.74 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.785 1.634 . . . . 0.0 108.548 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -76.33 106.52 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.321 1.448 . . . . 0.0 109.61 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -70.38 85.25 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.481 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.55 -122.47 1.35 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.508 2.004 . . . . 0.0 110.563 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -146.64 144.65 29.65 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.578 1.151 . . . . 0.0 111.101 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.796 HH22 ' HB2' ' A' ' 89' ' ' ALA . 20.2 ttp85 -150.49 122.95 8.46 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.139 1.376 . . . . 0.0 110.789 175.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.69 152.66 45.23 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.038 1.335 . . . . 0.0 109.873 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.474 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -80.81 115.26 20.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.483 -0.761 . . . . 0.0 109.289 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.9 p30 -156.79 -177.77 6.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.618 1.167 . . . . 0.0 113.012 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -53.75 -38.42 64.38 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.382 1.073 . . . . 0.0 112.73 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.93 -42.5 94.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.414 1.007 . . . . 0.0 112.378 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.425 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 1.5 ptm -60.72 -50.94 71.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.188 0.994 . . . . 0.0 110.383 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -57.9 -36.54 72.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.658 0.783 . . . . 0.0 112.226 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -65.65 -46.6 78.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 0.0 110.912 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -20.72 66.22 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.321 -1.487 . . . . 0.0 113.48 174.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.35 -17.17 37.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.867 2.467 . . . . 0.0 115.131 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.23 -23.44 4.89 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -123.83 -25.74 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.829 1.252 . . . . 0.0 111.968 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.28 -68.19 1.74 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.775 1.655 . . . . 0.0 113.579 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -141.62 55.02 4.58 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 98.1 Cg_endo -64.33 141.06 73.33 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 123.905 3.07 . . . . 0.0 113.966 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -124.07 174.73 7.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.643 1.977 . . . . 0.0 113.102 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -129.23 141.95 50.99 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.623 -1.298 . . . . 0.0 110.546 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.61 120.02 1.07 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -134.06 83.97 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.49 0.716 . . . . 0.0 111.705 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 m120 56.75 93.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.976 2.51 . . . . 0.0 114.478 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 148.56 140.6 3.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.918 1.723 . . . . 0.0 111.928 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -67.06 141.58 57.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.009 0.923 . . . . 0.0 111.849 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -144.3 140.96 29.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.907 1.283 . . . . 0.0 111.915 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -132.24 151.83 51.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 127.537 2.335 . . . . 0.0 110.506 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.614 ' HE3' HD12 ' A' ' 151' ' ' LEU . 1.8 pttt -150.86 157.56 43.06 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 110.638 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.63 88.33 3.92 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.614 HD12 ' HE3' ' A' ' 149' ' ' LYS . 1.7 tp -50.01 -39.42 41.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.966 1.707 . . . . 0.0 114.314 -174.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.38 1.61 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 117.767 1.867 . . . . 0.0 117.767 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -132.52 -32.93 1.28 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.09 -37.54 0.7 Allowed Glycine 0 N--CA 1.474 1.218 0 C-N-CA 124.665 1.126 . . . . 0.0 113.239 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.31 172.2 7.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.283 1.833 . . . . 0.0 111.112 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -133.13 156.32 47.66 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.544 1.538 . . . . 0.0 109.681 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.653 ' HB3' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -133.22 162.99 30.29 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.253 0.621 . . . . 0.0 110.902 176.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 134.7 53.17 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.726 1.21 . . . . 0.0 108.296 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.4 148.42 18.92 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.217 0.913 . . . . 0.0 112.421 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -121.65 113.86 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.734 1.214 . . . . 0.0 111.168 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.52 125.9 45.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.829 0.74 . . . . 0.0 109.385 174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.3 p -123.63 159.87 28.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.205 1.802 . . . . 0.0 110.365 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.5 t -147.23 -73.63 0.21 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.11 -0.994 . . . . 0.0 112.376 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.33 106.79 0.48 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.79 1.236 . . . . 0.0 112.469 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.31 97.89 0.19 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 60.29 79.36 0.24 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.392 1.877 . . . . 0.0 113.274 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.03 86.14 0.24 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.134 1.373 . . . . 0.0 113.853 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 -170.62 3.06 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.1 ptm -155.4 169.48 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.04 1.336 . . . . 0.0 111.477 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -148.33 157.24 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.994 1.317 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.551 HG21 HG21 ' A' ' 117' ' ' VAL . 37.2 mm -123.7 123.01 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.833 1.253 . . . . 0.0 108.62 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -118.43 122.52 42.96 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.49 0.716 . . . . 0.0 110.289 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 157' ' ' MET . 25.2 pt -105.72 132.89 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.449 1.099 . . . . 0.0 108.829 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.7 p -150.93 163.71 38.06 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.316 0.647 . . . . 0.0 110.645 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.229 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.209 0.077 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.03 -33.37 59.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.745 0.818 . . . . 0.0 111.9 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.46 169.81 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.337 1.065 . . . . 0.0 110.982 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.6 -30.48 9.59 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.643 1.592 . . . . 0.0 111.567 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.5 p -144.87 146.08 31.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.656 1.728 . . . . 0.0 111.966 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mm -139.71 156.39 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.6 1.16 . . . . 0.0 110.839 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.21 163.32 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.431 1.493 . . . . 0.0 111.984 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.48 -29.43 58.74 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.48 -15.47 3.89 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.267 1.889 . . . . 0.0 112.327 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.99 -28.85 69.32 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.414 1.485 . . . . 0.0 114.115 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 m -119.88 3.25 11.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.898 1.679 . . . . 0.0 113.848 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -78.36 133.02 37.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.439 1.096 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m -150.48 147.88 28.04 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.637 1.175 . . . . 0.0 109.196 175.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.16 -32.91 56.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.217 0.917 . . . . 0.0 113.202 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -60.99 -48.4 82.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.89 1.276 . . . . 0.0 113.509 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.07 -45.2 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 121.559 -0.713 . . . . 0.0 110.602 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -53.24 -37.59 62.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.956 1.303 . . . . 0.0 112.125 -176.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -52.03 -67.2 0.27 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.436 2.295 . . . . 0.0 110.871 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -38.16 79.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.834 0.854 . . . . 0.0 112.056 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.2 -48.64 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.235 1.379 . . . . 0.0 111.435 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.663 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -75.18 -27.27 59.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.322 1.049 . . . . 0.0 113.44 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.37 -35.14 54.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 116.986 -1.483 . . . . 0.0 112.41 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -45.3 -27.77 0.71 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.71 2.804 . . . . 0.0 114.52 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -52.1 -37.03 52.72 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.963 0.905 . . . . 0.0 111.41 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.83 -164.34 10.33 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.073 2.273 . . . . 0.0 112.488 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -141.42 52.1 1.55 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.243 1.417 . . . . 0.0 112.586 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 m -136.01 169.46 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.413 1.485 . . . . 0.0 112.657 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 m -64.4 -2.97 2.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.265 1.826 . . . . 0.0 115.138 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.86 130.22 55.02 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.469 1.508 . . . . 0.0 109.071 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 138.37 20.32 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.007 1.323 . . . . 0.0 110.766 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -132.12 137.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.541 1.136 . . . . 0.0 112.194 175.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.663 ' HB2' ' CB ' ' A' ' 21' ' ' LEU . . . -126.27 116.49 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.549 2.339 . . . . 0.0 110.564 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.19 127.95 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 120.819 -1.176 . . . . 0.0 110.739 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.21 170.88 43.24 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 121.969 -0.457 . . . . 0.0 113.699 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.34 126.57 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.509 1.523 . . . . 0.0 110.108 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -77.53 108.0 10.38 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.523 -1.36 . . . . 0.0 112.125 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.89 93.73 9.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.211 1.404 . . . . 0.0 113.258 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.19 18.5 2.6 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 120.799 -1.188 . . . . 0.0 112.644 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 -7.8 59.5 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.5 7.61 71.95 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.657 1.123 . . . . 0.0 115.44 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.58 100.01 0.38 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.778 1.656 . . . . 0.0 111.891 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.7 m -52.18 124.44 13.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.784 2.033 . . . . 0.0 113.108 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.603 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 7.5 m0 -90.8 168.03 12.03 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.521 -0.737 . . . . 0.0 112.783 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -140.37 111.83 7.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.179 2.192 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . . . -66.21 162.51 19.76 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.068 -1.02 . . . . 0.0 111.975 174.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -133.41 -64.56 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.628 1.171 . . . . 0.0 112.587 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -145.87 167.41 23.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.858 0.863 . . . . 0.0 111.533 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.3 134.46 31.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.816 1.247 . . . . 0.0 111.622 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -117.19 118.0 31.13 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.038 1.735 . . . . 0.0 109.749 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 118.86 25.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.372 2.269 . . . . 0.0 109.265 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.28 -30.54 11.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.206 1.403 . . . . 0.0 112.452 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -120.41 107.37 12.83 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.448 1.499 . . . . 0.0 108.447 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.99 123.09 3.35 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.524 1.059 . . . . 0.0 113.666 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -95.91 100.96 12.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.426 1.49 . . . . 0.0 109.515 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -67.68 168.99 10.22 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -138.92 0.32 1.96 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.936 1.695 . . . . 0.0 113.071 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG23 ' CE1' ' A' ' 71' ' ' TYR . 33.2 m -90.09 156.12 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.747 -1.221 . . . . 0.0 111.876 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.41 128.11 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.863 1.265 . . . . 0.0 112.537 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 tp -80.79 130.1 65.36 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 108.968 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.657 ' CG ' HD12 ' A' ' 69' ' ' LEU . 56.9 Cg_endo -65.51 123.35 11.31 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.79 2.993 . . . . 0.0 111.184 175.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.65 -53.39 9.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.73 0.812 . . . . 0.0 112.96 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -114.58 157.35 23.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.165 0.986 . . . . 0.0 111.449 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.71 87.98 11.04 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 124.024 0.93 . . . . 0.0 108.843 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.65 159.21 54.59 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.849 1.699 . . . . 0.0 111.183 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -58.47 158.49 7.46 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.718 -0.613 . . . . 0.0 111.035 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 6.9 p 58.17 42.47 22.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.223 1.409 . . . . 0.0 112.157 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -155.65 163.9 39.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.475 1.91 . . . . 0.0 111.762 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.06 -174.73 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.789 0.804 . . . . 0.0 109.422 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 ' CG ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -157.52 154.52 28.75 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.542 -0.724 . . . . 0.0 111.425 176.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mt -136.15 164.42 28.07 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.901 0.881 . . . . 0.0 111.348 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' A' ' 57' ' ' VAL . 1.2 t80 -136.71 163.55 30.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.797 1.239 . . . . 0.0 109.698 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -131.01 172.36 12.17 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.3 1.84 . . . . 0.0 109.245 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.65 117.02 0.83 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-O 118.706 -1.052 . . . . 0.0 111.568 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 93.1 mtm-85 -140.47 -172.37 3.42 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.253 1.421 . . . . 0.0 111.135 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.38 77.44 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.228 2.211 . . . . 0.0 113.304 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.87 -8.95 59.72 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.483 1.513 . . . . 0.0 112.99 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t -144.57 11.16 1.45 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.471 1.508 . . . . 0.0 114.448 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.42 40.78 47.21 Favored Glycine 0 CA--C 1.551 2.293 0 C-N-CA 125.294 1.426 . . . . 0.0 115.941 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.27 -32.44 16.45 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 124.242 3.295 . . . . 0.0 114.417 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -133.05 161.45 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.011 2.124 . . . . 0.0 109.94 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.48 -56.69 8.92 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.409 1.484 . . . . 0.0 112.578 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -158.6 140.9 14.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.804 2.042 . . . . 0.0 111.354 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.748 ' HA3' HG21 ' A' ' 104' ' ' VAL . . . 72.27 -169.25 51.65 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.359 1.457 . . . . 0.0 115.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . -137.31 161.59 35.84 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.821 1.648 . . . . 0.0 114.14 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -155.37 119.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.609 1.963 . . . . 0.0 109.034 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.12 171.65 16.54 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.205 1.402 . . . . 0.0 109.119 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 127.67 6.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -131.1 165.09 24.03 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.007 0.923 . . . . 0.0 111.309 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -125.61 148.66 48.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.7 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 26.3 m-85 -123.36 120.09 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.216 1.406 . . . . 0.0 110.528 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.457 ' HB2' HD22 ' A' ' 46' ' ' LEU . 8.3 t80 -71.73 102.35 2.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 0.0 110.23 175.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.4 mtp -66.11 152.35 44.91 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 0.0 111.893 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -56.57 -30.65 63.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.489 1.116 . . . . 0.0 113.423 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.4 p -65.27 -11.9 46.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.966 2.106 . . . . 0.0 115.157 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 18.8 41.89 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.519 1.057 . . . . 0.0 114.579 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -111.68 167.6 10.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.762 1.625 . . . . 0.0 110.804 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.514 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 59.1 m -128.94 101.06 5.9 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.233 -0.917 . . . . 0.0 112.767 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 173' ' ' ILE . 9.6 tp -71.64 116.34 11.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.749 0.82 . . . . 0.0 110.97 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.34 105.11 3.22 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.208 0.909 . . . . 0.0 111.876 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.04 156.32 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 0.0 110.152 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.587 ' HB3' HD13 ' A' ' 134' ' ' LEU . 2.2 ppp? -136.57 162.85 31.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.759 1.224 . . . . 0.0 109.046 175.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -162.97 155.55 18.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.112 0.565 . . . . 0.0 111.022 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 t -153.53 164.01 38.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 110.645 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.748 HG21 ' HA3' ' A' ' 83' ' ' GLY . 9.2 m -105.02 146.64 33.06 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.493 1.117 . . . . 0.0 112.367 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.24 99.54 1.13 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.033 3.155 . . . . 0.0 112.055 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.64 26.79 0.74 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -126.25 82.54 2.08 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.174 -1.579 . . . . 0.0 111.478 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -59.6 -24.96 64.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.08 -30.76 68.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.071 1.348 . . . . 0.0 112.039 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -108.02 155.1 20.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.054 1.741 . . . . 0.0 110.386 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.94 155.92 17.68 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.309 -0.87 . . . . 0.0 111.013 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.2 m 55.15 -163.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.138 1.375 . . . . 0.0 112.326 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.36 149.53 52.0 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.512 -1.367 . . . . 0.0 110.216 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -84.38 142.54 30.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.331 1.452 . . . . 0.0 113.146 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.01 146.2 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -163.17 152.88 15.4 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.106 0.962 . . . . 0.0 112.957 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.563 ' O ' HD11 ' A' ' 151' ' ' LEU . 49.7 t -138.9 140.84 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.031 0.932 . . . . 0.0 109.258 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -145.32 133.97 22.16 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.164 1.386 . . . . 0.0 109.387 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.3 mt -95.61 110.17 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 124.869 1.267 . . . . 0.0 108.496 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -76.21 96.26 3.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.3 p -55.69 119.42 5.69 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.82 -111.61 3.04 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 143.0 27.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.549 1.14 . . . . 0.0 112.281 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -158.87 117.53 2.97 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.657 1.583 . . . . 0.0 111.902 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 166.74 22.46 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.745 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 115.52 20.04 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.198 0.599 . . . . 0.0 110.535 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.21 -173.14 4.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.789 1.236 . . . . 0.0 111.872 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -50.73 -49.43 57.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.136 0.974 . . . . 0.0 111.732 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.73 -36.87 50.31 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.597 1.094 . . . . 0.0 113.683 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.72 -63.25 1.11 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.106 0.962 . . . . 0.0 110.425 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -51.61 -34.14 36.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.271 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -64.73 -47.86 76.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.645 1.178 . . . . 0.0 110.627 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.08 -25.25 66.93 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.11 -1.619 . . . . 0.0 113.401 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 101' ' ' MET . 70.2 mt -83.48 -12.2 56.59 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.857 1.663 . . . . 0.0 114.941 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -124.16 -32.6 3.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.93 1.292 . . . . 0.0 114.094 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -114.87 -23.75 8.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.883 1.673 . . . . 0.0 112.778 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.93 -85.87 0.03 OUTLIER Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.251 1.881 . . . . 0.0 112.21 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -164.07 63.35 1.13 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.643 1.577 . . . . 0.0 112.15 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.15 178.32 7.45 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.896 2.398 . . . . 0.0 115.706 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.57 -171.07 2.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.539 1.936 . . . . 0.0 113.819 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -139.2 146.58 40.7 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.535 1.934 . . . . 0.0 111.365 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.65 -57.74 0.46 Allowed Glycine 0 N--CA 1.479 1.554 0 C-N-CA 124.503 1.049 . . . . 0.0 115.664 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.1 t0 52.86 68.62 0.8 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.826 1.651 . . . . 0.0 114.431 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.312 0.1 OUTLIER 40.95 69.05 0.37 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.122 2.169 . . . . 0.0 114.441 176.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -171.92 119.75 0.8 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.213 1.863 . . . . 0.0 111.496 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CZ3' ' HB ' ' A' ' 160' ' ' ILE . 8.2 m95 -57.78 132.89 54.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.159 0.983 . . . . 0.0 112.028 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -147.9 125.06 11.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.293 1.037 . . . . 0.0 112.364 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.01 137.47 49.99 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.895 1.678 . . . . 0.0 109.859 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 151.77 40.25 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.111 0.965 . . . . 0.0 110.877 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -74.53 93.94 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.682 HD13 ' SD ' ' A' ' 157' ' ' MET . 6.8 tp -48.62 -30.46 5.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.58 31.59 2.12 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.81 -27.36 1.15 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 150.45 -15.35 0.96 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.594 1.092 . . . . 0.0 114.675 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.49 171.64 13.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.647 1.579 . . . . 0.0 111.208 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.44 157.11 24.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.515 1.126 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -134.94 164.65 27.13 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.637 0.775 . . . . 0.0 109.447 174.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -133.2 122.8 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.924 1.69 . . . . 0.0 108.757 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -111.43 143.76 17.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.564 0.602 . . . . 0.0 113.19 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.4 ' HB ' ' CZ3' ' A' ' 146' ' ' TRP . 4.8 tp -122.11 143.84 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.514 1.526 . . . . 0.0 110.222 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 9.6 tpt -132.44 124.9 29.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.122 1.369 . . . . 0.0 109.458 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.9 p -128.96 135.53 49.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.933 0.893 . . . . 0.0 110.82 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -97.43 178.31 5.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.666 1.986 . . . . 0.0 112.135 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.05 -171.04 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.045 2.138 . . . . 0.0 112.132 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.66 174.67 45.25 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 47.43 21.78 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.472 1.909 . . . . 0.0 116.137 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.24 150.27 45.5 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.503 1.921 . . . . 0.0 113.079 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 39.3 tptt -164.63 154.41 13.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.053 1.341 . . . . 0.0 113.654 175.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.55 138.7 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.333 2.253 . . . . 0.0 112.448 174.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -143.11 161.45 38.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.22 1.808 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 mm -126.44 117.11 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.436 1.095 . . . . 0.0 109.96 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -96.24 117.16 30.23 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.534 1.134 . . . . 0.0 108.181 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.673 HD13 HD22 ' A' ' 98' ' ' LEU . 4.3 pt -109.88 130.9 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.31 142.93 2.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.736 0.814 . . . . 0.0 112.342 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.49 1.516 . . . . 0.0 113.435 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.831 0.348 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.02 -54.38 6.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.313 1.045 . . . . 0.0 113.372 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 142.95 33.56 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.343 0.592 . . . . 0.0 110.875 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.63 -21.81 13.84 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.249 1.88 . . . . 0.0 112.242 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -150.67 155.64 39.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.699 1.999 . . . . 0.0 112.005 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -140.82 167.91 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.93 1.692 . . . . 0.0 111.17 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -169.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.301 1.841 . . . . 0.0 111.04 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.72 -41.98 5.14 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.01 -32.55 5.42 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.161 1.362 . . . . 0.0 112.84 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.87 74.7 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 118.437 1.119 . . . . 0.0 111.608 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -85.39 -5.33 59.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.107 1.763 . . . . 0.0 113.778 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 13' ' ' THR . 5.0 tt -65.46 137.33 57.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.089 0.956 . . . . 0.0 109.914 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -141.55 146.01 35.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.322 1.049 . . . . 0.0 109.799 179.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -54.87 -32.8 61.18 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.888 0.767 . . . . 0.0 112.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -56.6 -56.45 21.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.452 1.101 . . . . 0.0 112.702 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -64.56 -49.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -57.83 -19.17 26.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.237 1.415 . . . . 0.0 113.523 -177.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -82.59 -47.92 11.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.973 2.109 . . . . 0.0 111.514 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -33.25 73.14 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.546 -1.346 . . . . 0.0 110.84 174.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -45.69 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.493 1.517 . . . . 0.0 112.821 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 32' ' ' ALA . 0.5 OUTLIER -71.95 -33.53 68.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.819 0.448 . . . . 0.0 111.259 175.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.85 -23.04 58.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.77 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -47.38 -25.22 0.96 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.813 2.045 . . . . 0.0 113.19 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.51 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.7 tp -51.68 -27.11 10.63 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.164 1.786 . . . . 0.0 112.33 175.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.39 -136.08 2.17 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.919 1.724 . . . . 0.0 112.819 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -141.53 43.03 1.75 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 126.644 1.978 . . . . 0.0 113.2 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.69 159.12 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.233 1.813 . . . . 0.0 112.428 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.76 -26.56 59.86 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -69.43 82.87 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.962 1.305 . . . . 0.0 112.859 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 161.95 40.6 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.023 -1.048 . . . . 0.0 113.095 -176.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -134.41 139.55 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 112.313 177.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -117.83 98.93 6.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.365 2.266 . . . . 0.0 110.891 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 34' ' ' GLY . 14.0 p -125.33 159.3 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.796 -1.19 . . . . 0.0 110.881 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 33' ' ' VAL . . . 169.3 -176.34 43.35 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-O 121.36 0.422 . . . . 0.0 112.079 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.494 HG21 HD23 ' A' ' 98' ' ' LEU . 4.0 mp -138.39 144.7 29.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 124.022 0.929 . . . . 0.0 110.703 -175.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.17 106.05 16.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.508 1.523 . . . . 0.0 112.006 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 p-10 -93.45 107.66 19.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.676 1.59 . . . . 0.0 111.963 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -136.84 10.27 3.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.302 1.441 . . . . 0.0 112.206 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -8.66 55.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.656 1.582 . . . . 0.0 115.13 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.05 28.38 41.63 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.611 1.101 . . . . 0.0 114.419 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.12 128.15 3.47 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 126.005 1.764 . . . . 0.0 111.206 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 m -58.22 147.6 29.89 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.315 1.446 . . . . 0.0 111.35 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.712 ' CZ2' HD11 ' A' ' 173' ' ' ILE . 45.9 m0 -110.72 173.48 6.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.875 -1.141 . . . . 0.0 112.966 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -153.63 98.78 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.573 1.549 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . . . -72.67 137.34 45.96 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.005 -1.684 . . . . 0.0 110.603 175.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.76 -64.35 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.409 0.684 . . . . 0.0 111.224 178.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -154.26 -171.82 4.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.494 1.918 . . . . 0.0 110.885 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.23 134.77 29.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.033 1.333 . . . . 0.0 111.886 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -110.3 131.0 55.44 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.832 1.253 . . . . 0.0 109.915 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB3' ' CB ' ' A' ' 86' ' ' ALA . 14.9 p90 -153.0 162.29 41.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.069 1.348 . . . . 0.0 111.377 174.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -124.58 -56.67 1.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.143 1.377 . . . . 0.0 109.885 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.6 m -91.83 113.3 25.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.111 0.965 . . . . 0.0 110.559 177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.09 115.78 3.71 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.55 HG21 ' HB3' ' A' ' 76' ' ' ASP . 5.3 t -76.17 -179.76 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.911 1.284 . . . . 0.0 112.238 176.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.4 p -79.6 163.36 24.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 112.184 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -154.74 -35.65 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.981 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 160.25 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.59 1.956 . . . . 0.0 109.709 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 tt -80.32 133.89 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.85 0.86 . . . . 0.0 110.743 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.7 tp -80.88 128.33 71.83 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.05 163.77 27.45 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.347 2.031 . . . . 0.0 111.132 175.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.9 pt-20 -112.6 -66.05 1.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.514 1.126 . . . . 0.0 110.356 178.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.6 126.74 44.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.975 0.91 . . . . 0.0 109.819 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -114.32 129.91 24.45 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.593 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.26 -172.51 0.44 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.044 3.829 . . . . 0.0 113.204 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -82.06 153.01 26.35 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 119.685 -1.884 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.9 p 49.83 42.15 23.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.618 1.567 . . . . 0.0 114.736 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -156.0 122.6 5.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 126.067 1.747 . . . . 0.0 113.875 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -177.86 6.82 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.497 1.519 . . . . 0.0 114.125 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -143.27 152.37 41.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.244 1.418 . . . . 0.0 110.633 174.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -123.52 164.18 19.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -136.53 166.78 22.7 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.089 1.755 . . . . 0.0 110.539 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.6 p -138.71 168.5 19.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.297 1.439 . . . . 0.0 111.098 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.89 165.97 36.63 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.337 0.97 . . . . 0.0 111.569 174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -143.49 171.46 14.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.981 1.313 . . . . 0.0 112.082 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -94.87 80.84 3.72 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.267 1.427 . . . . 0.0 113.556 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.55 ' HB3' HG21 ' A' ' 54' ' ' THR . 1.4 t70 -122.21 -11.72 8.38 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.74 13.73 1.35 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.761 1.224 . . . . 0.0 113.286 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.49 -95.46 0.3 Allowed Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.85 -1.156 . . . . 0.0 113.683 -176.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.87 -25.53 12.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.268 1.978 . . . . 0.0 113.507 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.343 12.4 p 49.95 -1.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 130.189 3.395 . . . . 0.0 117.347 -176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.94 19.53 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 128.822 2.849 . . . . 0.0 113.317 -175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -144.43 -178.72 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.911 1.685 . . . . 0.0 111.591 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 82' ' ' THR . . . -73.73 145.68 35.8 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.103 1.335 . . . . 0.0 114.382 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 151.95 40.23 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.321 1.048 . . . . 0.0 111.337 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.6 105.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.77 2.428 . . . . 0.0 110.59 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -135.06 156.21 49.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.287 1.041 . . . . 0.0 110.897 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 134' ' ' LEU . . . -145.29 111.65 5.71 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.517 1.127 . . . . 0.0 109.091 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -125.73 154.17 42.87 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.518 1.127 . . . . 0.0 112.074 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.734 ' HB1' HG22 ' A' ' 97' ' ' THR . . . -119.88 140.6 50.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.274 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.66 110.36 19.05 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.712 1.205 . . . . 0.0 110.022 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.618 ' HB2' HD11 ' A' ' 46' ' ' LEU . 11.2 t80 -68.72 96.0 0.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.253 1.421 . . . . 0.0 110.41 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.4 ttt -62.95 146.91 51.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.038 1.735 . . . . 0.0 111.522 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 t -53.27 -23.65 9.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.648 1.179 . . . . 0.0 114.118 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.5 m -67.42 0.5 2.91 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.0 31.87 54.41 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.388 0.994 . . . . 0.0 112.125 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -124.15 166.52 15.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.486 1.914 . . . . 0.0 109.649 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.734 HG22 ' HB1' ' A' ' 89' ' ' ALA . 10.5 m -137.83 101.05 4.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.159 -0.963 . . . . 0.0 111.697 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 HG21 ' A' ' 35' ' ' ILE . 13.1 tp -69.77 112.72 6.42 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.345 -0.847 . . . . 0.0 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.5 102.97 2.99 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.705 1.145 . . . . 0.0 112.782 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.62 151.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.67 0.788 . . . . 0.0 111.699 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.544 ' HB2' HD13 ' A' ' 134' ' ' LEU . 6.3 ttp -134.54 150.65 50.77 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.385 1.474 . . . . 0.0 111.642 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 4.6 p90 -162.34 151.37 15.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.341 1.057 . . . . 0.0 110.78 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -158.35 126.86 5.42 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 110.447 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.12 128.4 60.17 Favored Pre-proline 0 N--CA 1.48 1.049 0 O-C-N 121.209 -0.932 . . . . 0.0 111.2 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.79 167.59 25.34 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.802 3.002 . . . . 0.0 112.529 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.64 22.32 0.46 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.8 t70 87.18 126.98 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.101 2.96 . . . . 0.0 110.191 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.57 168.38 18.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.771 1.228 . . . . 0.0 111.669 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -58.26 -61.78 2.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.827 0.851 . . . . 0.0 111.02 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -168.77 90.6 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.811 1.644 . . . . 0.0 110.998 175.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.33 136.49 16.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.433 -0.792 . . . . 0.0 111.757 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -169.77 1.42 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.867 0.841 . . . . 0.0 110.615 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 131.11 35.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.726 1.21 . . . . 0.0 112.462 -175.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -97.67 131.16 44.48 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.078 0.951 . . . . 0.0 112.447 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.6 129.19 15.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.159 0.981 . . . . 0.0 109.941 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -160.73 107.76 1.52 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 m -115.83 161.5 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.368 0.667 . . . . 0.0 109.337 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.635 ' HA ' HD21 ' A' ' 151' ' ' LEU . 28.1 tttt -154.65 154.48 33.03 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.06 0.544 . . . . 0.0 111.367 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.578 HD12 HD22 ' A' ' 151' ' ' LEU . 5.3 mp -107.66 110.19 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.991 0.916 . . . . 0.0 109.869 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.64 92.74 1.98 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.829 1.652 . . . . 0.0 109.919 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.6 t -68.78 81.08 0.29 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.567 -1.333 . . . . 0.0 111.497 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.13 -99.12 0.13 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.453 1.978 . . . . 0.0 112.354 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -165.33 104.19 0.74 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.911 1.684 . . . . 0.0 110.832 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -149.86 103.44 3.22 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 172.26 1.75 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.16 1.384 . . . . 0.0 112.386 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.39 119.96 19.3 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.62 -0.675 . . . . 0.0 112.184 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.62 -173.29 3.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.579 1.551 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -51.06 -52.98 38.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.427 1.091 . . . . 0.0 112.183 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.03 -31.05 64.48 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.769 0.7 . . . . 0.0 113.175 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.7 ttt -65.81 -64.45 0.86 Allowed 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -53.65 -33.67 56.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.026 0.93 . . . . 0.0 112.221 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.48 -49.14 78.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.039 0.936 . . . . 0.0 109.195 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.54 -3.79 19.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 101' ' ' MET . 30.8 mt -102.78 -22.23 13.94 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.91 -25.24 9.52 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.959 -1.088 . . . . 0.0 113.671 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.56 0.85 8.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.408 1.483 . . . . 0.0 112.599 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.99 71.63 0.3 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.401 1.953 . . . . 0.0 114.535 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.27 2.2 m120 85.49 57.49 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 130.203 3.401 . . . . 0.0 112.376 -175.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.91 125.0 14.47 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.763 2.976 . . . . 0.0 112.886 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.58 173.75 6.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.24 1.416 . . . . 0.0 112.82 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.06 142.84 51.43 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.119 1.767 . . . . 0.0 110.212 -174.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -137.09 118.07 1.66 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 121.658 0.588 . . . . 0.0 112.569 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -97.67 26.17 5.26 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.459 2.303 . . . . 0.0 114.528 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 77.12 94.86 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.235 2.614 . . . . 0.0 111.919 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 138.74 2.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.112 1.339 . . . . 0.0 112.862 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.469 ' CE3' ' HB ' ' A' ' 160' ' ' ILE . 22.4 m95 -64.59 130.81 45.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.487 1.515 . . . . 0.0 112.037 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -145.25 119.27 9.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.416 1.486 . . . . 0.0 112.114 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.91 143.02 27.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.546 1.138 . . . . 0.0 111.788 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.32 155.93 29.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.108 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 96.91 2.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.892 0.877 . . . . 0.0 108.923 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 118' ' ' LYS . 2.7 tp -49.82 -49.97 46.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.458 1.103 . . . . 0.0 112.048 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.6 80.12 1.25 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.883 1.706 . . . . 0.0 114.733 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -168.92 -36.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.819 2.047 . . . . 0.0 111.688 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.07 -80.51 0.06 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.372 1.463 . . . . 0.0 113.058 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.07 -179.2 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.786 1.235 . . . . 0.0 112.837 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -117.29 145.35 44.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 0.0 112.169 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.419 ' CB ' HG22 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -135.34 172.32 13.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.069 0.938 . . . . 0.0 112.211 -179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 146' ' ' TRP . 18.4 ttpt -133.18 139.13 46.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.499 1.12 . . . . 0.0 110.263 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -122.55 164.46 15.56 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.233 1.397 . . . . 0.0 113.516 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.469 ' HB ' ' CE3' ' A' ' 146' ' ' TRP . 5.2 tp -139.23 95.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.18 99.04 10.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.861 -1.775 . . . . 0.0 112.351 176.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.71 132.68 56.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.436 1.094 . . . . 0.0 112.725 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 69.4 p -152.86 91.82 1.58 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.395 1.478 . . . . 0.0 112.711 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.9 52.5 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.511 -1.368 . . . . 0.0 111.57 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.8 125.94 1.44 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.252 17.5 pt-20 46.02 36.74 3.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.595 1.558 . . . . 0.0 114.195 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -118.21 162.46 18.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.085 2.154 . . . . 0.0 112.507 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.97 -172.68 4.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.541 1.536 . . . . 0.0 112.991 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -119.24 153.54 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.798 2.039 . . . . 0.0 111.883 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.438 HE22 HD13 ' A' ' 12' ' ' LEU . 31.4 tt0 -136.72 154.72 50.51 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.785 1.634 . . . . 0.0 110.468 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.68 120.19 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 109.731 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -112.08 111.06 21.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.581 1.552 . . . . 0.0 109.707 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.712 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 22.9 pt -97.23 144.3 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.882 1.273 . . . . 0.0 111.761 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.7 p -158.07 151.73 23.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.34 1.056 . . . . 0.0 112.535 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.679 1.591 . . . . 0.0 112.325 -176.138 . . . . . . . . 0 0 . 1 stop_ save_